Psyllid ID: psy6327
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | 2.2.26 [Sep-21-2011] | |||||||
| Q96PF2 | 358 | Testis-specific serine/th | yes | N/A | 0.757 | 0.743 | 0.367 | 4e-46 | |
| O54863 | 358 | Testis-specific serine/th | yes | N/A | 0.757 | 0.743 | 0.353 | 6e-44 | |
| Q61241 | 365 | Testis-specific serine/th | no | N/A | 0.715 | 0.687 | 0.359 | 4e-43 | |
| Q3SZW1 | 367 | Testis-specific serine/th | yes | N/A | 0.715 | 0.683 | 0.359 | 1e-42 | |
| Q925K9 | 273 | Testis-specific serine/th | no | N/A | 0.709 | 0.912 | 0.359 | 5e-41 | |
| Q9BXA7 | 367 | Testis-specific serine/th | no | N/A | 0.715 | 0.683 | 0.355 | 7e-41 | |
| Q9BXA6 | 273 | Testis-specific serine/th | no | N/A | 0.709 | 0.912 | 0.363 | 2e-40 | |
| Q9D2E1 | 268 | Testis-specific serine/th | no | N/A | 0.706 | 0.925 | 0.348 | 8e-39 | |
| Q96PN8 | 268 | Testis-specific serine/th | no | N/A | 0.706 | 0.925 | 0.344 | 3e-38 | |
| Q6SA08 | 328 | Testis-specific serine/th | no | N/A | 0.700 | 0.75 | 0.323 | 9e-38 |
| >sp|Q96PF2|TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 185 bits (470), Expect = 4e-46, Method: Compositional matrix adjust.
Identities = 105/286 (36%), Positives = 166/286 (58%), Gaps = 20/286 (6%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G+Y V +R + A K D K+ D++E+F PRE+DIL V+H +II +
Sbjct: 18 LGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDILATVNHGSIIKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y+IM+ + DL +I C +HE+ AR RQ+++A++Y H++
Sbjct: 78 IFETSDGRIYIIMELGVQGDLLEFIK--CQGALHEDVARKMFRQLSSAVKYCHDL----- 130
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKE---LSNTFCGTTSYAAPE 189
IVHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 131 -----DIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDSNGRIILSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
++++ PY PK+ DIWSLGV+LY ++ P+ D R +L+ Q+ F R ++
Sbjct: 186 VLQSIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIRK--MLRIQKEHRVDFPRSKNLTC 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ-NEPTCQTMTAEEREA 294
K LI RML+P+ R + ++ +H+W+Q +P + + +RE
Sbjct: 244 ECKDLIYRMLQPDVSQRLHIDEILSHSWLQPPKPKATSSASFKREG 289
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates TSKS at 'Ser-288' and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O54863|TSSK2_MOUSE Testis-specific serine/threonine-protein kinase 2 OS=Mus musculus GN=Tssk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 178 bits (451), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 101/286 (35%), Positives = 165/286 (57%), Gaps = 20/286 (6%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G+Y V +R + A K D K+ D++E+F PRE+DIL V+H +II +
Sbjct: 18 LGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDILATVNHRSIIKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I C +HE+ AR RQ+++A++Y H++
Sbjct: 78 IFETSDGRIYIVMELGVQGDLLEFIK--CRGALHEDVARKMFRQLSSAVKYCHDL----- 130
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKE---LSNTFCGTTSYAAPE 189
+VHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 131 -----DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDGSGRIVLSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKK--MLRIQKEHRVDFPRSKNLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ-NEPTCQTMTAEEREA 294
K LI R+L+P+ R + ++ +H+W+Q +P + + +RE
Sbjct: 244 ECKDLIYRILQPDVNRRLHIDEILSHSWLQPPKPKAMSSASFKREG 289
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q61241|TSSK1_MOUSE Testis-specific serine/threonine-protein kinase 1 OS=Mus musculus GN=Tssk1b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 175 bits (444), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 97/270 (35%), Positives = 156/270 (57%), Gaps = 19/270 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEG+Y V +R + A K D K+ D++EKF PREI+IL ++H +I+ +
Sbjct: 18 LGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPSDFLEKFLPREIEILAMLNHRSIVKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I + E+ AR + H++++A++
Sbjct: 78 IFETSDGKVYIVMELGVQGDLLEFIK--TRGALQEDDAR----------KKFHQLSSAIK 125
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKE---LSNTFCGTTSYAAPE 189
Y H++ +VHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 126 YCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLILSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKK--MLRIQKEHRVNFPRSKHLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
K LI RML+P+ R + ++ NH W+Q
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEILNHCWVQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus GN=TSSK1B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 97/270 (35%), Positives = 156/270 (57%), Gaps = 19/270 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEG+Y V +R + A K D K+ D++EKF PREI+IL ++H +II +
Sbjct: 18 LGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEILAMLNHRSIIKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I + E+ AR + H++++A++
Sbjct: 78 IFETSDGKVYIVMELGVQGDLLEFIK--TRGALQEDDAR----------KKFHQLSSAIK 125
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPK---ELSNTFCGTTSYAAPE 189
Y H++ +VHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 126 YCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLTLSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKK--MLRIQKEHRVNFPRSKHLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
K LI RML+P+ R + ++ +H W+Q
Sbjct: 244 ECKDLIYRMLQPDVTRRLHIDEILSHCWVQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q925K9|TSSK6_MOUSE Testis-specific serine/threonine-protein kinase 6 OS=Mus musculus GN=Tssk6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 168 bits (426), Expect = 5e-41, Method: Compositional matrix adjust.
Identities = 96/267 (35%), Positives = 148/267 (55%), Gaps = 18/267 (6%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
+GEG+Y V + + K+ + A K D +R D++ KF PRE+ IL V HP+I+ V
Sbjct: 18 IGEGSYSKVKVATSKKYKGTVAIKVVDRRRAPPDFVNKFLPRELSILRGVRHPHIVHVFE 77
Query: 75 MVK-AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
++ LY++M+ A DL + + N I +QAR E +IA A+
Sbjct: 78 FIEVCNGKLYIVME-AAATDLLQAVQR--NGRIPGSQAR----------ELFSQIAGAVR 124
Query: 134 YLHEVGIVHRDIKCENILIS-RLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR 192
YLH+ +VHRD+KCEN+L+S K+ DFGF R +LS T+CG+ +YA+PE++
Sbjct: 125 YLHDHHLVHRDLKCENVLLSPDERRVKITDFGFGRQAHGYPDLSTTYCGSAAYASPEVLL 184
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252
PY+PK D+WSLGVVLY ++ PF D L +++ + L+ E+S K
Sbjct: 185 GIPYDPKKYDVWSLGVVLYVMVTGCMPFDDSDIAG---LPRRQKRGVLYPDGLELSERCK 241
Query: 253 QLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
LI +L+ +P RP+A V + W++
Sbjct: 242 SLIAELLQFSPSARPSAGQVARNGWLR 268
|
Required for sperm production and function. Plays a role in DNA condensation during postmeiotic chromatin remodeling. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA7|TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 168 bits (425), Expect = 7e-41, Method: Compositional matrix adjust.
Identities = 96/270 (35%), Positives = 155/270 (57%), Gaps = 19/270 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEG+Y V +R + A K D K+ D++EKF PREI+IL ++H +II +
Sbjct: 18 LGEGSYAKVKSAYSERLKFNVAIKIIDRKKAPADFLEKFLPREIEILAMLNHCSIIKTYE 77
Query: 75 MVKAG-TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ A + DL I +HE++AR + H+++ A++
Sbjct: 78 IFETSHGKVYIVMELAVQGDLLELIK--TRGALHEDEAR----------KKFHQLSLAIK 125
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPK---ELSNTFCGTTSYAAPE 189
Y H++ +VHRD+KC+N+L+ + N KL+DF FS R LR LS TFCG+ +YAAPE
Sbjct: 126 YCHDLDVVHRDLKCDNLLLDKDFNIKLSDFSFSKRCLRDDSGRMALSKTFCGSPAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKK--MLRIQKEHRVNFPRSKHLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
K LI ML+P+ R + ++ +H W+Q
Sbjct: 244 ECKDLIYHMLQPDVNRRLHIDEILSHCWMQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA6|TSSK6_HUMAN Testis-specific serine/threonine-protein kinase 6 OS=Homo sapiens GN=TSSK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 166 bits (420), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 97/267 (36%), Positives = 147/267 (55%), Gaps = 18/267 (6%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
+GEG+Y V + + K+ + A K D +R D++ KF PRE+ IL V HP+I+ V
Sbjct: 18 IGEGSYSKVKVATSKKYKGTVAIKVVDRRRAPPDFVNKFLPRELSILRGVRHPHIVHVFE 77
Query: 75 MVK-AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
++ LY++M+ A DL + + N I QAR QIA A+ YLH+
Sbjct: 78 FIEVCNGKLYIVME-AAATDLLQAVQR--NGRIPGVQARDLFAQIAGAVRYLHD------ 128
Query: 134 YLHEVGIVHRDIKCENILIS-RLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR 192
H +VHRD+KCEN+L+S KL DFGF R +LS T+CG+ +YA+PE++
Sbjct: 129 --HH--LVHRDLKCENVLLSPDERRVKLTDFGFGRQAHGYPDLSTTYCGSAAYASPEVLL 184
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252
PY+PK D+WS+GVVLY ++ PF D L +++ + L+ E+S K
Sbjct: 185 GIPYDPKKYDVWSMGVVLYVMVTGCMPFDDSDIAG---LPRRQKRGVLYPEGLELSERCK 241
Query: 253 QLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
LI +L+ +P RP+A V + W++
Sbjct: 242 ALIAELLQFSPSARPSAGQVARNCWLR 268
|
Required for sperm production and function. Plays a role in DNA condensation during postmeiotic chromatin remodeling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9D2E1|TSSK3_MOUSE Testis-specific serine/threonine-protein kinase 3 OS=Mus musculus GN=Tssk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (407), Expect = 8e-39, Method: Compositional matrix adjust.
Identities = 94/270 (34%), Positives = 150/270 (55%), Gaps = 22/270 (8%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
+GEG Y V K+ + A K D +++++F PRE+ I+ + H NII V+
Sbjct: 16 IGEGTYSKVKEAFSKKHQRKVAIKIIDKMGGPEEFIQRFLPRELQIVRTLDHKNIIQVYE 75
Query: 75 MVK-AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
M++ A +Y++M+ AE D+ + + E++A+ RQ+ A+ Y H
Sbjct: 76 MLESADGKIYLVMELAEGGDVFDCVLNG--GPLPESRAKALFRQMVEAIRYCHG------ 127
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL-RTPKELSNTFCGTTSYAAPEIIR 192
G+ HRD+KCEN L+ N KL DFGF+++L ++ +ELS TFCG+T+YAAPE+++
Sbjct: 128 ----CGVAHRDLKCENALLQGF-NLKLTDFGFAKVLPKSRRELSQTFCGSTAYAAPEVLQ 182
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK--QEGKEYLFNRKYEISIG 250
P++ K D+WS+GVVLY +L PF D D+ K Q+ K F IS
Sbjct: 183 GIPHDSKKGDVWSMGVVLYVMLCASLPFDD-----TDIPKMLWQQQKGVSFPTHLGISTE 237
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ L+ R+LEP+ RP+ ++V H W+ +
Sbjct: 238 CQDLLKRLLEPDMILRPSIEEVSWHPWLAS 267
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PN8|TSSK3_HUMAN Testis-specific serine/threonine-protein kinase 3 OS=Homo sapiens GN=TSSK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (402), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 93/270 (34%), Positives = 149/270 (55%), Gaps = 22/270 (8%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
+GEG Y V K+ + A K D +++++F PRE+ I+ + H NII V+
Sbjct: 16 IGEGTYSKVKEAFSKKHQRKVAIKVIDKMGGPEEFIQRFLPRELQIVRTLDHKNIIQVYE 75
Query: 75 MVK-AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
M++ A + ++M+ AE D+ + + E++A+ RQ+ A+ Y H
Sbjct: 76 MLESADGKICLVMELAEGGDVFDCVLNG--GPLPESRAKALFRQMVEAIRYCHG------ 127
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL-RTPKELSNTFCGTTSYAAPEIIR 192
G+ HRD+KCEN L+ N KL DFGF+++L ++ +ELS TFCG+T+YAAPE+++
Sbjct: 128 ----CGVAHRDLKCENALLQGF-NLKLTDFGFAKVLPKSHRELSQTFCGSTAYAAPEVLQ 182
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK--QEGKEYLFNRKYEISIG 250
P++ K D+WS+GVVLY +L PF D D+ K Q+ K F IS
Sbjct: 183 GIPHDSKKGDVWSMGVVLYVMLCASLPFDD-----TDIPKMLWQQQKGVSFPTHLSISAD 237
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ L+ R+LEP+ RP+ ++V H W+ +
Sbjct: 238 CQDLLKRLLEPDMILRPSIEEVSWHPWLAS 267
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6SA08|TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (398), Expect = 9e-38, Method: Compositional matrix adjust.
Identities = 91/281 (32%), Positives = 149/281 (53%), Gaps = 35/281 (12%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
+G G+YG+VY + + + A K K+ DY+ KF PREI ++ + H +I +R
Sbjct: 31 IGHGSYGSVYEAFYTKQKVMVAVKIISKKKASDDYLNKFLPREIQVMKVLRHKYLINFYR 90
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISK--ACNENIHENQARIWIRQIANALEYLHEIANAL 132
+++ + +Y+I++ A+ D+ +I + AC+E + A W Q+ + YLH +
Sbjct: 91 AIESTSRVYIILELAQGGDVLEWIQRYGACSEPL----AGKWFSQLTLGIAYLHSKS--- 143
Query: 133 EYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK---------------ELSN 177
IVHRD+K EN+L+ + N K++DFGF++++ + + LS
Sbjct: 144 -------IVHRDLKLENLLLDKWENVKISDFGFAKMVPSNQPVGCSPSYRQVNCFSHLSQ 196
Query: 178 TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237
T+CG+ +YA PEI+R PYNP L+D WS+GV+LY ++ PF D N L ++ K
Sbjct: 197 TYCGSFAYACPEILRGLPYNPFLSDTWSMGVILYTLVVAHLPFDD---TNLKKLLRETQK 253
Query: 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
E F + IS K LI +ML K R D+ +W+
Sbjct: 254 EVTFPANHTISQECKNLILQMLRQATK-RATILDIIKDSWV 293
|
May be involved in a signaling pathway during male germ cell development or mature sperm function (By similarity). Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | ||||||
| 328777814 | 375 | PREDICTED: testis-specific serine/threon | 0.817 | 0.765 | 0.424 | 1e-62 | |
| 383859254 | 359 | PREDICTED: testis-specific serine/threon | 0.857 | 0.838 | 0.414 | 1e-60 | |
| 350411528 | 365 | PREDICTED: testis-specific serine/threon | 0.772 | 0.742 | 0.427 | 5e-60 | |
| 340729810 | 365 | PREDICTED: testis-specific serine/threon | 0.772 | 0.742 | 0.423 | 1e-59 | |
| 242018660 | 347 | cAMP-dependent protein kinase catalytic | 0.766 | 0.775 | 0.430 | 3e-59 | |
| 357624074 | 684 | hypothetical protein KGM_12206 [Danaus p | 0.851 | 0.437 | 0.407 | 1e-58 | |
| 307191145 | 375 | Testis-specific serine/threonine-protein | 0.763 | 0.714 | 0.412 | 8e-56 | |
| 322799279 | 388 | hypothetical protein SINV_14525 [Solenop | 0.811 | 0.734 | 0.394 | 1e-55 | |
| 357608284 | 344 | hypothetical protein KGM_17405 [Danaus p | 0.717 | 0.732 | 0.407 | 2e-55 | |
| 332016294 | 380 | Testis-specific serine/threonine-protein | 0.794 | 0.734 | 0.390 | 1e-53 |
| >gi|328777814|ref|XP_395507.4| PREDICTED: testis-specific serine/threonine-protein kinase 1-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 246 bits (628), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 132/311 (42%), Positives = 189/311 (60%), Gaps = 24/311 (7%)
Query: 11 YISKLGEGAYGNVYLV-----SDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS 65
++ KLGEGAY VYL SD + ACK D +D++ KF PRE+DIL+K++
Sbjct: 21 FLKKLGEGAYAKVYLAEYKPESDPEKNSTLACKVIDTGVAPKDFVRKFLPRELDILVKLN 80
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
HP+++ VH + + T Y+ M YAE DL +I K N + E QAR+W RQ+A L+YL
Sbjct: 81 HPHVVHVHSIFQRRTKYYIFMRYAENGDLLEFILK--NGAVAEGQARVWFRQLALGLQYL 138
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL---RTPKELSNTFCGT 182
HE+ I HRD+KCEN+L++ LN KLADFGF+R + R + +S+T+CG+
Sbjct: 139 HEME----------IAHRDMKCENVLLTSNLNVKLADFGFARYVIDNRGKRVMSDTYCGS 188
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
SYAAPEI+R SPYNPK+AD+WSLGV+LY +LNK PF D T + + ++Q +++ F
Sbjct: 189 LSYAAPEILRASPYNPKIADLWSLGVILYILLNKSMPFDD--TDIKRLYEQQTNRKWKFR 246
Query: 243 RKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKL 300
K +S K+L+ R+LEP+ R V N WI +P +T E+ AL
Sbjct: 247 SKIAETLSDQVKKLVARLLEPDVSKRWKMDQVINSEWIAMDPRLLILTPAEQAALNNAIQ 306
Query: 301 KSKVFMQKYTV 311
+ K F +K++V
Sbjct: 307 EKKKFEEKFSV 317
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383859254|ref|XP_003705110.1| PREDICTED: testis-specific serine/threonine-protein kinase 1-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 239 bits (611), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 138/333 (41%), Positives = 196/333 (58%), Gaps = 32/333 (9%)
Query: 11 YISKLGEGAYGNVYL------VSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV 64
+I KLGEG+Y VYL +R+ TL ACK D +D++ KF PRE+DIL+K+
Sbjct: 21 FIKKLGEGSYAKVYLAEYRPETDPERNNTL-ACKVIDTVNAPKDFVRKFLPRELDILVKL 79
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
+HP+++ VH + + + ++ M YAE DL ++ K N + E QAR+WIRQ+A L+Y
Sbjct: 80 NHPHVVHVHSIFQRRSKYFIFMRYAENGDLLDFVLK--NGAVSEGQARVWIRQLALGLQY 137
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL---RTPKELSNTFCG 181
LHE+ I HRD+KCEN+L++ N KLADFGF+R + R + LS+T+CG
Sbjct: 138 LHEME----------IAHRDMKCENVLLTSNYNVKLADFGFARYVIDNRGKRVLSDTYCG 187
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241
+ SYAAPEI+R SPYNPK+ADIWSLGV+LY +LNK PF D T + + ++Q +++ F
Sbjct: 188 SLSYAAPEILRASPYNPKIADIWSLGVILYILLNKAMPFDD--TDIKSLYEQQTNRKWKF 245
Query: 242 NRKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIG- 298
K +S K+L+ +LEPNP R + N WI +P +T E+ AL
Sbjct: 246 RSKVINSLSDHVKKLVTHLLEPNPHKRWKLNQIINSDWIAMDPRLLVLTPAEQIALNNAI 305
Query: 299 ----KLKSKVFMQKYTVVQALTSSNNVDVTEEN 327
KL+ K F QK + + VDV N
Sbjct: 306 EERKKLEGK-FTQKDPKLFKVEEKKKVDVDPSN 337
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350411528|ref|XP_003489378.1| PREDICTED: testis-specific serine/threonine-protein kinase 1-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 237 bits (605), Expect = 5e-60, Method: Compositional matrix adjust.
Identities = 126/295 (42%), Positives = 179/295 (60%), Gaps = 24/295 (8%)
Query: 11 YISKLGEGAYGNVYLV-----SDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS 65
++ KLGEGAY VYL SD + ACK D +D++ KF PRE+DIL+K++
Sbjct: 21 FLKKLGEGAYAKVYLAEYKPESDPERNSTLACKVIDTGLAPKDFVRKFLPRELDILVKLN 80
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
HP+++ VH + + T ++ M YAE DL +I K N + E QAR+W RQ+A L+YL
Sbjct: 81 HPHVVHVHSIFQRRTKYFIFMRYAENGDLLEFILK--NGAVAEGQARVWFRQLALGLQYL 138
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL---RTPKELSNTFCGT 182
HE+ I HRDIKCEN+L++ N KLADFGF+R + R + LS+T+CG+
Sbjct: 139 HEME----------IAHRDIKCENVLLTSNFNVKLADFGFARYVIDNRGKRVLSDTYCGS 188
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
SYAAPEI+R SPYNPK+AD+WSLGV+LY +LNK PF D T + + ++Q +++ F
Sbjct: 189 LSYAAPEILRASPYNPKIADLWSLGVILYILLNKSMPFDD--TDIKRLYEQQTNRKWKFR 246
Query: 243 RKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREAL 295
K +S K+L+ R+LEP+ R + WI +P +T E+ AL
Sbjct: 247 SKIAETLSEQVKKLVTRLLEPDVSKRWKLDQTLHSEWIAMDPRLLVLTPAEQTAL 301
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340729810|ref|XP_003403188.1| PREDICTED: testis-specific serine/threonine-protein kinase 1-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 236 bits (602), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 125/295 (42%), Positives = 179/295 (60%), Gaps = 24/295 (8%)
Query: 11 YISKLGEGAYGNVYLV-----SDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS 65
++ KLGEGAY VYL SD + ACK D +D++ KF PRE+DIL+K++
Sbjct: 21 FLKKLGEGAYAKVYLAEYKPESDPERNSTLACKVIDTGLAPKDFVRKFLPRELDILVKLN 80
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
HP+++ VH + + T ++ M YAE DL +I K N + E QAR+W RQ+A L+YL
Sbjct: 81 HPHVVHVHSIFQRRTKYFIFMRYAENGDLLEFILK--NGAVAEGQARVWFRQLALGLQYL 138
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL---RTPKELSNTFCGT 182
HE+ I HRD+KCEN+L++ N KLADFGF+R + R + LS+T+CG+
Sbjct: 139 HEME----------IAHRDMKCENVLLTSNFNVKLADFGFARYVIDNRGKRVLSDTYCGS 188
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
SYAAPEI+R SPYNPK+AD+WSLGV+LY +LNK PF D T + + ++Q +++ F
Sbjct: 189 LSYAAPEILRASPYNPKIADLWSLGVILYILLNKSMPFDD--TDIKRLYEQQTNRKWKFR 246
Query: 243 RKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREAL 295
K +S K+L+ R+LEP+ R + WI +P +T E+ AL
Sbjct: 247 SKIAETLSEQVKKLVTRLLEPDVSKRWKLDQTLHSEWIAMDPRLLVLTPAEQTAL 301
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242018660|ref|XP_002429792.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212514804|gb|EEB17054.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 235 bits (599), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 128/297 (43%), Positives = 181/297 (60%), Gaps = 28/297 (9%)
Query: 12 ISKLGEGAYGNVYLV---------SDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILL 62
+ KLGEG+Y VYL S +T ACK D + RD++ KF PRE+DIL+
Sbjct: 24 VKKLGEGSYAKVYLSEYHPVGTNQSSTEHKTQLACKIIDTTKAPRDFVRKFLPRELDILV 83
Query: 63 KVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
K++HP+II VH + + + ++ M +AE DL ++ K N I E+QAR+W+RQ+A L
Sbjct: 84 KLNHPHIIHVHSIFQRRSKYFIFMRFAENGDLLDFVLK--NGAIVESQARVWLRQMALGL 141
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---LSNTF 179
+YLHE+ I HRD+KCENILI+ N KLADFGF+R + K LS T+
Sbjct: 142 QYLHELE----------IAHRDLKCENILITSNYNVKLADFGFARYVVDSKGRRILSETY 191
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239
CG+ SYAAPEI+R +PYNPK++D+WSLGV+LY +LNK PF D T + + ++Q +++
Sbjct: 192 CGSLSYAAPEILRGTPYNPKISDLWSLGVILYIMLNKAMPFDD--TNIKRLYEQQTSRKW 249
Query: 240 LFNRKYE--ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREA 294
F K E ++ AK+L+ MLEP+ R + + N WI +P MT ER A
Sbjct: 250 KFRAKVENILTDQAKKLVTLMLEPDVTKRLSMYQILNSDWIAMDPRLMVMTPAERMA 306
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357624074|gb|EHJ74978.1| hypothetical protein KGM_12206 [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 233 bits (593), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 134/329 (40%), Positives = 193/329 (58%), Gaps = 30/329 (9%)
Query: 15 LGEGAYGNVYLVS-----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
+GEGAY VYL D TL ACK + + +D++ KF PREID+L++++HP++
Sbjct: 25 IGEGAYAKVYLTEYTAREDSNKVTL-ACKIIETSKAPKDFVLKFLPREIDVLIRLNHPHL 83
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
I VH + + T Y+ M Y+E DL Y+ K N + ENQ+R+W+RQ+A L+YLHE+
Sbjct: 84 IHVHSIFQRKTKYYIFMRYSENGDLLGYVLK--NGCVSENQSRVWLRQLALGLQYLHELE 141
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---LSNTFCGTTSYA 186
I HRDIKCEN+L++ N KL+DFGF+R ++ LS T+CG+ SYA
Sbjct: 142 ----------ITHRDIKCENVLLTANFNVKLSDFGFARFCIDDEDQPILSETYCGSMSYA 191
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246
APEI+R PY PK D+WSLGVVL+ +LNK PF D TR R + ++Q GK+Y F +
Sbjct: 192 APEILRGKPYLPKPTDLWSLGVVLFVMLNKSMPFDD--TRMRKLYEQQMGKKYRFRSRVA 249
Query: 247 --ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKV 304
+S+ K L+ +LEP+P R +A + N WI + T+ A E AL+ K+K
Sbjct: 250 TVLSLECKALVKHLLEPDPGLRHSATQILNSDWIAMDSRLTTLNAVEAAALQ----KAKE 305
Query: 305 FMQKYTVVQALTSSNNVDVTE-ENKEKKY 332
QK + + D+ E E++E Y
Sbjct: 306 ERQKLSDIHKGPPKRQGDILEREHRESAY 334
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307191145|gb|EFN74843.1| Testis-specific serine/threonine-protein kinase 1 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 223 bits (569), Expect = 8e-56, Method: Compositional matrix adjust.
Identities = 122/296 (41%), Positives = 175/296 (59%), Gaps = 28/296 (9%)
Query: 12 ISKLGEGAYGNVYLV-------SDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV 64
+ KLGEG Y VYL SD+ S + ACK D +D + KF PRE+DIL+K+
Sbjct: 22 LRKLGEGCYAKVYLAEYKPEHESDRNS--ILACKIVDTAIASKDVVRKFLPRELDILVKL 79
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
+HP+++ VH + + T ++ M +AE DL ++ K N + ENQARIW RQ+A L+Y
Sbjct: 80 NHPHVVHVHSIFQRHTKYFIFMRFAENGDLLDFVLK--NGAVSENQARIWFRQLALGLQY 137
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL---RTPKELSNTFCG 181
LHE+ I HRDIKCENIL++ N KLADFGF+R + R + LS+T+CG
Sbjct: 138 LHEME----------IAHRDIKCENILLTANYNVKLADFGFARYMIDSRGKRVLSDTYCG 187
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241
+ SY APE++R PYNPK++DIWSLGV+LY +LNK PF + + + + Q +++ F
Sbjct: 188 SLSYVAPEVLRAYPYNPKISDIWSLGVILYILLNKAMPFDEDNIKR--LYELQIARKWKF 245
Query: 242 NRKYE--ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREAL 295
K + I+ K+L+ MLEP+ R + WI +P +T E+ AL
Sbjct: 246 RSKVKDRITDSVKKLVNNMLEPDVSKRWRLDQIVQSEWIAMDPRLLVLTPAEQTAL 301
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322799279|gb|EFZ20670.1| hypothetical protein SINV_14525 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 223 bits (568), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 122/309 (39%), Positives = 182/309 (58%), Gaps = 24/309 (7%)
Query: 12 ISKLGEGAYGNVYLV-----SDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH 66
+ KLGEG Y V+L D ++ ACK D +D++ KF PRE+DIL+K++H
Sbjct: 34 LQKLGEGYYAKVFLAEYKPEQDGEKNSVLACKIIDTASAPKDFVRKFLPRELDILVKLNH 93
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P+++ VH + + T ++ M +AE DL +I K N + ENQAR+W RQ+ L+YLH
Sbjct: 94 PHVVHVHSIFQRRTKYFIFMRFAENGDLFDFILK--NGAVGENQARVWFRQLTLGLQYLH 151
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL---RTPKELSNTFCGTT 183
E+ I HRDIKCEN+LI+ N KLADFGF+R + R + LS+T+CG+
Sbjct: 152 EME----------IAHRDIKCENVLITSNYNVKLADFGFARYILDNRGKRVLSDTYCGSL 201
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243
SYAAPEI+R PYNPK++DIWS+GV+LY +LNK PF + T + + + Q +++ F
Sbjct: 202 SYAAPEILRGYPYNPKVSDIWSMGVILYILLNKAMPFDE--TNVKRLYELQITRKWKFRS 259
Query: 244 KY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLK 301
K I+ K+L+ +LEP+ R + + WI +P +T+ E+ AL +
Sbjct: 260 KVTDNITDRVKKLVTNLLEPDVSRRWHTDQIVQSDWIAMDPRLVVLTSAEQTALNNAIEE 319
Query: 302 SKVFMQKYT 310
K +K+T
Sbjct: 320 RKRHEEKFT 328
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357608284|gb|EHJ65907.1| hypothetical protein KGM_17405 [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 222 bits (566), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 112/275 (40%), Positives = 171/275 (62%), Gaps = 23/275 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLK----ACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
K+G+G+Y V+L +LK ACK +D ++ RD++EKF PRE+DIL K+ +P+I
Sbjct: 25 KIGQGSYATVHLAEYCDGSSLKRMHLACKIFDKEKAPRDFLEKFFPRELDILTKIENPHI 84
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
I VH +++ G +++ M +A+ DL +I + N + ENQA++W RQ+A+ L+YLH
Sbjct: 85 IQVHSILQRGPRVFIFMRHADNGDLLEFIKR--NGVVPENQAKLWFRQMASGLQYLHS-- 140
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR---TPKELSNTFCGTTSYA 186
I HRD+KCENIL+SR N KLADFGF+R + LS T+CG+ +YA
Sbjct: 141 --------KNIAHRDLKCENILLSRRFNVKLADFGFARFCTDGDNRRVLSQTYCGSAAYA 192
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246
APE++ +PYNPKLAD+WSLG++L+ +LN PF D + +R +LK Q + ++F +
Sbjct: 193 APEVVSGTPYNPKLADVWSLGIILFIMLNASMPFDD--SNHRKLLKDQMSRNWVFRSRIR 250
Query: 247 --ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+S AK ++ +LEP+ R V +H W +
Sbjct: 251 DTVSAAAKSIVRHILEPDITLRLTLDRVLSHEWTR 285
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332016294|gb|EGI57207.1| Testis-specific serine/threonine-protein kinase 1 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 216 bits (550), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 120/307 (39%), Positives = 182/307 (59%), Gaps = 28/307 (9%)
Query: 14 KLGEGAYGNVYLV-------SDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH 66
K+GEG Y VYL SDK + + ACK D +D+++KF PRE+DIL+K++H
Sbjct: 24 KIGEGCYAKVYLAEYKPEHESDKNN--ILACKIIDTANAPKDFVQKFLPRELDILVKLNH 81
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P+++ VH + + + ++ M +AE DL ++I K N + E+QAR+W RQ+A L+YLH
Sbjct: 82 PHVVHVHSIFQRRSKYFIFMRFAENGDLFNFILK--NGRVPESQARVWFRQLAIGLQYLH 139
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL---RTPKELSNTFCGTT 183
E+ I HRDIKCEN+L++ N KLADFGF+R + + LS+T+CG+
Sbjct: 140 EME----------IAHRDIKCENVLLTANYNVKLADFGFARYMIDSHGKRVLSDTYCGSL 189
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243
SYAAPEI+R PYNPK++DIW+LGV+LY +LNK PF + + + + Q +++ F
Sbjct: 190 SYAAPEILRGYPYNPKMSDIWALGVILYIMLNKSMPFDEDNLKR--LYELQVARKWKFRS 247
Query: 244 KYEISIG--AKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLK 301
K S+ K+L+ +LEP+ R + + WI +P +T E+ AL +
Sbjct: 248 KIIDSLTDRVKKLVSNLLEPDISKRWHLDQIVQSDWIAMDPRLLVLTPAEQIALNSAIEE 307
Query: 302 SKVFMQK 308
K F +K
Sbjct: 308 RKRFEEK 314
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | ||||||
| FB|FBgn0038630 | 302 | CG14305 [Drosophila melanogast | 0.737 | 0.857 | 0.402 | 2.2e-50 | |
| UNIPROTKB|Q96PF2 | 358 | TSSK2 "Testis-specific serine/ | 0.754 | 0.740 | 0.368 | 1e-43 | |
| UNIPROTKB|E2R1G2 | 358 | TSSK2 "Uncharacterized protein | 0.754 | 0.740 | 0.357 | 4.5e-43 | |
| UNIPROTKB|H9GWF7 | 358 | TSSK2 "Uncharacterized protein | 0.754 | 0.740 | 0.357 | 9.3e-43 | |
| UNIPROTKB|G3N136 | 358 | G3N136 "Uncharacterized protei | 0.754 | 0.740 | 0.357 | 1.9e-42 | |
| UNIPROTKB|F1RK79 | 358 | TSSK2 "Uncharacterized protein | 0.754 | 0.740 | 0.357 | 2.5e-42 | |
| MGI|MGI:1347559 | 358 | Tssk2 "testis-specific serine | 0.754 | 0.740 | 0.354 | 2.5e-42 | |
| RGD|1304951 | 358 | Tssk2 "testis-specific serine | 0.754 | 0.740 | 0.354 | 2.5e-42 | |
| UNIPROTKB|H9GWF8 | 368 | TSSK1B "Uncharacterized protei | 0.715 | 0.682 | 0.362 | 5.2e-42 | |
| MGI|MGI:1347557 | 365 | Tssk1 "testis-specific serine | 0.715 | 0.687 | 0.359 | 6.6e-42 |
| FB|FBgn0038630 CG14305 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 2.2e-50, P = 2.2e-50
Identities = 113/281 (40%), Positives = 168/281 (59%)
Query: 14 KLGEGAYGNVYLV--SDKRSETLK-ACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
K+GEG+Y V +D + ACK D + D++ KF PRE++IL K+ H NII
Sbjct: 33 KIGEGSYATVITAGYADDHGHGVHLACKIIDKAKAPTDFVNKFFPRELEILTKIDHSNII 92
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+H +++ G +++ M YAE DL +I ++ I E Q++IW Q++ AL+YLH +
Sbjct: 93 QIHSILQRGPKIFIFMRYAENGDLLSHIKRS--GPIDEKQSKIWFFQMSKALKYLHNL-- 148
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP--KEL-SNTFCGTTSYAA 187
I HRD+KCENIL+S+ LN KLADFGF+R R +E+ S T+CG+ +YAA
Sbjct: 149 --------DIAHRDLKCENILLSKRLNIKLADFGFARYCRDDNGREMKSETYCGSAAYAA 200
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE- 246
PE++ PY+PKLAD WSLGV+L+ ++N K PF D +L+ Q +++ F RK +
Sbjct: 201 PEVVCGRPYDPKLADAWSLGVILFIMMNAKMPFDDSNLTK--LLEDQRNRKFAFRRKLQE 258
Query: 247 -ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQT 286
IS AK + +LEP R N +++ N AW++ QT
Sbjct: 259 TISAQAKATVSVLLEPEAHARWNLREILNCAWLRTVEESQT 299
|
|
| UNIPROTKB|Q96PF2 TSSK2 "Testis-specific serine/threonine-protein kinase 2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 461 (167.3 bits), Expect = 1.0e-43, P = 1.0e-43
Identities = 105/285 (36%), Positives = 166/285 (58%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G+Y V +R + A K D K+ D++E+F PRE+DIL V+H +II +
Sbjct: 18 LGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDILATVNHGSIIKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y+IM+ + DL +I C +HE+ AR RQ+++A++Y H++
Sbjct: 78 IFETSDGRIYIIMELGVQGDLLEFIK--CQGALHEDVARKMFRQLSSAVKYCHDL----- 130
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKE---LSNTFCGTTSYAAPE 189
IVHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 131 -----DIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDSNGRIILSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
++++ PY PK+ DIWSLGV+LY ++ P+ D R +L+ Q+ F R ++
Sbjct: 186 VLQSIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIRK--MLRIQKEHRVDFPRSKNLTC 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN-EPTCQTMTAEERE 293
K LI RML+P+ R + ++ +H+W+Q +P + + +RE
Sbjct: 244 ECKDLIYRMLQPDVSQRLHIDEILSHSWLQPPKPKATSSASFKRE 288
|
|
| UNIPROTKB|E2R1G2 TSSK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 4.5e-43, P = 4.5e-43
Identities = 102/285 (35%), Positives = 167/285 (58%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEG+Y V +R + A K D K+ +D++EKF PREI+IL ++H +I+ +
Sbjct: 18 LGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPKDFLEKFLPREIEILAMLNHRSIVKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I +HE+ AR R+ H++++A++
Sbjct: 78 IFETSDGKVYIVMELGVQGDLLEFIKT--RGALHEDDAR---RKF-------HQLSSAIK 125
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPK---ELSNTFCGTTSYAAPE 189
Y H++ IVHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 126 YCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLTLSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKK--MLRIQKEHRVDFPRSKNLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN-EPTCQTMTAEERE 293
K LI RML+P+ R + ++ +H+W+Q +P + + +RE
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEILSHSWLQPPKPKAMSSASFKRE 288
|
|
| UNIPROTKB|H9GWF7 TSSK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 452 (164.2 bits), Expect = 9.3e-43, P = 9.3e-43
Identities = 102/285 (35%), Positives = 165/285 (57%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G+Y V +R + A K D K+ D++E+F PRE+DIL V+H +II +
Sbjct: 18 LGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDILATVNHRSIIKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I C +HE+ AR RQ+++A++Y H++
Sbjct: 78 IFETSDGRIYIVMELGVQGDLLEFIK--CRGALHEDVARKMFRQLSSAVKYCHDL----- 130
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKE---LSNTFCGTTSYAAPE 189
+VHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 131 -----DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDGSGRIILSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKK--MLRIQKEHRVDFPRSKNLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN-EPTCQTMTAEERE 293
K LI RML+P+ R + ++ +H+W+Q +P + + +RE
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEILSHSWLQPPKPKAMSSASFKRE 288
|
|
| UNIPROTKB|G3N136 G3N136 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 1.9e-42, P = 1.9e-42
Identities = 102/285 (35%), Positives = 164/285 (57%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G+Y V +R + A K D K+ D++E+F PRE+DIL V+H +II +
Sbjct: 18 LGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDILATVNHRSIIKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I C +HE+ AR RQ+++A++Y H++
Sbjct: 78 IFETSDGRIYIVMELGVQGDLLEFIK--CRGALHEDVARKMFRQLSSAVKYCHDL----- 130
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPK---ELSNTFCGTTSYAAPE 189
+VHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 131 -----DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDGSGRLTLSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKK--MLRIQKEHRVDFPRSKNLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN-EPTCQTMTAEERE 293
K LI R+L+P+ R + ++ +HAW+Q +P + +RE
Sbjct: 244 ECKDLIYRILQPDVTRRLHIDEILSHAWLQPPKPKAMPSASFKRE 288
|
|
| UNIPROTKB|F1RK79 TSSK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 2.5e-42, P = 2.5e-42
Identities = 102/285 (35%), Positives = 167/285 (58%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G+Y V +R + A K D K+ D++E+F PRE+DIL V+H +II +
Sbjct: 18 LGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDILATVNHRSIIKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I C +HE+ AR RQ+++A++Y H++
Sbjct: 78 IFETSDGRIYIVMELGVQGDLLEFIK--CRGALHEDVARKMFRQLSSAVKYCHDL----- 130
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLR--TPKE-LSNTFCGTTSYAAPE 189
+VHRD+KCEN+L+ + N KL+DFGFS R LR T + LS TFCG+ +YAAPE
Sbjct: 131 -----DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDGTGRIILSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKK--MLRIQKEHRVDFPRSKNLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN-EPTCQTMTAEERE 293
K LI R+L+P+ R + ++ +H+W+Q +P + + +RE
Sbjct: 244 ECKDLIYRILQPDVNRRLHIDEILSHSWLQPPKPKAMSSASFKRE 288
|
|
| MGI|MGI:1347559 Tssk2 "testis-specific serine kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 2.5e-42, P = 2.5e-42
Identities = 101/285 (35%), Positives = 165/285 (57%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G+Y V +R + A K D K+ D++E+F PRE+DIL V+H +II +
Sbjct: 18 LGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDILATVNHRSIIKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I C +HE+ AR RQ+++A++Y H++
Sbjct: 78 IFETSDGRIYIVMELGVQGDLLEFIK--CRGALHEDVARKMFRQLSSAVKYCHDL----- 130
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKE---LSNTFCGTTSYAAPE 189
+VHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 131 -----DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDGSGRIVLSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKK--MLRIQKEHRVDFPRSKNLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN-EPTCQTMTAEERE 293
K LI R+L+P+ R + ++ +H+W+Q +P + + +RE
Sbjct: 244 ECKDLIYRILQPDVNRRLHIDEILSHSWLQPPKPKAMSSASFKRE 288
|
|
| RGD|1304951 Tssk2 "testis-specific serine kinase 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 2.5e-42, P = 2.5e-42
Identities = 101/285 (35%), Positives = 165/285 (57%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G+Y V +R + A K D K+ D++E+F PRE+DIL V+H +II +
Sbjct: 18 LGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDILATVNHRSIIKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I C +HE+ AR RQ+++A++Y H++
Sbjct: 78 IFETSDGRIYIVMELGVQGDLLEFIK--CRGALHEDVARKMFRQLSSAVKYCHDL----- 130
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKE---LSNTFCGTTSYAAPE 189
+VHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 131 -----DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDGSGRIVLSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKK--MLRIQKEHRVDFPRSKNLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN-EPTCQTMTAEERE 293
K LI R+L+P+ R + ++ +H+W+Q +P + + +RE
Sbjct: 244 ECKDLIYRILQPDVNRRLHIDEILSHSWLQPPKPKAMSSASFKRE 288
|
|
| UNIPROTKB|H9GWF8 TSSK1B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 445 (161.7 bits), Expect = 5.2e-42, P = 5.2e-42
Identities = 98/270 (36%), Positives = 158/270 (58%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEG+Y V +R + A K D K+ +D++EKF PREI+IL ++H +I+ +
Sbjct: 18 LGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPKDFLEKFLPREIEILAMLNHRSIVKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I +HE+ AR R+ H++++A++
Sbjct: 78 IFETSDGKVYIVMELGVQGDLLEFIKT--RGALHEDDAR---RKF-------HQLSSAIK 125
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPK---ELSNTFCGTTSYAAPE 189
Y H++ IVHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 126 YCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLTLSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKK--MLRIQKEHRVNFPLSKHLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
K LI RML+P+ R + ++ +H W+Q
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEILSHCWVQ 273
|
|
| MGI|MGI:1347557 Tssk1 "testis-specific serine kinase 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 444 (161.4 bits), Expect = 6.6e-42, P = 6.6e-42
Identities = 97/270 (35%), Positives = 156/270 (57%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEG+Y V +R + A K D K+ D++EKF PREI+IL ++H +I+ +
Sbjct: 18 LGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPSDFLEKFLPREIEILAMLNHRSIVKTYE 77
Query: 75 MVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y++M+ + DL +I + E+ AR + H++++A++
Sbjct: 78 IFETSDGKVYIVMELGVQGDLLEFIKT--RGALQEDDAR----------KKFHQLSSAIK 125
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKE---LSNTFCGTTSYAAPE 189
Y H++ +VHRD+KCEN+L+ + N KL+DFGFS R LR LS TFCG+ +YAAPE
Sbjct: 126 YCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLILSKTFCGSAAYAAPE 185
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ PY PK+ DIWSLGV+LY ++ P+ D + +L+ Q+ F R ++
Sbjct: 186 VLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKK--MLRIQKEHRVNFPRSKHLTG 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
K LI RML+P+ R + ++ NH W+Q
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEILNHCWVQ 273
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q3SZW1 | TSSK1_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.3592 | 0.7150 | 0.6839 | yes | N/A |
| Q96PF2 | TSSK2_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.3671 | 0.7578 | 0.7430 | yes | N/A |
| Q6C3J2 | IPL1_YARLI | 2, ., 7, ., 1, 1, ., 1 | 0.3272 | 0.6780 | 0.6415 | yes | N/A |
| O54863 | TSSK2_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.3531 | 0.7578 | 0.7430 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.19 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 351 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-79 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-72 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-65 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-63 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-48 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-48 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-45 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-44 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-43 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-43 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-42 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-41 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-41 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-41 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-39 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-38 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-38 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-38 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-37 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-37 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-37 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-37 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-37 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-36 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-36 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-35 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-33 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-33 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-32 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-32 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-31 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-31 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-31 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-31 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-30 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-30 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-29 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-29 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-29 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-28 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-28 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-28 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-28 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-27 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-27 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-27 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-27 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-27 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-27 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-26 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-26 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-26 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-25 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-24 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-23 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-23 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-23 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-22 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-21 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-21 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-21 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-20 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-20 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-20 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-20 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-19 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-19 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-19 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-18 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-17 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-16 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-16 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-16 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-15 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-14 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 1e-79
Identities = 106/269 (39%), Positives = 150/269 (55%), Gaps = 20/269 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ KLGEG++G VYL DK++ L A K K++K+D + REI IL K+ HPNI+
Sbjct: 4 LEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPNIVR 61
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + + LY++M+Y E DL + K + E++AR YL +I +A
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEAR----------FYLRQILSA 109
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
LEYLH GIVHRD+K ENIL+ + KLADFG +R L P E TF GT Y APE++
Sbjct: 110 LEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFVGTPEYMAPEVL 168
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ--EGKEYLFNRKYEISI 249
Y DIWSLGV+LY +L K PF PG L K+ + K +++IS
Sbjct: 169 LGKGYGKA-VDIWSLGVILYELLTGKPPF--PGDDQLLELFKKIGKPKPPFPPPEWDISP 225
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
AK LI ++L +P+ R A++ H +
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 4e-72
Identities = 92/270 (34%), Positives = 137/270 (50%), Gaps = 16/270 (5%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ KLG G++G VY K + + A K KR ++ ++ A REI IL ++SHPNI+
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILK-KRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + +LY++M+Y E DL Y+S+ + E++A+ QI LEYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN--- 117
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
GI+HRD+K ENIL+ K+ADFG ++ L TF GT Y APE++
Sbjct: 118 -------GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL 170
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE-GKEYLFNRKYEISIG 250
D+WSLGV+LY +L K PF ++ L ++ G F+ S
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 251 --AKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
AK LI + L +P RP A+++ H W
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 9e-65
Identities = 90/265 (33%), Positives = 134/265 (50%), Gaps = 19/265 (7%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
I ++G+G++G VYLV K L K D + E A E+ IL K++HPNII
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERED-ALNEVKILKKLNHPNII 62
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIH--ENQARIWIRQIANALEYLHEI 128
+ + L ++M+YA+ DL I K E E Q W Q+ AL+YLH
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
I+HRDIK +NI ++ KL DFG S++L + +L+ T GT Y +P
Sbjct: 123 ----------KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL-FNRKYEI 247
E+ +N PYN K +DIWSLG VLY + K+PF G ++ K +Y +Y
Sbjct: 173 ELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFE--GENLLELALKILKGQYPPIPSQY-- 227
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDV 272
S + L+ +L+ +P+ RP+ +
Sbjct: 228 SSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 3e-63
Identities = 85/262 (32%), Positives = 129/262 (49%), Gaps = 49/262 (18%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEG +G VYL DK++ A K + + + REI+IL K++HPNI+ ++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ + +LY++M+Y E L+ + + + E++ + QI LEYLH
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSN------ 111
Query: 135 LHEVGIVHRDIKCENILISRL-LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
GI+HRD+K ENIL+ KLADFG S+LL + K L T GT +Y APE++
Sbjct: 112 ----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG 167
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQ 253
Y + +DIWSLGV+LY + K
Sbjct: 168 KGYYSEKSDIWSLGVILYELPE-----------------------------------LKD 192
Query: 254 LIGRMLEPNPKHRPNAKDVQNH 275
LI +ML+ +P+ RP+AK++ H
Sbjct: 193 LIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 2e-55
Identities = 88/270 (32%), Positives = 138/270 (51%), Gaps = 28/270 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G++G V LV K + L A K K++ + + E +IL +++HP I+ +H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ LY++++YA +L ++SK E +AR Y EI ALEY
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARF----------YAAEIVLALEY 108
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH +GI++RD+K ENIL+ + KL DFG ++ L + +NTFCGT Y APE++
Sbjct: 109 LHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE----ISIG 250
Y K D WSLGV+LY +L K PF ++E E + +S
Sbjct: 169 GYG-KAVDWWSLGVLLYEMLTGKPPFYAE--------DRKEIYEKILKDPLRFPEFLSPE 219
Query: 251 AKQLIGRMLEPNPKHR---PNAKDVQNHAW 277
A+ LI +L+ +P R A++++ H +
Sbjct: 220 ARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 88/272 (32%), Positives = 126/272 (46%), Gaps = 25/272 (9%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII--- 70
LG G++G+VYL DK + L A K+ + + +E REI IL + HPNI+
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE-REIRILSSLQHPNIVRYY 65
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
G R + L + ++Y L + K + E R + RQI LE
Sbjct: 66 GSER-DEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQI---LE------- 112
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT--PKELSNTFCGTTSYAAP 188
L YLH GIVHRDIK NIL+ KLADFG ++ L E + + GT + AP
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE--YLFNRKYE 246
E+IR Y ADIWSLG + + K P+ + G + K E +
Sbjct: 173 EVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE---H 228
Query: 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
+S AK + + L +PK RP A ++ H ++
Sbjct: 229 LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 6e-48
Identities = 80/300 (26%), Positives = 134/300 (44%), Gaps = 60/300 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNII 70
+GEG++ V L +K + A K D ++L ++ K+ E ++L +++ HP II
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
++ + LY +++YA +L YI K + + R Y EI
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK------CTRF------YAAEILL 113
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL-RTPKELSN------------ 177
ALEYLH GI+HRD+K ENIL+ + ++ K+ DFG +++L SN
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 178 -------TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV 230
+F GT Y +PE++ P +D+W+LG ++Y++L K PF
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSN------ 226
Query: 231 LKKQEGKEYL-----FNRKYEISIG----AKQLIGRMLEPNPKHRP----NAKDVQNHAW 277
EYL +Y AK LI ++L +P+ R +++ H +
Sbjct: 227 -------EYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-47
Identities = 93/280 (33%), Positives = 137/280 (48%), Gaps = 37/280 (13%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM-----EKFAPREIDILLKVSHPNI 69
LG G +G V LV K + K +K+ ++ ++ E +IL + +HP I
Sbjct: 1 LGVGGFGRVELVKVKSKNRT-----FALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI 55
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ ++R K Y+YM+M+Y +L + + E AR +I + A EYLH
Sbjct: 56 VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD--EYTARFYIACVVLAFEYLHNR- 112
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
GI++RD+K EN+L+ KL DFGF++ L++ + + TFCGT Y APE
Sbjct: 113 ---------GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWTFCGTPEYVAPE 162
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFG----DPGTRNRDVLKKQEGKEYLFNRKY 245
II N Y+ D WSLG++LY +L + PFG DP D+LK G L Y
Sbjct: 163 IILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK---GNGKLEFPNY 218
Query: 246 EISIGAKQLIGRMLEPNPKHR-----PNAKDVQNHAWIQN 280
I AK LI ++L NP+ R KD++ H W
Sbjct: 219 -IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 81/268 (30%), Positives = 124/268 (46%), Gaps = 17/268 (6%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
+ K+G+G +G VY KR+ A K + ++ + EI IL K HPNI
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHPNI 59
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ + L+++M++ L+ + K+ N+ + E+Q IA E+
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQ-------IA---YVCKELL 108
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
LEYLH GI+HRDIK NIL++ KL DFG S L + + NT GT + APE
Sbjct: 109 KGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYWMAPE 167
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+I PY+ K ADIWSLG+ + K P+ + G + S
Sbjct: 168 VINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSD 225
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAW 277
K + + L+ NP+ RP A+ + H +
Sbjct: 226 EFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-44
Identities = 87/280 (31%), Positives = 128/280 (45%), Gaps = 29/280 (10%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
ISK GAYG V+L K + + A K + R E DIL + P ++
Sbjct: 1 ISK---GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + LY++M+Y DL + ++ E+ ARI Y+ EI A
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARI----------YIAEIVLA 105
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL--------LRTPKELSNTFCGTT 183
LEYLH GI+HRD+K +NILI + KL DFG S++ L ++ GT
Sbjct: 106 LEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243
Y APE+I ++ D WSLG +LY L PF T GK +
Sbjct: 166 DYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGE-TPEEIFQNILNGK-IEWPE 222
Query: 244 KYEISIGAKQLIGRMLEPNPKHRPNAK---DVQNHAWIQN 280
E+S A LI ++L P+P+ R AK +++NH + +
Sbjct: 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-44
Identities = 81/273 (29%), Positives = 133/273 (48%), Gaps = 24/273 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +G+G++G V V K + K D+ + ++ E++IL ++ HPNI+
Sbjct: 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV-SEVNILRELKHPNIVR 63
Query: 72 -VHRMV-KAGTYLYMIMDYAEKKDLEHYISKACNEN--IHENQARIW--IRQIANALEYL 125
R++ ++ LY++M+Y E DL I K E I E IW + Q+ AL
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF--IWRILTQLLLALYEC 121
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
H ++ ++HRD+K NI + N KL DFG +++L + T+ GT Y
Sbjct: 122 HNRSDPGNT-----VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL--KKQEGKEYLFNR 243
+PE + + Y+ K +DIWSLG ++Y + PF RN+ L K +EGK F R
Sbjct: 177 MSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPF---TARNQLQLASKIKEGK---FRR 229
Query: 244 -KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
Y S ++I ML +P RP+ +++
Sbjct: 230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 6e-43
Identities = 87/307 (28%), Positives = 133/307 (43%), Gaps = 64/307 (20%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----REIDILLKVS 65
+ KLGEG YG VY DK++ + A K +++ D E+ P REI +L ++
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKELK 56
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
HPNI+ + ++ LY++ +Y + DL+ Y+ K + N + + Q+ L Y
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK-RPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS- 184
H I+HRD+K +NILI+R KLADFG +R P T+ T
Sbjct: 115 HSH----------RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL---RTY--THEV 159
Query: 185 ----YAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF-GD---------------- 222
Y APEI+ S Y+ + DIWS+G + ++ K F GD
Sbjct: 160 VTLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP 218
Query: 223 -----PGTRN----RDVLKKQEGK--EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKD 271
PG + K K E + R L+ +ML+ NP R +AK+
Sbjct: 219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDP---EGIDLLSKMLQYNPAKRISAKE 275
Query: 272 VQNHAWI 278
H +
Sbjct: 276 ALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 9e-43
Identities = 81/268 (30%), Positives = 126/268 (47%), Gaps = 23/268 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+G GA+G VY + + A K +++K + ++ +EID+L + HPNI+
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHPNIVKYI 65
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
++ LY+I++YAE L I K E+ +++ Q+ L+ L
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQV---LQ-------GLA 113
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
YLHE G++HRDIK NIL ++ KLADFG + L + + GT + APE+I
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN---RDVLKKQEGKEYLFNRKYEISIG 250
S + +DIWSLG + +L P+ D R V Q+ L IS
Sbjct: 174 SGASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV---QDDHPPLPEG---ISPE 226
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
K + + + +P RP AK + H WI
Sbjct: 227 LKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 5e-42
Identities = 79/273 (28%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK---RDYMEKFAPREIDILLKVSHPN 68
+ LG+G+ G VY V K + K Y K++ + K RE+ L P
Sbjct: 6 VKVLGQGSSGVVYKVRHKPT-----GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
++ + + ++++Y + L + K I E RQI L+YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
+ I+HRDIK N+LI+ K+ADFG S++L + NTF GT +Y +P
Sbjct: 119 RH---------IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ-EGKEYLFNRKYEI 247
E I+ Y+ ADIWSLG+ L K+PF PG + L + E
Sbjct: 170 ERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
S + I L+ +PK RP+A ++ H +I+
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 27/270 (10%)
Query: 16 GEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPR----EIDILLKVSHPNIIG 71
G+GA+G V +V + ++ + A K + K+ +EK + R E IL +++HP ++
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMN----KQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + +Y+++D DL +++S+ E Q + WI EI A
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQ--KVKFSEEQVKFWIC----------EIVLA 112
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
LEYLH GI+HRDIK +NIL+ + + DF + + TP L+ + GT Y APE++
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTSGTPGYMAPEVL 171
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPF-GDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250
Y+ D WSLGV Y L K P+ G T + KQE + L+ + S
Sbjct: 172 CRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW--STE 228
Query: 251 AKQLIGRMLEPNPKHR--PNAKDVQNHAWI 278
A I ++LE +P+ R N KD++NH +
Sbjct: 229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 8e-41
Identities = 83/270 (30%), Positives = 130/270 (48%), Gaps = 29/270 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG G++G V LV K S A K ++ + + E IL + HP ++ ++
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ + LY++M+Y +L ++ K + E AR Y ++ ALEY
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARF----------YAAQVVLALEY 116
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH + IV+RD+K EN+L+ K+ DFGF++ + K + T CGT Y APEII +
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYTLCGTPEYLAPEIILSK 173
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ--EGKEYLFNRKYEISIGAK 252
Y K D W+LG+++Y +L PF D N + ++ EGK F + S AK
Sbjct: 174 GYG-KAVDWWALGILIYEMLAGYPPFFD---DNPIQIYEKILEGK-VRFPSFF--SPDAK 226
Query: 253 QLIGRMLEPNPKHR-----PNAKDVQNHAW 277
LI +L+ + R D++NH W
Sbjct: 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 9e-41
Identities = 88/296 (29%), Positives = 139/296 (46%), Gaps = 33/296 (11%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP-NI 69
+ KLGEG++G VYL D++ L A K K + + REI IL ++HP NI
Sbjct: 4 ILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISK-ACNENIHENQARIWIRQIANALEYLHEI 128
+ ++ + LY++M+Y + LE + K + E++A + QI +ALEYLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLN-AKLADFGFSRLLR------TPKELSNTFCG 181
GI+HRDIK ENIL+ R KL DFG ++LL + L +T G
Sbjct: 121 ----------GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 182 TTSYAAPEIIR--NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN---------RDV 230
T Y APE++ + Y +DIWSLG+ LY +L PF + ++
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230
Query: 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQT 286
+ IS A L+ ++L +PK+R ++ +H + + ++
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286
|
Length = 384 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 90/270 (33%), Positives = 124/270 (45%), Gaps = 25/270 (9%)
Query: 12 ISKLGEGAYGNVYLV---SDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN 68
+ KLG+G+YG+VY V SD + LK + A EI IL V+HPN
Sbjct: 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMSQKEREDAVNEIRILASVNHPN 60
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISK-ACNENIHENQARIWIRQIANALEYLHE 127
II G L ++M+YA DL ISK + Q IW +
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQE-IW--------RIFIQ 111
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ L+ LHE I+HRD+K NIL+ K+ D G S++L+ K ++ T GT Y A
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQIGTPHYMA 169
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV-LKKQEGKEYLFNRKYE 246
PE+ + PY+ K +DIWSLG +LY + PF +D+ K Q GK Y
Sbjct: 170 PEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFE--ARSMQDLRYKVQRGKYPPIPPIY- 225
Query: 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276
S + I ML+ PK RPN +
Sbjct: 226 -SQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-38
Identities = 84/261 (32%), Positives = 131/261 (50%), Gaps = 15/261 (5%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ K+GEG++G LV K K + ++ E+ + +E+ +L + HPNI+
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREE-SRKEVAVLSNMKHPNIVQ 63
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ LY++MDY E DL I+ E+Q W QI AL+++H+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK-- 121
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
I+HRDIK +NI +++ KL DFG +R+L + EL+ T GT Y +PEI
Sbjct: 122 --------ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC 173
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
N PYN K +DIW+LG VLY + K+ F + G VLK G + Y S
Sbjct: 174 ENRPYNNK-SDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYPPVSSHY--SYDL 229
Query: 252 KQLIGRMLEPNPKHRPNAKDV 272
+ L+ ++ + NP+ RP+ +
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 47/284 (16%)
Query: 14 KLGEGAYGNVYL--VSDKRSETL----KACKAYDFKRLKRDYMEKFAPREIDILLKVSHP 67
KLGEGA+G VY + K +T K K + ++D++ +E ++ K+ HP
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL-----KEARVMKKLGHP 56
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
N++ + + LY++++Y E DL Y+ K+ ++ + + + L + +
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL---SLKDLLSFAIQ 113
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS--- 184
IA +EYL VHRD+ N L+ L K++DFG SR + + + T
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV----YDDDYYRKKTGGKL 169
Query: 185 ---YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK-QEGK-- 237
+ APE +++ + K +D+WS GV+L+ I P+ PG N +VL+ ++G
Sbjct: 170 PIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPY--PGLSNEEVLEYLRKGYRL 226
Query: 238 ---EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
EY + YE+ ML +P+ RP ++
Sbjct: 227 PKPEYCPDELYEL----------MLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 94/276 (34%), Positives = 137/276 (49%), Gaps = 35/276 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I +G G +G V+LV D+ SE A K + R E+ E +L +VSHP II
Sbjct: 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN--ALEYLHEIA 129
+ +LYM+M+Y +L Y+ + + +N L Y EI
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNS--------------GRFSNSTGLFYASEIV 111
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
ALEYLH IV+RD+K ENIL+ + + KL DFGF++ LR + + T CGT Y APE
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWTLCGTPEYLAPE 168
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP---GTRNRDVLKKQEGKEYLFNRKYE 246
+I++ +N K D W+LG+++Y +L PF D G + + K E F R +
Sbjct: 169 VIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE-----FPRHLD 222
Query: 247 ISIGAKQLIGRMLEPNPKHR-----PNAKDVQNHAW 277
+ AK LI ++L + R A DV+NH W
Sbjct: 223 LY--AKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 85/302 (28%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I LG+G G V+LV K + L A K D K + + K E +IL + HP +
Sbjct: 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + TYL ++MDY +L + + + + E AR Y E+ A
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF----------YAAEVLLA 115
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT-------------------- 171
LEYLH +GIV+RD+K ENIL+ + L+DF S+
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 172 ---------PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222
P SN+F GT Y APE+I + + D W+LG++LY +L PF
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPF-- 232
Query: 223 PGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAK----DVQNHAWI 278
G+ + KE F +S A+ LI ++L +P R +K +++ H +
Sbjct: 233 KGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
Query: 279 QN 280
+
Sbjct: 293 RG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 83/299 (27%), Positives = 134/299 (44%), Gaps = 47/299 (15%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I+++GEG YG VY +K++ L A K + +++ A REI +L K+ HPNI+
Sbjct: 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 72 VHRMV--KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ +V K +YM+ +Y + DL + + + QI Y+ ++
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DL--------TGLLDSPEVKFTESQIKC---YMKQLL 110
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL--RTPKELSNTFCGTTSYAA 187
L+YLH GI+HRDIK NILI+ KLADFG +R R + +N T Y
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 188 PEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF-GD---------------------PG 224
PE++ + Y P++ D+WS+G +L + K F G PG
Sbjct: 170 PELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228
Query: 225 TRNR---DVLKKQEGKEYLFNRKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
+ LK ++ + + I A L+ ++L +PK R +A H +
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 79/297 (26%), Positives = 132/297 (44%), Gaps = 47/297 (15%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY----MEKFAPREIDILLKVSHP 67
+ K+GEG YG VY DK + + A K ++K + + K A REI +L +++HP
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIK-----KIKLRFESEGIPKTALREIKLLKELNHP 58
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
NII + + + LY++ ++ + DL I K + E+ + YL++
Sbjct: 59 NIIKLLDVFRHKGDLYLVFEFMDT-DLYKLI-KDRQRGLPESLIK----------SYLYQ 106
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ L + H GI+HRD+K EN+LI+ KLADFG +R +P + T Y A
Sbjct: 107 LLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKK-------------YPFGDPGTRNRDVLKK- 233
PE++ DIWS+G + +L+++ F GT + +V K
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226
Query: 234 -QEGKEYLFNRKYEISIG-----------AKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
+ Y F+ + + A L+ +ML +P R A+ H +
Sbjct: 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 89/279 (31%), Positives = 145/279 (51%), Gaps = 30/279 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPR------EIDILLKV-SHP 67
LG GAYG V+LV ++ A K Y K LK+ + + A E +L V P
Sbjct: 8 LGTGAYGKVFLV--RKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
++ +H + T L++I+DY +L ++ + E+ E++ R+ Y+ E
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRV----------YIAE 113
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP-KELSNTFCGTTSYA 186
I AL++LH++GI++RDIK ENIL+ + L DFG S+ +E + +FCGT Y
Sbjct: 114 IVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 187 APEIIRN-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN--RDVLKKQEGKEYLFNR 243
APE+IR S + K D WSLGV+ + +L PF G +N ++ ++ + F +
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK 233
Query: 244 KYEISIGAKQLIGRMLEPNPKHR---PNAKDVQNHAWIQ 279
+S A+ I ++LE +PK R A +++NH + Q
Sbjct: 234 --TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 82/256 (32%), Positives = 133/256 (51%), Gaps = 18/256 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILL-KVSHPNIIGVH 73
+GEG++G LV S+ A K RL + R+ +LL K+ HPNI+
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEI---RLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+A +LY++M+Y + DL + I + +++ L++ ++ ++
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLM--------QKIKLQRGKLFPEDTI--LQWFVQMCLGVQ 114
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
++HE ++HRDIK +NI +++ KL DFG +RLL +P + T+ GT Y PEI N
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQ 253
PYN K +DIWSLG +LY + K+PF +N +LK +G Y + +
Sbjct: 175 MPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNL-ILKVCQGSYKPLPSHYSYEL--RS 230
Query: 254 LIGRMLEPNPKHRPNA 269
LI +M + NP+ RP+A
Sbjct: 231 LIKQMFKRNPRSRPSA 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-37
Identities = 85/258 (32%), Positives = 135/258 (52%), Gaps = 16/258 (6%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I K+GEG++G +YL K K D ++ E + +E+ +L K+ HPNI+
Sbjct: 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEA-SKKEVILLAKMKHPNIVT 63
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ L+++M+Y + DL I++ E+Q W QI+ L+++H+
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK-- 121
Query: 132 LEYLHEVGIVHRDIKCENILISRL-LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
I+HRDIK +NI +S+ + AKL DFG +R L EL+ T GT Y +PEI
Sbjct: 122 --------ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250
+N PYN K DIWSLG VLY + K+PF + ++ VLK +G + + S
Sbjct: 174 CQNRPYNNK-TDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYFAPISPNF--SRD 229
Query: 251 AKQLIGRMLEPNPKHRPN 268
+ LI ++ + +P+ RP+
Sbjct: 230 LRSLISQLFKVSPRDRPS 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-37
Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 15/256 (5%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G+G++G V+ V K + + A K D ++ R + A E +L K+ II +
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYY 65
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
L ++M+YAE DL + + E+Q +W + +I L
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQ--VW--------RFFIQILLGLA 115
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
+LH I+HRDIK N+ + N K+ D G ++LL +NT GT Y +PE+ +
Sbjct: 116 HLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQ 253
PYN K +D+W+LGVVLY K+PF D + +LK G ++ Y + Q
Sbjct: 176 KPYNEK-SDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFPPVSQMYSQQLA--Q 231
Query: 254 LIGRMLEPNPKHRPNA 269
LI + L + + RP+
Sbjct: 232 LIDQCLTKDYRQRPDT 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 83/269 (30%), Positives = 135/269 (50%), Gaps = 16/269 (5%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
++ +G+G+YG V LV + K + + R K A +E +L ++ HPNI+
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIV 62
Query: 71 GVHRMVKAGT-YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ LY++M + E DL H + + + + ENQ W QIA AL+YLHE
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE-- 120
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
I+HRD+K +N+ ++R K+ D G +R+L ++++T GT Y +PE
Sbjct: 121 --------KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+ N PYN K +D+W+LG +Y + K+ F + N V + EGK + Y +
Sbjct: 173 LFSNKPYNYK-SDVWALGCCVYEMATLKHAF-NAKDMNSLVYRIIEGKLPPMPKDYSPEL 230
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
G +LI ML P+ RP+ K + +I
Sbjct: 231 G--ELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 77/276 (27%), Positives = 135/276 (48%), Gaps = 25/276 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR--DYMEKFAPREIDILLKVSHPNI 69
I +LG+GA+G VY K + A K + + D+M EIDIL + HPNI
Sbjct: 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-----EIDILSECKHPNI 64
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+G++ L++++++ + L+ I + E Q IR + ++
Sbjct: 65 VGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQ----IRYVC------RQML 113
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
AL +LH ++HRD+K NIL++ + KLADFG S ++ + +TF GT + APE
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173
Query: 190 II-----RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244
++ +++PY+ K ADIWSLG+ L + + P + R +LK + + ++
Sbjct: 174 VVACETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSEPPTLDQP 231
Query: 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ S + L +P RP A ++ H ++ +
Sbjct: 232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 85/266 (31%), Positives = 127/266 (47%), Gaps = 17/266 (6%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I +G GA+G V+L K + L K +++ +D A E +L +SHPNII
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPNIIE 63
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ L ++M+YA L YI K CN + E+ L + +I A
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT----------ILHFFVQILLA 113
Query: 132 LEYLHEVGIVHRDIKCENILISRLLN-AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
L ++H I+HRD+K +NIL+ + K+ DFG S++L + K + T GT Y +PE+
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYTVVGTPCYISPEL 172
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250
PYN K +DIW+LG VLY + + K F + VLK G + +Y S
Sbjct: 173 CEGKPYNQK-SDIWALGCVLYELASLKRAF-EAANLPALVLKIMSGTFAPISDRY--SPD 228
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQNHA 276
+QLI ML +P RP +
Sbjct: 229 LRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 2e-35
Identities = 85/303 (28%), Positives = 135/303 (44%), Gaps = 61/303 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP-------REIDILLKV 64
I +LG+G +G+VYL +K + L A K++K+ KF RE+ L K+
Sbjct: 4 IKQLGDGTFGSVYLARNKETGELVA-----IKKMKK----KFYSWEECMNLREVKSLRKL 54
Query: 65 -SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
HPNI+ + + + LY + +Y E +L + + E+ R I QI L
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
++H+ G HRD+K EN+L+S K+ADFG +R +R+ + + T
Sbjct: 114 HIHKH----------GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT-DYVSTR 162
Query: 184 SYAAPEII-RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ-------- 234
Y APEI+ R++ Y+ + DIW+LG ++ + + F PG+ D L K
Sbjct: 163 WYRAPEILLRSTSYSSPV-DIWALGCIMAELYTLRPLF--PGSSEIDQLYKICSVLGTPT 219
Query: 235 -----EGKE------YLFNRKYEISI---------GAKQLIGRMLEPNPKHRPNAKDVQN 274
EG + + F + S+ A LI ML +PK RP A
Sbjct: 220 KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279
Query: 275 HAW 277
H +
Sbjct: 280 HPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 35/287 (12%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
+S+LGEGA G+V K + + A K ++K RE++I P I+
Sbjct: 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKT--ITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 71 GVHR--MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+ + ++ + + + M+Y E L+ + + + + RI + + E +
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAE---SV 114
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
L YLH I+HRDIK NIL++R KL DFG S L L+ TF GT+ Y AP
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN--SLAGTFTGTSFYMAP 172
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN--------------RDVLKKQ 234
E I+ PY+ +D+WSLG+ L + ++PF G LK +
Sbjct: 173 ERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 235 EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
G ++ ++ K I + LE +P RP D+ H WI+ +
Sbjct: 232 PGNGIKWSEEF------KDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 78/276 (28%), Positives = 118/276 (42%), Gaps = 29/276 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG-- 71
K+G G +G VY + + L A K + +++ A E+ +L + HPN++
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA-DEMKVLELLKHPNLVKYY 65
Query: 72 ---VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
VHR +Y+ M+Y LE + + H IR Y ++
Sbjct: 66 GVEVHR-----EKVYIFMEYCSGGTLEELLEHGRILDEH------VIRV------YTLQL 108
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL----RTPKELSNTFCGTTS 184
L YLH GIVHRDIK NI + KL DFG + L T E + GT +
Sbjct: 109 LEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168
Query: 185 YAAPEIIRNSPYNPKL--ADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
Y APE+I ADIWSLG V+ + K P+ + + + G +
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIP 228
Query: 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
++S K + R LE +PK RP A ++ H ++
Sbjct: 229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 89/287 (31%), Positives = 124/287 (43%), Gaps = 49/287 (17%)
Query: 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAY----DFKRLKRDYMEKFAPREIDI 60
DILE KLGEG+YG+VY K + + A K D + + + EI I
Sbjct: 6 DILE-----KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK---------EISI 51
Query: 61 LLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
L + P I+ + T L+++M+Y + I K N+ + E +IA
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTE-------EEIAA 103
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC 180
L LEYLH +HRDIK NIL++ AKLADFG S L NT
Sbjct: 104 ILYQ---TLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI 160
Query: 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD--P-------GTRNRDVL 231
GT + APE+I+ YN K ADIWSLG+ + K P+ D P + L
Sbjct: 161 GTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL 219
Query: 232 KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
E FN + + L +P+ RP+A + H +I
Sbjct: 220 SDPEKWSPEFND----------FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 82/293 (27%), Positives = 131/293 (44%), Gaps = 65/293 (22%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ K+GEGA G VY +D+ + A K ++ ++ + EI I+ HPNI+
Sbjct: 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVD 79
Query: 72 VHRMVKAGTYLYMIMDYAEKKDL----EHYISKACNENIHENQARIWIRQIANALEYL-H 126
+ G L+++M+Y + L + NE QIA Y+
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNE-----------PQIA----YVCR 123
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
E+ LEYLH ++HRDIK +NIL+S+ + KLADFGF+ L K N+ GT +
Sbjct: 124 EVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM 183
Query: 187 APEIIRNSPYNPKLADIWSLGVV-------------------LYRILNKKYPFGDPGTRN 227
APE+I+ Y PK DIWSLG++ L+ I K G P +N
Sbjct: 184 APEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK----GIPPLKN 238
Query: 228 RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ + K + + L +P+ RP+A+++ H +++
Sbjct: 239 PEKWSPE----------------FKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 81/264 (30%), Positives = 130/264 (49%), Gaps = 21/264 (7%)
Query: 14 KLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
+LG+G++G VYLV DK E LK K L + + A +E +L K+ HP I+
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKLDHPAIV 65
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYIS--KACNENIHENQARIWIRQIANALEYLHEI 128
H +I +Y E +DL+ + K + + ENQ E+ ++
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV----------CEWFIQL 115
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
+ Y+H+ I+HRD+K +NI + L K+ DFG SRLL +L+ TF GT Y +P
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248
E +++ Y+ K +DIWSLG +LY + + F + VL+ EG Y
Sbjct: 175 EALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSV-VLRIVEGPTPSLPETYSRQ 232
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDV 272
+ + ++ ML +P RP+A ++
Sbjct: 233 LNS--IMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 85/270 (31%), Positives = 136/270 (50%), Gaps = 30/270 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK-VSHPNIIGVH 73
+G+G++G V L K A K K + + +K E ++LLK V HP ++G+H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ LY ++DY +L ++ + + E +AR Y EIA+AL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQR--ERSFPEPRARF----------YAAEIASALG 110
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
YLH + I++RD+K ENIL+ + L DFG + + ++TFCGT Y APE++R
Sbjct: 111 YLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR----KYEISI 249
PY+ + D W LG VLY +L +G P +RD E + + N+ K IS+
Sbjct: 171 QPYD-RTVDWWCLGAVLYEML-----YGLPPFYSRDT---AEMYDNILNKPLRLKPNISV 221
Query: 250 GAKQLIGRMLEPNPKHRPNAK----DVQNH 275
A+ L+ +L+ + R AK +++NH
Sbjct: 222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 72/279 (25%), Positives = 117/279 (41%), Gaps = 46/279 (16%)
Query: 12 ISKLGEGAYGNVYL-----VSDKRSET--LKACKAYDFKRLKRDYMEKFAPREIDILLKV 64
KLGEGA+G VY D + +K K ++ +++ RE I+ K+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-----REARIMRKL 58
Query: 65 SHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
HPNI+ GV L ++M+Y DL Y+ K + + + + QIA
Sbjct: 59 DHPNIVKLLGV---CTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
+EYL +HRD+ N L+ L K++DFG SR L + G
Sbjct: 116 MEYLESK----------NFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYKVKGG 164
Query: 182 TTSYA--APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD---PGTRNRDVLKKQEG 236
APE ++ + K +D+WS GV+L+ I G+ PG N +VL+ +
Sbjct: 165 KLPIRWMAPESLKEGKFTSK-SDVWSFGVLLWEIFT----LGEEPYPGMSNAEVLEYLKK 219
Query: 237 KEYLFNRKY---EISIGAKQLIGRMLEPNPKHRPNAKDV 272
L E+ +L+ + +P+ RP ++
Sbjct: 220 GYRLPKPPNCPPEL----YKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 50/284 (17%)
Query: 12 ISKLGEGAYGNVYL----VSDKRSET---LKACKAYDFKRLKRDYMEKFAPREIDILLKV 64
KLGEGA+G VY + +ET +K K + + +++ E I+ K+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-----EEASIMKKL 58
Query: 65 SHPNI---IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
SHPNI +GV G LY++ +Y DL ++ ++ ++ ++ +
Sbjct: 59 SHPNIVRLLGV---CTQGEPLYIVTEYMPGGDLLDFL--------RKHGEKLTLKDL--- 104
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
L+ +IA +EYL VHRD+ N L++ L K++DFG SR + + G
Sbjct: 105 LQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDI-YEDDYYRKRGG 163
Query: 182 TTS---YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD---PGTRNRDVLKKQE 235
+ APE +++ + K +D+WS GV+L+ I G+ PG N +VL+ E
Sbjct: 164 GKLPIKWMAPESLKDGKFTSK-SDVWSFGVLLWEIFT----LGEQPYPGMSNEEVLELLE 218
Query: 236 GKEYLFNRKYEISIGA----KQLIGRMLEPNPKHRPNAKDVQNH 275
L +L+ + +P+ RP ++
Sbjct: 219 DGYRL-----PRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 47/280 (16%)
Query: 12 ISKLGEGAYGNVYL-----VSDKRSET--LKACKAYDFKRLKRDYMEKFAPREIDILLKV 64
KLGEGA+G VY K+ +K K ++ +++ RE I+ K+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-----REARIMRKL 58
Query: 65 SHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
HPN++ GV LY++M+Y E DL Y+ K N+ ++ + +
Sbjct: 59 DHPNVVKLLGV---CTEEEPLYIVMEYMEGGDLLSYLRK--------NRPKLSLSDL--- 104
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
L + +IA +EYL +HRD+ N L+ L K++DFG SR L + G
Sbjct: 105 LSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYRKRGG 163
Query: 182 TTSYA--APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD---PGTRNRDVLKKQEG 236
APE ++ + K +D+WS GV+L+ I G+ PG N +VL+ +
Sbjct: 164 KLPIRWMAPESLKEGKFTSK-SDVWSFGVLLWEIFT----LGEQPYPGMSNEEVLEYLKN 218
Query: 237 KEYLFNRKY---EISIGAKQLIGRMLEPNPKHRPNAKDVQ 273
L E+ L+ + +P+ RP ++
Sbjct: 219 GYRLPQPPNCPPEL----YDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 88/285 (30%), Positives = 138/285 (48%), Gaps = 39/285 (13%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPR------EIDILLKVSH-P 67
LG GAYG V+LV ++ K Y K L++ + + A E ++L V P
Sbjct: 8 LGTGAYGKVFLV--RKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
++ +H + L++I+DY ++ ++ + +N E++ R Y E
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRF----------YSGE 113
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR-LLRTPKELSNTFCGTTSYA 186
I ALE+LH++GIV+RDIK ENIL+ + L DFG S+ L KE + +FCGT Y
Sbjct: 114 IILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN------RDVLKKQEGKEYL 240
APEIIR + K D WSLG++++ +L PF G RN R +LK
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233
Query: 241 FNRKYEISIGAKQLIGRMLEPNPKHR-----PNAKDVQNHAWIQN 280
I A+ L+ ++L +PK R A +++ H + +
Sbjct: 234 ------IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 51/298 (17%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV---SHPN 68
++++GEGAYG VY D + A K L + + REI +L ++ HPN
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRV-PLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 69 I-----IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
I + L ++ ++ ++ DL Y+SK + + +RQ+ ++
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
+LH ++ IVHRD+K +NIL++ K+ADFG +R+ E++ T T
Sbjct: 122 FLH--SHR--------IVHRDLKPQNILVTSDGQVKIADFGLARIYSF--EMALTSVVVT 169
Query: 184 S-YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK--------Q 234
Y APE++ S Y + D+WS+G + + ++ F GT D L K
Sbjct: 170 LWYRAPEVLLQSSYATPV-DMWSVGCIFAELFRRRPLF--RGTSEADQLDKIFDVIGLPS 226
Query: 235 EG---KEYLFNRKY--------------EISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
E + R EI L+ +ML NP R +A + H
Sbjct: 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 6e-32
Identities = 84/274 (30%), Positives = 132/274 (48%), Gaps = 28/274 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK-VSHPNIIGVH 73
+G+G++G V L K A K K + +K E ++LLK V HP ++G+H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ LY ++D+ +L ++ + + E +AR Y EIA+AL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQR--ERSFPEPRARF----------YAAEIASALG 110
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
YLH + IV+RD+K ENIL+ + L DFG + + + TFCGT Y APE+IR
Sbjct: 111 YLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---KEYLFNRKYEISIG 250
PY+ D W LG VLY +L +G P RDV + + K + S+
Sbjct: 171 QPYD-NTVDWWCLGAVLYEML-----YGLPPFYCRDVAEMYDNILHKP--LVLRPGASLT 222
Query: 251 AKQLIGRMLEPNPKHRPNAKD----VQNHAWIQN 280
A ++ +LE + + R AK+ +Q H + ++
Sbjct: 223 AWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 87/269 (32%), Positives = 129/269 (47%), Gaps = 22/269 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+G+G++G VY DKR+ + A K D + + D +E +EI L + P I +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE-DEIEDIQ-QEIQFLSQCRSPYITKYY 65
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
G+ L++IM+Y + K + E +R++ L LE
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLL-KPGK--LDETYIAFILREV------LL----GLE 112
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
YLHE G +HRDIK NIL+S + KLADFG S L + NTF GT + APE+I+
Sbjct: 113 YLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGD--PGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
S Y+ K ADIWSLG+ + + P D P R ++ K N + S
Sbjct: 173 SGYDEK-ADIWSLGITAIELAKGEPPLSDLHP-MRVLFLIPKNNPPSLEGN---KFSKPF 227
Query: 252 KQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
K + L +PK RP+AK++ H +I+
Sbjct: 228 KDFVSLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 37/279 (13%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDIL--------LKVSH 66
LG+G++G V L K ++ L A K LK+D + +++ L H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKV-----LKKDVI--LQDDDVECTMTEKRVLALAGKH 55
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P + +H + L+ +M+Y DL +I ++ E +AR Y
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARF----------YAA 103
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
EI L++LHE GI++RD+K +N+L+ + K+ADFG + ++TFCGT Y
Sbjct: 104 EIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYI 163
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246
APEI+ PY P D W+LGV+LY +L + PF G ++ + E + R
Sbjct: 164 APEILSYQPYGPA-VDWWALGVLLYEMLAGQSPF--EGDDEDELFQSILEDEVRYPR--W 218
Query: 247 ISIGAKQLIGRMLEPNPKHR----PNAK-DVQNHAWIQN 280
+S AK ++ L NP+ R P + D++ H + +
Sbjct: 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 88/282 (31%), Positives = 143/282 (50%), Gaps = 32/282 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPR------EIDILLKVSH-P 67
LG GAYG V+LV ++ + K Y K LK+ + + A E +L + P
Sbjct: 8 LGTGAYGKVFLV--RKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
++ +H + T L++I+DY +L ++S+ E E + +I Y E
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ--RERFKEQEVQI----------YSGE 113
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR-LLRTPKELSNTFCGTTSYA 186
I ALE+LH++GI++RDIK ENIL+ + L DFG S+ E + +FCGT Y
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 187 APEIIRNSPY-NPKLADIWSLGVVLYRILNKKYPFGDPGTRNR--DVLKKQEGKEYLFNR 243
AP+I+R + K D WS+GV++Y +L PF G +N ++ ++ E + +
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 233
Query: 244 KYEISIGAKQLIGRMLEPNPKHR-----PNAKDVQNHAWIQN 280
E+S AK +I R+L +PK R +A +++ H + Q
Sbjct: 234 --EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 86/276 (31%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYME-KFAPREIDILLKVSHPNI 69
Y+ +LG G G V V + + + A K RL+ + K RE+DIL K + P I
Sbjct: 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTI---RLEINEAIQKQILRELDILHKCNSPYI 61
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+G + + + M+Y + L+ I K I E + +IA A +
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERI----LGKIAVA------VL 110
Query: 130 NALEYLHEV-GIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
L YLHE I+HRD+K NIL++ KL DFG S L L+ TF GT+SY AP
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFVGTSSYMAP 168
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPF---GDPGTRNRDVLKK--QEGKEYLFNR 243
E I+ + Y+ K +DIWSLG+ L + ++P+ DP ++L+ E L +
Sbjct: 169 ERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG 227
Query: 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
K+ S + + L +P+ RP+ K++ H +I+
Sbjct: 228 KF--SPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-31
Identities = 86/268 (32%), Positives = 130/268 (48%), Gaps = 26/268 (9%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK-VSHPNIIGVH 73
+G+G++G V L K E A K K + + EK E ++LLK V HP ++G+H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ LY ++DY +L +++ + E +AR Y EIA+AL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARF----------YAAEIASALG 110
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
YLH + IV+RD+K ENIL+ + L DFG + ++TFCGT Y APE++
Sbjct: 111 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK 170
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR--DVLKKQEGKEYLFNRKYEISIGA 251
PY+ + D W LG VLY +L PF T ++L K K I+ A
Sbjct: 171 QPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------LQLKPNITNSA 223
Query: 252 KQLIGRMLEPNPKHRPNAKD----VQNH 275
+ L+ +L+ + R AKD ++NH
Sbjct: 224 RHLLEGLLQKDRTKRLGAKDDFMEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-31
Identities = 79/272 (29%), Positives = 138/272 (50%), Gaps = 30/272 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK-VSHPNIIGVH 73
+G+G++G V L K + A K K + + + E ++LLK + HP ++G+H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ LY ++DY +L ++ + E +AR Y E+A+A+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQR--ERCFLEPRARF----------YAAEVASAIG 110
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
YLH + I++RD+K ENIL+ + L DFG + P+E ++TFCGT Y APE++R
Sbjct: 111 YLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI----SI 249
PY+ + D W LG VLY +L +G P +RDV + + + ++ ++ ++
Sbjct: 171 EPYD-RTVDWWCLGAVLYEML-----YGLPPFYSRDVSQMYDN---ILHKPLQLPGGKTV 221
Query: 250 GAKQLIGRMLEPNPKHRPNAK----DVQNHAW 277
A L+ +L + + R AK +++NH +
Sbjct: 222 AACDLLVGLLHKDQRRRLGAKADFLEIKNHVF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-31
Identities = 82/279 (29%), Positives = 130/279 (46%), Gaps = 36/279 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRSE---TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN 68
ISK GA+G+VYL + + +K K D + K A R I ++++ P
Sbjct: 4 ISK---GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-AERAI-MMIQGESPY 58
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISK--ACNENIHENQARIWIRQIANALEYLH 126
+ ++ ++ YLY++M+Y D I E+ W +Q Y+
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPED--------WAKQ------YIA 104
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
E+ +E LH+ GI+HRDIK EN+LI + + KL DFG SR K+ F GT Y
Sbjct: 105 EVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK----FVGTPDYL 160
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF--GDPGTRNRDVLKKQEGKEYLFNRK 244
APE I + K++D WSLG V++ L PF P ++L ++ + K
Sbjct: 161 APETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPEEVK 217
Query: 245 YEISIGAKQLIGRMLEPNPKHRPNAK---DVQNHAWIQN 280
S A LI R+L +P R A ++++H + ++
Sbjct: 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 81/281 (28%), Positives = 139/281 (49%), Gaps = 31/281 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVH 73
+G G+Y V LV K++E + A K + + D + E + + S HP ++G+H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + L+ +++Y DL ++ + + E AR Y EI+ AL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARF----------YSAEISLALN 110
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
YLHE GI++RD+K +N+L+ + KL D+G + P + ++TFCGT +Y APEI+R
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE------- 246
Y + D W+LGV+++ ++ + PF G+ + Q ++YLF E
Sbjct: 171 EDYGFSV-DWWALGVLMFEMMAGRSPFDIVGSSDN---PDQNTEDYLFQVILEKQIRIPR 226
Query: 247 -ISIGAKQLIGRMLEPNPKHR----PNA--KDVQNHAWIQN 280
+S+ A ++ L +PK R P D+Q H + +N
Sbjct: 227 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 87/305 (28%), Positives = 133/305 (43%), Gaps = 56/305 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK-----FAPREIDILLKVSH 66
I +G GA+G V+LV DK + + Y K L++ M K E DIL
Sbjct: 6 IKVIGRGAFGEVWLVRDKDTG-----QVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P I+ ++ + +LY++M+Y DL + + + + E AR Y+
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARF----------YIA 108
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-------------------- 166
E+ AL+ +H++G +HRDIK +NILI + KLADFG
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 167 -----RLLRTPKELSNTFC----GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKK 217
+ R + GT Y APE++R +PY D WSLGV+LY +L
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGF 227
Query: 218 YPFGDPGTRNRDVLKKQEGKEYL-FNRKYEISIGAKQLIGRMLEPNPKHR-PNAKDVQNH 275
PF T K KE L F +S A LI R+L P+ R + +++++H
Sbjct: 228 PPFYSD-TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSH 285
Query: 276 AWIQN 280
+ +
Sbjct: 286 PFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 84/261 (32%), Positives = 126/261 (48%), Gaps = 15/261 (5%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I LG+GA+G L ++L K + RL + A EI IL + HPNII
Sbjct: 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIA 63
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ L + M+YA L I + + E + +W YL +I +A
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQ-KGQLFEEEMVLW---------YLFQIVSA 113
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
+ Y+H+ GI+HRDIK NI +++ KL DFG S++L + ++ T GT Y +PE+
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
+ YN K +DIW+LG VLY +L K F D V+K +G Y S
Sbjct: 174 QGVKYNFK-SDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVSVY--SSEL 229
Query: 252 KQLIGRMLEPNPKHRPNAKDV 272
L+ +L+ +P+ RP A +V
Sbjct: 230 ISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 5e-30
Identities = 84/302 (27%), Positives = 127/302 (42%), Gaps = 44/302 (14%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETL---KACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN 68
KLGEG Y VY DK + + K K + K K D + A REI +L ++ HPN
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAK-DGINFTALREIKLLQELKHPN 63
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
IIG+ + + + ++ ++ E DLE I + + + A+ Y+
Sbjct: 64 IIGLLDVFGHKSNINLVFEFMET-DLEKVI-----------KDKSIVLTPADIKSYMLMT 111
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
LEYLH I+HRD+K N+LI+ KLADFG +R +P T Y AP
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK--------------- 233
E++ + + D+WS+G + +L + PF PG + D L K
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRV-PFL-PGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 234 -QEGKEYL-------FNRKYEISIG---AKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
+Y+ K A L+ R+L NP R A+ H + N+P
Sbjct: 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289
Query: 283 TC 284
Sbjct: 290 AP 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-30
Identities = 90/282 (31%), Positives = 139/282 (49%), Gaps = 40/282 (14%)
Query: 12 ISKLGEGAYGNVYLV-----SDK-RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS 65
+ LG+G YG V+ V +D + +K K R ++D A R +IL V
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER--NILEAVK 58
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIH-ENQARIWIRQIANALEY 124
HP I+ + + G LY+I++Y +L ++ + E I E+ A Y
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER---EGIFMEDTACF----------Y 105
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
L EI+ ALE+LH+ GI++RD+K ENIL+ + KL DFG + +++TFCGT
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIE 165
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK----EYL 240
Y APEI+ S + K D WSLG ++Y +L PF R + + K +GK YL
Sbjct: 166 YMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPF-TAENRKKTIDKILKGKLNLPPYL 223
Query: 241 FNRKYEISIGAKQLIGRMLEPNPKHR-----PNAKDVQNHAW 277
A+ L+ ++L+ NP R +A +VQ+H +
Sbjct: 224 TPE-------ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 32/274 (11%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+GEG+ G V + +DK + A K D ++ +R + E+ I+ HPNI+ ++
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR---RELLFNEVVIMRDYQHPNIVEMY 82
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
G L+++M++ E L ++ R+ QIA + AL
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIVT----------HTRMNEEQIATVCLA---VLKALS 129
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL--RTPKELSNTFCGTTSYAAPEII 191
+LH G++HRDIK ++IL++ KL+DFGF + P+ S GT + APE+I
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVI 187
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYP-FGDPG----TRNRDVLKKQEGKEYLFNRKYE 246
PY + DIWSLG+++ +++ + P F +P R RD L + ++
Sbjct: 188 SRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK------LKNLHK 240
Query: 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+S + + RML +P R A ++ NH ++
Sbjct: 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 66/206 (32%), Positives = 95/206 (46%), Gaps = 30/206 (14%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFA--PREIDILLKVSHPNI 69
I ++G G YG+VY D + L A K +K + + F +EI +L + HPNI
Sbjct: 8 IQRIGSGTYGDVYKARDIATGELVAIKV-----IKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 70 IGVHRMVKAGTYLYMIMDYAEK---KDLEHYISKACNENIHENQARIWIRQIANALEYL- 125
+ L+++M+Y +D+ +E QIA Y+
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE-----------LQIA----YVC 107
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
E L YLHE G +HRDIK NIL++ + KLADFG S L +F GT +
Sbjct: 108 RETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYW 167
Query: 186 AAPEII---RNSPYNPKLADIWSLGV 208
APE+ R Y+ K DIW+LG+
Sbjct: 168 MAPEVAAVERKGGYDGK-CDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 73/210 (34%), Positives = 112/210 (53%), Gaps = 19/210 (9%)
Query: 15 LGEGAYGNVYLV---SDKRSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKVSHPNII 70
LG+G++G V+LV + + L A K LK RD + R DIL +V+HP I+
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMER--DILAEVNHPFIV 61
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+H + LY+I+D+ DL +SK E + YL E+A
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKF----------YLAELAL 109
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
AL++LH +GI++RD+K ENIL+ + KL DFG S+ ++ + +FCGT Y APE+
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
+ N + + AD WS GV+++ +L PF
Sbjct: 170 V-NRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 85/284 (29%), Positives = 132/284 (46%), Gaps = 35/284 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK-----FAPREIDILLKVSH 66
I +G GA+G V LV K S+ + Y K L + M K F E DI+ +
Sbjct: 48 IKVIGRGAFGEVQLVRHKSSKQV-----YAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
I+ +H + YLYM+M+Y DL + +S N +I E AR Y
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS---NYDIPEKWARF----------YTA 149
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGTTSY 185
E+ AL+ +H +G +HRD+K +N+L+ + + KLADFG ++ +T GT Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 186 AAPEIIRN---SPYNPKLADIWSLGVVLYRILNKKYPFGDP---GTRNRDVLKKQEGKEY 239
+PE++++ Y + D WS+GV LY +L PF GT ++ + K
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT-- 267
Query: 240 LFNRKYEISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNE 281
F EIS AK LI L R ++++H + +N+
Sbjct: 268 -FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 79/277 (28%), Positives = 132/277 (47%), Gaps = 30/277 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH---PNIIG 71
+G+G +G VY V K + + A K K + E +IL++ P I+G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + + LY++ DY +L ++ K E++A+ Y+ E+ A
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQK--EGRFSEDRAKF----------YIAELVLA 108
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
LE+LH+ IV+RD+K ENIL+ + L DFG S+ T + +NTFCGTT Y APE++
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR----KYEI 247
+ K D WSLGV+++ + PF T +Q + F + K +
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFGKVRFPKNVL 221
Query: 248 SIGAKQLIGRMLEPNPKHR----PNAKDVQNHAWIQN 280
S +Q + +L NP+HR +A +++ H + +
Sbjct: 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 77/281 (27%), Positives = 141/281 (50%), Gaps = 33/281 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVH 73
+G G+Y V LV K+++ + A K + + D + E + + S +P ++G+H
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + L+++++Y DL ++ + + E AR Y EI AL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQR--QRKLPEEHARF----------YAAEICIALN 110
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
+LHE GI++RD+K +N+L+ + KL D+G + P + ++TFCGT +Y APEI+R
Sbjct: 111 FLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE------- 246
Y + D W+LGV+++ ++ + PF D T N D+ ++YLF E
Sbjct: 171 EEYGFSV-DWWALGVLMFEMMAGRSPF-DIITDNPDM----NTEDYLFQVILEKPIRIPR 224
Query: 247 -ISIGAKQLIGRMLEPNPKHRPNAK------DVQNHAWIQN 280
+S+ A ++ L +PK R + D+++H + ++
Sbjct: 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 77/274 (28%), Positives = 130/274 (47%), Gaps = 29/274 (10%)
Query: 13 SKLGEGAYGNVY---LVSDKRSETLKACKAYDF--KRLKRDYMEKFAPREIDILLKVSHP 67
K+G+G + VY + D R LK + ++ + ++D + +EID+L ++ HP
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL-----KEIDLLKQLDHP 62
Query: 68 NIIGVHRMVKAGTY---LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
N+I + + + L ++++ A+ DL I + + IW +Y
Sbjct: 63 NVI---KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW--------KY 111
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
++ +ALE++H I+HRDIK N+ I+ KL D G R + +++ GT
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY--LFN 242
Y +PE I + YN K +DIWSLG +LY + + PF + KK E +Y L
Sbjct: 172 YMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPA 230
Query: 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276
Y S + L+ R + P+P+ RP+ V A
Sbjct: 231 DHY--SEELRDLVSRCINPDPEKRPDISYVLQVA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 39/277 (14%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACK---AYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
LG G++G+VY + A K D + ++ +++ +EI +L K+ HPNI+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE-QEIALLSKLQHPNIVQ 66
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ LY+ ++ L + K + E R++ RQI LEYLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD---- 120
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
VHRDIK NIL+ KLADFG ++ + +F G+ + APE+I
Sbjct: 121 ------RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK-SFKGSPYWMAPEVI 173
Query: 192 -RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN--RKYE-- 246
+ Y ADIWSLG + + K P+ EG +F R E
Sbjct: 174 AQQGGYGLA-ADIWSLGCTVLEMATGKPPWSQ-----------LEGVAAVFKIGRSKELP 221
Query: 247 -----ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
+S AK I + L+ +P RP A ++ H ++
Sbjct: 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 78/271 (28%), Positives = 120/271 (44%), Gaps = 22/271 (8%)
Query: 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGV 72
S +G G +G V +V +K + + A K L F E DIL + P I +
Sbjct: 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
+ LY++M+Y DL +++ + E+ A+ YL E+ A+
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQF----------YLAELVLAI 115
Query: 133 EYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGTTSYAAPEII 191
+H++G VHRDIK EN+LI R + KLADFG + RL S GT Y APE++
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 192 R------NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL-FNRK 244
Y + D WSLGV+ Y ++ + PF + GT + + +L F
Sbjct: 176 TTMNGDGKGTYGVE-CDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPED 233
Query: 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
++S LI +L K R + + H
Sbjct: 234 PKVSSDFLDLIQSLL-CGQKERLGYEGLCCH 263
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 85/288 (29%), Positives = 124/288 (43%), Gaps = 50/288 (17%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVH 73
+GEG YG VY K++ L A K D + D E+ E +IL K S HPNI +
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKE-EYNILRKYSNHPNIATFY 69
Query: 74 RMVK------AGTYLYMIMDYAEK---KDLEHYISKACNENIHENQARIWIRQIANALEY 124
L+++M+ DL + + + + E WI I
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL-RKKGKRLKEE----WIAYI------ 118
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
L E L YLHE ++HRDIK +NIL+++ KL DFG S L + NTF GT
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 185 YAAPEII-----RNSPYNPKLADIWSLGVVLYRILNKKYPFGD-PGTRN-----RDV--- 230
+ APE+I ++ Y+ + +D+WSLG+ + + K P D R R+
Sbjct: 179 WMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237
Query: 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
LK E FN I L N + RP +++ H +I
Sbjct: 238 LKSPENWSKKFN----------DFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 72/252 (28%), Positives = 117/252 (46%), Gaps = 12/252 (4%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G +G V K + + ACK D KRLK+ E+ A E IL KVS I+ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ L ++M DL+++I E +A Y +I LE+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF----------YAAQIICGLEH 110
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH+ IV+RD+K EN+L+ N +++D G + L+ K++ GT Y APE+++
Sbjct: 111 LHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG-RAGTPGYMAPEVLQGE 169
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQL 254
Y+ D ++LG LY ++ + PF + K+ E + S AK L
Sbjct: 170 VYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDL 228
Query: 255 IGRMLEPNPKHR 266
+L+ +P+ R
Sbjct: 229 CEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-28
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM-EKFAPREIDILLKVSHPNI 69
+ +GEGAYG V +K + + A K FK + D +K A RE+ +L ++ H NI
Sbjct: 5 VLGVVGEGAYGVVLKCRNKATGEIVAIK--KFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ + + LY++ +Y E+ LE + ++ IW ++
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW------------QLL 110
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT-FCGTTSYAAP 188
A+ Y H I+HRDIK ENIL+S KL DFGF+R LR T + T Y AP
Sbjct: 111 QAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL 231
E++ K D+W++G ++ +L+ + F PG + D L
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF--PGDSDIDQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 93/298 (31%), Positives = 134/298 (44%), Gaps = 54/298 (18%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-RDYMEK-FAPREIDILLKVSHPN 68
I + GAYG VYLV K + A K + + L R+ +++ F R DIL +P
Sbjct: 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER--DILTFAENPF 62
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHE---NQARIWIRQIANALEYL 125
++ + + +L M+M+Y E D + +NI + AR+ Y
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLL-----KNIGALPVDMARM----------YF 107
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL---------------LR 170
E ALEYLH GIVHRD+K +N+LI+ + + KL DFG S++
Sbjct: 108 AETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 171 TPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GDP-----G 224
T + L CGT Y APE+I Y K D W++G++LY L PF GD G
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226
Query: 225 TRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHR---PNAKDVQNHAWIQ 279
D ++ EG E L A+ LI R+L NP R A +V+ H +
Sbjct: 227 QVISDDIEWPEGDEAL-------PADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 82/274 (29%), Positives = 134/274 (48%), Gaps = 38/274 (13%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM---EKFAPR--EIDILLKVSHPNI 69
LG+G +G V LV +K + K Y K LK++ + ++ A E +L HP +
Sbjct: 3 LGKGTFGKVILVREKATG-----KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ + L +M+YA +L ++S+ E++AR Y EI
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARF----------YGAEIV 105
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
+AL YLH +V+RD+K EN+++ + + K+ DFG + + TFCGT Y APE
Sbjct: 106 SALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---GKEYLFNRKYE 246
++ ++ Y + D W LGVV+Y ++ + PF N+D K E +E F R
Sbjct: 166 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLFELILMEEIRFPRT-- 217
Query: 247 ISIGAKQLIGRMLEPNPKHR-----PNAKDVQNH 275
+S AK L+ +L+ +PK R +AK++ H
Sbjct: 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 30/279 (10%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKR---LKRDYME--KFAPREIDILLKVSH 66
++ LG G +G V L K++ L A KA K+ + RD +E R + H
Sbjct: 4 LAVLGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P ++ + + ++ +M+YA DL +I + E +A Y
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVF----------YAA 108
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
+ L+YLHE IV+RD+K +N+L+ K+ADFG + + ++TFCGT +
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFL 168
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246
APE++ + Y + D W LGV++Y +L + PF PG +V E + R
Sbjct: 169 APEVLTETSYT-RAVDWWGLGVLIYEMLVGESPF--PGDDEEEVFDSIVNDEVRYPR--F 223
Query: 247 ISIGAKQLIGRMLEPNPKHR-----PNAKDVQNHAWIQN 280
+S A ++ R+L NP+ R +A+DV+ + ++
Sbjct: 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 76/281 (27%), Positives = 136/281 (48%), Gaps = 31/281 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVH 73
+G G+Y V LV K++ + A K + + D + E + S HP ++G+H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + L+ ++++ DL ++ + + E AR Y EI+ AL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQR--QRKLPEEHARF----------YSAEISLALN 110
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
+LHE GI++RD+K +N+L+ + KL D+G + P + ++TFCGT +Y APEI+R
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE------- 246
Y + D W+LGV+++ ++ + PF G + Q ++YLF E
Sbjct: 171 EDYGFSV-DWWALGVLMFEMMAGRSPFDIVGMSDN---PDQNTEDYLFQVILEKQIRIPR 226
Query: 247 -ISIGAKQLIGRMLEPNPKHRPNAK------DVQNHAWIQN 280
+S+ A ++ L +PK R D+++H + +N
Sbjct: 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 81/277 (29%), Positives = 125/277 (45%), Gaps = 38/277 (13%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSH---PN 68
+G GAYG VY R + + + K + D + RE+ +L ++ PN
Sbjct: 9 IGRGAYGAVY-----RGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I + G L++IM+YAE + + I E + IR E+
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIR----------EV 110
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
AL+Y+H+VG++HRDIK NIL++ N KL DFG + LL +TF GT + AP
Sbjct: 111 LVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD-PGTRNRDVLKKQ-----EGKEYLFN 242
E+I Y ADIWSLG+ +Y + P+ D R ++ K E Y
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGY--- 227
Query: 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
S ++ + L+ PK R +A+++ WI+
Sbjct: 228 -----SKLLREFVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 86/312 (27%), Positives = 146/312 (46%), Gaps = 61/312 (19%)
Query: 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD-YMEKF---APREIDI 60
D E ++++ EG YG VY DK++ + A K+LK + E F + REI+I
Sbjct: 5 DEYEK--LNRIEEGTYGVVYRARDKKTGEIVA-----LKKLKMEKEKEGFPITSLREINI 57
Query: 61 LLKVSHPNIIGVHRMVKAGTYL---YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQ 117
LLK+ HPNI+ V +V G+ L YM+M+Y E DL K+ E + + + ++
Sbjct: 58 LLKLQHPNIVTVKEVV-VGSNLDKIYMVMEYVE-HDL-----KSLMETMKQPFLQSEVKC 110
Query: 118 IANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSN 177
+ + ++ + + +LH+ I+HRD+K N+L++ K+ DFG +R +P +
Sbjct: 111 L------MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT 164
Query: 178 TFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL----- 231
T Y APE++ + Y+ + D+WS+G + +L KK F PG D L
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLF--PGKSEIDQLNKIFK 221
Query: 232 -------------------KKQEGKEYLFNR------KYEISIGAKQLIGRMLEPNPKHR 266
KK+ +Y +N+ +S L+ R+L +P R
Sbjct: 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKR 281
Query: 267 PNAKDVQNHAWI 278
+A+D H +
Sbjct: 282 ISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 74/261 (28%), Positives = 125/261 (47%), Gaps = 29/261 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G +G V V K + + ACK D KRLK+ EK A E +IL KV+ P I+ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
++ T+L ++M DL+++I + + + Y +I + +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER----------VIHYSAQITCGILH 110
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH + IV+RD+K EN+L+ N +L+D G + L+ K ++ GT Y APEI++
Sbjct: 111 LHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR-AGTNGYMAPEILKEE 169
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG---- 250
PY+ + D +++G +Y ++ + PF D K++ KE L R E +
Sbjct: 170 PYSYPV-DWFAMGCSIYEMVAGRTPFKD--------HKEKVAKEELKRRTLEDEVKFEHQ 220
Query: 251 -----AKQLIGRMLEPNPKHR 266
+K + L P+ R
Sbjct: 221 NFTEESKDICRLFLAKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 78/280 (27%), Positives = 132/280 (47%), Gaps = 44/280 (15%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPR-----EIDILLKVSH 66
++++G+G YG V+L K + + A KR+K+ + K E DIL
Sbjct: 6 LTQVGQGGYGQVFLAKKKDTGEIVA-----LKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENI-HENQARIWIRQIANALEYL 125
++ + + YLY+ M+Y D + N + E+ AR Y+
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARF----------YM 107
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
E+ A++ LHE+G +HRD+K EN LI + KL DFG S+ + T +N+ G+ Y
Sbjct: 108 AEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDY 164
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN---------RDVLKKQEG 236
APE++R Y+ + D WSLG +LY L PF T N ++ L++
Sbjct: 165 MAPEVLRGKGYDFTV-DYWSLGCMLYEFLCGFPPF-SGSTPNETWENLKYWKETLQRPVY 222
Query: 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNA-KDVQNH 275
+ ++ +S A LI +++ +P R + +D++NH
Sbjct: 223 DD----PRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNH 257
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 9e-27
Identities = 77/276 (27%), Positives = 137/276 (49%), Gaps = 21/276 (7%)
Query: 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK 63
P L +YI K+GEG+ G V + +K S A K D ++ +R + E+ I+
Sbjct: 19 PRSLLENYI-KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRD 74
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
H N++ +++ G L+++M++ + L +S Q R+ QIA E
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----------QTRLNEEQIATVCE 124
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
+ AL YLH G++HRDIK ++IL++ KL+DFGF + + GT
Sbjct: 125 ---SVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP 181
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP-FGDPGTRNRDVLKKQEGKEYLFN 242
+ APE+I +PY ++ DIWSLG+++ +++ + P F D + L+ +
Sbjct: 182 YWMAPEVISRTPYGTEV-DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK--LK 238
Query: 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
++IS + + RML P+ R A+++ +H ++
Sbjct: 239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK-------FAPREIDILLKVSHP 67
LG+G++G V L K ++ + Y K LK+D + + + I + L HP
Sbjct: 3 LGKGSFGKVMLAELKGTD-----EVYAIKVLKKDVILQDDDVDCTMTEKRI-LALAAKHP 56
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+ +H + L+ +M+Y DL I ++ E ++R Y E
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRF----------YAAE 104
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ AL +LH G+++RD+K +NIL+ + KLADFG + + TFCGT Y A
Sbjct: 105 VTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIA 164
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
PEI++ Y P + D W+LGV++Y ++ + PF
Sbjct: 165 PEILQELEYGPSV-DWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 16/211 (7%)
Query: 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP 67
+ ++GEGA+G V+ D+ + A K +RL+ + A REI L HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHP 59
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
++ + + G+ ++M+Y DL + + + E Q + Y+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYM-PSDL-SEVLRDEERPLPEAQVK----------SYMRM 107
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF-CGTTSYA 186
+ + Y+H GI+HRD+K N+LIS K+ADFG +RL + + T Y
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYR 167
Query: 187 APEIIRNSP-YNPKLADIWSLGVVLYRILNK 216
APE++ + Y+P D+W++G + +LN
Sbjct: 168 APELLYGARKYDP-GVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 83/349 (23%), Positives = 142/349 (40%), Gaps = 78/349 (22%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACK--------AYDFKRLKRDYMEKFAPREIDILL 62
+ +G GAYG V DKR+ A K D KR REI +L
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR---------ILREIKLLR 54
Query: 63 KVSHPNIIGVHRMVKAGTY-----LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQ 117
+ H NIIG+ +++ + +Y++ + E DL H + K+ + + ++ + ++ Q
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDL-HKVIKS-PQPLTDDHIQYFLYQ 111
Query: 118 IANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSN 177
I L+YLH ++HRD+K NIL++ + K+ DFG +R + ++
Sbjct: 112 ----------ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
Query: 178 TFCG---TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK- 233
T Y APE++ +S K DIWS+G + +L +K F PG D L
Sbjct: 162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF--PGRDYIDQLNLI 219
Query: 234 -----------------QEGKEYLFNRKY-----------EISIGAKQLIGRMLEPNPKH 265
++ + YL + S A L+ +ML +PK
Sbjct: 220 VEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKK 279
Query: 266 RPNAKDVQNHAWIQ------NEPTCQTMTA---EEREALKIGKLKSKVF 305
R A + H ++ +EP + + + L +LK ++
Sbjct: 280 RITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEELKELIY 328
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 71/224 (31%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKA-YDFKRLKRDYMEKFAPREIDILL 62
+ E ++++G GA G VY V + + L A K Y D + + REI+IL
Sbjct: 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILR 127
Query: 63 KVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLE-HYISKACNENIHENQARIWIRQIANA 121
V+HPN++ H M + +++++ + LE +I+ E RQI +
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA-------DEQFLADVARQILSG 180
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
+ YLH IVHRDIK N+LI+ N K+ADFG SR+L + N+ G
Sbjct: 181 IAYLHRRH----------IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVG 230
Query: 182 TTSYAAPEII----RNSPYNPKLADIWSLGVVLYRILNKKYPFG 221
T +Y +PE I + Y+ DIWSLGV + ++PFG
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
|
Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 18/209 (8%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKR---LKRDYMEKFAPREIDILLKVSHPNIIG 71
LG+G++G V L K S L A K K+ L+ D +E + + L +HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + L+ +M++ DL +I K+ E +AR Y EI +A
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARF----------YAAEITSA 108
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
L +LH+ GI++RD+K +N+L+ + KLADFG + + ++TFCGT Y APEI+
Sbjct: 109 LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPF 220
+ Y P D W++GV+LY +L PF
Sbjct: 169 QEMLYGP-SVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 78/298 (26%), Positives = 131/298 (43%), Gaps = 51/298 (17%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----REIDILLKVSHP 67
+ K+GEG YG VY DK + + A K+++ + ++ P REI +L +++HP
Sbjct: 4 VEKIGEGTYGVVYKARDKLTGEIVA-----LKKIRLETEDEGVPSTAIREISLLKELNHP 58
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
NI+ + +V + LY++ ++ + DL+ Y+ + + + YL++
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIK----------SYLYQ 107
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ + Y H ++HRD+K +N+LI R KLADFG +R P T Y A
Sbjct: 108 LLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GDP------------GTRNRDVLKKQ 234
PEI+ S DIWS+G + ++N++ F GD GT + DV
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP-- 225
Query: 235 EGKEYLFNRK---------------YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAW 277
G L + K + L+ +ML +P R +AK H +
Sbjct: 226 -GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 78/282 (27%), Positives = 129/282 (45%), Gaps = 57/282 (20%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD-----------YMEKFAPREIDILLK 63
LG+G++G V L K + A KA LK+D +E+ + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKA-----LKKDVVLEDDDVECTMVERRV-----LALA 52
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
HP + + + +L+ +M+Y DL +I + E +AR
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS--GRFDEARARF---------- 100
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
Y EI L++LH+ GI++RD+K +N+L+ + + K+ADFG + + ++TFCGT
Sbjct: 101 YAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243
Y APEI++ YN + D WS GV+LY +L + PF E ++ LF+
Sbjct: 161 DYIAPEILKGQKYNESV-DWWSFGVLLYEMLIGQSPF------------HGEDEDELFDS 207
Query: 244 ---------KYEISIGAKQLIGRMLEPNPKHRPNAK-DVQNH 275
++ IS AK + ++ E +P R D++ H
Sbjct: 208 ILNDRPHFPRW-ISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 74/287 (25%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 12 ISKLGEGAYGNVY-LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
I +G GA VY + +E + A K D + K +E+ + + +HPN++
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKV-AIKRIDLE--KCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ G L+++M Y L + + + IA L E+
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI------IAT---VLKEVLK 113
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS----NTFCGTTSYA 186
LEYLH G +HRDIK NIL+ + K+ADFG S L + + TF GT +
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 187 APEIIRNSP-YNPKLADIWSLGVVLYRILN-----KKYP---------FGDPGTRNRDVL 231
APE++ Y+ K ADIWS G+ + KYP DP +
Sbjct: 174 APEVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232
Query: 232 KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
K+ K + +++I L+ +P RP A+++ H +
Sbjct: 233 YKKYSKSF------------RKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 77/302 (25%), Positives = 124/302 (41%), Gaps = 64/302 (21%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY---MEKFAPREIDILLKVS-HP 67
+ K+GEG + V +++ A K +K+ + + REI L ++S HP
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIK-----CMKKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 68 NIIGVHRMV---KAG--TYLYMIMD---YAEKKDLEHYISKACNENIHENQARIWIRQIA 119
NI+ + ++ K G ++ +MD Y K + + E + + ++ Q+
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLP--------EKRVKSYMYQLL 110
Query: 120 NALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF 179
+L+++H GI HRDIK ENILI + KLADFG R + + K +
Sbjct: 111 KSLDHMHRN----------GIFHRDIKPENILI-KDDILKLADFGSCRGIYS-KPPYTEY 158
Query: 180 CGTTSYAAPE-IIRNSPYNPKLADIWSLGVVLYRILNKKYPF----------------GD 222
T Y APE ++ + Y PK+ DIW++G V + IL+ F G
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKM-DIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT 217
Query: 223 PGTRNRDVLKKQEGKEYLFNRKY---------EISIGAKQLIGRMLEPNPKHRPNAKDVQ 273
P +K Y F K S L+ ++L +P R AK
Sbjct: 218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
Query: 274 NH 275
H
Sbjct: 278 RH 279
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 79/264 (29%), Positives = 113/264 (42%), Gaps = 23/264 (8%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILL--KVSHPNIIGV 72
LG+G YG VY D ++ A K + P +I L + H NI+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYI-SKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + M+ L + SK +E + +QI LE
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI---LE-------G 120
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNA-KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
L+YLH+ IVHRDIK +N+L++ K++DFG S+ L + TF GT Y APE+
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEV 180
Query: 191 IRNSP--YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248
I P Y ADIWSLG + + K PF + G + K K + +S
Sbjct: 181 IDKGPRGYGAP-ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP-EIPESLS 238
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDV 272
AK I R EP+P R +A D+
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 26/272 (9%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPNIIG 71
LG GA+ + Y D ++ TL A K + R E+ +EI ++ +++HP+II
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISK--ACNENIHENQARIWIRQIANALEYLHEIA 129
+ ++ + +++ + H +SK A E + + Y ++
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV--------------IINYTEQLL 113
Query: 130 NALEYLHEVGIVHRDIKCENILI-SRLLNAKLADFGFSRLLRT----PKELSNTFCGTTS 184
L YLHE I+HRD+K N+LI S ++ADFG + L E GT +
Sbjct: 114 RGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLKKQEGKEYLFNR 243
+ APE++R Y + D+WS+G V+ + K P+ N ++ K +
Sbjct: 174 FMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232
Query: 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+S G + + R LE P+ RP ++++ H
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 82/277 (29%), Positives = 126/277 (45%), Gaps = 40/277 (14%)
Query: 15 LGEGAYGNVYLVSDK-RSETLKACKAYD-----FKRLKRDYMEKFAP--REIDILLK-VS 65
LG GA+G VY V K + L A K + F + KR+ + E+ I+ + +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDL-EHYIS-KACNENIHENQARIW--IRQIANA 121
HPNI+ ++ LY++MD E L EH+ S K + E RIW Q+ A
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE--RIWNIFVQMVLA 125
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
L YLH+ E IVHRD+ NI++ + DFG ++ + P+ + G
Sbjct: 126 LRYLHK---------EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVG 175
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241
T Y+ PEI++N PY K AD+W+ G +LY++ + PF + N L + +
Sbjct: 176 TILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPF---YSTNMLSLATK-----IV 226
Query: 242 NRKYE------ISIGAKQLIGRMLEPNPKHRPNAKDV 272
YE S +I L P+ + RP+ V
Sbjct: 227 EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 90/300 (30%), Positives = 135/300 (45%), Gaps = 42/300 (14%)
Query: 11 YISK-LGEGAYGNVYLVSDKRSETLKACKAYDFKRL-KRDYMEKFAPREIDILLKVSHPN 68
+IS+ LG GA G V A K D + + + D A E+ LL +
Sbjct: 35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNR--AQAEVCCLLNCDFFS 92
Query: 69 IIGVHR-MVKAG-------TYLYMIMDYAEKKDLEHYI---SKACNENIHENQARIWIRQ 117
I+ H K + +++DYA DL I +K N E++A + Q
Sbjct: 93 IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQ 151
Query: 118 IANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL--RTPKEL 175
+ A+ ++H H ++HRDIK NIL+ KL DFGFS++ ++
Sbjct: 152 VLLAVHHVHS-------KH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 176 SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235
TFCGT Y APEI R PY+ K AD++SLGV+LY +L K PF G +V+ K
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFD--GENMEEVMHKTL 258
Query: 236 GKEY--LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEERE 293
Y L IS ++++ +L +PK RP++ + N P C+ + E
Sbjct: 259 AGRYDPLPP---SISPEMQEIVTALLSSDPKRRPSSSK------LLNMPICKLFISGLLE 309
|
Length = 496 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----REIDILLKVSHP 67
+ K+GEG YG VY +K + + A K+++ D + P REI +L +++HP
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVA-----LKKIRLDTETEGVPSTAIREISLLKELNHP 59
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
NI+ + ++ LY++ ++ + DL+ ++ + I + YL +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIK----------SYLFQ 108
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ L + H ++HRD+K +N+LI+ KLADFG +R P T Y A
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL 231
PEI+ Y DIWSLG + ++ ++ F PG D L
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 21/223 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +GEG+YG V K + + A K + + ++K A REI +L ++ H N++
Sbjct: 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 72 VHRMVKAGTYLYMIMDYAEK---KDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+ + + LY++ ++ + DLE Y N + E++ R +YL +I
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKY----PN-GLDESRVR----------KYLFQI 109
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
+E+ H I+HRDIK ENIL+S+ KL DFGF+R L P E+ + T Y AP
Sbjct: 110 LRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAP 169
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL 231
E++ + DIW++G ++ +L + F PG + D L
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF--PGDSDIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 82/294 (27%), Positives = 129/294 (43%), Gaps = 52/294 (17%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDIL------LK 63
+++ LG+G++G V L K ++ L Y K LK+D + + E ++ L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDEL-----YAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
P + +H + LY +M+Y DL ++I + E A
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVF---------- 105
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
Y EIA L +LH GI++RD+K +N+++ + K+ADFG + + + TFCGT
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP 165
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243
Y APEII PY K D W+ GV+LY +L + PF E ++ LF
Sbjct: 166 DYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPF------------DGEDEDELFQS 212
Query: 244 KYE--------ISIGAKQLIGRMLEPNPKHR----PNA-KDVQNHA---WIQNE 281
E +S A + +L +P R P +D++ HA I E
Sbjct: 213 IMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 83/281 (29%), Positives = 136/281 (48%), Gaps = 42/281 (14%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREI-------DILLKVSHP 67
LG+G +G V LV +K + + Y K L+++ + A E+ +L HP
Sbjct: 3 LGKGTFGKVILVREKATG-----RYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHP 55
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+ + + L +M+YA +L ++S+ E +AR Y E
Sbjct: 56 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARF----------YGAE 103
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
I +ALEYLH +V+RDIK EN+++ + + K+ DFG + + TFCGT Y A
Sbjct: 104 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---GKEYLFNRK 244
PE++ ++ Y + D W LGVV+Y ++ + PF N+D + E +E F R
Sbjct: 164 PEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPF-----YNQDHERLFELILMEEIRFPRT 217
Query: 245 YEISIGAKQLIGRMLEPNPKHR----PN-AKDVQNHAWIQN 280
+S AK L+ +L+ +PK R P+ AK+V H + +
Sbjct: 218 --LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-25
Identities = 71/263 (26%), Positives = 118/263 (44%), Gaps = 9/263 (3%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G G + VY + A K L +EID+L +++HPN+I +
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
L ++++ A+ DL I + + +W +Y ++ +ALE
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--------KYFVQLCSALE 120
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
++H ++HRDIK N+ I+ KL D G R + +++ GT Y +PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQ 253
+ YN K +DIWSLG +LY + + PF + KK E +Y S +Q
Sbjct: 181 NGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239
Query: 254 LIGRMLEPNPKHRPNAKDVQNHA 276
L+ + P+P+ RP+ V + A
Sbjct: 240 LVNMCINPDPEKRPDITYVYDVA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 79/281 (28%), Positives = 126/281 (44%), Gaps = 38/281 (13%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACK-------AYDFKRLKRDYMEKFAPREIDILLKVSHP 67
+G G++G+VYL + S L A K + K KR ++ A REI +L ++ H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA-REIALLKELQHE 66
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKD----LEHYISKACNENIHENQARIWIRQIANALE 123
NI+ +L + ++Y L +Y + E R ++RQI L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA------FEETLVRNFVRQILKGLN 120
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR------LLRTPKELSN 177
YLH GI+HRDIK NIL+ K++DFG S+ L
Sbjct: 121 YLHN----------RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 178 TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237
+ G+ + APE+++ + Y K ADIWSLG ++ +L K+PF D T+ + + K G+
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDC-TQLQAIFKI--GE 226
Query: 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
IS A + + E + RP A ++ H ++
Sbjct: 227 NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 29/268 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG G++G V + K + A K + + + + +E IL+++SHP I+ +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN--ALEYLHEIANAL 132
+ +Y ++++ +L ++ KA + N A Y E+ A
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKA--------------GRFPNDVAKFYHAELVLAF 131
Query: 133 EYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR 192
EYLH I++RD+K EN+L+ + K+ DFGF++ + + + T CGT Y APE+I+
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DRTFTLCGTPEYLAPEVIQ 188
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252
+ + K D W++GV+LY + PF D T R K G+ F ++ A+
Sbjct: 189 SKGHG-KAVDWWTMGVLLYEFIAGYPPFFDD-TPFRIYEKILAGR-LKFPNWFDGR--AR 243
Query: 253 QLIGRMLEPNPKHR-----PNAKDVQNH 275
L+ +L+ + R DV+NH
Sbjct: 244 DLVKGLLQTDHTKRLGTLKGGVADVKNH 271
|
Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 81/267 (30%), Positives = 125/267 (46%), Gaps = 19/267 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ ++G+G++G V+ D R++ + A K D + + D +E +EI +L + P +
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQ-QEITVLSQCDSPYVTK 66
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ GT L++IM+Y + + QIA L+ EI
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF----------QIATMLK---EILKG 113
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
L+YLH +HRDIK N+L+S + KLADFG + L + NTF GT + APE+I
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
+ S Y+ K ADIWSLG+ + + P D L + L E S
Sbjct: 174 QQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTG---EFSKPF 229
Query: 252 KQLIGRMLEPNPKHRPNAKDVQNHAWI 278
K+ I L +P RP AK++ H +I
Sbjct: 230 KEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-24
Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 24/268 (8%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP--REIDILLKVSHPNIIGV 72
LG+GA+G VYL D + A K F + ++ EI +L + H I+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISK--ACNENIHENQARIWIRQIANALEYLHEIAN 130
+ ++ L + M+Y ++ + A E + R + RQI +EYLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVEYLHS--- 122
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT---PKELSNTFCGTTSYAA 187
+ IVHRDIK NIL N KL DFG S+ L+T + GT + +
Sbjct: 123 -----NM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247
PE+I Y K AD+WS+G + +L +K P+ + + K + +
Sbjct: 176 PEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAE--FEAMAAIFKIATQPTNPQLPSHV 232
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
S A+ + R N K RP+A+++ H
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRH 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 72/274 (26%), Positives = 132/274 (48%), Gaps = 22/274 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+GEG+ G V + + K S L A K D ++ +R + E+ I+ H N++ ++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMY 83
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
G L+++M++ E L ++ R+ QIA + AL
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVT----------HTRMNEEQIAAVCL---AVLKALS 130
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
LH G++HRDIK ++IL++ KL+DFGF + + GT + APE+I
Sbjct: 131 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR 190
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYP-FGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252
PY P++ DIWSLG+++ +++ + P F +P + +++ + +++S K
Sbjct: 191 LPYGPEV-DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK--LKNLHKVSPSLK 247
Query: 253 QLIGRMLEPNPKHRPNAKDVQNHAWIQNE--PTC 284
+ R+L +P R A ++ H ++ P+C
Sbjct: 248 GFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSC 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 78/318 (24%), Positives = 122/318 (38%), Gaps = 76/318 (23%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRL----KRDYMEKFAPREIDILLKVSHPNI 69
KLGEG +G VY ++ +K + K++ ++D A REI IL K+ HPN+
Sbjct: 15 KLGEGTFGEVY-----KARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 70 IGVHRMV--------KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
+ + M + +YM+ Y + DL + N ++ ++ QI
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE---NPSVKLTES-----QIKC- 119
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
Y+ ++ + YLHE I+HRDIK NILI K+ADFG +R P G
Sbjct: 120 --YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 182 -----------TTSYAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227
T Y PE++ R Y + DIW +G V + ++ G +
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERR--YTTAV-DIWGIGCVFAEMFTRRPIL--QGKSD 232
Query: 228 RDVLKK---------QE---GKEYLFNRKYEISIGAKQ----------------LIGRML 259
D L +E G L + S L+ ++L
Sbjct: 233 IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLL 292
Query: 260 EPNPKHRPNAKDVQNHAW 277
+P R A D H +
Sbjct: 293 SLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-24
Identities = 77/301 (25%), Positives = 132/301 (43%), Gaps = 57/301 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYME---KFAPREIDILLKVSHPN 68
+ KLGEG Y VY ++ + + A K + D E A REI ++ ++ H N
Sbjct: 5 LEKLGEGTYATVYKGRNRTTGEIVA-----LKEIHLDAEEGTPSTAIREISLMKELKHEN 59
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I+ +H ++ L ++ +Y +K DL+ Y+ + H + + + + + +++
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDK-DLKKYM------DTHGVRGALDPNTVKS---FTYQL 109
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG---TTSY 185
+ + HE ++HRD+K +N+LI++ KLADFG +R P NTF T Y
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---VNTFSNEVVTLWY 166
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------------ 233
AP+++ S DIWS+G ++ ++ + F PGT N D L K
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF--PGTNNEDQLLKIFRIMGTPTEST 224
Query: 234 ----QEGKEYLFNRKYEISIGAKQ-------------LIGRMLEPNPKHRPNAKDVQNHA 276
+ EY + L+ R+L+ NP+ R +A D H
Sbjct: 225 WPGISQLPEY--KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282
Query: 277 W 277
W
Sbjct: 283 W 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 87/282 (30%), Positives = 136/282 (48%), Gaps = 41/282 (14%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYD-FKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+G GA+G V +V K + + A K + ++ LKR F E D+L+ I +H
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFR-EERDVLVNGDRRWITNLH 67
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ LY++MDY DL +SK + + E+ AR YL E+ A++
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARF----------YLAEMVLAID 116
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGTTSYAAPEIIR 192
+H++G VHRDIK +N+L+ + + +LADFG RLL SN GT Y +PEI++
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 193 -----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK--- 244
Y P+ D WSLGV +Y +L + PF + L + GK + N K
Sbjct: 177 AMEDGKGRYGPE-CDWWSLGVCMYEMLYGETPF------YAESLVETYGK--IMNHKEHF 227
Query: 245 ------YEISIGAKQLIGRMLEPNPKHR---PNAKDVQNHAW 277
++S AK LI R++ P+ R +D ++H +
Sbjct: 228 QFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 6e-24
Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G+GA G VY D + A K + L++ ++ EI ++ + HPNI+
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
G L+++M+Y L +++ C + QIA E ALE
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----------GQIAAVCR---ECLQALE 129
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
+LH ++HRDIK +NIL+ + KL DFGF + + +T GT + APE++
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQ 253
Y PK+ DIWSLG++ ++ + P+ + L G L N + ++S +
Sbjct: 190 KAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE-KLSAIFRD 247
Query: 254 LIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+ R LE + + R +AK++ H +++
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-23
Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 19/267 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ ++G+G++G VY D R++ + A K D + + D +E +EI +L + P I
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQ-QEITVLSQCDSPYITR 66
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ GT L++IM+Y + E + IA L EI
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETY----------IATILR---EILKG 113
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
L+YLH +HRDIK N+L+S + KLADFG + L + NTF GT + APE+I
Sbjct: 114 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
+ S Y+ K ADIWSLG+ + + P D L + L + + S
Sbjct: 174 KQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL---EGQYSKPF 229
Query: 252 KQLIGRMLEPNPKHRPNAKDVQNHAWI 278
K+ + L +P+ RP AK++ H +I
Sbjct: 230 KEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-23
Identities = 70/259 (27%), Positives = 126/259 (48%), Gaps = 13/259 (5%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G +G V + + L ACK + KRLK+ + A E IL KV I+ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ T L ++M DL ++I EN + R A Y +I + LE+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPR--------ACFYTAQIISGLEH 112
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH+ I++RD+K EN+L+ N +++D G + L+ + + + GT + APE+++
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--NRDVLKKQEGKEYLFNRKYEISIGAK 252
Y+ + D ++LGV LY ++ + PF G + N+++ ++ + K+ S +K
Sbjct: 173 EYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKF--SPASK 229
Query: 253 QLIGRMLEPNPKHRPNAKD 271
+L +P+ R +D
Sbjct: 230 SFCEALLAKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-23
Identities = 73/273 (26%), Positives = 133/273 (48%), Gaps = 38/273 (13%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREID-------ILLKVSHP 67
+G+G++G V V + ++ + Y K +++ ++ + E+ +L +V+ P
Sbjct: 1 IGKGSFGKVMQVRKRDTQ-----RIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCP 53
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
I+ + ++ LY+++ + +L H++ + + ++AR Y E
Sbjct: 54 FIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFD--LSRARF----------YTAE 101
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ ALE LH+ +++RD+K ENIL+ + L DFG +L + +NTFCGT Y A
Sbjct: 102 LLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLA 161
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN--RDVLKKQEGKEYLFNRKY 245
PE++ Y K D W+LGV+LY +L PF D R +L++ F+R
Sbjct: 162 PELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRD- 219
Query: 246 EISIGAKQLIGRMLEPNPKHR---PNAKDVQNH 275
AK L+ +L +P R A++++NH
Sbjct: 220 -----AKDLLIGLLSRDPTRRLGYNGAQEIKNH 247
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 24/228 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDILLKVSHPNII 70
+G G +G V K K K LK +K F E I+ + HPNII
Sbjct: 12 IGGGEFGEVCRGRLK--LPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNII 68
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ +V + +I +Y E L+ ++ EN + + Q+ + L IA+
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--------RENDGKFTVGQL---VGMLRGIAS 117
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS--YAAP 188
++YL E+ VHRD+ NIL++ L K++DFG SR L + T G + AP
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQE 235
E I + +D+WS G+V++ +++ + P+ D N+DV+K E
Sbjct: 178 EAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD--MSNQDVIKAVE 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-23
Identities = 60/209 (28%), Positives = 112/209 (53%), Gaps = 23/209 (11%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD-YMEKFAPREIDILLKVSHPNII 70
+SK+GEG+YG V+ ++ + + A K F + D ++K A REI +L ++ HPN++
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 71 GVHRMVKAGTYLYMIMDYAEK---KDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+ + + L+++ +Y + +LE + E++ I++I + +
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNELEKN-PRGVPEHL--------IKKI------IWQ 108
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
A+ + H+ +HRD+K ENILI++ KL DFGF+R+L P + + T Y A
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRA 168
Query: 188 PE-IIRNSPYNPKLADIWSLGVVLYRILN 215
PE ++ ++ Y P + D+W++G V +L
Sbjct: 169 PELLVGDTQYGPPV-DVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-23
Identities = 74/286 (25%), Positives = 136/286 (47%), Gaps = 21/286 (7%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G+GA G V+ D + A K + ++ + ++ EI ++ ++ +PNI+
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFL 82
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
G L+++M+Y L +++ C + QIA E ALE
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA----------QIAAVCR---ECLQALE 129
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
+LH ++HRDIK +N+L+ + KL DFGF + + +T GT + APE++
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQ 253
Y PK+ DIWSLG++ ++ + P+ + L G L N + ++S +
Sbjct: 190 KAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE-KLSPIFRD 247
Query: 254 LIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTA---EEREALK 296
+ R LE + + R +AK++ H +++ ++T +EA+K
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKEAMK 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-23
Identities = 73/278 (26%), Positives = 132/278 (47%), Gaps = 30/278 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+GEG+ G V + ++K + A K D ++ +R + E+ I+ H N++ ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR---RELLFNEVVIMRDYHHENVVDMY 85
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
G L+++M++ E L ++ R+ QIA + AL
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVT----------HTRMNEEQIATVC---LSVLRALS 132
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
YLH G++HRDIK ++IL++ KL+DFGF + + GT + APE+I
Sbjct: 133 YLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR 192
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYP-FGDPG----TRNRDVLKKQEGKEYLFNRKYEIS 248
PY ++ DIWSLG+++ +++ + P F +P R RD L + +++S
Sbjct: 193 LPYGTEV-DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------VKDSHKVS 245
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ--NEPTC 284
+ + ML P R A+++ H +++ P+C
Sbjct: 246 SVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-23
Identities = 78/276 (28%), Positives = 141/276 (51%), Gaps = 25/276 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR--DYMEKFAPREIDILLKVSHPNI 69
I +LG+GA+G VY +K + L A K + K + DYM EI+IL +HP I
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-----EIEILATCNHPYI 71
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ + L++++++ ++ I + + E Q ++ RQ+ LE
Sbjct: 72 VKLLGAFYWDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVICRQM---LE------ 121
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
AL+YLH + I+HRD+K N+L++ + KLADFG S + ++F GT + APE
Sbjct: 122 -ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 190 II-----RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244
++ +++PY+ K ADIWSLG+ L + + P + R +LK + + ++
Sbjct: 181 VVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPTLSQP 238
Query: 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ S+ + + L+ +P+ RP+A + H ++ +
Sbjct: 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-23
Identities = 74/268 (27%), Positives = 126/268 (47%), Gaps = 21/268 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAY--DFKRLKRDYMEKFAPREIDILLKVSHPNIIGV 72
LG+G++G V+L K + A KA D + D + + + L HP + +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHL 61
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
+ + L+ +M+Y DL +I ++C++ + A Y EI L
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHI-QSCHK-----------FDLPRATFYAAEIICGL 109
Query: 133 EYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR 192
++LH GIV+RD+K +NIL+ + K+ADFG + + TFCGT Y APEI+
Sbjct: 110 QFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252
YN + D WS GV+LY +L + PF G ++ + + R ++ AK
Sbjct: 170 GQKYNTSV-DWWSFGVLLYEMLIGQSPFH--GHDEEELFQSIRMDNPCYPR--WLTREAK 224
Query: 253 QLIGRMLEPNPKHRPNAK-DVQNHAWIQ 279
++ ++ P+ R K D++ H + +
Sbjct: 225 DILVKLFVREPERRLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-23
Identities = 67/258 (25%), Positives = 120/258 (46%), Gaps = 15/258 (5%)
Query: 14 KLGEGAYGNVYLVS---DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
K+G G + VY + D++ LK + ++ K + +EID+L +++HPN+I
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK---ARQDCVKEIDLLKQLNHPNVI 65
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
L ++++ A+ DL I + + +W +Y ++ +
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW--------KYFVQLCS 117
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
A+E++H ++HRDIK N+ I+ KL D G R + +++ GT Y +PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250
I + YN K +DIWSLG +LY + + PF + +K E +Y S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236
Query: 251 AKQLIGRMLEPNPKHRPN 268
++L+ + P+P RP+
Sbjct: 237 LRELVSMCIYPDPDQRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-23
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDIL------LKV 64
++ LG+G++G V L K ++ L Y K LK+D + + E ++ L+
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDEL-----YAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
P + +H + LY +M+Y DL ++I + E QA + Y
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQA----------VFY 106
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
EI+ L +LH GI++RD+K +N+++ + K+ADFG + + TFCGT
Sbjct: 107 AAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
Y APEII PY K D W+ GV+LY +L + PF
Sbjct: 167 YIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-23
Identities = 81/281 (28%), Positives = 130/281 (46%), Gaps = 28/281 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR--DYMEKFAPREIDILLKVSHPNI 69
I +LG+GA+G VY +K + L A K D K + DYM EIDIL HPNI
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-----EIDILASCDHPNI 64
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ + L++++++ ++ + + + E Q R+ +Q AL YLHE
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
I+HRD+K NIL + + KLADFG S + ++F GT + APE
Sbjct: 124 ----------IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 173
Query: 190 II-----RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244
++ ++ PY+ K AD+WSLG+ L + + P + R +LK + + +
Sbjct: 174 VVMCETSKDRPYDYK-ADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPTLAQP 231
Query: 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI---QNEP 282
S K + + LE N R + H ++ N+P
Sbjct: 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 75/223 (33%), Positives = 113/223 (50%), Gaps = 27/223 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRS-ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNI 69
+ KLG+GAYG V+ D+R+ E + K +D R D F REI L ++ HPNI
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDHPNI 69
Query: 70 IGVHRMVKA--GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+ + ++KA +Y++ +Y E DL I E++H R I +++
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVH-------KRYI------MYQ 115
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT-----FCGT 182
+ AL+Y+H ++HRD+K NIL++ KLADFG +R L +E + T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGT 225
Y APEI+ S K D+WS+G +L +L K F PGT
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF--PGT 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 75/286 (26%), Positives = 133/286 (46%), Gaps = 21/286 (7%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G+GA G VY D + A K + ++ + ++ EI ++ + +PNI+
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYL 82
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
G L+++M+Y L +++ C + E Q R E AL+
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCR----------ECLQALD 129
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
+LH ++HRDIK +NIL+ + KL DFGF + + +T GT + APE++
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQ 253
Y PK+ DIWSLG++ ++ + P+ + L G L N + +S +
Sbjct: 190 KAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE-RLSAVFRD 247
Query: 254 LIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTA---EEREALK 296
+ R LE + R +AK++ H +++ ++T +EA+K
Sbjct: 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEAIK 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 83/295 (28%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----REIDILLKVSHP 67
I K+GEG YG VY +K++ + A K RL+ + E+ P REI +L ++ HP
Sbjct: 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKI---RLESE--EEGVPSTAIREISLLKELQHP 59
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL--EYL 125
NI+ + ++ + LY+I ++ DL+ Y+ +++ + Q + L YL
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSM-DLKKYL-----DSLPKGQ------YMDAELVKSYL 107
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
++I + + H ++HRD+K +N+LI KLADFG +R P + T Y
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWY 167
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GDP------------GTRNRDVLK 232
APE++ SP DIWS+G + + KK F GD GT DV
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP 227
Query: 233 KQEG------------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
K L + + L+ +ML +P R +AK NH
Sbjct: 228 GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-22
Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 41/276 (14%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREI-------DILLKVSHP 67
LG+G +G V LV +K + + Y K LK++ + A E+ +L HP
Sbjct: 3 LGKGTFGKVILVKEKATG-----RYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHP 55
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+ + + L +M+YA +L ++S+ E++AR + +I +AL+YLH
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHS 113
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
E +V+RD+K EN+++ + + K+ DFG + TFCGT Y A
Sbjct: 114 ---------EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 164
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---GKEYLFNRK 244
PE++ ++ Y + D W LGVV+Y ++ + PF N+D K E +E F R
Sbjct: 165 PEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLFELILMEEIRFPRT 218
Query: 245 YEISIGAKQLIGRMLEPNPKHR-----PNAKDVQNH 275
+S AK L+ +L+ +PK R +AK++ H
Sbjct: 219 --LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-22
Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 34/273 (12%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDI--LLKVSHPNIIG 71
KL +G +G V ++ K ++ K + K +K + F E + L+K +PN I
Sbjct: 23 KLIDGKFGKVSVLKHKPTQ-----KLFVQKIIK---AKNFNAIEPMVHQLMK-DNPNFIK 73
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ V +IMDY + DL + K + E + + IRQ+ AL LH+
Sbjct: 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKHN-- 129
Query: 132 LEYLHEVGIVHRDIKCENILISRLLN-AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
I+H DIK EN+L R + L D+G +++ TP + + GT Y +PE
Sbjct: 130 --------IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEK 177
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPF-GDPG-TRNRDVLKKQEGKEYLFNRKYEIS 248
I+ Y+ D W++GV+ Y +L K+PF D + + L K++ K+ +S
Sbjct: 178 IKGHNYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK--LPFIKNVS 234
Query: 249 IGAKQLIGRMLEPNPKHR-PNAKDVQNHAWIQN 280
A + ML+ N +R N ++ H +++
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 82/277 (29%), Positives = 135/277 (48%), Gaps = 27/277 (9%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYD-FKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+G GA+G V LV K S+ + A K F+ +KR F E DI+ + P ++ +
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRS-DSAFFWEERDIMAFANSPWVVQLF 109
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ YLYM+M+Y DL + +S N ++ E A+ Y E+ AL+
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMS---NYDVPEKWAKF----------YTAEVVLALD 156
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGTTSYAAPEIIR 192
+H +G++HRD+K +N+L+ + + KLADFG ++ T +T GT Y +PE+++
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 193 NS---PYNPKLADIWSLGVVLYRILNKKYPF-GDP--GTRNRDVLKKQEGKEYLFNRKYE 246
+ Y + D WS+GV L+ +L PF D GT ++ + K F E
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN---SLNFPEDVE 273
Query: 247 ISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNE 281
IS AK LI L R ++++ H + +N+
Sbjct: 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 88/353 (24%), Positives = 145/353 (41%), Gaps = 90/353 (25%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP-----------REIDI 60
+S +GEGAYG V + K + A K K +P REI I
Sbjct: 10 LSYIGEGAYGMVCSATHKPTGVKVAIK-------------KISPFEHQTFCQRTLREIKI 56
Query: 61 LLKVSHPNIIGVHRMVKAGTY-----LYMIMDYAEKKDLEHYISKACNENIHENQARIWI 115
L + H NIIG+ +++ ++ +Y++ + E DL I N H
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDH-------- 107
Query: 116 RQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL 175
+L++I L+Y+H ++HRD+K N+L++ + K+ DFG +R+ E
Sbjct: 108 -----IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEH 160
Query: 176 SNT-----FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKK--YP--------- 219
+T + T Y APEI+ NS K DIWS+G +L +L+ + +P
Sbjct: 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN 220
Query: 220 --FGDPGTRNRDVL---KKQEGKEYL----FNRKYEISIG---------AKQLIGRMLEP 261
G GT +++ L + Y+ F K + A L+ +ML
Sbjct: 221 LILGVLGTPSQEDLNCIISLRARNYIKSLPFKPK--VPWNKLFPNADPKALDLLDKMLTF 278
Query: 262 NPKHRPNAKDVQNHAWIQ------NEPTCQ---TMTAEEREALKIGKLKSKVF 305
NP R ++ H +++ +EP + E + L KLK +F
Sbjct: 279 NPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIF 331
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 22/221 (9%)
Query: 14 KLGEGAYGNVY--LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
KLG G +G V+ L ++ +K K+ D LK+ +K E+ L ++ H ++I
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQK----EVQALKRLRHKHLIS 66
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + G +Y+I + EK L ++ E Q +A+ ++ ++A
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSP------EGQVL----PVASLIDMACQVAEG 116
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
+ YL E +HRD+ NIL+ L K+ADFG +RL++ LS+ + APE
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 192 RNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVL 231
+ ++ K +D+WS G++LY + + P+ PG N +V
Sbjct: 177 SHGTFSTK-SDVWSFGILLYEMFTYGQVPY--PGMNNHEVY 214
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-22
Identities = 75/286 (26%), Positives = 135/286 (47%), Gaps = 21/286 (7%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G+GA G VY D + A + + ++ + ++ EI ++ + +PNI+
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYL 83
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
G L+++M+Y L +++ C + E Q R E ALE
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCR----------ECLQALE 130
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
+LH ++HRDIK +NIL+ + KL DFGF + + +T GT + APE++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQ 253
Y PK+ DIWSLG++ ++ + P+ + L G L N + ++S +
Sbjct: 191 KAYGPKV-DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE-KLSAIFRD 248
Query: 254 LIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMT---AEEREALK 296
+ R L+ + + R +AK++ H +++ ++T A +EA K
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-22
Identities = 81/278 (29%), Positives = 132/278 (47%), Gaps = 42/278 (15%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREI-------DILLKVSHP 67
LG+G +G V LV +K S K Y K LK++ + A E+ +L HP
Sbjct: 3 LGKGTFGKVILVREKASG-----KYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHP 55
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+ + + L +M+Y +L ++S+ E++ R Y E
Sbjct: 56 FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR--ERVFSEDRTRF----------YGAE 103
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
I +AL+YLH IV+RD+K EN+++ + + K+ DFG + T TFCGT Y A
Sbjct: 104 IVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLA 163
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---GKEYLFNRK 244
PE++ ++ Y + D W LGVV+Y ++ + PF N+D K E ++ F R
Sbjct: 164 PEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLFELILMEDIKFPRT 217
Query: 245 YEISIGAKQLIGRMLEPNPKHR-----PNAKDVQNHAW 277
+S AK L+ +L +P R +AK++ H++
Sbjct: 218 --LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-22
Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 23/274 (8%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G +G V + + + ACK + KR+K+ E A E IL KV+ ++ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ L +++ DL+ +I N E + AL Y EI LE
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER----------ALFYAAEILCGLED 117
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK-ELSNTFCGTTSYAAPEIIRN 193
LH V+RD+K ENIL+ + +++D G + ++ P+ E GT Y APE++ N
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNN 175
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--NRDVLKKQEGKEYLFNRKYEISIGA 251
Y D W LG ++Y ++ + PF + +V ++ E +++ K+ S A
Sbjct: 176 QRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF--SEEA 232
Query: 252 KQLIGRMLEPNPKHR-----PNAKDVQNHAWIQN 280
K + +L +PK R A +V+ H + +N
Sbjct: 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 9e-22
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDIL------LK 63
+++ LG+G++G V L K ++ L Y K LK+D + + E ++ L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDEL-----YAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
P + +H + LY +M+Y DL + I + R + +A+
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV---------GRF---KEPHAVF 105
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
Y EIA L +LH GI++RD+K +N+++ + K+ADFG + + TFCGT
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTP 165
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
Y APEII PY K D W+ GV+LY +L + PF
Sbjct: 166 DYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
++GEG YG VY D S + A K +RD + + REI +LL + HPNI+ +
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 74 RMV--KAGTYLYMIMDYAEKKDLEHYISKACNENIH----ENQARIWIRQIANALEYLHE 127
+V K ++++M+Y E+ DL + +N+ E+Q + + Q+ L+YLHE
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLL-----DNMPTPFSESQVKCLMLQLLRGLQYLHE 126
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ I+HRD+K N+L++ K+ADFG +R P + T Y A
Sbjct: 127 -----NF-----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRA 176
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKK 217
PE++ D+W++G +L +L K
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 88/351 (25%), Positives = 142/351 (40%), Gaps = 82/351 (23%)
Query: 5 DILECSY--ISKLGEGAYGNVYLVSDKRS----ETLKACKAYDFKRL-KRDYMEKFAPRE 57
+ Y I +G GAYG V D RS K A+D L KR RE
Sbjct: 1 FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL------RE 54
Query: 58 IDILLKVSHPNIIGVHRMVKA----GTYLYMIMDYAEKKDLEHYISKACNENIHENQARI 113
+ IL H NII + +++ +Y++MD E DL H I ++ + E R
Sbjct: 55 LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIH--SDQPLTEEHIRY 111
Query: 114 WIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT-P 172
+L+++ L+Y+H ++HRD+K N+L++ ++ DFG +R L + P
Sbjct: 112 ----------FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
Query: 173 KELSN---TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD 229
E + T Y APE++ + P D+WS+G + +L ++ F PG
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF--PGKNYVH 219
Query: 230 VLK--------------KQEGKEYLFNRKYEISIGAKQ-----------------LIGRM 258
LK + G + + RKY ++ KQ L+ +M
Sbjct: 220 QLKLILSVLGSPSEEVLNRIGSDRV--RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQM 277
Query: 259 LEPNPKHRPNAKDVQNHAWI------QNEPTCQT-------MTAEEREALK 296
L+ +P+ R + H ++ +EPTC RE LK
Sbjct: 278 LQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSREQLK 328
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-21
Identities = 80/268 (29%), Positives = 123/268 (45%), Gaps = 21/268 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ K+G+G++G V+ D R++ + A K D + + D +E +EI +L + P +
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQ-QEITVLSQCDSPYVTK 66
Query: 72 VHRMVKAGTYLYMIMDY-AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ T L++IM+Y L+ +E QIA L EI
Sbjct: 67 YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET-----------QIATILR---EILK 112
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
L+YLH +HRDIK N+L+S KLADFG + L + NTF GT + APE+
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250
I+ S Y+ K ADIWSLG+ + + P + L + L + S
Sbjct: 173 IKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTL---EGNYSKP 228
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
K+ + L P RP AK++ H +I
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----REIDILLKVSHP 67
+ KLGEG Y V+ K +E L A K RL+ E+ AP RE+ +L + H
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEI---RLEH---EEGAPCTAIREVSLLKDLKHA 64
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
NI+ +H +V L ++ +Y +K DL+ Y+ N I + N +L++
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN-----------IMSMHNVKIFLYQ 112
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
I L Y H ++HRD+K +N+LI+ KLADFG +R P + + T Y
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 188 PEIIRNSPYNPKLADIWSLGVVLY----------------------RILNKKYPFGDPGT 225
P+++ S D+W +G + + R+L PG
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232
Query: 226 RNRDVLKKQEGKEY----LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ D K +Y L N + +L+ + L+ K R +A++ HA+ ++
Sbjct: 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 83/314 (26%), Positives = 134/314 (42%), Gaps = 69/314 (21%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDILLKVSHP 67
I +G GA+G V LV K + + A K K K + +EK E DIL + +P
Sbjct: 6 IKVIGRGAFGEVRLVQKKDTGHIYAMK----KLRKSEMLEKEQVAHVRAERDILAEADNP 61
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
++ ++ + YLY+IM+Y D+ + K + E + R Y+ E
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRF----------YIAE 109
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG----------------------- 164
A++ +H++G +HRDIK +N+L+ + KL+DFG
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 165 ----FSRLLRTPKELSNTF-----------CGTTSYAAPEIIRNSPYNPKLADIWSLGVV 209
F + K + T+ GT Y APE+ + YN K D WSLGV+
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVI 228
Query: 210 LYRILNKKYPF--GDPGTRNRDVLKKQEGKEYL-FNRKYEISIGAKQLIGRMLEPNPKHR 266
+Y +L PF +P R ++ KE L F + +S AK LI R+ + R
Sbjct: 229 MYEMLVGYPPFCSDNPQETYRKIIN---WKETLQFPDEVPLSPEAKDLIKRLC-CEAERR 284
Query: 267 ---PNAKDVQNHAW 277
++++H +
Sbjct: 285 LGNNGVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 5e-21
Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 11 YISKLGEGAYGNVYLVSDK--RSETLKACKAYDFKRLKRDY--MEKFAPREIDILLKVSH 66
+G G YG VY K + A K FK K Y + + A REI +L ++ H
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK--FKGDKEQYTGISQSACREIALLRELKH 61
Query: 67 PNIIGVHRMV--KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWI-RQIANALE 123
N++ + + A +Y++ DYAE DL I H R+ I + +L
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII------KFHRQAKRVSIPPSMVKSL- 113
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNA----KLADFGFSRLLRTP-KELS-- 176
L +I N + YLH ++HRD+K NIL+ K+ D G +RL P K L+
Sbjct: 114 -LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 177 NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
+ T Y APE++ + + K DIW++G + +L + F
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 9e-21
Identities = 72/225 (32%), Positives = 113/225 (50%), Gaps = 19/225 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD--YMEKFAPREIDILLKVSHPNI 69
+ K+GEG YG VY D+ + A K RL+++ + A REI +L ++ H NI
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ + +V + LY++ +Y + DL+ ++ + + +N I YL++I
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSS--PDFAKNPRLIKT--------YLYQIL 112
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNA-KLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
+ Y H ++HRD+K +N+LI R NA KLADFG +R P T Y AP
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233
EI+ S + DIWS+G + ++N+K F PG D L K
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF--PGDSEIDELFK 215
|
Length = 294 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 83/279 (29%), Positives = 134/279 (48%), Gaps = 31/279 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYD-FKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+G GA+G V LV K + + A K F+ +KR F E DI+ + P ++ +
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS-DSAFFWEERDIMAFANSPWVVQLF 109
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ YLYM+M+Y DL + +S N ++ E AR Y E+ AL+
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARF----------YTAEVVLALD 156
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---LSNTFCGTTSYAAPEI 190
+H +G +HRD+K +N+L+ + + KLADFG ++ KE +T GT Y +PE+
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMNKEGMVRCDTAVGTPDYISPEV 214
Query: 191 IRNS---PYNPKLADIWSLGVVLYRILNKKYPF-GDP--GTRNRDVLKKQEGKEYLFNRK 244
+++ Y + D WS+GV LY +L PF D GT ++ + K F
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---SLTFPDD 271
Query: 245 YEISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNE 281
+IS AK LI L R ++++ H + +N+
Sbjct: 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 74/301 (24%), Positives = 133/301 (44%), Gaps = 54/301 (17%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----REIDILLKVSHP 67
+ KLGEG Y VY K ++ L A K RL+ E+ AP RE+ +L + H
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEI---RLEH---EEGAPCTAIREVSLLKDLKHA 64
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
NI+ +H ++ L ++ +Y +K DL+ Y+ C +I+ + ++ +L +
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD-CGNSINMHNVKL----------FLFQ 112
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ L Y H ++HRD+K +N+LI+ KLADFG +R P + + T Y
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRP 172
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD------------------ 229
P+I+ S D+W +G + Y + + F PG+ +
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF--PGSTVEEQLHFIFRILGTPTEETWP 230
Query: 230 -VLKKQEGKEYLFNRKYEISI----------GAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
+L +E K Y + + + GA+ L+ ++L+ + R +A++ H +
Sbjct: 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAE-LLSKLLQFEGRKRISAEEAMKHPYF 289
Query: 279 Q 279
Sbjct: 290 H 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-20
Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 39/230 (16%)
Query: 11 YISKLGEGAYGNVYL-----VSDKRSE--TLKACKAYDFKRLKRDYMEKFAPREIDILLK 63
+I +LGEG +G V L + D E +K+ ++ + D+ REI+IL
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF-----EREIEILRT 62
Query: 64 VSHPNIIGVHRMVKA--GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
+ H NI+ + + G L +IM+Y L Y+ + ++ +I ++++
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR--------HRDQINLKRL--- 111
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL------ 175
L + +I ++YL +HRD+ NIL+ K++DFG +++L K+
Sbjct: 112 LLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP 171
Query: 176 --SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP 223
S F + APE +R S ++ +D+WS GV LY + P P
Sbjct: 172 GESPIF-----WYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 76/288 (26%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 1 MKFPDILECSYISKLGEGAYGNVYLVSDKRSETLK-ACKAYDFKRLKRDYMEKFAPREID 59
MK+ D ++I LG G++G V L + K + A K ++ ++ + E
Sbjct: 27 MKYEDF---NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERK 83
Query: 60 ILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIA 119
IL ++HP + ++ K +YLY+++++ + ++ + ++
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--------------KRFP 129
Query: 120 NALE--YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSN 177
N + Y +I EYL + IV+RD+K EN+L+ + K+ DFGF++++ T +
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---TY 186
Query: 178 TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237
T CGT Y APEI+ N + K AD W+LG+ +Y IL PF N +L Q+
Sbjct: 187 TLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPF----YANEPLLIYQKIL 241
Query: 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHR-----PNAKDVQNHAWIQN 280
E + + K L+ ++L + R A++V+ H W N
Sbjct: 242 EGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289
|
Length = 340 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 81/329 (24%), Positives = 140/329 (42%), Gaps = 69/329 (20%)
Query: 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYD--FKRL---KRDYMEKFAPRE 57
PD + +S +G GAYG V D ++ A K F+ KR Y RE
Sbjct: 13 VPDRYQ--NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY------RE 64
Query: 58 IDILLKVSHPNIIGVHRMVKAGTYL------YMIMDYAEKKDLEHYISKACNENIHENQA 111
+ +L + H N+IG+ + + L Y++ DL + + + + ++
Sbjct: 65 LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKC---QKLSDDHI 120
Query: 112 RIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171
+ + QI L+Y+H GI+HRD+K NI ++ K+ DFG +R T
Sbjct: 121 QFLVYQILRGLKYIHS----------AGIIHRDLKPSNIAVNEDCELKILDFGLARH--T 168
Query: 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKK--YPFGDP------ 223
E++ + T Y APEI+ N + + DIWS+G ++ +L K +P D
Sbjct: 169 DDEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR 227
Query: 224 -----GTRNRDVLKK---QEGKEYL-----FNRK--YEISIGAK----QLIGRMLEPNPK 264
GT + ++L+K + + Y+ +K E+ GA L+ +ML +P
Sbjct: 228 IMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD 287
Query: 265 HRPNAKDVQNHAWI------QNEPTCQTM 287
R A + H ++ ++EP
Sbjct: 288 KRITAAEALAHPYLAEYHDPEDEPVAPPY 316
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 70/238 (29%), Positives = 108/238 (45%), Gaps = 24/238 (10%)
Query: 42 FKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKA 101
F L + +A E+ L H I+ K+ L +IM+Y DL I +
Sbjct: 100 FVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR 159
Query: 102 CNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161
E++ + + + ++I AL+ +H ++HRD+K NI + KL
Sbjct: 160 LKEHLPFQEYEVGL--------LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211
Query: 162 DFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP 219
DFGFS+ L +++FCGT Y APE+ Y+ K AD+WSLGV+LY +L P
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRP 270
Query: 220 FGDPGTRNRDVLKKQEGKEYLFNRKYE-----ISIGAKQLIGRMLEPNPKHRPNAKDV 272
F P R E + + KY+ +S G K L+ +L NP RP + +
Sbjct: 271 FKGPSQR--------EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 18/224 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY--MEKFAPREIDILLKVSHPNI 69
+ K+GEG YG V+ ++ + + A K RL D + A REI +L ++ H NI
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ ++ ++ + L ++ +Y ++ DL+ Y +CN +I + ++ Q+ L + H
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQ-DLKKYFD-SCNGDIDPEIVKSFMFQLLKGLAFCHS-- 117
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
H V +HRD+K +N+LI++ KLADFG +R P + T Y P+
Sbjct: 118 ------HNV--LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 169
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233
++ + D+WS G + + N P PG D LK+
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLF-PGNDVDDQLKR 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-20
Identities = 87/310 (28%), Positives = 131/310 (42%), Gaps = 62/310 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF---APREIDILLKVSHPN 68
I ++GEG YG VY DK + L A K RL + E F A REI IL +++H N
Sbjct: 12 IGQIGEGTYGQVYKARDKDTGELVALKKV---RLDNE-KEGFPITAIREIKILRQLNHRN 67
Query: 69 IIGVHRMV----------KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQI 118
I+ + +V K Y++ +Y + + S + + E+ + +++Q+
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS--EDHIKSFMKQL 125
Query: 119 ANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT 178
L Y H+ +HRDIKC NIL++ KLADFG +RL E S
Sbjct: 126 LEGLNYCHK----------KNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRP 173
Query: 179 FCG---TTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF-------------- 220
+ T Y PE++ Y P + D+WS G +L + KK F
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAI-DVWSCGCILGELFTKKPIFQANQELAQLELISR 232
Query: 221 --GDPGTRN-RDVLK------KQEGKEYLFNRKYEISI---GAKQLIGRMLEPNPKHRPN 268
G P DV+K + K+Y + E S A L+ ML +P R
Sbjct: 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT 292
Query: 269 AKDVQNHAWI 278
A++ N W+
Sbjct: 293 AEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 79/292 (27%), Positives = 125/292 (42%), Gaps = 54/292 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAY--DFKRLKRDYMEKFAPREIDILLKVSHPNI 69
IS LG G G+V V + T+ A K K + K RE+ I+ + P I
Sbjct: 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS----SVRKQILRELQIMHECRSPYI 65
Query: 70 IGVHRMVKAGTYLY-----MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
+ + G +L M M++ + L+ RI+ + +E
Sbjct: 66 VSFY-----GAFLNENNICMCMEFMDCGSLD----------------RIYKKGGPIPVEI 104
Query: 125 LHEIANA----LEYLHEV-GIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF 179
L +IA A L YL+ V I+HRDIK NIL++ KL DFG S L +++TF
Sbjct: 105 LGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL--INSIADTF 162
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR---------DV 230
GT++Y +PE I+ Y K +D+WSLG+ + + K+PF + D+
Sbjct: 163 VGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL 221
Query: 231 LKK--QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKD-VQNHAWIQ 279
L++ QE L + + + + L +P RP + +IQ
Sbjct: 222 LQQIVQEPPPRLPSSDF--PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-20
Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----REIDILLKVSHP 67
+ KLGEG Y V+ K +E L A K RL+ E+ AP RE+ +L + H
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEI---RLEH---EEGAPCTAIREVSLLKNLKHA 63
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
NI+ +H ++ L ++ +Y + DL+ Y+ N + + N ++ +
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN-----------LMSMHNVKIFMFQ 111
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ L Y H+ I+HRD+K +N+LI+ KLADFG +R P + + T Y
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 171
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL 231
P+++ S D+W +G +LY + + F PG+ ++ L
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF--PGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 80/315 (25%), Positives = 127/315 (40%), Gaps = 62/315 (19%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I +G GA+G V LV + L A K + E DIL + + ++
Sbjct: 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVK 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + LY +MDY D+ + + E+ AR Y+ E+ A
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARF----------YIAELTCA 113
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR--------------------- 170
+E +H++G +HRDIK +NILI R + KL DFG R
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173
Query: 171 ------------TPKE----------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGV 208
P E L+++ GT +Y APE++ + Y +L D WS+GV
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGV 232
Query: 209 VLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL-FNRKYEISIGAKQLIGRMLEPNPKHR- 266
+LY +L + PF T LK + L + ++S A LI R L + R
Sbjct: 233 ILYEMLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRL 290
Query: 267 --PNAKDVQNHAWIQ 279
A +++ H + +
Sbjct: 291 GKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYD-FKRLKRDYMEKFAPREIDILLKVSHPNII 70
I +G GA+G V +V K +E + A K + ++ LKR F E ++L+ I
Sbjct: 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR-EERNVLVNGDCQWIT 64
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+H + YLY++MDY DL +SK + + E+ AR Y+ E+
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARF----------YIAEMVL 113
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGTTSYAAPE 189
A+ +H++ VHRDIK +N+L+ + +LADFG ++ + S+ GT Y +PE
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 190 IIRN-----SPYNPKLADIWSLGVVLYRILNKKYPF 220
I++ Y P+ D WSLGV +Y +L + PF
Sbjct: 174 ILQAMEDGMGKYGPE-CDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 69/213 (32%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYD-FKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+G GA+G V +V K ++ + A K + ++ LKR F E D+L+ + I +H
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR-EERDVLVNGDNQWITTLH 67
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ LY++MDY DL +SK + + E+ AR YL E+ A++
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARF----------YLAEMVIAID 116
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGTTSYAAPEIIR 192
+H++ VHRDIK +NIL+ + +LADFG +L+ S+ GT Y +PEI++
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 193 -----NSPYNPKLADIWSLGVVLYRILNKKYPF 220
Y P+ D WSLGV +Y +L + PF
Sbjct: 177 AMEDGKGKYGPE-CDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF-APREIDILLKVSHPNII 70
+ KLGEG+Y VY K + L A K RL+ + F A RE +L + H NI+
Sbjct: 10 LDKLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+H ++ L ++ +Y + DL+ Y+ C + + R+ +L ++
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDT-DLKQYMDD-CGGGLSMHNVRL----------FLFQLLR 114
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG---TTSYAA 187
L Y H+ ++HRD+K +N+LIS KLADFG +R P S T+ T Y
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEVVTLWYRP 171
Query: 188 PEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227
P+++ S Y+ L D+W +G + Y + + F PG+ +
Sbjct: 172 PDVLLGSTEYSTSL-DMWGVGCIFYEMATGRPLF--PGSTD 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 59/239 (24%), Positives = 113/239 (47%), Gaps = 29/239 (12%)
Query: 11 YISKLGEGAYGNVY-----LVSDKRSETLKACKAYDFK---RLKRDYMEKFAPREIDILL 62
++ +LGEGA+G VY +++ S T A K ++++++ +E +++
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR-----QEAELMS 63
Query: 63 KVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHY-ISKACNENIHENQARIWIRQIANA 121
+ HPNI+ + + M+ +Y DL + + + + ++ ++ +
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 122 LEYLH---EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP---KEL 175
++LH +IA +EYL VHRD+ N L+ L K++DFG SR + + +
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 176 SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFG-DP--GTRNRDVL 231
S + + PE I + + +DIWS GVVL+ I + +G P G N++V+
Sbjct: 184 SKSLL-PVRWMPPEAILYGKFTTE-SDIWSFGVVLWEI----FSYGLQPYYGFSNQEVI 236
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-19
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM------EKFAPREIDILLKVSHPN 68
LG+G++G V L K A KA LK+D + E + + L +P
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKA-----LKKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+ ++ + +L+ +M++ DL +I +++ R + A Y EI
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHI---------QDKGRF---DLYRATFYAAEI 105
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
L++LH GI++RD+K +N+++ R + K+ADFG + ++TFCGT Y AP
Sbjct: 106 VCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GD 222
EI++ Y + D WS GV+LY +L + PF GD
Sbjct: 166 EILQGLKYTFSV-DWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 67/267 (25%), Positives = 126/267 (47%), Gaps = 27/267 (10%)
Query: 14 KLGEGAYGNVYLVSDKR-SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGV 72
+ GE G + L + +K KA ++ +RD++ E I+ + HPNII +
Sbjct: 16 EFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-----SEASIMGQFDHPNIIHL 70
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
+V + ++ +Y E L+ ++ K + + + Q+ L IA+ +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRK--------HDGQFTVIQLVGMLR---GIASGM 119
Query: 133 EYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG---TTSYAAPE 189
+YL ++G VHRD+ NIL++ L K++DFG SR+L E + T G + APE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKK-QEGKEYLFNRKYEI 247
I + +D+WS G+V++ +++ + P+ + N+DV+K +EG Y +
Sbjct: 180 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE--MSNQDVIKAIEEG--YRLPAPMDC 234
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQN 274
QL+ + + RP + + +
Sbjct: 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-19
Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 27/276 (9%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G +G V + + + ACK + KR+K+ E A E IL KV+ ++ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ L +++ DL+ +I N E A+ Y EI LE
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE----------ERAVFYAAEITCGLED 117
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH IV+RD+K ENIL+ + +++D G + + E GT Y APE+++N
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE-GETIRGRVGTVGYMAPEVVKNE 176
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE-----ISI 249
Y D W LG ++Y ++ K PF R R K+E E E S
Sbjct: 177 RYTFS-PDWWGLGCLIYEMIEGKSPF-----RQRKEKVKREEVERRVKEDQEEYSEKFSE 230
Query: 250 GAKQLIGRMLEPNPKHR-----PNAKDVQNHAWIQN 280
A+ + ++L +P R A++V+ H + +
Sbjct: 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 5e-19
Identities = 81/283 (28%), Positives = 123/283 (43%), Gaps = 31/283 (10%)
Query: 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP--REIDILLKVS 65
E + +LG+G YG+VY V + + A K RL+ D KF E+DIL K
Sbjct: 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI---RLELD-ESKFNQIIMELDILHKAV 57
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEH-YISKACNENIHENQARIWIRQIANALEY 124
P I+ + +YM M+Y + L+ Y E I E+ +R+I A
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV----LRRITYA--- 110
Query: 125 LHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
+ L++L E I+HRD+K N+L++ KL DFG S L L+ T G
Sbjct: 111 ---VVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV--ASLAKTNIGCQ 165
Query: 184 SYAAPEIIRNSPYNPKL-----ADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ---E 235
SY APE I++ N +D+WSLG+ + + +YP+ P T + +
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-PPETYANIFAQLSAIVD 224
Query: 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
G Y S A+ + + L P RP + H W+
Sbjct: 225 GDPPTLPSGY--SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 5e-19
Identities = 67/218 (30%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G G YG+VY + + K K Y K+++ + A REI +L ++ HPN+I +
Sbjct: 8 KVGRGTYGHVY---KAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 74 R--MVKAGTYLYMIMDYAEKKDLEHYIS--KACNENIHENQARIWIRQIANALEYLHEIA 129
+ + + ++++ DYAE DL H I +A N Q R + +L L++I
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLP---RSMVKSL--LYQIL 118
Query: 130 NALEYLHEVGIVHRDIKCENILI----SRLLNAKLADFGFSRLLRTP-KELS--NTFCGT 182
+ + YLH ++HRD+K NIL+ K+AD GF+RL +P K L+ + T
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
Y APE++ + + K DIW++G + +L + F
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 85/310 (27%), Positives = 134/310 (43%), Gaps = 59/310 (19%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
+ +S L G+ G V++ + E K +K K REIDIL +SH I
Sbjct: 95 NILSSLTPGSEGEVFVCTKHGDEQRKKVI------VKAVTGGKTPGREIDILKTISHRAI 148
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
I + + + + M+M K DL Y+ ++ + QA I I++ +
Sbjct: 149 INLIHAYRWKSTVCMVMPKY-KCDLFTYVDRS--GPLPLEQA-ITIQR---------RLL 195
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL----RTPKELSNTFCGTTSY 185
AL YLH GI+HRD+K ENI + NA L DFG + L TP+ + GT
Sbjct: 196 EALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG--WSGTLET 253
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP-FG----DPGTRNRDVLKK------- 233
+PE++ PY K DIWS G+VL+ + K FG ++ R +++
Sbjct: 254 NSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312
Query: 234 ----------QEGKEYLFN-----------RKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272
+ K+Y RKY + + + LI +ML + + RP+A+D+
Sbjct: 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI 372
Query: 273 QNHAWIQNEP 282
+ EP
Sbjct: 373 LSLPLFTKEP 382
|
Length = 392 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 7e-19
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
KLG G +G V++ + T K K LK M E F +E I+ K+ H ++
Sbjct: 13 KLGAGQFGEVWM--GTWNGTTKVA----VKTLKPGTMSPEAFL-QEAQIMKKLRHDKLVQ 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + +Y++ +Y K L ++ + + Q ++ +IA
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL----------VDMAAQIAEG 115
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR----TPKELSNTFCGTTSYAA 187
+ YL +HRD+ NIL+ L K+ADFG +RL+ T +E F + A
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE-GAKF--PIKWTA 172
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQE 235
PE + K +D+WS G++L I+ + P+ PG NR+VL++ E
Sbjct: 173 PEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPY--PGMTNREVLEQVE 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 9e-19
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 20/218 (9%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G G YG+VY K K + Y K+++ + A REI +L ++ HPN+I +
Sbjct: 8 KVGRGTYGHVYKAKRKDG---KDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 74 R--MVKAGTYLYMIMDYAEKKDLEHYIS--KACNENIHENQARIWIRQIANALEYLHEIA 129
+ + A ++++ DYAE DL H I +A N Q R + +L L++I
Sbjct: 65 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLP---RGMVKSL--LYQIL 118
Query: 130 NALEYLHEVGIVHRDIKCENILI----SRLLNAKLADFGFSRLLRTP-KELS--NTFCGT 182
+ + YLH ++HRD+K NIL+ K+AD GF+RL +P K L+ + T
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
Y APE++ + + K DIW++G + +L + F
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 76/326 (23%), Positives = 122/326 (37%), Gaps = 78/326 (23%)
Query: 15 LGEGAYGNVYLVSDKRSET------LKACKAYDFKRLKRDYMEKF-----APREIDILLK 63
LGEG YG V D + +K + + R + RE+ I+ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIH--ENQARIWIRQIANA 121
+ H NI+G+ + G ++ ++MD DL K + I E+Q + + QI N
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DL----KKVVDRKIRLTESQVKCILLQILNG 131
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR------LLRT---- 171
L LH+ +HRD+ NI I+ K+ADFG +R T
Sbjct: 132 LNVLHKWY----------FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 172 ----PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227
+E + T Y APE++ + D+WS+G + +L K F PG
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF--PGENE 239
Query: 228 RDVL------------------------------KKQEGKEYLFNRKYEISIGAKQLIGR 257
D L K ++ K N S A L+
Sbjct: 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNA----SDDAIDLLQS 295
Query: 258 MLEPNPKHRPNAKDVQNHAWIQNEPT 283
+L+ NP R +AK+ H + +++P
Sbjct: 296 LLKLNPLERISAKEALKHEYFKSDPL 321
|
Length = 335 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 67/259 (25%), Positives = 109/259 (42%), Gaps = 60/259 (23%)
Query: 60 ILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIA 119
+L V+HP++I + + +G M++ + DL Y++K + I Q
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTK--------RSRPLPIDQ-- 158
Query: 120 NALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL-LRTPKELSNT 178
AL +I L YLH I+HRD+K ENI I+ + + D G ++ + P L
Sbjct: 159 -ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-- 215
Query: 179 FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF------------------ 220
GT APE++ YN K ADIWS G+VL+ +L YP
Sbjct: 216 LAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEML--AYPSTIFEDPPSTPEEYVKSCH 272
Query: 221 ------------------GDPGTRNR------DVLKKQEGKEYLFNRKYEISIGAKQLIG 256
DPG+R L++Q Y ++ + I + L+
Sbjct: 273 SHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVH 332
Query: 257 RMLEPNPKHRPNAKDVQNH 275
+ML + RP+A+++ N+
Sbjct: 333 KMLTFDAAMRPSAEEILNY 351
|
Length = 357 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 2e-18
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 19/224 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF-APREIDILLKVSHPNII 70
+ KLGEG+Y VY K + L A K RL+ + F A RE +L + H NI+
Sbjct: 10 LEKLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+H ++ L ++ +Y DL Y+ K +H ++ +L ++
Sbjct: 67 LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPG-GLHPENVKL----------FLFQLLR 114
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
L Y+H+ I+HRD+K +N+LIS KLADFG +R P + T Y P++
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN-RDVLKK 233
+ S D+W +G + ++ F PG ++ +D L++
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAF--PGMKDIQDQLER 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 74/276 (26%), Positives = 124/276 (44%), Gaps = 27/276 (9%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G +G V + + + ACK + KR+K+ E A E IL KV+ ++ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ L +++ DL+ +I N E + A+ Y E+ LE
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR----------AIFYAAELCCGLED 117
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK-ELSNTFCGTTSYAAPEIIRN 193
L IV+RD+K ENIL+ + +++D G + ++ P+ E GT Y APE+I N
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE----ISI 249
Y D W LG ++Y ++ + PF + ++ +K++E + + E S
Sbjct: 176 EKYTFS-PDWWGLGCLIYEMIQGQSPF----RKRKERVKREEVDRRVKEDQEEYSEKFSE 230
Query: 250 GAKQLIGRMLEPNPKHR-----PNAKDVQNHAWIQN 280
AK + +L NPK R A V+ H +N
Sbjct: 231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 78/298 (26%), Positives = 147/298 (49%), Gaps = 36/298 (12%)
Query: 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP 67
E I K+G G +G V+LV KR++ KA ++ LK + E++++ ++ H
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMRELKHK 72
Query: 68 NIIG-VHRMV-KAGTYLYMIMDYAEKKDLEHYISKACNE---NIHENQARIWIRQIANAL 122
NI+ + R + KA LY++M++ + DL I K C + I E+ RQ+ +AL
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK-CYKMFGKIEEHAIVDITRQLLHAL 131
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLN-----------------AKLADFGF 165
Y H + + + ++HRD+K +NI +S + AK+ DFG
Sbjct: 132 AYCHNLKDG---PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 166 SRLLRTPKELSNTFCGTTSYAAPEII--RNSPYNPKLADIWSLGVVLYRILNKKYPFGDP 223
S+ + + ++++ GT Y +PE++ Y+ K +D+W+LG ++Y + + K PF
Sbjct: 189 SKNIGI-ESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFHKA 246
Query: 224 GTRNRDVLKKQEGKEY-LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
++ + + + G + + + E++I LI +L + K RP+A + I+N
Sbjct: 247 NNFSQLISELKRGPDLPIKGKSKELNI----LIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-18
Identities = 74/271 (27%), Positives = 121/271 (44%), Gaps = 27/271 (9%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G +G V + + + ACK + KR+K+ E A E IL KV+ ++ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ L +++ DL+ +I E A+ Y EI LE
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE----------GRAVFYAAEICCGLED 117
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH+ IV+RD+K ENIL+ + +++D G + + + + GT Y APE+++N
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMAPEVVKNE 176
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE-----ISI 249
Y D W+LG +LY ++ + PF + R K+E E L E S
Sbjct: 177 RYTFS-PDWWALGCLLYEMIAGQSPF-----QQRKKKIKREEVERLVKEVQEEYSEKFSP 230
Query: 250 GAKQLIGRMLEPNPKHR-----PNAKDVQNH 275
A+ L +L +PK R A++V+ H
Sbjct: 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEH 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 4e-18
Identities = 81/295 (27%), Positives = 127/295 (43%), Gaps = 41/295 (13%)
Query: 1 MKFP-DILECSYISKLGEGAYGNVYLVSDKRSETLKACK-------AYDFKRLKRDYMEK 52
K+P D+ + + ++G G G VY + K++ + A K + KR+ D
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD---- 63
Query: 53 FAPREIDILLKVSH--PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQ 110
+D++LK SH P I+ Y Y I D +E + C + + +
Sbjct: 64 -----LDVVLK-SHDCPYIVK--------CYGYFITDSDVFICME--LMSTCLDKLLKRI 107
Query: 111 ARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLLNAKLADFGFSRLL 169
I + I AL YL E G++HRD+K NIL+ N KL DFG S L
Sbjct: 108 QGPIPEDILGKMTV--AIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165
Query: 170 RTPKELSNTFCGTTSYAAPEIIRNSPYNPKL---ADIWSLGVVLYRILNKKYPFGDPGTR 226
K + + G +Y APE I NPK AD+WSLG+ L + ++P+ + T
Sbjct: 166 VDSKAKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT- 223
Query: 227 NRDVLKK--QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+VL K QE L + S + L + + RP +++ H +I+
Sbjct: 224 EFEVLTKILQEEPPSLPPNE-GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-18
Identities = 77/301 (25%), Positives = 126/301 (41%), Gaps = 48/301 (15%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----REIDILLKVSHP 67
+ K+GEG YG VY DK + L A K RL+ D E+ P REI +L +S
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLVALKK---TRLEMD--EEGIPPTALREISLLQMLSES 60
Query: 68 NII-----GVHRMVKAG-TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
I H K G LY++ +Y + DL+ ++ A+
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKT-------I 112
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA-KLADFGFSRLLRTPKELSNTFC 180
+++++ + + H+ G++HRD+K +N+L+ + K+AD G R P +
Sbjct: 113 KSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GDP------------GTRN 227
T Y APE++ S + DIWS+G + + K+ F GD GT
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232
Query: 228 RD----VLKKQEGKEY-------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276
V K ++ E+ L ++S L+ +ML +P R +AK H
Sbjct: 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292
Query: 277 W 277
+
Sbjct: 293 Y 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 34/219 (15%)
Query: 15 LGEGAYGNVYL--------VSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH 66
LGEGA+G V+L +DK +K K ++D+ RE ++L H
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFE-----REAELLTNFQH 67
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN----AL 122
NI+ + + G M+ +Y E DL ++ H A + L
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRS------HGPDAAFLKSPDSPMGELTL 121
Query: 123 EYLHEI----ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT 178
L +I A+ + YL VHRD+ N L+ L K+ DFG SR + T
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR-- 179
Query: 179 FCGTT----SYAAPEIIRNSPYNPKLADIWSLGVVLYRI 213
G T + PE I + + +D+WS GVVL+ I
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-18
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
+GEGAYG V K ++ + A K + + E RE+ +L + NI+ +
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKET-TLRELKMLRTLKQENIVELKE 67
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ LY++ +Y EK LE + + + + R Y++++ A+ +
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVR----------SYIYQLIKAIHW 115
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT-FCGTTSYAAPEIIRN 193
H+ IVHRDIK EN+LIS KL DFGF+R L + T + T Y +PE++
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 194 SPYNPKLADIWSLGVVL 210
+PY K D+WS+G +L
Sbjct: 176 APYG-KAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 32/213 (15%)
Query: 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD--YMEKFAPREIDILLKVSHPNII 70
+ +G+G +G+V L D R + + K LK D + F E ++ + HPN++
Sbjct: 12 ATIGKGEFGDVML-GDYRGQKVA------VKCLKDDSTAAQAFLA-EASVMTTLRHPNLV 63
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ +V G LY++ +Y K L Y+ ++ R I +A L + ++
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYL---------RSRGRAVI-TLAQQLGFALDVCE 113
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT--TSYAAP 188
+EYL E VHRD+ N+L+S L AK++DFG ++ + G + AP
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAP 168
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFG 221
E +R ++ K +D+WS G++L+ I Y FG
Sbjct: 169 EALREKKFSTK-SDVWSFGILLWEI----YSFG 196
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-17
Identities = 75/272 (27%), Positives = 116/272 (42%), Gaps = 24/272 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFA--PREIDILLKVSHPNI 69
I ++G G YG+VY + + L A K +K + E FA +EI ++ H NI
Sbjct: 14 IQRIGSGTYGDVYKARNVNTGELAAIKV-----IKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ L++ M++ L+ +I+ + QIA E
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQ---------DIYHVTGPLSESQIAYVSR---ETL 116
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
L YLH G +HRDIK NIL++ + KLADFG S + +F GT + APE
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176
Query: 190 II---RNSPYNPKLADIWSLGVVLYRILNKKYPFGD-PGTRNRDVLKKQEGKEYLFNRKY 245
+ R YN +L DIW++G+ + + P D R ++ K + K
Sbjct: 177 VAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAW 277
+ S + L NPK RP A+ + H +
Sbjct: 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 63/239 (26%), Positives = 111/239 (46%), Gaps = 36/239 (15%)
Query: 14 KLGEGAYGNVY------LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP 67
+GEG +G+VY ++K + +K CK ++ +++ E I+ + HP
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-----EAYIMRQFDHP 67
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+I+ + ++ ++++M+ A +L Y+ N+ + +A+ + Y ++
Sbjct: 68 HIVKLIGVITENP-VWIVMELAPLGELRSYLQV--------NKYSL---DLASLILYSYQ 115
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS--- 184
++ AL YL VHRDI N+L+S KL DFG SR L E + + +
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL----EDESYYKASKGKLP 171
Query: 185 --YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYL 240
+ APE I N +D+W GV ++ IL PF G +N DV+ + E E L
Sbjct: 172 IKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQ--GVKNNDVIGRIENGERL 227
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 18/220 (8%)
Query: 10 SYIS--KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP 67
SY++ KLGEG+Y VY + + L A K K + + A RE +L + H
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHA 63
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
NI+ +H ++ L + +Y DL Y+ + +H R+ ++ +
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPG-GLHPYNVRL----------FMFQ 111
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ L Y+H I+HRD+K +N+LIS L KLADFG +R P + ++ T Y
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRP 171
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227
P+++ + DIW G + +L + F PG +
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF--PGVSD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 77/340 (22%), Positives = 135/340 (39%), Gaps = 66/340 (19%)
Query: 12 ISKLGEGAYGNVYLVSDK---RSETLKACKA--YDFKRLKRDYMEKFAPREIDILLKVSH 66
I +G+G G VYL D R LK + + LK+ ++ RE I + H
Sbjct: 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-----REAKIAADLIH 61
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYIS-----KACNENIHENQARIWIRQIANA 121
P I+ V+ + G +Y M Y E L+ + ++ ++ + E + +
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTS------VGAF 115
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE------- 174
L H+I +EY+H G++HRD+K +NIL+ + D+G + + +E
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 175 -----------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP 223
+ GT Y APE + P + DI++LGV+LY++L +P+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPY--- 231
Query: 224 GTRNRD---------VLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNA----- 269
R + +L E Y EI Q+ + L +P R ++
Sbjct: 232 --RRKKGRKISYRDVILSPIEVAPY-----REIPPFLSQIAMKALAVDPAERYSSVQELK 284
Query: 270 KDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKVFMQKY 309
+D++ H +Q P + K + + KY
Sbjct: 285 QDLEPH--LQGSPEWTVKATLMTKKKSCWKFYEPILLSKY 322
|
Length = 932 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 76/294 (25%), Positives = 121/294 (41%), Gaps = 68/294 (23%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP--REIDILLKVSHPNIIG 71
++G G++G VY D R+ + A K + + EK+ +E+ L ++ HPN I
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 72 VHRMVKAGTYL-----YMIMDY--AEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
G YL +++M+Y D+ K E +IA
Sbjct: 80 YK-----GCYLREHTAWLVMEYCLGSASDILEVHKKPLQEV-----------EIA---AI 120
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
H L YLH +HRDIK NIL++ KLADFG S L +P +N+F GT
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG-SASLVSP---ANSFVGTPY 176
Query: 185 YAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPF--------------GDPGTRN 227
+ APE+I Y+ K D+WSLG+ + +K P D T
Sbjct: 177 WMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT-- 233
Query: 228 RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
L + +Y + + L+ P+ RP+++++ H ++ E
Sbjct: 234 ---LSSNDWSDYF-----------RNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 46/301 (15%)
Query: 1 MKFPDILECSY----------ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM 50
+K P+I E + + ++G G++G VY D R+ + A K + + +
Sbjct: 9 LKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK 68
Query: 51 EKFAPREIDILLKVSHPNIIGVHRMVKAGTYL-----YMIMDY--AEKKDLEHYISKACN 103
+ +E+ L ++ HPN I G YL +++M+Y DL K
Sbjct: 69 WQDIIKEVKFLQRIKHPNSIEYK-----GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ 123
Query: 104 ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163
E + I I H L YLH ++HRDIK NIL++ KLADF
Sbjct: 124 E--------VEIAAIT------HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 169
Query: 164 GFSRLLRTPKELSNTFCGTTSYAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPF 220
G S + +P +N+F GT + APE+I Y+ K+ D+WSLG+ + +K P
Sbjct: 170 G-SASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGITCIELAERKPPL 224
Query: 221 GDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ + Q L + E S + + L+ P+ RP ++++ H ++
Sbjct: 225 FNMNAMSALYHIAQNESPTL--QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282
Query: 281 E 281
E
Sbjct: 283 E 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 36/280 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ ++G G++G VY D R+ + A K + + + + +E+ L K+ HPN I
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 72 VHRMVKAGTYL-----YMIMDY--AEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
G YL +++M+Y DL K E + I +
Sbjct: 80 YR-----GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--------VEIAAVT----- 121
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
H L YLH ++HRD+K NIL+S KL DFG + ++ +N F GT
Sbjct: 122 -HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTPY 176
Query: 185 YAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241
+ APE+I Y+ K+ D+WSLG+ + +K P + + Q L
Sbjct: 177 WMAPEVILAMDEGQYDGKV-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235
Query: 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
+ + + + L+ P+ RP ++ + H ++ E
Sbjct: 236 SGHWSEYF--RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 46/270 (17%)
Query: 15 LGEGAYGNV----YLVSDKRSET--LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN 68
LG G +G+V YL+ + +K K K++++ RE ++ ++ HP
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL-----REASVMAQLDHPC 57
Query: 69 IIGVHRM--VKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
I+ R+ V G L ++M+ A L Y+ K I +++ E H
Sbjct: 58 IV---RLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREI----------PVSDLKELAH 102
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS-- 184
++A + YL VHRD+ N+L+ AK++DFG SR L S+ + TT+
Sbjct: 103 QVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG---SDYYRATTAGR 159
Query: 185 ----YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP---GTRNRDVLKKQEGK 237
+ APE I ++ K +D+WS GV L+ + +G + +V+ E
Sbjct: 160 WPLKWYAPECINYGKFSSK-SDVWSYGVTLWEA----FSYGAKPYGEMKGAEVIAMLESG 214
Query: 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRP 267
E L R E ++ + P+ RP
Sbjct: 215 ERL-PRPEECPQEIYSIMLSCWKYRPEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-17
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS---HPN 68
++++G GAYG VY D S A K+ + D + RE+ +L ++ HPN
Sbjct: 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQT-NEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 69 IIGVHRMVKAG-----TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
I+ + + T + ++ ++ ++ DL Y+ K + + +RQ L+
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
+LH AN IVHRD+K ENIL++ KLADFG +R+ L+ T
Sbjct: 123 FLH--ANC--------IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TL 171
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
Y APE++ S Y + D+WS+G + + +K F
Sbjct: 172 WYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 58/304 (19%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKA-----YDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
+G GA+G V+ V+D R A K + KR + RE+ +L H N+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF------RELKMLCFFKHDNV 61
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY----L 125
+ +++ +D E E Y+ E + + +I + + ++ L
Sbjct: 62 LSALDILQPPH-----IDPFE----EIYV---VTELMQSDLHKIIVSPQPLSSDHVKVFL 109
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL--LRTPKELSNTFCGTT 183
++I L+YLH GI+HRDIK N+L++ K+ DFG +R+ K ++ T
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQ 168
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF--GDP-----------GTRNRDV 230
Y APEI+ S + DIWS+G + +L ++ F P GT + +
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
Query: 231 LKK--QEGKEYLFNRK---------YEISIGAKQ----LIGRMLEPNPKHRPNAKDVQNH 275
++ + + ++ Y +S A L+ RML +P R +A D H
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288
Query: 276 AWIQ 279
++
Sbjct: 289 PYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 8e-17
Identities = 84/286 (29%), Positives = 130/286 (45%), Gaps = 51/286 (17%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDI-LLK-VSHPNIIGV 72
LG+GA+G VYL D + A K F + ++ + E +I LLK + H I+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 73 HRMVK--AGTYLYMIMDY----AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
+ ++ A L + M+Y + K L+ Y + + E+ R + RQI + YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA------LTESVTRKYTRQILEGMSYLH 123
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT----FCGT 182
+N IVHRDIK NIL N KL DFG S+ L+T +S T GT
Sbjct: 124 --SNM--------IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC-MSGTGIRSVTGT 172
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
+ +PE+I Y K AD+WSLG + +L +K P+ + E +F
Sbjct: 173 PYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAE-----------YEAMAAIFK 220
Query: 243 RKYE---------ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+ IS A+ +G + +HRP+A+++ H + Q
Sbjct: 221 IATQPTNPQLPSHISEHARDFLGCIF-VEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 81/323 (25%), Positives = 136/323 (42%), Gaps = 72/323 (22%)
Query: 12 ISKLGEGAYGNVYLVSDKRSET------LKACKAYD-FKRLKRDYMEKFAPREIDILLKV 64
I +G GAYG V S K SET K A+D KR REI +L +
Sbjct: 10 IKPIGRGAYGIV--CSAKNSETNEKVAIKKIANAFDNRIDAKRTL------REIKLLRHL 61
Query: 65 SHPNIIGV-------HRMVKAGTYL-YMIMDYAEKKDLEHYISKACNENIHENQARIWIR 116
H N+I + HR Y+ Y +MD DL H I ++ ++ + ++ + ++
Sbjct: 62 DHENVIAIKDIMPPPHREAFNDVYIVYELMD----TDL-HQIIRS-SQTLSDDHCQYFLY 115
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS 176
Q+ L+Y+H AN ++HRD+K N+L++ + K+ DFG +R +
Sbjct: 116 QLLRGLKYIHS-AN---------VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM 165
Query: 177 NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF---------------- 220
+ T Y APE++ N D+WS+G + +L +K F
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225
Query: 221 GDPGTRNRDVLKKQEGKEYL----------FNRKY-EISIGAKQLIGRMLEPNPKHRPNA 269
G P + ++ ++ + Y+ F R + + A L+ +ML +P R
Sbjct: 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV 285
Query: 270 KDVQNHAW------IQNEPTCQT 286
++ H + +EP CQT
Sbjct: 286 EEALAHPYLASLHDPSDEPVCQT 308
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 81/313 (25%), Positives = 134/313 (42%), Gaps = 67/313 (21%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF---APREIDILLKVSHPN 68
++K+G+G +G V+ K+++ + A K K L + E F A REI IL + H N
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALK----KVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 69 IIGVHRMV--KAGTY------LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
++ + + KA Y Y++ ++ E DL +S N+N+ + I
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS---NKNVKFTLSEI------- 121
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS-NTF 179
+ + + N L Y+H I+HRD+K NILI++ KLADFG +R K N +
Sbjct: 122 -KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 180 CG---TTSYAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPF--GD--------- 222
T Y PE++ R+ Y P + D+W G ++ + + P G+
Sbjct: 181 TNRVVTLWYRPPELLLGERD--YGPPI-DMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLI 236
Query: 223 ------------PGTRNRDVLKK------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPK 264
PG ++ KK Q+ K + Y A LI ++L +P
Sbjct: 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA 296
Query: 265 HRPNAKDVQNHAW 277
R +A NH +
Sbjct: 297 KRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 29/276 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH- 73
+G G YG VY ++ L A K D + + +++ EI++L K SH I +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSHHRNIATYY 69
Query: 74 -RMVKAG-----TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+K L+++M++ + I + E WI I E
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE----WIAYIC------RE 119
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
I L +LH+ ++HRDIK +N+L++ KL DFG S L NTF GT + A
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179
Query: 188 PEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
PE+I ++ Y+ K +D+WSLG+ + P D L + L +
Sbjct: 180 PEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238
Query: 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
+K+ S + I L N RP + + H +I
Sbjct: 239 KKW--SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 69/272 (25%), Positives = 112/272 (41%), Gaps = 67/272 (24%)
Query: 57 EIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY----AEKKDLEHYISKACNENIHENQAR 112
E IL ++HP+II + GT+ Y K DL Y++ +
Sbjct: 133 EAHILRAINHPSIIQL-----KGTFTYNKFTCLILPRYKTDLYCYLA---------AKRN 178
Query: 113 IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP 172
I I + L + A++YLHE I+HRDIK ENI I+ + L DFG + P
Sbjct: 179 I---AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF---P 232
Query: 173 KELSNT----FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN------------- 215
+++ + GT + APE++ PY P + DIWS G+VL+ +
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAV-DIWSAGIVLFEMATCHDSLFEKDGLDG 291
Query: 216 -------------------KKYPFGDPGTRNRDVLK------KQEGKEYLFNRKYEISIG 250
++P + + ++ G L+ YE+ I
Sbjct: 292 DCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPID 351
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
+ LI +ML + HRP+A+ + + A Q+ P
Sbjct: 352 LEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383
|
Length = 391 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 77/284 (27%), Positives = 122/284 (42%), Gaps = 60/284 (21%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREI----DILLKVSHPNII 70
+G GA+G V LV K + + A K K D +EK I DIL++ ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILR----KADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ + LY+IM++ D+ + K + + E + Y+ E
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQF----------YIAETVL 112
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFG-------------FSRLLRTP----- 172
A++ +H++G +HRDIK +N+L+ + KL+DFG + L P
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 173 -----------------KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN 215
++L+ + GT Y APE+ + YN KL D WSLGV++Y +L
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLI 231
Query: 216 KKYPFGD--PGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGR 257
PF P R V+ +E +F + IS AK LI R
Sbjct: 232 GYPPFCSETPQETYRKVMNWKE--TLVFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 73/270 (27%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFA--PREIDILLKVSHPNI 69
I ++G G YG+VY + + L A K +K + + F+ +EI ++ + H NI
Sbjct: 14 IQRVGSGTYGDVYKARNLHTGELAAVKI-----IKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ + L++ M+Y L+ +I+ + QIA E
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQ---------DIYHVTGPLSELQIAYVCR---ETL 116
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
L YLH G +HRDIK NIL++ + KLADFG + + +F GT + APE
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176
Query: 190 II---RNSPYNPKLADIWSLGVVLYRILNKKYPFGD-PGTRNRDVLKKQEGKEYLFNRKY 245
+ +N YN +L DIW++G+ + + P D R ++ K + K
Sbjct: 177 VAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKT 235
Query: 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+ S + L NPK RP A+ + H
Sbjct: 236 KWSSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 76/221 (34%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDI-LLK-VSHPNII-- 70
LG+GA+G VYL D + A K F + ++ E +I LLK + H I+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 71 -GVHRMVKAGTYLYMIMDYAE----KKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
G R T L + M++ K L+ Y + + EN R + RQI LE +
Sbjct: 70 YGCLRDPMERT-LSIFMEHMPGGSIKDQLKSYGA------LTENVTRKYTRQI---LEGV 119
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT----FCG 181
YLH IVHRDIK NIL + N KL DFG S+ L+T LS T G
Sbjct: 120 S-------YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC-LSGTGMKSVTG 171
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222
T + +PE+I Y K ADIWS+G + +L +K P+ +
Sbjct: 172 TPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK--AYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
+ ++G G++G VY ++ + + A K +Y K+ + + +E+ L ++ HPN
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDII--KEVKFLQQLKHPNT 83
Query: 70 IGVHRMVKAGTYL-----YMIMDY--AEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
I G YL +++M+Y DL K E + I I
Sbjct: 84 IEYK-----GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE--------VEIAAIT--- 127
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
H L YLH ++HRDIK NIL++ KLADFG S +P +N+F GT
Sbjct: 128 ---HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-SASKSSP---ANSFVGT 180
Query: 183 TSYAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239
+ APE+I Y+ K+ D+WSLG+ + +K P + + Q
Sbjct: 181 PYWMAPEVILAMDEGQYDGKV-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT 239
Query: 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
L + ++ S + + L+ P+ RP + ++ H +++ +
Sbjct: 240 LQSNEWTDSF--RGFVDYCLQKIPQERPASAELLRHDFVRRD 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----REIDILLKVS-- 65
++++GEGAYG V+ D ++ + KR++ E+ P RE+ +L +
Sbjct: 6 VAEIGEGAYGKVFKARDLKN----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 66 -HPNIIGVHRMVKAG-----TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIA 119
HPN++ + + T L ++ ++ ++ DL Y+ K + + + Q+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 120 NALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF 179
L++LH H V VHRD+K +NIL++ KLADFG +R+ L++
Sbjct: 121 RGLDFLHS--------HRV--VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 170
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
T Y APE++ S Y + D+WS+G + + +K F
Sbjct: 171 V-TLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 81/323 (25%), Positives = 130/323 (40%), Gaps = 78/323 (24%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK-----FAPREIDILLKVSH 66
+ +G+GA+G V LV K + K Y K L + M K E D+L +
Sbjct: 6 VKVIGKGAFGEVRLVQKKDTG-----KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P ++ ++ + YLY+IM++ DL + K + E+ R Y+
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRF----------YMA 108
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS------------RLLRTPKE 174
E A+E +H++G +HRDIK +NILI R + KL+DFG S + L K
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 175 LSNTF-----------------------------------CGTTSYAAPEIIRNSPYNPK 199
N GT Y APEI Y +
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 200 LADIWSLGVVLYRILNKKYPF--GDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGR 257
D WSLG +++ L PF + R ++ +E F +S+ A+ LI R
Sbjct: 229 -CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE--TLYFPDDIHLSVEAEDLIRR 285
Query: 258 MLEPNPKH---RPNAKDVQNHAW 277
++ N ++ R A ++++H +
Sbjct: 286 LIT-NAENRLGRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-16
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 14 KLGEGAYGNVY--LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
K+G+G +G+VY ++ +K C++ LKR +++ E +IL + HPNI+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ-----EAEILKQYDHPNIVK 56
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + +Y++M+ L ++ K + R+ ++++ L+ + A
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRK--------KKNRLTVKKL---LQMSLDAAAG 105
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT-------S 184
+EYL +HRD+ N L+ K++DFG SR +E + +
Sbjct: 106 MEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIK 160
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD---PGTRNR 228
+ APE + Y + +D+WS G++L+ + GD PG N+
Sbjct: 161 WTAPEALNYGRYTSE-SDVWSYGILLWET----FSLGDTPYPGMSNQ 202
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 56/292 (19%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRL-------KRDYMEKFAPREIDILLKVSHP 67
+G+G YG VYL + + + A K + ++ M K EI+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
NI+ YL + ++ Y+ + R + Q+ +
Sbjct: 69 NIVQYLGFETTEEYLSIFLE---------YVPGGSIGSCLRTYGR-FEEQLVRFF--TEQ 116
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSN----TFCGTT 183
+ L YLH GI+HRD+K +N+L+ K++DFG S+ ++ N + G+
Sbjct: 117 VLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSV 174
Query: 184 SYAAPEIIRNSP--YNPKLADIWSLGVVLYRILNKKYPFGDP---------GTRNR---- 228
+ APE+I + Y+ K+ DIWSLG V+ + + P+ D G +
Sbjct: 175 FWMAPEVIHSYSQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233
Query: 229 --DVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
DV +S A + NP +RP A+++ H +I
Sbjct: 234 PPDVSMN-------------LSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 28/224 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNII 70
I +G+G YG VY V++K+ +L A K D + +E E +IL + HPN++
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA----EYNILQSLPNHPNVV 82
Query: 71 GVHRMVK-----AGTYLYMIMDYAEKKDLEHYISK--ACNENIHENQARIWIRQIANALE 123
+ M G L+++++ + + C + + E A
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE----------AMISY 132
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
L+ L++LH I+HRD+K NIL++ KL DFG S L + + NT GT
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 192
Query: 184 SYAAPEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPFGD 222
+ APE+I + Y+ + D+WSLG+ + + P D
Sbjct: 193 FWMAPEVIACEQQYDYSYDAR-CDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 25/232 (10%)
Query: 3 FPDILEC-SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDIL 61
FPD + I +G+G YG V+ V +K++ + A K D + +E E +IL
Sbjct: 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA----EYNIL 68
Query: 62 LKVS-HPNIIGVHRM-----VKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWI 115
+S HPN++ + M VK G L+++++ + + + I
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 116 RQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL 175
LHE L++LH +HRD+K NIL++ KL DFG S L + +
Sbjct: 129 --------ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 180
Query: 176 SNTFCGTTSYAAPEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPFGD 222
NT GT + APE+I +S Y+ + D+WSLG+ + + P D
Sbjct: 181 RNTSVGTPFWMAPEVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 74/324 (22%), Positives = 131/324 (40%), Gaps = 68/324 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL-KRDYMEKFAPREIDILLKV-SHPNI 69
I +LG+GAYG V + + + + + + K A RE+ +L H NI
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI 64
Query: 70 IGVHRMVKA------GTYLYM-IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA- 121
++ M YLY +M+ DL ++ I Q + +A
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEA----DL--------HQIIRSGQ------PLTDAH 106
Query: 122 -LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF- 179
++++I L+Y+H ++HRD+K N+L++ K+ DFG +R + F
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 180 ---CGTTSYAAPEI-IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP------------ 223
T Y APEI + Y K D+WS+G +L +L +K F
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYT-KAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225
Query: 224 -GTRNRDVLKK---QEGKEYLFN------RKYE-ISIGAK----QLIGRMLEPNPKHRPN 268
GT + + L + + + Y+ + + +E I A L+ ++L +P R +
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285
Query: 269 AKDVQNHAW------IQNEPTCQT 286
++ H + +EP CQ
Sbjct: 286 VEEALEHPYLAIWHDPDDEPVCQK 309
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 46/287 (16%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK-------AYDFKRLKRDYMEKFAPREIDILLKV 64
I +LG GAYG V + + T+ A K + + KRL D +DI ++
Sbjct: 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMD---------LDISMRS 56
Query: 65 SH-PNIIGVH-RMVKAG-TYLYM-IMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
P + + + + G ++ M +MD + K + K I E+ I
Sbjct: 57 VDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDK--GLTIPEDILGKIAVSIVK 114
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF- 179
ALEYLH ++ ++HRD+K N+LI+R KL DFG S L ++ T
Sbjct: 115 ALEYLHS---------KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163
Query: 180 CGTTSYAAPEII----RNSPYNPKLADIWSLGVVLYRILNKKYPF---GDPGTRNRDVLK 232
G Y APE I Y+ K +D+WSLG+ + + ++P+ P + + V++
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
Query: 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+ + L K+ + + + L+ N K RPN ++ H + +
Sbjct: 223 EPSPQ--LPAEKFSPEF--QDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 60/284 (21%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDILLKVSHPNII 70
+G GA+G V LV K + + A K K D +EK E DIL++ ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILR----KADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ + LY+IM++ D+ + K + + E + + Y+ E
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQF----------YIAETVL 112
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFG------------FSRLL--------- 169
A++ +H++G +HRDIK +N+L+ + KL+DFG F R L
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 170 --------------RTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN 215
R ++L+ + GT Y APE+ + YN KL D WSLGV++Y +L
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLI 231
Query: 216 KKYPFGD--PGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGR 257
PF P + V+ +E +F + IS AK LI R
Sbjct: 232 GYPPFCSETPQETYKKVMNWKE--TLIFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 15 LGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPN 68
+G G +G V+ L R E A K LK Y EK E I+ + SH N
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKT-----LKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
II + +V +I +Y E L+ Y+ ++ Q+ L I
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYL--------RDHDGEFSSYQLVGML---RGI 116
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG---TTSY 185
A ++YL ++ VHRD+ NIL++ L K++DFG SR+L E + T G +
Sbjct: 117 AAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK 232
APE I + +D+WS G+V++ +++ + P+ D N +V+K
Sbjct: 177 TAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWD--MSNHEVMK 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 40/220 (18%)
Query: 11 YISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS 65
+I +LG+G +G+V L + D E + K + +++ F REI+IL +
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKK---LQHSTAEHLRDFE-REIEILKSLQ 63
Query: 66 HPNII---GVHRMVKAGTY-LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
H NI+ GV AG L ++M+Y L Y+ K ++ R+ R++
Sbjct: 64 HDNIVKYKGV--CYSAGRRNLRLVMEYLPYGSLRDYLQK--------HRERLDHRKL--- 110
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL------ 175
L Y +I +EYL VHRD+ NIL+ K+ DFG +++L KE
Sbjct: 111 LLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP 170
Query: 176 --SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRI 213
S F + APE + S ++ +D+WS GVVLY +
Sbjct: 171 GESPIF-----WYAPESLTESKFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 24/226 (10%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYME----KFAPREIDILLKVSHP 67
+S +G GAYG+V D ++ A K+L R + K RE+ +L + H
Sbjct: 22 LSPVGSGAYGSVCAAFDTKTGLRVAV-----KKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL-H 126
N+IG+ + L ++ + + H + N NI + Q + + +++L +
Sbjct: 77 NVIGLLDVFTPARSL---EEFNDVYLVTHLMGADLN-NIVKCQ-----KLTDDHVQFLIY 127
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
+I L+Y+H I+HRD+K N+ ++ K+ DFG +R T E++ + T Y
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTG-YVATRWYR 184
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK 232
APEI+ N + + DIWS+G ++ +L + F PGT + D LK
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 228
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 29/276 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH- 73
+G G YG VY ++ L A K D + + ++ EI++L K SH I +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL----EINMLKKYSHHRNIATYY 79
Query: 74 -RMVKAG-----TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+K L+++M++ + + + E+ WI I E
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED----WIAYIC------RE 129
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
I L +LH ++HRDIK +N+L++ KL DFG S L NTF GT + A
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189
Query: 188 PEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
PE+I ++ Y+ + +DIWSLG+ + P D L + L +
Sbjct: 190 PEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248
Query: 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
+K+ S I L N RP+ + + H +I
Sbjct: 249 KKW--SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 68/273 (24%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRS-----ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH 66
I+ LG G +G V+L K ETL KA K + +F RE+D+ K+SH
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ-KTKDENLQSEFR-RELDMFRKLSH 67
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
N++ + + + YMI++Y + DL+ ++ +++ + +Q +
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK---VALCT 124
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP--KE---LSNTFCG 181
+IA +++L VHRD+ N L+S K+ L + E L N
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKV---SLLSLSKDVYNSEYYKLRNALI- 180
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYL 240
+ APE ++ ++ K +D+WS GV+++ + + + PF G + +VL + L
Sbjct: 181 PLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPF--YGLSDEEVLNR------L 231
Query: 241 FNRKYEISIGAK------QLIGRMLEPNPKHRP 267
K E+ + +L+ R NPK RP
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 68/253 (26%), Positives = 113/253 (44%), Gaps = 51/253 (20%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYME----KFAPREIDILLKVSHPNII 70
+G GAYG+V DKR+ A K+L R + K A RE+ +L + H N+I
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVA-----IKKLSRPFQSEIFAKRAYRELTLLKHMQHENVI 77
Query: 71 G-VHRMVKAGTY-----LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
G + A + Y++M Y + DL+ + +E+ ++Y
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSED---------------KVQY 121
Query: 125 L-HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
L +++ L+Y+H GI+HRD+K N+ ++ K+ DFG +R E++ + T
Sbjct: 122 LVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTG-YVVTR 178
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF----------------GDPGTRN 227
Y APE+I N + + DIWS+G ++ +L K F G PG
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238
Query: 228 RDVLKKQEGKEYL 240
L+ + K Y+
Sbjct: 239 VQKLEDKAAKSYI 251
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 15 LGEGAYGNVYLVSDKR-----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH-PN 68
+GEG +G V K+ +K K Y K RD+ E+++L K+ H PN
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-----ELEVLCKLGHHPN 57
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKA-------CNENIHENQARIWIRQIANA 121
II + + YLY+ ++YA +L ++ K+ + + + +Q+
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL--- 114
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR-----LLRTPKELS 176
L + ++A ++YL + +HRD+ NIL+ AK+ADFG SR + +T L
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 177 NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN 215
+ A E + S Y +D+WS GV+L+ I++
Sbjct: 175 ------VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 15 LGEGAYGNVYLV-----SDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPN 68
+GEG +G V K + +K K + + RD+ E+++L K+ HPN
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAG-----ELEVLCKLGHHPN 64
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKA-------CNENIHENQARIWIRQIANA 121
II + + YLY+ ++YA +L ++ K+ H + + +Q+
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL--- 121
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR-----LLRTPKELS 176
L++ ++A ++YL E +HRD+ N+L+ L +K+ADFG SR + +T L
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 177 NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN 215
+ A E + S Y K +D+WS GV+L+ I++
Sbjct: 182 ------VRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ ++G GAYG V D+R+ A K ++ + + K A RE+ +L + H N+IG
Sbjct: 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHENVIG 78
Query: 72 VHRMVKAGTYL------YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
+ + L Y++M + DL + +E + E++ + + Q+ L+Y+
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYI 134
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
H GI+HRD+K N+ ++ K+ DFG +R +T E++ + T Y
Sbjct: 135 HA----------AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTG-YVVTRWY 181
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
APE+I N + + DIWS+G ++ +L K F
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 28/226 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK-VSHPNII 70
+ KLG G +G V++ S + K LK M A E L+K + H ++
Sbjct: 11 VKKLGAGQFGEVWMGYYNNSTKVAV------KTLKPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
++ +V +Y+I +Y K L ++ + + +++ +IA
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKV----------LLPKLIDFSAQIAE 114
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR----TPKELSNTFCGTTSYA 186
+ Y+ +HRD++ N+L+S L K+ADFG +R++ T +E + +
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF---PIKWT 171
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVL 231
APE I + K +D+WS G++LY I+ K P+ PG N DV+
Sbjct: 172 APEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPY--PGMSNSDVM 214
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 62/269 (23%), Positives = 122/269 (45%), Gaps = 30/269 (11%)
Query: 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL-KRDYMEKFAPREIDILLK 63
D E +++ +LG G +G V+L R + A K + + D++E E +++K
Sbjct: 2 DPSELTFLKELGSGQFGVVHL-GKWRGKIDVAIKMIREGAMSEDDFIE-----EAKVMMK 55
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
+SHPN++ ++ + ++++ +Y L +Y+ + R L+
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-----------RERKGKLGTEWLLD 104
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT- 182
++ A+EYL G +HRD+ N L+ K++DFG +R + + S+ GT
Sbjct: 105 MCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--GTK 162
Query: 183 --TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK-QEGKE 238
+A PE+ S ++ K +D+WS GV+++ + ++ K P+ N +V++ G
Sbjct: 163 FPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPY--ERFSNSEVVESVSAG-- 217
Query: 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRP 267
Y R ++ P+ RP
Sbjct: 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 77/297 (25%), Positives = 124/297 (41%), Gaps = 69/297 (23%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACK----AYDFKRLKRDYMEKFAPREIDILLKVSH-PNI 69
+G GA+G V + K S T+ A K D K KR M+ +D++++ S P I
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMD------LDVVMRSSDCPYI 65
Query: 70 IGVHRMV--KAGTYLYM-IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
+ + + + ++ M +MD + K + ++E + +I +
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDK---------FYKYVYEVLKSVIPEEILGKIAV-- 114
Query: 127 EIANALEYL-HEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC----- 180
AL YL E+ I+HRD+K NIL+ R N KL DFG S +L ++
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS------GQLVDSIAKTRDA 168
Query: 181 GTTSYAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPF---------------GD 222
G Y APE I Y+ + +D+WSLG+ LY + K+P+ GD
Sbjct: 169 GCRPYMAPERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD 227
Query: 223 PGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
P +L E +E+ S I L + RP K++ H +I+
Sbjct: 228 P-----PILSNSEEREF--------SPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 60/256 (23%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I LG GA+G V L ++ L A K K + E DIL + + ++
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + LY +MDY D+ + R+ I A Y+ E+ A
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLL------------IRMGIFPEDLARFYIAELTCA 113
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR--------------------- 170
+E +H++G +HRDIK +NILI R + KL DFG R
Sbjct: 114 VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 171 ----------------TPKE----------LSNTFCGTTSYAAPEIIRNSPYNPKLADIW 204
P E L+++ GT +Y APE++ + Y +L D W
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWW 232
Query: 205 SLGVVLYRILNKKYPF 220
S+GV+LY +L + PF
Sbjct: 233 SVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 9e-15
Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 31/233 (13%)
Query: 15 LGEGAYGNVY---LVSDKRSET---LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN 68
+G G +G V L + E +K K+ ++ +RD++ E I+ + HPN
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-----EASIMGQFDHPN 66
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
II + +V + +I ++ E L+ ++ +N + + Q+ L I
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFL--------RQNDGQFTVIQLVGMLR---GI 115
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT----PKELSNTFCGT-T 183
A ++YL E+ VHRD+ NIL++ L K++DFG SR L P S+
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQE 235
+ APE I + +D+WS G+V++ +++ + P+ D N+DV+ E
Sbjct: 176 RWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD--MSNQDVINAIE 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 54/218 (24%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL-KRDYMEKFAPREIDILLKVSH 66
E +++ +LG G +G V+L R++ A KA + + + D++E E +++K+SH
Sbjct: 5 ELTFMKELGSGQFGVVHL-GKWRAQIKVAIKAINEGAMSEEDFIE-----EAKVMMKLSH 58
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P ++ ++ + LY++ ++ E L +Y+ + Q ++ + L
Sbjct: 59 PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL--------RQRQGKLSKDML---LSMCQ 107
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT---T 183
++ +EYL +HRD+ N L+S K++DFG +R + + S+ G
Sbjct: 108 DVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS--SGAKFPV 165
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPF 220
++ PE+ S Y+ K +D+WS GV+++ + + K PF
Sbjct: 166 KWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 49/219 (22%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 8 ECSYISKLGEGAYGNVYLVS--DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS 65
E + + ++G G +G V+L +KR +K + + D++E E +++K+S
Sbjct: 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIE-----EAQVMMKLS 57
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
HP ++ ++ + + + ++ ++ E L Y+ +A+ L
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-----------RAQRGKFSQETLLGMC 106
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT--- 182
++ + YL ++HRD+ N L+ K++DFG +R + + S+T GT
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST--GTKFP 164
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPF 220
+++PE+ S Y+ K +D+WS GV+++ + ++ K P+
Sbjct: 165 VKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPY 202
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 84/327 (25%), Positives = 141/327 (43%), Gaps = 68/327 (20%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP-----REIDILLKVSHPNI 69
+G+G+YG V D + A K D E + REI +L + HP+I
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKI------NDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 70 IGV-HRMVKAGTY----LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
+ + H M+ +Y++ + E DL H + KA N+++ + +
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMES-DL-HQVIKA-NDDLTPEHHQF----------F 108
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR--LLRTPKELSNT-FCG 181
L+++ AL+Y+H + HRD+K +NIL + K+ DFG +R TP + T +
Sbjct: 109 LYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 182 TTSYAAPEIIRN--SPYNPKLADIWSLGVVLYRILNKKYPF----------------GDP 223
T Y APE+ + S Y P + DIWS+G + +L K F G P
Sbjct: 169 TRWYRAPELCGSFFSKYTPAI-DIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227
Query: 224 GTRNRDVLKKQEGKEYL--FNRKYEISIGAK---------QLIGRMLEPNPKHRPNAKDV 272
++ ++ + YL +K + K +L+ R+L +PK RP A++
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287
Query: 273 QNH------AWIQNEPTCQTMTAEERE 293
A ++ EP+ Q +T E E
Sbjct: 288 LADPYFKGLAKVEREPSAQPITKLEFE 314
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK 63
P I E + + GA+G VYL K + L A K + M E D L
Sbjct: 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL 60
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDY---AEKKDLEHYISKACNENIHENQARIWIRQIAN 120
P I+ ++ +++ +Y++M+Y + K L H I +E +
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDEEM-------------- 105
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168
A++Y+ E+A AL+YLH GI+HRD+K +N+LIS + KL DFG S++
Sbjct: 106 AVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 74/259 (28%), Positives = 117/259 (45%), Gaps = 34/259 (13%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKA--YDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
IS+LG G G V+ VS K S + A K + K R+ + RE+ +L + + P I
Sbjct: 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI----IRELQVLHECNSPYI 65
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+G + + + + M++ + L+ + KA RI QI + +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---------GRI-PEQILGKVSI--AVI 113
Query: 130 NALEYLHEV-GIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
L YL E I+HRD+K NIL++ KL DFG S L ++N+F GT SY +P
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSP 171
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248
E ++ + Y+ + +DIWS+G+ L + +YP P + E +F E
Sbjct: 172 ERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKEL---------ELMFGCPVEGD 221
Query: 249 IGAKQLIGRMLEPNPKHRP 267
+ R P P RP
Sbjct: 222 PAESETSPR---PRPPGRP 237
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 17/217 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH---PNIIG 71
+G G +G VY + + A K D KR+K E A E +L VS P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ L I+D DL +++S+ + E + R Y EI
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQ--HGVFSEKEMRF----------YATEIILG 109
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
LE++H +V+RD+K NIL+ + +++D G + K+ + GT Y APE++
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVL 167
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR 228
+ AD +SLG +L+++L PF T+++
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 72/267 (26%), Positives = 118/267 (44%), Gaps = 34/267 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKA--YDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
IS+LG G G V V K S + A K + K R+ + RE+ +L + + P I
Sbjct: 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI----IRELQVLHECNSPYI 65
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+G + + + + M++ + L+ + +A + I E + L YL E
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE-- 121
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
H+ I+HRD+K NIL++ KL DFG S L ++N+F GT SY +PE
Sbjct: 122 -----KHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPE 172
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
++ + Y+ + +DIWS+G+ L + +YP P + E +F R
Sbjct: 173 RLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKEL---------EAIFGRPVVDGE 222
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHA 276
+ + P P RP + V H
Sbjct: 223 EGE---PHSISPRP--RPPGRPVSGHG 244
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 14 KLGEGAYGNVYLV-SDKRSETL----------------KACKAYDFKRLKRDYMEKFAPR 56
KLGEG +G V+L ++ +E L K +A K + D++ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL-----K 66
Query: 57 EIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIR 116
EI I+ ++ +PNII + + + L MI +Y E DL ++S+ E+ + I
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK--E 174
IAN L +IA+ ++YL + VHRD+ N L+ K+ADFG SR L +
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 175 LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRI--LNKKYPF 220
+ + A E I + +D+W+ GV L+ + L K+ P+
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPY 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 70/259 (27%), Positives = 103/259 (39%), Gaps = 60/259 (23%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I LG GA+G V L + L A K K + E DIL + + ++
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + LY +MDY D+ + + E E AR Y+ E+ A
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARF----------YIAELTLA 113
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR-------------------TP 172
+E +H++G +HRDIK +NILI + KL DFG R P
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 173 KEL----SNTFC------------------------GTTSYAAPEIIRNSPYNPKLADIW 204
+L SN C GT +Y APE++ Y +L D W
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWW 232
Query: 205 SLGVVLYRILNKKYPFGDP 223
S+GV+L+ +L + PF P
Sbjct: 233 SVGVILFEMLVGQPPFLAP 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH---PNIIG 71
+G G +G VY + + A K D KR+K E A E +L VS P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ L I+D DL +++S+ + E + R Y EI
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEAEMRF----------YAAEIILG 109
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
LE++H +V+RD+K NIL+ + +++D G + K+ + GT Y APE++
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVL 167
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233
+ AD +SLG +L+++L PF T+++ + +
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 54/177 (30%), Positives = 86/177 (48%), Gaps = 24/177 (13%)
Query: 56 REIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWI 115
RE+ +L + + P I+G + + + + M++ + L+ + KA I EN
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEN------ 99
Query: 116 RQIANALEYLHEIANA----LEYLHEV-GIVHRDIKCENILISRLLNAKLADFGFSRLLR 170
L +I+ A L YL E I+HRD+K NIL++ KL DFG S L
Sbjct: 100 --------ILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151
Query: 171 TPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227
++N+F GT SY +PE ++ + Y +DIWSLG+ L + +YP P +
Sbjct: 152 --DSMANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 57/232 (24%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPR---EIDILLKVSHPNIIG 71
LG+GAYG VY + + L A K + EK + E+D+L + H NI+
Sbjct: 8 LGKGAYGTVYCGLTNQGQ-LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV- 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIR-----QIANAL---- 122
YL +D +N I++ I++ L
Sbjct: 66 --------QYLGTCLD--------------------DNTISIFMEFVPGGSISSILNRFG 97
Query: 123 --------EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR---- 170
+Y +I + + YLH +VHRDIK N+++ KL DFG +R L
Sbjct: 98 PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157
Query: 171 --TPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
T + + GT + APE+I S Y K +DIWS+G ++ + K P
Sbjct: 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 62/276 (22%), Positives = 121/276 (43%), Gaps = 43/276 (15%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETL-KACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPN 68
+ KLG G +G V+ E L K LK M + F E I+ K+ HP
Sbjct: 11 LRKLGAGQFGEVW-------EGLWNNTTPVAVKTLKPGTMDPKDFL-AEAQIMKKLRHPK 62
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+I ++ + +Y++ + + L Y+ + ++ ++ ++
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL----------KLPQLIDMAAQV 112
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT---TSY 185
A+ + YL +HRD+ N+L+ K+ADFG +R+++ +++ G +
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK--EDIYEAREGAKFPIKW 170
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244
APE + ++ K +D+WS G++L I+ + P+ PG N +VL++ + +
Sbjct: 171 TAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPY--PGMTNAEVLQQVD-------QG 220
Query: 245 YEISIGA---KQLIGRMLE---PNPKHRPNAKDVQN 274
Y + K+L ML+ +P RP + +Q
Sbjct: 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 64/228 (28%), Positives = 111/228 (48%), Gaps = 26/228 (11%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYD--FKRL---KRDYMEKFAPREIDILLKVSH 66
++ +G GAYG+V D R A K F+ L +R Y RE+ +L + H
Sbjct: 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY------RELRLLKHMKH 73
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL- 125
N+IG+ + T I ++ E + + + N NI + Q + +++L
Sbjct: 74 ENVIGLLDVFTPAT---SIENFNEVYLVTNLMGADLN-NIVKCQ-----KLSDEHVQFLI 124
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
+++ L+Y+H GI+HRD+K N+ ++ ++ DFG +R + E++ + T Y
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTG-YVATRWY 181
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233
APEI+ N + + DIWS+G ++ +L K F PG D LK+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF--PGNDYIDQLKR 227
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 65/267 (24%), Positives = 124/267 (46%), Gaps = 26/267 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNI 69
I KLG G +G V++ T K LK M E F E I+ K+ H +
Sbjct: 11 IKKLGNGQFGEVWM------GTWNGNTKVAVKTLKPGTMSPESFL-EEAQIMKKLRHDKL 63
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ ++ +V +Y++ +Y K L ++ + ++ N ++ ++A
Sbjct: 64 VQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRAL----------KLPNLVDMAAQVA 112
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG-TTSYAAP 188
+ Y+ + +HRD++ NIL+ L K+ADFG +RL+ + + + AP
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247
E + K +D+WS G++L ++ K + P+ PG NR+VL++ E + Y +
Sbjct: 173 EAALYGRFTIK-SDVWSFGILLTELVTKGRVPY--PGMNNREVLEQVE-RGYRMPCPQDC 228
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQN 274
I +L+ + + +P+ RP + +Q+
Sbjct: 229 PISLHELMLQCWKKDPEERPTFEYLQS 255
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-14
Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 34/268 (12%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
KLG G YG VY K+ A K LK D M E+F +E ++ ++ HPN++
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFL-KEAAVMKEIKHPNLVQ 66
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH---EI 128
+ + Y+I ++ +L Y+ + CN RQ NA+ L+ +I
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYL-RECN------------RQEVNAVVLLYMATQI 113
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT---SY 185
++A+EYL + +HRD+ N L+ K+ADFG SRL+ + G +
Sbjct: 114 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKW 171
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKY-PFGDPGTRNRDVLKKQEGKEYLFNRK 244
APE + + ++ K +D+W+ GV+L+ I P+ PG V + E K Y R
Sbjct: 172 TAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY--PGIDLSQVYELLE-KGYRMERP 227
Query: 245 YEISIGAKQLIGRMLEPNPKHRPNAKDV 272
+L+ + NP RP+ ++
Sbjct: 228 EGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 29/236 (12%)
Query: 12 ISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH 66
I +LG+G++G VY V ET A K + R+ +E E ++ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN--EASVMKEFNC 68
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
+++ + +V G ++M+ K DL+ Y+ E + Q ++
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ--KFIQMAA 126
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL-------RTPKELSNTF 179
EIA+ + YL VHRD+ N +++ L K+ DFG +R + + K L
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL--- 183
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD---PGTRNRDVLK 232
+ APE +++ + K +D+WS GVVL+ + + G N +VLK
Sbjct: 184 --PVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMAT----LAEQPYQGLSNEEVLK 232
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG GA+G VYL D + A K F ++ ++ E +I L + R
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQL-------LKNLR 62
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL-EYLHEIANALE 133
+ Y + D EKK L ++ +I ++Q + + N Y +I +
Sbjct: 63 HDRIVQYYGCLRDPEEKK-LSIFVEYMPGGSI-KDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT----FCGTTSYAAPE 189
YLH IVHRDIK NIL N KL DFG S+ ++T +S T GT + +PE
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC-MSGTGIKSVTGTPYWMSPE 179
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222
+I Y K AD+WS+ + +L +K P+ +
Sbjct: 180 VISGEGYGRK-ADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 8e-14
Identities = 61/266 (22%), Positives = 119/266 (44%), Gaps = 24/266 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFA-PREIDILLKVSHPNII 70
+ KLG G +G V++ + K LK+ M A E +++ ++ HP ++
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVA------IKSLKQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
++ +V +Y+I +Y E L ++ + I ++ +IA
Sbjct: 65 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKL----------TINKLIDMAAQIAE 113
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG-TTSYAAPE 189
+ ++ +HRD++ NIL+S L K+ADFG +RL+ + + + APE
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248
I + K +D+WS G++L I+ + P+ PG N +V++ E + Y R
Sbjct: 174 AINYGTFTIK-SDVWSFGILLTEIVTYGRIPY--PGMTNPEVIQNLE-RGYRMPRPDNCP 229
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQN 274
+L+ + P+ RP + +++
Sbjct: 230 EELYELMRLCWKEKPEERPTFEYLRS 255
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-14
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 14 KLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN 68
+LGEGA+G V+L + ++ + L A KA K + F RE ++L + H +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQ-REAELLTVLQHQH 68
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYI-SKACNENIHENQARIWIRQI--ANALEYL 125
I+ + + G L M+ +Y DL ++ S + I + Q+ L
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK--ELSNTFCGTT 183
+IA+ + YL + VHRD+ N L+ + L K+ DFG SR + + +
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
+ PE I + + +DIWS GVVL+ I
Sbjct: 189 RWMPPESILYRKFTTE-SDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 74/308 (24%), Positives = 127/308 (41%), Gaps = 52/308 (16%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
+G GA+G V D+ + A K K + K RE+ +L + H NII +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 75 M-VKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +Y + + DL + +R +Q +L++I L+
Sbjct: 77 IFISPLEDIYFVTELL-GTDLHRLL-----------TSRPLEKQFIQY--FLYQILRGLK 122
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT-FCGTTSYAAPEIIR 192
Y+H G+VHRD+K NILI+ + K+ DFG +R ++ T + T Y APEI+
Sbjct: 123 YVHSAGVVHRDLKPSNILINENCDLKICDFGLAR----IQDPQMTGYVSTRYYRAPEIML 178
Query: 193 N-SPYNPKLADIWSLGVVLYRILNKK--YPFGDP-----------GTRNRDVLKK----- 233
Y+ ++ DIWS G + +L K +P D GT DV+
Sbjct: 179 TWQKYDVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 234 ---------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ--NEP 282
+ + A L+ +ML +P+ R +A + H ++ ++P
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297
Query: 283 TCQTMTAE 290
T + + E
Sbjct: 298 TDEPVAEE 305
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 57 EIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIR 116
E L + H NI+ + ++ G + ++ +Y L+ ++ K HE Q
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK------HEGQL----- 104
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS 176
+ L +A+ ++YL E+G VH+ + +L++ L K++ GF RL E
Sbjct: 105 VAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAI 162
Query: 177 NTFCGTTS---YAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK 232
T S +AAPE I+ ++ +D+WS G+V++ +++ + P+ D +DV+K
Sbjct: 163 YTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMS--GQDVIK 219
Query: 233 KQE 235
E
Sbjct: 220 AVE 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 65/264 (24%), Positives = 121/264 (45%), Gaps = 26/264 (9%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
KLG+G +G V++ T K LK M E F +E ++ K+ H ++
Sbjct: 13 KLGQGCFGEVWM------GTWNGTTRVAIKTLKPGTMSPEAFL-QEAQVMKKLRHEKLVQ 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ +V +Y++ +Y K L ++ + + ++R + ++ +IA+
Sbjct: 66 LYAVVSEEP-IYIVTEYMSKGSLLDFL---------KGEMGKYLR-LPQLVDMAAQIASG 114
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG-TTSYAAPEI 190
+ Y+ + VHRD++ NIL+ L K+ADFG +RL+ + + + APE
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+ K +D+WS G++L + K + P+ PG NR+VL + E + Y E
Sbjct: 175 ALYGRFTIK-SDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVE-RGYRMPCPPECPE 230
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQ 273
L+ + P+ RP + +Q
Sbjct: 231 SLHDLMCQCWRKEPEERPTFEYLQ 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 56/243 (23%)
Query: 14 KLGEGAYGNVYL----------------VSDKRSETLKACK---AYDFKRLKRDYMEKFA 54
KLGEG +G V+L + + L A K + D++
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL---- 67
Query: 55 PREIDILLKVSHPNIIGVHRMVKAGTY---LYMIMDYAEKKDLEHYISKACNENIHENQA 111
+E+ IL ++S PNI R++ T L MIM+Y E DL ++ K E +
Sbjct: 68 -KEVKILSRLSDPNIA---RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET---SGL 120
Query: 112 RIWIRQI-ANALEYLH-EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL 169
+ + + L Y+ +IA+ + YL + VHRD+ N L+ + K+ADFG SR L
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 170 ----------RTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN--KK 217
R P + + A E + + K +D+W+ GV L+ IL ++
Sbjct: 181 YSSDYYRVQGRAPLPI--------RWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCRE 231
Query: 218 YPF 220
P+
Sbjct: 232 QPY 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 13 SKLGEGAYGN--VYLVSDKRSETLKACKAYDFKRLKRDYME--KFAPREIDILLKVSHPN 68
+ +G+ V+L K + TL A K + L E K +EI ++ HPN
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN---LDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 69 IIGVHRMVKAGTYLYMI---MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
I+ + LY++ M Y +DL + E + E + I I L
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDL---LKTHFPEGLPE----LAIAFI------L 107
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR-LLRTPKELSNTFCGTTS 184
++ NAL+Y+H G +HR +K +IL+S L+ +S +++ K S
Sbjct: 108 KDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167
Query: 185 ------YAAPEIIRNS--PYNPKLADIWSLGVVLYRILNKKYPFGD 222
+ +PE+++ + YN K +DI+S+G+ + N PF D
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 58/264 (21%), Positives = 121/264 (45%), Gaps = 24/264 (9%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFA-PREIDILLKVSHPNIIGV 72
KLG G +G V++ + + + K +K M A E +++ + H ++ +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAV------KTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
H +V +Y+I ++ K L ++ + ++ + +++ +IA +
Sbjct: 67 HAVVTKEP-IYIITEFMAKGSLLDFLKS-------DEGSKQ---PLPKLIDFSAQIAEGM 115
Query: 133 EYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG-TTSYAAPEII 191
++ + +HRD++ NIL+S L K+ADFG +R++ + + + APE I
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 192 RNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250
+ K +D+WS G++L I+ + P+ PG N +V++ E + Y R
Sbjct: 176 NFGSFTIK-SDVWSFGILLMEIVTYGRIPY--PGMSNPEVIRALE-RGYRMPRPENCPEE 231
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQN 274
++ R + P+ RP + +Q+
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQS 255
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFK---RLKRDYMEKFAPREIDILLKVSHP 67
Y LG G G VY + + A K L++ M E++IL K P
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS-----ELEILYKCDSP 59
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
IIG + + + ++ + L+ Y + E++ + +IA A
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVY--RKIPEHV--------LGRIAVA------ 103
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ L YL + I+HRD+K N+L++ KL DFG S L ++ T+ GT +Y A
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYVGTNAYMA 161
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
PE I Y +D+WSLG+ + ++P+
Sbjct: 162 PERISGEQYG-IHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 56/226 (24%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
KLG+G +G V++ T K LK M E F +E I+ K+ H ++
Sbjct: 13 KLGQGCFGEVWM------GTWNGTTKVAIKTLKPGTMMPEAFL-QEAQIMKKLRHDKLVP 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ +V +Y++ ++ K L ++ + + + ++ ++ +IA+
Sbjct: 66 LYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYL----------KLPQLVDMAAQIADG 114
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG-TTSYAAPEI 190
+ Y+ + +HRD++ NIL+ L K+ADFG +RL+ + + + APE
Sbjct: 115 MAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQE 235
+ K +D+WS G++L ++ K + P+ PG NR+VL++ E
Sbjct: 175 ALYGRFTIK-SDVWSFGILLTELVTKGRVPY--PGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 77/312 (24%), Positives = 129/312 (41%), Gaps = 68/312 (21%)
Query: 14 KLGEGAYGNVYLVSDKRSETL-------------------KACKAYDFKRLKRDYMEKFA 54
KLGEG +G V+L + L K + K + D++
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL---- 67
Query: 55 PREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYIS------KACNENIHE 108
+E+ IL ++ PNII + + L MI +Y E DL ++S K N N
Sbjct: 68 -KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 109 NQARIWIRQIANALEYLH---EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165
A ++L LH +IA+ ++YL + VHRD+ N L+ L K+ADFG
Sbjct: 127 PPAHCLPAISYSSL--LHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 166 SRLLRTPKELSNTFCGT-----------TSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
SR N + G + A E I + +D+W+ GV L+ IL
Sbjct: 185 SR---------NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEIL 234
Query: 215 N--KKYPFGDPGTRNRDVLK------KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHR 266
K+ P+G+ + V++ + +G++ R G +L+ + + + R
Sbjct: 235 MLCKEQPYGE--LTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRER 292
Query: 267 PNAKDVQNHAWI 278
P+ D+ HA++
Sbjct: 293 PSFSDI--HAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 55/213 (25%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII-- 70
+GEG +G V + E A K +K D + E ++ K+ H N++
Sbjct: 12 EIIGEGEFGAVL-----QGEYTGQKVA--VKNIKCDVTAQAFLEETAVMTKLHHKNLVRL 64
Query: 71 -GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
GV ++ G LY++M+ K +L +++ + R + + L++ ++A
Sbjct: 65 LGV--ILHNG--LYIVMELMSKGNLVNFL---------RTRGRALV-SVIQLLQFSLDVA 110
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
+EYL +VHRD+ NIL+S AK++DFG +R+ + N+ + APE
Sbjct: 111 EGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKL-PVKWTAPE 167
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILN---KKYP 219
+++ ++ K +D+WS GV+L+ + + YP
Sbjct: 168 ALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 30/280 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR-----DYMEKFAPREIDILLKVSHPNI 69
LGEG +G V + R + K LK + + + E ++L +V+HP++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS--EFNLLKQVNHPHV 65
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYI------------SKACNENIHENQARIWIRQ 117
I ++ L +I++YA+ L ++ S + + +
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 118 IANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSN 177
+ + + + +I+ ++YL E+ +VHRD+ N+L++ K++DFG SR +
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 178 TFCG--TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN---KKYPFGDPGTRNRDVLK 232
G + A E + + Y + +D+WS GV+L+ I+ YP G R ++LK
Sbjct: 186 RSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYP-GIAPERLFNLLK 243
Query: 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272
Y R S L+ + P RP D+
Sbjct: 244 TG----YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 24/222 (10%)
Query: 11 YISKLGEGAYGNVY------LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV 64
Y+ +G+GA+G V+ L+ T+ A K K M+ RE ++ +
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPY-EPFTMVAVKM--LKEEASADMQADFQREAALMAEF 65
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
HPNI+ + + G + ++ +Y DL ++ + + + + L
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL-RHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 125 L-----------HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK 173
L ++A + YL E VHRD+ N L+ + K+ADFG SR + +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 174 --ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRI 213
+ S + PE I + Y + +D+W+ GVVL+ I
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 63/245 (25%), Positives = 113/245 (46%), Gaps = 38/245 (15%)
Query: 12 ISKLGEGAYGNVYLVSDKRS--------------ETLKACKAYDFKRLKRD-----YMEK 52
I L GA+G +++ + + S + C+ KR+K +E
Sbjct: 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLEN 212
Query: 53 FAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIH-ENQA 111
EI L +++H NI+ + ++++ YMI +K D + Y S +E +++
Sbjct: 213 ----EILALGRLNHENILKIEEILRSEANTYMI---TQKYDFDLY-SFMYDEAFDWKDRP 264
Query: 112 RIW-IRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170
+ R I + ++ A+EY+H+ ++HRDIK ENI ++ L DFG +
Sbjct: 265 LLKQTRAI------MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 171 TPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKY-PFGDPGTRNR 228
+E + GT + +PEI+ Y ++ DIWS G++L +L+ + P GD G +
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377
Query: 229 DVLKK 233
L K
Sbjct: 378 KQLLK 382
|
Length = 501 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 58/238 (24%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDF-----KRLKRDYMEKFAP---REIDILLKVS 65
KLG+G++G V +R E + K LK D + +E I+ +
Sbjct: 2 KLGDGSFGVV-----RRGEWSTS--GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
H N+I ++ +V L M+ + A L + + ++ ++ I+ +Y
Sbjct: 55 HENLIRLYGVVLTHP-LMMVTELAPLGSLL--------DRLRKDALGHFL--ISTLCDYA 103
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL-------RTPKELSNT 178
+IAN + YL +HRD+ NIL++ K+ DFG R L + L
Sbjct: 104 VQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP 163
Query: 179 FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFG-DP--GTRNRDVLKK 233
F ++ APE +R ++ +D+W GV L+ + + +G +P G +LKK
Sbjct: 164 F----AWCAPESLRTRTFS-HASDVWMFGVTLWEM----FTYGEEPWAGLSGSQILKK 212
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 35/89 (39%), Positives = 53/89 (59%), Gaps = 7/89 (7%)
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG---FSRLLR-TPKELSNTFCGT 182
++ +A++Y+H GI+HRDIK EN+L++ + L DFG F+R TP GT
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG--IAGT 325
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLY 211
APE++ PY P + DIWS G+V++
Sbjct: 326 VDTNAPEVLAGDPYTPSV-DIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 12 ISKLGEGAYGNVYLVS-DKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHP 67
I LGEG +G V L D + A K LK + +EI+IL + H
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVA--VKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 68 NIIGVHRMVK--AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
NI+ + G + +IM++ L+ Y+ + N+ +I ++Q L+Y
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR--------NKNKINLKQQ---LKYA 115
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---LSNTFCGT 182
+I ++YL VHRD+ N+L+ K+ DFG ++ + T KE + +
Sbjct: 116 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
+ APE + S + +D+WS GV LY +L
Sbjct: 176 VFWYAPECLIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYD-----FKRLK--RDYMEKFAPREIDILLKVSH 66
+LGEGA+G V+L +E C D K LK D K RE ++L + H
Sbjct: 12 ELGEGAFGKVFL-----AECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH 66
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENI--HENQARIWIRQIANALEY 124
+I+ + + G L M+ +Y + DL ++ + + E + Q + L
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ-SQMLHI 125
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK--ELSNTFCGT 182
+IA + YL VHRD+ N L+ L K+ DFG SR + + +
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
+ PE I + + +D+WSLGVVL+ I
Sbjct: 186 IRWMPPESIMYRKFTTE-SDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 14 KLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRL--KRDYMEKFAPREIDILLKVSH 66
+LGEGA+G V+L +S + + L A KA L ++D+ RE ++L + H
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-----REAELLTNLQH 66
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWI----RQIANAL 122
+I+ + + G L M+ +Y + DL ++ H A I + RQ L
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA------HGPDAMILVDGQPRQAKGEL 120
Query: 123 ---EYLH---EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK--E 174
+ LH +IA+ + YL VHRD+ N L+ L K+ DFG SR + +
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 175 LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
+ + PE I + + +D+WS GV+L+ I
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 29/217 (13%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPR----EIDILLKVS-HPNI 69
+GEG +G V L + + + L+ A KR+K +Y K R E+++L K+ HPNI
Sbjct: 15 IGEGNFGQV-LKARIKKDGLRMDAA--IKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL---EYLH 126
I + + YLY+ ++YA +L ++ K+ + + A A+ L + LH
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKS--RVLETDPAFAIANSTASTLSSQQLLH 128
Query: 127 ---EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR-----LLRTPKELSNT 178
++A ++YL + +HRD+ NIL+ AK+ADFG SR + +T L
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 186
Query: 179 FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN 215
+ A E + S Y +D+WS GV+L+ I++
Sbjct: 187 ----VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 61/268 (22%), Positives = 120/268 (44%), Gaps = 34/268 (12%)
Query: 15 LGEGAYGNVY--LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGV 72
LG+G +G V+ + DK +K CK + LK ++ E IL + HPNI+ +
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLS-----EARILKQYDHPNIVKL 57
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
+ +Y++M+ D ++ K +E + +Q+ +++ + A +
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDE--------LKTKQL---VKFALDAAAGM 106
Query: 133 EYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT------TSYA 186
YL +HRD+ N L+ K++DFG SR +E + + +
Sbjct: 107 AYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWT 161
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKY-PFGDPGTRNRDVLKKQEGKEYLFNRKY 245
APE + Y+ + +D+WS G++L+ + P+ PG N+ ++Q K Y +
Sbjct: 162 APEALNYGRYSSE-SDVWSYGILLWETFSLGVCPY--PGMTNQQA-REQVEKGYRMSCPQ 217
Query: 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQ 273
+ +++ R + P++RP ++Q
Sbjct: 218 KCPDDVYKVMQRCWDYKPENRPKFSELQ 245
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 15 LGEGAYGNVYLVS----DKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVS-H 66
LGEG +G V + DK + K K LK D EK E++++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYIS--KACNENIHENQARIWIRQIA--NAL 122
NII + LY+I++YA K +L Y+ + + AR+ Q+ + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG- 181
+++A +EYL +HRD+ N+L++ K+ADFG +R + T G
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200
Query: 182 -TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
+ APE + + Y + +D+WS GV+++ I
Sbjct: 201 LPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIF 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKR--LKRDYMEKFAPREIDILLKVSHPNIIGV 72
LG G+ G V+ D K K+ L K A REI I+ ++ H NI+ V
Sbjct: 13 LGCGSNGLVFSAVDSDC-----DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV 67
Query: 73 HRMVKAGTY--------------LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQI 118
+ ++ +Y++ +Y E DL + + + + E AR+++ Q+
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG---PLSEEHARLFMYQL 123
Query: 119 ANALEYLHEIANALEYLHEVGIVHRDIKCENILIS-RLLNAKLADFGFSRLLRTPKE--- 174
L+Y+H AN L HRD+K N+ I+ L K+ DFG +R++
Sbjct: 124 LRGLKYIHS-ANVL---------HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173
Query: 175 -LSNTFCGTTSYAAPEIIRNSPYN-PKLADIWSLGVVLYRILNKKYPF 220
LS T Y +P ++ SP N K D+W+ G + +L K F
Sbjct: 174 YLSEGLV-TKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 67/287 (23%), Positives = 128/287 (44%), Gaps = 32/287 (11%)
Query: 11 YISKLGEGAYGNVYL-------VSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK 63
++ +LGE A+G +Y + + +K K + + ++ + E ++ +
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ-----EASLMAE 63
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDL-EHYISKACNENIH-ENQARIWIRQIANA 121
+ HPNI+ + +V + M+ +Y + DL E I ++ + ++ + ++ +
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 122 LEYLH---EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP---KEL 175
++LH +IA +EYL VH+D+ NILI L+ K++D G SR + + +
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 176 SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFG-DP--GTRNRDVLK 232
+ + PE I ++ +DIWS GVVL+ I + FG P G N++V++
Sbjct: 184 PKSLL-PIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEI----FSFGLQPYYGFSNQEVIE 237
Query: 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN--HAW 277
K L + L+ + P RP KD+ +W
Sbjct: 238 MVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
++G G +G V+ L +D +K+C+ + L D KF +E IL + SHPNI+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCR----ETLPPDLKAKFL-QEARILKQYSHPNIV 56
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ + +Y++M+ + D ++ E + + I+ + NA A
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGGDFLTFLR---TEGPRL-KVKELIQMVENA-------AA 105
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT-------T 183
+EYL +HRD+ N L++ K++DFG SR +E + T
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPV 160
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLY 211
+ APE + Y+ + +D+WS G++L+
Sbjct: 161 KWTAPEALNYGRYSSE-SDVWSFGILLW 187
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-12
Identities = 54/210 (25%), Positives = 105/210 (50%), Gaps = 34/210 (16%)
Query: 14 KLGEGAYGNVYLVSDKRS--ETLKACKAYDFKRLKRD----YMEKFAPREIDILLKVSHP 67
+LG G +G V K+ + K+ K K LK D ++ RE +++ ++ +P
Sbjct: 2 ELGSGNFGTV-----KKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNP 56
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
I+ + + +A +++ ++M+ AE L ++ K N+++ E N E +H+
Sbjct: 57 YIVRMIGICEAESWM-LVMELAELGPLNKFLQK--NKHVTEK----------NITELVHQ 103
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS--- 184
++ ++YL E VHRD+ N+L+ AK++DFG S+ L + N + T
Sbjct: 104 VSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKW 160
Query: 185 ---YAAPEIIRNSPYNPKLADIWSLGVVLY 211
+ APE + ++ K +D+WS GV+++
Sbjct: 161 PVKWYAPECMNYYKFSSK-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 50/239 (20%), Positives = 100/239 (41%), Gaps = 40/239 (16%)
Query: 47 RDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENI 106
RD + F ++ ++SH +++ ++ + + M+ +Y + L+ ++
Sbjct: 43 RDSLAFF--ETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFL-------- 91
Query: 107 HENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-------LNAK 159
H + + + L+ ++A+AL YL + +VH ++ +NIL++R K
Sbjct: 92 HREKNNVSL---HWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148
Query: 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLA-DIWSLGVVLYRIL-NKK 217
L+D G + + +E + APE IRN + +A D WS G L I N +
Sbjct: 149 LSDPGIPITVLSREERVE----RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
Query: 218 YPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK----QLIGRMLEPNPKHRPNAKDV 272
P L E KE + ++ + + LI + +P RP+ + +
Sbjct: 205 EPLST--------LSSSE-KERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 36/220 (16%)
Query: 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP 67
E + +G+G +G+V ++ D R + K +K D + E ++ ++ H
Sbjct: 7 ELKLLQTIGKGEFGDV-MLGDYRGNKVAV------KCIKNDATAQAFLAEASVMTQLRHS 59
Query: 68 NII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA--- 121
N++ GV +V+ LY++ +Y K L Y+ R R +
Sbjct: 60 NLVQLLGV--IVEEKGGLYIVTEYMAKGSLVDYL-------------RSRGRSVLGGDCL 104
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
L++ ++ A+EYL VHRD+ N+L+S AK++DFG ++ + ++
Sbjct: 105 LKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--- 161
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFG 221
+ APE +R ++ K +D+WS G++L+ I Y FG
Sbjct: 162 PVKWTAPEALREKKFSTK-SDVWSFGILLWEI----YSFG 196
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 15 LGEGAYGNVYLVS------DKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKV- 64
LGEG +G V + +K + K K LK D EK E++++ +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVA----VKMLKSDATEKDLSDLISEMEMMKMIG 81
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYIS----KACNENIHENQARIWIRQIAN 120
H NII + LY+I++YA K +L Y+ + Q +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC 180
+ +++A +EYL +HRD+ N+L++ K+ADFG +R + T
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 181 G--TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
G + APE + + Y + +D+WS GV+L+ I
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIF 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 13/212 (6%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDF--KRLKRDYMEKFAP---REIDILLKV-SHPN 68
LGEG +G V + + K K K LK D +K E++++ + H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYIS--KACNENIHENQARIWIRQIA--NALEY 124
II + LY++++YA K +L Y+ + + + ++ Q+ + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG--T 182
+++A +EYL +HRD+ N+L++ K+ADFG +R + T G
Sbjct: 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
+ APE + + Y + +D+WS GV+L+ I
Sbjct: 200 VKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 60/242 (24%), Positives = 112/242 (46%), Gaps = 17/242 (7%)
Query: 11 YISKLGEGAYGNVY---LVSDKRSETLKACKAYDFK-RLKRDYMEKFAPREIDILLKVSH 66
++ +LGE +G VY L E +A K + + E+F E + ++ H
Sbjct: 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFK-HEAMMRSRLQH 67
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDL-EHYISKACNENIHENQARIWIRQIANALEYL 125
PNI+ + +V L MI Y DL E + ++ + ++ ++ +++
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 126 H---EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP---KELSNTF 179
H +IA +E+L +VH+D+ N+L+ LN K++D G R + K + N+
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKY-PFGDPGTRNRDVLKKQEGKE 238
+ +PE I ++ +DIWS GVVL+ + + P+ G N+DV++ ++
Sbjct: 188 L-PIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYC--GYSNQDVIEMIRNRQ 243
Query: 239 YL 240
L
Sbjct: 244 VL 245
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 66/282 (23%), Positives = 119/282 (42%), Gaps = 48/282 (17%)
Query: 15 LGEGAYGNVY--LVSDKRSETLK---ACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
LG GA+G VY L + + ++ A K ++D + E I+ K +H NI
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL--MEALIMSKFNHQNI 71
Query: 70 ---IGV--HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
IGV R+ + +++++ DL+ ++ + + + +
Sbjct: 72 VRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTM--------KDL 118
Query: 125 LH---EIANALEYLHEVGIVHRDIKCENILIS-----RLLNAKLADFGFSR-LLRTPKEL 175
L ++A +YL E +HRDI N L++ R+ AK+ADFG +R + R
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV--AKIADFGMARDIYRASYYR 176
Query: 176 SNTFCGTT----SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKY-PFGDPGTRNRDV 230
G + PE + + K D+WS GV+L+ I + Y P+ PG N++V
Sbjct: 177 KG---GRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY--PGRTNQEV 230
Query: 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272
++ G L + +++ + P+ RPN +
Sbjct: 231 MEFVTGGGRL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 30/173 (17%)
Query: 56 REIDILLKVSHPNIIGVHRMVKAG-TYLYMIMDYAEKKDLEHYISKACNENIHENQARIW 114
RE + ++ HPNI+ + +A L+ + +Y + L + +
Sbjct: 27 RETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL---------------REVLA 71
Query: 115 IRQIANALEYLH---EIANALEYLHEVGIVHRDIKCENILISRL---LNAKLADFGFSRL 168
A E ++ +AL H GIVHRD+K +NI++S+ +AK+ DFG L
Sbjct: 72 ADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL 131
Query: 169 L-------RTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
L + GT +Y APE +R P P +D+++ G++ L
Sbjct: 132 LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN-SDLYAWGLIFLECL 183
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 76/242 (31%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYD--------FKRLKRDYME----KFAPREIDILL 62
+G GA G V C AYD K+L R + K A RE+ ++
Sbjct: 24 IGSGAQGIV-------------CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK 70
Query: 63 KVSHPNIIGV------HRMVKAGTYLYMIMDYAE-------KKDLEHYISKACNENIHEN 109
V+H NIIG+ + ++ +Y++M+ + + DL+H
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH------------- 117
Query: 110 QARIWIRQIANALEYL-HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR- 167
+ YL +++ +++LH GI+HRD+K NI++ K+ DFG +R
Sbjct: 118 ----------ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167
Query: 168 ----LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP 223
+ TP + T Y APE+I Y + DIWS+G ++ ++ F P
Sbjct: 168 AGTSFMMTP------YVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLF--P 218
Query: 224 GT 225
GT
Sbjct: 219 GT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 46/242 (19%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSE-------------------TLKACKAYDFKRLKRDYM 50
++ KLGEG +G V+L + E +K + K + D++
Sbjct: 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 51 EKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQ 110
+EI I+ ++ PNII + + L MI +Y E DL ++S+ + E
Sbjct: 68 -----KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 111 ARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170
+ I + + +IA+ ++YL + VHRD+ N L+ + K+ADFG SR
Sbjct: 123 DVVTI-SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR--- 178
Query: 171 TPKELSNTFCGT---TSYAAPEIIRNSPYNPKL-------ADIWSLGVVLYRILN--KKY 218
N + G A IR + L +D+W+ GV L+ IL K+
Sbjct: 179 ------NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232
Query: 219 PF 220
P+
Sbjct: 233 PY 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 37/161 (22%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 57 EIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNEN-IHENQARIWI 115
E +++K+SH ++ ++ + +Y++ +Y +S C N + E+ R
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY---------MSNGCLLNYLREHGKRF-- 97
Query: 116 RQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL 175
Q + LE ++ + YL +HRD+ N L+ K++DFG SR + +
Sbjct: 98 -QPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156
Query: 176 SNTFCGT---TSYAAPEIIRNSPYNPKLADIWSLGVVLYRI 213
S+ G+ ++ PE++ S ++ K +D+W+ GV+++ +
Sbjct: 157 SSV--GSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 33/239 (13%)
Query: 12 ISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRD---YMEKFAPREIDILLK 63
I LGEG +G V L +D E + K LKR+ +EI+IL
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAV------KTLKRECGQQNTSGWKKEINILKT 62
Query: 64 VSHPNIIGVHRMV--KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
+ H NI+ + G L +IM+Y L Y+ K ++ Q ++ +QI
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEG 119
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---LSNT 178
+ YLH +HRD+ N+L+ K+ DFG ++ + E +
Sbjct: 120 MAYLHSQH----------YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169
Query: 179 FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237
+ A E ++ + ++ +D+WS GV LY +L P + +++ ++G+
Sbjct: 170 GDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 39/237 (16%)
Query: 15 LGEGAYGNVYLVSDK---RSETLKACKAYDFKRLKRDYMEKFAP-------REIDILLKV 64
LG GA+G VY K E K K L+ E+ +P E ++ V
Sbjct: 15 LGSGAFGTVY----KGVWIPEGEKVKIPVAIKVLR----EETSPKANKEILDEAYVMASV 66
Query: 65 SHPNIIGVHRM--VKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
HP+++ R+ + + + +I L Y+ ++ I + + L
Sbjct: 67 DHPHVV---RLLGICLSSQVQLITQLMPLGCLLDYV--------RNHKDNIGSQYL---L 112
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
+ +IA + YL E +VHRD+ N+L+ + K+ DFG ++LL ++ + G
Sbjct: 113 NWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 183 T--SYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPF-GDPGTRNRDVLKKQE 235
+ A E I + Y K +D+WS GV ++ ++ P+ G P D+L+K E
Sbjct: 173 VPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 11/210 (5%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK-FAP--REIDILLKV-SHPNII 70
LGEGA+G V + K LK D EK + E++++ + H NII
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYI--SKACNENIHENQARIWIRQIANA--LEYLH 126
+ + LY++++YA +L ++ + E + R + + + +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
++A +E+L +HRD+ N+L++ K+ADFG +R + T G
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVK 199
Query: 187 --APEIIRNSPYNPKLADIWSLGVVLYRIL 214
APE + + Y + +D+WS GV+L+ I
Sbjct: 200 WMAPEALFDRVYTHQ-SDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 9e-11
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 37/215 (17%)
Query: 37 CKAYD--------FKRLKRDYME----KFAPREIDILLKVSHPNIIGV------HRMVKA 78
C AYD K+L R + K A RE+ ++ V+H NIIG+ + ++
Sbjct: 41 CAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100
Query: 79 GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV 138
+Y++M+ + +L I + HE + + L+++ +++LH
Sbjct: 101 FQDVYIVMELMDA-NLCQVIQMELD---HERMSYL-----------LYQMLCGIKHLHSA 145
Query: 139 GIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNP 198
GI+HRD+K NI++ K+ DFG +R T + + T Y APE+I Y
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 199 KLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233
+ DIWS+G ++ ++ F PGT + D K
Sbjct: 205 NV-DIWSVGCIMGEMIKGGVLF--PGTDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 55/233 (23%), Positives = 105/233 (45%), Gaps = 31/233 (13%)
Query: 14 KLGEGAYGNV-----YLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN 68
++G G +G V Y + +K KA + + +++++ P I + HPN
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI-----LQHPN 56
Query: 69 IIG-VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
I+ + + V+A YL ++ +Y E DL+ Y+ E H +++ + Q E
Sbjct: 57 ILQCLGQCVEAIPYL-LVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQ-----RMACE 107
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADF--GFSRLLRTPKELSNTFCGTTSY 185
IA + ++H+ +H D+ N ++ L K+ D+ G SR E + C +
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 186 AAPEIIRN------SPYNPKLADIWSLGVVLYRIL-NKKYPFGDPGTRNRDVL 231
APE++ + K +++W+LGV L+ + N P+ +R+VL
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY--SHLSDREVL 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 65/265 (24%), Positives = 119/265 (44%), Gaps = 20/265 (7%)
Query: 14 KLGEGAYGNVY------LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP 67
+LG+G++G VY +V D+ ET A K + R+ +E E ++ + +
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDE-PETRVAIKTVNEAASMRERIEFL--NEASVMKEFNCH 69
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+++ + +V G +IM+ + DL+ Y+ E EN + ++ E
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM--ENNPVQAPPSLKKMIQMAGE 127
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG--TTSY 185
IA+ + YL+ VHRD+ N +++ K+ DFG +R + G +
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK-KQEGKEYLFNR 243
+PE +++ + +D+WS GVVL+ I + P+ G N VL+ EG L ++
Sbjct: 188 MSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY--QGMSNEQVLRFVMEGG--LLDK 242
Query: 244 KYEISIGAKQLIGRMLEPNPKHRPN 268
+L+ + NPK RP+
Sbjct: 243 PDNCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 30/241 (12%)
Query: 15 LGEGAYGNVY------LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN 68
LG GA+G VY ++ A K ++ D +K +E ++ +HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKT--LRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I+ + + Y+IM+ E DL Y+ A E + + L+ ++
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPP-----LLTLKELLDICLDV 115
Query: 129 ANALEYLHEVGIVHRDIKCENILIS-----RLLNAKLADFGFSRLLRTPKELSNTFCG-- 181
A YL ++ +HRD+ N L+S K+ DFG +R + G
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL---NKKYPFGDPGTRNRDVLK--KQEG 236
+ APE + + + + +D+WS GV+++ IL + Y P N++VL+ G
Sbjct: 176 PVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPY----PALNNQEVLQHVTAGG 230
Query: 237 K 237
+
Sbjct: 231 R 231
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 37/206 (17%)
Query: 37 CKAYD--------FKRLKRDYME----KFAPREIDILLKVSHPNIIGV------HRMVKA 78
C AYD K+L R + K A RE+ ++ V+H NII + + ++
Sbjct: 34 CAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93
Query: 79 GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV 138
+Y++M+ + +L I + HE + + L+++ +++LH
Sbjct: 94 FQDVYLVMELMDA-NLCQVIQMELD---HERMSYL-----------LYQMLCGIKHLHSA 138
Query: 139 GIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNP 198
GI+HRD+K NI++ K+ DFG +R T ++ + T Y APE+I Y
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT-PYVVTRYYRAPEVILGMGYKE 197
Query: 199 KLADIWSLGVVLYRILNKKYPFGDPG 224
+ DIWS+G ++ ++ K F PG
Sbjct: 198 NV-DIWSVGCIMGEMVRHKILF--PG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 30/203 (14%)
Query: 18 GAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK 77
G V LV D R++ + + K L++ RE ++ PN++ +H+ +
Sbjct: 4 GVIDKVLLVMDTRTQ-----QTFILKGLRKSSE---YSRERLTIIPHCVPNMVCLHKYIV 55
Query: 78 AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE 137
+ +++++ +AE L +ISK N I E + W E+ AL+ LH
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAA----------EMVVALDALHR 103
Query: 138 VGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG---TTSYAAPEIIRNS 194
GIV RD+ NIL+ + +L F E+ ++ G Y APE+ S
Sbjct: 104 EGIVCRDLNPNNILLDDRGHIQLTYFSRWS------EVEDSCDGEAVENMYCAPEVGGIS 157
Query: 195 PYNPKLADIWSLGVVLYRILNKK 217
+ D WSLG +L+ +L K
Sbjct: 158 EET-EACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 44/209 (21%)
Query: 29 KRSETLKA---------CKAYD--------FKRLKRDYME----KFAPREIDILLKVSHP 67
KR + LK C A+D K+L R + K A RE+ +L V+H
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 68 NIIGV------HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
NII + + ++ +Y++M+ + +L I + HE + +
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELD---HERMSYL-------- 128
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
L+++ +++LH GI+HRD+K NI++ K+ DFG +R T + +
Sbjct: 129 ---LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT-NFMMTPYVV 184
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVL 210
T Y APE+I Y + DIWS+G ++
Sbjct: 185 TRYYRAPEVILGMGYKENV-DIWSVGCIM 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 48/206 (23%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 17 EGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK-------VSHPNI 69
EG +G ++ E + K +K + + ++ +LL+ +SH NI
Sbjct: 16 EGTFGRIFYGI-LIDEKPGKEEEVFVKTVK----DHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 70 IGV-HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+ + H ++ G +++ Y +L+ ++ + C N + +Q+ + +I
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQ-CRLGEANNPQALSTQQL---VHMAIQI 126
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---LSNTFCGTTSY 185
A + YLH+ G++H+DI N +I L K+ D SR L P + L + +
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL-FPMDYHCLGDNENRPVKW 185
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLY 211
A E + N Y+ +D+WS GV+L+
Sbjct: 186 MALESLVNKEYSSA-SDVWSFGVLLW 210
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 62/264 (23%), Positives = 116/264 (43%), Gaps = 16/264 (6%)
Query: 12 ISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH 66
+ +LG+G++G VY + + +ET A K + R+ +E E ++ +
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL--NEASVMKGFTC 68
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
+++ + +V G ++M+ DL+ Y+ ++ N R + ++
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRP-PPTLQEMIQMAA 126
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG--TTS 184
EIA+ + YL+ VHRD+ N +++ K+ DFG +R + G
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243
+ APE +++ + +D+WS GVVL+ I + + P+ G N VLK YL ++
Sbjct: 187 WMAPESLKDGVFTT-SSDMWSFGVVLWEITSLAEQPY--QGLSNEQVLKFVMDGGYL-DQ 242
Query: 244 KYEISIGAKQLIGRMLEPNPKHRP 267
L+ + NPK RP
Sbjct: 243 PDNCPERVTDLMRMCWQFNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 49/210 (23%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 14 KLGEGAYG----NVYLVSDKRSE-TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN 68
+LG G +G VY + K+ + +K K + K ++ + M RE +I+ ++ +P
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMM-----REAEIMHQLDNPY 56
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I+ + + +A L ++M+ A L ++S +E ++N +E +H++
Sbjct: 57 IVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDE-----------ITVSNVVELMHQV 104
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT---SY 185
+ ++YL VHRD+ N+L+ AK++DFG S+ L +
Sbjct: 105 SMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKW 164
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILN 215
APE I ++ + +D+WS G+ ++ +
Sbjct: 165 YAPECINFRKFSSR-SDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 40/196 (20%), Positives = 82/196 (41%), Gaps = 27/196 (13%)
Query: 55 PREIDILLK-------VSHPNIIG-VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENI 106
P E + L+ ++HPN++ + + +++ YL +++++ DL++Y+
Sbjct: 36 PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL-LVLEFCPLGDLKNYLRS---NRG 91
Query: 107 HENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG-- 164
Q Q E+A+ L +LH+ +H D+ N ++ L+ K+ D+G
Sbjct: 92 MVAQMA----QKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLA 147
Query: 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLAD------IWSLGVVLYRIL-NKK 217
+ + + APE++ + D IWSLGV ++ +
Sbjct: 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD 207
Query: 218 YPFGDPGTRNRDVLKK 233
P+ P + VLK+
Sbjct: 208 QPY--PDLSDEQVLKQ 221
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR-LLRTPKELSNTFC 180
+ + +++AN +E+L VHRD+ N+LI K+ DFG +R ++R +S
Sbjct: 242 VGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--- 298
Query: 181 GTT----SYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
G+T + APE I N+ Y L+D+WS G++L+ I
Sbjct: 299 GSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIF 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 41/137 (29%), Positives = 70/137 (51%), Gaps = 10/137 (7%)
Query: 104 ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163
+ + EN+ RI + + L + +IA + YL EV +VHRD+ N+L+ + K+ DF
Sbjct: 97 DYVRENKDRIGSQDL---LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDF 153
Query: 164 GFSRLLRTPKELSNTFCGTT--SYAAPEIIRNSPYNPKLADIWSLGVVLYRILN---KKY 218
G +RLL + + G + A E I + + + +D+WS GV ++ ++ K Y
Sbjct: 154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPY 212
Query: 219 PFGDPGTRNRDVLKKQE 235
G P D+L+K E
Sbjct: 213 D-GIPAREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 34/233 (14%)
Query: 22 NVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81
+VYL + TL + D + +++ K E+ + HPNI+ + G++
Sbjct: 15 SVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNIMTSWTVFTTGSW 73
Query: 82 LYMI---MDYAEKKDL-EHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE 137
L++I M Y L + Y + +E + I I L L YLH+
Sbjct: 74 LWVISPFMAYGSANSLLKTYFPEGMSEAL--------IGNI------LFGALRGLNYLHQ 119
Query: 138 VGIVHRDIKCENILISRLLNAKLADFGFSRLL---------RTPKELSNTFCGTTSYAAP 188
G +HR+IK +ILIS L+ G S L + + + +P
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177
Query: 189 EIIRN--SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239
E++R YN K +DI+S+G+ + + PF D R + +L+K +G Y
Sbjct: 178 ELLRQDLYGYNVK-SDIYSVGITACELATGRVPFQDM-LRTQMLLQKLKGPPY 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 48/277 (17%)
Query: 15 LGEGAYGNVY--LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI--- 69
LGEG +G+V ++ S A K R ME F E + + HPN+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHPNVMRL 65
Query: 70 IGV-HRMVKAGTYL--YMIMDYAEKKDLEHYI--SKACNENIHENQARIWIRQIANALEY 124
IGV + V++ Y +I+ + + DL ++ S+ + + + +++
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML--------VKF 117
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS------------RLLRTP 172
+ +IA+ +EYL +HRD+ N +++ +N +ADFG S R+ + P
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 173 KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVL 231
+ A E + + Y K +D+WS GV ++ I + + P+ PG N ++
Sbjct: 178 ----------VKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPY--PGVENSEIY 224
Query: 232 KK-QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRP 267
++G + + G L+ NPK RP
Sbjct: 225 DYLRQGNR--LKQPPDCLDGLYSLMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 104 ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163
+ +HE++ I + + N + +IA + YL E +VHRD+ N+L+ + K+ DF
Sbjct: 97 DYVHEHKDNIGSQLLLN---WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDF 153
Query: 164 GFSRLLRTPKELSNTFCGTT--SYAAPEIIRNSPYNPKLADIWSLGVVLYRILN---KKY 218
G +RLL ++ N G + A E I + + +D+WS GV ++ ++ K Y
Sbjct: 154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPY 212
Query: 219 PFGDPGTRNRDVLKKQE 235
G P D+L+K E
Sbjct: 213 D-GIPTREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 37/135 (27%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 106 IHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165
+ E++ I + + N + +IA + YL E +VHRD+ N+L+ + K+ DFG
Sbjct: 99 VREHKDNIGSQYLLN---WCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL 155
Query: 166 SRLLRTPKELSNTFCGTT--SYAAPEIIRNSPYNPKLADIWSLGVVLYRILN---KKYPF 220
++LL ++ + G + A E I + Y + +D+WS GV ++ ++ K Y
Sbjct: 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD- 213
Query: 221 GDPGTRNRDVLKKQE 235
G P + +L+K E
Sbjct: 214 GIPASEISSILEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 15 LGEGAYGNV-----YLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDI--LLKV--S 65
LGEG +G V Y + R + K LK + +K I L+K+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAV---KMLKDNATDKDLADLISEMELMKLIGK 76
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYI--SKACNENIHENQARIWIRQIA--NA 121
H NII + + LY+I++YA K +L ++ + + + ++ Q++ +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
+ +++A +EYL +HRD+ N+L++ K+ADFG +R + T G
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 182 --TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
+ APE + + Y + +D+WS G++++ I
Sbjct: 197 RLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 30/97 (30%), Positives = 56/97 (57%), Gaps = 5/97 (5%)
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR-LLRTPKELS--NT 178
L + +++A +E+L VHRD+ N+L+++ K+ DFG +R ++ +S +T
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGST 299
Query: 179 FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN 215
F + APE I ++ Y L+D+WS G++L+ I +
Sbjct: 300 FL-PVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 42/183 (22%), Positives = 79/183 (43%), Gaps = 20/183 (10%)
Query: 41 DFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYIS 99
+F R KR++ + + + + V R ++AG A S
Sbjct: 101 NFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQ--------ASVLFSRFQPS 152
Query: 100 KACNENIHENQARIWIR--QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN 157
+ + N + +W + + + Y ++A +E+L +HRD+ NIL+S
Sbjct: 153 TSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV 212
Query: 158 AKLADFGFSR-LLRTPKELSNTFCGTT----SYAAPEIIRNSPYNPKLADIWSLGVVLYR 212
K+ DFG +R + + P + G+ + APE I + Y + +D+WS GV+L+
Sbjct: 213 VKICDFGLARDIYKDPDYVRK---GSARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWE 268
Query: 213 ILN 215
I +
Sbjct: 269 IFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 60/267 (22%), Positives = 119/267 (44%), Gaps = 25/267 (9%)
Query: 15 LGEGAYGNV---YLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-- 69
LG+G +G+V L S+ S A K +E+F RE + + HPN+
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFL-REAACMKEFDHPNVIK 65
Query: 70 -IGV--HRMVKAGTYLYM-IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
IGV K + M I+ + + DL ++ + I E + ++ + + ++
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS---RIGEEPFTLPLQTL---VRFM 119
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT--- 182
+IA+ +EYL +HRD+ N +++ + +ADFG S+ + + + C +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS-GDYYRQGCASKLP 178
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYLF 241
+ A E + ++ Y +D+W+ GV ++ I+ + + P+ G N ++ L
Sbjct: 179 VKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY--AGVENSEIYNYLIKGNRL- 234
Query: 242 NRKYEISIGAKQLIGRMLEPNPKHRPN 268
+ + +L+ + P PK RP+
Sbjct: 235 KQPPDCLEDVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
+H NI+ + G + +I +Y DL +++ + E+ + + L +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-----RESFLTLE-----DLLSF 146
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL---SNTFCG 181
+++A + +L +HRD+ N+L++ K+ DFG +R + N
Sbjct: 147 SYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL- 205
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRI 213
+ APE I N Y +D+WS G++L+ I
Sbjct: 206 PVKWMAPESIFNCVYT-FESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 50/213 (23%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH- 73
+G G++G VY + + + K++ +D ++ RE+ I+ ++H NII +
Sbjct: 74 IGNGSFGVVY-----EAICIDTSEKVAIKKVLQD--PQYKNRELLIMKNLNHINIIFLKD 126
Query: 74 -------RMVKAGTYLYMIMDYAEK---KDLEHYISKACNENIHENQA-RIWIRQIANAL 122
+ + +L ++M++ + K ++HY N A +++ ++
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA--------RNNHALPLFLVKL---- 174
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILIS-RLLNAKLADFGFSRLLRTPKELSNTFCG 181
Y +++ AL Y+H I HRD+K +N+LI KL DFG ++ L + + C
Sbjct: 175 -YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC- 232
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
+ Y APE++ + D+WSLG ++ ++
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR-LLRTPKELSNTFC 180
+ Y ++A +E+L +HRD+ NIL+S K+ DFG +R + + P +
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK--- 232
Query: 181 GTT----SYAAPEIIRNSPYNPKLADIWSLGVVLYRI 213
G + APE I + Y + +D+WS GV+L+ I
Sbjct: 233 GDARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 53/240 (22%), Positives = 104/240 (43%), Gaps = 28/240 (11%)
Query: 15 LGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-- 69
LGEG +G+V L D S+ A K +E+F E + HPN+
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHPNVMK 65
Query: 70 -IGVHRMVKAGTYL---YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
IGV + + +I+ + + DL ++ + + ++ ++ + L+++
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS---RLGGLPEKLPLQTL---LKFM 119
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT--T 183
+IA +EYL +HRD+ N ++ + +ADFG S+ + +
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYLFN 242
+ A E + + Y K +D+W+ GV ++ I + + P+ PG N ++ +YL +
Sbjct: 180 KWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPY--PGVENHEIY------DYLRH 230
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 33/164 (20%), Positives = 59/164 (35%), Gaps = 31/164 (18%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH--- 66
S I L G VYL+ K + Y K RE+ IL ++
Sbjct: 1 SSIKLLKGGLTNRVYLLGTK-------DEDYVLKINPSREKGADREREVAILQLLARKGL 53
Query: 67 --PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
P ++ + Y++M++ E + L+ +E E+ A Q+A L
Sbjct: 54 PVPKVLASGES---DGWSYLLMEWIEGETLDE-----VSEEEKEDIAE----QLAELLAK 101
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168
LH++ + H D+ NIL+ + D+ ++
Sbjct: 102 LHQLPLL-------VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 63/208 (30%), Positives = 89/208 (42%), Gaps = 51/208 (24%)
Query: 14 KLGEGAYGNVYLVS--DKRSET-----LKACKAYDF------KRLKR-------DYMEKF 53
KLGEGA+G VY S +K+S+ LK Y +R++R D++ F
Sbjct: 139 KLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGF 198
Query: 54 APREIDILLKVSH---PNIIGVHRMVKAGTYLYMIMDYAE-KKDLEHYISKACNENIH-- 107
L VS V R T L +M E ++E Y+ +
Sbjct: 199 -------LEPVSSKKEDEYWLVWRYEGEST-LADLMQSKEFPYNVEPYLLGKVQDLPKGL 250
Query: 108 ENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA-KLADFGFS 166
E + +I I+ I + +I AL+ LH GIVHRD+K +NI+ S + K+ D G +
Sbjct: 251 ERENKI-IQTI------MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
Query: 167 RLLRT-----PKELSNTFCGTTSYAAPE 189
LR PKE F YAAPE
Sbjct: 304 ADLRVGINYIPKE----FLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 22/120 (18%)
Query: 170 RTPKEL--------SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFG 221
RTPK + GT Y APE++ P+ P + D W+LGV L+ L PF
Sbjct: 523 RTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFN 581
Query: 222 D--PGTRNRDVLKKQ----EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
D P +++L + EG+E ++S+ A+ I +L +P R K+++ H
Sbjct: 582 DETPQQVFQNILNRDIPWPEGEE-------KLSVNAQNAIEILLTMDPTKRAGLKELKQH 634
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 12/106 (11%)
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
L + +++A + +L +HRD+ NIL++ K+ DFG +R +R SN
Sbjct: 217 LSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND---SNYVVK 273
Query: 182 TTS-----YAAPEIIRNSPYNPKLADIWSLGVVLYRIL---NKKYP 219
+ + APE I N Y + +D+WS G++L+ I + YP
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYP 318
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 35/215 (16%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRL-------KRDYMEKFAPREIDILLKVSHP 67
LG+G + ++ R E + + + L R+Y E F ++ ++SH
Sbjct: 3 LGQGTFTKIF--KGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFF-EAASMMSQLSHK 59
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNE-NIHENQARIWIRQIANALEYLH 126
+++ + + G M+ +Y + L+ Y+ K N NI W ++A L +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SWKLEVAKQLAW-- 111
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNA--------KLADFGFSRLLRTPKELSNT 178
AL +L + G+ H ++ +N+L+ R + KL+D G S + PKE+
Sbjct: 112 ----ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEI--- 163
Query: 179 FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRI 213
+ PE I N AD WS G L+ I
Sbjct: 164 LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR-LLRTPKELSNTFCG- 181
Y ++A +E+L +HRD+ NIL+S K+ DFG +R + + P +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 182 TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN 215
+ APE I + Y + +D+WS GV+L+ I +
Sbjct: 244 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL--RTPKELSNTF 179
L + +IA + YL E +VHR++ NIL+ ++ADFG + LL K +
Sbjct: 112 LNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN 215
+ A E I Y + +D+WS GV ++ +++
Sbjct: 172 KTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 28/105 (26%), Positives = 53/105 (50%), Gaps = 9/105 (8%)
Query: 114 WIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK 173
W + + L + ++A +++L +HRD+ N+L++ AK+ DFG +R +
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND- 265
Query: 174 ELSNTFCGTTS-----YAAPEIIRNSPYNPKLADIWSLGVVLYRI 213
SN + + APE I + Y + +D+WS G++L+ I
Sbjct: 266 --SNYVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 31/194 (15%)
Query: 50 MEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI---MDYAEKKDL--EHYISKACNE 104
M F E+ + +HPNI+ A L+++ M Y KDL H++
Sbjct: 42 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM------ 95
Query: 105 NIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS-------RLLN 157
+ + + I I L + AL+Y+H +G VHR +K +ILIS L
Sbjct: 96 ---DGMSELAIAYI------LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 146
Query: 158 AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS--PYNPKLADIWSLGVVLYRILN 215
+ L+ + LR + + +PE+++ + Y+ K +DI+S+G+ + N
Sbjct: 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELAN 205
Query: 216 KKYPFGD-PGTRNR 228
PF D P T+
Sbjct: 206 GHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 52/226 (23%)
Query: 63 KVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
+VSH ++ VH + G+ M+ ++ E L+ + K E A W +A L
Sbjct: 72 QVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVA--WKITVAQQL 126
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA-------KLADFGFS--------R 167
A+AL YL + +VH ++ +NIL++RL A KL+D G S R
Sbjct: 127 ------ASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER 180
Query: 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRI-LNKKYPFGDPGTR 226
+ R P + APE + AD WS G L I + + P +
Sbjct: 181 VERIP------------WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE---- 224
Query: 227 NRDVLKKQEGKEYLFNRKYEISIGAKQ----LIGRMLEPNPKHRPN 268
+ KE + +K+ + + + LI + L P RP+
Sbjct: 225 -----RTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 53/220 (24%), Positives = 101/220 (45%), Gaps = 36/220 (16%)
Query: 15 LGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKR----DYMEKFAPREIDILLKVSHP 67
+G+G +G VY L+ + A K+ L R + +E+F +E I+ SHP
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKS-----LNRITDLEEVEQFL-KEGIIMKDFSHP 56
Query: 68 NI---IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
N+ +G+ + G+ L +++ Y + DL ++I + + + + +
Sbjct: 57 NVLSLLGIC-LPSEGSPL-VVLPYMKHGDLRNFIRSETHNP-----------TVKDLIGF 103
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT-- 182
++A +EYL VHRD+ N ++ K+ADFG +R + KE + T
Sbjct: 104 GLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD-KEYYSVHNHTGA 162
Query: 183 ---TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP 219
+ A E ++ + K +D+WS GV+L+ ++ + P
Sbjct: 163 KLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 18/40 (45%), Positives = 26/40 (65%)
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164
+ ++ L LH +GIVHRDIK EN+L++ K+ DFG
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 38/167 (22%), Positives = 60/167 (35%), Gaps = 29/167 (17%)
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
L L E+ HR K NIL++ + L G + E S + APE+
Sbjct: 26 CLGALREL---HRQAKSGNILLT--WDGLLKLDGS--VAFKTPEQSR---PDPYFMAPEV 75
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP------------GTRNRDVLKKQEGKE 238
I+ Y K ADI+SLG+ LY L+ + P+ + G D + +
Sbjct: 76 IQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLEG 134
Query: 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQ 285
R +E + + R+ + R A H T +
Sbjct: 135 VSAARSFEDFM--RLCASRLPQR----REAANHYLAHCRALFAETLE 175
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 8e-04
Identities = 38/171 (22%), Positives = 73/171 (42%), Gaps = 26/171 (15%)
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
+ H N++ T ++M++ DL+ Y+ ++C + ++++A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMA---- 106
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL------LRTPKELSN 177
EIA L +LH+ +H D+ N L++ L K+ D+G S TP +L
Sbjct: 107 --CEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV 164
Query: 178 TFCGTTSYAAPEIIRNSPYNPKLAD------IWSLGVVLYRIL---NKKYP 219
+ APE++ N + D +WSLGV ++ + ++ Y
Sbjct: 165 PL----RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 8/96 (8%)
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-------RLLRTPKELSNTFCGTTS 184
LEY+HE GI H DIK ENI++ + D+G + + + KE + GT
Sbjct: 139 LEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLY 198
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220
YA + N + D+ SLG + + K P+
Sbjct: 199 YAGLD-AHNGACVTRRGDLESLGYCMLKWAGIKLPW 233
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576|consensus | 829 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG2052|consensus | 513 | 100.0 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0590|consensus | 601 | 99.97 | ||
| KOG1345|consensus | 378 | 99.97 | ||
| KOG1024|consensus | 563 | 99.97 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1164|consensus | 322 | 99.95 | ||
| KOG0603|consensus | 612 | 99.94 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG1163|consensus | 341 | 99.92 | ||
| KOG1165|consensus | 449 | 99.92 | ||
| KOG0606|consensus | 1205 | 99.92 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG1240|consensus | 1431 | 99.91 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195|consensus | 448 | 99.89 | ||
| KOG4158|consensus | 598 | 99.89 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0590|consensus | 601 | 99.86 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1166|consensus | 974 | 99.85 | ||
| KOG1033|consensus | 516 | 99.83 | ||
| KOG1023|consensus | 484 | 99.82 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG0601|consensus | 524 | 99.7 | ||
| KOG0606|consensus | 1205 | 99.66 | ||
| KOG1243|consensus | 690 | 99.63 | ||
| KOG1266|consensus | 458 | 99.59 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG0601|consensus | 524 | 99.53 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| KOG3087|consensus | 229 | 99.4 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.37 | |
| KOG2137|consensus | 700 | 99.29 | ||
| KOG3741|consensus | 655 | 99.28 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.84 | |
| KOG0576|consensus | 829 | 98.72 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.67 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.66 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.55 | |
| KOG1035|consensus | 1351 | 98.48 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.31 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.27 | |
| KOG1826|consensus | 2724 | 98.23 | ||
| KOG1235|consensus | 538 | 98.23 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.23 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.19 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.04 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.98 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.97 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.91 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.88 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.78 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.77 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.63 | |
| KOG2268|consensus | 465 | 97.62 | ||
| PRK05231 | 319 | homoserine kinase; Provisional | 97.59 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.54 | |
| PLN02236 | 344 | choline kinase | 97.52 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.28 | |
| KOG1093|consensus | 725 | 97.18 | ||
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.17 | |
| KOG2270|consensus | 520 | 97.09 | ||
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.88 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.86 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.8 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.74 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.43 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.36 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.09 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.04 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.03 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.98 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.94 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.88 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.58 | |
| KOG1033|consensus | 516 | 94.43 | ||
| KOG1236|consensus | 565 | 94.4 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-64 Score=439.37 Aligned_cols=261 Identities=33% Similarity=0.544 Sum_probs=222.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHH----HhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY----MEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
.|.+.+.||+|+||.|-+|..+.+|+.||||++......... ....+++|+++|++|+|||||+++++|+.....|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 488899999999999999999999999999999877664422 2334569999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC---CCeEE
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL---LNAKL 160 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~---~~~kl 160 (351)
+||||++||+|.+++.. ++.+.+...+. +++|++.|+.|||++||+||||||+|||++.+ ..+||
T Consensus 253 mVlE~v~GGeLfd~vv~--nk~l~ed~~K~----------~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVA--NKYLREDLGKL----------LFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred EEEEEecCccHHHHHHh--ccccccchhHH----------HHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence 99999999999999987 67777776654 56677777889999999999999999999876 66999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPY--NPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
+|||+|+... ......+.||||.|.|||++..... +..++|+|||||++|-+++|.+||++.... ....+++..+.
T Consensus 321 tDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-~sl~eQI~~G~ 398 (475)
T KOG0615|consen 321 TDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-PSLKEQILKGR 398 (475)
T ss_pred cccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-ccHHHHHhcCc
Confidence 9999999876 5667889999999999999976653 344589999999999999999999876543 22444455555
Q ss_pred ccc--cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 239 YLF--NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 239 ~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
|.+ +.+..+|+++.+||..||..||++|||++|+|+||||+..+
T Consensus 399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 544 34557999999999999999999999999999999998764
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-61 Score=444.50 Aligned_cols=256 Identities=30% Similarity=0.569 Sum_probs=239.0
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|...+.||+|||+.||.+++..+|..||+|+++++.+......+.+.+||+|.++|+|||||+++++|++.+++|||.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 39999999999999999999999999999999999888877777777799999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
+|+.++|..++++ .+.++|+.++. |++||+.||.|||+++|+|||||..|+|++++.++||+|||+|+
T Consensus 99 LC~~~sL~el~Kr--rk~ltEpEary----------~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 99 LCHRGSLMELLKR--RKPLTEPEARY----------FLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred ecCCccHHHHHHh--cCCCCcHHHHH----------HHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceee
Confidence 9999999999986 78999988775 67888888889999999999999999999999999999999999
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.+..+.....+.||||.|.|||++....++.. +||||+||++|.|+.|++||.... -.+....+....|.+|. .+
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~--vkety~~Ik~~~Y~~P~--~l 241 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKT--VKETYNKIKLNEYSMPS--HL 241 (592)
T ss_pred eecCcccccceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccch--HHHHHHHHHhcCccccc--cc
Confidence 99988888899999999999999998888877 999999999999999999997655 56788888888898887 89
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
|.+++|||.+||++||.+|||++++|.|+||..
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 999999999999999999999999999999943
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-60 Score=409.88 Aligned_cols=264 Identities=30% Similarity=0.498 Sum_probs=233.2
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
....+|.++++||+|+||.||+++.+++++.||+|++.++.............|..+|.+++||.||+++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34678999999999999999999999999999999999888776655566679999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+|+||+.||.|+.+|.+ .+.++|..++. |+.+|+.||.|||++||+||||||+|||+|.+|+++|+||
T Consensus 102 lVld~~~GGeLf~hL~~--eg~F~E~~arf----------YlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR--EGRFSEDRARF----------YLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred EEEeccCCccHHHHHHh--cCCcchhHHHH----------HHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEecc
Confidence 99999999999999987 78899988777 5566777777999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++........+.+.|||+.|||||++.+.+|+.. +|.|||||++|+|++|.+||.+.+ .....+.+..... ...
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~--~~~~~~~I~~~k~-~~~ 245 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAED--VKKMYDKILKGKL-PLP 245 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCcc--HHHHHHHHhcCcC-CCC
Confidence 999987777777888999999999999999998876 999999999999999999998765 4455555554442 222
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCC----CHHHHhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRP----NAKDVQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rp----t~~ell~hp~~~~~~~ 283 (351)
+..++.++++||+++|+.||++|. .+.+|.+||||.+..|
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 335899999999999999999996 6889999999987765
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-58 Score=402.97 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=219.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-EEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT-YLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-~~~lv 85 (351)
.+.+-++.||+|+.|+||+|.|+.+++.+|+|++... .... ..+.+.+|+++++.++|||||.+|++|.... .++|+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~-~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPA-LQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHH-HHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 3667789999999999999999999999999998332 2222 2444559999999999999999999999988 59999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+||||.++++. .+.++|..... ++.++++||.|||+ ++|+||||||+|||++..|.+||||||
T Consensus 157 mEYMDgGSLd~~~k~--~g~i~E~~L~~----------ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKR--VGRIPEPVLGK----------IARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred hhhcCCCCHHHHHhh--cCCCCHHHHHH----------HHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccc
Confidence 999999999999987 47788866543 57788999999995 999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---CCchHHHHhhhC-cccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPG---TRNRDVLKKQEG-KEYL 240 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~-~~~~ 240 (351)
.++.+... ...+.+||..|||||.+.+..|+.+ +||||||+.++|+++|+.||.... ....+.+..+.. .++.
T Consensus 225 VS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~ 301 (364)
T KOG0581|consen 225 VSGILVNS--IANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR 301 (364)
T ss_pred ccHHhhhh--hcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC
Confidence 99987665 6788999999999999999999987 999999999999999999998752 233445555544 3333
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.|.. .+|+++++||..||++||.+|||+.|+++|||++...
T Consensus 302 lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 302 LPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 3332 5999999999999999999999999999999998643
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-59 Score=394.63 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=216.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|+.+.++|+|+||+||+|++++||+.||||+|. +...+....+...|||++|++|+|||+|.++++|+....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~-Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFV-ESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeec-cCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46888999999999999999999999999999994 44445556677779999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|||+ .++.+.+...+ ..+++..++ +|++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|
T Consensus 81 E~~d-hTvL~eLe~~p-~G~~~~~vk----------~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 81 EYCD-HTVLHELERYP-NGVPSELVK----------KYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred eecc-hHHHHHHHhcc-CCCCHHHHH----------HHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhh
Confidence 9998 66666666654 445555544 47788888899999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc--------
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE-------- 238 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------- 238 (351)
+.+..+++....++.|.||+|||++.++..+.+.+||||+||++.||++|.+-|.+.+.-++.......-++
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 999888888899999999999999998665555699999999999999999999876643332221111100
Q ss_pred ----c-----ccc----------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 239 ----Y-----LFN----------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 239 ----~-----~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
. .+| ..+.++.-+.||+.+||.+||++|++.+|+|.||||.+
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 0 011 11256778899999999999999999999999999954
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-58 Score=402.72 Aligned_cols=265 Identities=32% Similarity=0.597 Sum_probs=227.7
Q ss_pred CCCCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 1 MKFPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 1 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
+..+.+.+|.+.+.||+|+||+||+|.++.++..||||.+..+.+.... .+.+..||.+|+.++|||||.++++++.++
T Consensus 4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~-~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKL-VELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHH-HHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 3567889999999999999999999999999999999999988765544 344458999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-----
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL----- 155 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~----- 155 (351)
++|+|||||+||+|.++|.+ .+.+++..++. |+.||+.||++||+++|+||||||.||||+..
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~--~~~l~e~t~r~----------Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~ 150 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRR--RGRLPEATARH----------FMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDT 150 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCC
Confidence 99999999999999999988 56888887765 56777778889999999999999999999864
Q ss_pred -CCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh
Q psy6327 156 -LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ 234 (351)
Q Consensus 156 -~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 234 (351)
-.+||+|||+|+.+. +.....+.||+|.|||||++...+|+.+ +|+||+|+++|+|++|+.||...+ ..+.+..+
T Consensus 151 ~~~LKIADFGfAR~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t--~~eL~~~~ 226 (429)
T KOG0595|consen 151 SPVLKIADFGFARFLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAET--PKELLLYI 226 (429)
T ss_pred CceEEecccchhhhCC-chhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccC--HHHHHHHH
Confidence 458999999999976 4556778999999999999999999987 899999999999999999998665 33444444
Q ss_pred hCccccc-cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 235 EGKEYLF-NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 235 ~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
....... ..+..++....+++...|+.+|.+|.+..+-+.|+++...+
T Consensus 227 ~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 227 KKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 3333322 23345778888999999999999999999999999997654
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-58 Score=416.37 Aligned_cols=262 Identities=31% Similarity=0.571 Sum_probs=236.6
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 83 (351)
...+|.+.+.||.|+|++|++|+++.+++.||||++.++-+-...-.+++.+|-.+|.+| .||+|++++-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 356899999999999999999999999999999999988887777778888999999999 7999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+|+||+++|+|.++|++ .+.+++..++. |+.+|+.||+|||++|||||||||+|||++.++++||+||
T Consensus 151 FvLe~A~nGdll~~i~K--~Gsfde~caR~----------YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK--YGSFDETCARF----------YAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred EEEEecCCCcHHHHHHH--hCcchHHHHHH----------HHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeec
Confidence 99999999999999998 68888887775 6777888888999999999999999999999999999999
Q ss_pred cccccccCCccc-----------c--cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHH
Q psy6327 164 GFSRLLRTPKEL-----------S--NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV 230 (351)
Q Consensus 164 g~a~~~~~~~~~-----------~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 230 (351)
|.|+.+.+.... . .+++||..|++||++.+...+.. +|+|+||||+|+|+.|.+||.+.+ ....
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~N--eyli 295 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAAN--EYLI 295 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCcccc--HHHH
Confidence 999987543221 1 45899999999999998887766 999999999999999999998765 6678
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
++++....|.++. ..++.++|||+++|..||++|+|+.||.+||||.+..+
T Consensus 296 FqkI~~l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 296 FQKIQALDYEFPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred HHHHHHhcccCCC--CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 8888888887776 78999999999999999999999999999999987654
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-57 Score=383.16 Aligned_cols=259 Identities=33% Similarity=0.547 Sum_probs=235.9
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|.+++.||.|+||.|.+++++.+|..+|+|+++++..-+....+...+|..+|+.+.||+++++++.+.+.+++|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 46789999999999999999999999999999999998887666556666799999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||.+||.|+.++++ .+++++..++. |+.||+.||+|||+++|++|||||||||+|.+|.+||+|||
T Consensus 122 vmeyv~GGElFS~Lrk--~~rF~e~~arF----------YAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK--SGRFSEPHARF----------YAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEeccCCccHHHHHHh--cCCCCchhHHH----------HHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999988 68999988776 67788888889999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+|+.+.. .+.+.||||.|+|||++...+++.. +|.|||||++|||+.|.+||.+.. ......++......+|.
T Consensus 190 FAK~v~~---rT~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~--~~~iY~KI~~~~v~fP~- 262 (355)
T KOG0616|consen 190 FAKRVSG---RTWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDN--PIQIYEKILEGKVKFPS- 262 (355)
T ss_pred ceEEecC---cEEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCC--hHHHHHHHHhCcccCCc-
Confidence 9997654 3678999999999999999999876 999999999999999999998766 47788888888888877
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEPT 283 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 283 (351)
..+.+++|||.++|+.|-.+|. ...+|..||||++..|
T Consensus 263 -~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 263 -YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred -ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 7899999999999999999993 4789999999997655
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-56 Score=406.76 Aligned_cols=261 Identities=36% Similarity=0.619 Sum_probs=229.8
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH--HHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD--YMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~ 81 (351)
....|.+.+.||+|+||.|+.|.+..++..||+|+++.+..... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 35689999999999999999999999999999998877533311 34556668999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-CCeEE
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-LNAKL 160 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~-~~~kl 160 (351)
+|+|||||.||+|.+++.+ .+++.|..++. +++|++.|++|||++||+||||||+|||++.+ +++||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~----------~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl 162 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARK----------YFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKL 162 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHH----------HHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEE
Confidence 9999999999999999988 68888877665 56667777779999999999999999999999 99999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
+|||++...........+.||||.|+|||++.+.. |+..++||||+||+||.|++|..||.+.. ......++....+
T Consensus 163 ~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 163 SDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--VPNLYRKIRKGEF 240 (370)
T ss_pred eccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--HHHHHHHHhcCCc
Confidence 99999998754556778899999999999999988 98888999999999999999999998744 4556666777777
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.++.... |.++++|+.+||..||.+|+|+.+++.||||+.
T Consensus 241 ~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 KIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 7666433 999999999999999999999999999999996
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=413.45 Aligned_cols=261 Identities=30% Similarity=0.528 Sum_probs=233.8
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.++-|++.+.||.|+.|.|-+|++..||+..|||++.+.....+.....+.+||-||+.+.||||+++|+++++..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 46679999999999999999999999999999999988744444445566799999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|.||++||.|++++.. .+++++..+. .|+.||+.|+.|+|..+|+||||||+|+|++..+++||+|||
T Consensus 90 vlEyv~gGELFdylv~--kG~l~e~eaa----------~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVR--KGPLPEREAA----------HFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred EEEecCCchhHHHHHh--hCCCCCHHHH----------HHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccc
Confidence 9999999999999987 6888887654 567778888889999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+|.. ..++..-.+.||+|.|.|||++.+.+|+..++||||+|||||-|++|+.||++.+ ....+.+...+.|.+|.
T Consensus 158 MAsL-e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--ir~LLlKV~~G~f~MPs- 233 (786)
T KOG0588|consen 158 MASL-EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--IRVLLLKVQRGVFEMPS- 233 (786)
T ss_pred eeec-ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--HHHHHHHHHcCcccCCC-
Confidence 9986 4455667788999999999999999999999999999999999999999998655 55666777777777774
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.+|.++++||.+||..||++|+|.+||+.|||+.+..
T Consensus 234 -~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 234 -NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred -cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 8999999999999999999999999999999997643
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-56 Score=399.93 Aligned_cols=265 Identities=28% Similarity=0.487 Sum_probs=231.0
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
..+.+|.++..||+|+||.||+|+.+.||..+|+|++.+...........++.|-.+|....+|+||++|-.|.+..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35788999999999999999999999999999999999988877666777778999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
|||||++||++..+|.+ ...+++..++. |+.+++.|++.||+.|++||||||+|+|||..|++||+||
T Consensus 218 LiMEylPGGD~mTLL~~--~~~L~e~~arf----------YiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR--KDTLTEDWARF----------YIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred EEEEecCCccHHHHHHh--cCcCchHHHHH----------HHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccc
Confidence 99999999999999987 78899988776 5666677778999999999999999999999999999999
Q ss_pred cccccccCC---------------------cc-c-------------------------ccccccccceeccccccCCCC
Q psy6327 164 GFSRLLRTP---------------------KE-L-------------------------SNTFCGTTSYAAPEIIRNSPY 196 (351)
Q Consensus 164 g~a~~~~~~---------------------~~-~-------------------------~~~~~gt~~y~aPE~~~~~~~ 196 (351)
|++..+... .. . ....+|||.|+|||++.+..|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 998643210 00 0 013579999999999999998
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc--ccccccccCCHhHHHHHHHhcCCCCCCCCC---HHH
Q psy6327 197 NPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE--YLFNRKYEISIGAKQLIGRMLEPNPKHRPN---AKD 271 (351)
Q Consensus 197 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e 271 (351)
+.. +|+||||||+||||.|.+||...+ ..++..++.... +.+|....++++++|||.+||. ||++|.. ++|
T Consensus 366 ~~~-cDwWSLG~ImyEmLvGyPPF~s~t--p~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 366 GKE-CDWWSLGCIMYEMLVGYPPFCSET--PQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred Ccc-ccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 876 999999999999999999997655 566777766655 5567777899999999999999 9999985 899
Q ss_pred HhcCccccCCccc
Q psy6327 272 VQNHAWIQNEPTC 284 (351)
Q Consensus 272 ll~hp~~~~~~~~ 284 (351)
|..||||++..|-
T Consensus 442 IK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 442 IKKHPFFKGVDWD 454 (550)
T ss_pred HhcCCccccCCcc
Confidence 9999999987663
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-56 Score=396.52 Aligned_cols=260 Identities=30% Similarity=0.481 Sum_probs=218.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCC-EEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGT-YLY 83 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~-~~~ 83 (351)
+.+|+.+++||.|+||.||+|+.+.+|..||||.+..+-..-+ +..-.||+..|++|+ |||||++.+++.+.. .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e--e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH--HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4579999999999999999999999999999999876655533 333349999999998 999999999998888 999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+|||||+ .+|+++++.. +..+++..++. |+.||+.||+|+|.+|++|||+||||||+.....+||+||
T Consensus 87 fVfE~Md-~NLYqLmK~R-~r~fse~~irn----------im~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR-NRLFSESDIRN----------IMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred eeHHhhh-hhHHHHHhhc-CCcCCHHHHHH----------HHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccc
Confidence 9999997 9999999886 88899888765 5778888899999999999999999999998889999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh--------
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE-------- 235 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------- 235 (351)
|+||.+.+.. ....++.|.||+|||++....++..++||||+|||++|+.+-++-|.+.+.. +.+.++.
T Consensus 155 GLARev~Skp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~--Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 155 GLAREVRSKP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI--DQIYKICEVLGTPDK 231 (538)
T ss_pred ccccccccCC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH--HHHHHHHHHhCCCcc
Confidence 9999876543 4567889999999999887777666799999999999999999999776532 2222111
Q ss_pred -----------Ccccccccc---------ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 236 -----------GKEYLFNRK---------YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 236 -----------~~~~~~~~~---------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
...+.++.. .+++.++.++|.+||.+||++||||.|+|+||||+...
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 111222211 24788999999999999999999999999999998654
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-56 Score=367.97 Aligned_cols=259 Identities=32% Similarity=0.502 Sum_probs=226.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|.|+.|+++.+..+|+.+|+|+++.+....... +.+.+|+.|.+.|+|||||++++.+.+.+..|+|+|
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~-e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccH-HHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4788899999999999999999999999999999888766543 445699999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---CCCeEEeecc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---LLNAKLADFG 164 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~~~~kl~Dfg 164 (351)
++.|++|..-|-.. .+.+.+.+-.++.||+++|.|+|.+||+|||+||+|+++.. ..-+||+|||
T Consensus 91 ~m~G~dl~~eIV~R------------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR------------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred cccchHHHHHHHHH------------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccc
Confidence 99999998776541 45566667789999999999999999999999999999954 3459999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc-
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR- 243 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 243 (351)
+|..+. .+....+.+|||.|||||+++..+|+.. +|||+.|+++|-|+.|.+||++.+ .....+.+....|.++.
T Consensus 159 vAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I~~g~yd~~~~ 234 (355)
T KOG0033|consen 159 LAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDED--QHRLYEQIKAGAYDYPSP 234 (355)
T ss_pred eEEEeC-CccccccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHhccccCCCCc
Confidence 999887 5566678899999999999999999876 999999999999999999998755 55666666666665554
Q ss_pred -cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 244 -KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 244 -~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
+..+++++++||++||..||.+|+|+.|+|+|||+.+...
T Consensus 235 ~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 235 EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 5689999999999999999999999999999999986543
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-55 Score=385.09 Aligned_cols=263 Identities=30% Similarity=0.491 Sum_probs=215.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC--EEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT--YLY 83 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--~~~ 83 (351)
..+|...+.||+|+||.||++.+.++|...|+|.+....... .+.+.+|+.+|++|+|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888999999999999999999999999999987663222 344569999999999999999999854444 799
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-CCCeEEee
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-LLNAKLAD 162 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-~~~~kl~D 162 (351)
++|||++||+|.+++....+ .+++..++. |..||++||.|||++||+||||||+|||++. ++.+||+|
T Consensus 93 i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~----------ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG-KLPEPLVRR----------YTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC-CCCHHHHHH----------HHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEecc
Confidence 99999999999999998544 789887654 7888899999999999999999999999999 79999999
Q ss_pred ccccccccCC---cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 163 FGFSRLLRTP---KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 163 fg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
||+++..... ........|||.|||||++.++....+.+||||+||++.||+||++||... .........+.....
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~~ 240 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGREDS 240 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccCC
Confidence 9999876631 122445789999999999986443333599999999999999999999874 112222222222223
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
....+..+|.++++||.+|+..||++|||++++|+|||.+....
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 33455579999999999999999999999999999999976543
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-56 Score=374.46 Aligned_cols=251 Identities=29% Similarity=0.468 Sum_probs=216.3
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeee-EEEeC-CEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR-MVKAG-TYL 82 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~-~~~~~-~~~ 82 (351)
.+.+|+++++||.|+||.||++.+..+|..+|.|.+............. ..|+.+|++|+|||||++++ .+.++ .-+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~-v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDC-VKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHH-HHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 4678999999999999999999999999999999998666655544444 48999999999999999998 44444 449
Q ss_pred EEEEecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh--CC--ceeccCCCCCEeEcCCC
Q psy6327 83 YMIMDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHE--VG--IVHRDIKCENILISRLL 156 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~--~~--i~H~Dlkp~NIll~~~~ 156 (351)
+||||||.+|+|...|+... .+.++|..++ +|+.|+|.||..+|+ .. |+||||||.||+|+.+|
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vw----------k~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g 165 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVW----------KYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG 165 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHH----------HHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC
Confidence 99999999999999997543 3456766544 477788888999999 45 99999999999999999
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 236 (351)
.+||+|||+++.+........+.+|||.||+||++.+.+|+.+ +||||+||++|||+.-.+||.+.+ ......++..
T Consensus 166 vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~n--~~~L~~KI~q 242 (375)
T KOG0591|consen 166 VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGDN--LLSLCKKIEQ 242 (375)
T ss_pred ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCccccc--HHHHHHHHHc
Confidence 9999999999999988888899999999999999999999987 999999999999999999998764 5566777777
Q ss_pred ccccccccccCCHhHHHHHHHhcCCCCCCCCCH
Q psy6327 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNA 269 (351)
Q Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 269 (351)
+.+..-.....|.++..+|..|+.+||+.||+.
T Consensus 243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 766433334689999999999999999999985
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-55 Score=363.16 Aligned_cols=264 Identities=28% Similarity=0.399 Sum_probs=218.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|..+++||+|.||.||+|++..+|+.||||++......+...... .|||+.|+.++|+||+.++++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~ta-lREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTA-LREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHH-HHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46888999999999999999999999999999998886665443444 49999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++ .+|...|+.. ...+.... .-.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|
T Consensus 81 Efm~-tdLe~vIkd~-~i~l~pa~----------iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDK-NIILSPAD----------IKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred Eecc-ccHHHHhccc-ccccCHHH----------HHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccch
Confidence 9997 9999999863 33344333 3347888999999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh---Ccc--ccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---GKE--YLF 241 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~~--~~~ 241 (351)
+.+.++.......+-|.+|+|||++.+...+...+||||.|||+.||+-|.+-|.+.+ +.+.+..+- +.+ ..+
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s--DidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS--DIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc--hHHHHHHHHHHcCCCCcccC
Confidence 9998887776666889999999999987766566999999999999999999997654 233222110 000 000
Q ss_pred ---------------c------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccc
Q psy6327 242 ---------------N------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQ 285 (351)
Q Consensus 242 ---------------~------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 285 (351)
| .-...+.++.||+.+||.+||.+|+|+.|+|+|+||...+.+.
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 0 0113577889999999999999999999999999998765543
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-55 Score=396.94 Aligned_cols=263 Identities=27% Similarity=0.489 Sum_probs=227.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|+-..+||+|+.|.||.|....+++.||||.++...... .+.+.+|+.+|+.++|+|||++++.|..++.+++|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 3778899999999999999999999999999998776655 3445699999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++||+|.|.+.. ..+.|.++.. ++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++.
T Consensus 351 ym~ggsLTDvVt~---~~~~E~qIA~----------Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK---TRMTEGQIAA----------ICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred ecCCCchhhhhhc---ccccHHHHHH----------HHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeee
Confidence 9999999999975 4466765443 57789999999999999999999999999999999999999999
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.+........+.+|||+|||||++....|+.+ +||||||++++||+-|++||-....-....+ --....+.+..+..+
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-Ia~ng~P~lk~~~kl 495 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTPKLKNPEKL 495 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHHH-HhhcCCCCcCCcccc
Confidence 98887777889999999999999999999987 9999999999999999999975443222222 223345566667789
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccccCC
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMT 288 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~ 288 (351)
|..++||+.+||+.||++|+++.+||+||||+.......++
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~ 536 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLN 536 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhH
Confidence 99999999999999999999999999999997655444443
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-53 Score=373.69 Aligned_cols=267 Identities=32% Similarity=0.492 Sum_probs=238.9
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++++.||.|.-|+||+|..+.++..+|+|++++..+........+.-|-.||+.++||.++.+|..|+++...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 35678999999999999999999999999999999999888766556666689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
+||||+||+|..++++...+.+++..++. |+.+++.||+|||-.|||+|||||+||||.++|+|-|+||.
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRF----------YaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARF----------YAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHH----------HHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecc
Confidence 99999999999999999999999998887 56677888889999999999999999999999999999998
Q ss_pred ccccccC---------------------------------C-c----------------------ccccccccccceecc
Q psy6327 165 FSRLLRT---------------------------------P-K----------------------ELSNTFCGTTSYAAP 188 (351)
Q Consensus 165 ~a~~~~~---------------------------------~-~----------------------~~~~~~~gt~~y~aP 188 (351)
++..... . . ......+||-.|.||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 7744210 0 0 112346799999999
Q ss_pred ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCC
Q psy6327 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPN 268 (351)
Q Consensus 189 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt 268 (351)
|++.+...+.. +|.|+|||++|||+.|..||.+.+ +.+.+..+......++....++..++|||+++|.+||.+|..
T Consensus 305 EvI~G~GHgsA-VDWWtfGIflYEmLyG~TPFKG~~--~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 305 EVIRGEGHGSA-VDWWTFGIFLYEMLYGTTPFKGSN--NKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred eeeecCCCCch-hhHHHHHHHHHHHHhCCCCcCCCC--chhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence 99999998876 999999999999999999998766 778888888888999988899999999999999999999998
Q ss_pred ----HHHHhcCccccCCccc
Q psy6327 269 ----AKDVQNHAWIQNEPTC 284 (351)
Q Consensus 269 ----~~ell~hp~~~~~~~~ 284 (351)
+.||.+||||++..|.
T Consensus 382 ~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 382 SKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred cccchHHhhcCccccCCChh
Confidence 9999999999988764
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-54 Score=385.49 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=214.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--CEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--TYLYM 84 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~l 84 (351)
..|..+++||+|+||.||+|++..+|+.||+|++.......... .+..|||.||++|+||||+++.++..+. +.+|+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~-~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFP-ITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcch-HHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35888999999999999999999999999999998877655443 3445999999999999999999998766 78999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|+|||+ .+|..++... ...+++.+++. |+.||+.||+|||++||+|||||.+|||||.+|.+||+|||
T Consensus 196 VFeYMd-hDL~GLl~~p-~vkft~~qIKc----------~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSSP-GVKFTEPQIKC----------YMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred EEeccc-chhhhhhcCC-CcccChHHHHH----------HHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEecccc
Confidence 999997 9999998753 56788877664 67888899999999999999999999999999999999999
Q ss_pred ccccccCCccc-ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh---hCcc--
Q psy6327 165 FSRLLRTPKEL-SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ---EGKE-- 238 (351)
Q Consensus 165 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---~~~~-- 238 (351)
+|+++...... ....+-|+||+|||++.+..-+...+|+||+||||.||+.|++.|.+.+. .+.+..+ .+.+
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--veQl~kIfklcGSP~e 341 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--VEQLHKIFKLCGSPTE 341 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--HHHHHHHHHHhCCCCh
Confidence 99987765543 55667899999999999877666669999999999999999999987652 2222211 1100
Q ss_pred --c---ccc-----------------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 239 --Y---LFN-----------------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 239 --~---~~~-----------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
| .++ ....++..+.+|+..||..||++|.|+.++|+|+||...
T Consensus 342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 0 000 001367889999999999999999999999999999543
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-54 Score=398.23 Aligned_cols=262 Identities=28% Similarity=0.485 Sum_probs=230.5
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~ 82 (351)
..+.+|+++++||+|+||.|++|..+.+++.||||++++..+-..........|-+|+.... ||.++.++.+|.+.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 35678999999999999999999999999999999998877644333334447888888775 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||||+.||++..++. ...+++..++. |+.+|+.||.|||++||||||||.+|||+|.+|++||+|
T Consensus 445 ~fvmey~~Ggdm~~~~~---~~~F~e~rarf----------yaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiAD 511 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH---TDVFSEPRARF----------YAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIAD 511 (694)
T ss_pred EEEEEecCCCcEEEEEe---cccccHHHHHH----------HHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecc
Confidence 99999999999665554 36778776665 677788888899999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
||+++.....+..++++||||.|+|||++.+..|+.. +|.|||||+||||+.|..||.+.+ ..+.+..+....+.+|
T Consensus 512 FGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gdd--Eee~FdsI~~d~~~yP 588 (694)
T KOG0694|consen 512 FGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDD--EEEVFDSIVNDEVRYP 588 (694)
T ss_pred cccccccCCCCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHhcCCCCCC
Confidence 9999987666778899999999999999999999876 999999999999999999998655 7788888888777776
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEPT 283 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 283 (351)
. .+|.++.++++++|.++|++|.. +.+|..||||+...|
T Consensus 589 ~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 589 R--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred C--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 6 79999999999999999999986 578999999998765
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-54 Score=389.27 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=226.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+....+.. .+.+++|+++++.|+|||||.++++|++..++++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~-l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE-LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH-HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 5688899999999999999999999999999999776655544 345569999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|||. |+|+.++.. ++.++|+.++. ++.+++.||.|||+++|.|||+||.|||+..++.+|+||||+|
T Consensus 81 e~a~-g~L~~il~~--d~~lpEe~v~~----------~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 81 EYAV-GDLFTILEQ--DGKLPEEQVRA----------IAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred hhhh-hhHHHHHHh--ccCCCHHHHHH----------HHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhh
Confidence 9998 599999988 88999988775 5677888888999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
+.+..........-|||.|||||++.+.+|+-. +|+|||||++|||+.|++||...+ ..+..+.+...+..++. .
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~s--i~~Lv~~I~~d~v~~p~--~ 222 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARS--ITQLVKSILKDPVKPPS--T 222 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHH--HHHHHHHHhcCCCCCcc--c
Confidence 998776666677889999999999999999876 999999999999999999996544 34555555555544444 7
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.|..+.+|+..+|.+||.+|.|..+++.|||.++.
T Consensus 223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 89999999999999999999999999999998653
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=371.07 Aligned_cols=268 Identities=27% Similarity=0.428 Sum_probs=224.4
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
++..+|.+...||.|..++||+|....++.+||||+++.+.-... -..+++|++.|+.++||||++++..|..+..+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 466789999999999999999999999999999999998877665 455669999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||.||.+||+.++++......+.|..+.. +++++++||.|||.+|.+|||||+.||||+.+|.|||+||
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~----------iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIAT----------ILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHH----------HHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCc
Confidence 999999999999999998888888876543 6778899999999999999999999999999999999999
Q ss_pred cccccccCCcccc----cccccccceecccccc-C-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc
Q psy6327 164 GFSRLLRTPKELS----NTFCGTTSYAAPEIIR-N-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 164 g~a~~~~~~~~~~----~~~~gt~~y~aPE~~~-~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
|.+-.+...+... .+.+|||+|||||++. . ..|+.+ +|||||||+..||++|..||...... .-.+....+.
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPm-kvLl~tLqn~ 248 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPM-KVLLLTLQND 248 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChH-HHHHHHhcCC
Confidence 9886655443322 5668999999999953 3 345655 99999999999999999999876532 2223333333
Q ss_pred ccc-------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccc
Q psy6327 238 EYL-------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQ 285 (351)
Q Consensus 238 ~~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 285 (351)
++. .......+..++.+|..||++||.+|||++++|.|+||+....+.
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 331 112234677899999999999999999999999999998776543
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=362.96 Aligned_cols=263 Identities=29% Similarity=0.497 Sum_probs=217.9
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--CEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--TYL 82 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~ 82 (351)
.+.+|..++.|++|+||.||+|.+++|++.||+|.++.+.-........+ |||.+|.+++|||||.+-++.... +.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsL-REIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSL-REINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhH-HHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 56789999999999999999999999999999999988775444333333 999999999999999999998654 479
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+|||||+ .+|..++... ..++...+.+. ++.|+++|++|||.+.|+||||||+|+|++..|.+||+|
T Consensus 153 y~VMe~~E-hDLksl~d~m-~q~F~~~evK~----------L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaD 220 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETM-KQPFLPGEVKT----------LMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIAD 220 (419)
T ss_pred eeeHHHHH-hhHHHHHHhc-cCCCchHHHHH----------HHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecc
Confidence 99999997 9999999764 34666555443 567888899999999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh---Cc--
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---GK-- 237 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~-- 237 (351)
||+|+.+.++.......+-|.+|+|||++.+.+.++.++|+||+|||+.||+++++-|.+.+. .+.+..+- +.
T Consensus 221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--IDQLDKIFKLLGTPS 298 (419)
T ss_pred cchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch--HHHHHHHHHHhCCCc
Confidence 999999988877778888999999999999888666679999999999999999999977653 22222110 00
Q ss_pred --------------ccccccc-----------ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 238 --------------EYLFNRK-----------YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 238 --------------~~~~~~~-----------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
...++.. ..+++...+|+..+|..||.+|.|+.|.|+|+||...+
T Consensus 299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 0000000 02568999999999999999999999999999998754
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=371.90 Aligned_cols=254 Identities=33% Similarity=0.593 Sum_probs=229.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|.+.+.||+|+||.|-+|.+...|+.||||.+.+..+.+..---.+++||+||..|+||||+.+|++|++.+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 58999999999999999999999999999999999888877666677899999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|..+|.|+|++.+ .+.+++..++.++ +||..|++|+|.++++|||||.+|||+|+++++||+|||++.
T Consensus 134 YaS~GeLYDYiSe--r~~LsErEaRhfF----------RQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 134 YASGGELYDYISE--RGSLSEREARHFF----------RQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred ecCCccHHHHHHH--hccccHHHHHHHH----------HHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhh
Confidence 9999999999988 7889998888754 555666679999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.+.. ..+..++||+|.|.+||++.+.+|....+|.||||++||.|..|.+||++.+ .....+++..+.|.-|. -
T Consensus 202 ly~~-~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--hk~lvrQIs~GaYrEP~---~ 275 (668)
T KOG0611|consen 202 LYAD-KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--HKRLVRQISRGAYREPE---T 275 (668)
T ss_pred hhcc-ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--HHHHHHHhhcccccCCC---C
Confidence 7644 4566789999999999999999998888999999999999999999998766 56777777777776554 5
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
+.++.-||+-||..||++|.|+.+|-+|-|++
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 67889999999999999999999999999985
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-52 Score=379.67 Aligned_cols=257 Identities=32% Similarity=0.557 Sum_probs=223.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.|++.+.||+|.||.||.|.++.+|+.+|+|.+.+...........+.+|+.+|+++. |||||.++++|++...+++||
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm 115 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM 115 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence 4899999999999999999999999999999998888765444456679999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC----CCeEEee
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL----LNAKLAD 162 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~----~~~kl~D 162 (351)
|+|.||.|++.|... .+++..+. .++.|++.+++|||+.||+||||||+|+|+... +.+|++|
T Consensus 116 EL~~GGeLfd~i~~~---~~sE~da~----------~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK---HYSERDAA----------GIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EecCCchHHHHHHHc---cCCHHHHH----------HHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 999999999999874 36665544 467778888889999999999999999999653 4799999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc--
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL-- 240 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-- 240 (351)
||++..... .......+|||.|+|||++...+|+.. +||||+|+++|.|++|.+||.+.+ .......+....+.
T Consensus 183 FGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~--~~~~~~~i~~~~~~f~ 258 (382)
T KOG0032|consen 183 FGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGET--EFEIFLAILRGDFDFT 258 (382)
T ss_pred CCCceEccC-CceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCC--hhHHHHHHHcCCCCCC
Confidence 999998777 666788999999999999998888877 999999999999999999998766 33444455545444
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.+....+|..+++||.+||..||.+|+|+.++|+|||++..
T Consensus 259 ~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 259 SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 34456789999999999999999999999999999999875
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-53 Score=375.95 Aligned_cols=261 Identities=33% Similarity=0.546 Sum_probs=221.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHH-----------hhhHHHHHHHHHhCCCCCceeeee
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM-----------EKFAPREIDILLKVSHPNIIGVHR 74 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-----------~~~~~~Ei~~l~~l~hp~iv~~~~ 74 (351)
+..|++.+.||+|.||.|-+|.+..+++.||+|++++........ .+.+++||.+|++|.|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 567999999999999999999999999999999998876543321 235679999999999999999999
Q ss_pred EEEe--CCEEEEEEecCCCCChHHHHHhhccCC-CchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEe
Q psy6327 75 MVKA--GTYLYMIMDYAEKKDLEHYISKACNEN-IHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENIL 151 (351)
Q Consensus 75 ~~~~--~~~~~lv~e~~~ggsL~~~l~~~~~~~-~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIl 151 (351)
+..+ .+.+|||+|||..|.+.+-- .... +.+.+ |.+|+++++.||+|||.+||+||||||+|+|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~----------Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQ----------ARKYLRDVVLGLEYLHYQGIIHRDIKPSNLL 242 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHH----------HHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence 9865 46899999999999876532 2333 55544 4458899999999999999999999999999
Q ss_pred EcCCCCeEEeeccccccccCC-----cccccccccccceeccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy6327 152 ISRLLNAKLADFGFSRLLRTP-----KELSNTFCGTTSYAAPEIIRN---SPYNPKLADIWSLGVVLYRILNKKYPFGDP 223 (351)
Q Consensus 152 l~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (351)
++.+|++||+|||.+...... .......+|||-|+|||.+.+ ..+...+.||||+||+||.|+.|+.||-+.
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 999999999999999866322 222334689999999999987 446677789999999999999999999654
Q ss_pred CCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 224 GTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. ..+...++......++....+...++|||.+||++||++|+++.+|..|||....
T Consensus 323 ~--~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 323 F--ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred h--HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 4 6778888888888888888899999999999999999999999999999998644
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-53 Score=346.56 Aligned_cols=259 Identities=32% Similarity=0.529 Sum_probs=235.3
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|.+.+.||+|-||.||+|..+.++-.+|+|++.+..+......+.+++|+++-..|+||||+++|++|.+...+|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 35789999999999999999999999999999999999998888888999999999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
++||..+|+|+..+.......+.+..... |+.|++.||.|+|.++|+||||||+|+|++..+.+||+|||
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~----------Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAAT----------YIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhH----------HHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence 99999999999999977778888876544 67778888889999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
.+-... .....+.|||..|.+||...+..++.. +|+|++|++.||++.|.+||.... ..+..+.+....+.+|
T Consensus 170 wsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~~~p-- 242 (281)
T KOG0580|consen 170 WSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDLKFP-- 242 (281)
T ss_pred ceeecC--CCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHccccCC--
Confidence 987633 455678999999999999999999877 999999999999999999997665 6677777777766666
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
..++.++.|+|.+||.++|.+|.+..|++.|||+..
T Consensus 243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 489999999999999999999999999999999864
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=375.60 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=216.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++.+.||+|+||.||+|.+..+++.+|+|++.............+.+|+.++++++||||+++++++.+++..|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999999976654443334556689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+.||+|.+++.. ...+++..+. .++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 96 v~e~~~~~~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK--AGRFPNDVAK----------FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred EEcCCCCChHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999976 4566665543 356788889999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+++..... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.. .......+......+ +
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~--p 235 (329)
T PTZ00263 164 FAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDT--PFRIYEKILAGRLKF--P 235 (329)
T ss_pred CceEcCCC---cceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCC--HHHHHHHHhcCCcCC--C
Confidence 99865432 234579999999999988887765 999999999999999999997543 333344444333333 3
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNE 281 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~ 281 (351)
..++..+++||.+||+.||.+||+ +.++++||||.+.
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 358899999999999999999997 7999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=374.84 Aligned_cols=253 Identities=29% Similarity=0.495 Sum_probs=210.6
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKK 92 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg 92 (351)
+.||+|+||.||+|.+..+|+.+|+|++.............+.+|+.++++++||||+++++++...+..|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997655433333344558999999999999999999999999999999999999
Q ss_pred ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCC
Q psy6327 93 DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP 172 (351)
Q Consensus 93 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 172 (351)
+|.+++.. ...+++..+.. ++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~----------~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 81 ELFFHLSR--ERVFSEDRARF----------YGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 99999976 45666655443 5678888999999999999999999999999999999999999864443
Q ss_pred cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHH
Q psy6327 173 KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252 (351)
Q Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (351)
.......+||+.|+|||++.+..++.+ +||||+||++|+|++|..||...+ .......+......+ +..++.++.
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~~~~~~~~~--p~~~~~~~~ 223 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEEIRF--PRTLSPEAK 223 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCC--HHHHHHHHHcCCCCC--CCCCCHHHH
Confidence 344456679999999999988888765 999999999999999999997644 233333333333333 346899999
Q ss_pred HHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 253 QLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 253 ~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
+||.+||+.||++|| ++.++++||||.+..
T Consensus 224 ~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 224 SLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-51 Score=365.45 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=212.8
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|+..+.||+|+||.||+|.+..+++.+|+|.+.............+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37889999999999999999999999999999876655443334455689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++|+|.+++.......+++... +.++.|++.||.|||++||+||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~----------~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRA----------IFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHH----------HHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 999999998886543444555443 3467788999999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch--HHHHhhhCccccccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR--DVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 245 (351)
..... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........ ....... ........
T Consensus 151 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~ 226 (285)
T cd05631 151 QIPEG-ETVRGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK--EDQEEYSE 226 (285)
T ss_pred EcCCC-CeecCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh--cccccCCc
Confidence 75332 22345579999999999998888766 9999999999999999999976543211 1111111 11222334
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEP 282 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~ 282 (351)
.++.++.+||.+||+.||++||+ ++++++||||.+..
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 68999999999999999999997 89999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=368.60 Aligned_cols=255 Identities=35% Similarity=0.542 Sum_probs=213.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 68999999999999999999999999999999876554433334556689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++|+|.+++.. ...+++.... .++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~----------~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 82 YVPGGELFSYLRN--SGRFSNSTGL----------FYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149 (291)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcch
Confidence 9999999999976 4556665443 467788889999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
..... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... .......+......++ ..+
T Consensus 150 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~--~~~ 221 (291)
T cd05612 150 KLRDR---TWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDN--PFGIYEKILAGKLEFP--RHL 221 (291)
T ss_pred hccCC---cccccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCcCCC--ccC
Confidence 65432 234579999999999988877765 999999999999999999997654 3333444333333333 356
Q ss_pred CHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEP 282 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~ 282 (351)
+..+++||.+||+.||.+||+ +.++++||||+...
T Consensus 222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 899999999999999999995 99999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=376.43 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=212.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||+||+|.+..+++.+|+|++.............+.+|+.++..++||||+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 68999999999999999999999999999999976555444444556689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
||+||+|.+++.+ ...+++..++ .++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~gg~L~~~l~~--~~~l~~~~~~----------~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 82 FLPGGDMMTLLMK--KDTLTEEETQ----------FYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 9999999999976 4566766544 356788888999999999999999999999999999999999987
Q ss_pred cccCCcc-----------------------------------cccccccccceeccccccCCCCCCCcchHHHHHHHHHH
Q psy6327 168 LLRTPKE-----------------------------------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYR 212 (351)
Q Consensus 168 ~~~~~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 212 (351)
....... .....+||+.|+|||++.+..++.+ +|||||||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~e 228 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYE 228 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHH
Confidence 5432110 0124579999999999988888765 999999999999
Q ss_pred HHhCCCCCCCCCCCchHHHHhhhC--ccccccccccCCHhHHHHHHHhcCCCCC---CCCCHHHHhcCccccCCcc
Q psy6327 213 ILNKKYPFGDPGTRNRDVLKKQEG--KEYLFNRKYEISIGAKQLIGRMLEPNPK---HRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 213 ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~---~Rpt~~ell~hp~~~~~~~ 283 (351)
|++|..||.... .......+.. ....++....+++++++||.+|+. +|. .||+++|+++||||++..+
T Consensus 229 ll~G~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 229 MLIGYPPFCSET--PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred HHhCCCCCCCCC--HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 999999997654 2333333332 223344445689999999999876 444 4589999999999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=357.77 Aligned_cols=259 Identities=28% Similarity=0.461 Sum_probs=207.1
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-----CCEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA-----GTYL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-----~~~~ 82 (351)
.|..++.||+|+||.|+.|.++.+|+.||||++... .......+...||+.+|+.++|+||+.+.+++.. -+.+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 356689999999999999999999999999998633 3333334455599999999999999999999865 3579
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+|+|+|+ .+|...|++ +..+.+.-+.. ++.|+++||+|+|+.+|+||||||.|+|++.+..+||+|
T Consensus 102 YiV~elMe-tDL~~iik~--~~~L~d~H~q~----------f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIKS--QQDLTDDHAQY----------FLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred EEehhHHh-hHHHHHHHc--CccccHHHHHH----------HHHHHHHhcchhhcccccccccchhheeeccCCCEEecc
Confidence 99999995 999999987 45466655443 678899999999999999999999999999999999999
Q ss_pred ccccccccCC--cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch------------
Q psy6327 163 FGFSRLLRTP--KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR------------ 228 (351)
Q Consensus 163 fg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------------ 228 (351)
||+|+..... ....+.++.|.+|+|||++......++..||||+|||+.||++|++-|.+.+..++
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 9999987542 33446778899999999987655555569999999999999999999977654322
Q ss_pred -HHHHhhh---Cccccc-----------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 229 -DVLKKQE---GKEYLF-----------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 229 -~~~~~~~---~~~~~~-----------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
+.+..+. ...|.. ..-+..++.+.||+.+||..||.+|+|++|+|+|||+..
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 1111111 011110 011257889999999999999999999999999999964
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-53 Score=372.92 Aligned_cols=265 Identities=29% Similarity=0.463 Sum_probs=224.0
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
+.-..|+.++.||+|+||.||+|.+..+++.||+|+++....... ...+.+|+.++.+++++||.++|+.|-.+..++
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 334458899999999999999999999999999999998776654 344558999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
++||||.||++.++++. ...+.+..+.. ++++++.||.|||+++.+|||||+.|||+..+|.+||+||
T Consensus 88 iiMey~~gGsv~~lL~~--~~~~~E~~i~~----------ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~Df 155 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKS--GNILDEFEIAV----------ILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADF 155 (467)
T ss_pred HHHHHhcCcchhhhhcc--CCCCccceeee----------ehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEec
Confidence 99999999999999986 34445554433 5678888899999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|.+-.+........+.+|||.|||||+++...|+.+ +||||||++.|||++|.+|+.+.......+.... ..++.+.
T Consensus 156 gVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-~~PP~L~- 232 (467)
T KOG0201|consen 156 GVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-SAPPRLD- 232 (467)
T ss_pred ceeeeeechhhccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-CCCCccc-
Confidence 999988777777789999999999999998889887 8999999999999999999987764222111111 1111222
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccccc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQT 286 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 286 (351)
..+|..+++|+..||++||+.||+|.++|.|+|++....+..
T Consensus 233 -~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~ 274 (467)
T KOG0201|consen 233 -GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSE 274 (467)
T ss_pred -cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchH
Confidence 278999999999999999999999999999999998554433
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=349.94 Aligned_cols=256 Identities=30% Similarity=0.489 Sum_probs=216.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh-----hHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-----RDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTY 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~ 81 (351)
.|...+.||+|..++|-++.++.+|+.+|+|++...... .....+.-++|+.||+++. ||+|+++.++|+++..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 366778899999999999999999999999998653321 1222333458999999995 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
+++|+|.|+.|.|+|++.+ ...+++..++. +++|+++|+.|||.++|+||||||+|||++++.++||+
T Consensus 98 ~FlVFdl~prGELFDyLts--~VtlSEK~tR~----------iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTS--KVTLSEKETRR----------IMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred hhhhhhhcccchHHHHhhh--heeecHHHHHH----------HHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEe
Confidence 9999999999999999987 67888888776 46667777889999999999999999999999999999
Q ss_pred eccccccccCCcccccccccccceeccccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN------SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 235 (351)
|||+|+.+... ......||||+|.|||.+.. ..|+. .+|+||+|+|+|.|+.|.+||+... ...++..+.
T Consensus 166 DFGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~-EVD~Wa~GVImyTLLaGcpPFwHRk--QmlMLR~Im 241 (411)
T KOG0599|consen 166 DFGFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSK-EVDEWACGVIMYTLLAGCPPFWHRK--QMLMLRMIM 241 (411)
T ss_pred ccceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccc-hhhHHHHHHHHHHHHcCCCchhHHH--HHHHHHHHH
Confidence 99999987654 44567899999999998753 33444 4999999999999999999997543 455666666
Q ss_pred Cccccc--cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 236 GKEYLF--NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 236 ~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
.+.|.+ +.+.++|...+|||.+||+.||.+|.|+.|+|.||||.
T Consensus 242 eGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 242 EGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred hcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 666655 44567999999999999999999999999999999994
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=363.21 Aligned_cols=260 Identities=25% Similarity=0.452 Sum_probs=205.9
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
|.++.+|+++++||.|+||.||+|.+..++..||+|++........ ...+.+|+.+++.++||||+++++++.++...
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKNLKHANIVTLHDIIHTERCL 78 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc--chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 5678899999999999999999999999999999999865432211 22344899999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||++ ++|.+++... ...+++... ..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 79 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~----------~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~D 146 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNC-GNLMSMHNV----------KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLAD 146 (288)
T ss_pred EEEEeCCC-cCHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECc
Confidence 99999998 5999988653 233444433 34677889999999999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh---C---
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---G--- 236 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~--- 236 (351)
||+++.............|++.|+|||++.+......++||||+||++|+|++|++||...+.. +....+. .
T Consensus 147 fG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 224 (288)
T cd07871 147 FGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--EELHLIFRLLGTPT 224 (288)
T ss_pred CcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence 9999865544444455678999999999876443334599999999999999999999765421 1111000 0
Q ss_pred -------------cccccc---------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 -------------KEYLFN---------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 -------------~~~~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
..+.++ ....++.++++||.+||++||.+|||+.|+++||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 225 EETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 000111 112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=371.25 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=214.4
Q ss_pred CccceeeeeecCcccceEEEEEEecCCc-eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSE-TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
.+.+|++++.||+|+||.||+|.+..++ ..+|+|.+.............+.+|+.+++.++||||+++++++.+++..|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3567999999999999999999976654 789999987655443333445568999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+.||+|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 lv~Ey~~~g~L~~~i~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR--NKRFPNDVGC----------FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecC
Confidence 99999999999999976 4566665443 46778888899999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++..... ....+||+.|+|||++.+..++.. +||||+||++|+|++|..||...+ .......+......+
T Consensus 176 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~i~~~~~~~-- 247 (340)
T PTZ00426 176 GFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANE--PLLIYQKILEGIIYF-- 247 (340)
T ss_pred CCCeecCCC---cceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCC--HHHHHHHHhcCCCCC--
Confidence 999865432 245679999999999988777765 999999999999999999997644 333334443333333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 283 (351)
+..++..++++|++||+.||.+|+ +++++++||||++..+
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 336899999999999999999995 8999999999987543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=376.07 Aligned_cols=262 Identities=28% Similarity=0.416 Sum_probs=211.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
+.|++++.||+|+||+||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999998766544444455678999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++||+|.+++.+ ...+++..++. ++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~--~~~~~e~~~~~----------~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 81 DYIPGGDMMSLLIR--MEVFPEVLARF----------YIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred ecCCCCcHHHHHHh--cCCCCHHHHHH----------HHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 99999999999976 45666655444 5667888888999999999999999999999999999999997
Q ss_pred ccccCCc-----------------------------------------------ccccccccccceeccccccCCCCCCC
Q psy6327 167 RLLRTPK-----------------------------------------------ELSNTFCGTTSYAAPEIIRNSPYNPK 199 (351)
Q Consensus 167 ~~~~~~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 199 (351)
+...... ......+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 6431100 01124579999999999988888765
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh--CccccccccccCCHhHHHHHHHhcCC--CCCCCCCHHHHhcC
Q psy6327 200 LADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE--GKEYLFNRKYEISIGAKQLIGRMLEP--NPKHRPNAKDVQNH 275 (351)
Q Consensus 200 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~~L~~--dp~~Rpt~~ell~h 275 (351)
+|||||||++|+|++|..||..... ......+. ......+....+++++++||.+|+.. +|..|+++.++++|
T Consensus 229 -~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 229 -CDWWSVGVILFEMLVGQPPFLAPTP--TETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred -cceeehhhHHHHHHhCCCCCcCCCH--HHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999999999999976542 22222222 22233444456899999999996654 55559999999999
Q ss_pred ccccCCcc
Q psy6327 276 AWIQNEPT 283 (351)
Q Consensus 276 p~~~~~~~ 283 (351)
|||+...+
T Consensus 306 p~f~~~~~ 313 (381)
T cd05626 306 PFFSEVDF 313 (381)
T ss_pred cccCCCCh
Confidence 99986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=375.89 Aligned_cols=260 Identities=28% Similarity=0.485 Sum_probs=213.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 37999999999999999999999999999999997665444334455668999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+.||+|.+++.. ...+++..++. ++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~l~~--~~~l~~~~~~~----------~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 81 EYLPGGDMMTLLMK--KDTFTEEETRF----------YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred CCCCCcHHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccc
Confidence 99999999999976 45666665443 6678888889999999999999999999999999999999998
Q ss_pred ccccCCcc--------------------------------------cccccccccceeccccccCCCCCCCcchHHHHHH
Q psy6327 167 RLLRTPKE--------------------------------------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGV 208 (351)
Q Consensus 167 ~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 208 (351)
+.+..... .....+||+.|+|||++....++.+ +|||||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~ 227 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGV 227 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchh
Confidence 75432110 1113469999999999988888765 99999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHhhhCc--cccccccccCCHhHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCc
Q psy6327 209 VLYRILNKKYPFGDPGTRNRDVLKKQEGK--EYLFNRKYEISIGAKQLIGRMLEPNPKHRPN---AKDVQNHAWIQNEP 282 (351)
Q Consensus 209 il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~~~~ 282 (351)
++|+|++|..||...+ ........... ....+....+++++++||.+||. +|.+|++ +.++++||||.+..
T Consensus 228 il~el~~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 228 IMYEMLVGYPPFCSDN--PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred HHHHhhcCCCCCCCCC--HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9999999999997654 22333322221 22334444689999999999997 9999998 99999999998654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=366.03 Aligned_cols=250 Identities=28% Similarity=0.481 Sum_probs=208.1
Q ss_pred cCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCCh
Q psy6327 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDL 94 (351)
Q Consensus 15 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL 94 (351)
||+|+||.||+|.+..+++.+|+|++.............+.+|+.++++++||||+++++++.+.+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999998765443333334455899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc
Q psy6327 95 EHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE 174 (351)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 174 (351)
.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~--~~~~~~~~~~----------~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 81 FHHLQR--EGRFDLSRAR----------FYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred HHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence 999976 4556665443 4667888899999999999999999999999999999999999986544334
Q ss_pred cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHH
Q psy6327 175 LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQL 254 (351)
Q Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (351)
.....+||+.|+|||++.+..++.+ +||||+||++|+|++|..||.+.. ..............+ +..+++++++|
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~l 223 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDEN--VNEMYRKILQEPLRF--PDGFDRDAKDL 223 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCC--HHHHHHHHHcCCCCC--CCcCCHHHHHH
Confidence 4456679999999999988887765 999999999999999999997644 333344433333333 33689999999
Q ss_pred HHHhcCCCCCCCC---CHHHHhcCccccCC
Q psy6327 255 IGRMLEPNPKHRP---NAKDVQNHAWIQNE 281 (351)
Q Consensus 255 i~~~L~~dp~~Rp---t~~ell~hp~~~~~ 281 (351)
|.+||+.||.+|| ++.++++||||...
T Consensus 224 i~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 224 LIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 9999999999997 57999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=369.70 Aligned_cols=258 Identities=27% Similarity=0.472 Sum_probs=213.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999997665443333445568999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++||+|.+++.. ...+++..++. ++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~--~~~l~~~~~~~----------~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 81 EYVPGGDFRTLLNN--LGVLSEDHARF----------YMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 99999999999976 45566655443 5678888889999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc--ccccc-
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE--YLFNR- 243 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~- 243 (351)
..... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+. .+......... ...+.
T Consensus 149 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 149 KGIVT---YANSVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTP--NETWENLKYWKETLQRPVY 222 (333)
T ss_pred ccccc---ccCCcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCH--HHHHHHHHhccccccCCCC
Confidence 86543 3345679999999999988887765 9999999999999999999976542 22222221111 11111
Q ss_pred ---cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 244 ---KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 244 ---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
...++.++.+||.+||+.+|.+||++.++++||||....
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 125699999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=365.68 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=209.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCcee-EEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-EEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETL-KACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT-YLY 83 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-~~~ 83 (351)
..+..+.+.||+|+||+||++.++ |+. +|+|++......... .+.+.+|+.+|.+|+|||||+++|++.+.. ..+
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 344556677999999999999987 555 999999877766555 566779999999999999999999999887 799
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC-ceeccCCCCCEeEcCCC-CeEEe
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG-IVHRDIKCENILISRLL-NAKLA 161 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~-i~H~Dlkp~NIll~~~~-~~kl~ 161 (351)
|||||+++|+|.+++.......++. ..++.++.||++||+|||+++ ||||||||+|||++.++ ++||+
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~----------~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPL----------KVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCH----------HHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEEC
Confidence 9999999999999997643444443 345678899999999999999 99999999999999997 99999
Q ss_pred eccccccccCCcccccccccccceecccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIR--NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
|||+++.............||+.|||||++. ...|+.+ +||||+|+++|||+||+.||.+... ............
T Consensus 187 DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~ 263 (362)
T KOG0192|consen 187 DFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGL 263 (362)
T ss_pred CCccceeeccccccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCC
Confidence 9999988765433344467999999999999 5577776 9999999999999999999987664 333333333333
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
....+..+++.+..|+.+||..||++||++.+++.
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 33334459999999999999999999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=363.43 Aligned_cols=264 Identities=26% Similarity=0.428 Sum_probs=206.0
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
-...+|++++.||+|+||.||+|.+..+++.+|+|++........ .....+|+.+++.++||||+++++++.++...+
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 345689999999999999999999999999999999865432221 223458999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+. ++|.+++... ...+++..++ .++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 80 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~----------~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Df 147 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKH-PGGLHPENVK----------LFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADF 147 (303)
T ss_pred EEEECCC-cCHHHHHHhC-CCCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCC
Confidence 9999996 7888888653 3445554433 46778899999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh---Cc---
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---GK--- 237 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~--- 237 (351)
|+++.............||+.|+|||++.+......++||||+||++|+|++|..||.+..... ....... ..
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 226 (303)
T cd07869 148 GLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLERIFLVLGTPNE 226 (303)
T ss_pred CcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhCCCCh
Confidence 9997654443344456789999999998765433345899999999999999999997643211 1111100 00
Q ss_pred ---------------cccc--c-------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 238 ---------------EYLF--N-------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 238 ---------------~~~~--~-------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.+.. + .....+.++.+||.+||++||.+|||+.|+++||||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0000 0 0112457899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=376.27 Aligned_cols=259 Identities=29% Similarity=0.436 Sum_probs=211.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|+++++||+|+||.||+|.+..+++.+|+|++.............+.+|+.++++++||||+++++.+.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58999999999999999999999999999999976654444445566689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
||+||+|.+++.+ ...+++..++. ++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~----------~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARF----------YIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHH----------HHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 9999999999976 45566665443 56678888889999999999999999999999999999999975
Q ss_pred cccCCc-----------------------------------------------ccccccccccceeccccccCCCCCCCc
Q psy6327 168 LLRTPK-----------------------------------------------ELSNTFCGTTSYAAPEIIRNSPYNPKL 200 (351)
Q Consensus 168 ~~~~~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 200 (351)
...... ......+||+.|+|||++.+..++.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~- 228 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL- 228 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-
Confidence 321100 01123579999999999988888865
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--ccccccccccCCHhHHHHHHHhcCCCCCCCCC---HHHHhcC
Q psy6327 201 ADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPN---AKDVQNH 275 (351)
Q Consensus 201 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~h 275 (351)
+||||+||++|+|++|+.||...+ .......+.. .....+....+++++.++|.+|+ .+|.+|++ +.++++|
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQT--PLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCC--HHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999999999999997654 2222222222 22333444578999999999987 59999997 9999999
Q ss_pred ccccCCc
Q psy6327 276 AWIQNEP 282 (351)
Q Consensus 276 p~~~~~~ 282 (351)
|||+...
T Consensus 306 p~f~~~~ 312 (382)
T cd05625 306 PFFKTID 312 (382)
T ss_pred CCcCCcC
Confidence 9998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=366.95 Aligned_cols=253 Identities=28% Similarity=0.482 Sum_probs=209.3
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKK 92 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg 92 (351)
+.||+|+||.||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997655433333344558999999999999999999999999999999999999
Q ss_pred ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCC
Q psy6327 93 DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP 172 (351)
Q Consensus 93 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 172 (351)
+|.+++.. ...+++..+. .++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~--~~~l~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 81 ELFFHLSR--ERVFSEDRTR----------FYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 99998876 4556665544 35678888999999999999999999999999999999999998764333
Q ss_pred cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHH
Q psy6327 173 KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252 (351)
Q Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (351)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+ ..............+ +..++.++.
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~~--p~~~~~~~~ 223 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEDIKF--PRTLSADAK 223 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCC--HHHHHHHhccCCccC--CCCCCHHHH
Confidence 333445679999999999988887765 999999999999999999997644 333333333333333 346899999
Q ss_pred HHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 253 QLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 253 ~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
+||.+||+.||++|+ ++.++++||||.+..
T Consensus 224 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 224 SLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999997 899999999997653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=365.95 Aligned_cols=253 Identities=30% Similarity=0.489 Sum_probs=209.0
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKK 92 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg 92 (351)
+.||+|+||.||++.+..+|..||+|++.............+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997655433333344458999999999999999999999999999999999999
Q ss_pred ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCC
Q psy6327 93 DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP 172 (351)
Q Consensus 93 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 172 (351)
+|..++.. ...+++.... .++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 81 ELFFHLSR--ERVFTEERAR----------FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 99998876 4556665544 35678888999999999999999999999999999999999998764333
Q ss_pred cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHH
Q psy6327 173 KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252 (351)
Q Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (351)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+ ..............+ +..+++++.
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~~~~~~~~~--p~~~~~~~~ 223 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILMEEIRF--PRTLSPEAK 223 (323)
T ss_pred CCccccccCCcCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCCCC--CCCCCHHHH
Confidence 333445679999999999988888765 999999999999999999997644 233333333333322 336899999
Q ss_pred HHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 253 QLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 253 ~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
+||.+||+.||++|+ ++.++++||||.+..
T Consensus 224 ~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 224 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999998 899999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=372.69 Aligned_cols=262 Identities=30% Similarity=0.463 Sum_probs=214.2
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++++.||+|+||.||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45799999999999999999999999999999999765544333344556899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++||+|.+++.. ..+++.... .++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 122 ~Ey~~gg~L~~~l~~---~~l~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 122 MEYMPGGDLVNLMSN---YDIPEKWAR----------FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHH----------HHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 999999999999865 345554433 3567888999999999999999999999999999999999999
Q ss_pred cccccCCcc-cccccccccceeccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--cc
Q psy6327 166 SRLLRTPKE-LSNTFCGTTSYAAPEIIRNSP----YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KE 238 (351)
Q Consensus 166 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~ 238 (351)
+........ .....+||+.|+|||++.+.. ++. ++|||||||++|+|++|+.||...+. ......+.. ..
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~~~~ 265 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR-ECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMDHKNS 265 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCC-ceeeeehhHHHHHHHhCCCCcCCCCH--HHHHHHHHcCCCc
Confidence 987644322 234567999999999986543 444 49999999999999999999976542 233333322 22
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCcc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~~ 283 (351)
..++....+|.++++||.+||+.+|.+ |+|+.++++||||++..+
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 334444568999999999999999998 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=375.99 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=211.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
++|++++.||+|+||.||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987655443333455668999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|||+||+|.+++.+ ...+++..++. ++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 81 E~~~~g~L~~~i~~--~~~~~~~~~~~----------~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 81 DYIPGGDMMSLLIR--LGIFEEDLARF----------YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 99999999999976 45566655443 5667888889999999999999999999999999999999997
Q ss_pred ccccCCc-------------------------------------------ccccccccccceeccccccCCCCCCCcchH
Q psy6327 167 RLLRTPK-------------------------------------------ELSNTFCGTTSYAAPEIIRNSPYNPKLADI 203 (351)
Q Consensus 167 ~~~~~~~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 203 (351)
..+.... ......+||+.|+|||++.+..++.+ +||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di 227 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDW 227 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eee
Confidence 5321000 00123579999999999988888765 999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--ccccccccccCCHhHHHHHHHhcCCCCCCCC---CHHHHhcCccc
Q psy6327 204 WSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KEYLFNRKYEISIGAKQLIGRMLEPNPKHRP---NAKDVQNHAWI 278 (351)
Q Consensus 204 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~ell~hp~~ 278 (351)
|||||++|+|++|+.||..... .+....... .....+....++.++.+||.+|+ .+|.+|+ |+.++++||||
T Consensus 228 wSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~ 304 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTP--AETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF 304 (376)
T ss_pred eeccceeeehhhCCCCCCCCCH--HHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence 9999999999999999976542 222222222 22233344468999999999987 5999999 99999999999
Q ss_pred cCCc
Q psy6327 279 QNEP 282 (351)
Q Consensus 279 ~~~~ 282 (351)
+...
T Consensus 305 ~~~~ 308 (376)
T cd05598 305 KGID 308 (376)
T ss_pred CCCC
Confidence 8643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=349.79 Aligned_cols=264 Identities=28% Similarity=0.504 Sum_probs=213.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCC-ceeeeeEEEeCC----
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN-IIGVHRMVKAGT---- 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~---- 80 (351)
+..|..+++||+|+||+||+|.++.+|+.||+|++......+ .......+|+.+++.|+|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 345788999999999999999999999999999998765532 23444459999999999999 999999998877
Q ss_pred --EEEEEEecCCCCChHHHHHhhcc--CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 81 --YLYMIMDYAEKKDLEHYISKACN--ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 81 --~~~lv~e~~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
.+++|+||++ .+|..++..... ..++... +..+++||+.||+|||+++|+||||||.||||++.|
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~----------ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G 157 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRL----------IKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG 157 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHH----------HHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC
Confidence 8999999997 999999987432 2344422 234788999999999999999999999999999999
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh-
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE- 235 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~- 235 (351)
.+||+|||+|+...-+.......++|.+|+|||++.+...+...+||||+|||++||+++++-|.+.+. .+.+..+-
T Consensus 158 ~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~ 235 (323)
T KOG0594|consen 158 VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFR 235 (323)
T ss_pred cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHH
Confidence 999999999998776666677788999999999999886555559999999999999999999976553 22222110
Q ss_pred --C-------------ccc--ccccc----------ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 236 --G-------------KEY--LFNRK----------YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 236 --~-------------~~~--~~~~~----------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
+ ..+ .++.. ...+.+..+++.+||+.+|.+|.|+..+|.||||...+.
T Consensus 236 ~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred HcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 0 000 01110 123458999999999999999999999999999987643
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=362.39 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=212.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC-CCceeeeeEEEeCCEEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH-PNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 86 (351)
+|++++.||+|+||.||+|.+..+++.+|+|++.............+..|+.++..+.| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999976554333333445589999999976 56889999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++||+|.+++.. ...+++... ..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~--~~~~~~~~~----------~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 81 EYVNGGDLMYHIQQ--VGKFKEPHA----------VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 99999999999976 455665543 346778899999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
.............+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.... .......+......+ +..
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~--~~~~~~~i~~~~~~~--~~~ 223 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGED--EDELFQSIMEHNVSY--PKS 223 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCC--CCC
Confidence 754333333445679999999999998888765 999999999999999999997644 334444444333333 336
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccCCc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNA-----KDVQNHAWIQNEP 282 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~ 282 (351)
++.++.+++.+||..||.+|++. .++++||||....
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 224 LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 89999999999999999999986 8999999998653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=372.58 Aligned_cols=259 Identities=28% Similarity=0.501 Sum_probs=209.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 68999999999999999999999999999999876554333334556689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++||+|.+++.. ...+++..++. ++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~gg~L~~~l~~--~~~~~~~~~~~----------~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 82 FLPGGDLMTMLIK--YDTFSEDVTRF----------YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHH----------HHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999999976 45666655443 56678888899999999999999999999999999999999986
Q ss_pred cccCCcc-----------------------------------------------cccccccccceeccccccCCCCCCCc
Q psy6327 168 LLRTPKE-----------------------------------------------LSNTFCGTTSYAAPEIIRNSPYNPKL 200 (351)
Q Consensus 168 ~~~~~~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 200 (351)
.+..... .....+||+.|+|||++.+..++.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~- 228 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE- 228 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-
Confidence 4321000 0012469999999999988888765
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--ccccccccccCCHhHHHHHHHhcCCCCCCC---CCHHHHhcC
Q psy6327 201 ADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KEYLFNRKYEISIGAKQLIGRMLEPNPKHR---PNAKDVQNH 275 (351)
Q Consensus 201 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---pt~~ell~h 275 (351)
+|||||||++|+|++|..||.... ..+....+.. ....++....++.++.+||.+||+ +|.+| +|+.++++|
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSEN--SHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCC--HHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999999999997644 2233333322 122334444689999999999998 77765 599999999
Q ss_pred ccccCCc
Q psy6327 276 AWIQNEP 282 (351)
Q Consensus 276 p~~~~~~ 282 (351)
|||++..
T Consensus 306 p~~~~~~ 312 (377)
T cd05629 306 PFFRGVD 312 (377)
T ss_pred CCcCCCC
Confidence 9998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=362.71 Aligned_cols=253 Identities=30% Similarity=0.493 Sum_probs=208.3
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.++.+++.||+|++.............+..|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998765443322233444788888876 699999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|.+++.+ ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~--~~~l~~~~~~----------~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 81 GDLMFHIQK--SRRFDEARAR----------FYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred chHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 999999876 4566665443 4677888899999999999999999999999999999999999876443
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...+ .......+.......+ ..++.++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i~~~~~~~~--~~~~~~~ 223 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILNDEVVYP--TWLSQDA 223 (320)
T ss_pred CCCcccccccCccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCCCCCC--CCCCHHH
Confidence 3334455679999999999988877765 999999999999999999997654 3344444443333332 3589999
Q ss_pred HHHHHHhcCCCCCCCCCH------HHHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRPNA------KDVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rpt~------~ell~hp~~~~~~ 282 (351)
.+||.+||+.||.+||++ .++++||||+...
T Consensus 224 ~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 224 VDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred HHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999999998 8999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=354.73 Aligned_cols=265 Identities=27% Similarity=0.408 Sum_probs=231.2
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|.++++||+|+||.||+|.|+.+|+.+|||.++.+..-. .+..||.+|.+++.|+||++||.|-....++|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQ-----EIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQ-----EIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHH-----HHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 788999999999999999999999999999987665432 233899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
|..|++.+.++.. ++++.+..+.. +++..+.||+|||...-+|||||..|||++.+|..||+|||.|-.
T Consensus 110 CGAGSiSDI~R~R-~K~L~E~EIs~----------iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 110 CGAGSISDIMRAR-RKPLSEQEISA----------VLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred cCCCcHHHHHHHh-cCCccHHHHHH----------HHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccch
Confidence 9999999998753 67888776543 567889999999999999999999999999999999999999988
Q ss_pred ccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCC
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (351)
+...-...++.+|||.|||||++..-.|+.. +||||||++..||..|++||.+.......+. -....++.+..+..+|
T Consensus 179 LTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-IPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 179 LTDTMAKRNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-IPTKPPPTFKKPEEWS 256 (502)
T ss_pred hhhhHHhhCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccceeEe-ccCCCCCCCCChHhhh
Confidence 8776667788899999999999999999887 8999999999999999999988765433222 2334556677777899
Q ss_pred HhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccccCCHHH
Q psy6327 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEE 291 (351)
Q Consensus 249 ~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~ 291 (351)
+++.|||++||-++|++|.|+.++++|||+++.+.|.-+....
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I 299 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMI 299 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHH
Confidence 9999999999999999999999999999999999887655433
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=362.32 Aligned_cols=256 Identities=28% Similarity=0.439 Sum_probs=209.6
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHH---HhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDIL---LKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l---~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999765533322233444666655 566799999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++|++|..++.. ..+++.... .++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~----------~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAV----------FYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHH----------HHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccC
Confidence 999999999988854 456655443 4677888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
++............+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... .......+.......+ .
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~--~~~~~~~i~~~~~~~p--~ 222 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDD--EEEVFDSIVNDEVRYP--R 222 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCC--C
Confidence 8765444444456789999999999988887765 999999999999999999997654 3344444443333333 3
Q ss_pred cCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
.++..+.+||.+||+.||.+|| ++.++++||||++..
T Consensus 223 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 223 FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 6899999999999999999999 699999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-50 Score=369.51 Aligned_cols=260 Identities=31% Similarity=0.510 Sum_probs=216.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 69999999999999999999999999999999986655443334556689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++|++|.+++.. ...+++...+. ++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~~~L~~~l~~--~~~l~~~~~~~----------i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 82 YMPGGDLMNLLIR--KDVFPEETARF----------YIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCK 149 (350)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence 9999999999976 35666655443 56788888999999999999999999999999999999999998
Q ss_pred cccCCc-----------------------------ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCC
Q psy6327 168 LLRTPK-----------------------------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKY 218 (351)
Q Consensus 168 ~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 218 (351)
...... .......||+.|+|||++.+..++.. +|||||||++|+|++|+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFP 228 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCC
Confidence 765433 12335679999999999998887766 999999999999999999
Q ss_pred CCCCCCCCchHHHHhhhC--ccccccccccCCHhHHHHHHHhcCCCCCCCCC-HHHHhcCccccCCcc
Q psy6327 219 PFGDPGTRNRDVLKKQEG--KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPN-AKDVQNHAWIQNEPT 283 (351)
Q Consensus 219 pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~ell~hp~~~~~~~ 283 (351)
||.... .......+.. .....+....+++++.+||.+||. ||.+||+ +.++++||||++..+
T Consensus 229 Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 229 PFYSDT--LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred CCCCCC--HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 997655 2333333332 223344444579999999999998 9999999 999999999986543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=369.67 Aligned_cols=261 Identities=26% Similarity=0.462 Sum_probs=213.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.+..+++.+|+|++.............+.+|+.++..++||||+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36899999999999999999999999999999997655444444556668999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++||+|.+++.+ ...+++..++. ++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~--~~~l~~~~~~~----------~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 81 EFLPGGDMMTLLMK--KDTLSEEATQF----------YIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred eCCCCccHHHHHHh--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCC
Confidence 99999999999976 45666655443 5678888889999999999999999999999999999999998
Q ss_pred ccccCCc-----------------------------------ccccccccccceeccccccCCCCCCCcchHHHHHHHHH
Q psy6327 167 RLLRTPK-----------------------------------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLY 211 (351)
Q Consensus 167 ~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 211 (351)
+...... ......+||+.|+|||++.+..++.. +|||||||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvily 227 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMY 227 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceee
Confidence 7543211 01124579999999999988888765 99999999999
Q ss_pred HHHhCCCCCCCCCCCchHHHHhhhC--ccccccccccCCHhHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCcc
Q psy6327 212 RILNKKYPFGDPGTRNRDVLKKQEG--KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPN---AKDVQNHAWIQNEPT 283 (351)
Q Consensus 212 ~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~~~~~ 283 (351)
+|++|..||..... ......+.. ....++....++.++++||.+|+. ||.+|++ +.++++||||++..+
T Consensus 228 el~tG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 228 EMLIGYPPFCSETP--QETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred ecccCCCCCCCCCH--HHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 99999999976542 233333322 223344444689999999999875 9999984 899999999987644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=368.89 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=211.9
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++++.||+|+||.||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 45799999999999999999999999999999998765444333344566899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++||+|.+++.. ..+++.... .++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 122 ~Ey~~gg~L~~~l~~---~~~~~~~~~----------~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 122 MEYMPGGDLVNLMSN---YDVPEKWAK----------FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHH----------HHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999965 345554433 3567888899999999999999999999999999999999999
Q ss_pred cccccCCcc-cccccccccceeccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--cc
Q psy6327 166 SRLLRTPKE-LSNTFCGTTSYAAPEIIRNSP----YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KE 238 (351)
Q Consensus 166 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~ 238 (351)
+........ .....+||+.|+|||++.+.. ++. ++|+||+||++|+|++|..||...+. ......+.. ..
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~~DiwSlG~ilyell~G~~Pf~~~~~--~~~~~~i~~~~~~ 265 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR-ECDWWSVGVFLFEMLVGDTPFYADSL--VGTYSKIMDHKNS 265 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCc-ccCEEeehHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCcc
Confidence 987643322 234667999999999987543 344 49999999999999999999976542 223333322 22
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~ 282 (351)
..++....++..++++|.+||+.++.+ |+|+.++++||||+...
T Consensus 266 ~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 266 LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 344454578999999999999865544 89999999999998643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=353.19 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=205.9
Q ss_pred cCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCCh
Q psy6327 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDL 94 (351)
Q Consensus 15 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL 94 (351)
||+|+||+||++.+..+++.+|+|.+.............+..|+.+++.++||||+++++++..+...|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998765544333334455899999999999999999999999999999999999999
Q ss_pred HHHHHhh--ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCC
Q psy6327 95 EHYISKA--CNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP 172 (351)
Q Consensus 95 ~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 172 (351)
.+++... ....+++... +.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~----------~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRA----------CFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHH----------HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 9887542 1234555443 346778889999999999999999999999999999999999999876554
Q ss_pred cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc--hHHHHhhhCccccccccccCCHh
Q psy6327 173 KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN--RDVLKKQEGKEYLFNRKYEISIG 250 (351)
Q Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~ 250 (351)
........||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||...+... ........... ...+..++.+
T Consensus 151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 227 (280)
T cd05608 151 QSKTKGYAGTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--VTYPDKFSPA 227 (280)
T ss_pred CccccccCCCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC--CCCcccCCHH
Confidence 444455679999999999998888765 999999999999999999997644221 11111111111 1223468999
Q ss_pred HHHHHHHhcCCCCCCCC-----CHHHHhcCccccCC
Q psy6327 251 AKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNE 281 (351)
Q Consensus 251 ~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~ 281 (351)
+.+++.+||+.||++|| |++++++||||++.
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=365.93 Aligned_cols=260 Identities=31% Similarity=0.539 Sum_probs=229.0
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE-EE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY-LY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~-~~ 83 (351)
.+.+|..++++|+|+||.++++.++.+++.+++|++........... ....|+.+++++.|||||.+.+.|..++. ++
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~-~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR-SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH-HHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 46789999999999999999999999999999999998887665544 44489999999999999999999988887 99
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
|||+||+||+|.+.|++.+...+++..+..| +.|++.|++|||+++|+|||||+.|||++.++.|||+||
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~----------~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDf 150 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKW----------FVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDF 150 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHH----------HHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecch
Confidence 9999999999999999887788898877665 455666677999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+|+.+.++.....+.+|||.||.||++.+.+|+.+ +|||||||++|||++-+++|...+.. ....++.... ..+.
T Consensus 151 GlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~--~Li~ki~~~~-~~Pl 226 (426)
T KOG0589|consen 151 GLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMS--ELILKINRGL-YSPL 226 (426)
T ss_pred hhhhhcCCchhhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchH--HHHHHHhhcc-CCCC
Confidence 999999888778889999999999999999999987 99999999999999999999876643 2333332222 4555
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
+...+.+++.+|..||+.+|..||++.++|.+|.++
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 667899999999999999999999999999999876
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=361.67 Aligned_cols=254 Identities=28% Similarity=0.532 Sum_probs=207.9
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999766554443344566899999998 699999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|.+++.+ ...+++..+. .++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~--~~~l~~~~~~----------~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 81 GDLMFHMQR--QRKLPEEHAR----------FYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 999998876 4567765544 4677888899999999999999999999999999999999999875433
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc-------hHHHHhhhCcccccccc
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN-------RDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~ 244 (351)
........+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||....... ............. .+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~p 225 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IP 225 (329)
T ss_pred CCCccccccCCccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--CC
Confidence 3444456789999999999988887765 999999999999999999996432111 1122222222222 23
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCC------HHHHhcCccccCC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPN------AKDVQNHAWIQNE 281 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt------~~ell~hp~~~~~ 281 (351)
..++..+.++|.+||+.||.+|+| ++++++||||...
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 368999999999999999999997 7899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=360.68 Aligned_cols=253 Identities=28% Similarity=0.497 Sum_probs=209.4
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.+..+++.+|+|++.............+..|+.++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999998765543333333444788888866 799999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|..++.. ...+++.... .++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 81 GDLMFQIQR--SRKFDEPRSR----------FYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999876 4556655433 3677888999999999999999999999999999999999999986544
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+ .......+.......+ ..++.++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~--~~~~~~~i~~~~~~~p--~~~~~~~ 223 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADN--EDDLFESILHDDVLYP--VWLSKEA 223 (321)
T ss_pred CCccccccccCccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCC--CCCCHHH
Confidence 4444556679999999999988887765 999999999999999999997654 3444444444433333 3578999
Q ss_pred HHHHHHhcCCCCCCCC-------CHHHHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRP-------NAKDVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rp-------t~~ell~hp~~~~~~ 282 (351)
.++|.+||+.||++|| ++.++++||||....
T Consensus 224 ~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 224 VSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 9999999999999999 899999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=363.65 Aligned_cols=253 Identities=29% Similarity=0.486 Sum_probs=208.6
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKK 92 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg 92 (351)
+.||+|+||.||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++++...+..|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997655433333344458999999999999999999999999999999999999
Q ss_pred ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 93 DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 93 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
+|..++.. ...+++..+. .++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~--~~~l~~~~~~----------~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 81 ELFFHLSR--ERVFSEDRAR----------FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred cHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 99998876 4556665543 356788889999998 7999999999999999999999999999876443
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... ..............+ +..++.++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~--~~~~~~~i~~~~~~~--p~~~~~~~ 223 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEEIRF--PRTLSPEA 223 (325)
T ss_pred CCcccccccCCcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCC--HHHHHHHHhcCCCCC--CCCCCHHH
Confidence 3333445679999999999988887765 999999999999999999997644 233333333333322 33689999
Q ss_pred HHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
.+||.+||+.||++|+ ++.++++||||.+..
T Consensus 224 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 224 KSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred HHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999999999997 899999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=359.58 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=213.6
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
+|++++.||+|+||.||+|.+..+++.+|+|++................|..++..+ +||+|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999765543333233344788888877 5899999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++|+|.+++.. ...+++..+ +.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~--~~~~~~~~~----------~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 81 EYVNGGDLMYQIQQ--VGRFKEPHA----------VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCCHHHHHHH--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCc
Confidence 99999999999876 455665443 346778899999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
+............+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+ .......+......++ ..
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~~~p--~~ 223 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEHNVAYP--KS 223 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCC--Cc
Confidence 765433334456679999999999998888765 999999999999999999997654 3344444443333333 36
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccCCcc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNA-----KDVQNHAWIQNEPT 283 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~~ 283 (351)
++.++.+++.+||+.||++|+++ .++++||||+...+
T Consensus 224 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 224 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 89999999999999999999984 89999999986543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=360.48 Aligned_cols=261 Identities=32% Similarity=0.504 Sum_probs=207.8
Q ss_pred ceeeeeecCcccceEEEEEEec---CCceeEEEEecchhhhh-hHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~ 82 (351)
+|++++.||+|+||.||++.+. .+++.+|+|++...... .......+.+|+.+++.+. ||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998764 57899999998754432 2222344558999999994 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||++||+|.+++.+ ...+++..+. .++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~----------~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVR----------FYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEee
Confidence 999999999999999976 4566665544 3567888888999999999999999999999999999999
Q ss_pred ccccccccCCc-ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc--hHHHHhhhCccc
Q psy6327 163 FGFSRLLRTPK-ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN--RDVLKKQEGKEY 239 (351)
Q Consensus 163 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~ 239 (351)
||+++...... ......+||+.|+|||++.+......++|||||||++|+|++|..||....... ............
T Consensus 149 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (332)
T cd05614 149 FGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP 228 (332)
T ss_pred CcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC
Confidence 99998653322 223456799999999999865533345999999999999999999996543221 122222222222
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
+.+..++..+.+||.+||+.||++|| +++++++||||++..
T Consensus 229 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 229 --PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 22346899999999999999999999 788999999998643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=353.64 Aligned_cols=257 Identities=27% Similarity=0.423 Sum_probs=202.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|+||.||+|.++.+++.+|+|++........ ....+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE-VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc-chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 69999999999999999999999999999999865433222 23445589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++++.+..+... ...+++..+. .++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~----------~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVR----------SYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 9997766655432 3455555433 467788899999999999999999999999999999999999998
Q ss_pred cccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHH-HhhhC---------
Q psy6327 168 LLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL-KKQEG--------- 236 (351)
Q Consensus 168 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~--------- 236 (351)
....... ......||+.|+|||++.+..++.+ +|+||+||++|+|++|++||...+....... .....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 149 NLSEGSNANYTEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred cccccccccccccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 7643222 2334578999999999988887765 9999999999999999999976442111000 00000
Q ss_pred ----c---ccccc-----------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 ----K---EYLFN-----------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 ----~---~~~~~-----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
. ....+ ....+|.++.+||.+||++||++|||++++++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 00000 011368889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=364.81 Aligned_cols=261 Identities=29% Similarity=0.429 Sum_probs=205.9
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|+.+++||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 4677999999999999999999999999999999985432 22223455689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++++|.+.. ...+.. ...++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 150 v~e~~~~~~L~~~~------~~~~~~----------~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG 213 (353)
T PLN00034 150 LLEFMDGGSLEGTH------IADEQF----------LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFG 213 (353)
T ss_pred EEecCCCCcccccc------cCCHHH----------HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccc
Confidence 99999999986532 122222 23467899999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRN----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
+++.............||+.|+|||++.. ..+...++|||||||++|+|++|+.||....................
T Consensus 214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 293 (353)
T PLN00034 214 VSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP 293 (353)
T ss_pred cceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC
Confidence 99876544433455679999999998753 23333459999999999999999999974332222111111111112
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
......++.++++||.+||+.||++|||+.|+++||||.....
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 2233468899999999999999999999999999999987543
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-49 Score=357.33 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=205.0
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.++.+|..+|+|.+................|..++..+ +||||+++++++.+.+..|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999765432222223344678887755 899999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|..++.. ...+++..+ ..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~--~~~~~~~~~----------~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 81 GDLMFHIQD--KGRFDLYRA----------TFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred CcHHHHHHH--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 999999876 445555443 34677889999999999999999999999999999999999999875433
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +||||+||++|+|++|..||...+ .......+....+..+ ..++.++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~--~~~~~~~~~~~~~~~~--~~~~~~~ 223 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDD--EDELFESIRVDTPHYP--RWITKES 223 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCC--CCCCHHH
Confidence 3333456779999999999988888765 999999999999999999997544 3333333333332222 3589999
Q ss_pred HHHHHHhcCCCCCCCCCH-HHHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRPNA-KDVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rpt~-~ell~hp~~~~~~ 282 (351)
++||.+||+.||++||++ +++++||||....
T Consensus 224 ~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 224 KDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 999999999999999998 5899999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=356.77 Aligned_cols=252 Identities=29% Similarity=0.492 Sum_probs=204.9
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.+..+++.||+|++................|..++..+ +||||+++++++..+...|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999765543322222333566776654 799999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~--~~~~~~~~~~----------~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQS--SGRFDEARAR----------FYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 999999976 4556665543 3567888899999999999999999999999999999999999986544
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +||||+||++|+|++|..||.+.+ .......+....+.. +..++.++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~~~~~--~~~~~~~~ 223 (316)
T cd05592 149 GEGKASTFCGTPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGED--EDELFDSILNDRPHF--PRWISKEA 223 (316)
T ss_pred CCCccccccCCccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCC--CCCCCHHH
Confidence 4444456789999999999988887765 999999999999999999997654 333443333332222 33689999
Q ss_pred HHHHHHhcCCCCCCCCCHH-HHhcCccccCC
Q psy6327 252 KQLIGRMLEPNPKHRPNAK-DVQNHAWIQNE 281 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rpt~~-ell~hp~~~~~ 281 (351)
.+||.+||+.||++||++. ++++||||...
T Consensus 224 ~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 224 KDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 9999999999999999864 88899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=348.48 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=203.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----CEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG-----TYL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~ 82 (351)
.|.-.+++|.|+||.||+|....++..+|||++-.+..... +|+++|+.++|||||++.-+|... -..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn-------rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN-------RELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc-------HHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 47789999999999999999999999999999865554332 899999999999999999888432 246
Q ss_pred EEEEecCCCCChHHHHHhh--ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-CCeE
Q psy6327 83 YMIMDYAEKKDLEHYISKA--CNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-LNAK 159 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~-~~~k 159 (351)
.+||||++ .+|.+.++.. .+..++...++ -|..||++||.|||+.||+||||||.|+|+|.+ |.+|
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iK----------LYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIK----------LYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeH----------HHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEE
Confidence 79999998 9999999853 13344443333 378899999999999999999999999999986 8899
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH-------
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK------- 232 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------- 232 (351)
|||||.|+.+...... .++.-|..|+|||++.+...++.+.||||.||++.||+-|++-|.+.+..++....
T Consensus 167 icDFGSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred eccCCcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 9999999987654443 66677999999999998887666799999999999999999999876543221111
Q ss_pred ------hhhCc--ccccc----------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 233 ------KQEGK--EYLFN----------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 233 ------~~~~~--~~~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.+... ...++ ....+++++.+|+.++|+++|++|.++.|++.||||..-
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 11110 00000 112468899999999999999999999999999999643
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=362.31 Aligned_cols=260 Identities=29% Similarity=0.434 Sum_probs=213.0
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|+||.||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 68999999999999999999999999999999987665444445666789999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++||+|.+++.+. ...+++..... ++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~~~L~~~l~~~-~~~l~~~~~~~----------~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 82 YQPGGDLLSLLNRY-EDQFDEDMAQF----------YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred CCCCCCHHHHHHHh-cCCCCHHHHHH----------HHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCe
Confidence 99999999999763 24566665443 56678888899999999999999999999999999999999998
Q ss_pred cccCCcc-cccccccccceecccccc------CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--cc
Q psy6327 168 LLRTPKE-LSNTFCGTTSYAAPEIIR------NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KE 238 (351)
Q Consensus 168 ~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~ 238 (351)
....... ......||+.|+|||++. ...++.+ +|||||||++|+|++|..||.... .......+.. ..
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i~~~~~~ 227 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE-CDWWSLGVIAYEMIYGRSPFHEGT--SAKTYNNIMNFQRF 227 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCc-ceeecccceeeeeccCCCCCCCCC--HHHHHHHHHcCCCc
Confidence 7654332 223457999999999986 3344444 999999999999999999997544 2222222221 12
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
..++....++.++.+||.+||+ ||.+|||+.++++||||....
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 228 LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 2334445689999999999998 999999999999999998643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=363.61 Aligned_cols=262 Identities=28% Similarity=0.452 Sum_probs=211.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++++.||+|+||.||+|.++.+++.+|+|++.............+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 35799999999999999999999999999999998765544333344566899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++||+|.+++.. ..+++.... .++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 122 ~Ey~~gg~L~~~~~~---~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 122 MEYMPGGDLVNLMSN---YDVPEKWAR----------FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHH----------HHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999865 345554433 3667888999999999999999999999999999999999999
Q ss_pred cccccCCcc-cccccccccceeccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--cc
Q psy6327 166 SRLLRTPKE-LSNTFCGTTSYAAPEIIRNSP----YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KE 238 (351)
Q Consensus 166 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~ 238 (351)
++....... .....+||+.|+|||++.+.. ++. ++|||||||++|+|++|..||...+. ......+.. ..
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~-~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~ 265 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR-ECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMNHKNS 265 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCC-ccceeehhHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCc
Confidence 987654322 234567999999999987543 444 49999999999999999999976542 233333322 22
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCcc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~~ 283 (351)
..++....++..+++||.+||+.++.+ |+++.++++||||++..+
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 334455578999999999999844443 789999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=357.34 Aligned_cols=253 Identities=32% Similarity=0.506 Sum_probs=206.8
Q ss_pred eeecCcccceEEEEEEec---CCceeEEEEecchhhhhhH-HHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 12 ISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLKRD-YMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
++.||+|+||.||+|.+. .+++.+|+|++........ .....+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999864 5789999999876543221 223345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++|++|.+++.. ...+.+.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~----------~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 81 YLSGGELFMHLER--EGIFMEDTAC----------FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148 (323)
T ss_pred CCCCchHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence 9999999999976 4555554433 356788899999999999999999999999999999999999987
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
............+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... ............. ..+..+
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~--~~~~~~~~~~~~~--~~~~~~ 223 (323)
T cd05584 149 ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAEN--RKKTIDKILKGKL--NLPPYL 223 (323)
T ss_pred ecccCCCcccccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC--CCCCCC
Confidence 64444444455679999999999988777665 999999999999999999997654 2333333333332 233468
Q ss_pred CHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCC
Q psy6327 248 SIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNE 281 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~ 281 (351)
++++.+||.+||+.||++|| ++.++++||||...
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=356.67 Aligned_cols=253 Identities=30% Similarity=0.525 Sum_probs=209.5
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.+..+++.+|+|++...............+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999766543333334445788999888 699999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|.+++.+ ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~----------~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 81 GDLMFHIQR--SGRFDEPRAR----------FYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred CCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 999999876 4566665543 4567888899999999999999999999999999999999999875433
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +|+||+||++|+|++|..||...+ .......+.......+ ..++..+
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~--~~~~~~~i~~~~~~~~--~~~~~~~ 223 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDD--EDELFQSILEDEVRYP--RWLSKEA 223 (318)
T ss_pred CCCcccceecCccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcCCCCCC--CcCCHHH
Confidence 3334445679999999999998888765 999999999999999999997544 3344444433333333 3689999
Q ss_pred HHHHHHhcCCCCCCCCCH-----HHHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRPNA-----KDVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~ 282 (351)
.+||.+||+.||++|||+ .++++||||+...
T Consensus 224 ~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 224 KSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999999999 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=357.10 Aligned_cols=257 Identities=31% Similarity=0.547 Sum_probs=227.4
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|.+.+.||+|-|++|-+|.|.-+|..||||++++..+......+.+ .|+.-|+.++|||||++|++..+...+|+|+|.
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlf-qEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLF-QEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHH-HHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 6778899999999999999999999999999998887766656666 899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc-CCCCeEEeeccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS-RLLNAKLADFGFSR 167 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~-~~~~~kl~Dfg~a~ 167 (351)
-+||+|++||-++ ...+.|..++ +|+.||+.|+.|+|+..+|||||||+||.+- .-|-+||+|||++.
T Consensus 99 GD~GDl~DyImKH-e~Gl~E~La~----------kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH-EEGLNEDLAK----------KYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred cCCchHHHHHHhh-hccccHHHHH----------HHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence 9999999999875 4566766655 4667777778899999999999999998764 56889999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.+.+ +....+.||+..|-|||++.+..|+..++||||||+|||.|.||++||...+ +.+.+..+....|..|. .+
T Consensus 168 kf~P-G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN--DSETLTmImDCKYtvPs--hv 242 (864)
T KOG4717|consen 168 KFQP-GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN--DSETLTMIMDCKYTVPS--HV 242 (864)
T ss_pred cCCC-cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc--chhhhhhhhcccccCch--hh
Confidence 7654 4445678999999999999999999999999999999999999999998766 56777777777777665 78
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
|.+++|||.+||..||.+|.+.++|..|+|++...
T Consensus 243 S~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 243 SKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred hHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 99999999999999999999999999999998654
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=358.85 Aligned_cols=255 Identities=29% Similarity=0.546 Sum_probs=206.9
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.+..+++.+|+|++.............+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999766544433344556889888877 799999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|..++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~----------~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 81 GDLMFHMQR--QRKLPEEHAR----------FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 999998876 4566665544 3567888889999999999999999999999999999999999976444
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC------ch-HHHHhhhCcccccccc
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR------NR-DVLKKQEGKEYLFNRK 244 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~-~~~~~~~~~~~~~~~~ 244 (351)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...... .. ............. +
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~--p 225 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--P 225 (329)
T ss_pred CCCccccccCCccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC--C
Confidence 3444456789999999999988887765 99999999999999999999532211 11 1222222222222 3
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCC------HHHHhcCccccCCc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPN------AKDVQNHAWIQNEP 282 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt------~~ell~hp~~~~~~ 282 (351)
..++..+.+||.+||+.||++||+ +.++++||||++..
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 368899999999999999999998 57999999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=358.24 Aligned_cols=253 Identities=31% Similarity=0.540 Sum_probs=205.6
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHH-HHHhCCCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREID-ILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||+||+|.+..+|+.+|+|++.............+..|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999997655433322233334544 56789999999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|.+++.. ...+++.... .++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~----------~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 81 GELFFHLQR--ERSFPEPRAR----------FYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 999999876 4566665543 3677888999999999999999999999999999999999999876444
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+ .............. ....++..+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~--~~~~~~~~~ 223 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRD--TAEMYDNILNKPLR--LKPNISVSA 223 (323)
T ss_pred CCCccccccCChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCC--HHHHHHHHHcCCCC--CCCCCCHHH
Confidence 3444456679999999999988887765 999999999999999999997644 33333333333322 233679999
Q ss_pred HHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRPNA----KDVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rpt~----~ell~hp~~~~~~ 282 (351)
.++|.+||+.||.+||++ .++++||||....
T Consensus 224 ~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 224 RHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred HHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999999997 6999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=349.92 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=211.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|++.++||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999876555444334445589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+.||+|.+++.......+++.... .++.|++.||.|||+.|++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~----------~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAV----------FYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHH----------HHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999998865434456665433 467788889999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch--HHHHhhhCccccccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR--DVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 245 (351)
...... .....+|++.|+|||++.+..++.. +|+||+||++|+|++|..||.+...... .......... ...+.
T Consensus 151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 226 (285)
T cd05605 151 EIPEGE-TIRGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--EEYSE 226 (285)
T ss_pred ecCCCC-ccccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--cccCc
Confidence 654322 2234578999999999988777765 8999999999999999999976442111 1111121111 12233
Q ss_pred cCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCC
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNE 281 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~ 281 (351)
.++..+.+||.+||+.||++|| ++.++++||||...
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 5899999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=345.49 Aligned_cols=261 Identities=28% Similarity=0.501 Sum_probs=227.6
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh-HHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR-DYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+.+|.++++||+|.||.|.+|+.+.+++.||+|++.+..+-. +.....+ -|-++|+..+||.+..+--.|.+.+++|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTl-TE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTL-TENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhh-hHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 567999999999999999999999999999999998776643 3333443 79999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||.+||.|+-++.. ...+++..++. |..+|..||.|||+++|++||||.+|+|+|.+|++||+|||
T Consensus 246 VMeyanGGeLf~HLsr--er~FsE~RtRF----------YGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR--ERVFSEDRTRF----------YGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred EEEEccCceEeeehhh--hhcccchhhhh----------hhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecc
Confidence 9999999999999977 67788887776 45567777779999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+++.--.......+.||||.|.|||++....|+.. +|.|.+|+++|||+||+.||...+ ....+..+......+|.
T Consensus 314 LCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~d--h~kLFeLIl~ed~kFPr- 389 (516)
T KOG0690|consen 314 LCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKD--HEKLFELILMEDLKFPR- 389 (516)
T ss_pred cchhcccccceeccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccc--hhHHHHHHHhhhccCCc-
Confidence 99876666677889999999999999998888865 999999999999999999997655 45555555555555555
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCccc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEPTC 284 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~~ 284 (351)
.++++++.|+..+|.+||.+|.. +.+|.+|+||.+..|.
T Consensus 390 -~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 390 -TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred -cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 79999999999999999999974 8899999999877653
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=355.12 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=205.5
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.+..+++.||+|++................|..++..+ +||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999998765432222223334677787764 899999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|.+++.+ ...+++.... .++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~----------~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 81 GDLMFHIQS--CHKFDLPRAT----------FYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 999999976 3455554433 4677888999999999999999999999999999999999999875433
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +||||+||++|+|++|..||...+ ...............+ ..++.++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~--~~~~~~~i~~~~~~~~--~~~~~~~ 223 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHD--EEELFQSIRMDNPCYP--RWLTREA 223 (316)
T ss_pred CCCceeeecCCccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCC--ccCCHHH
Confidence 3333455679999999999988887765 999999999999999999997654 3344444333333222 3588999
Q ss_pred HHHHHHhcCCCCCCCCCHH-HHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRPNAK-DVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rpt~~-ell~hp~~~~~~ 282 (351)
++||.+||+.||++||++. ++++||||+...
T Consensus 224 ~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 224 KDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 9999999999999999996 899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=354.18 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=206.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++++.||+|+||.||++.+..++..+|+|.+..... ......+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3579999999999999999999999999999999865422 12234456899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||++|++|.+++.. ...+++.... .++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 82 ~e~~~~~~L~~~l~~--~~~~~~~~~~----------~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 82 MEHMDGGSLDQVLKE--AKRIPEEILG----------KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred eecCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCc
Confidence 999999999999976 3455554433 4567888899999986 69999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH------------
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK------------ 232 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------------ 232 (351)
++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............
T Consensus 150 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (331)
T cd06649 150 VSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEP 226 (331)
T ss_pred cccccccc--ccccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCc
Confidence 98765332 2345579999999999988887765 99999999999999999999654321110000
Q ss_pred --------------------------------hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 233 --------------------------------KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 233 --------------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.+............++.++++||.+||++||++|||+.++++||||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 000000000011246789999999999999999999999999999985
Q ss_pred C
Q psy6327 281 E 281 (351)
Q Consensus 281 ~ 281 (351)
.
T Consensus 307 ~ 307 (331)
T cd06649 307 S 307 (331)
T ss_pred c
Confidence 4
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=353.92 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=211.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 86 (351)
+|++.+.||+|+||.||+|.++.+++.||+|++.............+..|+.++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999987655433333344457888888886 578889999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++||+|.+++.. ...+++..+ +.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~i~~--~~~l~~~~~----------~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 81 EYVNGGDLMYHIQQ--VGKFKEPQA----------VFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccc
Confidence 99999999999976 455666554 346778888999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
+............+||+.|+|||++.+..++.+ +|+||+||++|+|++|..||.... .......+....... +..
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~--~~~~~~~i~~~~~~~--p~~ 223 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGED--EDELFQSIMEHNVSY--PKS 223 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCC--Ccc
Confidence 865443334455679999999999988887765 999999999999999999997654 333333333333322 336
Q ss_pred CCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEP 282 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~ 282 (351)
++.++.+++.+||+.||.+|++ ..++++||||+...
T Consensus 224 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 224 LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 8999999999999999999997 47899999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=353.62 Aligned_cols=255 Identities=27% Similarity=0.505 Sum_probs=208.4
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.+..+++.+|+|++.............+.+|+.++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876554444445566899999888 599999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|..++.. ...+++..+. .++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~----------~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 81 GDLMFHMQR--QRKLPEEHAR----------FYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 999998876 4566665544 4677888889999999999999999999999999999999999976433
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC----Cc-hHHHHhhhCcccccccccc
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGT----RN-RDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~-~~~~~~~~~~~~~~~~~~~ 246 (351)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||..... .. ............. .+..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~ 225 (327)
T cd05617 149 PGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--IPRF 225 (327)
T ss_pred CCCceecccCCcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC--CCCC
Confidence 3344456789999999999988888765 9999999999999999999964221 11 1222222222222 2336
Q ss_pred CCHhHHHHHHHhcCCCCCCCCC------HHHHhcCccccCCc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPN------AKDVQNHAWIQNEP 282 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt------~~ell~hp~~~~~~ 282 (351)
++..+.++|.+||+.||.+|++ +.++++||||+...
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 8899999999999999999998 56999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=355.29 Aligned_cols=253 Identities=31% Similarity=0.518 Sum_probs=205.3
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHH-HHHhCCCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREID-ILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||+||+|.+..+|+.+|+|++.............+..|.. +++.++||||+++++++...+..|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433322333335554 56778999999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|..++.. ...+++..+.. ++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~----------~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 81 GELFFHLQR--ERSFPEPRARF----------YAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 999998876 45666665443 567888899999999999999999999999999999999999876443
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+ ............... ....+..+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~--~~~~~~~~~~~~~~~--~~~~~~~~ 223 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRD--VAEMYDNILHKPLVL--RPGASLTA 223 (325)
T ss_pred CCCCcccccCChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCC--HHHHHHHHHcCCccC--CCCCCHHH
Confidence 3344456679999999999988888765 999999999999999999997644 333333333332222 23688999
Q ss_pred HHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRPNA----KDVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rpt~----~ell~hp~~~~~~ 282 (351)
.++|.+||+.||.+||++ .+++.||||....
T Consensus 224 ~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 224 WSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred HHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999999986 5899999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=349.83 Aligned_cols=266 Identities=25% Similarity=0.428 Sum_probs=207.6
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
|-.+.+|+++++||+|+||.||+|.++.++..+|+|.+........ .....+|+.++++++||||+++++++..++..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence 5567889999999999999999999999999999999865433221 22344899999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||++ ++|.+++... ...++.... ..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~----------~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 80 TLVFEYLD-KDLKQYMDDC-GNIMSMHNV----------KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred EEEEeCCC-CCHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECc
Confidence 99999997 6888888653 233444433 34677888999999999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHH-HHhh-------
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV-LKKQ------- 234 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~------- 234 (351)
||+++.............+|+.|+|||++.+......++||||+||++|+|++|+.||...+...... ....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
T cd07872 148 FGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227 (309)
T ss_pred cccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99998654444334455789999999998764433345999999999999999999997654221100 0000
Q ss_pred --------------hCccc----cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 235 --------------EGKEY----LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 235 --------------~~~~~----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
....+ .......++.++++||.+||+.||.+|||+.|+++||||+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00000 0011125788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=357.00 Aligned_cols=253 Identities=30% Similarity=0.496 Sum_probs=203.3
Q ss_pred cCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC---CCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV---SHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 15 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
||+|+||+||+|.+..+++.+|+|++................|..++..+ .||||+++++++.+.+..|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998765543322222233567776655 699999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|.+++.+ ...+++..+. .++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~----------~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAK----------FYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 999999876 4566765544 3567888889999999999999999999999999999999999976544
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+......++|||||||++|+|++|..||.... .......+......++. ..+++++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~-~~~~~~~ 225 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--TQQMYRNIAFGKVRFPK-NVLSDEG 225 (330)
T ss_pred CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--HHHHHHHHHcCCCCCCC-ccCCHHH
Confidence 44445567899999999998765433345999999999999999999997644 33334444333333332 2579999
Q ss_pred HHHHHHhcCCCCCCCC----CHHHHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRP----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rp----t~~ell~hp~~~~~~ 282 (351)
.+||.+||+.||.+|| ++.++++||||....
T Consensus 226 ~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 226 RQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 9999999999999998 689999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=336.65 Aligned_cols=256 Identities=30% Similarity=0.456 Sum_probs=214.0
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
.+.||+|+|+.|-.|+...+|..||||++.+... .....+.||++++.+++ |+||+.++++|+++..+|+|||.|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 4679999999999999999999999999976632 22445559999999996 9999999999999999999999999
Q ss_pred CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC---eEEeeccccc
Q psy6327 91 KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN---AKLADFGFSR 167 (351)
Q Consensus 91 ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~---~kl~Dfg~a~ 167 (351)
||+|..+|.+ ...+.+..+.. +..+|+.||.|||.+||.||||||+|||..+... +|||||.+..
T Consensus 160 GGplLshI~~--~~~F~E~EAs~----------vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 160 GGPLLSHIQK--RKHFNEREASR----------VVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred CchHHHHHHH--hhhccHHHHHH----------HHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 9999999987 67788877655 5667788888999999999999999999977544 8999999876
Q ss_pred cccCCcc-------cccccccccceecccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC----------
Q psy6327 168 LLRTPKE-------LSNTFCGTTSYAAPEIIR----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR---------- 226 (351)
Q Consensus 168 ~~~~~~~-------~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------- 226 (351)
....... ...+.+|+..|||||++. ...++.+++|.||||+|+|-|++|.+||.+....
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 5432222 224678999999999852 3445566799999999999999999999654211
Q ss_pred ---chHHHHhhhCcccccccc--ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 227 ---NRDVLKKQEGKEYLFNRK--YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 227 ---~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
....+..+..+.|.||.. ..+|.+++|+|+.+|..|+.+|.++.++++|||++...
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 335667788888888865 36899999999999999999999999999999997643
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=353.51 Aligned_cols=253 Identities=32% Similarity=0.524 Sum_probs=204.4
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHH-HHHHhCCCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREI-DILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei-~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.+..+++.+|+|++.............+..|. .+++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999765543322222223444 456788999999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
++|.+++.. ...+.+..++ .++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~--~~~~~~~~~~----------~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 81 GELFYHLQR--ERCFLEPRAR----------FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 999999976 4556655443 3577889999999999999999999999999999999999999976544
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+ ............. .....++..+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~--~~~~~~~~~~ 223 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNILNKPL--QLKPNITNSA 223 (325)
T ss_pred CCCCcccccCCccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCC--HHHHHHHHHhCCc--CCCCCCCHHH
Confidence 3344456679999999999988887765 999999999999999999997644 3333333332222 2233689999
Q ss_pred HHHHHHhcCCCCCCCCCHH----HHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRPNAK----DVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rpt~~----ell~hp~~~~~~ 282 (351)
.++|.+||+.||.+|+++. ++++|+||....
T Consensus 224 ~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 224 RHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred HHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 9999999999999999876 899999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=354.97 Aligned_cols=252 Identities=31% Similarity=0.506 Sum_probs=206.7
Q ss_pred eeecCcccceEEEEEEe---cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 12 ISKLGEGAYGNVYLVSD---KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
++.||+|+||.||++.+ ..+|+.+|+|++......... .....+|+.++++++||||+++++++.+.+..|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRD-RVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhh-HHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 46799999999999876 367899999999765543322 22344799999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+++|+|.+++.+ ...+++..+. .++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~~L~~~l~~--~~~l~~~~~~----------~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 80 LRGGDLFTRLSK--EVMFTEEDVK----------FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 999999999976 4556665544 4567888889999999999999999999999999999999999987
Q ss_pred ccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCC
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (351)
...........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... .......+....... +..++
T Consensus 148 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~--~~~~~~~i~~~~~~~--p~~~~ 222 (318)
T cd05582 148 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKD--RKETMTMILKAKLGM--PQFLS 222 (318)
T ss_pred cCCCCCceecccCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCC--HHHHHHHHHcCCCCC--CCCCC
Confidence 5544344456679999999999988777765 999999999999999999997644 333333333333222 33689
Q ss_pred HhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCC
Q psy6327 249 IGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNE 281 (351)
Q Consensus 249 ~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~ 281 (351)
.++.+||.+||+.||++||+ +.++++||||...
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999999999999999999 7789999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=351.99 Aligned_cols=253 Identities=29% Similarity=0.511 Sum_probs=204.4
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHH-HHHHhCCCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREI-DILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei-~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
+.||+|+||.||+|.+..+++.+|+|++.............+.+|+ .+++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999766543333233333454 467889999999999999999999999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
++|...+.. ...+++..... ++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~----------~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 81 GELFFHLQR--ERCFLEPRARF----------YAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 999998865 45566655443 567888899999999999999999999999999999999999876433
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+ .............. .+...+..+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~--~~~~~~~~~ 223 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRD--VSQMYDNILHKPLQ--LPGGKTVAA 223 (321)
T ss_pred CCCccccccCCcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCC--HHHHHHHHhcCCCC--CCCCCCHHH
Confidence 3334455679999999999988888765 999999999999999999997654 23333333333222 223678899
Q ss_pred HHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q psy6327 252 KQLIGRMLEPNPKHRPNA----KDVQNHAWIQNEP 282 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rpt~----~ell~hp~~~~~~ 282 (351)
.++|.+||+.||.+||++ .++++||||....
T Consensus 224 ~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 224 CDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred HHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 999999999999999975 4999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=353.80 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=200.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----CEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG-----TYL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~ 82 (351)
+|++.++||+|+||.||+|.+..++..||+|.+......... ...+.+|+.+++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD-ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchh-HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 489999999999999999999999999999998643222222 23345899999999999999999988543 358
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+|||||. ++|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~lv~e~~~-~~L~~~l~~--~~~~~~~~~~----------~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 80 YVVFELME-SDLHQVIKA--NDDLTPEHHQ----------FFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred EEEEecCC-CCHHHHHHh--cccCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEcc
Confidence 99999995 799999876 4456655433 4677889999999999999999999999999999999999
Q ss_pred ccccccccCCcc---cccccccccceeccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchH--------
Q psy6327 163 FGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRN--SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD-------- 229 (351)
Q Consensus 163 fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------- 229 (351)
||+++....... .....+||+.|+|||++.+ ..++.+ +|||||||++|+|++|++||.+.......
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~ 225 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCch-hHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence 999986432221 2234679999999999865 455554 99999999999999999999754321100
Q ss_pred -----HHHh------------hhCccc--cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 230 -----VLKK------------QEGKEY--LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 230 -----~~~~------------~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
.... ...... .......++..+.++|.+||+.||++|||++++++||||++...
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000 000000 00111246788999999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=359.75 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=199.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|++++.||+|+||.||+|.+..+++.+|+|.... ..+.+|+.++++|+||||+++++++......++|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 469999999999999999999999999999996432 12348999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|++. ++|..++.. ...++... ++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 163 e~~~-~~L~~~l~~--~~~l~~~~----------~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 163 PRYK-TDLYCYLAA--KRNIAICD----------ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred ecCC-CCHHHHHHh--cCCCCHHH----------HHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 9996 889988876 34455443 3456788999999999999999999999999999999999999999
Q ss_pred ccccCC-cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-----chHHHHhh------
Q psy6327 167 RLLRTP-KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR-----NRDVLKKQ------ 234 (351)
Q Consensus 167 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~~~~------ 234 (351)
+..... .......+||+.|+|||++.+..++.+ +||||+||++|+|++|..||...... ....+..+
T Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred cccccccccccccccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 754322 122345679999999999988887765 99999999999999999887432110 00000000
Q ss_pred --------------------hCc-------cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 235 --------------------EGK-------EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 235 --------------------~~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
... ...+.....++.++.+||.+||+.||.+|||+.|+|+||||+..+
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 000 000011123567899999999999999999999999999998643
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=345.52 Aligned_cols=255 Identities=26% Similarity=0.431 Sum_probs=197.8
Q ss_pred ceeeeeecCcccceEEEEEEecC-CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC---CCCCceeeeeEEE-----e
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKR-SETLKACKAYDFKRLKRDYMEKFAPREIDILLKV---SHPNIIGVHRMVK-----A 78 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~-----~ 78 (351)
+|++++.||+|+||.||+|.+.. ++..+|+|.+.......... ....+|+.+++.+ +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch-HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 68999999999999999999854 57889999886544332221 2233677777766 6999999999985 3
Q ss_pred CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
...+++||||++ ++|.+++.......+++... ..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~----------~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETI----------KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCE
Confidence 457999999997 79999997644445555443 3467888999999999999999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc-
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK- 237 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~- 237 (351)
||+|||+++..... .......||+.|+|||++.+..++.+ +||||+||++|+|++|.+||.+... .+....+...
T Consensus 150 kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~--~~~~~~i~~~~ 225 (290)
T cd07862 150 KLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVI 225 (290)
T ss_pred EEccccceEeccCC-cccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHh
Confidence 99999999865433 33445678999999999988877765 9999999999999999999976542 2221111100
Q ss_pred ----cccc--------------------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 238 ----EYLF--------------------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 238 ----~~~~--------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
...+ .....++..+++||.+||+.||++|||+.++|+||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0000 0112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=342.88 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=209.5
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|++.+.||+|+||.||++.+..+++.+|+|.+.............+.+|+.++++++|++|+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 77889999999999999999999999999998765544433344455899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+.|++|.+++.......+++... +.++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~----------~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRA----------VFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHH----------HHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 99999999986543445555443 34677889999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHhhhCccccccccccC
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 247 (351)
..... ......|++.|+|||++.+..++.+ +|+||+||++|+|++|..||........ ........ .........+
T Consensus 152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 228 (285)
T cd05630 152 VPEGQ-TIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKF 228 (285)
T ss_pred cCCCc-cccCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCccC
Confidence 43322 2234579999999999988887765 9999999999999999999976432111 11111111 1111223367
Q ss_pred CHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCC
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNE 281 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~ 281 (351)
+.++++|+.+||+.||++||| +.++++||||+..
T Consensus 229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 889999999999999999999 8999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=348.70 Aligned_cols=263 Identities=29% Similarity=0.439 Sum_probs=227.6
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|+.-+.||+||||.||-|+-+.||+.||+|.+.+++++....+....+|-+||.+++.+.||.+--.|++.+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45788899999999999999999999999999999999988777777889999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
..|+||+|.-+|....+..+++..++. |+.+|+.||++||..+||+|||||+|||+|+.|+++|+|+|+|
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~F----------YAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARF----------YAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHH----------HHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence 999999999999887666888866544 7889999999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch--HHHHhhhCcccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR--DVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 244 (351)
..+...... .+.+||.+|||||++.+..|+.. .|.|||||++|+|+.|+.||........ ++-+........++
T Consensus 335 vei~~g~~~-~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~-- 410 (591)
T KOG0986|consen 335 VEIPEGKPI-RGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS-- 410 (591)
T ss_pred EecCCCCcc-ccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--
Confidence 987654443 44589999999999999998876 8999999999999999999987653322 22223333332333
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEPT 283 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 283 (351)
...|+++++|.+.+|++||++|.. +.++.+||||++.++
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 478999999999999999999985 669999999987654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=350.23 Aligned_cols=261 Identities=29% Similarity=0.462 Sum_probs=207.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||++.+..+++.||+|++.............+.+|+.++..++||||+++++++.+++++|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 69999999999999999999999999999999876444333334556689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++||+|.+++.+. ...+++..++. ++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~----------~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 82 YYVGGDLLTLLSKF-EDRLPEDMARF----------YLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred cCCCCcHHHHHHHh-cCCCCHHHHHH----------HHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence 99999999999753 34566655443 56788888999999999999999999999999999999999987
Q ss_pred cccCCccc-ccccccccceeccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc--c
Q psy6327 168 LLRTPKEL-SNTFCGTTSYAAPEIIRN-----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE--Y 239 (351)
Q Consensus 168 ~~~~~~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~ 239 (351)
........ ....+||+.|+|||++.. ..++. ++||||+||++|+|++|+.||..... .+....+.... .
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DiwslG~~l~el~~g~~Pf~~~~~--~~~~~~i~~~~~~~ 227 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGP-ECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKEHF 227 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCC-cceeehhhhHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCcc
Confidence 65443322 233569999999999863 23344 49999999999999999999976442 22222222111 1
Q ss_pred c-ccccccCCHhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q psy6327 240 L-FNRKYEISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 240 ~-~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~ 282 (351)
. .+....++..+++||.+||..++++ |+++.++++||||.+..
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 1 1222358999999999999765544 78999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=340.78 Aligned_cols=254 Identities=28% Similarity=0.475 Sum_probs=203.3
Q ss_pred cCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCCh
Q psy6327 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDL 94 (351)
Q Consensus 15 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL 94 (351)
||+|+||.||++.++.+|+.+|+|.+................|++++++++||||+++++++.++...|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765554433344445799999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc
Q psy6327 95 EHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE 174 (351)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 174 (351)
.+++.......++... ++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~----------~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~- 149 (277)
T cd05607 81 KYHIYNVGERGLEMER----------VIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK- 149 (277)
T ss_pred HHHHHhccccCCCHHH----------HHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-
Confidence 9988654333444433 34567889999999999999999999999999999999999999988754332
Q ss_pred cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHhhhCccccccccccCCHhHH
Q psy6327 175 LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--NRDVLKKQEGKEYLFNRKYEISIGAK 252 (351)
Q Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (351)
......|++.|+|||++.+..++.+ +|+||+||++|+|++|..||...... ............... ....++.+++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 227 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESK 227 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHH
Confidence 2234568999999999988887765 99999999999999999999754321 112222222212111 1235799999
Q ss_pred HHHHHhcCCCCCCCCCH----HHHhcCccccCC
Q psy6327 253 QLIGRMLEPNPKHRPNA----KDVQNHAWIQNE 281 (351)
Q Consensus 253 ~li~~~L~~dp~~Rpt~----~ell~hp~~~~~ 281 (351)
+||.+||+.||++||++ .+++.||||+..
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 99999999999999999 678899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=349.46 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=204.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.++||+|+||.||+|.+..++..+|+|.+..... . .....+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-P-AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-H-HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 579999999999999999999999999999998765422 2 22344558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
||+.|++|.+++.. ...+++.... .++.|++.||.|||+. +++|+||||+|||++.++.+||+|||+
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~----------~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 83 EHMDGGSLDQVLKK--AGRIPEQILG----------KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 99999999999976 3455554433 4567788899999985 799999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH-------------
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK------------- 232 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------------- 232 (351)
+...... ......||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||............
T Consensus 151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (333)
T cd06650 151 SGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227 (333)
T ss_pred chhhhhh--ccccCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence 8765332 2234578999999999988777765 99999999999999999999754321111000
Q ss_pred -----------------------------hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 233 -----------------------------KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 233 -----------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
...............+.++++||.+||++||++|||+.|++.||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000000011357789999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=363.33 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=194.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-------
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG------- 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------- 79 (351)
.+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 469999999999999999999999999999998754321 123799999999999999999887432
Q ss_pred -CEEEEEEecCCCCChHHHHHhh--ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 80 -TYLYMIMDYAEKKDLEHYISKA--CNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 80 -~~~~lv~e~~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
..+++||||++ ++|.+++... ....+++..+ ..++.||+.||.|||++||+||||||+|||++.++
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~----------~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLV----------KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT 207 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHH----------HHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC
Confidence 25789999997 6788777542 1334554443 34677889999999999999999999999998654
Q ss_pred -CeEEeeccccccccCCcccccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh
Q psy6327 157 -NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ 234 (351)
Q Consensus 157 -~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 234 (351)
.+||+|||+|+...... .....+||+.|+|||++.+.. ++. ++|||||||++|+|++|.+||.+.... +....+
T Consensus 208 ~~vkL~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i 283 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTT-HIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRI 283 (440)
T ss_pred CceeeeccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHH
Confidence 69999999998764332 233567899999999987654 554 499999999999999999999765421 111111
Q ss_pred h---C--------------cccccc----------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 235 E---G--------------KEYLFN----------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 235 ~---~--------------~~~~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. . ....++ .+...+.++.+||.+||++||.+|||+.|+++||||...
T Consensus 284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0 0 000000 112467899999999999999999999999999999653
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=358.84 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=204.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-C-----CCceeeeeEEEeCCE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-H-----PNIIGVHRMVKAGTY 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----p~iv~~~~~~~~~~~ 81 (351)
+|.+++.||+|+||+|.+|.+..|++.||||+++.+..... +. ..|+.+|..|+ | -|+|+++++|.-.++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~---Q~-~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLR---QA-QIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHH---HH-HHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 58999999999999999999999999999999875543322 22 27999999997 3 699999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC--CCeE
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL--LNAK 159 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~--~~~k 159 (351)
+|||+|.++ .+|+++++......++...++. ++.||+.||.+||+.+|||+|||||||||.+. ..||
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~----------~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRK----------FAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHH----------HHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCcee
Confidence 999999996 9999999998888887766654 67788888889999999999999999999764 4599
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh----
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---- 235 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---- 235 (351)
|+|||+|+...... .+++-+..|+|||++.+.+|+.. .||||||||++||++|.+.|.+.+..+. +..+.
T Consensus 332 VIDFGSSc~~~q~v---ytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQ--l~~I~e~lG 405 (586)
T KOG0667|consen 332 VIDFGSSCFESQRV---YTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQ--LARIIEVLG 405 (586)
T ss_pred EEecccccccCCcc---eeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHH--HHHHHHHhC
Confidence 99999998754322 27788999999999999999987 9999999999999999999966542211 11000
Q ss_pred ------------------------------------------------Ccccccc-ccc--------cCCHhHHHHHHHh
Q psy6327 236 ------------------------------------------------GKEYLFN-RKY--------EISIGAKQLIGRM 258 (351)
Q Consensus 236 ------------------------------------------------~~~~~~~-~~~--------~~s~~~~~li~~~ 258 (351)
......+ ... .-...+.|||.+|
T Consensus 406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 0000001 000 1123578999999
Q ss_pred cCCCCCCCCCHHHHhcCccccCCc
Q psy6327 259 LEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 259 L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
|.+||.+|+|+.++|+||||....
T Consensus 486 L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred hccCchhcCCHHHHhcCccccccc
Confidence 999999999999999999998543
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=361.58 Aligned_cols=258 Identities=29% Similarity=0.525 Sum_probs=219.8
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|.|++.||.|+||.||+|..+.++...|.|++..+. ....+.++ -||.||..++||+||++++.|.-++.++|+.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDyl-VEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYL-VEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhh-hhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 889999999999999999999999999999876544 33445555 799999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
|.||-+...+-.. ...+.+.++.. +++|+|.||+|||+++|+|||||..|||++-+|.++|+|||.+..
T Consensus 111 C~GGAVDaimlEL-~r~LtE~QIqv----------vc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL-GRVLTEDQIQV----------VCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred cCCchHhHHHHHh-ccccchHHHHH----------HHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccccc
Confidence 9999998888764 67788887654 577889999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccceeccccc-----cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh-Ccccccc
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEII-----RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE-GKEYLFN 242 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 242 (351)
.........+++|||+|||||++ +..+|+.. +|||||||+|.+|..+.+|....+. ..++.++. ..++.+.
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnp--MRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKSEPPTLL 256 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccch--HHHHHHHhhcCCCccc
Confidence 55555566788999999999986 45667776 9999999999999999999876653 33333333 3344455
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
.+..++..+.||+.+||.+||..||++++||+|||+++.+.
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 56689999999999999999999999999999999997754
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=348.83 Aligned_cols=261 Identities=29% Similarity=0.441 Sum_probs=208.0
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|+++++||+|+||.||++.++.+++.+|+|++.............+.+|+.++..++|++|+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999876544443334456689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++|+|.+++.+. ...+++...+ .++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 82 y~~~g~L~~~l~~~-~~~l~~~~~~----------~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 82 YYVGGDLLTLLSKF-EDRLPEDMAR----------FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred ccCCCcHHHHHHHh-cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence 99999999999753 3455665443 356788888899999999999999999999999999999999987
Q ss_pred cccCCcc-cccccccccceeccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc--c
Q psy6327 168 LLRTPKE-LSNTFCGTTSYAAPEIIRN-----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE--Y 239 (351)
Q Consensus 168 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~ 239 (351)
....... .....+||+.|+|||++.. ..++. ++|||||||++|+|++|+.||...+ .......+.... .
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DvwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~ 227 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGP-ECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKERF 227 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCC-cCCEEeeHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCccc
Confidence 6543322 2234579999999999862 33454 4999999999999999999997654 233333332221 1
Q ss_pred cccc-cccCCHhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q psy6327 240 LFNR-KYEISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 240 ~~~~-~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~ 282 (351)
.++. ...++.++++||.+||..++++ |+++.++++||||.+..
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 1222 2367999999999999765554 68999999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=354.84 Aligned_cols=258 Identities=32% Similarity=0.585 Sum_probs=224.8
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+..|.++..||+|.|+.|.+|.+..++..||+|.+++.........+. .+|+++|+.|+|||||+++.+.+....+|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~-~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKL-GREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHH-HHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 4567999999999999999999999999999999999888877766664 499999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+.+|.+++++.+ .+...+..++.. +.|+..|++|||+++|+|||||++||||+.+.++||+|||
T Consensus 133 V~eya~~ge~~~yl~~--~gr~~e~~ar~~----------F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVK--HGRMKEKEARAK----------FRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred EEEeccCchhHHHHHh--cccchhhhhhhh----------hHHHHHHHHHHhhcceeccccchhhcccccccceeeeccc
Confidence 9999999999999988 666666666654 5556777779999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
++.++. ......+.||+|.|.|||++.+..|+...+|+||+|+++|.|++|..||.+.... ..........+. .+
T Consensus 201 fS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--~Lr~rvl~gk~r--Ip 275 (596)
T KOG0586|consen 201 FSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--ELRPRVLRGKYR--IP 275 (596)
T ss_pred cceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--cccchheeeeec--cc
Confidence 999987 4556778999999999999999999988899999999999999999999876532 222222223333 33
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
..++.++.++|+++|..+|.+|++++++..|+|...
T Consensus 276 ~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 276 FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred ceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 368899999999999999999999999999999854
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=338.74 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=210.8
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|+..+.||+|+||+||+|.+..+++.+|+|.+.............+.+|+.+++.++|+||+.+++.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 78889999999999999999999999999998766554443344456899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+.+++|.+++.......+++.... .++.|++.||.|||++||+||||||+||++++++.++|+|||++..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~----------~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERAL----------FYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHH----------HHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence 999999998876444456665544 4667888889999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch--HHHHhhhCcccccccccc
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR--DVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 246 (351)
..... ......|++.|+|||.+.+..++.+ +|+||+||++|+|++|..||........ ......... .......
T Consensus 152 ~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 227 (285)
T cd05632 152 IPEGE-SIRGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAK 227 (285)
T ss_pred cCCCC-cccCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCcc
Confidence 43322 2234578999999999988877765 9999999999999999999975432111 111111111 1122346
Q ss_pred CCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEP 282 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~ 282 (351)
++.++.+|+.+||+.||++||+ +.+++.||||+...
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 8889999999999999999999 88999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=349.61 Aligned_cols=247 Identities=24% Similarity=0.442 Sum_probs=207.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
++++++.||+|-||.||.|.+.. ...+|+|.+........ .+.+|+++|++|+|++||++++++..+..+|||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~----~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPE----AFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChh----HHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 36678999999999999999873 33789998877655543 23389999999999999999999999889999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
||+.|+|.++++......+.. .+.+.++.|||+|++||+++++|||||-..|||++++..+||+|||+|+
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~----------~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNL----------PQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred ecccCcHHHHhhhcCCCccch----------HHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccc
Confidence 999999999998744444443 3455688999999999999999999999999999999999999999999
Q ss_pred cccCCcccc-cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 168 LLRTPKELS-NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 168 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
......... ...--...|+|||.+....++.+ ||||||||+||||+| |+.||...+ +.+++.... ..+.++.+.
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~ms--n~ev~~~le-~GyRlp~P~ 427 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMS--NEEVLELLE-RGYRLPRPE 427 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCC--HHHHHHHHh-ccCcCCCCC
Confidence 654433222 22223458999999999999987 999999999999998 999997654 667766665 567788888
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHh
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQ 273 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell 273 (351)
.+|+++.+++..||..+|++|||++.+.
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999999999998764
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=361.55 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=209.5
Q ss_pred ccceeeeeecCcccceEEEEEEecCC-ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRS-ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
...|.+.+.||+|+||.||+|.+..+ +..+|+|.+..... .....+++|+.+++.++||||+++++++..++..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34499999999999999999998877 78888887644322 223455689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 85 IMDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
||||++||+|.+++.... ...+++... ..++.|++.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~----------~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~D 212 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEV----------GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGD 212 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHH----------HHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEe
Confidence 999999999999886532 233444433 34677889999999999999999999999999999999999
Q ss_pred ccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 163 FGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 163 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
||+++....... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... ............+.
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~--~~~~~~~~~~~~~~ 289 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPS--QREIMQQVLYGKYD 289 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCC
Confidence 999987644322 2345679999999999988877765 999999999999999999997644 33333333322221
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
+.+..++.++++||.+||+.||++||++.+++.|||++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 233468899999999999999999999999999999864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=338.04 Aligned_cols=256 Identities=36% Similarity=0.640 Sum_probs=207.4
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|++++.||+|+||+||++.+..+++.+|+|.+.............. +|+.++++++||||+++++++......++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~-~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENI-REIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHH-HHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhh-hhhhccccccccccccccccccccccccccccc
Confidence 7899999999999999999999999999999987766555433333 699999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+.+++|.+++.. ...++.... +.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+..
T Consensus 80 ~~~~~L~~~l~~--~~~~~~~~~----------~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 80 CPGGSLQDYLQK--NKPLSEEEI----------LKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp ETTEBHHHHHHH--HSSBBHHHH----------HHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred cccccccccccc--ccccccccc----------ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 998899999984 456665544 34677888899999999999999999999999999999999999976
Q ss_pred ccCCcccccccccccceecccccc-CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHhhhCcccccccc--
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIR-NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR-NRDVLKKQEGKEYLFNRK-- 244 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~-- 244 (351)
............+++.|+|||++. +..++. ++|+||||+++|+|++|..||...... ..................
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQGKKYTR-KSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTTTSSBST-HHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred ccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 433344455677899999999998 555554 599999999999999999999865211 111222221111111111
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
...+..+.++|.+||+.||++|||+.++++||||
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 1224899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=341.10 Aligned_cols=265 Identities=24% Similarity=0.441 Sum_probs=206.6
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
|-.+.+|++++.||.|+||.||+|.+..++..+|+|.+........ ...+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence 4467789999999999999999999999999999999865432221 22344899999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||+. ++|.+++... ...+++..+. .++.|++.||.|||++|++|+||||+|||++.++.++|+|
T Consensus 80 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~----------~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 147 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDC-GNSINMHNVK----------LFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLAD 147 (301)
T ss_pred EEEEeccc-cCHHHHHHhc-CCCCCHHHHH----------HHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECc
Confidence 99999997 6999888653 3345554433 4667888889999999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHH-Hhhh------
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL-KKQE------ 235 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~------ 235 (351)
||++..............+++.|+|||++.+......++|||||||++|+|++|++||...+....... ....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 227 (301)
T cd07873 148 FGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEE 227 (301)
T ss_pred CcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 999976544433344456799999999987654333459999999999999999999976542111000 0000
Q ss_pred -------C---cccccc---------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 236 -------G---KEYLFN---------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 236 -------~---~~~~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. ..+..+ ....+++.+++||.+||+.||.+|||+.++++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 000000 112578899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=345.98 Aligned_cols=261 Identities=29% Similarity=0.464 Sum_probs=207.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||++.+..+++.+|+|++.............+.+|+.++..++|+||+++++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 69999999999999999999999999999999876444333334445689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++||+|.+++.+. ...+++.... .++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 82 y~~gg~L~~~l~~~-~~~l~~~~~~----------~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 82 YYVGGDLLTLLSKF-EDRLPEDMAR----------FYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred CCCCCcHHHHHHHh-cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEecccee
Confidence 99999999999763 3456655443 356788889999999999999999999999999999999999998
Q ss_pred cccCCccc-ccccccccceeccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc--c
Q psy6327 168 LLRTPKEL-SNTFCGTTSYAAPEIIRN-----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE--Y 239 (351)
Q Consensus 168 ~~~~~~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~ 239 (351)
........ ....+||+.|+|||++.+ ..++. ++|+||+||++|+|++|+.||.... .......+.... .
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~ 227 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP-ECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHEERF 227 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCC-cccEEeeehhhhhhhhCCCCccCCC--HHHHHHHHHcCCCcc
Confidence 66443322 234579999999999865 34454 4999999999999999999997544 223333322211 1
Q ss_pred cccc-cccCCHhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q psy6327 240 LFNR-KYEISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 240 ~~~~-~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~ 282 (351)
.++. ...++.++++||.+||..++.+ |++++++++||||+...
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 1222 2357899999999999976655 56899999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=352.75 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=202.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-----EE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT-----YL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-----~~ 82 (351)
+|++++.||+|+||.||+|.+..+++.||+|++........ ....+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV-SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH-HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 57899999999999999999999999999998854322222 2334558999999999999999999998776 89
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||||+. ++|.+++.. ...+++..+. .++.||+.||.|||++|++||||||+|||++.++.+||+|
T Consensus 80 ~lv~e~~~-~~l~~~~~~--~~~l~~~~~~----------~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVS--PQPLSSDHVK----------VFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEEeeccc-cCHHHHHhc--CCCCCHHHHH----------HHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecc
Confidence 99999997 788888865 4556665544 4677888889999999999999999999999999999999
Q ss_pred ccccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh------
Q psy6327 163 FGFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE------ 235 (351)
Q Consensus 163 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------ 235 (351)
||+++....... ......+|+.|+|||++.+......++||||+||++|+|++|+.||...+.. .....+.
T Consensus 147 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~ 224 (372)
T cd07853 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTP 224 (372)
T ss_pred ccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCC
Confidence 999986543221 2234568999999999887553334599999999999999999999765421 1111100
Q ss_pred -----------------Ccccc-------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 236 -----------------GKEYL-------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 236 -----------------~~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
..... .......++++.+||.+||+.||++|||+.|+++||||+...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00000 011224588999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=350.40 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=199.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG----- 79 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~----- 79 (351)
-+.+|++++.||+|+||.||+|.+..+|..+|+|++......... ...+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH-AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhH-HHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 457899999999999999999999999999999998654332222 33445899999999999999999998644
Q ss_pred -CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 80 -TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 80 -~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
...|+||||++ ++|...+.. .+++..+ ..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~----------~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIHM----ELDHERM----------SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHhc----cCCHHHH----------HHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 35799999997 567666632 3444433 2467789999999999999999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch----------
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR---------- 228 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---------- 228 (351)
||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....
T Consensus 163 kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 240 (359)
T cd07876 163 KILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240 (359)
T ss_pred EEecCCCccccccC-ccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999999764332 22344578999999999988888776 9999999999999999999976532110
Q ss_pred ---HHH-------HhhhCcc--------------cccc----ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 229 ---DVL-------KKQEGKE--------------YLFN----RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 229 ---~~~-------~~~~~~~--------------~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
... ....... +.++ .....+.++++||.+||++||++|||+.|+|+||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000 0000000 0000 01124678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=325.55 Aligned_cols=259 Identities=29% Similarity=0.454 Sum_probs=213.8
Q ss_pred ccceeee-eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEe----C
Q psy6327 6 ILECSYI-SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKA----G 79 (351)
Q Consensus 6 ~~~~~~~-~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~----~ 79 (351)
..+|++. ++||-|-.|.|-.|.++++|+.+|+|++.-.. ..++|+++.-... |||||.++++|++ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3456664 46899999999999999999999999864211 1238888877774 9999999999853 4
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---CC
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---LL 156 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~~ 156 (351)
..+.+|||.++||.|+..|.+.....+.|.++.. +++||+.|+.|||+.+|.||||||+|+|... +.
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~e----------I~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASE----------IMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHH----------HHHHHHHHHHHHHhcchhhccCChhheeeecCCCCc
Confidence 6789999999999999999998777788877554 5677777888999999999999999999975 45
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC--CchHHHHhh
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGT--RNRDVLKKQ 234 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~ 234 (351)
.+||+|||+|+.-..+. ...+.|-||+|.|||++...+|+.. +|+||+||++|-|++|.+||..... -......++
T Consensus 202 ~lKLtDfGFAK~t~~~~-~L~TPc~TPyYvaPevlg~eKydks-cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI 279 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPG-DLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI 279 (400)
T ss_pred ceEecccccccccCCCc-cccCCcccccccCHHHhCchhcCCC-CCccchhHHHHHhhcCCCcccccCCccCChhHHhHh
Confidence 58999999999755433 3456788999999999998888765 9999999999999999999965432 133555667
Q ss_pred hCcccccccc--ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccc
Q psy6327 235 EGKEYLFNRK--YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTC 284 (351)
Q Consensus 235 ~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 284 (351)
....|.||.+ .++|+.++|+|+.+|+.+|++|.|+.++++|||+......
T Consensus 280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v 331 (400)
T KOG0604|consen 280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV 331 (400)
T ss_pred hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence 7777777654 5789999999999999999999999999999999876543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=329.09 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=212.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|++|.||+|.+..+++.+++|.+......... ...+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE-REEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHH-HHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999998765544333 3345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++|++|.+++.......+++.... .++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~----------~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVW----------RFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHH----------HHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccce
Confidence 9999999999987544455554433 456788889999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.............|++.|+|||++.+..++.+ +|+|||||++|+|++|+.||.... ............ ..+....+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~ 225 (256)
T cd08529 150 LLSDNTNFANTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANN--QGALILKIIRGV-FPPVSQMY 225 (256)
T ss_pred eccCccchhhccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCC-CCCCcccc
Confidence 76655444455678999999999988877765 999999999999999999997554 233333322222 11222367
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
+..+.+++.+||+.+|++||++.++++|||+
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=330.73 Aligned_cols=257 Identities=28% Similarity=0.404 Sum_probs=208.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH--HHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD--YMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+|.+.+.||+|++|.||.|.+..+++.+|+|.+........ .....+.+|+.++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 368899999999999999999999999999999865433221 122345689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|+||++|++|.+++.. ...+++... ..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~----------~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 82 FMEYMPGGSVKDQLKA--YGALTETVT----------RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred EEEECCCCcHHHHHHH--hCCCCHHHH----------HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999976 345555443 3467788899999999999999999999999999999999999
Q ss_pred ccccccCCcccc---cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 165 FSRLLRTPKELS---NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 165 ~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
+++......... ....|++.|+|||++.+..++.+ +||||+|+++|+|++|+.||.... ...............
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~ 226 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFE--AMAAIFKIATQPTNP 226 (263)
T ss_pred cceeccccccccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccc--hHHHHHHHhccCCCC
Confidence 997654322211 34568899999999988876665 999999999999999999997643 222222222222233
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
..+..++..+.++|.+||..+|++|||+.++++||||
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 3344689999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=338.13 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=197.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC---CCCCceeeeeEEEe-----C
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV---SHPNIIGVHRMVKA-----G 79 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~-----~ 79 (351)
+|++++.||+|+||.||+|.++.+++.+|+|.+......... .....+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC-chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 489999999999999999999999999999998654332211 12223677777665 69999999998854 3
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
...+++|||+. ++|.+++.......+++..+. .++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~----------~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIK----------DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 56899999998 689998876444446665544 4677888889999999999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--- 236 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--- 236 (351)
|+|||+++...... ......||+.|+|||++.+..++.+ +||||+||++|+|++|.+||..... ......+..
T Consensus 149 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~ 224 (288)
T cd07863 149 LADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLIG 224 (288)
T ss_pred ECccCccccccCcc-cCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCH--HHHHHHHHHHhC
Confidence 99999998754322 2334568999999999988877765 9999999999999999999965432 111111100
Q ss_pred ---------------ccc-------cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 ---------------KEY-------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 ---------------~~~-------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
..+ .......++..+.+||.+||++||++|||+.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 000112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=340.83 Aligned_cols=263 Identities=32% Similarity=0.473 Sum_probs=216.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|++|.||+|.+..+++.+|+|.+.............+.+|+.+++.++||||+++++.+..+...|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 68999999999999999999999999999999987655543344556689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+.|++|.+++.......+++.... .++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~----------~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVAR----------FYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHH----------HHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence 9999999999976544566665544 356788888999999999999999999999999999999999987
Q ss_pred cccCCcc-----------------------------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCC
Q psy6327 168 LLRTPKE-----------------------------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKY 218 (351)
Q Consensus 168 ~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 218 (351)
....... ......||..|+|||++.+..++.+ +||||||+++|+|++|..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTT 230 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCC
Confidence 5432111 1123468899999999988777665 999999999999999999
Q ss_pred CCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCC----HHHHhcCccccCCcc
Q psy6327 219 PFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPN----AKDVQNHAWIQNEPT 283 (351)
Q Consensus 219 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt----~~ell~hp~~~~~~~ 283 (351)
||...+ ..............++....++..++++|.+||..||++||| +.++++||||++..+
T Consensus 231 pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 231 PFKGSN--RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred CCCCCc--hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 997654 233333333334444444457999999999999999999999 999999999987543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=360.20 Aligned_cols=259 Identities=30% Similarity=0.460 Sum_probs=209.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC------
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT------ 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------ 80 (351)
.+|++.+.||+|+||+||+|.+..+++.||+|.+......... ...+.+|+.++..++|+||++++..+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~-~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD-KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHH-HHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 5799999999999999999999999999999998766554433 334458999999999999999988774322
Q ss_pred --EEEEEEecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 81 --YLYMIMDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 81 --~~~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
.+++||||+++|+|.+++.... ...+++..+ ..++.|++.||+|||+++|+||||||+|||++.++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~----------~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEA----------GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHH----------HHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC
Confidence 4789999999999999997532 234555443 34677889999999999999999999999999999
Q ss_pred CeEEeeccccccccCC--cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh
Q psy6327 157 NAKLADFGFSRLLRTP--KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ 234 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 234 (351)
.+||+|||+++..... .......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... ........
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~--~~~~~~~~ 257 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGEN--MEEVMHKT 257 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHH
Confidence 9999999999875432 223345679999999999998887765 999999999999999999997644 23333333
Q ss_pred hCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 235 EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
....+ .+.+..+++++.+++.+||+.||.+||++.++++|||++.
T Consensus 258 ~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 258 LAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred hcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 32222 2234478999999999999999999999999999999764
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=335.41 Aligned_cols=265 Identities=25% Similarity=0.434 Sum_probs=214.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||++.+..+++.+++|.+....... ...+.+|+.+++.+.||||+++++.+..+...|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 46999999999999999999999999999999987654432 233558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++|++|.+++.+ ..++... .+.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~----------~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 97 EYLAGGSLTDVVTE---TCMDEGQ----------IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred cccCCCCHHHHHHh---cCCCHHH----------HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence 99999999999864 3344433 3457788999999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
..............|++.|+|||.+.+..++.+ +|+||+||++|+|++|+.||........ .........+..+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQNPEK 241 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCCCCCCCccc
Confidence 865443333345578999999999988777665 9999999999999999999976542111 11111112222233446
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccccCCH
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTA 289 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~ 289 (351)
++..+.++|.+||..||++|||+.++++||||.........++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~ 284 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCccccHH
Confidence 8889999999999999999999999999999987665554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=334.42 Aligned_cols=257 Identities=30% Similarity=0.479 Sum_probs=213.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||++.+..+++.+|+|.+.............+.+|++++++++||||+++++++..+...|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 37999999999999999999999999999999987655444333455568999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|.+++.. ...+++.... .++.|++.||.|||++|++|+||+|.|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~~~~--~~~l~~~~~~----------~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 81 EYVPGGELFSHLRK--SGRFPEPVAR----------FYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999976 4566665543 35678888999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
...... ....+|++.|+|||.+.+...+.+ +|+||||+++|+|++|..||.... .............. .+..
T Consensus 149 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~--~~~~ 220 (290)
T cd05580 149 KRVKGR---TYTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILEGKVR--FPSF 220 (290)
T ss_pred cccCCC---CCCCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCcc--CCcc
Confidence 876443 344568999999999987776655 999999999999999999997644 22333333322222 2335
Q ss_pred CCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEPT 283 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 283 (351)
++..++++|.+||+.||.+|+ +++++++||||+...+
T Consensus 221 ~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 789999999999999999999 8999999999976543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=336.28 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=201.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|++|.||+|.+..++..+|+|++........ ....+.+|+.++++++||||+++++++.++...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG-VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC-chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999865433222 22344589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhcc-CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKKDLEHYISKACN-ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|++ ++|.+++..... ..+++.... .++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~----------~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVK----------SYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHH----------HHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence 997 789888865322 445554433 46778888999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHH--H------------
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL--K------------ 232 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--~------------ 232 (351)
.....+........+++.|+|||++.+......++|+|||||++|+|++|++||........... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 149 RAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred eecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 86554433334456789999999887654333449999999999999999999975432110000 0
Q ss_pred -----hhh------CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 233 -----KQE------GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 233 -----~~~------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
... ...........++.++.+||.+||+.||.+|||+.++++||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000 0000001122478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.35 Aligned_cols=256 Identities=30% Similarity=0.542 Sum_probs=209.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-CCEEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA-GTYLYMIM 86 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 86 (351)
+|++++.||.|++|.||++.+..+++.+|+|.+......... ...+.+|+.++++++|||++++++.+.. +...|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE-RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHH-HHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 589999999999999999999999999999998765543333 3335589999999999999999998764 45789999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|.+++.......+++.+. +.++.+++.||.+||++|++|+||+|+||+++.++.++|+|||++
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~----------~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQV----------VEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHH----------HHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccce
Confidence 9999999999997644445665543 346778888899999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
..............|++.|+|||++.+..++.+ +|+||+||++|+|++|+.||...+. .......... ...+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~-~~~~~~~~ 225 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDM--NSLVYRIIEG-KLPPMPKD 225 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhc-CCCCCccc
Confidence 876554444456678999999999988877765 9999999999999999999975442 2222222111 12223346
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
++.++.+|+.+||+.||++|||+.+++.||||
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 88999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=334.79 Aligned_cols=264 Identities=25% Similarity=0.436 Sum_probs=215.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|++++.||.|++|.||+|.+..+++.+++|.+....... ...+.+|+.+++.++||||+++++++......|+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch---HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 45999999999999999999999999999999986544322 234558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|..++.. ..+++.. ++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 96 e~~~~~~L~~~~~~---~~l~~~~----------~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 96 EYLAGGSLTDVVTE---TCMDEAQ----------IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred EecCCCcHHHHHHh---cCCCHHH----------HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 99999999999864 3455443 3446778889999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
..............|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||........ ..............+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (296)
T cd06655 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPELQNPEK 240 (296)
T ss_pred hhcccccccCCCcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCcccCCccc
Confidence 876544333445578999999999988777765 9999999999999999999976543211 11111122222334456
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccccCC
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMT 288 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~ 288 (351)
++..+.+||.+||..||++|||+.+++.||||+.......++
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~~ 282 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLT 282 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccccCC
Confidence 889999999999999999999999999999998766554444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=331.82 Aligned_cols=255 Identities=27% Similarity=0.384 Sum_probs=203.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe------C
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA------G 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~------~ 79 (351)
..|++.+.||+|+||.||+|.+..+++.+|+|.+...... ...+.+|+.+++++ +||||+++++++.. .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3488999999999999999999999999999998654322 22344899999998 69999999999865 3
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
...|+||||+.+++|.+++.......+++.... .++.|++.||.|||+++|+|+||+|+||++++++.++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~----------~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA----------YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHH----------HHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEE
Confidence 568999999999999999986544556654433 4677889999999999999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccceeccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN-----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ 234 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 234 (351)
|+|||++..............|++.|+|||++.. ..++.+ +|+||+||++|+|++|..||....... .....
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGv~l~el~~g~~p~~~~~~~~--~~~~~ 228 (272)
T cd06637 152 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMR--ALFLI 228 (272)
T ss_pred EccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCch-hhHHHHHHHHHHHHhCCCCccccCHHH--HHHHH
Confidence 9999999876543334455679999999999863 345544 999999999999999999997544221 11111
Q ss_pred hCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 235 EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
............++.++.+|+.+||..||.+|||+.+++.||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 229 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 11111222233678999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=334.46 Aligned_cols=265 Identities=25% Similarity=0.426 Sum_probs=214.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||++.+..+++.+|+|.+....... ...+.+|+.+++.++||||+++++++..+...|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 56999999999999999999999999999999986544332 234558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|.+++.+ ..+++.. ...++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~----------~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQ----------IAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHH----------HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccc
Confidence 99999999999864 3344433 2346778889999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
..............|++.|+|||.+.+..++.+ +|+||+||++|+|++|..||...+..... .............+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTPELQNPER 240 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchhe-eeeccCCCCCCCCccc
Confidence 875544333445678999999999988777665 99999999999999999999764421111 1111111222223346
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccccCCH
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTA 289 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~ 289 (351)
++..+++|+.+||+.||++||++.++++||||+........+.
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~ 283 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTP 283 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccccCH
Confidence 7889999999999999999999999999999987766555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=346.18 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=199.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG----- 79 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~----- 79 (351)
-+.+|++.+.||+|+||.||+|.+..+++.+|+|++......... ...+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh-HHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 457899999999999999999999999999999998654332222 23344899999999999999999987543
Q ss_pred -CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 80 -TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 80 -~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
...|+||||++ ++|.+.+.. .++... +..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~----------~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM----ELDHER----------MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh----cCCHHH----------HHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcE
Confidence 46899999997 678777743 244333 23467889999999999999999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG-- 236 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-- 236 (351)
||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+. .........
T Consensus 166 kL~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~~~~~~ 241 (364)
T cd07875 166 KILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDH--IDQWNKVIEQL 241 (364)
T ss_pred EEEeCCCccccCCC-CcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhc
Confidence 99999999865432 22344578999999999988887765 9999999999999999999975432 111111000
Q ss_pred --------------------ccc--------------ccc----ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 --------------------KEY--------------LFN----RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 --------------------~~~--------------~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
... .++ .....+..+++||.+||+.||.+|||+.++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 000 000 001235678999999999999999999999999999
Q ss_pred cC
Q psy6327 279 QN 280 (351)
Q Consensus 279 ~~ 280 (351)
..
T Consensus 322 ~~ 323 (364)
T cd07875 322 NV 323 (364)
T ss_pred cc
Confidence 64
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=346.06 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=199.4
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC----
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG---- 79 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~---- 79 (351)
.-+.+|++++.||+|+||.||+|.+..+++.+|+|.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHH-HHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 3467899999999999999999999999999999998654333222 23344899999999999999999998543
Q ss_pred --CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC
Q psy6327 80 --TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN 157 (351)
Q Consensus 80 --~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~ 157 (351)
...|+||||++ ++|.+.+.. .+++... ..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 93 ~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~----------~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~ 157 (355)
T cd07874 93 EFQDVYLVMELMD-ANLCQVIQM----ELDHERM----------SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred ccceeEEEhhhhc-ccHHHHHhh----cCCHHHH----------HHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC
Confidence 35799999997 577776643 3444332 346778899999999999999999999999999999
Q ss_pred eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchH--HHHhh-
Q psy6327 158 AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD--VLKKQ- 234 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~- 234 (351)
+||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..... .....
T Consensus 158 ~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 158 LKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred EEEeeCcccccCCCc-cccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999999865432 22345678999999999988887765 99999999999999999999764421100 00000
Q ss_pred -----------------hCcc--------------ccc----cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 235 -----------------EGKE--------------YLF----NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 235 -----------------~~~~--------------~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
.... ..+ ......+.++++||.+||+.||++|||+.|+|+||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 0000 000 01112456789999999999999999999999999997
Q ss_pred C
Q psy6327 280 N 280 (351)
Q Consensus 280 ~ 280 (351)
.
T Consensus 316 ~ 316 (355)
T cd07874 316 V 316 (355)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=339.89 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=187.1
Q ss_pred eeecCcccceEEEEEEec--CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--CCEEEEEEe
Q psy6327 12 ISKLGEGAYGNVYLVSDK--RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA--GTYLYMIMD 87 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e 87 (351)
..+||+|+||+||+|.++ .+++.+|+|.+....... ...+|+.++++++||||+++++++.. +...|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISM-----SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcH-----HHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999965 467899999886443222 23489999999999999999999853 567899999
Q ss_pred cCCCCChHHHHHhhcc-------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE----cCCC
Q psy6327 88 YAEKKDLEHYISKACN-------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI----SRLL 156 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~-------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll----~~~~ 156 (351)
|+. ++|.+++..... ..+++.. +..++.||+.||.|||++||+||||||+|||+ +..+
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~----------~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~ 149 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGM----------VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHH----------HHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcC
Confidence 996 789888764211 1234333 34577889999999999999999999999999 4557
Q ss_pred CeEEeeccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc------
Q psy6327 157 NAKLADFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN------ 227 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------ 227 (351)
.+||+|||+++....... .....+||+.|+|||++.+......++||||+||++|+|++|++||.......
T Consensus 150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~ 229 (317)
T cd07868 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 229 (317)
T ss_pred cEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccc
Confidence 899999999987654322 23456789999999998875533445999999999999999999996432110
Q ss_pred -hHHHHhhh------------------C----------ccc--------cccccccCCHhHHHHHHHhcCCCCCCCCCHH
Q psy6327 228 -RDVLKKQE------------------G----------KEY--------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAK 270 (351)
Q Consensus 228 -~~~~~~~~------------------~----------~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 270 (351)
......+. . ..+ ........+.++.+||.+||++||.+|||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~ 309 (317)
T cd07868 230 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 309 (317)
T ss_pred cHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHH
Confidence 00000000 0 000 0000112356789999999999999999999
Q ss_pred HHhcCccc
Q psy6327 271 DVQNHAWI 278 (351)
Q Consensus 271 ell~hp~~ 278 (351)
|+|+||||
T Consensus 310 e~l~hp~f 317 (317)
T cd07868 310 QAMQDPYF 317 (317)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=346.53 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=217.0
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|.=++.||.|+||.||.|.+..+...||||++.........-.+.+..|+..|.+|.|||+|.+-++|-.+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44577899999999999999999999999999876666655566677999999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
|- ||-.|++.-. .+++.+..+ ..+.++.+.||.|||+.+.||||||..|||+++.|.|||+|||.|..
T Consensus 108 Cl-GSAsDlleVh-kKplqEvEI----------AAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 108 CL-GSASDLLEVH-KKPLQEVEI----------AAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred Hh-ccHHHHHHHH-hccchHHHH----------HHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhh
Confidence 96 8888888543 456655443 34788999999999999999999999999999999999999999987
Q ss_pred ccCCcccccccccccceecccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
..+ .++++|||+|||||++. .+.|+.+ +|||||||+..+|...++|+-+.+ ....+.++......-....
T Consensus 176 ~~P----AnsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMN--AMSALYHIAQNesPtLqs~ 248 (948)
T KOG0577|consen 176 MAP----ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPTLQSN 248 (948)
T ss_pred cCc----hhcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCch--HHHHHHHHHhcCCCCCCCc
Confidence 543 56788999999999874 5778877 999999999999999999986544 3333344433332222345
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccccc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQT 286 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 286 (351)
.+|+.+++|+..||++-|.+|||.+++|.|+|+....+...
T Consensus 249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tv 289 (948)
T KOG0577|consen 249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTV 289 (948)
T ss_pred hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchH
Confidence 79999999999999999999999999999999987665443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=334.56 Aligned_cols=257 Identities=24% Similarity=0.449 Sum_probs=200.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||+|.+..+|..+|+|.+........ ....+.+|+.++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~-~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc-CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999875433222 22334589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++ ++|.+++... ...+++.... .++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++
T Consensus 80 ~~~-~~l~~~~~~~-~~~~~~~~~~----------~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 80 YCD-QDLKKYFDSC-NGDIDPEIVK----------SFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHH----------HHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 997 6888887653 3445655443 467788888999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh------------
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE------------ 235 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------ 235 (351)
.............+++.|+|||++.+......++|||||||++|+|++|..||...... ......+.
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHHHHHHHhCCCChHHhH
Confidence 76544333445568899999999877554334599999999999999999886432221 11111100
Q ss_pred ----Cccc----c-------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 236 ----GKEY----L-------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 236 ----~~~~----~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
...+ . ......++.++++||.+||+.||.+|||+.++++||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0000 0 00112478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=344.15 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=198.4
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC------
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG------ 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------ 79 (351)
..+|++++.||+|+||.||+|.+..+++.||+|++......... ...+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH-ARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHH-HHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 35699999999999999999999999999999998654332222 23344899999999999999999987543
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
...|++++++ +++|.+++.. ..+++..+. .++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~----------~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQ----------FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHH----------HHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEE
Confidence 4579999988 6999988753 456665543 4677888899999999999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh----
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---- 235 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---- 235 (351)
|+|||+++.... .....+||+.|+|||++.+......++|||||||++|+|++|..||.+.... .......
T Consensus 159 l~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~ 233 (343)
T cd07878 159 ILDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVG 233 (343)
T ss_pred EcCCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhC
Confidence 999999986543 2345679999999999877433334599999999999999999999754321 1111000
Q ss_pred -----------Cc--------ccccc------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 236 -----------GK--------EYLFN------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 236 -----------~~--------~~~~~------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.. ....+ .....++.+.+||.+||+.||++|||+.|+++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00 00000 001356678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=329.00 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=203.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.+..+++.+|+|.+....... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED---FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999986543222 223458999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|.+++.. .+.+++... +.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus 86 e~~~~~~L~~~~~~--~~~~~~~~~----------~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 86 EFCGGGSLQDIYHV--TGPLSESQI----------AYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred eccCCCcHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceee
Confidence 99999999999876 455666543 346778889999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccceecccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh-Ccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE-GKEYLFN 242 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 242 (351)
..............|++.|+|||++. ...++. ++|+||+||++|+|++|..||............... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ-LCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232 (267)
T ss_pred eEccCcccccccccCcccccChhhhccccCCCCCc-hhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc
Confidence 76654433344567999999999874 334554 499999999999999999999654321111111111 1111112
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAW 277 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 277 (351)
....++..+.++|.+||+.||++|||+.++++|||
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 22357889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=340.54 Aligned_cols=263 Identities=21% Similarity=0.313 Sum_probs=197.2
Q ss_pred cceeeeeecCcccceEEEEEEe-----cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeC-
Q psy6327 7 LECSYISKLGEGAYGNVYLVSD-----KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAG- 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~- 79 (351)
.+|++.++||+|+||.||+|.+ ..++..||+|++....... ....+.+|+.++..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS--EHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH--HHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4699999999999999999975 2446789999986432222 233455899999999 899999999988654
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCC--CchHH---HH------------------------------------------
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNEN--IHENQ---AR------------------------------------------ 112 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~--~~~~~---~~------------------------------------------ 112 (351)
..+++||||+++|+|.+++....... ..+.. ..
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46899999999999999997532110 00000 00
Q ss_pred ---HHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceec
Q psy6327 113 ---IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAA 187 (351)
Q Consensus 113 ---~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~a 187 (351)
.-......++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 00012334567888999999999999999999999999999999999999999986533221 1223446788999
Q ss_pred cccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCC
Q psy6327 188 PEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHR 266 (351)
Q Consensus 188 PE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 266 (351)
||++.+..++.+ +|||||||++|+|++ |..||.+.... ........... ....+..+++++.+++.+||+.||++|
T Consensus 245 PE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 245 PESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGT-RMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred cHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999988887765 999999999999997 99999765432 22222222221 222334688999999999999999999
Q ss_pred CCHHHHhc
Q psy6327 267 PNAKDVQN 274 (351)
Q Consensus 267 pt~~ell~ 274 (351)
||+.++++
T Consensus 322 Ps~~el~~ 329 (338)
T cd05102 322 PTFSALVE 329 (338)
T ss_pred cCHHHHHH
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=371.40 Aligned_cols=261 Identities=31% Similarity=0.468 Sum_probs=219.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|.++++||+|+||.|..++++.+++.||+|++.+-.......-..|..|-.+|.--+.+=|+.++-.|.+..++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 47999999999999999999999999999999998755543333445668999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++||+|..++.+. .++|+..++. |+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+
T Consensus 155 dY~pGGDlltLlSk~--~~~pE~~ArF----------Y~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKF--DRLPEDWARF----------YTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ecccCchHHHHHhhc--CCChHHHHHH----------HHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999884 4899988877 5556677777999999999999999999999999999999998
Q ss_pred ccccCCcc-cccccccccceecccccc----C-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--cc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIR----N-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KE 238 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~----~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~ 238 (351)
-.+...+. .....+|||-|.+||++. + +.|+.. +|.||+||++|||+.|..||...+ -.++..++.. ..
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~e-cDwWSlGV~~YEMlyG~TPFYads--lveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRE-CDWWSLGVFMYEMLYGETPFYADS--LVETYGKIMNHKES 299 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCc-cchhhhHHHHHHHHcCCCcchHHH--HHHHHHHHhchhhh
Confidence 87775443 566789999999999985 2 345555 999999999999999999996544 2233333332 24
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCcc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPN---AKDVQNHAWIQNEPT 283 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~~~~~ 283 (351)
+.||....+|.++++||.++|. +|+.|.. ++++.+||||.+..|
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 5566556899999999999997 5888988 999999999988766
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=333.04 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=204.0
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|+||.||++.+..++..+|+|.+..... .. ....+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PA-IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HH-HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 69999999999999999999999999999998764322 22 23345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|++|++|.+++.. ...+++.... .++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++
T Consensus 80 y~~~~~L~~~l~~--~~~~~~~~~~----------~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 80 HMDGGSLDQVLKK--AGRIPENILG----------KISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred ccCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999976 3556665443 457788889999998 59999999999999999999999999998
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC----------
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---------- 236 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 236 (351)
...... .....+|++.|+|||.+.+..++.+ +|+||+||++|+|++|..||...+............
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 148 GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred cccccc--ccccCCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 765332 2345678999999999887776655 999999999999999999996433211111000000
Q ss_pred -------------------------ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 237 -------------------------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 237 -------------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..... ....++.++++|+.+||..||++|||+.++++||||.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000 011367889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=328.26 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=202.6
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||+|.+..+++.+|+|.+...... .....+.+|+.++++++||||+++++.+...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV--ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh--HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 588999999999999999999999999999998654322 223445689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++++|..+. .+++.. +..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.
T Consensus 80 ~~~~~~l~~~~------~~~~~~----------~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 80 FMDGGSLDVYR------KIPEHV----------LGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred cCCCCChHHhh------cCCHHH----------HHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 99999986542 234333 23467889999999999999999999999999999999999999997
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc-----hHHHHhhhCcccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN-----RDVLKKQEGKEYLFN 242 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~ 242 (351)
..... .....+||+.|+|||.+.+..++.+ +|+||+||++|+|++|..||....... ...............
T Consensus 144 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (279)
T cd06619 144 QLVNS--IAKTYVGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220 (279)
T ss_pred ecccc--cccCCCCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC
Confidence 65432 2344679999999999988877765 999999999999999999996532111 111111111111111
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.....+.++.+|+.+||+.||++||++.++++||||+..
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 223578899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=325.75 Aligned_cols=253 Identities=34% Similarity=0.543 Sum_probs=208.5
Q ss_pred cCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCCh
Q psy6327 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDL 94 (351)
Q Consensus 15 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL 94 (351)
||.|++|.||+|.+..+++.+++|.+.............+.+|+.+++.++||||+++++.+.++...|+|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999766555444456677999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc
Q psy6327 95 EHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE 174 (351)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 174 (351)
.+++.+ ...+++.... .++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~--~~~l~~~~~~----------~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~- 147 (262)
T cd05572 81 WTILRD--RGLFDEYTAR----------FYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ- 147 (262)
T ss_pred HHHHhh--cCCCCHHHHH----------HHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence 999976 3445554433 356788889999999999999999999999999999999999998765432
Q ss_pred cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHH
Q psy6327 175 LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQL 254 (351)
Q Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (351)
......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||.......................+..++.++.++
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 2334568999999999887777765 999999999999999999997655323333333332122223333568999999
Q ss_pred HHHhcCCCCCCCCC-----HHHHhcCccccCC
Q psy6327 255 IGRMLEPNPKHRPN-----AKDVQNHAWIQNE 281 (351)
Q Consensus 255 i~~~L~~dp~~Rpt-----~~ell~hp~~~~~ 281 (351)
|.+||+.||++||+ +.|+++||||++.
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 99999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=329.29 Aligned_cols=257 Identities=29% Similarity=0.443 Sum_probs=205.5
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|++++.||+|+||.||++.+..++..+++|.+....... ...+.+|+.+++.++||||+++++++..++..|+|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHH---HHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 688999999999999999999999999999986543221 23345899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+++++|..++.+. ...+++.... .++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~~~~~l~~~~~~~-~~~l~~~~~~----------~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 84 CAGGAVDAVMLEL-ERPLTEPQIR----------VVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred cCCCcHHHHHHhc-CCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 9999999887642 3445554433 4677888999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccceecccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
............|++.|+|||++. +..++. ++|+||+||++|+|++|.+||..... .................
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~ 230 (282)
T cd06643 153 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY-KADVWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPPTLAQ 230 (282)
T ss_pred ccccccccccccccccccCHhhccccCCCCCCCCc-cchhhhHHHHHHHHccCCCCccccCH-HHHHHHHhhcCCCCCCC
Confidence 544333344567899999999984 233444 49999999999999999999976442 11222222222222333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
+..++.++++||.+||+.||++|||+.++++||||...
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 44688999999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=354.45 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=191.6
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC------CCCceeeeeEEEeC-
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS------HPNIIGVHRMVKAG- 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~------hp~iv~~~~~~~~~- 79 (351)
.+|+++++||+|+||+||+|.+..+++.||+|++...... ......|+.+++.+. |++++++++++...
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY----TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh----HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 5699999999999999999999999999999998542211 122235777777665 45688999988754
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCC--
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLL-- 156 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~-- 156 (351)
.+.|+|||++ |++|.+++.+ ...+++..+. .++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~----------~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLA----------QIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcc
Confidence 5799999988 6899998876 4556665443 467788999999998 5999999999999998765
Q ss_pred --------------CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy6327 157 --------------NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222 (351)
Q Consensus 157 --------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (351)
.+||+|||.+.... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999886432 22345689999999999998888875 9999999999999999999976
Q ss_pred CCCCchHHHHhhh---Ccc------------------------cc-cc------------ccccCCHhHHHHHHHhcCCC
Q psy6327 223 PGTRNRDVLKKQE---GKE------------------------YL-FN------------RKYEISIGAKQLIGRMLEPN 262 (351)
Q Consensus 223 ~~~~~~~~~~~~~---~~~------------------------~~-~~------------~~~~~s~~~~~li~~~L~~d 262 (351)
.+. .+....+. ... .. .+ .....+..+.|||.+||++|
T Consensus 348 ~~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 348 HDN--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCh--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 442 11111100 000 00 00 00011456789999999999
Q ss_pred CCCCCCHHHHhcCccccCC
Q psy6327 263 PKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 263 p~~Rpt~~ell~hp~~~~~ 281 (351)
|++|||+.|+|+||||+..
T Consensus 426 P~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 426 RQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hhhCCCHHHHhcCcccccc
Confidence 9999999999999999864
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=330.08 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=209.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||.|+||.||++.+..++..+|+|.+....... ...+.+|+.++++++||||+++++++..+...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE---LEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHH---HHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 35899999999999999999999899999999986443221 234558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|.+++.+. ...+++..+ ..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+
T Consensus 82 e~~~~~~L~~~~~~~-~~~l~~~~~----------~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 82 EFCDGGALDSIMLEL-ERGLTEPQI----------RYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHH----------HHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccc
Confidence 999999999998753 245665543 346778888899999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccceeccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc-ccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRN-----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK-EYL 240 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~ 240 (351)
..............|++.|+|||++.. ..++. ++|+||+|+++|+|++|+.||..... .......... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~-~sDi~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~ 227 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDY-KADIWSLGITLIELAQMEPPHHELNP--MRVLLKILKSEPPT 227 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCc-cccHHHHHHHHHHHHhCCCCcccCCH--HHHHHHHhcCCCCC
Confidence 765544444455678999999999753 33444 49999999999999999999976542 2222222222 122
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
...+..++.++.++|.+||+.||.+||++.++++||||.+.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 23344688999999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=321.85 Aligned_cols=256 Identities=32% Similarity=0.488 Sum_probs=211.8
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|+.++.||.|+||.||.+.+..++..+++|.+........... .+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~-~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERR-DALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHH-HHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999876655443333 34589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++++|.+++.+.....+++... ..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~----------~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~ 149 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMV----------LWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISK 149 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHH----------HHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceE
Confidence 999999999997643344555443 3467788889999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.............|++.|+|||.+.+..++.. +|+||+|+++|+|++|..||.... ..+.........+. +....+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~ 225 (256)
T cd08221 150 ILGSEYSMAETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATN--PLNLVVKIVQGNYT-PVVSVY 225 (256)
T ss_pred EcccccccccccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCC-CCcccc
Confidence 76554434456679999999999987776655 999999999999999999997543 22333232222222 222467
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
+.++.++|.+||+.+|++|||+.++++|||+
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 8999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=327.02 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=203.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+..+++.+|+|++....... ...+.+|+.++++++||||+++++++......|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 456999999999999999999999999999999986543222 23455899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++.. ...+++.... .++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||+
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~----------~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~ 152 (267)
T cd06646 85 MEYCGGGSLQDIYHV--TGPLSELQIA----------YVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGV 152 (267)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCcc
Confidence 999999999999875 4455554433 4567888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceecccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc---
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY--- 239 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--- 239 (351)
+..............|++.|+|||.+. ...++. ++|+||+||++|+|++|..||...... ..........+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~-~~Dvws~G~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 229 (267)
T cd06646 153 AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ-LCDIWAVGITAIELAELQPPMFDLHPM--RALFLMSKSNFQPP 229 (267)
T ss_pred ceeecccccccCccccCccccCHhHcccccCCCCcc-hhhHHHHHHHHHHHHhCCCCccccchh--hhheeeecCCCCCC
Confidence 987654333334567899999999874 233444 499999999999999999999644321 11111111111
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAW 277 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 277 (351)
.......++..+.+||.+||+.||++|||++++++|+|
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 11222357889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=351.11 Aligned_cols=255 Identities=31% Similarity=0.455 Sum_probs=214.6
Q ss_pred ecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCC
Q psy6327 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKD 93 (351)
Q Consensus 14 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggs 93 (351)
+||+|+||+||.|+|..+....|||.+..+.... .+-+..||.+.++|.|.|||+++|.+..++++-|+||-.+||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~---~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE---VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchh---hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 5999999999999999999999999987654433 3334489999999999999999999999999999999999999
Q ss_pred hHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-CCCeEEeeccccccccCC
Q psy6327 94 LEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-LLNAKLADFGFSRLLRTP 172 (351)
Q Consensus 94 L~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~ 172 (351)
|.+++++. -+++.++....- -|.+||++||+|||++.|||||||-+|||++. .|.+||+|||-++.+..-
T Consensus 659 LSsLLrsk-WGPlKDNEstm~--------fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 659 LSSLLRSK-WGPLKDNESTMN--------FYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred HHHHHHhc-cCCCccchhHHH--------HHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 99999764 667744332211 27789999999999999999999999999986 688999999999998888
Q ss_pred cccccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhH
Q psy6327 173 KELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251 (351)
Q Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (351)
...+.++.||..|||||++..++ .+.+++|||||||++.||.||++||-..+.....+++.- .-..-.+.+..+|.++
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-myKvHP~iPeelsaea 808 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-MYKVHPPIPEELSAEA 808 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-ceecCCCCcHHHHHHH
Confidence 88888999999999999997554 334559999999999999999999987765555444322 1222334455789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 252 KQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 252 ~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
+.||.+|+.+||.+||++.++|++||++..
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999999999865
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=328.80 Aligned_cols=260 Identities=27% Similarity=0.451 Sum_probs=207.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|+++++||.|+||.||+|.+..++..+++|.+...... ....+.+|+.+++.++||||+++++++..++..|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 3489999999999999999999999999999998654322 2333458999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++|++|..++.+. ...+++..+ ..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++
T Consensus 89 e~~~~~~l~~~~~~~-~~~l~~~~~----------~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 89 EFCPGGAVDAIMLEL-DRGLTEPQI----------QVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred ecCCCCcHHHHHHhh-cCCCCHHHH----------HHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccc
Confidence 999999998887653 244555443 346778888899999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccceeccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRN-----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
..............+++.|+|||++.. ..++.+ +|+|||||++|+|++|..||..... ...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~ 235 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPPTL 235 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCch-hhhHhHHHHHHHHhcCCCCCccccH-HHHHHHHhcCCCccC
Confidence 765443333345568999999999853 334444 9999999999999999999976542 122222222222223
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.....++.++.++|.+||+.||++||++.++++||||....
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 33446788999999999999999999999999999997543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=336.78 Aligned_cols=257 Identities=21% Similarity=0.360 Sum_probs=198.7
Q ss_pred eeeecCcc--cceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 11 YISKLGEG--AYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 11 ~~~~LG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
++++||+| +|++||++.++.+|+.||+|.+........ ....+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE-MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 57889999 789999999999999999999876544332 244566899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+++|+|.+++.......+++..+ ..++.|++.||.|||+++|+||||||+|||++.++.++++||+.+..
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~----------~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAI----------AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHH----------HHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence 99999999997644445655443 34677889999999999999999999999999999999999986544
Q ss_pred ccCCcc-------cccccccccceeccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc-
Q psy6327 169 LRTPKE-------LSNTFCGTTSYAAPEIIRNS--PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE- 238 (351)
Q Consensus 169 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 238 (351)
...... ......++..|+|||++.+. .++.+ +||||+||++|+|++|..||....... ..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~ 228 (327)
T cd08227 151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVP 228 (327)
T ss_pred cccccccccccccccccccceecccChHHhhcccCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCCcc
Confidence 321111 11223567889999998753 45554 999999999999999999997543211 1111100000
Q ss_pred ------------------------------------------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q psy6327 239 ------------------------------------------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276 (351)
Q Consensus 239 ------------------------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 276 (351)
...+....+++++.+||.+||++||++|||++++++||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 00011123577899999999999999999999999999
Q ss_pred cccC
Q psy6327 277 WIQN 280 (351)
Q Consensus 277 ~~~~ 280 (351)
||+.
T Consensus 309 ~f~~ 312 (327)
T cd08227 309 FFKQ 312 (327)
T ss_pred hhhh
Confidence 9975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=340.23 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=195.6
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.+..++..+|+|+..... ...|+.++++++||||+++++++......++||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 46999999999999999999999999999999743221 126999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+. ++|.+++... ...+++.. ++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 137 e~~~-~~l~~~l~~~-~~~~~~~~----------~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 137 PHYS-SDLYTYLTKR-SRPLPIDQ----------ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred EccC-CcHHHHHHhc-cCCCCHHH----------HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccc
Confidence 9996 7888888653 34455544 3456788899999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCCCchH--------HHH---hh
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKY-PFGDPGTRNRD--------VLK---KQ 234 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~--------~~~---~~ 234 (351)
+..... .......||+.|+|||++.+..++.+ +|||||||++|+|+++.. +|.+....... ... ..
T Consensus 205 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~ 282 (357)
T PHA03209 205 QFPVVA-PAFLGLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282 (357)
T ss_pred cccccC-cccccccccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHh
Confidence 753322 22345679999999999988888766 999999999999998544 44432211000 000 00
Q ss_pred hCccccc----------------------------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 235 EGKEYLF----------------------------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 235 ~~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
......+ .....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0000000 011246778889999999999999999999999999974
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=296.29 Aligned_cols=262 Identities=23% Similarity=0.416 Sum_probs=213.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|.-.++||+|.||+||+|+++.+++.||+|.+..+...+.. .....+||.+++.|+|.|||+++++...+..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-pssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-cHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 3577788999999999999999999999999999876655443 333449999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|||+ .+|..+..+. ++.++...++. ++.|+++||.|+|++++.||||||.|.||+.+|.+|++|||++
T Consensus 81 e~cd-qdlkkyfdsl-ng~~d~~~~rs----------fmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSL-NGDLDPEIVRS----------FMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred HHhh-HHHHHHHHhc-CCcCCHHHHHH----------HHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchh
Confidence 9997 8999888653 66666555443 6778889999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHH--HhhhC-cccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVL--KKQEG-KEYLFN 242 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~--~~~~~-~~~~~~ 242 (351)
+.+.-+....+..+-|.+|++|.++.+........|+||.|||+.|+.. |++.|.+.+..++... ..... ....+|
T Consensus 149 rafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred hhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 9888777777777789999999999998876666999999999999997 8888877664332111 11000 000011
Q ss_pred cc----------------------ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 243 RK----------------------YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 243 ~~----------------------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.. +.++..-+|+++++|..+|.+|++++.+++||||.+.
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 00 1244567899999999999999999999999999764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=324.77 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=209.2
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|++.+.||+|+||.||+|.+..+++.+|+|.+.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 46899999999999999999999999999999987654443333344556899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 86 MDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||+++++|.+++.... ...+++.. ++.++.|++.||.|||+++++|+||||+||+++.++.++|+||
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~----------~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERT----------VWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHH----------HHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999886432 22344433 3356788899999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|++..............|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||..................+....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP 229 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCC
Confidence 999876544433345578999999999988777665 9999999999999999999965543333443333332222222
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...++..+.+++.+||+.+|++|||+.++++.
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 23578899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=328.66 Aligned_cols=256 Identities=26% Similarity=0.362 Sum_probs=202.5
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEE------e
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVK------A 78 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~------~ 78 (351)
...|++.+.||.|+||.||+|.+..+++.+|+|.+...... ...+..|+.+++++ +||||+++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE----EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH----HHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 45799999999999999999999999999999988654322 22344799999998 6999999999984 3
Q ss_pred CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
....|++|||+.+|+|.+++.......+++... ..++.|++.||.|||++|++|+||+|+||++++++.+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~----------~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI----------AYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHH----------HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 568999999999999999997654455555432 3467788899999999999999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccceeccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN-----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 233 (351)
+|+|||++..............|++.|+|||++.. ..++.+ +|+|||||++|+|++|..||...... .....
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~--~~~~~ 237 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPM--RALFL 237 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHHHHhCCCCccccCHH--hhhhh
Confidence 99999998865443333445678999999999752 345544 99999999999999999999654321 11111
Q ss_pred hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
.............++.++.+||.+||+.||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 111111111223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=326.63 Aligned_cols=258 Identities=32% Similarity=0.478 Sum_probs=210.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||.|++|.||+|.+..+++.+|+|.+........ ...+.+|+.+++.++||||+++++++.++...|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchH--HHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 68899999999999999999999999999999875532221 2334589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++++|.+++... .+++.... .++.|++.||.|||+++++|+||+|+||++++++.++|+|||.++
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~----------~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 80 YCGGGSCLDLLKPG---KLDETYIA----------FILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred eeCCCcHHHHHhhc---CCCHHHHH----------HHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccce
Confidence 99999999999752 55555443 456788888889999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.............|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||..... ...................+
T Consensus 147 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 223 (274)
T cd06609 147 QLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHP--MRVLFLIPKNNPPSLEGNKF 223 (274)
T ss_pred eecccccccccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCch--HHHHHHhhhcCCCCCccccc
Confidence 87654444455678999999999988887765 9999999999999999999975442 22222222111111111127
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
+..+.+++.+||..||++|||++++++||||++...
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 889999999999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=326.77 Aligned_cols=254 Identities=30% Similarity=0.442 Sum_probs=203.7
Q ss_pred cCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCCh
Q psy6327 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDL 94 (351)
Q Consensus 15 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL 94 (351)
||+|+||+||+|.+..+|+.+|+|.+.............+.+|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998765544433344445899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc
Q psy6327 95 EHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE 174 (351)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 174 (351)
.+++.......+++.... .++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~~----------~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~ 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAI----------FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GK 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHH----------HHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CC
Confidence 999976443456655443 4567888888999999999999999999999999999999999876543 22
Q ss_pred cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHhhhCccccccccccCCHhHHH
Q psy6327 175 LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR-NRDVLKKQEGKEYLFNRKYEISIGAKQ 253 (351)
Q Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~ 253 (351)
......++..|+|||.+.+..++.+ +|+||+|+++|+|++|+.||...... ......... .......+..+++.+.+
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKD 227 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-ccccccCCccCCHHHHH
Confidence 2334567889999999887776655 99999999999999999999765431 111111111 11112223357999999
Q ss_pred HHHHhcCCCCCCCC-----CHHHHhcCccccCC
Q psy6327 254 LIGRMLEPNPKHRP-----NAKDVQNHAWIQNE 281 (351)
Q Consensus 254 li~~~L~~dp~~Rp-----t~~ell~hp~~~~~ 281 (351)
+|.+||+.||.+|| ++.++++||||...
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 99999999999999 88889999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=327.93 Aligned_cols=257 Identities=25% Similarity=0.480 Sum_probs=202.4
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||+|.++.+++.+|+|.+....... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 6899999999999999999999999999999886443222 123345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++++|..++.. ...+++.... .++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~----------~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 81 YCDHTVLNELEKN--PRGVPEHLIK----------KIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred ccCccHHHHHHhC--CCCCCHHHHH----------HHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccce
Confidence 9998888877654 3445554433 467788889999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh-hC---------
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ-EG--------- 236 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~--------- 236 (351)
.............++..|+|||.+.+.. ++. ++|+||+|+++|+|++|..||.+............ ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 149 ILTGPGDDYTDYVATRWYRAPELLVGDTQYGP-PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred ecCCCcccccCcccccccCCHHHHhCCCCcCc-hhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 7655443344556889999999987644 444 49999999999999999999976542211110000 00
Q ss_pred ---ccc----ccc----------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 ---KEY----LFN----------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 ---~~~----~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
..+ ..+ ....++..+.+||.+||+.||++|||+.+++.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 000 012468889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=343.02 Aligned_cols=253 Identities=30% Similarity=0.474 Sum_probs=199.4
Q ss_pred ceeeeeecCcccceEEEEEEec--CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDK--RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+|.+++.||+|+||.||+|... .++..+++|.+.... ...+|+.+++.++||||+++++++......|+|
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 5999999999999999999754 456889999875322 223899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
||++. ++|.+++.. ...+++.. ++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 165 ~e~~~-~~l~~~l~~--~~~l~~~~----------~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 165 MPKYK-CDLFTYVDR--SGPLPLEQ----------AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred ehhcC-CCHHHHHHh--cCCCCHHH----------HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcc
Confidence 99996 789998854 45566544 345677888999999999999999999999999999999999999
Q ss_pred cccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHh----hhC--
Q psy6327 166 SRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN-RDVLKK----QEG-- 236 (351)
Q Consensus 166 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~----~~~-- 236 (351)
++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..... ...+.. ...
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 976543322 2235679999999999988888765 999999999999999999996543211 011100 000
Q ss_pred -----------------------cccccc---ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 237 -----------------------KEYLFN---RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 237 -----------------------~~~~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
..+..+ .....+.++.+||.+||+.||++|||+.++|.||||+..+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 000000 0123567899999999999999999999999999998654
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=323.49 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=206.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh------HHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR------DYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.|++.+.||+|++|.||+|.+..+++.+|+|.+....... ......+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999999999999999886543321 2223456689999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++||||+++++|.+++.. ...+++... ..++.|++.||.|||++|++|+||+|+||++++++.++|+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~----------~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN--YGAFEETLV----------RNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred cEEEEEecCCCCHHHHHHh--ccCccHHHH----------HHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEec
Confidence 9999999999999999976 345555443 3467788899999999999999999999999999999999
Q ss_pred eccccccccCCcc------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh
Q psy6327 162 DFGFSRLLRTPKE------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 162 Dfg~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 235 (351)
|||.++....... ......|++.|+|||.+.+..++.. +|+||+||++|+|++|..||..... ........
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~ 225 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQ--LQAIFKIG 225 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccH--HHHHHHHh
Confidence 9999987653211 1123458899999999988777665 9999999999999999999976432 22222211
Q ss_pred CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
. ......+..++..+.++|.+||++||++||++.++++||||
T Consensus 226 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 226 E-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred c-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 1 11122234688999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=329.66 Aligned_cols=264 Identities=29% Similarity=0.410 Sum_probs=207.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh--hHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK--RDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... .......+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999765543 122334445899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+ +++|.+++.... ..+++... +.++.||++||.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~----------~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADI----------KSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHH----------HHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEcccee
Confidence 9999 899999997632 24555443 34677888999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc--------
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK-------- 237 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------- 237 (351)
++.............+++.|+|||.+.+......++|+||+||++|+|++|.+||..... ..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 149 ARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEEN 226 (298)
T ss_pred eeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcCCCchhh
Confidence 987665444444456788999999986544333459999999999999999888865432 1111111000
Q ss_pred --------ccc----------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccc
Q psy6327 238 --------EYL----------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQ 285 (351)
Q Consensus 238 --------~~~----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 285 (351)
.+. ......++..+.+||.+||++||++|||+.++++||||++.+...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 000 000124578899999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=345.55 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=197.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|.+.+.||+|+||.||+|.+..+++.||+|.... ....+|++++++|+|||||++++++..++..++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 369999999999999999999999999999996422 12238999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|++. ++|.+++... ...++... ++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 240 e~~~-~~L~~~l~~~-~~~l~~~~----------~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 240 PKYR-SDLYTYLGAR-LRPLGLAQ----------VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred EccC-CCHHHHHHhc-CCCCCHHH----------HHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 9996 7898888652 23455443 3457788899999999999999999999999999999999999999
Q ss_pred ccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC------chHHHHhhhCcc
Q psy6327 167 RLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR------NRDVLKKQEGKE 238 (351)
Q Consensus 167 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~ 238 (351)
+....... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..|+...... .......+....
T Consensus 308 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~ 386 (461)
T PHA03211 308 CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ 386 (461)
T ss_pred eecccccccccccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence 86543222 2234579999999999988888765 99999999999999987665322110 111111111000
Q ss_pred c--------------------------------cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 239 Y--------------------------------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 239 ~--------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
. .+.....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 387 VHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 00011135678999999999999999999999999999974
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=328.71 Aligned_cols=258 Identities=26% Similarity=0.443 Sum_probs=203.1
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||.|++|.||+|.+..+++.+|+|.+........ ....+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc-cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999998865443222 22345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+. ++|.+++.......+++.... .++.|++.||+|||+++++|+||+|+||+++.++.+||+|||++.
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~----------~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIK----------SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 996 789998876444555554433 467788889999999999999999999999999999999999988
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--cc-------
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KE------- 238 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~------- 238 (351)
.............+++.|+|||.+.+......++|+||||+++|+|++|+.||...... ......... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred hcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhh
Confidence 66544333344567899999999876554344599999999999999999999754321 111110000 00
Q ss_pred --------cc---------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 239 --------YL---------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 239 --------~~---------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
.. ......++.+++++|.+||+.||++|||+.+++.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00 00112468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=320.22 Aligned_cols=256 Identities=30% Similarity=0.524 Sum_probs=210.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||.+.+..+++.+|+|.+......... ...+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE-REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHH-HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 589999999999999999999999999999998765544333 2345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+.+++|.+++.......+++.... .++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~----------~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQIL----------DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHH----------HHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeecccee
Confidence 9999999999976434455555443 456788888899999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.............|++.|+|||++.+..++.+ +|+||+||++|+|++|..||.... ..+......... ..+.+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~ 225 (256)
T cd08218 150 VLNSTVELARTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGN--MKNLVLKIIRGS-YPPVSSHY 225 (256)
T ss_pred ecCcchhhhhhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCC--HHHHHHHHhcCC-CCCCcccC
Confidence 76554433344568999999999988777665 999999999999999999997543 222222222221 12233467
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
+.++.++|.+||+.+|++||++.++++||||
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 8999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=331.39 Aligned_cols=265 Identities=26% Similarity=0.431 Sum_probs=205.2
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--CE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--TY 81 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~ 81 (351)
..+.+|++.+.||+|+||.||+|.+..+|..||+|.+......... .....+|+.++++++|+||+++++++.+. +.
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI-PISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC-cchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 4678899999999999999999999999999999998755433221 12234799999999999999999998755 57
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++||||+. ++|.+++... ...+++... ..++.|++.||.|||++|++|+||||+||+++.++.+||+
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~----------~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNM-PTPFSESQV----------KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred EEEEEecCC-CCHHHHHHhc-ccCCCHHHH----------HHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEC
Confidence 899999997 6898888653 244555443 3467788889999999999999999999999999999999
Q ss_pred eccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-----
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG----- 236 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----- 236 (351)
|||.+..............+++.|+|||.+.+......++|+||+||++|+|++|.+||...+. .........
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~ 228 (309)
T cd07845 151 DFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTP 228 (309)
T ss_pred ccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCC
Confidence 9999987654433333445688999999987644333459999999999999999999975442 222111100
Q ss_pred --------------ccccccc---------cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 237 --------------KEYLFNR---------KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 237 --------------~~~~~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
..+..+. ....+..+.+||.+||++||++|||+.++++||||+..+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 0000000 0125888999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=328.13 Aligned_cols=260 Identities=30% Similarity=0.472 Sum_probs=208.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||++.+..+++.|++|.+.............+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999876654333333455589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++|++|.+++.. ...+++.... .++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~----------~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 82 YVEGGDCATLLKN--IGALPVDMAR----------MYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 9999999999976 3556665443 356678888999999999999999999999999999999999986
Q ss_pred cccCCc---------------ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q psy6327 168 LLRTPK---------------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 168 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 232 (351)
...... .......|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||.+.. ......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~--~~~~~~ 226 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDT--PEELFG 226 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC--HHHHHH
Confidence 421100 01112457889999999988777765 999999999999999999997543 233333
Q ss_pred hhhCcccccc-ccccCCHhHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCc
Q psy6327 233 KQEGKEYLFN-RKYEISIGAKQLIGRMLEPNPKHRPN---AKDVQNHAWIQNEP 282 (351)
Q Consensus 233 ~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~~~~ 282 (351)
.........+ ....++.++.++|.+||+.||++||+ +.++++||||...+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 3322222222 22257899999999999999999998 78999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=353.88 Aligned_cols=248 Identities=29% Similarity=0.437 Sum_probs=206.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeE-EE---e---C
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRM-VK---A---G 79 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~-~~---~---~ 79 (351)
.+++.+.|.+|||+.||+|.+...|..||+|.+-.. +....+.+.+||++|++|+ |+|||.+++. .. . .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 478899999999999999999988899999988655 3333566679999999997 9999999993 21 1 1
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEcCCCC
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILISRLLN 157 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~~~~~ 157 (351)
-.++|+||||.||.|-|++.+.....+.+.+ +++|+.|+|+|+.+||... |||||||-|||||+.+++
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~e----------VLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDE----------VLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHH----------HHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 3588999999999999999987777787765 4567889999999999987 999999999999999999
Q ss_pred eEEeeccccccccCCcccc---------cccccccceeccccc---cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q psy6327 158 AKLADFGFSRLLRTPKELS---------NTFCGTTSYAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGT 225 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~---------~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (351)
+||||||.|+..-...... -....|+.|+|||++ .+.+.+.+ +|||||||+||-|+....||...+.
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 9999999997543222111 123479999999986 46667765 9999999999999999999987642
Q ss_pred CchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 226 RNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
. .+....|.+|.....+..+++||+.||+.||++||++.|++.+
T Consensus 264 l------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 264 L------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred e------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 2 3456788888888999999999999999999999999999864
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=322.16 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=203.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh--HHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--CCEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR--DYMEKFAPREIDILLKVSHPNIIGVHRMVKA--GTYL 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~ 82 (351)
.+|+..+.||+|+||.||+|.+..++..+++|.+....... ......+.+|+.+++.++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36899999999999999999999999999999886543221 1223445689999999999999999999865 4678
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++++||+++++|.+++.. ...+++... +.++.|++.||+|||+++++|+||+|+||+++.++.++|+|
T Consensus 82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~----------~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA--YGALTESVT----------RKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHH----------HHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEcc
Confidence 999999999999999976 344554333 34677899999999999999999999999999999999999
Q ss_pred ccccccccCCc---ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 163 FGFSRLLRTPK---ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 163 fg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
||++....... .......++..|+|||.+.+..++.. +|+||+||++|+|++|+.||..... ............
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~--~~~~~~~~~~~~ 226 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEA--MAAIFKIATQPT 226 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccch--HHHHHHHhcCCC
Confidence 99987654321 11223458899999999988777665 9999999999999999999976532 222222222222
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
....+..++..++++| +||..+|++|||+.|+++||||+
T Consensus 227 ~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 2222345788899999 68888999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=326.67 Aligned_cols=242 Identities=17% Similarity=0.282 Sum_probs=196.1
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe----CCEEEEEEec
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA----GTYLYMIMDY 88 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~~lv~e~ 88 (351)
..||+|++|.||+|.+ +|+.||+|.+.............+.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999987 589999999876554444444556699999999999999999999876 4578999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
++||+|.+++.+ ...++.. .++.++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++
T Consensus 104 ~~~g~L~~~l~~--~~~~~~~----------~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 104 CTRGYLREVLDK--EKDLSFK----------TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CCCCcHHHHHhh--CCCCChh----------HHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 999999999976 3444433 244578899999999998 499999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRN--SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
...... ....|++.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.. ..+............+.+.
T Consensus 172 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~ 245 (283)
T PHA02988 172 ILSSPP---FKNVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLT--TKEIYDLIINKNNSLKLPL 245 (283)
T ss_pred hhcccc---ccccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhcCCCCCCCC
Confidence 654322 23468999999999976 556655 999999999999999999997654 3344444333333334444
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.++..+++|+.+||+.||++|||+.++++
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 68999999999999999999999999975
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=321.10 Aligned_cols=254 Identities=30% Similarity=0.440 Sum_probs=208.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.+..+++.+++|.+..... ...+.+|+.+++.++||||+++++++.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 579999999999999999999998899999999865432 344558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+.+++|.+++... ...+++.... .++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~----------~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIA----------AILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHH----------HHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccc
Confidence 999999999998653 3445554433 46778888899999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
..............|+..|+|||++.+..++.+ +||||+|+++|+|++|+.||........ .................
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 147 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRA-IFMIPNKPPPTLSDPEK 224 (256)
T ss_pred hhcccCccccccccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhh-hhhhccCCCCCCCchhh
Confidence 876554433444568899999999988877765 9999999999999999999976442211 11111111122223335
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
++.++.++|.+||+.||++|||+.+++.||||
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=336.23 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=198.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv 85 (351)
.+|+++++||+||.+.||++...+ .+.||+|++......... ..-+.+||..|.+|+ |.+||+++++-..++.+|+|
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qt-l~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQT-LDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHH-HHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 469999999999999999998654 456677766555444444 344459999999996 99999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||=+ .+|..+|++.. ...+....+ .|..|++.|++++|+.||||.||||.|+|+-+ |.+||+|||.
T Consensus 439 mE~Gd-~DL~kiL~k~~-~~~~~~~lk----------~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGI 505 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKK-SIDPDWFLK----------FYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGI 505 (677)
T ss_pred eeccc-ccHHHHHHhcc-CCCchHHHH----------HHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeech
Confidence 99765 99999998742 222222222 35678888999999999999999999999987 7899999999
Q ss_pred cccccCCcc--cccccccccceeccccccCCCCC----------CCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh
Q psy6327 166 SRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYN----------PKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 166 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 233 (351)
|..+..... ...+.+||+.||+||.+....++ .+++||||||||||+|+.|++||..... ....+..
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-~~aKl~a 584 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-QIAKLHA 584 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-HHHHHHh
Confidence 998765432 34577899999999998543322 3348999999999999999999975431 1122222
Q ss_pred hhCccc--cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 234 QEGKEY--LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 234 ~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
+....- .++.-. -..++.++++.||..||++|||+.++|+|||++..+-
T Consensus 585 I~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred hcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 222211 222211 1224999999999999999999999999999987544
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=362.46 Aligned_cols=261 Identities=27% Similarity=0.463 Sum_probs=204.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--CCEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA--GTYL 82 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~ 82 (351)
.+.+|.+++.||+|+||+||+|.+..++..+|+|++.......... ..+..|+.+++.|+|||||+++++|.. ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~-~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHH-HHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 4567999999999999999999999999999999987655444333 344589999999999999999998854 4679
Q ss_pred EEEEecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-------CceeccCCCCCEeEc
Q psy6327 83 YMIMDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEV-------GIVHRDIKCENILIS 153 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-------~i~H~Dlkp~NIll~ 153 (351)
||||||+++|+|.++|.... ...+++..+. .++.||+.||.|||+. +|+||||||+||||+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il----------~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV----------DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHH----------HHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 99999999999999997532 2346655433 4677888888999984 499999999999996
Q ss_pred CC-----------------CCeEEeeccccccccCCcccccccccccceeccccccCC--CCCCCcchHHHHHHHHHHHH
Q psy6327 154 RL-----------------LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS--PYNPKLADIWSLGVVLYRIL 214 (351)
Q Consensus 154 ~~-----------------~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll 214 (351)
.+ +.+||+|||++...... ......+||+.|+|||++.+. .++.+ +|||||||++|+|+
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~K-SDVWSLG~ILYELL 237 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELC 237 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCch-hHHHHHHHHHHHHH
Confidence 42 34899999999865432 223455799999999998643 35544 99999999999999
Q ss_pred hCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 215 NKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 215 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
+|..||..... ........... +..+ ....+.++.+||.+||+.+|.+||++.|+|.|||+...
T Consensus 238 TGk~PF~~~~~-~~qli~~lk~~-p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 238 SGKTPFHKANN-FSQLISELKRG-PDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HCCCCCCcCCc-HHHHHHHHhcC-CCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 99999975432 22222222221 2222 12468899999999999999999999999999999743
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=320.65 Aligned_cols=256 Identities=29% Similarity=0.427 Sum_probs=207.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||.|+||.||+|.+..+++.+++|.+...... ....+.+|+.++++++||||+++++++......|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 4699999999999999999999999999999998755433 2344558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+.+++|.+++... ...+++.... .++.|++.||.|||+++++|+||+|+||++++++.++|+|||.+
T Consensus 80 e~~~~~~l~~~~~~~-~~~l~~~~~~----------~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 80 EYCGGGSLQDIYQVT-RGPLSELQIA----------YVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred eCCCCCcHHHHHHhh-ccCCCHHHHH----------HHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccc
Confidence 999999999998763 2456655433 46778888999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-cccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNS---PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG-KEYLFN 242 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~ 242 (351)
..............++..|+|||.+... .++.. +|+||+|+++|+|++|..||.+.............. ......
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~-~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 149 AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK 227 (262)
T ss_pred hhhhhhhhccccccCCccccCchhhcccccCCcCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc
Confidence 8765443334456789999999998766 66654 999999999999999999997654222211111110 111122
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAW 277 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 277 (351)
....++.++.+|+.+||..||.+|||+.+++.|||
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 23356788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=323.40 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=206.1
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC---CCCceeeeeEEEeCCEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS---HPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~l 84 (351)
.|++++.||+|+||.||+|.+..++..+|+|.+........ ...+.+|+.+++.+. |||++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD--VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh--HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 47889999999999999999999999999998865432221 233458999999986 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||++|++|.+++.. ..+++... +.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||
T Consensus 80 v~e~~~~~~L~~~~~~---~~l~~~~~----------~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 80 IMEYAEGGSVRTLMKA---GPIAEKYI----------SVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred EEecCCCCcHHHHHHc---cCCCHHHH----------HHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCC
Confidence 9999999999999865 34554443 3467788899999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
.+..............|++.|+|||.+.+......++|+||||+++|+|++|..||...... ..........+.....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 224 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--RAMMLIPKSKPPRLED 224 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--hhhhccccCCCCCCCc
Confidence 99876554444445678999999999876544334599999999999999999999754421 1111111111111111
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
...+.++.+++.+||+.||++||++.+++.||||+....
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 137889999999999999999999999999999986543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=327.52 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=203.4
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|+++++||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.++...|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 6899999999999999999999999999999986544333 233445589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++++|..+... ...++... ++.++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~----------~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 81 FVDHTVLDDLEKY--PNGLDESR----------VRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred cCCccHHHHHHhc--cCCCCHHH----------HHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 9999888887654 23344443 34467788999999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-----------
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG----------- 236 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----------- 236 (351)
.............++..|+|||++.+......++||||+|+++|+|++|.+||..... .+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 149 TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHH
Confidence 7655444444567899999999987644333459999999999999999999965431 111110000
Q ss_pred -------------c-----cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 -------------K-----EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 -------------~-----~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
. .........++..+.+|+.+||+.||++||++.++++||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 00000122578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=322.21 Aligned_cols=256 Identities=28% Similarity=0.462 Sum_probs=211.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||.|+||.||+|.+..++..+|+|.+...........+.+.+|++++++++||||+++++.+.++...|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48999999999999999999999999999999986655443344556689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+.|++|.+++... ..+++..+. .++.|++.||.|||+++++|+||+|+||++++++.++|+|||.+.
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~----------~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVK----------FWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHH----------HHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 99999999999763 456655443 466788888999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
...... ......|+..|+|||.+.+..++.+ +|+||+|+++|+|++|..||................. .....+..+
T Consensus 149 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (258)
T cd05578 149 KVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATW 225 (258)
T ss_pred ccCCCc-cccccCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccC
Confidence 764432 2344568899999999988776665 9999999999999999999976553222222222221 222333467
Q ss_pred CHhHHHHHHHhcCCCCCCCCCH--HHHhcCccc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNA--KDVQNHAWI 278 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~--~ell~hp~~ 278 (351)
+..+.++|.+||+.||.+||++ .|+++||||
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 8999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=323.96 Aligned_cols=258 Identities=25% Similarity=0.396 Sum_probs=202.5
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeC-----
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAG----- 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~----- 79 (351)
..+|.+.+.||+|+||.||+|.+..+++.+|+|.+...... ...+.+|+.+++++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 45599999999999999999999999999999988643222 23344799999999 799999999998643
Q ss_pred CEEEEEEecCCCCChHHHHHhh--ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKA--CNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN 157 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~ 157 (351)
+..|+||||++|++|.++++.. ....+++.. +..++.|++.||+|||+.+++|+||||+||+++.++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~----------~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAM----------ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHH----------HHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC
Confidence 4689999999999999998642 123455443 3346778889999999999999999999999999999
Q ss_pred eEEeeccccccccCCcccccccccccceeccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q psy6327 158 AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSP-----YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 232 (351)
+||+|||++..............|++.|+|||.+.... ++. ++|+||+||++|+|++|+.||..... ......
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Di~slGvi~~el~~g~~p~~~~~~-~~~~~~ 244 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDA-RCDVWSLGITAIELGDGDPPLFDMHP-VKTLFK 244 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCC-ccchHHHHHHHHHHhhCCCCCCCCcH-HHHHHH
Confidence 99999999987654443344567899999999976433 344 49999999999999999999975432 112222
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
...........+..++..+.+||.+||+.||++||++.++++||||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 245 IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 21222222223345778899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=326.50 Aligned_cols=266 Identities=26% Similarity=0.436 Sum_probs=214.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|.+++.||+|+||.||++.+..+++.+++|.+....... ...+.+|+.+++.++||||+++++++......|+|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH---HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 56999999999999999999999899999999986433222 334558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|.+++.+ ..+++.. +..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 96 e~~~~~~L~~~~~~---~~l~~~~----------~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 96 EYLAGGSLTDVVTE---TCMDEGQ----------IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred ecCCCCcHHHHHhh---cCCCHHH----------HHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 99999999999865 2344433 3346788999999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
..............|++.|+|||.+....++.+ +|+||+|+++|++++|..||........ ...........+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPELQNPEK 240 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhcCCCCCCCCccc
Confidence 766544444445578999999999988777665 9999999999999999999975432111 11111112222333345
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccccCCHH
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAE 290 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~ 290 (351)
++..++++|.+||..+|++||++.+++.||||+.......+++-
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~ 284 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPL 284 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccch
Confidence 78899999999999999999999999999999987766665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=319.52 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=203.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh--hHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--CCEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK--RDYMEKFAPREIDILLKVSHPNIIGVHRMVKA--GTYL 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~ 82 (351)
.+|++.+.||+|+||.||.+.+..++..+|+|.+...... .......+.+|+.+++++.||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999999999999999987643321 12223455689999999999999999999866 3578
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
+++|||++|++|.+++.+ ...+++... +.++.|++.||.|||+++++|+||+|+||+++.++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~----------~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS--YGALTENVT----------RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred EEEEEecCCCcHHHHHHH--cCCCCHHHH----------HHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECc
Confidence 899999999999999876 344554433 34677889999999999999999999999999999999999
Q ss_pred ccccccccCCc---ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 163 FGFSRLLRTPK---ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 163 fg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
||.++...... .......|+..|+|||++.+..++.. +|+|||||++|+|++|+.||.... .............
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~ 226 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFE--AMAAIFKIATQPT 226 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccc--hHHHHHHHhcCCC
Confidence 99988654321 11233568999999999987776655 999999999999999999997643 2222222222222
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
....+..++..+.++|.+||. +|++||+++++++|||++
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 222334678899999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=319.69 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=203.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh---hHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK---RDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+|++.+.||.|+||.||+|.+ .+++.+|+|.+..+... .......+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588899999999999999986 47889999988654321 12223446689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
++||++|++|.+++.+ ...+++.... .++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 80 v~e~~~~~~L~~~l~~--~~~~~~~~~~----------~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 147 (265)
T cd06631 80 FMEFVPGGSISSILNR--FGPLPEPVFC----------KYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFG 147 (265)
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccch
Confidence 9999999999999976 3456655443 356788889999999999999999999999999999999999
Q ss_pred ccccccCC------cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc-
Q psy6327 165 FSRLLRTP------KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK- 237 (351)
Q Consensus 165 ~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~- 237 (351)
++...... ........|++.|+|||.+.+..++.. +|+||||+++|+|++|..||..... ..........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~ 224 (265)
T cd06631 148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDR--LAAMFYIGAHR 224 (265)
T ss_pred hhHhhhhccccccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCCh--HHHHHHhhhcc
Confidence 98764321 112234568999999999988777765 9999999999999999999975432 1111111111
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
......+..++.++.+||.+||+.+|++||++.++++||||
T Consensus 225 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 225 GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 12222334688999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=319.82 Aligned_cols=273 Identities=27% Similarity=0.438 Sum_probs=207.4
Q ss_pred CCCCccceeeeeecCcccceEEEEEEecCCce----eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE
Q psy6327 2 KFPDILECSYISKLGEGAYGNVYLVSDKRSET----LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK 77 (351)
Q Consensus 2 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 77 (351)
+.+++.+|..++.||+|+||.||+|..+.++. .+|+|+|......... .....||+.+++.|+||||+.+..++-
T Consensus 19 rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 19 RVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-SMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred hHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 44678889999999999999999997665543 7899998766443322 233349999999999999999999997
Q ss_pred e-CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-
Q psy6327 78 A-GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL- 155 (351)
Q Consensus 78 ~-~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~- 155 (351)
+ +..+++++||.+ .+|+..|+-...... +.+.+.+. -.++.||+.|++|||++-|+||||||.|||+..+
T Consensus 98 ~~d~~v~l~fdYAE-hDL~~II~fHr~~~~-----~~lp~~mv--KsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg 169 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAE-HDLWHIIKFHRASKA-----KQLPRSMV--KSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG 169 (438)
T ss_pred ccCceEEEEehhhh-hhHHHHHHHhccchh-----ccCCHHHH--HHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC
Confidence 6 889999999997 999999975432221 12222222 2468899999999999999999999999999877
Q ss_pred ---CCeEEeeccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC---
Q psy6327 156 ---LNAKLADFGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--- 226 (351)
Q Consensus 156 ---~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--- 226 (351)
|.+||+|||+++.+..+-.. ....+-|.+|+|||++.+...++++.||||.|||+.||++-++.|.+....
T Consensus 170 perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~ 249 (438)
T KOG0666|consen 170 PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT 249 (438)
T ss_pred CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhccc
Confidence 89999999999998766442 234567999999999999888878899999999999999998888543211
Q ss_pred ----chHHHHhhh---C---------------c---------cccccc--------cccCCHhHHHHHHHhcCCCCCCCC
Q psy6327 227 ----NRDVLKKQE---G---------------K---------EYLFNR--------KYEISIGAKQLIGRMLEPNPKHRP 267 (351)
Q Consensus 227 ----~~~~~~~~~---~---------------~---------~~~~~~--------~~~~s~~~~~li~~~L~~dp~~Rp 267 (351)
..+.+..+- + . .+..+. ...-++.+.+|+.+||++||.+|+
T Consensus 250 ~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI 329 (438)
T KOG0666|consen 250 KNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI 329 (438)
T ss_pred CCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc
Confidence 111111100 0 0 000000 001245689999999999999999
Q ss_pred CHHHHhcCccccCCcc
Q psy6327 268 NAKDVQNHAWIQNEPT 283 (351)
Q Consensus 268 t~~ell~hp~~~~~~~ 283 (351)
|++++|+|+||...+.
T Consensus 330 ta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 330 TAEQALEHPYFTEDPL 345 (438)
T ss_pred cHHHHhcccccccCCC
Confidence 9999999999987643
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=324.90 Aligned_cols=260 Identities=26% Similarity=0.459 Sum_probs=200.3
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
--+.+|++.+.||+|++|.||+|.++.+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+....|
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence 34678999999999999999999999999999999986543221 1223348999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+. ++|.+++... ...+++..+. .++.|++.||.|||+++++|+||||+||+++.++.+||+||
T Consensus 80 lv~e~~~-~~L~~~~~~~-~~~~~~~~~~----------~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 147 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDC-GGGLSMHNVR----------LFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADF 147 (291)
T ss_pred EEEecCC-CCHHHHHHhC-CCCCCHHHHH----------HHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECcc
Confidence 9999998 5999988753 2345555443 35668888889999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh--C----
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE--G---- 236 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--~---- 236 (351)
|+++.............+++.|+|||++.+.. ++. ++||||+|+++|+|++|..||.+............. .
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07844 148 GLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYST-SLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE 226 (291)
T ss_pred ccccccCCCCccccccccccccCCcHHhhcCcccCc-HHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCCh
Confidence 99876543332233345788999999987644 444 499999999999999999999654421111100000 0
Q ss_pred ------------cccc---------ccccccCC--HhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 ------------KEYL---------FNRKYEIS--IGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 ------------~~~~---------~~~~~~~s--~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
.... ......++ .++.+++.+||++||++|||+.++++||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 00001234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=318.30 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=208.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|++.+.||+|+||.||++.+..+++.+++|.+....... .....+.+|+.+++.++|+||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDP-KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccch-HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 4889999999999999999999999999999987665542 234455689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++++|.+++.. ...+++.... .++.|++.||.|||+.|++|+||+|+||++++++.+||+|||++.
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~----------~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 80 YCSGGTLEELLEH--GRILDEHVIR----------VYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred cCCCCcHHHHHhh--cCCCChHHHH----------HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccccccc
Confidence 9999999999976 3334444333 467788899999999999999999999999999999999999998
Q ss_pred cccCCcccc----cccccccceeccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 168 LLRTPKELS----NTFCGTTSYAAPEIIRNSP---YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 168 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
......... ....+++.|+|||++.... ...+ +||||+|+++|+|++|..||....................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~-~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP 226 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcc-cchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCC
Confidence 765433222 2356889999999987665 4544 9999999999999999999975432222222222222333
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
.+....++..+.+||.+||+.||++|||+.+++.|||+
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 44444568999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=339.70 Aligned_cols=255 Identities=30% Similarity=0.531 Sum_probs=218.3
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
-+.||+|.||+||-|+++++|+.||||++++.+..... +..+++|+.||..+.||+||.+.-.|++.+.+|+|||.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~- 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH- 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-
Confidence 47899999999999999999999999999887775544 3556699999999999999999999999999999999997
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC---CCeEEeecccccc
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL---LNAKLADFGFSRL 168 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~---~~~kl~Dfg~a~~ 168 (351)
|+..+.|-+...+++++...+..+ .||+.||.|||-+||+|+||||+|||+... -.+||||||+|+.
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlv----------tQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLV----------TQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHH----------HHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 777777766678899998887754 456666779999999999999999999764 4699999999998
Q ss_pred ccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc--ccc
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR--KYE 246 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~ 246 (351)
+.+ .....+.+|||.|.|||++.++.|+.. .|+||.|+|+|.-++|..||.. +++.-.++.+..+.+|. +.+
T Consensus 717 IgE-ksFRrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQNAaFMyPp~PW~e 790 (888)
T KOG4236|consen 717 IGE-KSFRRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQNAAFMYPPNPWSE 790 (888)
T ss_pred cch-hhhhhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCC----ccchhHHhhccccccCCCchhh
Confidence 765 345667889999999999999999976 8999999999999999999964 23444455555555443 457
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTC 284 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 284 (351)
++.++.|||..+|+..-.+|.|++..|.|||+++....
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w 828 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTW 828 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHH
Confidence 99999999999999999999999999999999986543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=324.33 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=199.6
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
...+|++++.||+|+||.||+|.+..++..+|+|.+....... ....+.+|+.+++.++|+||+++++++.++...|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 4568999999999999999999999999999999986543322 12234489999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+. ++|.+++... ...++..... .++.|++.||.|||++|++|+||||+|||++.++.++|+|||
T Consensus 81 v~e~~~-~~l~~~~~~~-~~~~~~~~~~----------~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 81 VFEYMH-TDLAQYMIQH-PGGLHPYNVR----------LFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred EEeccc-CCHHHHHHhC-CCCCCHHHHH----------HHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccc
Confidence 999996 7887776542 2334443332 356788999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh--------
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE-------- 235 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------- 235 (351)
+++.............+++.|+|||++.+.. ++. ++|+|||||++|+|++|..||...............
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 149 LARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS-ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred cccccCCCCCCCCCccccccccCCceeecCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 9986544333344556899999999987644 444 489999999999999999999754321111111000
Q ss_pred ------C-cc---ccc-----------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 236 ------G-KE---YLF-----------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 236 ------~-~~---~~~-----------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
. .. ... ......+.++.+++.+||..||++|||+.|++.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00 000 0011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=319.07 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=206.6
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||.|+||+||+|....++..+++|++....... ....+.+|+.+++.++|+||+++++.+..+...++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 6899999999999999999999899999999986544333 23445689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhcc-CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKKDLEHYISKACN-ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
+++|++|.+++..... ..+++.... .++.|++.||.|||++|++|+||+|+||++++++.++|+|||++
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~----------~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIA----------TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 9999999999976322 345555444 35677888888999999999999999999999999999999998
Q ss_pred ccccCCccc----ccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 167 RLLRTPKEL----SNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 167 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
......... .....|++.|+|||.+... .++. ++|+|||||++|+|++|+.||...... ..............
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~ 227 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF-KADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPPSL 227 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCc-ccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCCCc
Confidence 876543322 2345689999999998776 4444 499999999999999999999765421 11111112111112
Q ss_pred ccc---ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 242 NRK---YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 242 ~~~---~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
... ..++..+.+++.+||+.||++|||+.++++||||
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 211 2578899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.95 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=203.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|+||.||+|.+..+|..+++|++......... ...+.+|+.++++++||||+++++++..+...|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~-~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI-PNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchh-hHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 589999999999999999999999999999998765543322 3345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+ +++|.+++... ...+++..+ ..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus 80 ~~-~~~L~~~~~~~-~~~~~~~~~----------~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 80 YM-PSDLSEVLRDE-ERPLPEAQV----------KSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred cc-CCCHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 99 99999998753 244555543 3467788889999999999999999999999999999999999998
Q ss_pred cccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC----------
Q psy6327 168 LLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---------- 236 (351)
Q Consensus 168 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 236 (351)
....... ......|++.|+|||.+.+......++||||+||++|+|++|.+||..... .........
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETW 225 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHH
Confidence 7654332 233456899999999987655434459999999999999999888865431 111110000
Q ss_pred ---------ccccc---------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 237 ---------KEYLF---------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 237 ---------~~~~~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
....+ ......+..+.+||.+||+.||.+|||++++++||||.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00000 00124678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.67 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=207.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|++.+.||+|+||.||+|.+..++..+++|.+.............+.+|+.+++.++||||+++++++..++..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 46799999999999999999999999999999988655443333344556899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 86 MDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
|||++|++|.+++.... ...+++... ..++.|++.||.|||++|++|+||+|+||+++.++.++|+||
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~----------~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTV----------WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999986422 233454433 346778899999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|++..............|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||..................+....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP 229 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCC
Confidence 998876544333345578999999999988777765 9999999999999999999975443333333333322222222
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...++..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 3357889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.34 Aligned_cols=265 Identities=25% Similarity=0.388 Sum_probs=205.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|++.++||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++.+++..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 46899999999999999999999999999999998754444444455566899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhcc-CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 86 MDYAEKKDLEHYISKACN-ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||++||+|.+++..... ..+++.... ...+..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~--~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAE--KTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhc--ccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999999975321 122221111 11234456788899999999999999999999999999999999999999
Q ss_pred ccccccCCc------------------ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q psy6327 165 FSRLLRTPK------------------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR 226 (351)
Q Consensus 165 ~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (351)
+++...... ......+||+.|+|||++.+..++.+ +||||+||++|+|++|..||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 998652111 01123579999999999988887765 99999999999999999999764322
Q ss_pred chHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 227 NRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.... ...............+++.+.+++.+||+.||++|++..+.+.
T Consensus 238 ki~~-~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 238 KISY-RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhh-hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 1111111112222368899999999999999999988665543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=322.98 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=196.9
Q ss_pred ecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHH---HhCCCCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDIL---LKVSHPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 14 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l---~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
.||+|+||.||++.+..+++.+|+|.+...............+|..++ ....||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998765443222222233444433 34479999999999999999999999999
Q ss_pred CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 91 KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 91 ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
|++|.+++.. ...+++.... .++.|++.||.|||+++++|+||||+|||++.++.++|+|||++....
T Consensus 81 ~~~L~~~i~~--~~~l~~~~~~----------~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQ--HGVFSEKEMR----------FYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 9999999876 4556665544 467788889999999999999999999999999999999999987553
Q ss_pred CCcccccccccccceeccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCH
Q psy6327 171 TPKELSNTFCGTTSYAAPEIIRN-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249 (351)
Q Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (351)
... .....|++.|+|||.+.. ..++.+ +|+||+||++|+|++|..||................ ......+..++.
T Consensus 149 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (279)
T cd05633 149 KKK--PHASVGTHGYMAPEVLQKGTAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TVNVELPDSFSP 224 (279)
T ss_pred ccC--ccCcCCCcCccCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-cCCcCCccccCH
Confidence 322 233468999999999864 445544 999999999999999999997654333332222211 111222346889
Q ss_pred hHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 250 GAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 250 ~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
++.++|.+||+.||.+|| |+.++++||||++..
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 225 ELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 999999999999999999 699999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=330.52 Aligned_cols=250 Identities=27% Similarity=0.441 Sum_probs=185.1
Q ss_pred eecCcccceEEEEEEecC--CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE--eCCEEEEEEec
Q psy6327 13 SKLGEGAYGNVYLVSDKR--SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK--AGTYLYMIMDY 88 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~ 88 (351)
.+||+|+||.||+|.++. ++..+|+|.+...... ..+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999654 6688999987644322 22348999999999999999999984 45688999999
Q ss_pred CCCCChHHHHHhhcc-------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE----cCCCC
Q psy6327 89 AEKKDLEHYISKACN-------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI----SRLLN 157 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~-------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll----~~~~~ 157 (351)
+. ++|.+++..... ..+++.. +..++.|++.||.|||+++|+||||||+|||+ +.++.
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~----------~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 150 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSM----------VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 150 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHH----------HHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCc
Confidence 97 688888753211 1233322 34567889999999999999999999999999 45678
Q ss_pred eEEeeccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch------
Q psy6327 158 AKLADFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR------ 228 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------ 228 (351)
+||+|||+++....... ......||+.|+|||++.+......++||||+||++|+|++|++||........
T Consensus 151 ~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07867 151 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH 230 (317)
T ss_pred EEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccccc
Confidence 99999999987654322 223457899999999987755334459999999999999999999964321100
Q ss_pred -HHHH---------------hhh-------------Cccc--------cccccccCCHhHHHHHHHhcCCCCCCCCCHHH
Q psy6327 229 -DVLK---------------KQE-------------GKEY--------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKD 271 (351)
Q Consensus 229 -~~~~---------------~~~-------------~~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e 271 (351)
.... ... ...+ ........+..+++||.+||+.||.+|||+.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e 310 (317)
T cd07867 231 HDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHH
Confidence 0000 000 0000 00001124567899999999999999999999
Q ss_pred HhcCccc
Q psy6327 272 VQNHAWI 278 (351)
Q Consensus 272 ll~hp~~ 278 (351)
+|+||||
T Consensus 311 ~l~hp~f 317 (317)
T cd07867 311 ALQDPYF 317 (317)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=318.65 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=213.0
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|.+.+.||+|++|.||+|.+..+++.+++|.+...... .....+.+|+.++.+++||||+++++++......++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 689999999999999999999999999999998765442 223445689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|+++++|.+++.. ...+++.... .++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+
T Consensus 80 ~~~~~~L~~~l~~--~~~l~~~~~~----------~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 80 YMDGGSLADLLKK--VGKIPEPVLA----------YIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred ecCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999976 3555554433 467788889999999 99999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC-CchHHHHhhhCccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGT-RNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (351)
..............++..|+|||.+....++.+ +|+||||+++|+|++|..||..... ...+....... ........
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (264)
T cd06623 148 KVLENTLDQCNTFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GPPPSLPA 225 (264)
T ss_pred eecccCCCcccceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-CCCCCCCc
Confidence 877554444445678999999999988776665 9999999999999999999976542 12222222222 12222233
Q ss_pred c-CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 246 E-ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 246 ~-~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. ++..+.++|.+||..+|++|||+.++++|||++..
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 4 78999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=318.11 Aligned_cols=256 Identities=27% Similarity=0.494 Sum_probs=208.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE--eCCEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK--AGTYLYMI 85 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~~~~lv 85 (351)
+|++++.||.|+||.||+|.+..++..+|+|.+......... ...+.+|+++++.++||||+++++++. .+...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE-KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH-HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 588999999999999999999999999999998765544333 334558999999999999999999775 45678999
Q ss_pred EecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhH-----hCCceeccCCCCCEeEcCCCCe
Q psy6327 86 MDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLH-----EVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH-----~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
|||+++++|.+++.... ...+++.. ++.++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~----------~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~ 149 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEF----------IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNV 149 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHH----------HHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCE
Confidence 99999999999997532 23445443 3456778888999999 9999999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
||+|||++..............|++.|+|||.+....++.. +|+||||+++|+|++|..||.... ............
T Consensus 150 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~ 226 (265)
T cd08217 150 KLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGK 226 (265)
T ss_pred EEecccccccccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCC
Confidence 99999999887654443455678999999999988776655 999999999999999999997654 333333333222
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
. ...+..++..+.+++.+||+.+|++|||+.++++|||+
T Consensus 227 ~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 F-RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred C-CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 2 22334688999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=316.25 Aligned_cols=255 Identities=31% Similarity=0.484 Sum_probs=207.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||+|.+..+++.+|+|.+......... ...+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH-HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 589999999999999999999999999999998765544333 3455689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC-CeEEeecccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL-NAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~-~~kl~Dfg~a 166 (351)
|++|++|.+++.......+++.... .++.+++.||+|||++|++|+||+|+||++++++ .++|+|||.+
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~----------~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTIL----------HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 9999999999977544445555433 4567888889999999999999999999998654 5799999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
....... ......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...+.. .......... ..+....
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~ 224 (256)
T cd08220 150 KILSSKS-KAYTVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGT-FAPISDR 224 (256)
T ss_pred eecCCCc-cccccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHhcC-CCCCCCC
Confidence 8764432 2234568999999999987776665 99999999999999999999765432 2222222111 1122335
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
++.++.+++.+||+.||++|||+.++++||||
T Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 78999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=327.40 Aligned_cols=258 Identities=24% Similarity=0.448 Sum_probs=207.6
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|.....||+|+||.||++.+..++..+|+|.+...... ....+.+|+.+++.++||||+++++.+..++..|+||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH---HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 45567899999999999999999999999987643322 233455899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+++++|.+++.. ..+++.. +..++.||+.||.|||++|++||||||+||++++++.++|+|||++..
T Consensus 101 ~~~~~L~~~~~~---~~l~~~~----------~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 101 LEGGALTDIVTH---TRMNEEQ----------IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHH----------HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 999999998854 3455443 335678889999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh-CccccccccccC
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE-GKEYLFNRKYEI 247 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 247 (351)
............|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||..... ........ ......+....+
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIRDNLPPRVKDSHKV 244 (292)
T ss_pred cccccccCceeecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCcccccccc
Confidence 5444333445678999999999987777765 9999999999999999999975432 22222211 112222333357
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQ 285 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 285 (351)
+..+.+++.+||..||.+|||+.++++||||+.....+
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 88999999999999999999999999999998655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=323.23 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=203.8
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||+|+||.||+|.+..++..+|+|.+.... .... ...+.+|+.++++++||||+++++.+...+..|+|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~-~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESK-FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHH-HHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 6899999999999999999999999999999886432 2222 2344589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhc-cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 88 YAEKKDLEHYISKAC-NENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~-~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|++|++|..++.... ...+++... ..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~----------~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVL----------RRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHH----------HHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 999999999886521 124555443 3467788888999997 5999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHhhhCccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPY-----NPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLKKQEGKEY 239 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~ 239 (351)
+...... ......|++.|+|||.+.+... ...++|+||+||++|+|++|+.||........ ..........
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 226 (286)
T cd06622 150 SGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD- 226 (286)
T ss_pred cccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-
Confidence 8765332 2234468889999999865432 12348999999999999999999965432211 1111111111
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
....+..++.++.+||.+||+.+|++||++.++++||||....
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 1122335899999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=317.29 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=207.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.+..+|+.+|+|.+.............+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999999999999887544444433455668999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 87 DYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||+++++|.+++.... ...+++.. ++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~----------~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERT----------IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHH----------HHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccc
Confidence 9999999999986532 22344433 33567788899999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
++..............|++.|+|||.+.+..++.. +|+||+||++|+|++|..||..................+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08224 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPA 230 (267)
T ss_pred eeeeccCCCcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCCh
Confidence 98876544333445578999999999988777765 99999999999999999999655433333333332222211122
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..++..+.++|.+||..+|++|||+.++++
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 267889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=323.87 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=202.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|++.+.||+|++|.||+|.+..+++.+|+|.+........ ....+.+|+.++++++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG-VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc-chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3579999999999999999999999999999999865443222 223445899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-CCCeEEeecc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-LLNAKLADFG 164 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-~~~~kl~Dfg 164 (351)
|||++ ++|.+++........++..+ ..++.||+.||+|||+++++|+||+|+||+++. ++.+||+|||
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~----------~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLI----------KTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHH----------HHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccc
Confidence 99996 68888876533222333332 346778899999999999999999999999985 5579999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh--Ccc----
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE--GKE---- 238 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--~~~---- 238 (351)
++..............+++.|+|||.+.+......++|+||+||++|+|++|..||...... ........ ...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 227 (294)
T PLN00009 149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEET 227 (294)
T ss_pred cccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhh
Confidence 99765443333344567899999999876543334599999999999999999999754321 11111000 000
Q ss_pred --------------------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 239 --------------------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 239 --------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
........++..+.++|.+||+.||++||++.++++||||.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0000123578899999999999999999999999999999864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=326.39 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=204.0
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--CE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--TY 81 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~ 81 (351)
.++.+|++.+.||.|+||.||+|.+..+++.+++|.+........ ....+.+|+.++++++||||+++++++... +.
T Consensus 2 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-FPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred cchhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc-chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 356789999999999999999999999999999999875544322 222344899999999999999999999877 89
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.|+||||+. ++|.+++... ...+++... +.++.|++.||.|||+++++|+||||+||+++.++.++|+
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~-~~~l~~~~~----------~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETM-KQPFLQSEV----------KCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred EEEEehhcC-cCHHHHHHhc-cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEe
Confidence 999999997 6999988653 234555443 3467788889999999999999999999999999999999
Q ss_pred eccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-----
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG----- 236 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----- 236 (351)
|||++..............+++.|+|||.+.+......++|+||+|+++|+|++|.+||..... .........
T Consensus 149 d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~ 226 (293)
T cd07843 149 DFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--IDQLNKIFKLLGTP 226 (293)
T ss_pred ecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCC
Confidence 9999987665433344556889999999987655433459999999999999999999975432 111111000
Q ss_pred ---------------------c---cccccccc-cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 ---------------------K---EYLFNRKY-EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 ---------------------~---~~~~~~~~-~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
. ......+. .+++.+.++|.+||+.||++|||+.|+++||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 00000011 158889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=321.71 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=199.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEE-----eCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVK-----AGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~-----~~~ 80 (351)
.+|++++.||+|+||.||+|.+..+++.+|+|++...... ...+.+|+.+++.+ +||||+++++++. .+.
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 4699999999999999999999999999999987543221 23344799999999 6999999999873 456
Q ss_pred EEEEEEecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 81 YLYMIMDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
..++||||++|++|.+++.... ...+++..+ ..++.|++.||.|||+++++||||||+||++++++.+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~----------~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPII----------AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHH----------HHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence 7999999999999999886421 233444333 3467788889999999999999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccceeccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN-----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 233 (351)
+|+|||+++.............|++.|+|||++.. ..++. ++|+||+||++|+|++|+.||....... .....
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~ 241 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDA-RCDVWSLGITAIELGDGDPPLADLHPMR-ALFKI 241 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccc-hhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhc
Confidence 99999999876544333445579999999999753 23444 4999999999999999999997654211 11111
Q ss_pred hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
..........+..++..+.+||.+||+.||++|||+.++++|+||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 111111222233467889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=319.26 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=202.6
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh-------HHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR-------DYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
+|.+.+.||+|+||.||+|.+..+++.+|+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999999999999999886432211 112334568999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..++||||+++++|.+++... ..+++..+. .++.|++.||.|||+++++|+||+|+||+++.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~----------~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVR----------FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHH----------HHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEE
Confidence 999999999999999999763 556655433 35678888999999999999999999999999999999
Q ss_pred eeccccccccCCcc--cccccccccceeccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC
Q psy6327 161 ADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSP--YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 236 (351)
+|||+++....... ......|+..|+|||.+.... ++. ++|+||||+++|+|++|..||..... .........
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~ 226 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSA-KVDIWSLGCVVLEMFAGRRPWSDEEA--IAAMFKLGN 226 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCc-cchhHHHHHHHHHHHhCCCCCcCcch--HHHHHHhhc
Confidence 99999976543211 123446889999999987654 444 49999999999999999999965332 111111111
Q ss_pred c--ccccc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 K--EYLFN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 ~--~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
. ...++ ....++..+.++|.+||.+||++|||+.++++|||+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 1 11111 123578999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=324.00 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=198.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCE-----
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTY----- 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~----- 81 (351)
+|++.+.||+|+||.||+|.+..+++.||+|.+........ ....+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG-IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC-CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 68999999999999999999999999999998765433221 1233458999999995 6999999999877665
Q ss_pred EEEEEecCCCCChHHHHHhhcc---CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-CCC
Q psy6327 82 LYMIMDYAEKKDLEHYISKACN---ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-LLN 157 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~---~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-~~~ 157 (351)
.|+||||++ ++|.+++..... ..+++... +.++.||+.||.|||++|++||||+|+||+++. ++.
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~----------~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~ 149 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTI----------KSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL 149 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe
Confidence 899999998 589888865322 23455443 346778889999999999999999999999998 889
Q ss_pred eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-
Q psy6327 158 AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG- 236 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~- 236 (351)
+||+|||++..............+++.|+|||++.+......++|+||+|+++|+|++|..||...+. .........
T Consensus 150 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~ 227 (295)
T cd07837 150 LKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLHIFKL 227 (295)
T ss_pred EEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHH
Confidence 99999999986544433334446789999999886544333459999999999999999999975432 111110000
Q ss_pred ----cc---------------------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 237 ----KE---------------------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 237 ----~~---------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
.. ........++.++.+||.+||.+||.+|||+.+++.||||+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 00001125788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=321.26 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=200.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHH-HHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDI-LLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
.+|++++.||+|+||.||++.+..+|+.||+|.+......... ...+ .|+.+ ++.++||||+++++++..++..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~-~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLL-MDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHH-HHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 3789999999999999999999999999999998654332221 2222 45554 6667899999999999999999999
Q ss_pred EecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEcCCCCeEEee
Q psy6327 86 MDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|||++ |+|.+++.... ...+++..+ ..++.|++.||+|||++ +++||||||+||+++.++.+||+|
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~----------~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDIL----------GKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHH----------HHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEee
Confidence 99997 88988876532 234555443 35677888999999997 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRN----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
||.+....... ......|+..|+|||.+.+ ..++.+ +|+||+||++|+|++|+.||..................
T Consensus 148 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd06617 148 FGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS 225 (283)
T ss_pred ccccccccccc-ccccccCCccccChhhcCCcccccccCcc-ccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC
Confidence 99988654321 2233468899999998864 334444 99999999999999999999654322222222222222
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
...+ ...+|.++.+||.+||..+|++|||+.++++||||+...
T Consensus 226 ~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 226 PQLP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CCCC-ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 2222 225789999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=325.11 Aligned_cols=257 Identities=26% Similarity=0.476 Sum_probs=208.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|.....||+|+||.||+|.+..+++.+|+|.+....... ...+.+|+.+++.+.||||+++++++..++..|+|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch---HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 45677788999999999999999999999999986543322 233558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|..++.. ..+++... ..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~----------~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~ 164 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQI----------ATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC 164 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHH----------HHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhH
Confidence 99999999998754 34555443 346778888999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc-cccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK-EYLFNRKY 245 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 245 (351)
..............|++.|+|||++.+..++.+ +|+||+||++|+|++|+.||.... ........... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd06659 165 AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRDSPPPKLKNAH 241 (297)
T ss_pred hhcccccccccceecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhccCCCCccccC
Confidence 765544333445678999999999988777665 999999999999999999997543 22222222221 11222234
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.++..+.++|.+||+.+|++||++.++++||||....
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 6788999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=317.40 Aligned_cols=257 Identities=29% Similarity=0.420 Sum_probs=201.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..++.....||+|+||.||+|.+..++..+++|.+....... .+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY---VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH---HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 344555678999999999999999999999999876543322 33456899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCC--chHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-CCCeEEee
Q psy6327 86 MDYAEKKDLEHYISKACNENI--HENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-LLNAKLAD 162 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~--~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-~~~~kl~D 162 (351)
+||+++++|.+++.... ..+ ++.. +..++.|++.||.|||++||+|+||||+||+++. ++.++|+|
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~----------~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 84 MEQVPGGSLSALLRSKW-GPLKDNEQT----------IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred EecCCCCCHHHHHHHhc-ccCCCcHHH----------HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEec
Confidence 99999999999997531 222 3222 2346778999999999999999999999999976 67899999
Q ss_pred ccccccccCCcccccccccccceeccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSP--YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
||.+..............|++.|+|||.+.... ++. ++|+||+|+++|+|++|..||............. ......
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~-~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~ 230 (268)
T cd06624 153 FGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA-PADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIH 230 (268)
T ss_pred chhheecccCCCccccCCCCccccChhhhccccccCCc-hhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhccC
Confidence 999876644333334456899999999986543 444 4999999999999999999997543222222111 111111
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
...+..+++++++|+.+||+.+|++|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 12233578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=307.48 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=210.6
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~ 82 (351)
.|+.+..+++.||.|+.|+|+++..+.+|...|||.+....... ..+.+...+.++...+ +|+||+.+|+|..+..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke--e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH--HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 57778889999999999999999999999999999986544333 2455557777777665 89999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEe
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
++-||.|. .-+..+++ ...++++|..+..+. .-+..||.||.+ ++|+|||+||+|||+|..|++|||
T Consensus 167 ~IcMelMs-~C~ekLlk-rik~piPE~ilGk~t----------va~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 167 FICMELMS-TCAEKLLK-RIKGPIPERILGKMT----------VAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred HHHHHHHH-HHHHHHHH-HhcCCchHHhhhhhH----------HHHHHHHHHHHHhcceeecccCccceEEccCCCEEee
Confidence 99999884 55555554 346778886655443 345566778875 589999999999999999999999
Q ss_pred eccccccccCCcccccccccccceecccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|||.+-++-.+.... ...|.+.|||||.+. ...|+-+ +||||||++++||.||..||.+.........+.....+
T Consensus 235 DFGIsGrlvdSkAht-rsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP 312 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHT-RSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP 312 (391)
T ss_pred cccccceeecccccc-cccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC
Confidence 999998776554433 345999999999985 3456665 99999999999999999999886654443333334444
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
+.++.....|+++.+|+..||++|+.+||...++|+|||+....
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 55666667999999999999999999999999999999997643
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=320.07 Aligned_cols=257 Identities=30% Similarity=0.448 Sum_probs=207.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|+.++.||.|+||.||+|.+..++..+|+|.+....... ....+.+|+.+++++.||||+++++++.++...|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4888999999999999999999999999999986543222 23455589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++|++|.+++.. ..+++... ..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 83 ~~~~~~L~~~i~~---~~l~~~~~----------~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 83 YLGGGSALDLLRA---GPFDEFQI----------ATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred cCCCCcHHHHHhc---CCCCHHHH----------HHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccce
Confidence 9999999999864 34555443 3456788899999999999999999999999999999999999997
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.............++..|+|||.+.+..++.+ +|+|||||++|+|++|..||...... ........ .........+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~-~~~~~~~~~~ 225 (277)
T cd06640 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPM--RVLFLIPK-NNPPTLTGEF 225 (277)
T ss_pred eccCCccccccccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChH--hHhhhhhc-CCCCCCchhh
Confidence 76544333344568899999999987777665 99999999999999999999754321 11111111 1111122356
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
+..+.+++.+||+.+|++||++.++++||||.....
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 788999999999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=316.22 Aligned_cols=252 Identities=31% Similarity=0.524 Sum_probs=206.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|+||.||++.+..++..+|+|.+....... ..+.+.+|+.+++.++||||+++++.+.+++..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS--AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5889999999999999999999999999999986543222 23445589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++++|.+++.......+++.... .++.|++.||.|||++|++|+||||+||++++++.++|+|||.++
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~----------~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTIL----------QWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHH----------HHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcce
Confidence 9999999999876444555655443 456788888889999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.............|++.|+|||++.+..++.+ +|+||+|+++|+|++|..||...+. ...........+ .+.+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~~~~~-~~~~~~~ 224 (255)
T cd08219 149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSW--KNLILKVCQGSY-KPLPSHY 224 (255)
T ss_pred eecccccccccccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCH--HHHHHHHhcCCC-CCCCccc
Confidence 76555444455678999999999988777665 9999999999999999999975432 222222222221 2223467
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
+..+.+||.+||+.||++|||+.++++-
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 8899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=317.68 Aligned_cols=259 Identities=25% Similarity=0.452 Sum_probs=206.8
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh---HHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR---DYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+|+..+.||+|+||.||++.+..+++.+|+|++....... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4888999999999999999999999999999986543221 1234556689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC-CeEEeec
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL-NAKLADF 163 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~-~~kl~Df 163 (351)
|+||++|++|.+++.+ ...+++... ..++.|++.||+|||++|++|+||+|+||+++.++ .++|+||
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~----------~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 81 FVEWMAGGSVSHLLSK--YGAFKEAVI----------INYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred EEeccCCCcHHHHHHH--hCCCCHHHH----------HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccc
Confidence 9999999999999976 345555443 34677888889999999999999999999998765 5999999
Q ss_pred cccccccCCcc----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHhhhCcc
Q psy6327 164 GFSRLLRTPKE----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLKKQEGKE 238 (351)
Q Consensus 164 g~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~ 238 (351)
|.+........ ......|+..|+|||.+.+..++.+ +|+||+|+++|+|++|..||........ ..........
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC
Confidence 99987654321 1234568899999999987777665 9999999999999999999975443221 1111111112
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
.....+..++.++.+++.+||+.||++|||+.++++||||+
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 22223345788999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=316.88 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=198.0
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHH-HHhCCCCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDI-LLKVSHPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
++.||.|+||.||+|.+..+++.+|+|.+................|..+ ...++|||++++++++..++..|+|+||++
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 3579999999999999999999999999865443322222222345444 445589999999999999999999999999
Q ss_pred CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 91 KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 91 ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
|++|.+++.. ...+++.... .++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++...
T Consensus 81 ~~~L~~~l~~--~~~~~~~~~~----------~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 81 GGDCASLIKT--LGGLPEDWAK----------QYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 9999999976 3455654443 457788889999999999999999999999999999999999987643
Q ss_pred CCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc--cccccCC
Q psy6327 171 TPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF--NRKYEIS 248 (351)
Q Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~s 248 (351)
. .....|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||.... ..............+ .....++
T Consensus 149 ~----~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 221 (260)
T cd05611 149 E----NKKFVGTPDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAET--PDAVFDNILSRRINWPEEVKEFCS 221 (260)
T ss_pred c----cccCCCCcCccChhhhcCCCCcch-hhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhcccCCCCcccccCC
Confidence 3 234568899999999887776654 999999999999999999997544 223332222222111 2223578
Q ss_pred HhHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCcc
Q psy6327 249 IGAKQLIGRMLEPNPKHRPN---AKDVQNHAWIQNEPT 283 (351)
Q Consensus 249 ~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~~~~~ 283 (351)
..+.++|.+||+.||++||+ +.|++.||||++..+
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 99999999999999999995 579999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=334.98 Aligned_cols=263 Identities=21% Similarity=0.352 Sum_probs=198.5
Q ss_pred cceeeeeecCcccceEEEEEEecCC-----ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS-----ETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.+|++.+.||+|+||.||+|.+..+ +..||+|.+........ ...+.+|+.+++.+ +||||+++++++....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE--REALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH--HHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3589999999999999999986543 45799999865433222 34455899999999 7999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCch----------------------------------------------------
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHE---------------------------------------------------- 108 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~---------------------------------------------------- 108 (351)
..|+|||||++|+|.+++..........
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999986532100000
Q ss_pred ------HHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc--cccccc
Q psy6327 109 ------NQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFC 180 (351)
Q Consensus 109 ------~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~ 180 (351)
.....+......++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++....... ......
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 000001123344567889999999999999999999999999999999999999999986543322 112233
Q ss_pred cccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhc
Q psy6327 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRML 259 (351)
Q Consensus 181 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 259 (351)
+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||...... ....... ...+....+..++.++.+++.+||
T Consensus 276 ~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKMV-KRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCcccccc-HHHHHHH-HcccCccCCCCCCHHHHHHHHHHc
Confidence 5678999999988777765 999999999999997 99999764422 1222222 122222333457899999999999
Q ss_pred CCCCCCCCCHHHHhc
Q psy6327 260 EPNPKHRPNAKDVQN 274 (351)
Q Consensus 260 ~~dp~~Rpt~~ell~ 274 (351)
+.||.+|||+.++++
T Consensus 353 ~~dp~~RPs~~~l~~ 367 (374)
T cd05106 353 NLEPTERPTFSQISQ 367 (374)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=317.65 Aligned_cols=252 Identities=31% Similarity=0.517 Sum_probs=207.3
Q ss_pred cCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCCh
Q psy6327 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDL 94 (351)
Q Consensus 15 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL 94 (351)
||.|+||.||++.+..+|+.+++|.+.............+.+|+.++++++||||+++++.+..+...|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 69999999999999999999999998766554434455566899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc
Q psy6327 95 EHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE 174 (351)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 174 (351)
.+++.+. ..+++.... .++.|++.||.|||+++++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~--~~~~~~~~~----------~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 81 ASLLENV--GSLDEDVAR----------IYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred HHHHHHc--CCCCHHHHH----------HHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 9999763 355555433 4677888899999999999999999999999999999999999876543321
Q ss_pred --------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 175 --------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 175 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
......+++.|+|||.+.....+.. +|+||||+++|+|++|..||.... ..............++....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 225 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGET--PEEIFQNILNGKIEWPEDVE 225 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCcCCCcccc
Confidence 2234568889999999887776654 999999999999999999997544 33334444333444444334
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCH---HHHhcCccccCC
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNA---KDVQNHAWIQNE 281 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~---~ell~hp~~~~~ 281 (351)
++..+.+|+.+||+.+|++|||+ .++++||||++.
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 59999999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=334.68 Aligned_cols=264 Identities=21% Similarity=0.329 Sum_probs=199.1
Q ss_pred cceeeeeecCcccceEEEEEEe-----cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSD-----KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.+|++.+.||+|+||.||+|.+ ..++..||+|++....... ....+.+|+.+++.+ +||||+++++++.+++
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH--HHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 3699999999999999999974 3567789999986433222 234455899999999 7999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCc-----hHHH---HH---------------------------------------
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIH-----ENQA---RI--------------------------------------- 113 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~-----~~~~---~~--------------------------------------- 113 (351)
..++|||||+||+|.+++......... .... ..
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999999999999753211000 0000 00
Q ss_pred ----------------HHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCccc--
Q psy6327 114 ----------------WIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL-- 175 (351)
Q Consensus 114 ----------------~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 175 (351)
........+.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 00122345678899999999999999999999999999999999999999999865433221
Q ss_pred ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHH
Q psy6327 176 SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQL 254 (351)
Q Consensus 176 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (351)
.....++..|+|||++.+..++.+ +|||||||++|+|++ |..||...... ........ .......+...+.++.+|
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~l~~l 349 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIK-EGYRMLSPECAPSEMYDI 349 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHH-hCccCCCCCCCCHHHHHH
Confidence 122335668999999988888765 999999999999998 89999764322 12222222 122222233568899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcC
Q psy6327 255 IGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 255 i~~~L~~dp~~Rpt~~ell~h 275 (351)
|.+||+.||++|||+.++++.
T Consensus 350 i~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 350 MKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=317.80 Aligned_cols=247 Identities=27% Similarity=0.454 Sum_probs=195.7
Q ss_pred cceeeeeec--CcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q psy6327 7 LECSYISKL--GEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 7 ~~~~~~~~L--G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 83 (351)
.+|++.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.....+ +||||+++++.+...+..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 356777776 99999999999999999999999986544322 122222222 6999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC-CeEEee
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL-NAKLAD 162 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~-~~kl~D 162 (351)
+||||+++++|.+++.. ...+++..+. .++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|
T Consensus 86 iv~e~~~~~~L~~~l~~--~~~l~~~~~~----------~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKK--EGKLSEAEVK----------KIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred EEEEcCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999976 3466665544 4677888889999999999999999999999988 999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch--HHHHhhhCcccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR--DVLKKQEGKEYL 240 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~ 240 (351)
||.++..... ....|++.|+|||++.+..++.+ +|+||+|+++|+|++|..||........ ....... ...
T Consensus 154 fg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~ 226 (267)
T PHA03390 154 YGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKK 226 (267)
T ss_pred CccceecCCC----ccCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--ccc
Confidence 9998765432 23458999999999988887765 9999999999999999999975432211 1111111 112
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCC-HHHHhcCccccC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPN-AKDVQNHAWIQN 280 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~ell~hp~~~~ 280 (351)
.+....++..+.+||.+||+.||.+||+ ++++|+||||++
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 2233368999999999999999999996 699999999964
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=318.60 Aligned_cols=257 Identities=29% Similarity=0.433 Sum_probs=203.6
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeC-----
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAG----- 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~----- 79 (351)
..+|++.+.||+|++|.||+|.++.+++.+++|.+...... ...+.+|+.+++++ .||||+++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 35699999999999999999999999999999998654432 23455899999999 699999999999654
Q ss_pred -CEEEEEEecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 80 -TYLYMIMDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 80 -~~~~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
...|+||||+++++|.+++.... ...+++.... .++.|++.||.|||+++++|+||+|+||+++.++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~----------~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA----------YILRETLRGLAYLHENKVIHRDIKGQNILLTKNA 150 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHH----------HHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC
Confidence 45899999999999999987543 3455554433 4677888888899999999999999999999999
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS-----PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL 231 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 231 (351)
.++|+|||++..............|++.|+|||++... .++. ++|||||||++|+|++|..||...... ....
T Consensus 151 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~ 228 (275)
T cd06608 151 EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDA-RSDVWSLGITAIELADGKPPLCDMHPM-RALF 228 (275)
T ss_pred eEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccc-cccHHHhHHHHHHHHhCCCCccccchH-HHHH
Confidence 99999999998765444444556789999999987532 2344 489999999999999999999754321 1222
Q ss_pred HhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 232 KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
...............++.++++||.+||..||++|||+.++++|||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 229 KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 21211122222233478899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=314.90 Aligned_cols=255 Identities=29% Similarity=0.412 Sum_probs=205.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh--hHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK--RDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+|+..+.||+|+||.||+|.+..++..+++|.+...... .......+.+|+.+++.++||||+++++++.++...|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 477889999999999999999989999999998654421 122234456899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
+||+++++|.+++.+ ...+++.... .++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~~~~~~----------~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 81 LELVPGGSLAKLLKK--YGSFPEPVIR----------LYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred EEecCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCcc
Confidence 999999999999976 3445554433 3567888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+....... ......|++.|+|||.+.... ++.+ +|+||+|+++|+|++|..||.... .................+
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~-~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~ 224 (258)
T cd06632 149 AKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLA-ADIWSLGCTVLEMATGKPPWSQLE--GVAAVFKIGRSKELPPIP 224 (258)
T ss_pred ceeccccc-cccccCCCcceeCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcccCc--HHHHHHHHHhcccCCCcC
Confidence 88754433 234556899999999987665 5554 999999999999999999997654 222222222211222223
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
..++..+.+|+.+||+.+|++|||+.+++.|||+
T Consensus 225 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 225 DHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 4678999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=369.45 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=215.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|.-..+||.|.||.||.|.+..+|...|+|.+...... ......+.+|..++..|+|||+|++||+-..+...+|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 366678899999999999999999999999999877665 3334556699999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
||+||+|.+++.. .+-.++...+. |..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|.
T Consensus 1315 yC~~GsLa~ll~~--gri~dE~vt~v----------yt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH--GRIEDEMVTRV----------YTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HhccCcHHHHHHh--cchhhhhHHHH----------HHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeeccccee
Confidence 9999999999975 33444444333 66788999999999999999999999999999999999999998
Q ss_pred cccCCcc----cccccccccceeccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 168 LLRTPKE----LSNTFCGTTSYAAPEIIRNSP--YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 168 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
.+..... .-....|||.|||||++.+.. ....+.|||||||++.||+||+.||...+.....+...-.+..+..
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence 7765432 224678999999999997543 2233589999999999999999999887765555554444444444
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
|. .+|.+.+|||.+||..||++|.++.||++|-|-+..
T Consensus 1463 P~--~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1463 PE--RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ch--hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 44 499999999999999999999999999999987643
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=347.05 Aligned_cols=267 Identities=23% Similarity=0.374 Sum_probs=192.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCc-eeEEEE--------------ecchhhhhhHHHhhhHHHHHHHHHhCCCCCce
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSE-TLKACK--------------AYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~-~~~aiK--------------~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv 70 (351)
+.+|++++.||+|+||.||+|..+... ...+.| .+.............+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 357999999999999999998765332 222222 11111111222344566899999999999999
Q ss_pred eeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCE
Q psy6327 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENI 150 (351)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NI 150 (351)
++++++...+..|+|++++. ++|.+++...... ..... .+..+..++.||+.||.|||++||+||||||+||
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~------~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI 298 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD-WKDRP------LLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc-ccccc------cHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 99999999999999999996 7888877542111 00000 1123456788999999999999999999999999
Q ss_pred eEcCCCCeEEeeccccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCCCch
Q psy6327 151 LISRLLNAKLADFGFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP-FGDPGTRNR 228 (351)
Q Consensus 151 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~ 228 (351)
|++.++.+||+|||+++.+..... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..+ |........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999999987654332 2335679999999999998888765 9999999999999998754 433221111
Q ss_pred HHH-HhhhC---ccccc--------------------------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 229 DVL-KKQEG---KEYLF--------------------------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 229 ~~~-~~~~~---~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
..+ ..+.. ....+ -....++.++.++|.+||++||.+|||+.|+|+||||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 111 10000 00000 0112356788899999999999999999999999999
Q ss_pred cCC
Q psy6327 279 QNE 281 (351)
Q Consensus 279 ~~~ 281 (351)
...
T Consensus 458 ~~~ 460 (501)
T PHA03210 458 SAE 460 (501)
T ss_pred hcC
Confidence 764
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=303.04 Aligned_cols=255 Identities=27% Similarity=0.304 Sum_probs=200.6
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE-----eCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK-----AGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-----~~~~ 81 (351)
.+|+|.+.||+|||+-||+++...++..||+|++......+ .+...+|+...++++||||++++++.- ....
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~---~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED---IEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH---HHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 46999999999999999999999999999999997766333 334459999999999999999988752 3345
Q ss_pred EEEEEecCCCCChHHHHHhhccC--CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEcCCCC
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNE--NIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILISRLLN 157 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~--~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~~~~~ 157 (351)
.||++.|...|+|.+.+.....+ .+++.+ .+.++.+||+||++||+.. ++||||||.|||+++.+.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~----------iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQ----------ILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHH----------HHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence 99999999999999999654332 345543 4567888999999999998 999999999999999999
Q ss_pred eEEeeccccccccCCcccc---------cccccccceeccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q psy6327 158 AKLADFGFSRLLRTPKELS---------NTFCGTTSYAAPEIIRNS---PYNPKLADIWSLGVVLYRILNKKYPFGDPGT 225 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (351)
++|.|||.++...-.-... ....-|..|+|||++.-+ ..+. ++|||||||++|.|+.|..||.-.-.
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~e-rtDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITE-RTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccccc-ccchhhhhHHHHHHHHcCCcchHHhh
Confidence 9999999998653211110 112347889999998543 3444 49999999999999999999953211
Q ss_pred CchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 226 RNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.-....-......+.+|....+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 247 ~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 247 QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11111122334456667666799999999999999999999999999864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=320.03 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=201.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++++.||.|++|.||+|.+..+|..+|+|.+........ ...+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT--PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc--hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999875443221 2334479999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhc-cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKKDLEHYISKAC-NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~-~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|+. ++|.+++.... ...+++..+ ..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~----------~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTV----------KSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHH----------HHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 998 58988886532 133555443 346778888999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh-----------
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE----------- 235 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~----------- 235 (351)
..............+++.|+|||.+.+......++|+|||||++|+|++|..||.+.+.. +......
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhH
Confidence 866544333344567899999999876544344599999999999999999999765421 1111100
Q ss_pred ----C-ccc--ccc---------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 236 ----G-KEY--LFN---------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 236 ----~-~~~--~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
. ..+ ..+ ....++..++++|.+||+.||.+||++.++++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 000 000 012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=319.02 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=206.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||.|+||.||+|.++.+++.+++|.+...... .....+.+|+.+++++.||||+++++++..++..++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 688899999999999999999999999999988655432 223445589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|+.+++|.+++.... ..+++.... .++.|++.||+|||+ .|++|+||+|+||++++++.++|+|||.+
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~----------~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 80 YMDGGSLDKILKEVQ-GRIPERILG----------KIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred ecCCCcHHHHHHHcc-CCCCHHHHH----------HHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999997632 455554433 357788888999999 99999999999999999999999999998
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC---chHHHHhhhCcc-cccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR---NRDVLKKQEGKE-YLFN 242 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~-~~~~ 242 (351)
........ ....+++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...... ............ ...+
T Consensus 149 ~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06605 149 GQLVNSLA--KTFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP 225 (265)
T ss_pred hhhHHHHh--hcccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC
Confidence 76543222 12668999999999988877765 99999999999999999999754311 112222222111 1111
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
. ..++.++.++|.+||..||++|||+.+++.||||+.
T Consensus 226 ~-~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 226 S-GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred h-hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 1 127889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=337.41 Aligned_cols=262 Identities=22% Similarity=0.374 Sum_probs=211.7
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHH-HhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE--
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY-MEKFAPREIDILLKVSHPNIIGVHRMVKAGTY-- 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~-- 81 (351)
+-.-.++...||+|+|-+||+|.|..+|..||.-.+......... -.+.+..|+.+|+.|+||||+++|+++.+..+
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 334456778899999999999999999999998777666554322 23455689999999999999999999987665
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEcCC-CCe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILISRL-LNA 158 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~~~-~~~ 158 (351)
+.+|+|.+..|+|..|+++. +...-..++ .|++||++||.|||++. |+|||||.+||||+.+ |.|
T Consensus 118 in~iTEL~TSGtLr~Y~kk~--~~vn~kaik----------~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~V 185 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKH--RRVNIKAIK----------SWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEV 185 (632)
T ss_pred eeeeeecccCCcHHHHHHHh--ccCCHHHHH----------HHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCce
Confidence 88999999999999999984 444444444 46788899999999984 9999999999999875 889
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
||+|+|+|+....+. ....+|||.|||||+.. ..|+.. +||||||+++.||+|+..||..-......+.+.+.+..
T Consensus 186 KIGDLGLAtl~r~s~--aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 186 KIGDLGLATLLRKSH--AKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred eecchhHHHHhhccc--cceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence 999999999876543 34578999999999986 667765 99999999999999999999876654444444444443
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTC 284 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 284 (351)
+..-.. --.+++++||.+||.. .++|+|+.|||.||||.....+
T Consensus 262 P~sl~k-V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g~ 305 (632)
T KOG0584|consen 262 PAALSK-VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGGI 305 (632)
T ss_pred HHHhhc-cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccccc
Confidence 332222 2367999999999999 9999999999999999876554
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=323.51 Aligned_cols=255 Identities=30% Similarity=0.448 Sum_probs=205.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|+.++.||+|+||.||+|.+..++..+|+|.+....... ....+.+|+.++++++||||+++++++..++..|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH--HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4788899999999999999999999999999886443222 23456689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++++|.+++.. ..+++... ..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~----------~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYI----------ATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHH----------HHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccc
Confidence 9999999998864 34555443 3456788899999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.............|+..|+|||.+.+..++.+ +|+||+||++|+|++|..||...... .......... .......+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~-~~~~~~~~ 225 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPM--RVLFLIPKNS-PPTLEGQY 225 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchh--hHHhhhhcCC-CCCCCccc
Confidence 76544333344568899999999988777765 99999999999999999999654321 1111111111 11122357
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
+.++.++|.+||+.+|++|||+.++++||||...
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 8899999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=316.16 Aligned_cols=252 Identities=19% Similarity=0.325 Sum_probs=199.7
Q ss_pred ccceeeeeecCcccceEEEEEEec---CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
-.+|++.+.||+|+||.||+|.++ ..+..+|+|.+....... ....+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK--QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 346999999999999999999865 456789999986543222 234455899999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||+++|+|.+++... ...+++.. ++.++.|++.||+|||++|++||||||+|||++.++.++++|
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~----------~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH-EGQLVAGQ----------LMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC-CCCCCHHH----------HHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECC
Confidence 9999999999999998753 23455443 345778889999999999999999999999999999999999
Q ss_pred ccccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 163 FGFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 163 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
||.+........ ......+++.|+|||.+.+..++.+ +||||+||++|++++ |..||.... ........... ..
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~--~~~~~~~~~~~-~~ 226 (266)
T cd05064 151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMS--GQDVIKAVEDG-FR 226 (266)
T ss_pred CcccccccccchhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHHCC-CC
Confidence 998765322211 1112335678999999988887765 999999999999775 999997654 33333333322 23
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+.+..++..+.+++.+||+.+|++|||+.+|++
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 3445578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=335.15 Aligned_cols=262 Identities=27% Similarity=0.453 Sum_probs=227.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.++..+..||-||||.|=++........+|+|++++..+-+......+..|-++|..+..|.||++|..|++..++|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 45678899999999999999887766667999999888876666666667999999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
||-|-||.|+..++. .+.+++..++. |+..+++|++|||++||++|||||+|.+++.+|.+||.|||+
T Consensus 499 mEaClGGElWTiLrd--Rg~Fdd~tarF----------~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 499 MEACLGGELWTILRD--RGSFDDYTARF----------YVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred HHhhcCchhhhhhhh--cCCcccchhhh----------hHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhh
Confidence 999999999999988 78899888876 455677788899999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
|+.+.. +..+.++||||.|+|||++.++..+.. +|.||||+++|||++|.+||++.+.. .....+..+...+..+.
T Consensus 567 AKki~~-g~KTwTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpm--ktYn~ILkGid~i~~Pr 642 (732)
T KOG0614|consen 567 AKKIGS-GRKTWTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPM--KTYNLILKGIDKIEFPR 642 (732)
T ss_pred HHHhcc-CCceeeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHHhhhhhhhccc
Confidence 998765 345778999999999999999998876 99999999999999999999887743 33333333333333345
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEPT 283 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 283 (351)
.++..+.+||+++...+|.+|.. +.+|..|.||.+..|
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 79999999999999999999986 889999999998766
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=318.64 Aligned_cols=257 Identities=26% Similarity=0.489 Sum_probs=207.1
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|.-.+.||+|++|.||++.+..+++.+++|.+....... ...+.+|+.+++.++||||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR---RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4666789999999999999999999999999875433222 2334589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+.|++|.+++.. ..++.... ..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~----------~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQI----------ATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHH----------HHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccch
Confidence 9999999999875 34444433 3467788889999999999999999999999999999999999887
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc-ccccccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK-EYLFNRKYE 246 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~ 246 (351)
.............|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||..... .......... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 240 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPP--LQAMKRIRDNLPPKLKNLHK 240 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHhcCCCCCccccc
Confidence 65443333344568999999999988777765 9999999999999999999965432 2222222211 122222334
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
++..+.+|+.+||+.+|++|||+.++++||||+....
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 7899999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=319.53 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=203.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCc-----eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSE-----TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
+.+|++++.||+|+||.||+|.+...+ ..+|+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 467999999999999999999876555 7899998764332 222344668999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHH------HHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQAR------IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR 154 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~------~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~ 154 (351)
..+++|||+++++|.+++..... ..+.... .........+.++.|++.||.|||++|++|+||||+||++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSP--HSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCC--CcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999976321 1110000 000112234567889999999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q psy6327 155 LLNAKLADFGFSRLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVL 231 (351)
Q Consensus 155 ~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 231 (351)
++.++|+|||+++...... .......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.. ..+..
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~--~~~~~ 236 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFS--NQEVI 236 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCC--HHHHH
Confidence 9999999999998654322 12334467889999999988887765 999999999999998 999997644 33333
Q ss_pred HhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 232 KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..+... ...+.+..++.++.+|+.+||+.||.+||++.+++++
T Consensus 237 ~~i~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIRSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333322 2223345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=317.04 Aligned_cols=254 Identities=30% Similarity=0.446 Sum_probs=206.3
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|++++.||.|+||.||+|.+..++..+|+|.+....... ....+.+|+.++++++||||+++++.+..+...|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchH--HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 788999999999999999999999999999876443322 234456899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+++++|.+++.. ..++... +..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~l~~~i~~---~~~~~~~----------~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 84 LGGGSALDLLEP---GPLDETQ----------IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHH----------HHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeeccccee
Confidence 999999999864 3444433 334677888999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCC
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (351)
............|+..|+|||.+.+..++.+ +|+||+||++|+|++|..||..... ........... .......++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~-~~~~~~~~~ 226 (277)
T cd06641 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHP--MKVLFLIPKNN-PPTLEGNYS 226 (277)
T ss_pred cccchhhhccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccch--HHHHHHHhcCC-CCCCCcccC
Confidence 6543333344568999999999987777655 9999999999999999999975442 22222221111 111223578
Q ss_pred HhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 249 ~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.++.++|.+||+.+|++||++.++++||||...
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 899999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=326.73 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=197.8
Q ss_pred ceeeeeecCcccceEEEEEEecC--CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--CEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKR--SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--TYLY 83 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~ 83 (351)
.|+++++||+|+||.||+|.+.. ++..+|+|.+...............+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999998764322222223344899999999999999999999888 8899
Q ss_pred EEEecCCCCChHHHHHhhcc---CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC----CC
Q psy6327 84 MIMDYAEKKDLEHYISKACN---ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR----LL 156 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~---~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~----~~ 156 (351)
+||||++ ++|.+++..... ..+++..+. .++.|++.||+|||+++++||||||+||+++. ++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~----------~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~ 149 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVK----------SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG 149 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHH----------HHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc
Confidence 9999997 678887754322 234544433 46778888999999999999999999999999 89
Q ss_pred CeEEeeccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-----
Q psy6327 157 NAKLADFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR----- 228 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----- 228 (351)
.+||+|||+++....... ......+++.|+|||++.+......++|||||||++|+|++|.+||.+......
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 229 (316)
T cd07842 150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229 (316)
T ss_pred eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence 999999999987644322 223456899999999887654333449999999999999999999975443210
Q ss_pred --HHHHh----h----------------------hCcccccc---------ccccCCHhHHHHHHHhcCCCCCCCCCHHH
Q psy6327 229 --DVLKK----Q----------------------EGKEYLFN---------RKYEISIGAKQLIGRMLEPNPKHRPNAKD 271 (351)
Q Consensus 229 --~~~~~----~----------------------~~~~~~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e 271 (351)
..... . .......+ .....+..+.++|.+||++||++|||+.+
T Consensus 230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e 309 (316)
T cd07842 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE 309 (316)
T ss_pred HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 00000 0 00000000 00146778999999999999999999999
Q ss_pred HhcCccc
Q psy6327 272 VQNHAWI 278 (351)
Q Consensus 272 ll~hp~~ 278 (351)
+++||||
T Consensus 310 il~~~~f 316 (316)
T cd07842 310 ALEHPYF 316 (316)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=321.21 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=201.1
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|++++.||.|++|.||+|.+..+|..+|+|++......... ...+.+|+.+++.++|||++++++++.+++..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGV-PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccc-hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999998765433221 23344899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
++ ++|.+++.......+++... +.++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~----------~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLI----------KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 96 79999987643334555443 34677888899999999999999999999999999999999999976
Q ss_pred ccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh-------------
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE------------- 235 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------- 235 (351)
............+++.|+|||++.+......++|+||+|+++|+|++|..||...+... .......
T Consensus 149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 149 FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred cCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhh
Confidence 54433333444678999999988765433345999999999999999999997543211 1110000
Q ss_pred -----------Cc--cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 236 -----------GK--EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 236 -----------~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
.. .........++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00 00001123577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=319.72 Aligned_cols=255 Identities=31% Similarity=0.552 Sum_probs=211.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv 85 (351)
.+|.+.+.||+|+||.||+|.+..+++.+++|++.............+.+|+.+++++. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36999999999999999999999999999999987755544444456668999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++.+ ...++..... .++.|++.||.+||++|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~--~~~l~~~~~~----------~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 81 LEYAPNGELLQYIRK--YGSLDEKCTR----------FYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcc
Confidence 999999999999976 3456665544 4567888888899999999999999999999999999999999
Q ss_pred cccccCCc--------------------ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q psy6327 166 SRLLRTPK--------------------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGT 225 (351)
Q Consensus 166 a~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (351)
+....... .......|++.|+|||++....++.. +|+||||++++++++|..||...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~- 226 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSN- 226 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCcc-
Confidence 88764432 12234467899999999887776655 999999999999999999997655
Q ss_pred CchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCH----HHHhcCccc
Q psy6327 226 RNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNA----KDVQNHAWI 278 (351)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~hp~~ 278 (351)
............+. .+..+++.+.+||.+||+.||++|||+ .++++||||
T Consensus 227 -~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 227 -EYLTFQKILKLEYS--FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred -HHHHHHHHHhcCCC--CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 22333333322222 233678999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=320.13 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=201.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|+||.||+|.+..+++.+++|.+........ ....+.+|+++++.++|+||+++++++..++..++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED-VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccccc-chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 69999999999999999999999999999999865443322 23445589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++++.+..+..+ ...+++..+ ..++.|++.||.|||+++++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~----------~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAV----------RSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 9997766665544 344555443 3467788899999999999999999999999999999999999998
Q ss_pred cccCCcc-cccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh-----------
Q psy6327 168 LLRTPKE-LSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ----------- 234 (351)
Q Consensus 168 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----------- 234 (351)
....... ......+++.|+|||++... .++. ++|+||+|+++|+|++|..||..............
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 149 ALRARPASPLTDYVATRWYRAPELLVGDTNYGK-PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred ccCCCccccccCcccccCCcCCchhcCCCCcCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 7665443 33456789999999999877 5554 59999999999999999999975432111000000
Q ss_pred --h-Cc-----cc---------cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 235 --E-GK-----EY---------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 235 --~-~~-----~~---------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
. .. .+ ....+..++.++.+||.+||..+|++|||+++++.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 00 00 000111348899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=323.39 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=195.7
Q ss_pred cceeeeeecCcccceEEEEEEecC----------------CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCce
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKR----------------SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv 70 (351)
.+|++.++||+|+||.||+|.+.. ++..+|+|.+...... .....+.+|+.++.+++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK--NARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH--HHHHHHHHHHHHHhhcCCCCee
Confidence 468999999999999999997532 3457999988654322 2234456899999999999999
Q ss_pred eeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHH-------HHHHHHHHHHHHHHHHHHHHHHHHhHhCCceec
Q psy6327 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQ-------ARIWIRQIANALEYLHEIANALEYLHEVGIVHR 143 (351)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~-------~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~ 143 (351)
++++++.+.+..++||||+.+|+|.+++............ ...........+.++.||+.||.|||++||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9999999999999999999999999999653211110000 000011223445688899999999999999999
Q ss_pred cCCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh--CCCC
Q psy6327 144 DIKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN--KKYP 219 (351)
Q Consensus 144 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~p 219 (351)
||||+|||++.++.+||+|||+++....... ......+++.|+|||++....++.+ +|||||||++|+|++ +..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999986543321 2233456789999999988877765 999999999999987 5677
Q ss_pred CCCCCCCchHHHHhhh------CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHh
Q psy6327 220 FGDPGTRNRDVLKKQE------GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQ 273 (351)
Q Consensus 220 f~~~~~~~~~~~~~~~------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 273 (351)
|.... ......... ........+..++..+.+|+.+||+.||++|||+.+|.
T Consensus 242 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 242 YGELT--DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCcCC--HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 76543 222222111 01111122346789999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=316.81 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=197.6
Q ss_pred ecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHH---HHHHHhCCCCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPRE---IDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 14 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E---i~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
.||+|+||.||+|.+..+++.||+|.+..+.............| +..++...||+|+++++++.+....|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999876544322212222233 344455679999999999999999999999999
Q ss_pred CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 91 KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 91 ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
|++|.+++.. ...+++..+. .++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++....
T Consensus 81 g~~L~~~l~~--~~~l~~~~~~----------~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQ--HGVFSEAEMR----------FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 9999998875 4556665544 467788888999999999999999999999999999999999987654
Q ss_pred CCcccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH-hhhCccccccccccCC
Q psy6327 171 TPKELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK-KQEGKEYLFNRKYEIS 248 (351)
Q Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~s 248 (351)
.. .....+|++.|+|||.+.+. .++.+ +|+||+||++|+|++|..||.+.......... ....... ..+..+|
T Consensus 149 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~s 223 (278)
T cd05606 149 KK--KPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFS 223 (278)
T ss_pred cc--CCcCcCCCcCCcCcHHhcCCCCCCcc-cchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC--CCCCcCC
Confidence 32 22345799999999998754 45544 99999999999999999999765432222222 1211122 2233578
Q ss_pred HhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 249 IGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 249 ~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
.++.+++.+||..||.+|| ++.++++||||+...
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 9999999999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=319.34 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=205.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++++.||+|+||+||++.+..+++.+|+|++..... ......+.+|+++++.++||||+++++.+...+..++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 3579999999999999999999999999999998764332 22244556899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||+++++|.+++.. .+.++..... .++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||
T Consensus 82 ~e~~~~~~L~~~~~~--~~~~~~~~~~----------~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 82 MEFMDCGSLDRIYKK--GGPIPVEILG----------KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred EecCCCCCHHHHHHh--ccCCCHHHHH----------HHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCC
Confidence 999999999999876 3455554433 456778888999997 689999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc---------hHHHHhhh
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN---------RDVLKKQE 235 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~~~~~ 235 (351)
++...... ......|+..|+|||++.+..++.+ +|+||+||++|+|++|..||....... ........
T Consensus 150 l~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd06620 150 VSGELINS--IADTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226 (284)
T ss_pred cccchhhh--ccCccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence 98754322 2234578999999999887777665 999999999999999999997543210 01111111
Q ss_pred CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
...........++.++.+|+.+||+.||++|||+.++++||||...
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 1111111112377899999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=310.52 Aligned_cols=256 Identities=33% Similarity=0.546 Sum_probs=211.1
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||.|+||.||++.+..++..+++|.+......... ...+.+|+++++.++|||++++.+.+..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE-REDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHH-HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 588999999999999999999999999999998765543222 3345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 88 YAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|+++++|.+++.... ...++.... ..++.+++.||.+||++|++|+||+|+||++++++.++|+|||.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~----------~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQI----------LDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHH----------HHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccc
Confidence 999999999997643 244554443 34677888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
+..............|++.|+|||.+....++.+ +|+||+|+++|+|++|..||.... ............ ..+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~ 225 (258)
T cd08215 150 SKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGEN--LLELALKILKGQ-YPPIPS 225 (258)
T ss_pred eeecccCcceecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCc--HHHHHHHHhcCC-CCCCCC
Confidence 9876555434455678999999999888777665 999999999999999999996654 222222222221 222333
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
.++..+.+++.+||..+|++|||+.++++||||
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=322.53 Aligned_cols=262 Identities=24% Similarity=0.414 Sum_probs=196.9
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC---
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT--- 80 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--- 80 (351)
.++.+|+++++||+|+||.||+|.+..+++.+|+|.+......... .....+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc-hhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 3566799999999999999999999999999999988654332221 222347999999999999999999986543
Q ss_pred -----EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 81 -----YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 81 -----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
..++||||+. ++|.+++... ...+++..+ ..++.|++.||+|||++|++|+||||+||+++.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~----------~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~ 155 (310)
T cd07865 88 NRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEI----------KKVMKMLLNGLYYIHRNKILHRDMKAANILITKD 155 (310)
T ss_pred cCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHH----------HHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC
Confidence 4699999996 6888887652 234555443 3467788999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcc----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HH
Q psy6327 156 LNAKLADFGFSRLLRTPKE----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DV 230 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~ 230 (351)
+.+||+|||++........ ......++..|+|||.+.+......++|+||+|+++|+|++|..||........ ..
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~ 235 (310)
T cd07865 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235 (310)
T ss_pred CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999986643322 123446788999999887654333459999999999999999999965432111 00
Q ss_pred HHhhhCc----------------cccccc-----------cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 231 LKKQEGK----------------EYLFNR-----------KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 231 ~~~~~~~----------------~~~~~~-----------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
....... ....+. ....+..+.+||.+||+.||.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0110000 000000 01235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.93 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=195.5
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeC--CEEEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAG--TYLYMI 85 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~--~~~~lv 85 (351)
|++++.||+|+||.||+|.+..++..+|+|.+......... .. ..+|+.+++++. ||||+++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~-~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VN-NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hh-HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 67899999999999999999999999999988654322221 22 237999999995 99999999999887 899999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++ ++|.+.+... ...+++..+ ..++.|++.||.|||++|++|+||+|+||+++. +.+||+|||+
T Consensus 79 ~e~~~-~~l~~~l~~~-~~~~~~~~~----------~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~ 145 (282)
T cd07831 79 FELMD-MNLYELIKGR-KRPLPEKRV----------KSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGS 145 (282)
T ss_pred EecCC-ccHHHHHHhc-cCCCCHHHH----------HHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccc
Confidence 99997 6888888653 234555443 346778888999999999999999999999999 9999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh----------
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---------- 235 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---------- 235 (351)
++....... .....+++.|+|||.+........++|+||+||++|+|++|..||...+.. +......
T Consensus 146 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 222 (282)
T cd07831 146 CRGIYSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEV 222 (282)
T ss_pred ccccccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHH
Confidence 987644332 233568999999998755444344599999999999999999999754321 1111000
Q ss_pred --------Cccccccc---------cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 236 --------GKEYLFNR---------KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 236 --------~~~~~~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
...+.++. ...++.++.+||.+||++||++|||+.++++||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00111111 12568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.74 Aligned_cols=256 Identities=31% Similarity=0.547 Sum_probs=208.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|+||.||++.++.+|..+|+|.+......... ...+.+|+.+++.++||||+++++.+......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE-KEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchh-hHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 588999999999999999999999999999998775443322 3345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC-eEEeecccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN-AKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~-~kl~Dfg~a 166 (351)
|+.+++|.+++.......+++.... .++.|++.||.|||+++++|+||+|+||++++++. +||+|||.+
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~----------~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQIL----------SWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHH----------HHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccc
Confidence 9999999999976444445554433 45677888888999999999999999999988754 699999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
..............|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||..... ......... ....+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~-~~~~~~~~~ 225 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNL--HQLVLKICQ-GYFAPISPN 225 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHhc-ccCCCCCCC
Confidence 876554444445568999999999887777665 9999999999999999999975432 222222221 122223346
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
++.++.++|.+||..+|++|||+.+++.||||
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 78899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=321.38 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=201.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~l 84 (351)
..+|...+.||+|+||.||++.+..+++.+|+|.+....... ....+.+|+.++.++. ||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK--EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChH--HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 456788899999999999999999999999999987544332 2344558999999996 9999999999999999999
Q ss_pred EEecCCCCChHHHHH---hhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEcCCCCeEE
Q psy6327 85 IMDYAEKKDLEHYIS---KACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 85 v~e~~~ggsL~~~l~---~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~~~kl 160 (351)
+|||+. ++|.++.. ......+++.... .++.|++.||+|||+. +++||||||+||+++.++.++|
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~----------~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl 149 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILG----------KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKL 149 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHH----------HHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEE
Confidence 999986 66665442 2223455555433 4677888899999975 9999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh-hC
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS---PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ-EG 236 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~ 236 (351)
+|||+++....... .....|++.|+|||++.+. .++.+ +||||+||++|+|++|+.||..... ........ ..
T Consensus 150 ~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~ 226 (288)
T cd06616 150 CDFGISGQLVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPYPKWNS-VFDQLTQVVKG 226 (288)
T ss_pred eecchhHHhccCCc-cccccCccCccCHHHhccccccCCcch-hhhhHHHHHHHHHHhCCCCchhcch-HHHHHhhhcCC
Confidence 99999976543322 2334688999999998766 45554 9999999999999999999975431 11111111 11
Q ss_pred ccccc--cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 237 KEYLF--NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 237 ~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..+.. .....++.++.+||.+||+.||++|||+.+++.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 11111 1223588999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=319.25 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=202.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|++.+.||+|+||.||+|.+..+++.+|+|.+.............+.+|+.+++.++||||+++++++.+.+..|+|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 38899999999999999999999999999999865443333333455689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+. |+|.+++... ...+++... ..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++.
T Consensus 96 ~~~-g~l~~~~~~~-~~~l~~~~~----------~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 96 YCL-GSASDILEVH-KKPLQEVEI----------AAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred hhC-CCHHHHHHHc-ccCCCHHHH----------HHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcce
Confidence 997 7787777542 234554443 3467788899999999999999999999999999999999999987
Q ss_pred cccCCcccccccccccceecccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
..... ....|++.|+|||++. ...++.+ +||||+|+++|+|++|..||..... .................
T Consensus 164 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~s~G~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~ 236 (307)
T cd06607 164 LVSPA----NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNDSPTLSS 236 (307)
T ss_pred ecCCC----CCccCCccccCceeeeccCCCCCCcc-cchHHHHHHHHHHHcCCCCCCCccH--HHHHHHHhcCCCCCCCc
Confidence 64332 3446888999999874 3345544 9999999999999999999965432 22222222111111112
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
..++..+.++|.+||+.||++||++.+++.||||....
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 24788999999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=311.77 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=202.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.++++++.+|+|.+...... ...+.+|+.+++.++||||+++++++..++..+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH----HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 45799999999999999999999999999999987643221 23345899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++.......++.... +.++.|++.||.|||++|++|+||||+||++++++.+||+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~----------~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHH----------HHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcc
Confidence 99999999999997643444554433 34678889999999999999999999999999999999999999
Q ss_pred cccccCCcccc-cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 166 SRLLRTPKELS-NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 166 a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
+.......... ....+++.|+|||.+.+..++.. +|||||||++|+|++ |..||.... ..+....... .+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~-~~~~~~ 226 (263)
T cd05052 151 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEK-GYRMER 226 (263)
T ss_pred ccccccceeeccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHC-CCCCCC
Confidence 98765432211 12234668999999988777765 999999999999998 999997543 2233233222 222333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+..++.++.++|.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4468899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.00 Aligned_cols=261 Identities=23% Similarity=0.387 Sum_probs=202.4
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----C
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG-----T 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~ 80 (351)
..+|.+++.||+|+||+||+|.+..+++.+|+|.+......... .....+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch-hHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 45799999999999999999999999999999998643222222 22334899999999999999999987544 3
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+|+||+. ++|.+++.. ...+++.... .++.|++.||.|||+++++|+||||+||+++.++.+||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~----------~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS--SQTLSDDHCQ----------YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc--CCCCCHHHHH----------HHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEE
Confidence 5899999996 789998876 4566665543 46778888899999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHH---------
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV--------- 230 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------- 230 (351)
+|||++..............++..|+|||.+... .++. ++|+|||||++|+|++|++||...+......
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 150 CDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTT-AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred CcCccccccCCCcccccccccccCccChHHHhcCCCCCC-cccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998765543444456789999999988653 4444 4999999999999999999996543110000
Q ss_pred ----H------------HhhhCc--cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 231 ----L------------KKQEGK--EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 231 ----~------------~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. ...... .........++..+.+||.+||+.||++|||+.++++||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 000000 00001123578899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=310.20 Aligned_cols=256 Identities=26% Similarity=0.381 Sum_probs=204.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhh--hhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--CEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL--KRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--TYL 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~ 82 (351)
.+|++.+.||+|+||.||+|.+..++..+|+|.+..... ........+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 469999999999999999999999999999998754321 1222234566899999999999999999998654 568
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++++||+++++|.+++.. ...+++.... .++.|++.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~----------~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA--YGALTENVTR----------RYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred EEEEEeCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECc
Confidence 999999999999999875 3445554433 4667888899999999999999999999999999999999
Q ss_pred ccccccccCCc---ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 163 FGFSRLLRTPK---ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 163 fg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
||+++...... .......|++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||.+.. .............
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~ 226 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYE--AMAAIFKIATQPT 226 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccC--HHHHHHHHHcCCC
Confidence 99998654321 11234568999999999988777665 999999999999999999997653 2222333332222
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
....+..+++.+.++|.+||+ +|.+|||+.+++.|||+
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 223344788999999999999 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=317.95 Aligned_cols=270 Identities=22% Similarity=0.359 Sum_probs=203.2
Q ss_pred CccceeeeeecCcccceEEEEEEecC-----CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKR-----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG 79 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 79 (351)
+..+|++.+.||+|+||.||+|.++. .+..+|+|.+........ ...+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE--RIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34579999999999999999987652 356899998764332221 22345899999999999999999999999
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
...|+||||+.+|+|.+++....... +.............+.++.|++.||.|||+++|+||||||+||+++.++.++
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhcccc--ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999997532110 0000000001122345788999999999999999999999999999999999
Q ss_pred EeeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhC
Q psy6327 160 LADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 236 (351)
|+|||+++........ .....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.... ..........
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~ 236 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLS--NEQVLKFVMD 236 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc
Confidence 9999998865432221 122345778999999988777765 999999999999998 788997543 2333332222
Q ss_pred ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc------CccccCCc
Q psy6327 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN------HAWIQNEP 282 (351)
Q Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~------hp~~~~~~ 282 (351)
.. ....+..++..+.+++.+||+.||++|||+.++++ ||||++..
T Consensus 237 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 237 GG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 21 12223357889999999999999999999999986 99998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=326.91 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=197.6
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC------
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG------ 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------ 79 (351)
...|++++.||+|+||.||+|.+..+++.+|+|.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH-AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhH-HHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 56799999999999999999999999999999998643322222 23344899999999999999999988543
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
...|+||||+. ++|.+.+.. .+++.... .++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~----------~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM----DLDHERMS----------YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh----cCCHHHHH----------HHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEE
Confidence 35799999996 688888754 25544432 4677889999999999999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh----
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---- 235 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---- 235 (351)
|+|||+++...... ......|++.|+|||.+.+..++.+ +|||||||++|+|++|+.||...+. ........
T Consensus 159 L~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~ 234 (353)
T cd07850 159 ILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDH--IDQWNKIIEQLG 234 (353)
T ss_pred EccCccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcC
Confidence 99999998754432 2334568999999999988888765 9999999999999999999965431 11110000
Q ss_pred -------------------Ccc----c---------cccc-----cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 236 -------------------GKE----Y---------LFNR-----KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 236 -------------------~~~----~---------~~~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
... . .++. ....+..+++||.+||+.||.+|||+.|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence 000 0 0000 11246678999999999999999999999999998
Q ss_pred c
Q psy6327 279 Q 279 (351)
Q Consensus 279 ~ 279 (351)
+
T Consensus 315 ~ 315 (353)
T cd07850 315 N 315 (353)
T ss_pred h
Confidence 6
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=307.61 Aligned_cols=256 Identities=32% Similarity=0.486 Sum_probs=209.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--CEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--TYLYMI 85 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv 85 (351)
+|+..+.||+|++|.||+|.+..+++.+++|++........ ....+.+|+.++++++||||+++++.+... ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchH-HHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 58889999999999999999999999999999876654322 234556899999999999999999999988 899999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
+||+++++|.+++.+. ..+++.... .++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~----------~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 80 LEYVSGGSLSSLLKKF--GKLPEPVIR----------KYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred EEecCCCcHHHHHHHc--CCCCHHHHH----------HHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccccc
Confidence 9999999999999763 355554433 4677888889999999999999999999999999999999999
Q ss_pred cccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 166 SRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 166 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
+........ ......++..|+|||.+.....+.+ +|+||||+++|+|++|..||..... .................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~ 225 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGN-PMAALYKIGSSGEPPEI 225 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHhccccCCCcCC
Confidence 987765443 1344568999999999987776655 9999999999999999999976552 22222222221222233
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
+..++..+.+||.+||+.||++||++.++++||||
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 34678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.45 Aligned_cols=259 Identities=30% Similarity=0.443 Sum_probs=202.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--CCEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA--GTYLYMI 85 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv 85 (351)
+|.+++.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+++++.++||||+++++++.+ .+.+|+|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 689999999999999999999999999999998654332 223445589999999999999999998854 4578999
Q ss_pred EecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 86 MDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
|||++|++|.+++.... ...+++.. +..++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~----------~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKV----------LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHH----------HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeec
Confidence 99999999999876422 22334332 3456788999999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC---CchHHHHhhhC-ccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGT---RNRDVLKKQEG-KEY 239 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~-~~~ 239 (351)
|++....... .....++..|+|||.+.+..++.+ +|+|||||++|+|++|..||..... ...+....... ...
T Consensus 150 g~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd06621 150 GVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP 226 (287)
T ss_pred cccccccccc--cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch
Confidence 9987654322 223457889999999988887766 9999999999999999999976532 11222222221 111
Q ss_pred cccc----cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 240 LFNR----KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 240 ~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..+. ...+++.+.+||.+||+.||++|||+.|++.||||++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1111 12356789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=306.75 Aligned_cols=254 Identities=30% Similarity=0.484 Sum_probs=209.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|++|.||++.+..+++.+++|.+......... ...+.+|+++++++.|||++++++++.+++..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA-LKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHH-HHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 588999999999999999999999999999999776554333 3445689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+++++|.+++.. ...+++.... .++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 80 ~~~~~~L~~~~~~--~~~l~~~~~~----------~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 80 YAENGSLRQIIKK--FGPFPESLVA----------VYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred cCCCCcHHHHHHh--ccCCCHHHHH----------HHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccce
Confidence 9999999999976 3555554433 467788889999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.............+++.|+|||.+.+...+.+ +|+||+|+++|+|++|..||..... ........... ....+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~~lG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~--~~~~~~~~ 223 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLNP-MAALFRIVQDD--HPPLPEGI 223 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHhccC--CCCCCCCC
Confidence 77654443445678999999999887775554 9999999999999999999976542 11121211111 12233467
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
+..+.+++.+||..+|++|||+.+++.||||
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 224 SPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=315.29 Aligned_cols=256 Identities=30% Similarity=0.487 Sum_probs=209.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|++.+.||+|++|.||++.+..++..+++|++..... ....+.+|+.+++.++|+||+++++.+......|+|+|
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 38888999999999999999998999999999875443 23334589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++|++|.+++.... ..++... ++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~----------~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQ----------IAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHH----------HHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 999999999998732 2455543 33467888999999999999999999999999999999999999987
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh-hCcccccccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ-EGKEYLFNRKYE 246 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 246 (351)
.............+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||..... ....... ............
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPP--LRALFLITTKGIPPLKNPEK 241 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCcchhh
Confidence 65544333345568899999999988777765 9999999999999999999975432 2222221 112222223334
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
++..+.+||.+||+.+|.+|||+.++++||||...
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 78999999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.47 Aligned_cols=256 Identities=23% Similarity=0.419 Sum_probs=201.7
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|...+.||+|+||.||+|.+..++..+++|.+.............+.+|+.+++.++|||++++++++.++...|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56678899999999999999999999999998765443333334455899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+. |+|.+++... ...+++... +.++.|++.||.|||++|++|+||+|+||++++++.+||+|||++..
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~----------~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEI----------AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 96 6888877542 334554433 34677888899999999999999999999999999999999999864
Q ss_pred ccCCcccccccccccceecccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
... .....|+..|+|||++. ...++.+ +|+|||||++|+|++|..||..... ..................
T Consensus 171 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 243 (313)
T cd06633 171 SSP----ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNDSPTLQSN 243 (313)
T ss_pred cCC----CCCccccccccChhhccccCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCcc
Confidence 322 23456899999999974 3445544 9999999999999999999966432 222222221111111223
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
.++..+++|+.+||+++|.+||++.++++||||+..+.
T Consensus 244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 244 EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 56788999999999999999999999999999987553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=315.50 Aligned_cols=255 Identities=26% Similarity=0.461 Sum_probs=204.1
Q ss_pred eeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecC
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYA 89 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (351)
....+||+|+||.||++.+..++..+|+|++..... .....+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 345679999999999999999999999998754322 22344558999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccc
Q psy6327 90 EKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL 169 (351)
Q Consensus 90 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 169 (351)
++++|.+++.. ..+++.... .++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~----------~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 100 EGGALTDIVTH---TRMNEEQIA----------AVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred CCCcHHHHHhc---CCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 99999998754 345554433 46778888999999999999999999999999999999999998765
Q ss_pred cCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh-CccccccccccCC
Q psy6327 170 RTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE-GKEYLFNRKYEIS 248 (351)
Q Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~s 248 (351)
...........|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||..... ........ ...........++
T Consensus 167 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06657 167 SKEVPRRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLKNLHKVS 243 (292)
T ss_pred ccccccccccccCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcccCCcccCC
Confidence 443333344678999999999887777665 9999999999999999999975432 22222111 1112222334578
Q ss_pred HhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 249 ~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
..+.+++.+||+.||.+||++.++++||||.....
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 89999999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=323.60 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=195.2
Q ss_pred eecCcc--cceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 13 SKLGEG--AYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 13 ~~LG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
..||+| +||+||.|.+..+|+.||+|++......... .+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEH-LKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHH-HHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 457777 9999999999999999999998765443332 3556689999999999999999999999999999999999
Q ss_pred CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 91 KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 91 ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
+++|.+++.......+++..+. .++.|++.||+|||++|++||||||+|||++.++.++++||+.+....
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~----------~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIG----------NILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 9999999987544445554433 467788889999999999999999999999999999999998654332
Q ss_pred CCccc-------ccccccccceeccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc---
Q psy6327 171 TPKEL-------SNTFCGTTSYAAPEIIRNSP--YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE--- 238 (351)
Q Consensus 171 ~~~~~-------~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--- 238 (351)
..... .....++..|+|||++.+.. ++. ++||||+||++|+|++|..||...... ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~ 230 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNV-KSDIYSVGITACELATGRVPFQDMLRT-QMLLQKLKGPPYSP 230 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHhcCCCCCC
Confidence 11111 11123456799999987642 444 499999999999999999999764321 11111111000
Q ss_pred -----------------------------------------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q psy6327 239 -----------------------------------------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAW 277 (351)
Q Consensus 239 -----------------------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 277 (351)
...+....++..+.+||++||+.||++|||+.++++|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 001112235678999999999999999999999999999
Q ss_pred ccCC
Q psy6327 278 IQNE 281 (351)
Q Consensus 278 ~~~~ 281 (351)
|++.
T Consensus 311 ~~~~ 314 (328)
T cd08226 311 FKQV 314 (328)
T ss_pred HHHH
Confidence 9743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=309.01 Aligned_cols=251 Identities=22% Similarity=0.407 Sum_probs=200.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+..+|+++++||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 4567999999999999999999865 4567899987543322 2345589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
+|||+++++|.+++.......++... .+.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~----------~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg 148 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPK----------LIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFG 148 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHH----------HHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCc
Confidence 99999999999999764444444443 33467788999999999999999999999999999999999999
Q ss_pred ccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
+++....... ......++..|+|||.+....++.+ +|+|||||++|+|++ |..||.... .......... .+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~-~~~~~ 224 (261)
T cd05072 149 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQR-GYRMP 224 (261)
T ss_pred cceecCCCceeccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHHHc-CCCCC
Confidence 9987643221 1223345678999999988777765 999999999999998 999997543 2233333322 22334
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
....++.++.+++.+||..||++|||++++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 44468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=312.47 Aligned_cols=265 Identities=23% Similarity=0.361 Sum_probs=200.7
Q ss_pred CccceeeeeecCcccceEEEEEEec----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDK----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
++.+|++.+.||+|+||.||+|... .++..+++|.+...... .....+.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP--QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 45688999988643221 22344568999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCC-----chHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENI-----HENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~-----~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
..|+||||+++++|.+++........ ...............+.++.|++.||.|||++|++|+||||+|||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 99999999999999999864211000 0000000001122345578899999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q psy6327 156 LNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 232 (351)
+.+||+|||+++....... ......++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.... ......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~--~~~~~~ 237 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFS--NQEVIE 237 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHH
Confidence 9999999999986543221 2233446778999999987777765 999999999999998 999996543 233333
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...... ..+.+..++..+.+++.+||+.||.+||++.+++++
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 333222 233444689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=318.21 Aligned_cols=260 Identities=28% Similarity=0.473 Sum_probs=224.4
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh-hHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 83 (351)
..+|.++.+||+|+||.|-+|..+.+.+.||||++.++.+- ++..+..+ .|-++|... +-|.++.++.+|.+-+.+|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm-~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTM-VEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCccccee-hhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 45799999999999999999999999999999999776653 33333333 576777666 4689999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++||+|--.|++ -+.+.|+.+ +-|+.+|+-||-+||++||++||||.+|||++.+|++||+||
T Consensus 427 FVMEyvnGGDLMyhiQQ--~GkFKEp~A----------vFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQ--VGKFKEPVA----------VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred eEEEEecCchhhhHHHH--hcccCCchh----------hhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeec
Confidence 99999999999999988 577777653 447888899999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++.--.....+.+.||||.|+|||++...+|... +|.||+|++||||+.|++||.+.+ ..+.++.+......+|.
T Consensus 495 GmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeD--E~elF~aI~ehnvsyPK 571 (683)
T KOG0696|consen 495 GMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGED--EDELFQAIMEHNVSYPK 571 (683)
T ss_pred ccccccccCCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHccCcCcc
Confidence 999865555667789999999999999999999876 999999999999999999998765 66777777766666555
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNA-----KDVQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~~ 283 (351)
.+|.++.+++...|.+.|.+|..+ ++|-.||||+...|
T Consensus 572 --slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 572 --SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred --cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 789999999999999999999753 58999999987765
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=313.26 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=201.9
Q ss_pred ccceeeeeecCcccceEEEEEEecC-----CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKR-----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
..+|.+.+.||+|+||.||+|.+.. ++..+|+|.+...... .....+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4578999999999999999998753 4678999988644322 12345668999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCch--HHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHE--NQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~--~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
..++||||+++++|.+++.......... .....-......++.++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997632100000 00000011233455678899999999999999999999999999999999
Q ss_pred EEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhh
Q psy6327 159 KLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 235 (351)
||+|||+++....... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.... .........
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~--~~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLS--NEEVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHH
Confidence 9999999976533221 2233446789999999988888775 999999999999998 999997654 233333333
Q ss_pred CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.... ......++..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2222 2223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=310.84 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=204.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.++||.|+||.||+|.+.. +..+++|.+....... ...+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLK---QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhh---HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 569999999999999999999987 8899999986554322 233558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|.+++.+.....++..... .++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~----------~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLI----------DMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccch
Confidence 99999999999986544455554433 46678888888999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
..............++..|+|||.+....++.+ +|+||||+++|+|++ |..||.... ..+...... ..+..+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~-~~~~~~~~~ 227 (261)
T cd05148 152 RLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQIT-AGYRMPCPA 227 (261)
T ss_pred hhcCCccccccCCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHH-hCCcCCCCC
Confidence 876544333334446778999999988777765 999999999999998 899996544 333333333 223334445
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.++..+.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=322.32 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=198.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----C
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG-----T 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~ 80 (351)
-.+|++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 3579999999999999999999999999999999853221 11233344799999999999999999987544 3
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+|+||+. ++|.+++.. ..+++..+. .++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~----------~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl 147 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT---QHLSNDHIQ----------YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKI 147 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc---CCCCHHHHH----------HHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEE
Confidence 5899999997 688888754 456665543 35678888899999999999999999999999999999
Q ss_pred eeccccccccCCcc---cccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch--------
Q psy6327 161 ADFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-------- 228 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------- 228 (351)
+|||++........ ......||+.|+|||.+.+. .++. ++||||+||++|+|++|+.||.+......
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~ 226 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-AIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL 226 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 99999976543222 12345789999999987654 4444 59999999999999999999965432110
Q ss_pred -----HHHHhhhC---c--------cccc---cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 229 -----DVLKKQEG---K--------EYLF---NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 229 -----~~~~~~~~---~--------~~~~---~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
+....+.. . .... ......+.++.+||.+||+.||++|||+.++++||||+...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000000 0 0000 01124678899999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=324.20 Aligned_cols=263 Identities=26% Similarity=0.421 Sum_probs=201.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE----eCCEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK----AGTYL 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~----~~~~~ 82 (351)
.+|++.+.||+|+||.||+|.++.+++.||+|.+......... ...+.+|+.++++++||||+++++++. .....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL-AKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccc-hHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 5799999999999999999999999999999998654322222 334458999999999999999999875 34578
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||||+. ++|.+++.. ...+++..+. .++.|++.||.|||+++++||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~----------~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS--DQPLTEEHIR----------YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred EEEEehhh-hhHHHHhcc--CCCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecc
Confidence 99999996 789998865 3446665543 4667888889999999999999999999999999999999
Q ss_pred ccccccccCCcc----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchH---------
Q psy6327 163 FGFSRLLRTPKE----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD--------- 229 (351)
Q Consensus 163 fg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------- 229 (351)
||++........ ......|+..|+|||.+.+......++||||+||++|+|++|+.||.+.+.....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~ 230 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence 999976543222 1234578999999999866433334599999999999999999999664421110
Q ss_pred ----HHHh---------hhCccc--ccc---ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 230 ----VLKK---------QEGKEY--LFN---RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 230 ----~~~~---------~~~~~~--~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
.... ...... ..+ .....+.++.++|.+||+.||++|||+.+++.||||...+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0000 000000 000 01246889999999999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.93 Aligned_cols=239 Identities=31% Similarity=0.483 Sum_probs=201.7
Q ss_pred eeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecC
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYA 89 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (351)
..++.||+|+.|.||+++.. ++.||||++. .++. -+|+-|++|+||||+.|.|+|...-.+|||||||
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~--elkE--------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVR--ELKE--------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHh--hhhh--------hhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 34788999999999999876 7899999864 2222 5788999999999999999999999999999999
Q ss_pred CCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccc
Q psy6327 90 EKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL 169 (351)
Q Consensus 90 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 169 (351)
..|-|...++. ...+....... +..+|+.|++|||.+.|||||||.-||||+.+..|||+|||-++..
T Consensus 195 a~GqL~~VLka--~~~itp~llv~----------Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 195 AQGQLYEVLKA--GRPITPSLLVD----------WSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred ccccHHHHHhc--cCccCHHHHHH----------HHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999987 55555544444 4667788888999999999999999999999999999999999876
Q ss_pred cCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCH
Q psy6327 170 RTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249 (351)
Q Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (351)
... ...-.++||..|||||++++.+-+.+ +|||||||+||||+||..||.+.+. ..++--.......++-+..+++
T Consensus 263 ~~~-STkMSFaGTVaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVds--sAIIwGVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 263 SDK-STKMSFAGTVAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDS--SAIIWGVGSNSLHLPVPSTCPD 338 (904)
T ss_pred hhh-hhhhhhhhhHhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccch--heeEEeccCCcccccCcccCch
Confidence 543 34456789999999999999998876 9999999999999999999977553 2233233334445666778999
Q ss_pred hHHHHHHHhcCCCCCCCCCHHHHhcCc
Q psy6327 250 GAKQLIGRMLEPNPKHRPNAKDVQNHA 276 (351)
Q Consensus 250 ~~~~li~~~L~~dp~~Rpt~~ell~hp 276 (351)
.++=||+.||+-.|..||++++||.|-
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 999999999999999999999999984
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=317.33 Aligned_cols=264 Identities=22% Similarity=0.357 Sum_probs=197.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCCcee--EEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETL--KACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~ 81 (351)
.+.+|++.+.||+|+||.||+|.++.++.. +++|.+.. .........+.+|+.++.++ +||||+++++++..++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 467899999999999999999998877754 46666542 22222234556899999999 89999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHH----HHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQ----ARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN 157 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~----~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~ 157 (351)
.|+||||+++++|.+++........+... ..........++.++.|++.||+|||++|++||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 99999999999999999753211100000 00000112234557889999999999999999999999999999999
Q ss_pred eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhC
Q psy6327 158 AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 236 (351)
+||+|||++...... .......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.... ..+......
T Consensus 163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~- 237 (303)
T cd05088 163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLP- 237 (303)
T ss_pred EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCC--hHHHHHHHh-
Confidence 999999998643211 11122234668999999887776665 999999999999998 999996543 233333322
Q ss_pred ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..+....+..++.++.+|+.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222223334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=325.80 Aligned_cols=263 Identities=20% Similarity=0.325 Sum_probs=198.7
Q ss_pred cceeeeeecCcccceEEEEEEecCC-----ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS-----ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~ 80 (351)
.+|++.++||+|+||.||+|.+... +..||+|++...... ...+.+.+|+.+++++. ||||+++++++.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4577899999999999999987433 457999998543222 22344568999999996 999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCC------------------------------------------------------
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENI------------------------------------------------------ 106 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~------------------------------------------------------ 106 (351)
..|+|||||++|+|.+++........
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999865321000
Q ss_pred -----------------------chHHHHHHH-------HHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 107 -----------------------HENQARIWI-------RQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 107 -----------------------~~~~~~~~~-------~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
.......+. .....++.++.|++.||+|||+++|+|+||||+|||+++++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 000000010 12334567899999999999999999999999999999999
Q ss_pred CeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHh
Q psy6327 157 NAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 233 (351)
.+||+|||+++....... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||...... ......
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~~~~-~~~~~~ 352 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGMIVD-STFYNK 352 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCcccchh-HHHHHH
Confidence 999999999986543222 1223456788999999988777765 999999999999997 99999754322 122222
Q ss_pred hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.. .....+.+..++.++.+++.+||+.||++|||+.++.+
T Consensus 353 ~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IK-SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred Hh-cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22 22233344578999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=306.60 Aligned_cols=250 Identities=22% Similarity=0.409 Sum_probs=197.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
|..+|++.+.||+|+||.||++..+. +..+|+|.+....... ..+.+|+.+++.++||||+++++++......++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccH----HHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 45789999999999999999998764 5678999876443322 234589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++|+|.+++... ...+++.. ++.++.|++.||+|||++|++|+||+|+||++++++.+||+|||
T Consensus 77 v~e~~~~~~L~~~~~~~-~~~~~~~~----------~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g 145 (256)
T cd05114 77 VTEFMENGCLLNYLRQR-QGKLSKDM----------LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFG 145 (256)
T ss_pred EEEcCCCCcHHHHHHhC-ccCCCHHH----------HHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCC
Confidence 99999999999998753 22344433 33467788899999999999999999999999999999999999
Q ss_pred ccccccCCccc-ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKEL-SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
.++........ .....++..|+|||.+.+..++.+ +|+||+|+++|+|++ |+.||...+ ............. ..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i~~~~~-~~ 221 (256)
T cd05114 146 MTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMISRGFR-LY 221 (256)
T ss_pred CccccCCCceeccCCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCC-CC
Confidence 98865432222 122335668999999987777765 999999999999999 999997544 2333333332221 12
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+...+..+.+++.+||+.||++|||+.++++
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 23356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=313.31 Aligned_cols=261 Identities=22% Similarity=0.341 Sum_probs=197.5
Q ss_pred cceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|++.+.||+|+||.||+|.+. .++..+|+|.+....... ....+.+|+.+++.++||||+++++++..+..
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46999999999999999999864 345789999875432211 12335589999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++||||+++++|.+++.+.... ..... ..........+.++.|++.||.|||+.|++|+||||+||+++.++.++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPE-MENNP-VQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCcc-ccccc-cccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999653211 10000 00001122345578899999999999999999999999999999999999
Q ss_pred eccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcc
Q psy6327 162 DFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 162 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|||+++........ .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.... ............
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~~ 238 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMS--NEQVLRFVMEGG 238 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcCC
Confidence 99998765332211 122345788999999988777765 999999999999998 789997543 333333322222
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
. ...+..++..+.+++.+||+.||++|||+.+++++
T Consensus 239 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 22334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=317.96 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=197.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCcee----EEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETL----KACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
..+|++++.||+|+||.||+|.+..++.. +|+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 45799999999999999999998766654 89998753322 22234455899999999999999999998765 4
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++++||+++|+|.+++.+. ...++... .+.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~-~~~~~~~~----------~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~ 151 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH-KDNIGSQY----------LLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKIT 151 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc-cccCCHHH----------HHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEc
Confidence 77999999999999999763 22344333 33467789999999999999999999999999999999999
Q ss_pred eccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcc
Q psy6327 162 DFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 162 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|||+++........ .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+... ..... .....
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~-~~~~~ 227 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPA--SEISS-ILEKG 227 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH-HHhCC
Confidence 99999876543221 122334678999999988887765 999999999999997 9999976432 22222 22222
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...+.+..++.++.+++.+||..||++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 228 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3334445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=312.85 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=200.2
Q ss_pred ccceeeeeecCcccceEEEEEEecCC-----ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRS-----ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
..+|++.+.||+|+||.||++.++.. +..+|+|.+........ ...+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE--RIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHH--HHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 45799999999999999999988644 48899999754432221 234458999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..++||||+++++|.+++....... +.....-......++.++.|++.||.|||+++++|+||||+|||++.++.+||
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEA--ENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccch--hhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999997532111 00000000111234557789999999999999999999999999999999999
Q ss_pred eeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 161 ADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+|||+++....... ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...+ ..........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~- 236 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLS--NEEVLKFVID- 236 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCC--HHHHHHHHhc-
Confidence 99999986543321 2234456889999999987777765 999999999999998 999997544 2333333332
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
......+..++..+.+++.+||+.+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2222334467999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=303.25 Aligned_cols=253 Identities=31% Similarity=0.485 Sum_probs=206.4
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|+..+.||+|++|.||++.+..++..+++|.+..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999999999999999866543 123445589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++|++|.+++.... ..+++.... .++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~----------~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIA----------YVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHH----------HHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccc
Confidence 999999999987632 455554433 356788888889999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
....... .....|+..|+|||.+.....+.+ +|+||+|+++|+|++|..||...+..... ...........+....+
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 223 (253)
T cd05122 147 QLSDTKA-RNTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKAL-FKIATNGPPGLRNPEKW 223 (253)
T ss_pred ccccccc-ccceecCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcCCCCcCccccc
Confidence 7654432 345568999999999987776655 99999999999999999999765322211 11111222233333345
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAW 277 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 277 (351)
+..+.++|.+||+.||++|||+.++++|||
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 899999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=311.66 Aligned_cols=261 Identities=32% Similarity=0.519 Sum_probs=203.7
Q ss_pred ceeeeeecCcccceEEEEEEec---CCceeEEEEecchhhhh-hHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~ 82 (351)
+|++.+.||.|+||.||.|.+. .+|..+|+|.+...... .......+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5889999999999999999875 47899999998654332 122234455899999999 599999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||||+++++|.+++.. ...+++.... .++.|++.||.|||+.|++||||+|+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~----------~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 81 HLILDYINGGELFTHLSQ--RERFKEQEVQ----------IYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEee
Confidence 999999999999999976 3455554433 3566888899999999999999999999999999999999
Q ss_pred ccccccccCCcc-cccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHhhhCcc
Q psy6327 163 FGFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTR--NRDVLKKQEGKE 238 (351)
Q Consensus 163 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~ 238 (351)
||++........ ......|+..|+|||.+.... ....++||||+|+++|+|++|..||...... ............
T Consensus 149 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (290)
T cd05613 149 FGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228 (290)
T ss_pred CccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC
Confidence 999986543221 223456899999999986532 2233499999999999999999999643321 112222221112
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
. +.+..++..+.+++.+||+.||++|| ++.+++.||||+...
T Consensus 229 ~--~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 229 P--PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred C--CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 1 22345788999999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=307.27 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=201.4
Q ss_pred CccceeeeeecCcccceEEEEEEecCC---ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
+..+|++.+.||+|+||.||+|.+..+ ...+|+|.+..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 346799999999999999999998644 46899998764432 2223345589999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++||||+++++|.+++... ...++... ++.++.|++.||.|||+++|+|+||||+|||++.++.++|+
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~----------~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~ 148 (266)
T cd05033 80 VMIITEYMENGSLDKFLREN-DGKFTVGQ----------LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVS 148 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhc-cCCCCHHH----------HHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEEC
Confidence 99999999999999999763 23445443 34567788999999999999999999999999999999999
Q ss_pred eccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcc
Q psy6327 162 DFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 162 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|||+++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.... .......... .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~-~ 224 (266)
T cd05033 149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMS--NQDVIKAVED-G 224 (266)
T ss_pred ccchhhcccccccceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCC--HHHHHHHHHc-C
Confidence 99999876522221 112234678999999988777765 999999999999998 999996543 3333333332 2
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
+..+....++..+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2333445689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=305.24 Aligned_cols=254 Identities=33% Similarity=0.506 Sum_probs=206.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.++||+|+||.||++.+..+++.+++|.+......... ...+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE-REDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHH-HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999998765544333 2334489999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 88 YAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|+++++|.+++.... ...+++.. +..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~----------~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQE----------IWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHH----------HHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccc
Confidence 999999999986532 12334333 335677889999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
+...... ......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|+.||...+. ...........+ .+...
T Consensus 150 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~-~~~~~ 223 (256)
T cd08530 150 SKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSM--QDLRYKVQRGKY-PPIPP 223 (256)
T ss_pred hhhhccC--CcccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCC-CCCch
Confidence 9876544 3334568999999999988777765 9999999999999999999976542 222222222221 22223
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
.++.++++++.+||+.+|++|||+.++++||++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 678999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=312.92 Aligned_cols=253 Identities=20% Similarity=0.344 Sum_probs=198.0
Q ss_pred cceeeeeecCcccceEEEEEEe-----cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSD-----KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.+|.+.+.||+|+||.||++.+ ..++..+|+|.+...... .....+.+|+.+++++ +||||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3689999999999999999975 345678999987643322 1234456899999999 7999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+||||+.+|+|.+++.......+++.+. +.++.|++.||.|||+++++|+||||+|||++.++.++|
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~----------~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDL----------LSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHH----------HHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEE
Confidence 9999999999999999997643333555443 346778899999999999999999999999999999999
Q ss_pred eeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 161 ADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+|||+++....... ......+++.|+|||.+.+..++.+ +||||+||++|+|++ |..||...... .........
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~~ 259 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIKE 259 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHHc
Confidence 99999986543221 1223346788999999988877765 999999999999998 99999765432 222222111
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
......+...+..+.+|+.+||.++|++|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2222233457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=312.14 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=203.0
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|...+.||+|+||.||++.+..++..+|+|.+.............+.+|+.+++.++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 78899999999999999999999999999998654333333334556899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+. |+|.+++... ...+++... ..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~----------~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEI----------AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHH----------HHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence 97 6888877543 344554433 34677888999999999999999999999999999999999999875
Q ss_pred ccCCcccccccccccceecccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
... .....|++.|+|||++. ...++.+ +|+||+||++|+|++|..||.... ...................
T Consensus 175 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd06635 175 ASP----ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPTLQSN 247 (317)
T ss_pred cCC----cccccCCccccChhhhhcCCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhccCCCCCCc
Confidence 432 23446889999999974 3345544 999999999999999999996543 2222222222222222233
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
.++..+++++.+||+.+|.+||++.++++|+|+.....
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 57889999999999999999999999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=305.11 Aligned_cols=245 Identities=22% Similarity=0.366 Sum_probs=191.7
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKK 92 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg 92 (351)
+.||+|+||.||+|.+..+++.+|+|.+..... . .....+.+|+.+++.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-P-DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC-H-HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 469999999999999999999999998753322 2 22344568999999999999999999999999999999999999
Q ss_pred ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCC
Q psy6327 93 DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP 172 (351)
Q Consensus 93 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 172 (351)
+|.+++... ...+++.. ++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||.+......
T Consensus 79 ~L~~~~~~~-~~~~~~~~----------~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 79 DFLTFLRTE-GPRLKVKE----------LIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred cHHHHHHhC-CCCCCHHH----------HHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccc
Confidence 999998652 23455443 3346778888999999999999999999999999999999999998764322
Q ss_pred cccc--cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccCCH
Q psy6327 173 KELS--NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249 (351)
Q Consensus 173 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (351)
.... ....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.... .......... ....+.+..++.
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~--~~~~~~~~~~-~~~~~~~~~~~~ 223 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLS--NQQTREAIEQ-GVRLPCPELCPD 223 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccC--HHHHHHHHHc-CCCCCCcccCCH
Confidence 1111 11123457999999988777765 999999999999997 999996543 2222222221 122233446789
Q ss_pred hHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 250 GAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 250 ~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+.+|+.+||+.||++|||+.++++
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.06 Aligned_cols=269 Identities=28% Similarity=0.393 Sum_probs=204.6
Q ss_pred CCCCCccceeee-eecCcccceEEEEEEecCCceeEEEEecchhhhhhHH-----------HhhhHHHHHHHHHhCCCCC
Q psy6327 1 MKFPDILECSYI-SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY-----------MEKFAPREIDILLKVSHPN 68 (351)
Q Consensus 1 ~~~~~~~~~~~~-~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~~Ei~~l~~l~hp~ 68 (351)
|++.--.+|..+ +.||.|+||+||+|.+..+++.+|+|++......... ....+.+|+.++++++|||
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 81 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN 81 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence 444445567654 6699999999999999999999999998654332210 0113458999999999999
Q ss_pred ceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCC
Q psy6327 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCE 148 (351)
Q Consensus 69 iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~ 148 (351)
|+++++++..+...++||||+. ++|.+++.. ...+++... +.++.|++.||+|||++|++|+||+|+
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~----------~~~~~ql~~aL~~LH~~~i~H~dl~~~ 148 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQV----------KCILLQILNGLNVLHKWYFMHRDLSPA 148 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHhCCeecccccHH
Confidence 9999999999999999999997 799999865 344555443 346778888899999999999999999
Q ss_pred CEeEcCCCCeEEeeccccccccCC--------------cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHH
Q psy6327 149 NILISRLLNAKLADFGFSRLLRTP--------------KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214 (351)
Q Consensus 149 NIll~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 214 (351)
||+++.++.++|+|||.+...... ........+++.|+|||.+.+......++|+|||||++|+|+
T Consensus 149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 228 (335)
T PTZ00024 149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228 (335)
T ss_pred HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999765411 111223456889999999876554344599999999999999
Q ss_pred hCCCCCCCCCCCchHHHHhhh---C--ccccc---------------------cccccCCHhHHHHHHHhcCCCCCCCCC
Q psy6327 215 NKKYPFGDPGTRNRDVLKKQE---G--KEYLF---------------------NRKYEISIGAKQLIGRMLEPNPKHRPN 268 (351)
Q Consensus 215 ~g~~pf~~~~~~~~~~~~~~~---~--~~~~~---------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt 268 (351)
+|..||...+. ......+. . ....+ ......+..+.++|.+||+.||++|||
T Consensus 229 tg~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 306 (335)
T PTZ00024 229 TGKPLFPGENE--IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS 306 (335)
T ss_pred hCCCCCCCCCH--HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC
Confidence 99999976542 11111100 0 00000 001245788999999999999999999
Q ss_pred HHHHhcCccccCCccc
Q psy6327 269 AKDVQNHAWIQNEPTC 284 (351)
Q Consensus 269 ~~ell~hp~~~~~~~~ 284 (351)
+++++.||||+..+.+
T Consensus 307 ~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 307 AKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHhcCcccCCCCCC
Confidence 9999999999876544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=342.69 Aligned_cols=152 Identities=32% Similarity=0.508 Sum_probs=133.8
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
|++.+|.++++||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.....+|
T Consensus 1 p~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred CccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence 67889999999999999999999999999999999987655544444456668999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+.|++|.+++.. ...+++..+ +.++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 81 lVmEy~~g~~L~~li~~--~~~l~~~~~----------~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 81 LVMEYLIGGDVKSLLHI--YGYFDEEMA----------VKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred EEEeCCCCCCHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeC
Confidence 99999999999999976 344555433 456788999999999999999999999999999999999999
Q ss_pred cccc
Q psy6327 164 GFSR 167 (351)
Q Consensus 164 g~a~ 167 (351)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=320.00 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=197.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC------
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG------ 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------ 79 (351)
-.+|++.+.||.|+||.||+|.+..+++.+|+|.+....... .+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~---~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS---VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch---HHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 467999999999999999999999999999999986654322 23445899999999999999999876543
Q ss_pred --------CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEe
Q psy6327 80 --------TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENIL 151 (351)
Q Consensus 80 --------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIl 151 (351)
...|+||||+. ++|.+++.. ..+++..++ .++.||+.||.|||+.|++||||||+||+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~----------~~~~qi~~aL~~LH~~givH~dikp~Nil 146 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHAR----------LFMYQLLRGLKYIHSANVLHRDLKPANVF 146 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHH----------HHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 36899999997 689888854 456665544 46778888999999999999999999999
Q ss_pred EcC-CCCeEEeeccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc
Q psy6327 152 ISR-LLNAKLADFGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227 (351)
Q Consensus 152 l~~-~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (351)
++. ++.+||+|||.++........ .....|++.|+|||.+........++|||||||++|+|++|+.||......
T Consensus 147 i~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~- 225 (342)
T cd07854 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL- 225 (342)
T ss_pred EcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 974 567899999999865432221 123357889999998765443334599999999999999999999654321
Q ss_pred hHHHHhhhC-------------------------cccc---ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 228 RDVLKKQEG-------------------------KEYL---FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 228 ~~~~~~~~~-------------------------~~~~---~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
........ .... ......++.++.+||.+||+.||.+|||+.++++||||+
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 226 -EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred -HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 11111000 0000 001125788999999999999999999999999999998
Q ss_pred CC
Q psy6327 280 NE 281 (351)
Q Consensus 280 ~~ 281 (351)
..
T Consensus 305 ~~ 306 (342)
T cd07854 305 CY 306 (342)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=319.84 Aligned_cols=264 Identities=21% Similarity=0.299 Sum_probs=196.5
Q ss_pred cceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEE-eC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVK-AG 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~-~~ 79 (351)
.+|++.+.||+|+||.||+|.+. .+++.||+|++....... . ...+.+|+.++.++ +||||+++++++. .+
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-~-~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-E-YKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-H-HHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 36999999999999999999754 345789999886433222 1 23345899999999 7999999999875 45
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchH-------------------------------------------------H
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHEN-------------------------------------------------Q 110 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~-------------------------------------------------~ 110 (351)
..++++|||+++++|.+++........+.. .
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 678999999999999999865321100000 0
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceecc
Q psy6327 111 ARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAP 188 (351)
Q Consensus 111 ~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aP 188 (351)
...-.........++.||+.||.|||++||+||||||+|||+++++.++|+|||+++.+..... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 0000112334556788999999999999999999999999999999999999999987643221 12234467789999
Q ss_pred ccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCC
Q psy6327 189 EIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRP 267 (351)
Q Consensus 189 E~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp 267 (351)
|++.+..++.+ +|||||||++|+|++ |..||.+.... .......... .....+...++++.+++.+||+.+|++||
T Consensus 245 E~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 245 ESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEG-TRMRAPEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred HHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhcc-CCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 99988888876 999999999999998 99999764321 1222222211 12222336788999999999999999999
Q ss_pred CHHHHhcC
Q psy6327 268 NAKDVQNH 275 (351)
Q Consensus 268 t~~ell~h 275 (351)
++.++++|
T Consensus 322 s~~ell~~ 329 (337)
T cd05054 322 TFSELVEI 329 (337)
T ss_pred CHHHHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=311.92 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=201.5
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~ 83 (351)
++.+|++.+.||+|+||.||+|.+..+++.+|+|.+........ ...+.+|+.++..+. ||||+++++++.++...|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH--HHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 56779999999999999999999999999999999865433222 223336777676665 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEee
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++|||+. ++|.+++... ...+++... ..++.|++.||.|||+ .|++||||+|+||+++.++.+||+|
T Consensus 91 ~v~e~~~-~~l~~l~~~~-~~~l~~~~~----------~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~d 158 (296)
T cd06618 91 ICMELMS-TCLDKLLKRI-QGPIPEDIL----------GKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCD 158 (296)
T ss_pred EEeeccC-cCHHHHHHHh-cCCCCHHHH----------HHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECc
Confidence 9999985 6788777553 335555443 3467788999999997 5999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh-hhCc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSP----YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK-QEGK 237 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-~~~~ 237 (351)
||++......... ....+++.|+|||.+.... ++.+ +|+||||+++|+|++|+.||...... .+.... ....
T Consensus 159 fg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~ 235 (296)
T cd06618 159 FGISGRLVDSKAK-TRSAGCAAYMAPERIDPPDPNPKYDIR-ADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEE 235 (296)
T ss_pred cccchhccCCCcc-cCCCCCccccCHhhcCCCCCccccccc-hhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCC
Confidence 9998765433222 2335788999999986543 4444 99999999999999999999653321 222222 2222
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
....+....++.++.+|+.+||..||++|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 22233333578899999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=304.61 Aligned_cols=251 Identities=20% Similarity=0.347 Sum_probs=197.8
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+..+|++++.||+|+||.||.+.+.. +..+|+|.+....... ..+.+|+.++++++||||+++++++......++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccH----HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 35679999999999999999997654 4469999876543322 234589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+.+++|.+++.... ..+++.. .+.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||
T Consensus 77 v~e~~~~~~l~~~i~~~~-~~~~~~~----------~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g 145 (256)
T cd05113 77 VTEYMSNGCLLNYLREHG-KRFQPSQ----------LLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG 145 (256)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCHHH----------HHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCc
Confidence 999999999999997532 2445443 34577888999999999999999999999999999999999999
Q ss_pred ccccccCCccc-ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKEL-SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
.++........ .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.... ............. ..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~-~~ 221 (256)
T cd05113 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFN--NSETVEKVSQGLR-LY 221 (256)
T ss_pred cceecCCCceeecCCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHhcCCC-CC
Confidence 98865433221 112235668999999987777765 999999999999998 999996544 2233333332221 22
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.....+..+.+++.+||+.||++|||+.+++.+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 233568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=304.55 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=201.7
Q ss_pred eecCcccceEEEEEEecCC---ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecC
Q psy6327 13 SKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYA 89 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (351)
+.||+|+||.||+|.+... +..+++|.+....... ....+.+|+.+++.++|+||+++++++......++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999866 8999999987554433 2445568999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhc-------cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 90 EKKDLEHYISKAC-------NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 90 ~ggsL~~~l~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++++|.+++.... ...+++... ..++.|++.||+|||++|++|+||+|+||+++.++.++|+|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~----------~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~d 148 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDL----------LSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISD 148 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHH----------HHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcc
Confidence 9999999997632 244555444 34677888889999999999999999999999999999999
Q ss_pred ccccccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccc
Q psy6327 163 FGFSRLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 163 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
||.+....... .......+++.|+|||.+....++.+ +||||+|+++|+|++ |..||.... .......... ..
T Consensus 149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~-~~ 224 (262)
T cd00192 149 FGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLRK-GY 224 (262)
T ss_pred cccccccccccccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHc-CC
Confidence 99998765433 22334567889999999887777665 999999999999999 699997653 3334444332 22
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....+..++.++.+++.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 333445679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=308.61 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=198.7
Q ss_pred cceeeeeecCcccceEEEEEEecC-----CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKR-----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|++.+.||+|+||.||+|.+.. ++..+++|.+....... ....+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ--DESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 469999999999999999999987 78899999875433222 23345589999999999999999999998889
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC---Ce
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL---NA 158 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~---~~ 158 (351)
.++||||++|++|.+++........... ...+..++.++.||+.||+|||+++++|+||||+||+++.++ .+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPS-----SLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 9999999999999999976422110000 012233456788999999999999999999999999998754 58
Q ss_pred EEeeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhh
Q psy6327 159 KLADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 235 (351)
||+|||+++........ .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.... .........
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~--~~~~~~~~~ 235 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEFVT 235 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHH
Confidence 99999999876332211 112234568999999988887765 999999999999997 999997644 223332222
Q ss_pred CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.. .....+..++..+.+++.+||+.||++|||+.++++|
T Consensus 236 ~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 GG-GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 21 1222334688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=320.37 Aligned_cols=259 Identities=28% Similarity=0.417 Sum_probs=204.1
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-----EE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT-----YL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-----~~ 82 (351)
+|++.+.||.|++|.||+|.+..+++.+|+|.+....... ...+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL-IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc-hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5889999999999999999999999999999986543212 22344558999999999999999999987765 79
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|++|||+. ++|.+++.. ...+++.... .++.|++.||+|||++|++|+||||+|||++.++.++|+|
T Consensus 80 ~lv~e~~~-~~l~~~l~~--~~~l~~~~~~----------~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 80 YIVTELME-TDLHKVIKS--PQPLTDDHIQ----------YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred EEEecchh-hhHHHHHhC--CCCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcc
Confidence 99999997 689998875 3456665443 3677888889999999999999999999999999999999
Q ss_pred ccccccccCCc---ccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--
Q psy6327 163 FGFSRLLRTPK---ELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG-- 236 (351)
Q Consensus 163 fg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-- 236 (351)
||.+....... .......+++.|+|||++.+. .++. ++|+||+|+++|+|++|.+||...+. .+....+..
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~sDi~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~ 223 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK-AIDIWSVGCIFAELLTRKPLFPGRDY--IDQLNLIVEVL 223 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCc-chhHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHhc
Confidence 99998765543 123445689999999999877 5554 49999999999999999999976542 111111000
Q ss_pred c----------------------c-----ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 237 K----------------------E-----YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 237 ~----------------------~-----~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
. . ........++.++.+||.+||++||++|||+.++++||||++...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred CCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0 0 000011236889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.08 Aligned_cols=262 Identities=27% Similarity=0.453 Sum_probs=196.3
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-----
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA----- 78 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----- 78 (351)
+.+.+|++.++||+|+||.||+|.++.+++.+|+|.+......... .....+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-PITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-chhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 3467899999999999999999999999999999998655433221 2233489999999999999999998743
Q ss_pred ---CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 79 ---GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 79 ---~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
...+++|+||+. ++|...+... ...+++..+. .++.|++.||.|||++|++|+||||+||+++++
T Consensus 84 ~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~----------~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~ 151 (311)
T cd07866 84 KRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIK----------CYMLQLLEGINYLHENHILHRDIKAANILIDNQ 151 (311)
T ss_pred cccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 335799999997 6777776542 3355555443 467788888899999999999999999999999
Q ss_pred CCeEEeeccccccccCCccc-----------ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy6327 156 LNAKLADFGFSRLLRTPKEL-----------SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPG 224 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (351)
+.++|+|||+++........ .....|++.|+|||.+.+......++||||+||++|+|++|++||.+.+
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999865432211 1234578899999988665433334999999999999999999997544
Q ss_pred CCchHHH-HhhhCc--c---------------c---cc-----cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 225 TRNRDVL-KKQEGK--E---------------Y---LF-----NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 225 ~~~~~~~-~~~~~~--~---------------~---~~-----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
....... ...... . . .. ......+..+.+||.+||+.||++|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 2111000 000000 0 0 00 0012345788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=307.16 Aligned_cols=256 Identities=20% Similarity=0.313 Sum_probs=199.7
Q ss_pred CCCCCccceeeeeecCcccceEEEEEEecCCce----eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEE
Q psy6327 1 MKFPDILECSYISKLGEGAYGNVYLVSDKRSET----LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMV 76 (351)
Q Consensus 1 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 76 (351)
|.+=...+|++++.||+|+||+||+|.+..++. .||+|.+....... ....+.+|+.+++.++||||+++++++
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVMAGVGSPYVCRLLGIC 78 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH--HHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 556667889999999999999999999877765 47999875433222 234456899999999999999999998
Q ss_pred EeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 77 KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 77 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
... ..++++||+++|+|.+++... ...+++... +.++.|++.||.|||+++++||||||+|||+++++
T Consensus 79 ~~~-~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~----------~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~ 146 (279)
T cd05109 79 LTS-TVQLVTQLMPYGCLLDYVREN-KDRIGSQDL----------LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN 146 (279)
T ss_pred cCC-CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 754 478999999999999999753 234555443 34677889999999999999999999999999999
Q ss_pred CeEEeeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHh
Q psy6327 157 NAKLADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 233 (351)
.+||+|||+++........ .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.... .......
T Consensus 147 ~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~ 223 (279)
T cd05109 147 HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIP--AREIPDL 223 (279)
T ss_pred cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH
Confidence 9999999999876433221 122335678999999988877765 999999999999998 999996543 2222222
Q ss_pred hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.... ...+....++.++.+++.+||+.||++||++.+++.
T Consensus 224 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 224 LEKG-ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHCC-CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2221 222334468899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=338.79 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=212.0
Q ss_pred ceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
+..+.+.||+|+||.||+|.-. .....||||.++.+ .+....+.|+||+.++..|+|||||+++|++..++-+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 4567889999999999998743 34578999986533 3444567788999999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHH----HHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQAR----IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~----~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
|+|+|||..|+|.++|...... ....+. .-.....+-+.++.||+.|+.||-++.+|||||-..|+||.++..|
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~--a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPK--ADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEEecccccHHHHHHhhCCc--cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 9999999999999999753211 111000 0002234456788999999999999999999999999999999999
Q ss_pred EEeeccccccccCCcccc--cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhh
Q psy6327 159 KLADFGFSRLLRTPKELS--NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 235 (351)
||+|||+++.+....... ....-..+|||||.+..++++++ |||||+||+|||+++ |+.||.+.+ +.+++..+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glS--n~EVIe~i~ 719 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLS--NQEVIECIR 719 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccc--hHHHHHHHH
Confidence 999999999875543221 12233569999999999999988 999999999999998 999997755 888888888
Q ss_pred CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHH
Q psy6327 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272 (351)
Q Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el 272 (351)
.+.. ++.+..+|.++.+|+..||+.+|.+||++.||
T Consensus 720 ~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 720 AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 7776 77778999999999999999999999999998
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=312.16 Aligned_cols=265 Identities=22% Similarity=0.354 Sum_probs=202.4
Q ss_pred CccceeeeeecCcccceEEEEEEecC-----CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKR-----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG 79 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 79 (351)
++.+|.+++.||+|+||.||+|.+.. .+..+|+|.+..... ......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 35678999999999999999998754 357899999864432 22234466899999999999999999999999
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCC----CchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNEN----IHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~----~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
...++++||+.+++|.+++....... ........-......++.++.|++.||.|||++|++||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 99999999999999999985321100 00000000011223456678899999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q psy6327 156 LNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 232 (351)
+.+||+|||+++....... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.. ..+...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~ 237 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYS--NQDVIE 237 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHH
Confidence 9999999999886543221 1233456789999999987777765 999999999999998 888987644 334444
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.+..... .+.+..++..+.+|+.+||+.+|.+||++.++++.
T Consensus 238 ~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 238 MIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 4333322 23344689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=302.51 Aligned_cols=247 Identities=34% Similarity=0.577 Sum_probs=204.9
Q ss_pred cCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCCh
Q psy6327 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDL 94 (351)
Q Consensus 15 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL 94 (351)
||+|+||.||++.+..+++.+++|.+.............+.+|+.++++++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 79999999999999989999999998776654443445566899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc
Q psy6327 95 EHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE 174 (351)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 174 (351)
.+++.. ...+++.... .++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~l~~--~~~l~~~~~~----------~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 81 FSHLSK--EGRFSEERAR----------FYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred HHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence 999976 3455555443 3566788888899999999999999999999999999999999987655433
Q ss_pred cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHH
Q psy6327 175 LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQL 254 (351)
Q Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (351)
......++..|+|||...+...+.. +|+||||+++|+|++|..||.... ........... ..+.+..++..+.++
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~--~~~~~~~~~~~l~~~ 223 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAED--RKEIYEKILKD--PLRFPEFLSPEARDL 223 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHhcC--CCCCCCCCCHHHHHH
Confidence 4455678999999999987776655 999999999999999999996544 23333333322 233344568999999
Q ss_pred HHHhcCCCCCCCCCH---HHHhcCccc
Q psy6327 255 IGRMLEPNPKHRPNA---KDVQNHAWI 278 (351)
Q Consensus 255 i~~~L~~dp~~Rpt~---~ell~hp~~ 278 (351)
+.+||..||++|||+ .++++||||
T Consensus 224 i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 224 ISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=312.96 Aligned_cols=261 Identities=28% Similarity=0.468 Sum_probs=198.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC----
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT---- 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~---- 80 (351)
.+.+|++.+.||+|+||.||+|.++.+++.+|+|.+......... ...+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~-~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF-PITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCc-hHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 356799999999999999999999999999999998654432221 233458999999999999999999987654
Q ss_pred ------EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC
Q psy6327 81 ------YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR 154 (351)
Q Consensus 81 ------~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~ 154 (351)
.+++|+||++ ++|..++... ...+++... ..++.|++.||.|||+.||+|+||+|+||++++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~----------~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~ 151 (302)
T cd07864 84 FKKDKGAFYLVFEYMD-HDLMGLLESG-LVHFSEDHI----------KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN 151 (302)
T ss_pred ccccCCcEEEEEcccC-ccHHHHHhcC-CCCCCHHHH----------HHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 8999999998 5777777643 234555443 346778888999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HHHH
Q psy6327 155 LLNAKLADFGFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLK 232 (351)
Q Consensus 155 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~ 232 (351)
++.+||+|||.+........ ......+++.|+|||.+.+......++||||+||++|+|++|++||........ ....
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 152 KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred CCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999999987654332 122334678899999886543333449999999999999999999975432110 0011
Q ss_pred hhhCcc--cc-----------------------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 233 KQEGKE--YL-----------------------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 233 ~~~~~~--~~-----------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
...... .. ......++..+.++|.+||+.||++|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 100000 00 00112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=308.03 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=197.2
Q ss_pred cceeeeeecCcccceEEEEEEe-----cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSD-----KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|.+.+.||+|+||.||++.+ ..++..+|+|.+..... .....+.+|+.++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 4689999999999999999985 33566789998754321 123345589999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhcc-----------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCE
Q psy6327 82 LYMIMDYAEKKDLEHYISKACN-----------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENI 150 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~-----------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NI 150 (351)
.++||||+++++|.+++..... ..+++.. ++.++.|++.||+|||++|++||||||+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~----------~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ----------MLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHH----------HHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 9999999999999999975321 1234433 445778899999999999999999999999
Q ss_pred eEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCc
Q psy6327 151 LISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRN 227 (351)
Q Consensus 151 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 227 (351)
|+++++.++|+|||+++....... ......+++.|+|||++.+..++.+ +|+|||||++|+|++ |..||.... .
T Consensus 152 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~--~ 228 (288)
T cd05093 152 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLS--N 228 (288)
T ss_pred EEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCC--H
Confidence 999999999999999986543221 1223345778999999988777765 999999999999998 999996554 2
Q ss_pred hHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 228 RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
............ ......++.++.+|+.+||+.||.+|||+.+++.
T Consensus 229 ~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 229 NEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 333333332221 2223367899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=303.16 Aligned_cols=243 Identities=23% Similarity=0.389 Sum_probs=191.2
Q ss_pred ecCcccceEEEEEEe--cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 14 KLGEGAYGNVYLVSD--KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 14 ~LG~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
.||+|+||.||+|.+ ..++..+|+|++........ ....+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPA-LKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHH-HHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 689999999999964 46789999999865443322 33445589999999999999999998864 467899999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
++|.+++.. ...+++... +.++.|++.||+|||++|++|+||||.||+++.++.+||+|||+++....
T Consensus 80 ~~L~~~l~~--~~~~~~~~~----------~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 80 GPLNKFLQK--NKHVTEKNI----------TELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred CcHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 999999975 345555443 34677888999999999999999999999999999999999999987644
Q ss_pred Cccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 172 PKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 172 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
.... .....+++.|+|||.+....++.+ +|+|||||++|+|++ |..||.... .......+.... ..+.+..+
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~i~~~~-~~~~~~~~ 223 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMK--GNEVTQMIESGE-RMECPQRC 223 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCC-CCCCCCCC
Confidence 3321 122234678999999887776665 999999999999998 999997644 233333333222 23334468
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+.++.++|.+||+.||++||++++|..
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=312.48 Aligned_cols=263 Identities=23% Similarity=0.362 Sum_probs=195.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCce--eEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSET--LKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~ 82 (351)
+.+|++.+.||+|+||.||+|.+..++. .+++|.+.... .....+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 3579999999999999999999887765 45777765221 112234456899999999 699999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHH----HHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQA----RIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~----~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
|+|+||+++++|.+++............. ..-......++.++.|++.||+|||++|++||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999999999999997532111100000 00001223345578889999999999999999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
||+|||++........ ......+..|+|||.+....++.+ +|||||||++|+|++ |..||.... ..........
T Consensus 159 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~--~~~~~~~~~~- 233 (297)
T cd05089 159 KIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMT--CAELYEKLPQ- 233 (297)
T ss_pred EECCcCCCccccceec-cCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhc-
Confidence 9999999864322111 111223557999999988777765 999999999999997 999997654 2233333222
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
......+..++..+.+|+.+||+.||.+|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22233344688999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=304.06 Aligned_cols=251 Identities=22% Similarity=0.407 Sum_probs=197.9
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+..+|++.+.||+|+||.||++.++ ++..+|+|.+....... ..+.+|+.+++.++||||+++++++...+..|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 5668999999999999999999876 46689999886443332 223479999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||++|++|.+++.... ..+++.. .+.++.|++.||.|||++|++|+||||+||+++.++.+||+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~-~~~~~~~----------~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg 145 (256)
T cd05059 77 VTEYMANGCLLNYLRERK-GKLGTEW----------LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFG 145 (256)
T ss_pred EEecCCCCCHHHHHHhcc-cCCCHHH----------HHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcc
Confidence 999999999999997532 2344433 33467788899999999999999999999999999999999999
Q ss_pred ccccccCCcccc-cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKELS-NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
.++......... ....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.... .......... .....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~-~~~~~ 221 (256)
T cd05059 146 LARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFS--NSEVVESVSA-GYRLY 221 (256)
T ss_pred cceecccccccccCCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCC--HHHHHHHHHc-CCcCC
Confidence 998654322111 11223457999999988777765 999999999999998 899997543 2333333322 22223
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.+..++..+.+++.+||..+|++|||+.++++.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 334689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=304.72 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=199.7
Q ss_pred CccceeeeeecCcccceEEEEEEecCCc---eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSE---TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
+..+|++.+.||+|+||.||+|.++.++ ..+|+|.+...... . ....+.+|+.++++++||||+++++++..++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-K-QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-H-HHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 4578999999999999999999886544 47899988643322 2 23455689999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.|+||||+++++|.+++... ...++... ++.++.|++.||.|||+++++|+||||+|||++.++.++|+
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~----------~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~ 148 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKH-DGQFTVIQ----------LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVS 148 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhc-CCCCCHHH----------HHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeC
Confidence 99999999999999999753 23344433 34567788999999999999999999999999999999999
Q ss_pred eccccccccCCcccc---cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 162 DFGFSRLLRTPKELS---NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
|||.+.......... ....++..|+|||.+.+..++.+ +|+|||||++|++++ |..||..... ..........
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~~ 225 (267)
T cd05066 149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIEEG 225 (267)
T ss_pred CCCcccccccccceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHhCC
Confidence 999998765432211 11223568999999988777765 999999999999886 9999976542 2333333222
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+..+....++..+.+++.+||+.+|.+||++.++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 226 -YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 233444568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=324.69 Aligned_cols=246 Identities=28% Similarity=0.467 Sum_probs=202.7
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 83 (351)
...+|.+...+|.|+|+.|-.+.+..+++.+++|++........ +|+.++... +||||+++++++.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~-------~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQ-------DEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccc-------cccchhhhhcCCCcceeecceecCCceee
Confidence 34568888889999999999999999999999999876632222 677666666 6999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE-cCCCCeEEee
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI-SRLLNAKLAD 162 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll-~~~~~~kl~D 162 (351)
+|||.++|+.|.+.+... +..... +..++.+|+.|+.|||++||+||||||+|||+ ++.++++|+|
T Consensus 393 ~v~e~l~g~ell~ri~~~---~~~~~e----------~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSK---PEFCSE----------ASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred eeehhccccHHHHHHHhc---chhHHH----------HHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEE
Confidence 999999999999888652 222222 33466777888889999999999999999999 5889999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
||.++..... ..+.|-|..|.|||++....|+.. +|+||||++||+|++|+.||...... .+....+....+.
T Consensus 460 FG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~~~s-- 532 (612)
T KOG0603|consen 460 FGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMPKFS-- 532 (612)
T ss_pred echhhhCchh---hcccchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCCccc--
Confidence 9999876554 345567889999999998888876 99999999999999999999764432 3343333333222
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
..+|+.++|||+.||+.||.+||++.+++.|||+-
T Consensus 533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 533 --ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred --cccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence 57999999999999999999999999999999993
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=308.01 Aligned_cols=249 Identities=29% Similarity=0.484 Sum_probs=193.3
Q ss_pred eeeeecCcccceEEEEEEec----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 10 SYISKLGEGAYGNVYLVSDK----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
.+.+.||.|+||.||+|... ..+..|+||.+..... ... ...+.+|++.+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-~~~-~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-EEE-EEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-HHH-HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc-ccc-ceeeeeccccccccccccccccccccccccccccc
Confidence 56789999999999999987 5678899999854222 222 34455899999999999999999999988889999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
+||+++|+|.+++.......++.... +.++.|++.||.|||+++++|+||+++|||++.++.+||+|||+
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~----------~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~ 149 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQR----------LSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGL 149 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHH----------HHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTT
T ss_pred cccccccccccccccccccccccccc----------cccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998753355555443 35678899999999999999999999999999999999999999
Q ss_pred cccccCC--cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 166 SRLLRTP--KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 166 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
+...... ........+...|+|||.+.+..++.+ +||||||+++|||++ |+.||.+.. ..+........ ...+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~--~~~~~~~~~~~-~~~~ 225 (259)
T PF07714_consen 150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYD--NEEIIEKLKQG-QRLP 225 (259)
T ss_dssp GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSC--HHHHHHHHHTT-EETT
T ss_pred cccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccc--ccccccccccc-ccce
Confidence 9876322 122334456789999999988877665 999999999999999 789997653 44544444333 2334
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+..++..+.++|.+||..||++|||+.++++
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 44568999999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=302.30 Aligned_cols=249 Identities=21% Similarity=0.359 Sum_probs=198.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|++|.||+|.+.. ++.+|+|.+...... .+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 469999999999999999998754 567999998654332 233458999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+.+++|.+++.......++.... ..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~----------~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQL----------IDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHH----------HHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceE
Confidence 9999999999997643334554433 346778899999999999999999999999999999999999999
Q ss_pred ccccCCccc-ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKEL-SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+........ .....++..|+|||.+.+..++.+ +|+||||+++|+|++ |+.||.+.. .......... .+..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~-~~~~~~~ 226 (261)
T cd05068 151 RVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMT--NAEVLQQVDQ-GYRMPCP 226 (261)
T ss_pred EEccCCcccccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHc-CCCCCCC
Confidence 876532211 111223457999999988777765 999999999999999 999997543 3333333322 2233344
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..++..+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=317.26 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=198.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC------
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT------ 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------ 80 (351)
.+|++++.||+|+||.||+|.+..++..||+|.+...... ......+.+|+.+++.++||||+++++++..+.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 4599999999999999999999999999999988543222 222334558999999999999999999987553
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..++||||+ |++|.+++.. ..+++..+ ..++.|++.||.|||+.||+||||||+||+++.++.++|
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~----------~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH---EKLSEDRI----------QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHH----------HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEE
Confidence 469999999 6899988864 45665543 346778888999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---c
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---K 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~ 237 (351)
+|||++...... .....+++.|+|||.+.+......++|+|||||++|+|++|..||.+... ......... .
T Consensus 160 ~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~~~~~~~~ 234 (343)
T cd07880 160 LDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--LDQLMEIMKVTGT 234 (343)
T ss_pred eecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCC
Confidence 999999865332 23446789999999987643233459999999999999999999975432 111110000 0
Q ss_pred ---------------c-------c----cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 238 ---------------E-------Y----LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 238 ---------------~-------~----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
. . .......++..+.++|.+||+.||++|||+.+++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 0 0001125788899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=323.17 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=201.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+..+...||+|.||+||+|.+- -.||||++.......+. .+.|++|+.++++-+|-||+-+.|++..... .||+-
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~q-lqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQ-LQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred Hhhccceeccccccceeecccc---cceEEEEEecCCCCHHH-HHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 4566889999999999999875 36899999998887774 5667799999999999999999999999887 99999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
+|+|.+|+.+|.-.. .. ..+...+.++.||+.|+.|||.++|+|||||..|||+.+++.|||+|||++.
T Consensus 468 wCeGsSLY~hlHv~e-tk----------fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE-TK----------FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred hccCchhhhhccchh-hh----------hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 999999999986421 11 3456667889999999999999999999999999999999999999999997
Q ss_pred ccc--CCcccccccccccceeccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 168 LLR--TPKELSNTFCGTTSYAAPEIIRN---SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 168 ~~~--~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
... ..........|...|||||++.. .+|+.. +||||+||++|||++|..||... ..+.+.-+.+..|..+
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~q-SDVYaFGiV~YELltg~lPysi~---~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQ-SDVYAFGIVWYELLTGELPYSIQ---NRDQIIFMVGRGYLMP 612 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcc-cchhhhhHHHHHHHhCcCCcCCC---ChhheEEEecccccCc
Confidence 643 22222344568889999999863 445554 99999999999999999999832 3333333444444433
Q ss_pred c----cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 243 R----KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 243 ~----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
. ..+++.++++|+..||..++++||.+.+||.
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 3 3467889999999999999999999999986
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=302.99 Aligned_cols=249 Identities=23% Similarity=0.396 Sum_probs=195.9
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.++||+|+||.||+|.+..++ .+|+|.+....... ..+.+|+++++.++||||+++++.+.+ ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCH----HHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 356999999999999999999887664 59999986533322 234589999999999999999998754 558999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+.+|+|.+++.+.....++.... +.++.|++.||.|||+.+++|+||||+||++++++.++|+|||.
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~----------~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~ 148 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQL----------VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 148 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHH----------HHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCc
Confidence 99999999999997643334444433 34677888999999999999999999999999999999999999
Q ss_pred cccccCCccc-ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 166 SRLLRTPKEL-SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 166 a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
++........ .....++..|+|||.+.+..++.. +|+|||||++|+|++ |..||.+.. .......... ....+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~--~~~~~~~~~~-~~~~~~ 224 (262)
T cd05071 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVER-GYRMPC 224 (262)
T ss_pred eeeccccccccccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCC--hHHHHHHHhc-CCCCCC
Confidence 9866433221 223346778999999887777765 999999999999999 888997543 2233333222 122233
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...++..+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4468899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=321.37 Aligned_cols=262 Identities=28% Similarity=0.417 Sum_probs=215.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
+-|..++.||-|+||.|.++...+|...||.|.+.+...-.......++.|-.||..-+++-||++|-.|.+.+++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 45788999999999999999999999999999998877765555666778999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
+|++||++-.+|-+ .+-++|..++. |+.++..|++++|..|+|||||||+|||||.+|+|||+|||++
T Consensus 709 dYIPGGDmMSLLIr--mgIFeE~LARF----------YIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR--MGIFEEDLARF----------YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred eccCCccHHHHHHH--hccCHHHHHHH----------HHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccc
Confidence 99999999999987 67888888776 4556677778999999999999999999999999999999999
Q ss_pred cccc---C-----Ccc----------------------------------cccccccccceeccccccCCCCCCCcchHH
Q psy6327 167 RLLR---T-----PKE----------------------------------LSNTFCGTTSYAAPEIIRNSPYNPKLADIW 204 (351)
Q Consensus 167 ~~~~---~-----~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 204 (351)
+-+. . .+. .....+||+.|+|||++....++.. +|.|
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdww 855 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWW 855 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhh
Confidence 7541 0 000 0113579999999999999888876 9999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--ccccccccccCCHhHHHHHHHhcCCCCCCCCC---HHHHhcCcccc
Q psy6327 205 SLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPN---AKDVQNHAWIQ 279 (351)
Q Consensus 205 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~ 279 (351)
|.|||||+|+.|++||-+..... ...++.. ....++...++|.++.+||.++.. +++.|.. ++|+..||||+
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~--tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFk 932 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGE--TQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFK 932 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCc--ceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccc
Confidence 99999999999999997654322 2222221 122345566899999999998764 6888875 77899999999
Q ss_pred CCccc
Q psy6327 280 NEPTC 284 (351)
Q Consensus 280 ~~~~~ 284 (351)
...+.
T Consensus 933 gIDfs 937 (1034)
T KOG0608|consen 933 GIDFS 937 (1034)
T ss_pred ccchH
Confidence 77553
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=309.23 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=197.9
Q ss_pred ccceeeeeecCcccceEEEEEEecCCc----------------eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSE----------------TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~----------------~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i 69 (351)
..+|++++.||+|+||.||+|.+...+ ..+|+|.+...... .....+.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 357999999999999999999876543 56799987654332 223445689999999999999
Q ss_pred eeeeeEEEeCCEEEEEEecCCCCChHHHHHhhcc---------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCc
Q psy6327 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACN---------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGI 140 (351)
Q Consensus 70 v~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~---------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i 140 (351)
+++++++..+...+++|||+.+++|.+++..... ..+++.. .+.++.|++.||.|||++|+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~i~~al~~LH~~~i 151 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST----------LLYMATQIASGMRYLESLNF 151 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHH----------HHHHHHHHHHHHHHHHHcCc
Confidence 9999999999999999999999999999976321 1344433 34567888999999999999
Q ss_pred eeccCCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh--C
Q psy6327 141 VHRDIKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN--K 216 (351)
Q Consensus 141 ~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g 216 (351)
+|+||||+||+++.++.++|+|||+++....... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~ 230 (296)
T cd05051 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCR 230 (296)
T ss_pred cccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCC
Confidence 9999999999999999999999999986543321 2234456789999999887777765 999999999999998 7
Q ss_pred CCCCCCCCCCchHHHHhhhC------ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 217 KYPFGDPGTRNRDVLKKQEG------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 217 ~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..||.... .......... .....+.+..++.++.+++.+||+.||++|||+.++++
T Consensus 231 ~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 231 EQPYEHLT--DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCCCcC--hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 78886543 2232222211 11122233457889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=309.36 Aligned_cols=254 Identities=30% Similarity=0.488 Sum_probs=201.1
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|++++.||+|++|.||+|.+..+++.+++|.+........ ....+.+|+.++++++||||+++++++..++..++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG-IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch-hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6778999999999999999999999999999865544322 234455899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
++ ++|.+++... ...+++.. +..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 ~~-~~l~~~l~~~-~~~~~~~~----------~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 80 MD-TDLYKLIKDR-QRGLPESL----------IKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred cC-CCHHHHHHhh-cccCCHHH----------HHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 97 5888888653 23455443 345678888999999999999999999999999999999999999987
Q ss_pred ccCCcccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-----------
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG----------- 236 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----------- 236 (351)
............++..|+|||.+.+. .++. ++|+||+|+++|+|++|+.||...+. .+.......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYST-PVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWP 224 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcc
Confidence 76544333445688899999998776 4444 49999999999999999999965442 111111000
Q ss_pred --------ccccc---------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 --------KEYLF---------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 --------~~~~~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
....+ .....++.++.+||.+||++||.+||++.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00000 0112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.14 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=222.8
Q ss_pred CCCccc-eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEE---
Q psy6327 3 FPDILE-CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVK--- 77 (351)
Q Consensus 3 ~~~~~~-~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~--- 77 (351)
+||-.+ |.|.+.||.|.+|.||+++++++++..|+|+.......+.. ++.|..+++.+. |||++.+|++|.
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deE----iE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEE----IELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHH----HHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 455555 99999999999999999999999999999998766554433 347899999884 999999999984
Q ss_pred --eCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 78 --AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 78 --~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
.++.++||||||.|||..|+++...+..+.|..+. .+++.++.|+.+||.+.++|||||-.|||++.+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~Ia----------YI~re~lrgl~HLH~nkviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIA----------YILREILRGLAHLHNNKVIHRDIKGQNVLLTEN 159 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHH----------HHHHHHHHHHHHHhhcceeeecccCceEEEecc
Confidence 45789999999999999999998776666655433 367889999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcccccccccccceeccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHH
Q psy6327 156 LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSP-----YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV 230 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 230 (351)
+.+||+|||.+..+........+.+|||+|||||++.... |+.. +|+||||++..||..|.+|+-+.... ...
T Consensus 160 ~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPm-raL 237 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPM-RAL 237 (953)
T ss_pred CcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchh-hhh
Confidence 9999999999999888888888999999999999986433 4444 99999999999999999999876542 333
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
+......++.+..+..++.++.+||..||.+|-.+||+..++|+|||+...
T Consensus 238 F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 238 FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 444444455555566899999999999999999999999999999999844
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=307.52 Aligned_cols=255 Identities=30% Similarity=0.455 Sum_probs=198.1
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--CEEEEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--TYLYMIM 86 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 86 (351)
|++++.||.|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++|||++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE-GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999997654222 2223345899999999999999999999888 8999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++ ++|.+++... ...+++.. ++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~----------~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 80 EYMD-HDLTGLLDSP-EVKFTESQ----------IKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred cccc-ccHHHHHhcc-CCCCCHHH----------HHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccce
Confidence 9997 6899888653 23455444 3456778889999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---c--ccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---K--EYL 240 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~--~~~ 240 (351)
........ ......++..|+|||.+.+......++||||||+++|+|++|+.||..... ......... . ...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07840 148 RPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFELCGSPTDEN 225 (287)
T ss_pred eeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchhh
Confidence 87654432 123345788999999876543333459999999999999999999976542 111111100 0 000
Q ss_pred cc-----------------------cccc-CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 241 FN-----------------------RKYE-ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 241 ~~-----------------------~~~~-~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
++ .... ++..+.++|.+||+.||.+||++.++++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 0011 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=315.91 Aligned_cols=259 Identities=30% Similarity=0.437 Sum_probs=199.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe--CCEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA--GTYL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~--~~~~ 82 (351)
..+|++.+.||+|+||.||+|.+..++..+|+|++......... ...+.+|+.+++++ +||||+++++++.. ....
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~-~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD-AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh-hhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 45699999999999999999999999999999988543222222 23344799999999 99999999999864 3478
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||||+. ++|.+++.. ..+.+... ..++.|++.||.|||++||+|+||||+||+++.++.+||+|
T Consensus 85 ~lv~e~~~-~~L~~~~~~---~~~~~~~~----------~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA---NILEDVHK----------RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred EEEecccc-cCHHHHHhc---CCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEee
Confidence 99999997 699998865 24444332 34678899999999999999999999999999999999999
Q ss_pred ccccccccCCcc-----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh---
Q psy6327 163 FGFSRLLRTPKE-----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ--- 234 (351)
Q Consensus 163 fg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--- 234 (351)
||.+........ ......|++.|+|||++.+......++|+||+|+++|+|++|+.||....... .....
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~~~~~ 228 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEKIIEV 228 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHH
Confidence 999986643321 22345689999999988654433345999999999999999999997543211 11100
Q ss_pred ------------------------hCcc--ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 235 ------------------------EGKE--YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 235 ------------------------~~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.... ........++.++.+||.+||+.||++|||+.++++|||++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000 0001112368899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=318.46 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=199.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE-----
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY----- 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~----- 81 (351)
.+|++.+.||+|++|.||+|.+..+++.+|+|++......... ...+.+|+.+++.+.||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH-AKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhH-HHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 4699999999999999999999999999999988654322222 2334589999999999999999998866554
Q ss_pred -EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 82 -LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 82 -~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.++|+||+ +++|.+++.. ..+++..+. .++.|++.||.|||+.||+|+||+|+||+++.++.++|
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~----------~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL 159 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC---QKLSDDHIQ----------FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 159 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc---CCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEE
Confidence 89999999 5899999864 456655433 46778888999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-cc-
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG-KE- 238 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~- 238 (351)
+|||++...... .....+++.|+|||.+.+......++|||||||++|+|++|+.||..... ......+.. ..
T Consensus 160 ~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~ 234 (343)
T cd07851 160 LDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGT 234 (343)
T ss_pred cccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCC
Confidence 999999865432 34456889999999986543333459999999999999999999975432 111111100 00
Q ss_pred --------------------------ccc-cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 239 --------------------------YLF-NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 239 --------------------------~~~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
..+ ......+..+.+||.+||+.||++|||+.++++||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 000 00123588999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=309.09 Aligned_cols=262 Identities=20% Similarity=0.322 Sum_probs=199.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCC-----ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRS-----ETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAG 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~ 79 (351)
..+|++.+.||+|+||.||++.+... ...+|+|.+....... . ...+.+|+.+++++ +||||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-D-LSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-H-HHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 35799999999999999999987643 3789999886433222 2 23355899999999 799999999999999
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHH------HHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQAR------IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~------~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
+..+++|||+.+|+|.+++.... ...+.... .-......++.++.|++.||.|||+++|+|+||||+|||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARR--PPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcC--CCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 99999999999999999997521 10000000 00012234556788999999999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q psy6327 154 RLLNAKLADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDV 230 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 230 (351)
+++.+||+|||+++........ .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.... ....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~--~~~~ 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIP--VEEL 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCC--HHHH
Confidence 9999999999999876543221 122234678999999888777765 999999999999997 999997544 2233
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...... ......+..++..+.+|+.+||..||++|||+.+++++
T Consensus 244 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 244 FKLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 333222 22233344678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=302.45 Aligned_cols=248 Identities=23% Similarity=0.434 Sum_probs=196.6
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|+++++||+|+||.||+|... +++.+|+|.+....... ..+.+|+.++++++||||+++++++. .+..+++|
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcH----HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 35899999999999999999865 56789999886544332 23458999999999999999999874 45689999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+.+++|.+++.......++.... +.++.|++.||+|||+.|++|+||||+||++++++.++|+|||.+
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~----------~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKL----------IDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHH----------HHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcce
Confidence 9999999999987644445554443 346778888999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
........ ......++..|+|||.+....++.+ +|+||||+++|+|++ |+.||.+.+ .......... ....+.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~-~~~~~~~ 225 (260)
T cd05067 150 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLER-GYRMPRP 225 (260)
T ss_pred eecCCCCcccccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHc-CCCCCCC
Confidence 76552221 2223345678999999987777765 999999999999998 999997644 3333333322 2223344
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...+.++.+++.+||+.+|++|||++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 467889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=300.81 Aligned_cols=264 Identities=24% Similarity=0.400 Sum_probs=203.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--------
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA-------- 78 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-------- 78 (351)
+.|.-+.+||+|.||.||+|..+.+|+.||+|++..+..+.......+ +|+.+|..|+|+|++.+++++++
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpital-reikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITAL-REIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHH-HHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 347778899999999999999999999999998766554443333334 89999999999999999988743
Q ss_pred CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
...+|+||.+|+ .+|..++... ...++ +..+.+++.+++.||.|+|.+.|+|||+|++|+||+.+|.+
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~-~vr~s----------ls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNR-KVRFS----------LSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGIL 163 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCc-ccccc----------HHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceE
Confidence 346999999997 9999998652 23333 33445678899999999999999999999999999999999
Q ss_pred EEeeccccccccCCcc----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh
Q psy6327 159 KLADFGFSRLLRTPKE----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ 234 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 234 (351)
||+|||+++.+..+.. .....+-|.+|++||.+.+...+.++.|||+.|||+.+|.++.+-|.+.+......+...
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 9999999987643322 223445699999999998877666669999999999999999999976542211111110
Q ss_pred hCccc---ccc----------------------------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 235 EGKEY---LFN----------------------------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 235 ~~~~~---~~~----------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
.-+.. .+| .+..-++++.||+.+||..||.+|++++++++|.||...+.
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 00000 000 00112457889999999999999999999999999987654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=314.46 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=190.7
Q ss_pred cceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCChHHHH
Q psy6327 19 AYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYI 98 (351)
Q Consensus 19 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l 98 (351)
++|.||.+.+..+++.+|+|++......... ...+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKED-LKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhH-HHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 4556677777779999999998765333332 345669999999999999999999999999999999999999999999
Q ss_pred HhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc----
Q psy6327 99 SKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---- 174 (351)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---- 174 (351)
.......+++.... .++.|++.||+|||+++|+|+||||+||+++.++.+||+|||.+........
T Consensus 91 ~~~~~~~~~~~~~~----------~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 91 KTHFPEGLPELAIA----------FILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHhcccCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 87544556655433 3677889999999999999999999999999999999999998875532211
Q ss_pred ---cccccccccceeccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc-----------
Q psy6327 175 ---LSNTFCGTTSYAAPEIIRNS--PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE----------- 238 (351)
Q Consensus 175 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------- 238 (351)
......++..|+|||++... .++.+ +|+||+||++|+|++|..||....... ..........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhh
Confidence 12334578899999998653 35554 999999999999999999997543211 1111111000
Q ss_pred --------------------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 239 --------------------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 239 --------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
........++.++.+|+.+||+.||++|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0000111235678999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=303.65 Aligned_cols=252 Identities=19% Similarity=0.307 Sum_probs=195.6
Q ss_pred eeeeeecCcccceEEEEEEecCC---ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE----
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY---- 81 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~---- 81 (351)
|.+.+.||+|+||.||+|....+ +..+|+|.+......... ...+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHH-HHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987653 478999998754443333 2334589999999999999999998865443
Q ss_pred --EEEEEecCCCCChHHHHHhhcc----CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 82 --LYMIMDYAEKKDLEHYISKACN----ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 82 --~~lv~e~~~ggsL~~~l~~~~~----~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
.++++||+++++|..++..... ..+++. .++.++.|++.||.|||+++++||||||+||+++++
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~----------~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~ 149 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ----------TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED 149 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHH----------HHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC
Confidence 8999999999999999855321 123332 344578889999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q psy6327 156 LNAKLADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 232 (351)
+.+||+|||+++........ .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.. ......
T Consensus 150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~--~~~~~~ 226 (273)
T cd05035 150 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVE--NHEIYD 226 (273)
T ss_pred CeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCC--HHHHHH
Confidence 99999999999865433221 112234678999999887777765 999999999999999 999996543 333333
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...... ....+..++.++.+++.+||+.||++|||+.+++.+
T Consensus 227 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 227 YLRHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333222 223344689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=316.35 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=196.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC------C
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG------T 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~ 80 (351)
.+|.+.+.||+|+||.||+|.+..+|+.+|+|.+........ ....+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc-chhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 469999999999999999999999999999999865432222 223345899999999999999999998654 3
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+|+||+. .+|..++ ...+++..+. .++.|++.||.|||+++++||||||+||+++.++.+||
T Consensus 94 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~----------~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM----GHPLSEDKVQ----------YLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEecccc-cCHHHHH----cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 5799999996 5777665 2345554433 36778889999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--- 236 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--- 236 (351)
+|||+++.... ......+++.|+|||.+.+. .++. ++|+|||||++|+|++|+.||...+.. ........
T Consensus 159 ~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~~Dv~slGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~ 232 (342)
T cd07879 159 LDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQ-TVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTG 232 (342)
T ss_pred eeCCCCcCCCC---CCCCceeeecccChhhhcCccccCc-hHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcC
Confidence 99999876432 22345688999999998764 3444 499999999999999999999764321 11110000
Q ss_pred ---------------c-----ccccc------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 237 ---------------K-----EYLFN------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 237 ---------------~-----~~~~~------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
. ....+ .....+..+.+||.+||+.||++||++.+++.||||+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 00000 01246788999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=316.23 Aligned_cols=264 Identities=21% Similarity=0.342 Sum_probs=198.1
Q ss_pred cceeeeeecCcccceEEEEEEe-----cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe-C
Q psy6327 7 LECSYISKLGEGAYGNVYLVSD-----KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA-G 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~-~ 79 (351)
.+|++.+.||+|+||.||+|.+ ..+++.||+|.+........ ...+.+|+.++.++ +||||+++++++.. +
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH--HHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3699999999999999999984 35678999999865432221 23455899999999 68999999998754 4
Q ss_pred CEEEEEEecCCCCChHHHHHhhccC-------------------CCchHH------------------------------
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNE-------------------NIHENQ------------------------------ 110 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~-------------------~~~~~~------------------------------ 110 (351)
...++|||||++|+|.+++...... .+++..
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5689999999999999999753210 011100
Q ss_pred ---H---HHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccc
Q psy6327 111 ---A---RIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGT 182 (351)
Q Consensus 111 ---~---~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt 182 (351)
. ..-...+...+.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 0 001124556677899999999999999999999999999999999999999999986533221 12223456
Q ss_pred cceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCC
Q psy6327 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEP 261 (351)
Q Consensus 183 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 261 (351)
+.|+|||.+.+..++.+ +||||||+++|+|++ |..||...... .......... ...+.+...++++.+++.+||+.
T Consensus 245 ~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 245 LKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEG-TRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred cceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhcc-CCCCCCCCCCHHHHHHHHHHccC
Confidence 78999999988777765 999999999999997 99999764432 1222222111 12222335788999999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy6327 262 NPKHRPNAKDVQNH 275 (351)
Q Consensus 262 dp~~Rpt~~ell~h 275 (351)
||++|||+.++++|
T Consensus 322 ~p~~Rps~~eil~~ 335 (343)
T cd05103 322 EPSQRPTFSELVEH 335 (343)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=306.48 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=199.0
Q ss_pred ccceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
..+|.+.+.||+|+||.||+|.+. .++..+++|.+....... .+.+.+|+.++++++||||+++++++..+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---RKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH---HHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 356999999999999999999854 345678888875443322 244568999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhcc--------------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACN--------------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIK 146 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlk 146 (351)
..++||||+++++|.+++..... ..+++ ...+.++.|++.||.|||++|++|||||
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~i~~~i~~al~~lH~~~i~H~dlk 150 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL----------SQMLHIASQIASGMVYLASQHFVHRDLA 150 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCH----------HHHHHHHHHHHHHHHHHHhCCeeecccC
Confidence 99999999999999999975321 11222 3345678899999999999999999999
Q ss_pred CCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy6327 147 CENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDP 223 (351)
Q Consensus 147 p~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 223 (351)
|+|||++.++.++|+|||+++....... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||...
T Consensus 151 p~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 151 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred cceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999976543321 2234456889999999988877765 999999999999998 99999654
Q ss_pred CCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 224 GTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
. ............. ......++..+.+++.+||+.||++|||+.++++
T Consensus 230 ~--~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 230 S--NTEVIECITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred C--HHHHHHHHhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 4 2233333322222 2223357889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=308.65 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=201.4
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|+.++.||+|+||.||+|.+..++..+++|.+.............+.+|+.+++.++|||++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 77889999999999999999999999999988654332222233445899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+. |+|.+++... ...+++.. +..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus 97 ~~-~~l~~~~~~~-~~~l~~~~----------~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 97 CL-GSASDLLEVH-KKPLQEVE----------IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred cC-CCHHHHHHHc-CCCCCHHH----------HHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence 97 6888877542 33455433 334677888999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccceeccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRN---SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
.... ....|++.|+|||.+.. ..++.+ +|||||||++|+|++|..||..... ..................
T Consensus 165 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06634 165 MAPA----NXFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNESPALQSG 237 (308)
T ss_pred ecCc----ccccCCccccCHHHHhhcccCCCCcc-cchHHHHHHHHHHHcCCCCCccccH--HHHHHHHhhcCCCCcCcc
Confidence 5432 34468899999999742 344444 9999999999999999999965432 222222222222222233
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.++..+.+||.+||+.+|++||++.++++|||+....
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 6788999999999999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=303.44 Aligned_cols=252 Identities=20% Similarity=0.333 Sum_probs=193.1
Q ss_pred eeeeeecCcccceEEEEEEecCCce--eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe------CC
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSET--LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA------GT 80 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------~~ 80 (351)
+.+.+.||+|+||.||+|.+..++. .+|+|.+......... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE-MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH-HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999887765 6899988654333333 3344589999999999999999997632 23
Q ss_pred EEEEEEecCCCCChHHHHHhhc----cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKAC----NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~----~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
..+++|||+.+|+|.+++.... ...+++.. ++.++.|++.||.|||+++|+||||||+|||++.++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~----------~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 149 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQM----------LVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM 149 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHH----------HHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC
Confidence 5789999999999999885321 11233333 345678899999999999999999999999999999
Q ss_pred CeEEeeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHh
Q psy6327 157 NAKLADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 233 (351)
.+||+|||+++........ .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.... .......
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~ 226 (272)
T cd05075 150 NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDY 226 (272)
T ss_pred CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH
Confidence 9999999999876433221 122346778999999988877765 999999999999999 899997543 2333333
Q ss_pred hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..... ..+....++..+.++|.+||+.||++|||+.+++++
T Consensus 227 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 227 LRQGN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 33222 223334688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=319.08 Aligned_cols=263 Identities=22% Similarity=0.342 Sum_probs=199.4
Q ss_pred ceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTY 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~ 81 (351)
+|.+.++||+|+||.||+|.+. .++..||+|++....... . .+.+.+|+.++.++. ||||+++++++...+.
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-~-~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS-E-KQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh-H-HHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 4667899999999999999853 456789999986543222 1 234558999999997 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCc------------------------------------------------------
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIH------------------------------------------------------ 107 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~------------------------------------------------------ 107 (351)
.++||||+++|+|.+++.........
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 99999999999999999753210000
Q ss_pred --------------------------hHHHHH------HHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 108 --------------------------ENQARI------WIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 108 --------------------------~~~~~~------~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
+..... -...+...+.++.|++.||.|||+.+++||||||+|||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC
Confidence 000000 001234567788999999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q psy6327 156 LNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 232 (351)
+.+||+|||+++....... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||..... .+...
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~~~~~--~~~~~ 352 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYPELPM--NEQFY 352 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCCCCCc--hHHHH
Confidence 9999999999986532221 1223457889999999988777765 999999999999998 8999975442 22222
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.........+.+..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2112222233344678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=301.12 Aligned_cols=264 Identities=28% Similarity=0.538 Sum_probs=225.5
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 83 (351)
.+.+|.++++||+|+|+.|.++.++.+.+.||+|++++.-..++.-...+.-|-.+..+- +||.+|-++.+|.+++.++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 467899999999999999999999999999999999877776665556666777777766 6999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+|.||.+||+|--++.+ ...+++.-++. |..+|+.||+|||++||++||||.+|+|++..|++||+|+
T Consensus 328 fvieyv~ggdlmfhmqr--qrklpeeharf----------ys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR--QRKLPEEHARF----------YSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred EEEEEecCcceeeehhh--hhcCcHHHhhh----------hhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeeccc
Confidence 99999999999888877 67889988776 4566777888999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-----chH-HHHhhhCc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR-----NRD-VLKKQEGK 237 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~-~~~~~~~~ 237 (351)
|.++.--.+.+.+++.||||.|.|||++.+..|... +|.|+||++++||+.|+.||.-.+.. ..+ .++.+...
T Consensus 396 gmcke~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek 474 (593)
T KOG0695|consen 396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK 474 (593)
T ss_pred chhhcCCCCCcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence 999987778888999999999999999999999876 99999999999999999999643322 222 23334444
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCC------HHHHhcCccccCCcc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPN------AKDVQNHAWIQNEPT 283 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~ell~hp~~~~~~~ 283 (351)
....|. .+|-.+..+++..|++||.+|.. ++++..|+||+...|
T Consensus 475 qiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 475 QIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred cccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 444333 57778889999999999999964 689999999997655
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.45 Aligned_cols=254 Identities=27% Similarity=0.450 Sum_probs=197.2
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC---CCCCceeeeeEEEeCCE----
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV---SHPNIIGVHRMVKAGTY---- 81 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~~~~---- 81 (351)
|++.+.||+|+||.||+|.+..+++.+|+|.+........ ....+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6889999999999999999998999999999875543222 223344688777666 59999999999987776
Q ss_pred -EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 82 -LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 82 -~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.+++|||+. ++|.+++.......+++..+ +.++.|++.||.|||+.+++|+||+|+||+++.++.++|
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~----------~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETI----------KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEE
Confidence 999999997 68999887643334555443 346778888999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc---
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK--- 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--- 237 (351)
+|||++........ .....+++.|+|||.+.+..++.+ +|+||+||++|+|++|.+||..... .+....+...
T Consensus 149 ~dfg~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (287)
T cd07838 149 ADFGLARIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSE--ADQLDKIFDVIGL 224 (287)
T ss_pred eccCcceeccCCcc-cccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCCh--HHHHHHHHHHcCC
Confidence 99999987643322 233457889999999988877765 9999999999999999999976442 1211111000
Q ss_pred --ccc-----------c---------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 238 --EYL-----------F---------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 238 --~~~-----------~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
... + .....++..+.++|.+||+.||++||++.++++||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 0 0011356788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=321.27 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=205.4
Q ss_pred eeeeeecCcccceEEEEEEecCCce---e-EEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSET---L-KACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~---~-~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
..+.++||+|+||.||+|..+..+. . ||+|....+..........+.+|+++|++++|||||++||+.....-+|+
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 3456899999999999999765422 3 89998775342223334445599999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||+|+||+|.+++++... .++. .+.+.|+.+.+.||+|||+++++||||-..|+|++.++.+||+|||
T Consensus 239 vmEl~~gGsL~~~L~k~~~-~v~~----------~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKK-SLPT----------LEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EEEecCCCcHHHHHHhCCC-CCCH----------HHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999988432 3443 3345688999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccc-cccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKELSNTFC-GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~-gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
+++... ........+ -...|+|||.+....++.+ +||||+||++||+++ |..||.+.. ..+....+....+..+
T Consensus 308 Ls~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~--~~~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 308 LSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMK--NYEVKAKIVKNGYRMP 383 (474)
T ss_pred cccCCc-ceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCC--HHHHHHHHHhcCccCC
Confidence 988643 222222122 3458999999999988876 999999999999998 888997654 6677777766777777
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+...+.++..++.+|+..||++|||+.++.+
T Consensus 384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 384 IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 77788999999999999999999999998854
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=309.96 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=194.2
Q ss_pred cceeeeeecCcccceEEEEEEecCC--------------ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceee
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS--------------ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGV 72 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~--------------~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~ 72 (351)
.+|++.+.||+|+||.||+|.+..+ ...+|+|.+..... . .....+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~-~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-K-TARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-H-HHHHHHHHHHHHHHhCCCCCcCeE
Confidence 4699999999999999999987543 23589998864322 2 223345689999999999999999
Q ss_pred eeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE
Q psy6327 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI 152 (351)
Q Consensus 73 ~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll 152 (351)
++++...+..++||||+.+++|.+++...............-.......+.++.|++.||.|||++|++|+||||+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 99999999999999999999999999652111000000000001123345678899999999999999999999999999
Q ss_pred cCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCch
Q psy6327 153 SRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN--KKYPFGDPGTRNR 228 (351)
Q Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~ 228 (351)
++++.+||+|||++........ ......+++.|+|||++.+..++.+ +|+|||||++|+|++ |..||.... ..
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~--~~ 239 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLS--DE 239 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccC--hH
Confidence 9999999999999976543221 1223345778999999988877765 999999999999988 677876543 22
Q ss_pred HHHHhhh------CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 229 DVLKKQE------GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 229 ~~~~~~~------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
....... ...........+++.+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2222111 011111223357899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=304.24 Aligned_cols=261 Identities=24% Similarity=0.377 Sum_probs=196.9
Q ss_pred cceeeeeecCcccceEEEEEEe-----cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSD-----KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|.+.++||+|+||.||++.. ..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH---HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 5688899999999999999964 34567889998754322 223455689999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCC-C-chHH-HHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNEN-I-HENQ-ARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~-~-~~~~-~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
.+++|||+.+++|.+++....... . .... ...-......++.++.|++.||.|||++|++|+||||+|||+++++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 999999999999999997532100 0 0000 000001223345577899999999999999999999999999999999
Q ss_pred EEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhh
Q psy6327 159 KLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 235 (351)
||+|||+++....... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |.+||.... .........
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLS--NTEAIECIT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCC--HHHHHHHHH
Confidence 9999999876533221 1223345788999999988887765 999999999999998 999996543 233333332
Q ss_pred CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.... ...+..+++.+.+||.+||+.||.+||++.+++.
T Consensus 239 ~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2221 2233468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=303.81 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=191.5
Q ss_pred eeeeeecCcccceEEEEEE----ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--CCEE
Q psy6327 9 CSYISKLGEGAYGNVYLVS----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA--GTYL 82 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~ 82 (351)
|++++.||+|+||+||++. ...++..+|+|.+...... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 4899999999999998765 3457889999998654321 123345589999999999999999998765 3468
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
+++|||+++++|.+++.. ..+++... +.++.|++.||.|||++|++|+||||+|||++.++.++|+|
T Consensus 84 ~lv~e~~~~~~l~~~~~~---~~l~~~~~----------~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~d 150 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK---HKLNLAQL----------LLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGD 150 (283)
T ss_pred EEEecCCCCCCHHHHHHH---cCCCHHHH----------HHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEee
Confidence 999999999999999965 34555443 34678889999999999999999999999999999999999
Q ss_pred ccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh------
Q psy6327 163 FGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------ 233 (351)
Q Consensus 163 fg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~------ 233 (351)
||+++........ .....++..|+|||.+.+..++.+ +||||||+++|+|++|..||........+....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05080 151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229 (283)
T ss_pred cccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence 9999876433221 122345678999999987777765 999999999999999999986543211111100
Q ss_pred ------hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 234 ------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 234 ------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
........+.+..++..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00011112223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.82 Aligned_cols=246 Identities=22% Similarity=0.415 Sum_probs=194.6
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEE-EeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMV-KAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~-~~~~~~~ 83 (351)
+..+|++.+.||+|+||.||++... |..+++|.+..... ...+.+|+.++++++|+|++++++++ ..++..+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 4568999999999999999999765 77899998754322 23345899999999999999999975 4566799
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
++|||+++++|.+++.+.....+++... +.++.|++.||+|||++|++|+||||+||++++++.+||+||
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~----------~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCL----------LKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHH----------HHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCC
Confidence 9999999999999997643333454443 346778889999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
|+++...... ....++..|+|||++.+..++.+ +|||||||++|+|++ |+.||..... ......... .+...
T Consensus 147 g~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~-~~~~~ 219 (256)
T cd05082 147 GLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEK-GYKMD 219 (256)
T ss_pred ccceeccccC---CCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhc-CCCCC
Confidence 9987643322 23345678999999988777765 999999999999997 9999975442 222222221 22223
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
....++..+.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 33467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.00 Aligned_cols=248 Identities=23% Similarity=0.429 Sum_probs=195.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|+++++||+|+||.||+|.+. ++..+|+|.+....... ..+.+|+.++++++|||++++++++. ....|++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH----HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 46999999999999999999866 55678999886544432 23558999999999999999999885 45689999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|.+++.......++.... ..++.|++.||.|||+++++|+||||+||++++++.++|+|||++
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~----------~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNL----------VDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHH----------HHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceee
Confidence 9999999999997643444555443 346778888899999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
........ ......++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.+.. ..+....... ....+.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~-~~~~~~~ 225 (260)
T cd05070 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMN--NREVLEQVER-GYRMPCP 225 (260)
T ss_pred eeccCcccccccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHc-CCCCCCC
Confidence 86543221 1122335668999999887777765 999999999999999 899997644 3333333332 2223334
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...+..+.+|+.+||.+||++|||+.++.+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=299.36 Aligned_cols=247 Identities=24% Similarity=0.433 Sum_probs=198.4
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+..+|++.+.||.|+||.||+|... |+.+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 3467999999999999999999875 78899999865543 23344589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++++|.+++.......+++.... .++.|++.||.|||++|++|+||||+||+++.++.++|+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~----------~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g 147 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQL----------GFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFG 147 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHH----------HHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccc
Confidence 9999999999999976433355554443 466788888889999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
.++....... ...++..|+|||.+....++.+ +|+||||+++|+|++ |..||.... .......... .+....
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~-~~~~~~ 220 (256)
T cd05039 148 LAKEASQGQD---SGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPHVEK-GYRMEA 220 (256)
T ss_pred cccccccccc---cCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhc-CCCCCC
Confidence 9987632221 2334667999999987777665 999999999999997 999996543 2233322222 222233
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+..+++++.++|.+||..+|++|||+.+++.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.08 Aligned_cols=254 Identities=29% Similarity=0.464 Sum_probs=197.4
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEe
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e 87 (351)
|++.+.||+|++|.||+|.+..+++.+++|.+........ .....+|+..++++. ||||+++++++..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6789999999999999999999999999998865433221 122237999999999 9999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+ +|+|.+++.......+++.. ++.++.|++.+|.|||++|++|+||+|+||++++++.++|+|||.++
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~----------~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESV----------IRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHH----------HHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccce
Confidence 99 78999988764323455544 34567788899999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh------------
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE------------ 235 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------ 235 (351)
....... .....|+..|+|||++........++|+||+|+++++|++|++||....... ......
T Consensus 148 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 148 EIRSRPP-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYKICSVLGTPTKQDWP 224 (283)
T ss_pred eccCCCC-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHHHHHhcCCCChhhhh
Confidence 7644322 2345688999999988654433345999999999999999999996554211 111000
Q ss_pred -------Cccccc---------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 236 -------GKEYLF---------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 236 -------~~~~~~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
...... ......+..+.+||.+||+.||++|||+.|++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000 0011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.27 Aligned_cols=246 Identities=23% Similarity=0.368 Sum_probs=194.9
Q ss_pred eecCcccceEEEEEEecC-Cc--eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecC
Q psy6327 13 SKLGEGAYGNVYLVSDKR-SE--TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYA 89 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (351)
+.||+|++|.||+|.+.. .+ ..+|+|.+...... ...+.+.+|+.++++++||||+++++++.+ ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 33 36899998766554 334455689999999999999999999988 8899999999
Q ss_pred CCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccc
Q psy6327 90 EKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL 169 (351)
Q Consensus 90 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 169 (351)
++++|.+++.+.....++... +..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~----------~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLIST----------LCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred CCCcHHHHHHhcccccCcHHH----------HHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccc
Confidence 999999999764322344333 3446778899999999999999999999999999999999999999876
Q ss_pred cCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 170 RTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 170 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
..... ......++..|+|||.+....++.+ +|||||||++|+|++ |..||...+ ..+............+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~ 224 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLS--GSQILKKIDKEGERLERPE 224 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhcCCcCCCCc
Confidence 44222 1123456789999999887777765 999999999999998 999996543 2333333332223333344
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.++..+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 67899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=313.36 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=195.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC------C
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG------T 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~ 80 (351)
.+|++++.||+|+||.||+|.+..+++.||+|++........ ....+.+|+.++++++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH-HHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 569999999999999999999999999999999865332222 233345899999999999999999988543 3
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|++++++ |++|.+++.. ..+++..+. .++.|++.||+|||++|++||||||+||++++++.+||
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~----------~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQ----------FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc---CCCCHHHHH----------HHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEE
Confidence 478899887 6899988764 345554433 46678888999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh---hC
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ---EG 236 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---~~ 236 (351)
+|||+++.... ......|++.|+|||.+.+. .++. ++||||+||++|+|++|+.||...... ...... ..
T Consensus 162 ~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~~DvwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~ 235 (345)
T cd07877 162 LDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQ-TVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVG 235 (345)
T ss_pred ecccccccccc---cccccccCCCccCHHHHhCccCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence 99999876432 23345689999999998663 4444 499999999999999999999654321 111100 00
Q ss_pred ------------c---------cc----cc-cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 237 ------------K---------EY----LF-NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 237 ------------~---------~~----~~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. .. .+ ......+..+++||.+||+.||.+|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0 00 00 0011357889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=302.91 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=199.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhh---hhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKR---LKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+|.+.+.||+|+||.||++.+..++..+++|++..-. ..... ...+.+|+.+++.++||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE-TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcch-HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 4889999999999999999998777666666654322 22211 2223479999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 85 IMDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||+++++|.+++.+.. ...+++... +.++.|++.||.|||++|++|+||+|+||++++ +.++|+|
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~----------~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQV----------CEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHH----------HHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecc
Confidence 999999999999886421 234555443 346778888899999999999999999999986 5699999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
||.+..............|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||.... ........... ....
T Consensus 149 ~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~~-~~~~ 224 (260)
T cd08222 149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQN--FLSVVLRIVEG-PTPS 224 (260)
T ss_pred cCceeecCCCcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHcC-CCCC
Confidence 9999876554444455668999999999877777665 999999999999999999996543 22222222111 1112
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
.+..++.++.++|.+||+.||++||++.++++||||
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 233678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=307.47 Aligned_cols=263 Identities=21% Similarity=0.315 Sum_probs=197.4
Q ss_pred cceeeeeecCcccceEEEEEEecC-------CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKR-------SETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA 78 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 78 (351)
.+|.+.+.||+|+||.||+|.+.. ++..+|+|.+..... ... ...+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHH-HHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 579999999999999999998643 335799998865322 222 23455899999999 79999999999999
Q ss_pred CCEEEEEEecCCCCChHHHHHhhccCCCch----HHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACNENIHE----NQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR 154 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~----~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~ 154 (351)
.+..|+||||+.+|+|.+++.......... .....-.......+.++.|++.||+|||++|++|+||||+||+++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 999999999999999999997632211000 0000000112334567889999999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q psy6327 155 LLNAKLADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVL 231 (351)
Q Consensus 155 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 231 (351)
++.+||+|||.++........ .....+++.|+|||.+.+..++.+ +|+|||||++|+|++ |..||.... ..+..
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~--~~~~~ 252 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVP--VEELF 252 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCC--HHHHH
Confidence 999999999998765432211 112234578999999988777665 999999999999998 889996543 23333
Q ss_pred HhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 232 KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..... ......+..++.++.+|+.+||..+|++|||+.+++++
T Consensus 253 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHc-CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 33222 22233344688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=307.29 Aligned_cols=254 Identities=31% Similarity=0.481 Sum_probs=200.5
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|++.+.||+|++|.||+|.+..+++.+|+|.+........ ....+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc-ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 6778999999999999999999999999999876542222 233344899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
++ ++|.+++.+.. ..+++... ..++.|++.||+|||++|++|+||+|+||++++++.++|+|||.++.
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~----------~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLI----------KSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHH----------HHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 98 69999997632 34555443 34677888899999999999999999999999999999999999987
Q ss_pred ccCCcccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh------------
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE------------ 235 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------ 235 (351)
............++..|+|||.+.+. .++. ++|+|||||++|+|++|..||..... ......+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYST-AVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWP 224 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCCcCCCc-cccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHH
Confidence 65544334445568899999998766 4554 49999999999999999999965431 11111000
Q ss_pred ---Cc---cccc---------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 236 ---GK---EYLF---------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 236 ---~~---~~~~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
.. ...+ .....++..+.++|.+||+.||++||++.++++||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00 0000 0111357789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=301.74 Aligned_cols=254 Identities=23% Similarity=0.412 Sum_probs=201.2
Q ss_pred cceeeeeecCcccceEEEEEEecC-----CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKR-----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|+++..||+|+||.||+|..+. +.+.+++|.+...... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch--HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 579999999999999999999653 3567889887543322 123445689999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccC-------CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNE-------NIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR 154 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~-------~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~ 154 (351)
.++||||+++++|.+++...... .++... +..++.|++.||.|||+++|+|+||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~----------~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~ 152 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQ----------KVALCTQIALGMDHLSNARFVHRDLAARNCLVSS 152 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHH----------HHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC
Confidence 99999999999999999763311 344443 3446788889999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCc-ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q psy6327 155 LLNAKLADFGFSRLLRTPK-ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 155 ~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 232 (351)
++.++++|||++....... .......+++.|+|||.+.+..+... +||||||+++|+|++ |..||.... ......
T Consensus 153 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~--~~~~~~ 229 (275)
T cd05046 153 QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLS--DEEVLN 229 (275)
T ss_pred CCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccc--hHHHHH
Confidence 9999999999987543221 12234456788999999887776655 999999999999998 889996543 334444
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
........++....++..+.+++.+||+.||++|||+.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 4443343344445788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=304.61 Aligned_cols=261 Identities=21% Similarity=0.342 Sum_probs=196.2
Q ss_pred ceeeeeecCcccceEEEEEEecC-----CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKR-----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
+|++.+.||+|+||.||+|.+.. ....+++|.+....... . ...+.+|+.+++.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS-E-LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH-H-HHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 33568888875433222 1 23455899999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchH-----H-------HHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCE
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHEN-----Q-------ARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENI 150 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~-----~-------~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NI 150 (351)
++++||+.+++|.+++........... . ...-......++.++.|++.||.|||+++++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999999875321100000 0 0000012233556788999999999999999999999999
Q ss_pred eEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCc
Q psy6327 151 LISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRN 227 (351)
Q Consensus 151 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 227 (351)
|+++++.+||+|||+++....... ......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+.. .
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~--~ 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIA--P 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCC--H
Confidence 999999999999999986533222 1223345678999999877777655 999999999999998 999996543 2
Q ss_pred hHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 228 RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
........ .....+.+..++.++.+|+.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 236 ERLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 22222222 22333344568899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=304.25 Aligned_cols=261 Identities=31% Similarity=0.515 Sum_probs=203.0
Q ss_pred ceeeeeecCcccceEEEEEEec---CCceeEEEEecchhhhh-hHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~ 82 (351)
+|++.+.||+|++|.||++.+. .++..+|+|.+...... .......+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5889999999999999998864 46788999988654332 222234455899999999 599999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||+.+++|.+++.. ...+++.... .++.|++.||.|||+.+++|+||+|+||+++.++.++|+|
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~----------~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVR----------VYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHH----------HHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEE
Confidence 999999999999999875 3455554433 3566888889999999999999999999999999999999
Q ss_pred ccccccccCCcc-cccccccccceeccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc--hHHHHhhhCc
Q psy6327 163 FGFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSP--YNPKLADIWSLGVVLYRILNKKYPFGDPGTRN--RDVLKKQEGK 237 (351)
Q Consensus 163 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~ 237 (351)
||+++....... ......|++.|+|||.+.+.. .+. ++|+||+|+++|+|++|..||....... ..........
T Consensus 149 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd05583 149 FGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDK-AVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS 227 (288)
T ss_pred CccccccccccccccccccCCccccCHHHhcCCCCCCcc-hhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc
Confidence 999876543322 223456899999999986654 344 4999999999999999999996433211 1222222222
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCcc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPN---AKDVQNHAWIQNEPT 283 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~~~~~ 283 (351)
..+.+..++..+.++|.+||+.||++||| +.++|+||||++..+
T Consensus 228 --~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 228 --KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred --CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 12333457889999999999999999998 567899999987644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=300.45 Aligned_cols=253 Identities=24% Similarity=0.406 Sum_probs=199.6
Q ss_pred CccceeeeeecCcccceEEEEEEecCCce---eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSET---LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
++.+|++.+.||+|+||.||+|.+..++. .+|+|.+.... .. .....+..|+.+++.++||||+++++++.++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CH-HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 56789999999999999999999887664 69999886432 22 223445689999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++||||+++++|.+++... ...++... .+.++.|++.||.|||++|++|+||||+||+++.++.+||+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~ 148 (269)
T cd05065 80 VMIITEFMENGALDSFLRQN-DGQFTVIQ----------LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVS 148 (269)
T ss_pred eEEEEecCCCCcHHHHHhhC-CCCCCHHH----------HHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEEC
Confidence 99999999999999998753 23344433 34567888999999999999999999999999999999999
Q ss_pred eccccccccCCccc--ccccc---cccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhh
Q psy6327 162 DFGFSRLLRTPKEL--SNTFC---GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 162 Dfg~a~~~~~~~~~--~~~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 235 (351)
|||++......... ..... .+..|+|||.+.+..++.+ +||||+||++|+|++ |..||.... .........
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i~ 225 (269)
T cd05065 149 DFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAIE 225 (269)
T ss_pred CCccccccccCccccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHHH
Confidence 99998765432211 11111 2457999999988887765 999999999999886 999997644 233333332
Q ss_pred CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.....+....++..+.+++.+||+.+|++||++.+++.
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 226 -QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22333444578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=298.17 Aligned_cols=248 Identities=22% Similarity=0.400 Sum_probs=194.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|.+.+.||+|++|.||+|.+..++ .+|+|.+...... ...+.+|+.+++.++|||++++++++.. +..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 46999999999999999999876654 5899987543322 2334589999999999999999998854 5689999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+.+++|.+++.......++... ++.++.|++.||.|||+.|++|+||||+||++++++.++|+|||.+
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~----------~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQ----------LVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHH----------HHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccc
Confidence 999999999999764333344433 3346778899999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+....... ......++..|+|||.+.+..++.. +|+||||+++|+|++ |..||.+.. .......... .+..+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~-~~~~~~~ 225 (260)
T cd05069 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMV--NREVLEQVER-GYRMPCP 225 (260)
T ss_pred eEccCCcccccCCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc-CCCCCCC
Confidence 86543221 1123345678999999887776655 999999999999999 999997643 2333333322 2223334
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...+..+.+++.+||.+||++||++.++++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=306.70 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=195.6
Q ss_pred cceeeeeecCcccceEEEEEEec----------------CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCce
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK----------------RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~----------------~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv 70 (351)
.+|++.+.||+|+||.||++.+. .++..+|+|.+..... ......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcc
Confidence 35999999999999999998543 2455789998864422 22234455899999999999999
Q ss_pred eeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCE
Q psy6327 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENI 150 (351)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NI 150 (351)
++++++...+..++||||+.+++|.+++.......... ....-......+..++.|++.||+|||++|++|+||||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE-KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccc-cccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999997632211110 00000112234556788999999999999999999999999
Q ss_pred eEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCC
Q psy6327 151 LISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN--KKYPFGDPGTR 226 (351)
Q Consensus 151 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~ 226 (351)
|++.++.++|+|||+++.+..... ......+++.|+|||......++.+ +|+|||||++|+|++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 999999999999999986543221 1222345678999998887777765 999999999999998 7788865432
Q ss_pred chHHHHhh------hCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 227 NRDVLKKQ------EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 227 ~~~~~~~~------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+..... .......+.+..++..+.+|+.+||+.||++||++.++++
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 -EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred -HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2222111 0111122334467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=301.19 Aligned_cols=252 Identities=19% Similarity=0.264 Sum_probs=193.8
Q ss_pred CccceeeeeecCcccceEEEEEEecCCce----eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSET----LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
...+|++++.||+|+||+||+|.+..++. .+++|.+..... ......+..|+.+++++.||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc--hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 34689999999999999999999877776 467777643221 1222344578889999999999999998754 4
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..++++||+++|+|.+++... ...+++... +.++.|++.||.|||+++++|+||||+|||++.++.+||
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~----------~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl 150 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQH-RDSLDPQRL----------LNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQI 150 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhc-ccCCCHHHH----------HHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEE
Confidence 578999999999999999753 234555443 346778889999999999999999999999999999999
Q ss_pred eeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 161 ADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+|||.++....... ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+... ..........
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~ 227 (279)
T cd05111 151 ADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKG 227 (279)
T ss_pred cCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCC
Confidence 99999986543221 1223456778999999988877765 999999999999998 9999976432 2222222222
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
. ..+.+..++.++.+++.+||..||++|||+.++++
T Consensus 228 ~-~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 228 E-RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred C-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1 22233356788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=338.69 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=208.0
Q ss_pred eeeeeecCcccceEEEEEEecCC-c----eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRS-E----TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~-~----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
.++.+.||+|+||.||.|..... | ..||+|.+. ...+......+.+|..+|+.++|||||+++|++-+....+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~--~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK--RLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEecc--ccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 57788999999999999986533 2 347888764 3333333555669999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
|++|||+||+|..+|++.....+... ...+.+.+.++.||++|++||+++++|||||...|+|++....+||+||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~-----~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPS-----NLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCC-----CCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999987543333211 1344566788999999999999999999999999999999999999999
Q ss_pred cccccccCCccc-cccc-ccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 164 GFSRLLRTPKEL-SNTF-CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 164 g~a~~~~~~~~~-~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
|+|+.+...... .... .-...|||||.+....++++ +|||||||++||+++ |..||++.+ +.+++....... .
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~--n~~v~~~~~~gg-R 922 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRS--NFEVLLDVLEGG-R 922 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcc--hHHHHHHHHhCC-c
Confidence 999955433222 2222 12358999999999999987 999999999999999 999998765 666666444444 6
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
++.+..|++.+.+++..||+.+|++||++..|++
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 6777799999999999999999999999999986
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=303.50 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=193.7
Q ss_pred ceeeeeecCcccceEEEEEEe----cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--CE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSD----KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--TY 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~ 81 (351)
-|++++.||+|+||.||.|.. ..++..+|+|.+..... ......+.+|+.+++.+.||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 378999999999999999974 56789999999864432 22234466899999999999999999998765 67
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++||||++|++|.+++.+. ...++... ++.++.|++.||+|||++|++||||||+||+++.++.++|+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~----------~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~ 151 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN-KNKINLKQ----------QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 151 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc-cCCCCHHH----------HHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEEC
Confidence 89999999999999998653 22344433 34567888999999999999999999999999999999999
Q ss_pred eccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch----------
Q psy6327 162 DFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR---------- 228 (351)
Q Consensus 162 Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---------- 228 (351)
|||+++....... ......|+..|+|||.+.+..++.+ +|||||||++|+|+++..|+........
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05079 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230 (284)
T ss_pred CCccccccccCccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence 9999987654322 1223456778999999887777665 9999999999999998776533211000
Q ss_pred --H-HHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 229 --D-VLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 229 --~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
. ...... .....+....++..+.+|+.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 TVTRLVRVLE-EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cHHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 000111 111222334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=339.42 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=196.6
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe------
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA------ 78 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------ 78 (351)
.+.+|..++.||+||||.||+++++-+|+.||||++.... ... ....+.+|+..+.+|+|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~-~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDK-LYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHH-HHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4568999999999999999999999999999999998776 333 34445599999999999999988743200
Q ss_pred --------------------------------------------------------------------------------
Q psy6327 79 -------------------------------------------------------------------------------- 78 (351)
Q Consensus 79 -------------------------------------------------------------------------------- 78 (351)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHH
Q psy6327 79 -------------------------G--------TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125 (351)
Q Consensus 79 -------------------------~--------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~ 125 (351)
+ ..+||-||||+..+|.+++.+. .... +.-.+..++
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~---------~~d~~wrLF 703 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNS---------QRDEAWRLF 703 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccch---------hhHHHHHHH
Confidence 0 2478999999988888888762 2221 223344678
Q ss_pred HHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccccc------------------CCcccccccccccceec
Q psy6327 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR------------------TPKELSNTFCGTTSYAA 187 (351)
Q Consensus 126 ~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~------------------~~~~~~~~~~gt~~y~a 187 (351)
++|++||.|+|++|||||||||.|||++.++.|||+|||+|+... ......++.+||..|+|
T Consensus 704 reIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 704 REILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 899999999999999999999999999999999999999998721 00112346789999999
Q ss_pred cccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc---ccccCCHhHHHHHHHhcCC
Q psy6327 188 PEIIRNSP---YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN---RKYEISIGAKQLIGRMLEP 261 (351)
Q Consensus 188 PE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~ 261 (351)
||++.+.. |+.+ +|+|||||+++||+ .||+.. +.....+..........+ .... -+.-..+|+.||+.
T Consensus 784 PEll~~~~~~~Yn~K-iDmYSLGIVlFEM~---yPF~Ts-MERa~iL~~LR~g~iP~~~~f~~~~-~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSK-IDMYSLGIVLFEML---YPFGTS-MERASILTNLRKGSIPEPADFFDPE-HPEEASLIRWLLSH 857 (1351)
T ss_pred HHHhcccccccccch-hhhHHHHHHHHHHh---ccCCch-HHHHHHHHhcccCCCCCCccccccc-chHHHHHHHHHhcC
Confidence 99987655 7765 99999999999999 467543 222333333333332222 1112 23457799999999
Q ss_pred CCCCCCCHHHHhcCcccc
Q psy6327 262 NPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 262 dp~~Rpt~~ell~hp~~~ 279 (351)
||++||||.|+|++.||.
T Consensus 858 dP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 858 DPSKRPTATELLNSELLP 875 (1351)
T ss_pred CCccCCCHHHHhhccCCC
Confidence 999999999999999996
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=298.83 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=198.4
Q ss_pred ccceeeeeecCcccceEEEEEEecCCce---eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSET---LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
..+|+..+.||+|+||.||+|.+..++. .+++|.+....... ....+..|+.+++.++||||+++.+++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH--HHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3578999999999999999999876654 78999875442221 133455899999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||||+++++|.+++... ...++.... ..++.|++.||.|||+.|++|+||||+||++++++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~----------~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 82 MIITEYMENGALDKYLRDH-DGEFSSYQL----------VGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECC
Confidence 9999999999999999753 244555433 34677889999999999999999999999999999999999
Q ss_pred ccccccccCCccccc---ccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcc
Q psy6327 163 FGFSRLLRTPKELSN---TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 163 fg~a~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
||++........... ....++.|+|||++.+..++.+ +|+|||||++|+|++ |..||.... .......+...
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~--~~~~~~~i~~~- 226 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMS--NHEVMKAINDG- 226 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHhcC-
Confidence 999986543222111 1123457999999987777665 999999999999997 999996544 23333333322
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...+....++.++.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 233344467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=309.31 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=195.2
Q ss_pred ceeeeeecCcccceEEEEEEecCC--ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe----CC
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRS--ETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA----GT 80 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~----~~ 80 (351)
+|++.+.||+|+||.||++.+..+ +..+|+|.+....... ...+.+.+|+.+++++ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK-ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 9999999876432222 2233344899999999 59999999987532 25
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+++||+. ++|.+++.. ...+++.... .++.||+.||.|||++|++||||||+|||++.++.+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS--GQPLTDAHFQ----------SFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc--CCCCCHHHHH----------HHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEe
Confidence 6889999996 799998865 4556665444 35678888899999999999999999999999999999
Q ss_pred eeccccccccCCcc----cccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC---------
Q psy6327 161 ADFGFSRLLRTPKE----LSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--------- 226 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------- 226 (351)
+|||.++....... ......||+.|+|||++.+. .++. ++|+||+||++|+|++|.+||...+..
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~ 225 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTK-AIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCc-HHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHH
Confidence 99999986543221 12345789999999987654 4444 499999999999999999999754311
Q ss_pred ----chHHHHhhh------------Ccc-c-cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 227 ----NRDVLKKQE------------GKE-Y-LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 227 ----~~~~~~~~~------------~~~-~-~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
......... ... . .......++..+.+|+.+||+.||.+|||+.+++.|||++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 000000000 000 0 00111246789999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=301.14 Aligned_cols=253 Identities=24% Similarity=0.393 Sum_probs=192.1
Q ss_pred cceeeeeecCcccceEEEEEE----ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--CC
Q psy6327 7 LECSYISKLGEGAYGNVYLVS----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA--GT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~ 80 (351)
.+|++++.||+|+||.||.|. +..++..+|+|.+...... ....+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999987 4567889999997644321 13445689999999999999999998643 45
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..++||||+++++|.+++... ...++... ++.++.|++.||+|||++|++|+||||+||+++.++.+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~----------~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l 149 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH-RERLDHRK----------LLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKI 149 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc-CcCCCHHH----------HHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEE
Confidence 689999999999999999653 22344433 3346778899999999999999999999999999999999
Q ss_pred eeccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHH-------
Q psy6327 161 ADFGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV------- 230 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------- 230 (351)
+|||+++........ .....++..|+|||++.+..++.+ +|+|||||++|+|++|..|+..........
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05081 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228 (284)
T ss_pred CCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc
Confidence 999999876433221 111223456999999987777665 999999999999999887764432110000
Q ss_pred ------HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 231 ------LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 231 ------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...........+....++.++.+|+.+||..+|++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00011111222334467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=305.60 Aligned_cols=264 Identities=20% Similarity=0.321 Sum_probs=199.7
Q ss_pred ccceeeeeecCcccceEEEEEEec-------CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK-------RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVK 77 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~ 77 (351)
..+|++.+.||+|+||.||+|.+. .++..+|+|.+...... .. ...+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~-~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-KD-LSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch-HH-HHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 356899999999999999999753 23567999987643222 11 23455899999999 7999999999999
Q ss_pred eCCEEEEEEecCCCCChHHHHHhhccCCCchHH--H--HHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 78 AGTYLYMIMDYAEKKDLEHYISKACNENIHENQ--A--RIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 78 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~--~--~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
.....|+||||+++|+|.+++.+.......... . ..-...+...+.++.|++.||.|||++|++||||||+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 999999999999999999999763221110000 0 000112334566788999999999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q psy6327 154 RLLNAKLADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDV 230 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 230 (351)
.++.+||+|||+++........ .....+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.... ..+.
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~--~~~~ 248 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIP--VEEL 248 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCC--HHHH
Confidence 9999999999999876433221 222345678999999988777765 999999999999998 888886543 3333
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....... .....+..++..+++|+.+||+.+|++|||+.++++.
T Consensus 249 ~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEG-HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcC-CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 3333222 2223334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=305.67 Aligned_cols=263 Identities=19% Similarity=0.293 Sum_probs=196.7
Q ss_pred ccceeeeeecCcccceEEEEEEec-------CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK-------RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVK 77 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~ 77 (351)
..+|.+.++||+|+||.||+|.+. .....+|+|.+..... ... ...+.+|+.+++++ .||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~-~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKD-LADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHH-HHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 357999999999999999999763 2356789998764322 222 33455899999999 5999999999999
Q ss_pred eCCEEEEEEecCCCCChHHHHHhhccCCCchH----HHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 78 AGTYLYMIMDYAEKKDLEHYISKACNENIHEN----QARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 78 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~----~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
..+..|++|||+++|+|.+++........... ....-.......+.++.|++.||.|||++|++|+||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 99999999999999999999976321100000 00000012234456788999999999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q psy6327 154 RLLNAKLADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDV 230 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 230 (351)
.++.+||+|||.++........ .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.... ....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~--~~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIP--VEEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCC--HHHH
Confidence 9999999999999865432211 112234567999999988777765 999999999999999 899996543 2333
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
....... .....+..++.++++++.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 3333222 122334467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=308.50 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=197.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-CCEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA-GTYLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~l 84 (351)
-.+|++++.||.|+||.||+|.+..+++.+|+|.+........ ....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc-hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 3469999999999999999999999999999998864332222 23344589999999999999999999865 567899
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
++||+ +++|..+++. ..+++.... .++.|++.||.|||+++++|+||+|+||+++.++.++|+|||
T Consensus 88 v~e~~-~~~L~~~~~~---~~~~~~~~~----------~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg 153 (328)
T cd07856 88 VTELL-GTDLHRLLTS---RPLEKQFIQ----------YFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFG 153 (328)
T ss_pred Eeehh-ccCHHHHHhc---CCCCHHHHH----------HHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccc
Confidence 99999 5789988864 345544432 356788999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-------------HH
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRN-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-------------DV 230 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------------~~ 230 (351)
.+..... ......+++.|+|||.+.+ ..++. ++|+||+||++|+|++|+.||........ +.
T Consensus 154 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 154 LARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDV-EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred cccccCC---CcCCCcccccccCceeeeccCCcCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9875432 2234567889999998766 34444 59999999999999999999965432100 00
Q ss_pred HH------------hhhCcccc--ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 231 LK------------KQEGKEYL--FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 231 ~~------------~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.. ........ ......++..+.++|.+||+.+|++|||+.+++.||||...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00 00000000 00112467899999999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=296.14 Aligned_cols=243 Identities=26% Similarity=0.405 Sum_probs=191.3
Q ss_pred eecCcccceEEEEEEecCCc---eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSE---TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYA 89 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (351)
++||+|+||.||+|.+..++ ..+|+|.+...... .....+.+|+.+++.+.||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876554 78999998765543 22344558999999999999999999876 44689999999
Q ss_pred CCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccc
Q psy6327 90 EKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL 169 (351)
Q Consensus 90 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 169 (351)
++++|.+++.. ...+++... +.++.|++.||.|||+++++|+||||+|||++.++.+||+|||.++..
T Consensus 78 ~~~~L~~~l~~--~~~~~~~~~----------~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 78 PLGPLLKYLKK--RREIPVSDL----------KELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred CCCcHHHHHHh--CCCCCHHHH----------HHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEecccccccee
Confidence 99999999976 334555443 456778888899999999999999999999999999999999999876
Q ss_pred cCCccccc---ccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 170 RTPKELSN---TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 170 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
........ ...++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...+ ............ ..+.+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~ 221 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESGE-RLPRPE 221 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcCC-cCCCCC
Confidence 44332211 1123467999999988777765 999999999999998 999997654 233333332222 223445
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.++..++++|.+||+.||++||++.++++
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 68899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=304.26 Aligned_cols=256 Identities=20% Similarity=0.314 Sum_probs=199.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC--C----CceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH--P----NIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p----~iv~~~~~~~~~~ 80 (351)
..|.++.++|+|+||.|..+.+..++..+|+|++..-.... +..+-|++++.++.+ | -+|.+.++|.-.+
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr----eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR----EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh----hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 45999999999999999999999999999999975433222 222369999999942 2 2577888899999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC------
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR------ 154 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~------ 154 (351)
+.|||+|.+ |-|++++++.....+++-..++ .+..|++++++|||+.+++|.||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir----------~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIR----------HMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHH----------HHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 999999988 5799999998666666655544 46788899999999999999999999999942
Q ss_pred --------------CCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy6327 155 --------------LLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220 (351)
Q Consensus 155 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 220 (351)
+..|+|+|||.|+.-.. .....+.|..|+|||++.+-+|+.+ +||||+||||+|+.+|...|
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLF 309 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceec
Confidence 23589999999987443 2367789999999999999999987 99999999999999999999
Q ss_pred CCCCCCch-HHHHhhhCccc------------------ccc-------------ccc----------cCCHhHHHHHHHh
Q psy6327 221 GDPGTRNR-DVLKKQEGKEY------------------LFN-------------RKY----------EISIGAKQLIGRM 258 (351)
Q Consensus 221 ~~~~~~~~-~~~~~~~~~~~------------------~~~-------------~~~----------~~s~~~~~li~~~ 258 (351)
...+.... ..++.+.+..+ .++ ... .--.++.|||++|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 76552211 12222211110 000 000 0112578999999
Q ss_pred cCCCCCCCCCHHHHhcCccccCC
Q psy6327 259 LEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 259 L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
|..||.+|+|+.|+|+||||...
T Consensus 390 L~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 390 LEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HccCccccccHHHHhcCHHhhcC
Confidence 99999999999999999999754
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=299.11 Aligned_cols=256 Identities=22% Similarity=0.315 Sum_probs=200.7
Q ss_pred CCCCCccceeeeeecCcccceEEEEEEecCCce----eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEE
Q psy6327 1 MKFPDILECSYISKLGEGAYGNVYLVSDKRSET----LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMV 76 (351)
Q Consensus 1 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 76 (351)
|++-...+|++.+.||+|+||.||+|.++.+|. .+|+|.+..... ......+.+|+.++++++||||+++++++
T Consensus 1 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T cd05057 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGIC 78 (279)
T ss_pred CcccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 455667889999999999999999999876664 588888754433 22234455899999999999999999999
Q ss_pred EeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 77 KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 77 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
.+ ...++||||+.+|+|.+++.+. ...+++.. ++.++.|++.||+|||+++++|+||||+||++++++
T Consensus 79 ~~-~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~----------~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~ 146 (279)
T cd05057 79 LS-SQVQLITQLMPLGCLLDYVRNH-KDNIGSQY----------LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ 146 (279)
T ss_pred ec-CceEEEEecCCCCcHHHHHHhc-cCCCCHHH----------HHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC
Confidence 87 7899999999999999999753 23345443 345677889999999999999999999999999999
Q ss_pred CeEEeeccccccccCCcccc--cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHh
Q psy6327 157 NAKLADFGFSRLLRTPKELS--NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 233 (351)
.+||+|||.++......... ....++..|+|||.+....++.+ +|+||+|+++|++++ |..||.... ..+....
T Consensus 147 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~ 223 (279)
T cd05057 147 HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIP--AVEIPDL 223 (279)
T ss_pred eEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHH
Confidence 99999999998765332211 11223568999999887777765 999999999999998 999997654 2333333
Q ss_pred hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.... ...+.+...+.++.+++.+||..||++|||+.++++
T Consensus 224 ~~~~-~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 224 LEKG-ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HhCC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3322 223334457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=295.76 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=198.6
Q ss_pred eeeeeecCcccceEEEEEEecCCc----eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSE----TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+++.+.||.|+||.||++.+..++ ..+|+|.+....... ....+..|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467889999999999999998766 899999985443321 23455689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
+|||+++++|.+++.......+++... ..++.|++.||++||+.+++|+||+|+||++++++.++|+|||
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~----------~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDL----------LSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHH----------HHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccC
Confidence 999999999999997633222555443 3467788888899999999999999999999999999999999
Q ss_pred ccccccCCccccc-ccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKELSN-TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
.++.......... ...+++.|+|||.+.+..++.+ +|+||+|+++|+|++ |.+||.... ............ ...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~~ 224 (258)
T smart00219 149 LSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEYLKKGY-RLP 224 (258)
T ss_pred CceecccccccccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCC-CCC
Confidence 9987654322211 2236789999999877766665 999999999999998 889986533 333333333222 223
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
....++.++.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 33458999999999999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=303.70 Aligned_cols=262 Identities=21% Similarity=0.360 Sum_probs=199.9
Q ss_pred CccceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG 79 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 79 (351)
+..+|++.+.||+|+||.||+|.+. .++..+|+|.+...... .....+.+|+.+++.+.||||+++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--HHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3467999999999999999999874 36789999988643321 2234466899999999999999999999999
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHH------------HHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCC
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQAR------------IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKC 147 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~------------~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp 147 (351)
...+++|||+++++|.+++...... ...... .........+.++.|++.||.|||+++++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPR--AQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCcc--ccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 9999999999999999999753211 000000 00012233456788999999999999999999999
Q ss_pred CCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy6327 148 ENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPG 224 (351)
Q Consensus 148 ~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 224 (351)
+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999876433221 1222335677999999988887765 999999999999997 888986543
Q ss_pred CCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 225 TRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..+.......... .+.+..++.++.+||.+||+.||++|||+.|+++
T Consensus 238 --~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 --HEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred --HHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 2333333332222 2233467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=296.15 Aligned_cols=243 Identities=22% Similarity=0.365 Sum_probs=188.3
Q ss_pred ecCcccceEEEEEEec--CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 14 KLGEGAYGNVYLVSDK--RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 14 ~LG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
.||+|+||.||+|.+. .++..+|+|++..... ......+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999765 4566799998865432 2223456689999999999999999998864 468999999999
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
++|.+++... ...+++.. ++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++.....
T Consensus 79 ~~L~~~l~~~-~~~~~~~~----------~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSN----------VVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred CCHHHHHHhC-CCCCCHHH----------HHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 9999998642 33455544 345678899999999999999999999999999999999999999986543
Q ss_pred Ccccc---cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccC
Q psy6327 172 PKELS---NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247 (351)
Q Consensus 172 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (351)
..... ....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.... ............ ....+..+
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~ 223 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMK--GPEVMSFIEQGK-RLDCPAEC 223 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHHCCC-CCCCCCCC
Confidence 32211 11223578999999887777665 999999999999996 999997654 223332222221 22333467
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
++++.++|.+||..||++||++.++.+
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=294.94 Aligned_cols=229 Identities=26% Similarity=0.345 Sum_probs=184.2
Q ss_pred ccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCChHHH
Q psy6327 18 GAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHY 97 (351)
Q Consensus 18 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL~~~ 97 (351)
|.+|.||+|.++.+++.+|+|.+...... .+|...+....||||+++++++.+....++||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~--------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY--------SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh--------hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 89999999999999999999998654311 1455555666799999999999999999999999999999999
Q ss_pred HHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCccccc
Q psy6327 98 ISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSN 177 (351)
Q Consensus 98 l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 177 (351)
+.+. ..+++... ..++.|++.||+|||++|++||||||+||+++.++.++++|||.+...... ..
T Consensus 76 l~~~--~~l~~~~~----------~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~ 140 (237)
T cd05576 76 ISKF--LNIPEECV----------KRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CD 140 (237)
T ss_pred HHHh--cCCCHHHH----------HHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cc
Confidence 9763 34555443 346778888999999999999999999999999999999999987654332 22
Q ss_pred ccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHH
Q psy6327 178 TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGR 257 (351)
Q Consensus 178 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 257 (351)
...+++.|+|||.+....++.+ +|+||+|+++|+|++|..|+...... . . .......+..++..++++|.+
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~---~-~----~~~~~~~~~~~~~~~~~li~~ 211 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEA-CDWWSLGAILFELLTGKTLVECHPSG---I-N----THTTLNIPEWVSEEARSLLQQ 211 (237)
T ss_pred cCCcCccccCCcccCCCCCCch-hhHHHHHHHHHHHHHCcchhhcCchh---c-c----cccccCCcccCCHHHHHHHHH
Confidence 3456788999999887777665 89999999999999999988543211 0 0 001112233578999999999
Q ss_pred hcCCCCCCCCCH-----HHHhcCccc
Q psy6327 258 MLEPNPKHRPNA-----KDVQNHAWI 278 (351)
Q Consensus 258 ~L~~dp~~Rpt~-----~ell~hp~~ 278 (351)
||+.||++||++ +++++||||
T Consensus 212 ~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 212 LLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=297.80 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=188.0
Q ss_pred eecCcccceEEEEEEecCCce--eEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSET--LKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYA 89 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (351)
+.||+|+||.||+|.+..++. .+++|.+.... .......+.+|+.++.++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988775 45777765322 112233455899999999 7999999999999999999999999
Q ss_pred CCCChHHHHHhhcc--------------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 90 EKKDLEHYISKACN--------------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 90 ~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
++|+|.+++..... ..++. ...+.++.|++.||+|||++|++|+||||+|||++.+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~----------~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~ 148 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSS----------QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 148 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCH----------HHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC
Confidence 99999999975321 11222 2334578889999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhh
Q psy6327 156 LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQ 234 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 234 (351)
+.+||+|||++....... .......++.|+|||++....++.+ +|+|||||++|+|++ |..||.... ........
T Consensus 149 ~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~--~~~~~~~~ 224 (270)
T cd05047 149 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKL 224 (270)
T ss_pred CeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccC--HHHHHHHH
Confidence 999999999986422111 1112234567999999987777665 999999999999997 999996543 23333333
Q ss_pred hCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 235 EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.. .+....+..++.++.+++.+||+.||.+|||+.+++.
T Consensus 225 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 225 PQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred hC-CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 22 2222334467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.82 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=198.9
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+. +++.+|+|.+....... ..+.+|+.++++++||||+++++++......++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSP----EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCH----HHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 457999999999999999999876 45779999887544332 2345899999999999999999999998999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++.+.....++.... ..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~----------~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQL----------VDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHH----------HHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcccc
Confidence 99999999999997644345555443 34677888888999999999999999999999999999999999
Q ss_pred cccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 166 SRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 166 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
++....... ......++..|+|||.+.+..++.+ +|+||+|+++|+|++ |+.||.... .......... .+..+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~~~-~~~~~~ 225 (261)
T cd05034 150 ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQVER-GYRMPR 225 (261)
T ss_pred ceeccchhhhhhhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc-CCCCCC
Confidence 886543211 1112234568999999987777665 999999999999998 999996543 3333333332 223333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+...+..+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 4467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.65 Aligned_cols=250 Identities=18% Similarity=0.282 Sum_probs=184.1
Q ss_pred eecCcccceEEEEEEec--CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 13 SKLGEGAYGNVYLVSDK--RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
+.||+|+||.||+|... .++..+|+|.+....... ....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ--EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46999999999999754 456789999876543222 12345589999999999999999999999999999999999
Q ss_pred CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 91 KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 91 ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
+|+|.+++.......... .....++.++.|++.||+|||+++++|+||||+||+++.++.+||+|||.++...
T Consensus 79 ~g~L~~~l~~~~~~~~~~-------~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 79 LGDLKGYLRSCRKAELMT-------PDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred CCcHHHHHHHhhhccccc-------ccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999997532111000 0112234567889999999999999999999999999999999999999987543
Q ss_pred CCcc--cccccccccceeccccccCCC-------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 171 TPKE--LSNTFCGTTSYAAPEIIRNSP-------YNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 171 ~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
.... ......|++.|+|||++.+.. ++. ++|+||+|+++|+|++ |..||........... ........
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~-~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~ 229 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTK-ESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-TVREQQLK 229 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCc-cchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HhhcccCC
Confidence 3221 122345788999999986432 233 4999999999999996 9999976542211111 11111111
Q ss_pred ccc---cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 241 FNR---KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 241 ~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+. ....++.+.+++.+|+ .+|++|||+.+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 111 1246788999999999 68999999999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=293.85 Aligned_cols=249 Identities=22% Similarity=0.419 Sum_probs=195.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.++||+|+||.||++.+. .+..+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhH----HHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 356999999999999999999855 4566899987643322 2334589999999999999999999887 778999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++.+.....++... .+.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~----------~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPK----------LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHH----------HHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcc
Confidence 9999999999999764333344333 344677889999999999999999999999999999999999999
Q ss_pred cccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 166 SRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 166 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
+........ ......++..|+|||++....++.+ +|+|||||++|++++ |..||...+ .......... .+..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~-~~~~~~ 224 (260)
T cd05073 149 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALER-GYRMPR 224 (260)
T ss_pred eeeccCCCcccccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhC-CCCCCC
Confidence 976543221 1222345677999999987777665 999999999999998 999997644 2233333222 223333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
....+.++.+++.+||+.||++||++.+++.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 4568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.39 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=194.7
Q ss_pred cceeeeeecCcccceEEEEEEecCC---ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
.+|++.++||+|+||.||+|.+... ...+++|.+....... ..+.+.+|+.+++.++||||+++++++.+. ..|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS--VREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHH--HHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcE
Confidence 4588999999999999999987644 4568899876443221 233455899999999999999999998764 578
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+++++|.+++.+. ...++... ++.++.|++.||+|||++|++|+||||+||+++.++.++|+||
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~ 151 (270)
T cd05056 83 IVMELAPLGELRSYLQVN-KYSLDLAS----------LILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDF 151 (270)
T ss_pred EEEEcCCCCcHHHHHHhC-CCCCCHHH----------HHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccC
Confidence 999999999999999763 22344433 3346778899999999999999999999999999999999999
Q ss_pred cccccccCCccc-ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 164 GFSRLLRTPKEL-SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 164 g~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
|+++........ .....+++.|+|||.+....++.+ +||||||+++|+|++ |..||.... ..+......... ..
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~--~~~~~~~~~~~~-~~ 227 (270)
T cd05056 152 GLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVK--NNDVIGRIENGE-RL 227 (270)
T ss_pred ceeeecccccceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCC-cC
Confidence 999865443221 112234568999999887777665 999999999999986 999997654 223333332222 22
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
+.+..++..+.+++.+||..+|++|||+.+++..
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3344789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.50 Aligned_cols=240 Identities=20% Similarity=0.275 Sum_probs=181.6
Q ss_pred eecCcccceEEEEEEecC------------CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 13 SKLGEGAYGNVYLVSDKR------------SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~------------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
+.||+|+||.||+|.... ....+++|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR---DISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh---hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 234578888754332 22334558899999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC---
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN--- 157 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~--- 157 (351)
..++||||+++++|..++... ...+++... +.++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~----------~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~ 146 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWK----------FKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGE 146 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCC
Confidence 999999999999999888642 234554433 356788999999999999999999999999987654
Q ss_pred ----eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCchHHHH
Q psy6327 158 ----AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL-NKKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 158 ----~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~ 232 (351)
++++|||++...... ....|+..|+|||.+........++|||||||++|+|+ .|..||.........
T Consensus 147 ~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--- 219 (262)
T cd05077 147 CGPFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE--- 219 (262)
T ss_pred CCceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH---
Confidence 899999998764322 23457889999999874433334499999999999998 588888654322111
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....... ......+.++.+||.+||+.||++||++.+|+++
T Consensus 220 ~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 220 RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 1111111 1122346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=305.24 Aligned_cols=257 Identities=21% Similarity=0.345 Sum_probs=197.3
Q ss_pred ceeeeeecCcccceEEEEEEecCC-------ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeC
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRS-------ETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAG 79 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~ 79 (351)
+|++.+.||+|+||.||+|.+... ...+|+|.+..... .. ....+.+|+.+++++ +||||+++++++..+
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DK-DLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC-HH-HHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 588999999999999999986432 34689998764322 22 233455899999999 799999999999999
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCC---------CchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNEN---------IHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENI 150 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~---------~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NI 150 (351)
+..++++||+++|+|.+++.+..... .++.. ..+...+.++.|++.||.|||++|++||||||+||
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~-----l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ-----LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCcccc-----CCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 99999999999999999997632111 11111 12234556788999999999999999999999999
Q ss_pred eEcCCCCeEEeeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCc
Q psy6327 151 LISRLLNAKLADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRN 227 (351)
Q Consensus 151 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 227 (351)
|++.++.+||+|||+++........ .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||.... .
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~--~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIP--V 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCC--H
Confidence 9999999999999999865432211 122234568999999988887765 999999999999998 899996543 2
Q ss_pred hHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 228 RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
......... ....+.+..++.++.+++.+||+.+|++|||+.+++++
T Consensus 243 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 333333322 22223334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=308.53 Aligned_cols=253 Identities=30% Similarity=0.430 Sum_probs=189.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-EEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT-YLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-~~~lv 85 (351)
.+|...+.||+|+||.||+|...++ ..+|||.+....... ...+.+|+.++.+++|||+|+++|+|.+.+ ..+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 3566678999999999999987654 899999776544432 223669999999999999999999999988 59999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC---ceeccCCCCCEeEcCCCCeEEee
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG---IVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
+||++.|+|.+++.......++ |. ..++++.+++.||+|||+.. |+||||||+|||+|.+.+.||+|
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~------W~----~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLD------WE----TRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCC------HH----HHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999999999999753222332 22 23478889999999999854 99999999999999999999999
Q ss_pred ccccccccCCccccccc-ccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchH-HHH----hhhC
Q psy6327 163 FGFSRLLRTPKELSNTF-CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD-VLK----KQEG 236 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~----~~~~ 236 (351)
||+|+..........+. .||.+|+|||....+..+.+ +||||+|+++.||++|+.|.......... ... ....
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99997644311222222 79999999999988777766 99999999999999999888753211111 111 1111
Q ss_pred c---cccccc-c-ccCC--Hh---HHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 237 K---EYLFNR-K-YEIS--IG---AKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 237 ~---~~~~~~-~-~~~s--~~---~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
. ....+. . ...+ .. +..+..+|++.+|.+||++.|++.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1 111111 0 1222 22 456778999999999999999743
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=292.19 Aligned_cols=251 Identities=20% Similarity=0.382 Sum_probs=197.3
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+..+|++.+.||+|+||.||++.+. .+..+|+|.+....... ..+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 4568999999999999999999876 46689999886544432 234589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++++|.+++... ...+++... ..++.|++.||.|||+++++|+||||+||+++.++.++|+|||
T Consensus 77 v~e~~~~~~L~~~~~~~-~~~~~~~~~----------~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g 145 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQ-RGKFSQETL----------LGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFG 145 (256)
T ss_pred EEEcCCCCcHHHHHHhC-ccCCCHHHH----------HHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCc
Confidence 99999999999998653 234454443 3456778888999999999999999999999999999999999
Q ss_pred ccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
.++....... ......++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.... ............ ...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~-~~~ 221 (256)
T cd05112 146 MTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRS--NSEVVETINAGF-RLY 221 (256)
T ss_pred ceeecccCcccccCCCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHhCCC-CCC
Confidence 9876533221 1122335678999999987777765 999999999999998 999997543 233333332221 111
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 223468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=295.59 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=198.3
Q ss_pred ceeeeeecCcccceEEEEEEecC-CceeEEEEecchhhhh-------hHHHhhhHHHHHHHHHh-CCCCCceeeeeEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKR-SETLKACKAYDFKRLK-------RDYMEKFAPREIDILLK-VSHPNIIGVHRMVKA 78 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~-------~~~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~ 78 (351)
+|++.+.||+|+||.||++.+.. +++.+|+|.+...... .......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58899999999999999999987 7889999987643221 11112233478888875 689999999999999
Q ss_pred CCEEEEEEecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCC
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRL 155 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~ 155 (351)
++..+++|||++|++|.+++.... ...+++.. .+.++.|++.||.|||+ .+++|+||+|+||+++.+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~----------~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEER----------IWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED 150 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHH----------HHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC
Confidence 999999999999999999885421 23344432 34567789999999996 789999999999999999
Q ss_pred CCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh
Q psy6327 156 LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 235 (351)
+.++|+|||.+....... ......|+..|+|||.+.+..++.+ +|+||||+++|+|++|..||.... .........
T Consensus 151 ~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~ 226 (269)
T cd08528 151 DKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTN--MLSLATKIV 226 (269)
T ss_pred CcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccC--HHHHHHHHh
Confidence 999999999998755433 3345568999999999988777665 999999999999999999996543 222222332
Q ss_pred CccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...+.......++..+.++|.+||+.||++||++.|+..+
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 227 EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 2222222223578999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=296.30 Aligned_cols=253 Identities=19% Similarity=0.315 Sum_probs=197.0
Q ss_pred ccceeeeeecCcccceEEEEEEecC----CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-CC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKR----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA-GT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~ 80 (351)
-.+|++.+.||+|+||.||+|.+.. ++..+++|.+.... .......+.+|+.+++.++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4579999999999999999999876 36888999875322 22223445689999999999999999998765 56
Q ss_pred EEEEEEecCCCCChHHHHHhhcc------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACN------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR 154 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~ 154 (351)
..++++||+.+++|.+++..... ..+++.. .+.++.|++.||+|||+++++|+||||+||++++
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~----------~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~ 152 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ----------LVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE 152 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHH----------HHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC
Confidence 78999999999999999976422 2234333 3456788999999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q psy6327 155 LLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVL 231 (351)
Q Consensus 155 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 231 (351)
++.+||+|||+++.+..... ......++..|+|||.+.+..++.+ +|||||||++|++++ |+.||.... .....
T Consensus 153 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~--~~~~~ 229 (280)
T cd05043 153 ELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEID--PFEMA 229 (280)
T ss_pred CCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCC--HHHHH
Confidence 99999999999986543221 1122345678999999988777765 999999999999998 999997543 22222
Q ss_pred HhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 232 KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..... .+.......+++++.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 230 AYLKD-GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHHc-CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22222 2233334467899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=290.83 Aligned_cols=244 Identities=22% Similarity=0.362 Sum_probs=192.2
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKK 92 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg 92 (351)
++||+|+||.||+|.+.. ++.+++|.+...... .....+.+|+.++++++||||+++++++.+....++||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999887 999999988654443 22344568999999999999999999999999999999999999
Q ss_pred ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCC
Q psy6327 93 DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP 172 (351)
Q Consensus 93 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 172 (351)
+|.+++... ...++.... +.++.+++.||.|||+++++||||+|+||+++.++.++|+|||++......
T Consensus 78 ~l~~~l~~~-~~~~~~~~~----------~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 78 SLLTFLRKK-KNRLTVKKL----------LQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred cHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 999998653 223444332 346678888999999999999999999999999999999999999865422
Q ss_pred cccc--cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccCCH
Q psy6327 173 KELS--NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249 (351)
Q Consensus 173 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (351)
.... ....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||..... ......... ....+.+..++.
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~-~~~~~~~~~~~~ 222 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIES-GYRMPAPQLCPE 222 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhc-CCCCCCCccCCH
Confidence 1111 12234567999999987777765 999999999999998 8999965442 222222221 222333446789
Q ss_pred hHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 250 GAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 250 ~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+.+++.+||+.+|++|||+.++++
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=294.78 Aligned_cols=249 Identities=20% Similarity=0.336 Sum_probs=182.8
Q ss_pred eecCcccceEEEEEEecC--CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 13 SKLGEGAYGNVYLVSDKR--SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
+.||+|+||.||+|.... ....+++|.+..... ......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 369999999999996433 456788887653322 2223445589999999999999999999999999999999999
Q ss_pred CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 91 KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 91 ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
+|+|.+++.......... .....++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 79 ~g~L~~~l~~~~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQM-------AQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred CCcHHHHHHhcccccccc-------ccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccc
Confidence 999999997642211100 0112234578899999999999999999999999999999999999999987543
Q ss_pred CCcc--cccccccccceeccccccC-------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhh-hCccc
Q psy6327 171 TPKE--LSNTFCGTTSYAAPEIIRN-------SPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQ-EGKEY 239 (351)
Q Consensus 171 ~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~-~~~~~ 239 (351)
.... ......+++.|+|||++.. ..++ .++|||||||++|+|++ |..||.... ..+..... .....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~~~~ 228 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQT-KKSNIWSLGVTMWELFTAADQPYPDLS--DEQVLKQVVREQDI 228 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccc-hhhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHhhccCc
Confidence 2211 1233446778999998753 2233 45999999999999999 788986543 22222221 22111
Q ss_pred ccc---ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 240 LFN---RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 240 ~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..+ ....++..+.+++..|+ .||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 111 22357888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=296.38 Aligned_cols=240 Identities=20% Similarity=0.314 Sum_probs=181.9
Q ss_pred eecCcccceEEEEEEecCCcee-------EEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETL-------KACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~-------~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.||.|+||.||+|.+...+.. +++|.+..... .....+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR---NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH---HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4699999999999998665443 77777643321 1233445799999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC--------
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN-------- 157 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~-------- 157 (351)
|||+++|+|.+++.... ..+++.. .+.++.||+.||+|||++||+||||||+||+++.++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~----------~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~ 146 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISW----------KLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPF 146 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHH----------HHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCce
Confidence 99999999999997532 2334333 3457788999999999999999999999999987654
Q ss_pred eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHhhhC
Q psy6327 158 AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~ 236 (351)
++++|||.+..... .....+++.|+|||++.+......++|||||||++|+|++| ..||..... ........
T Consensus 147 ~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--~~~~~~~~- 219 (258)
T cd05078 147 IKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QKKLQFYE- 219 (258)
T ss_pred EEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--HHHHHHHH-
Confidence 69999999875432 22346788999999998754333349999999999999998 466654332 11111111
Q ss_pred ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
... ..+...+.++.+|+.+||+.||++|||++++++.
T Consensus 220 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 220 DRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ccc--cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 111 1222466889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=289.34 Aligned_cols=244 Identities=23% Similarity=0.390 Sum_probs=190.6
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKK 92 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg 92 (351)
+.||+|+||.||+|... ++..+|+|.+....... ....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQE--LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHH--HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999864 68889999876443222 2334558999999999999999999999999999999999999
Q ss_pred ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCC
Q psy6327 93 DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP 172 (351)
Q Consensus 93 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 172 (351)
+|.+++... ...+++... +.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 78 ~L~~~~~~~-~~~~~~~~~----------~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 78 DFLSFLRKK-KDELKTKQL----------VKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred cHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 999998653 233444333 345678888999999999999999999999999999999999998754332
Q ss_pred cccc-cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccCCHh
Q psy6327 173 KELS-NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250 (351)
Q Consensus 173 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 250 (351)
.... ....+++.|+|||++....++.+ +|+||+|+++|+|++ |..||.... ......... ..+....+..++..
T Consensus 147 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~ 222 (250)
T cd05085 147 IYSSSGLKQIPIKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMT--NQQAREQVE-KGYRMSCPQKCPDD 222 (250)
T ss_pred ccccCCCCCCcccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHH-cCCCCCCCCCCCHH
Confidence 2111 12234667999999987777665 999999999999998 999997543 222222222 22223334468899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 251 AKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 251 ~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+.+++.+||+.+|++||++.++++
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=295.28 Aligned_cols=238 Identities=23% Similarity=0.306 Sum_probs=180.1
Q ss_pred ecCcccceEEEEEEecCC------------------------ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc
Q psy6327 14 KLGEGAYGNVYLVSDKRS------------------------ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69 (351)
Q Consensus 14 ~LG~G~~g~V~~~~~~~~------------------------~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i 69 (351)
+||+|+||.||+|....+ ...+++|.+..... .....+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999875322 24578888754332 123334578999999999999
Q ss_pred eeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCC
Q psy6327 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCEN 149 (351)
Q Consensus 70 v~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~N 149 (351)
+++++++.++...++||||+++|+|..++... ...+++.. ++.++.|++.||+|||+++|+||||||+|
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~~l~~lH~~~iiH~dlkp~N 147 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAW----------KITVAQQLASALSYLEDKNLVHGNVCAKN 147 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHH----------HHHHHHHHHHHHHHHHcCCccCCCCCccc
Confidence 99999999999999999999999999998652 33455433 34578899999999999999999999999
Q ss_pred EeEcCCC-------CeEEeeccccccccCCcccccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHH-hCCCCC
Q psy6327 150 ILISRLL-------NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRIL-NKKYPF 220 (351)
Q Consensus 150 Ill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll-~g~~pf 220 (351)
||++..+ .+|++|||.+...... ....+++.|+|||.+.+.. ++. ++|||||||++|+|+ +|..||
T Consensus 148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~ 222 (274)
T cd05076 148 ILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLST-AADKWSFGTTLLEICFDGEVPL 222 (274)
T ss_pred EEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCc-HHHHHHHHHHHHHHHhCCCCCc
Confidence 9997643 3899999987653221 2235788899999887643 444 499999999999985 699999
Q ss_pred CCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 221 GDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.......... ... .....+ ...+..+.++|.+||+.+|++|||+.+++++
T Consensus 223 ~~~~~~~~~~--~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 223 KERTPSEKER--FYE-KKHRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred cccChHHHHH--HHH-hccCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 7654222111 111 111111 2356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.17 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=196.4
Q ss_pred cceeeeeecCcccceEEEEEEec----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--CC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA--GT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~ 80 (351)
.+|++++.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46888999999999999999864 45889999998655443 224456689999999999999999999877 66
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..++||||+++++|.+++.... ..++... .+.++.|++.||+|||++|++|+||||+||+++.++.++|
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~----------~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l 150 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKR----------LLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKI 150 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHH----------HHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEE
Confidence 8999999999999999997532 2244333 3456778899999999999999999999999999999999
Q ss_pred eeccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc----------
Q psy6327 161 ADFGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN---------- 227 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------- 227 (351)
+|||.+......... .....++..|+|||.+.+..++.. +|+||||+++|+|++|..||.......
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 151 SDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred cccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 999999876533221 112234567999999987777765 999999999999999999986543211
Q ss_pred --hHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 228 --RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 228 --~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..............+.+..++.++.+++.+||+.+|++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01111111112223334467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=299.55 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=195.6
Q ss_pred CccceeeeeecCcccceEEEEEEecCCce----eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSET----LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
...+|+..+.||+|+||.||+|.+..++. .+|+|.+....... ....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK--ANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH--HHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 34678999999999999999999887775 46888775433222 123355899999999999999999998754
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..++++||+++|+|.+++... ...+++.. ++.++.|++.||.|||+++|+|+||||+||++++++.+||
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~----------~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL 150 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEH-KDNIGSQL----------LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKI 150 (303)
T ss_pred CceeeehhcCCCCHHHHHHhc-ccCCCHHH----------HHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEE
Confidence 467999999999999998753 22344433 3456788999999999999999999999999999999999
Q ss_pred eeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 161 ADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+|||+++....... ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+... ........ .
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~-~ 226 (303)
T cd05110 151 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLE-K 226 (303)
T ss_pred ccccccccccCcccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH-C
Confidence 99999987543322 1223345778999999988777765 999999999999997 9999975432 22222222 2
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....+.+..++..+.+++.+||..||++||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 227 GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22233334578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=290.70 Aligned_cols=245 Identities=23% Similarity=0.410 Sum_probs=193.7
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++.+.||+|+||.||++.. +++.+|+|.+..... ...+.+|+.+++.++||||+++++++.... .++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEE
Confidence 356799999999999999999864 678899998854322 233458999999999999999999987654 799
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+.+++|.+++.......++... .+.++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~----------~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg 145 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQ----------LLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFG 145 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHH----------HHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCc
Confidence 99999999999999764333444433 33467788899999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
++...... ......+..|+|||.+.+..++.+ +|+|||||++|+|++ |..||..... ........ .......
T Consensus 146 ~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~-~~~~~~~ 218 (254)
T cd05083 146 LARVGSMG---VDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSL--KEVKECVE-KGYRMEP 218 (254)
T ss_pred cceecccc---CCCCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHh-CCCCCCC
Confidence 98764322 122234678999999987777765 999999999999997 9999976542 22222222 2233333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...++..+.+++.+||+.+|++||++.+++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=291.11 Aligned_cols=246 Identities=20% Similarity=0.316 Sum_probs=184.9
Q ss_pred eecCcccceEEEEEEecC---CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE-eCCEEEEEEec
Q psy6327 13 SKLGEGAYGNVYLVSDKR---SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK-AGTYLYMIMDY 88 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~ 88 (351)
+.||+|+||.||+|.+.. .+..+|+|.+..... .. ....+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LE-EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HH-HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 356799998743221 11 1234458999999999999999999765 45668999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+.+++|.+++.... ...... ..+.++.|++.||+|||+.+++||||||+|||+++++.+||+|||+++.
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~----------~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~ 147 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVK----------DLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARD 147 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHH----------HHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCcccccc
Confidence 99999999997531 222221 2345778999999999999999999999999999999999999999976
Q ss_pred ccCCcc----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 169 LRTPKE----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 169 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
...... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |.+||.... ..+......... ..+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~ 223 (262)
T cd05058 148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQGR-RLLQ 223 (262)
T ss_pred ccCCcceeecccccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCC-CCCC
Confidence 543211 1123345778999999988777765 999999999999999 566675433 222222222221 2222
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...++..+.+++.+||..+|++||++.+++..
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 33578899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=294.18 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=191.5
Q ss_pred eecCcccceEEEEEEecCCc------eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 13 SKLGEGAYGNVYLVSDKRSE------TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
+.||+|+||.||+|.++... ..+|+|.+....... . ...+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~-~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-E-KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchh-h-HHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876544 788999875432211 1 234558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC-----CeEEe
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL-----NAKLA 161 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~-----~~kl~ 161 (351)
||+++++|.+++........... ...+..++.++.|++.||.|||+.+++|+||+|+||+++.++ .++|+
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPP-----LLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCc-----cccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEEC
Confidence 99999999999975322211000 012334556788999999999999999999999999999877 89999
Q ss_pred eccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcc
Q psy6327 162 DFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 162 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|||++........ ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.... .......... .
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~-~ 229 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHVTA-G 229 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHHhc-C
Confidence 9999976543221 1123345788999999988887765 999999999999998 999997543 2333332221 1
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
........++..+.++|.+||+.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 222333467899999999999999999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=291.51 Aligned_cols=236 Identities=20% Similarity=0.304 Sum_probs=182.4
Q ss_pred eecCcccceEEEEEEecCCc----------eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 13 SKLGEGAYGNVYLVSDKRSE----------TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~----------~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999998776 35777776543321 3444589999999999999999999887 778
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC------
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL------ 156 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~------ 156 (351)
++||||+++|+|.+++.... ..++... ++.++.|++.||.|||++||+|+||||+|||++.++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~----------~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~ 144 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK-NNVSLHW----------KLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYV 144 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc-cCCCHHH----------HHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCc
Confidence 99999999999999997632 1444433 345678899999999999999999999999999877
Q ss_pred -CeEEeeccccccccCCcccccccccccceeccccccCC--CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q psy6327 157 -NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS--PYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 157 -~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 232 (351)
.+||+|||++..... .....++..|+|||++... .++. ++|+||||+++|+|++ |..||...... ....
T Consensus 145 ~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~-~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~ 217 (259)
T cd05037 145 PFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTI-AADKWSFGTTLLEICSNGEEPLSTLSSS--EKER 217 (259)
T ss_pred eeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcch-hhHHHHHHHHHHHHHhCCCCCcccCCch--hHHH
Confidence 799999999986543 2234567789999998776 4554 4999999999999999 68888665422 1111
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...... ..+ ......+.++|.+||..+|++|||+.++++
T Consensus 218 ~~~~~~-~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 218 FYQDQH-RLP--MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHhcCC-CCC--CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111 111 123478999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=320.68 Aligned_cols=269 Identities=22% Similarity=0.206 Sum_probs=177.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCC----ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeE-----
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRS----ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRM----- 75 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~----- 75 (351)
...+|.+.+.||+|+||.||+|.+..+ +..+|+|++......... . .| .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~----~-~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIW----M-NE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHH----H-HH--HHHhhchhhHHHHHHhhhccc
Confidence 456899999999999999999999988 999999986532211110 0 11 1112222222222221
Q ss_pred -EEeCCEEEEEEecCCCCChHHHHHhhccCCCchHH--------HHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCC
Q psy6327 76 -VKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQ--------ARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIK 146 (351)
Q Consensus 76 -~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~--------~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlk 146 (351)
...+...++|+||+.+++|.+++........-+.. .....+....+..++.|++.||+|||+++|+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 24566899999999999999998753110000000 000111112244578899999999999999999999
Q ss_pred CCCEeEcC-CCCeEEeeccccccccCCc-ccccccccccceeccccccCCCCC---------------------CCcchH
Q psy6327 147 CENILISR-LLNAKLADFGFSRLLRTPK-ELSNTFCGTTSYAAPEIIRNSPYN---------------------PKLADI 203 (351)
Q Consensus 147 p~NIll~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~Di 203 (351)
|+|||++. ++.+||+|||+|+.+.... ......+||+.|+|||.+...... ..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 5789999999998654322 233456799999999976432211 123699
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc-------------------ccccccCCHhHHHHHHHhcCCCCC
Q psy6327 204 WSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL-------------------FNRKYEISIGAKQLIGRMLEPNPK 264 (351)
Q Consensus 204 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~s~~~~~li~~~L~~dp~ 264 (351)
||+||++|+|+++..|+.... ...........+. +......+...++||.+||+.||.
T Consensus 363 wSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999999777654211 1111111100000 000001233466999999999999
Q ss_pred CCCCHHHHhcCccccCCcc
Q psy6327 265 HRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 265 ~Rpt~~ell~hp~~~~~~~ 283 (351)
+|||+.++|+||||++...
T Consensus 440 kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 440 QRISAKAALAHPYFDREGL 458 (566)
T ss_pred cCCCHHHHhCCcCcCCCCc
Confidence 9999999999999987654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.79 Aligned_cols=251 Identities=16% Similarity=0.215 Sum_probs=183.2
Q ss_pred cceeeeeecCcccceEEEEEEecCC---ceeEEEEecchhhhhh--HH------HhhhHHHHHHHHHhCCCCCceeeeeE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKR--DY------MEKFAPREIDILLKVSHPNIIGVHRM 75 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~--~~------~~~~~~~Ei~~l~~l~hp~iv~~~~~ 75 (351)
.+|.+.++||+|+||.||+|.+..+ +..+++|+........ .. .......+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 3699999999999999999998877 6677777643322110 00 00111133445566789999999998
Q ss_pred EEeCC----EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEe
Q psy6327 76 VKAGT----YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENIL 151 (351)
Q Consensus 76 ~~~~~----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIl 151 (351)
+.... ..++++|++. .++.+.+... ...++.. +..++.|++.||.|||+++|+||||||+|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~----------~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil 158 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKL----------IKNIMKDMLTTLEYIHEHGISHGDIKPENIM 158 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHH----------HHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 65443 4578889875 6777776542 2233332 2357789999999999999999999999999
Q ss_pred EcCCCCeEEeeccccccccCCc-------ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy6327 152 ISRLLNAKLADFGFSRLLRTPK-------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPG 224 (351)
Q Consensus 152 l~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (351)
++.++.++|+|||+|+.+.... .......||+.|+|||+..+..++.+ +||||+||++|+|++|..||....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999998653221 11223469999999999988888765 999999999999999999997664
Q ss_pred CCchH-------HHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 225 TRNRD-------VLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 225 ~~~~~-------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..... .......... ....++..+.+++..|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred cchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22211 1112221111 12356889999999999999999999999864
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=289.43 Aligned_cols=252 Identities=19% Similarity=0.332 Sum_probs=192.8
Q ss_pred eeeeeecCcccceEEEEEEec---CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-----
Q psy6327 9 CSYISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT----- 80 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----- 80 (351)
|++.+.||+|+||.||+|.+. .++..+|+|.+......... ...+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH-HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999865 35789999998655433333 334558999999999999999999885432
Q ss_pred -EEEEEEecCCCCChHHHHHhhccC----CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 81 -YLYMIMDYAEKKDLEHYISKACNE----NIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 81 -~~~lv~e~~~ggsL~~~l~~~~~~----~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
..+++++|+.+|+|.+++...... .++. ...+.++.|++.||+|||++||+|+||||+||+++.+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~----------~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~ 149 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL----------QTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN 149 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCH----------HHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC
Confidence 357899999999999887532111 1222 2345678899999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q psy6327 156 LNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 232 (351)
+.+||+|||+++....... ......+++.|++||.+....++.+ +|||||||++|+|++ |.+||.... ......
T Consensus 150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~--~~~~~~ 226 (273)
T cd05074 150 MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVE--NSEIYN 226 (273)
T ss_pred CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCC--HHHHHH
Confidence 9999999999986543221 1223345678999999987777765 999999999999999 899996543 233333
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....... .......+..+.+++.+||+.+|++|||+.++++.
T Consensus 227 ~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 227 YLIKGNR-LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3322221 22223678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.41 Aligned_cols=247 Identities=31% Similarity=0.482 Sum_probs=189.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC------
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT------ 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------ 80 (351)
+-|...+.||+||||.||++.++.+|+.+|||.+........ ....-+|+++|++|+|||||++.++=++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~--~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP--RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccch--HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 447778899999999999999999999999999876442221 222238999999999999999999865543
Q ss_pred EEEEEEecCCCCChHHHHHhhcc-CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC--CC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACN-ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL--LN 157 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~--~~ 157 (351)
...+|||||.||||...+.+..+ ..+++.... .++.+++.||+|||++||+||||||.||++-.+ |.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l----------~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq 160 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFL----------DLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQ 160 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHH----------HHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc
Confidence 57899999999999999977544 356776644 367788999999999999999999999998543 33
Q ss_pred --eEEeeccccccccCCcccccccccccceeccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--chHHHH
Q psy6327 158 --AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--NRDVLK 232 (351)
Q Consensus 158 --~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~ 232 (351)
.||+|||.|+.+.... ...+.+||+.|.+||++.. +.|+.. +|.||+||++|+++||..||...... +.++..
T Consensus 161 ~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~t-VDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 161 SIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTAT-VDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred eEEeeecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCce-eehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 6999999999876544 6678899999999999985 666655 99999999999999999999654332 111211
Q ss_pred hh---------------hCcc----ccccccccCCHh----HHHHHHHhcCCCCCCCC
Q psy6327 233 KQ---------------EGKE----YLFNRKYEISIG----AKQLIGRMLEPNPKHRP 267 (351)
Q Consensus 233 ~~---------------~~~~----~~~~~~~~~s~~----~~~li~~~L~~dp~~Rp 267 (351)
.. ..++ ..+|.+..++.. +-..+..+|..+|.+|.
T Consensus 239 ~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 239 HIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred hhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11 1111 122333334443 44678889999999998
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=285.81 Aligned_cols=246 Identities=20% Similarity=0.307 Sum_probs=180.5
Q ss_pred eecCcccceEEEEEEecCC--ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRS--ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
+.||+|+||.||++....+ ...+++|.+...... .....+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh--HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 345667765443221 223455689999999999999999999999999999999999
Q ss_pred CCChHHHHHhhccC--CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 91 KKDLEHYISKACNE--NIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 91 ggsL~~~l~~~~~~--~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+|+|.+++.+.... ..+. .....++.||+.||+|||+++++|+||||+|||++.++.++|+|||++..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~----------~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQL----------LLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred CCcHHHHHHhhhcccccccH----------HHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccc
Confidence 99999999763211 1121 22345678999999999999999999999999999999999999999864
Q ss_pred ccCCc--ccccccccccceeccccccCC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhh-Cc
Q psy6327 169 LRTPK--ELSNTFCGTTSYAAPEIIRNS-------PYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQE-GK 237 (351)
Q Consensus 169 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~-~~ 237 (351)
..... ......+|++.|+|||++... .++ .++|||||||++|+|++ |..||.... ..+...... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~~ 225 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQT-KPSNVWALGVTLWELFENAAQPYSHLS--DREVLNHVIKDQ 225 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhhc
Confidence 32211 122345688999999997532 223 34899999999999997 577886433 222222211 11
Q ss_pred cc---cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 238 EY---LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 238 ~~---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.. ........++.+.+++..|| .+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 226 QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 11 11222357888999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=313.75 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=214.5
Q ss_pred CccceeeeeecCcccceEEEEEEecCCc---eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSE---TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
|.....|.++||.|.||.|+++..+..| ..||||.++.. ..+.....|+.|+.||-+.+||||+++.|+.....-
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 3445678899999999999999987555 67899987543 333335556699999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
++||+|||++|+|..+|+... +.+.- .+.+.+++.|+.|++||-+.|+|||||-..|||++.+..+|++
T Consensus 705 vMIiTEyMENGsLDsFLR~~D-Gqftv----------iQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVs 773 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND-GQFTV----------IQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVS 773 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC-CceEe----------ehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEec
Confidence 999999999999999998754 33443 3345688999999999999999999999999999999999999
Q ss_pred eccccccccCCccccccccc---ccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 162 DFGFSRLLRTPKELSNTFCG---TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
|||+++.+.+......+..| ..+|.|||.+...++++. +||||+||+|||.++ |+.||++.+ ++++++.++ .
T Consensus 774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmS--NQdVIkaIe-~ 849 (996)
T KOG0196|consen 774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMS--NQDVIKAIE-Q 849 (996)
T ss_pred cccceeecccCCCccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccc--hHHHHHHHH-h
Confidence 99999987554433222222 458999999999999986 999999999999876 999998755 788887776 4
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.|.+|.+..+|..+.+|+..||++|-.+||.+.||+.
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 6788889999999999999999999999999999986
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=295.26 Aligned_cols=259 Identities=28% Similarity=0.477 Sum_probs=208.5
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhh----hhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-CCEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKR----LKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA-GTYLY 83 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~ 83 (351)
|-++.+||+|||+.||+|.+....++||||+-.... -+.....+..-+|..|.+.|+||.||++|++|.- .+.+|
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 778999999999999999999999999999865432 2222333444589999999999999999999964 45689
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC--CceeccCCCCCEeEcC---CCCe
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV--GIVHRDIKCENILISR---LLNA 158 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~--~i~H~Dlkp~NIll~~---~~~~ 158 (351)
-|+|||+|.+|.-+++. ...+++..++.+ +.||+.||.||.+. .|+|.||||.|||+.+ .|.+
T Consensus 545 TVLEYceGNDLDFYLKQ--hklmSEKEARSI----------iMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQ--HKLMSEKEARSI----------IMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeeeecCCCchhHHHHh--hhhhhHHHHHHH----------HHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence 99999999999999988 677788777764 55666666788875 5999999999999965 4779
Q ss_pred EEeeccccccccCCcc-------cccccccccceeccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch
Q psy6327 159 KLADFGFSRLLRTPKE-------LSNTFCGTTSYAAPEIIRNS---PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR 228 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 228 (351)
||+|||+++.+..... .++...||-||.+||.+.-+ +--..++||||.|||+|.++.|+.||+..- ...
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq-sQQ 691 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ-SQQ 691 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch-hHH
Confidence 9999999998865432 23456799999999987533 223445999999999999999999997543 233
Q ss_pred HHHHh---hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 229 DVLKK---QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 229 ~~~~~---~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
++++. +......||..+.++.++++||++||++-.++|....++-.||+|..
T Consensus 692 dILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 692 DILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred HHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 33332 23345567888899999999999999999999999999999999963
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=284.03 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=196.6
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHh-CCCCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK-VSHPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
++.||.|+||+|++..++.+|+..|||.+.......+ .+.++.|.....+ -+.||||++||..-.++..+|-||.|+
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke--q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE--QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH--HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 6789999999999999999999999999976665332 3444567776544 469999999999988888999999997
Q ss_pred CCChHHHHH---hhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 91 KKDLEHYIS---KACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 91 ggsL~~~l~---~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
.||..+.+ .-....++|..... +...+..||+||.. .+|+|||+||+|||++..|.+||||||.+
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~----------ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGH----------ITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhh----------eeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 88766543 22345555543332 23345678889976 57999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRN--SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
-.+..+... +...|...|||||.+.. ..|+-+ +|+||||++|||++||..|+...+....+..+...+.++.....
T Consensus 216 GqLv~SiAk-T~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 216 GQLVDSIAK-TVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred HhHHHHHHh-hhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 776554332 34469999999999853 346665 99999999999999999999765543333333333333333222
Q ss_pred ---ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 245 ---YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 245 ---~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
...+..+..||.-||.+|-+.||...+++.+||++..
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 3489999999999999999999999999999999754
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=267.63 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=198.5
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeC--C
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAG--T 80 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~--~ 80 (351)
-...+|++++++|+|.|+.||.|....+.+.++||+++.-. .+.+.+|+.+|..|. ||||++++++..+. .
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 35667999999999999999999999999999999875332 233459999999997 99999999998765 4
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-CCeE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-LNAK 159 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~-~~~k 159 (351)
...+|+||.+..+...+... +....++ .|+.+++.||.|+||+||+|||+||.|++|+.. ..++
T Consensus 109 tpaLiFE~v~n~Dfk~ly~t-----l~d~dIr----------yY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYPT-----LTDYDIR----------YYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred CchhHhhhhccccHHHHhhh-----hchhhHH----------HHHHHHHHHHhHHHhcCcccccCCcceeeechhhceee
Confidence 57899999998887766533 3333333 478888999999999999999999999999975 4599
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--- 236 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--- 236 (351)
|+|+|+|.++.+. ...+..+.+..|..||++..-+......|+|||||++..|+..+.||-... ++.+.+.++..
T Consensus 174 lIDWGLAEFYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 174 LIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLG 251 (338)
T ss_pred eeecchHhhcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhC
Confidence 9999999987654 455677789999999999876655555899999999999999999984322 22222221100
Q ss_pred ----------------------------cc---ccccc-cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 237 ----------------------------KE---YLFNR-KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 237 ----------------------------~~---~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.. +..+. ..-.++++.||+.++|..|-.+|+|+.|++.||||..
T Consensus 252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 00 00000 1124689999999999999999999999999999963
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.06 Aligned_cols=274 Identities=18% Similarity=0.207 Sum_probs=190.4
Q ss_pred ccceeeeeecCcccceEEEEEEec----------------CCceeEEEEecchhhhhh--H---------HHhhhHHHHH
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK----------------RSETLKACKAYDFKRLKR--D---------YMEKFAPREI 58 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~----------------~~~~~~aiK~~~~~~~~~--~---------~~~~~~~~Ei 58 (351)
..+|.+.++||+|+||+||+|.+. ..++.||+|.+....... . ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 457999999999999999999752 345679999986432110 0 0112233578
Q ss_pred HHHHhCCCCCc-----eeeeeEEEe--------CCEEEEEEecCCCCChHHHHHhhccCCCchHHH-------------H
Q psy6327 59 DILLKVSHPNI-----IGVHRMVKA--------GTYLYMIMDYAEKKDLEHYISKACNENIHENQA-------------R 112 (351)
Q Consensus 59 ~~l~~l~hp~i-----v~~~~~~~~--------~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~-------------~ 112 (351)
.++.+++|.++ +++++++.. .+..++||||+++++|.+++.... ..++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKL-GPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhcc-CCCcchHHHHHhcCCchhhhcc
Confidence 88888876554 566776642 356899999999999999996421 11111000 0
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCccc-ccccccccceeccccc
Q psy6327 113 IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL-SNTFCGTTSYAAPEII 191 (351)
Q Consensus 113 ~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~ 191 (351)
........+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++......... .....+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 001123345568899999999999999999999999999999999999999999765432221 1122358999999987
Q ss_pred cCCCC--------------------C-CCcchHHHHHHHHHHHHhCCC-CCCCCCCCchH---------HHHhhhCcccc
Q psy6327 192 RNSPY--------------------N-PKLADIWSLGVVLYRILNKKY-PFGDPGTRNRD---------VLKKQEGKEYL 240 (351)
Q Consensus 192 ~~~~~--------------------~-~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~---------~~~~~~~~~~~ 240 (351)
..... . ....|+||+||++|+|++|.. ||.+....+.+ ..+......+.
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 54321 1 113699999999999999875 77543211111 11122233444
Q ss_pred ccccccCCHhHHHHHHHhcCCCC---CCCCCHHHHhcCccccC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNP---KHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp---~~Rpt~~ell~hp~~~~ 280 (351)
++....+++.++||+.+||..+| .+|+|+.|+|+||||..
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 55455689999999999999866 68999999999999964
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.02 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=202.9
Q ss_pred CCCccceee-------eeecCcccceEEEEEEecC--Cc--eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCcee
Q psy6327 3 FPDILECSY-------ISKLGEGAYGNVYLVSDKR--SE--TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71 (351)
Q Consensus 3 ~~~~~~~~~-------~~~LG~G~~g~V~~~~~~~--~~--~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~ 71 (351)
.|...+|.+ .+.||.|-||.||.|.... .| -.||||..+.+...+. .+.+..|+.+|+.++|||||+
T Consensus 378 ~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 378 TPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred CCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhh
Confidence 355556655 5679999999999998642 23 4577887655443333 334458999999999999999
Q ss_pred eeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEe
Q psy6327 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENIL 151 (351)
Q Consensus 72 ~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIl 151 (351)
++|++.+. ..+||||.++-|.|..+++... ..+ .+...+.|+.||+.||.|||+.+.|||||-..|||
T Consensus 456 LIGv~~e~-P~WivmEL~~~GELr~yLq~nk-~sL----------~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiL 523 (974)
T KOG4257|consen 456 LIGVCVEQ-PMWIVMELAPLGELREYLQQNK-DSL----------PLRTLTLYCYQICTALAYLESKRFVHRDIAARNIL 523 (974)
T ss_pred eeeeeecc-ceeEEEecccchhHHHHHHhcc-ccc----------hHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhhee
Confidence 99999765 5899999999999999998732 222 23344568999999999999999999999999999
Q ss_pred EcCCCCeEEeeccccccccCCccccccccc--ccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCch
Q psy6327 152 ISRLLNAKLADFGFSRLLRTPKELSNTFCG--TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNR 228 (351)
Q Consensus 152 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 228 (351)
+.....+||+|||+++.+........+ .| ..-|||||-+....++.. +|||.||+++||+++ |..||.+.. +.
T Consensus 524 VsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvk--Ns 599 (974)
T KOG4257|consen 524 VSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVK--NS 599 (974)
T ss_pred ecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCcccccc--cc
Confidence 999999999999999987655433322 23 447999999999999886 999999999999987 999997654 56
Q ss_pred HHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 229 DVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+++-.++.+. ..|.+.+|++.+..|..+||.+||.+||++.+|..
T Consensus 600 DVI~~iEnGe-RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 600 DVIGHIENGE-RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ceEEEecCCC-CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 6666665443 45667799999999999999999999999988854
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=311.98 Aligned_cols=249 Identities=34% Similarity=0.476 Sum_probs=193.7
Q ss_pred eeecCcccceE-EEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEecC
Q psy6327 12 ISKLGEGAYGN-VYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIMDYA 89 (351)
Q Consensus 12 ~~~LG~G~~g~-V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~ 89 (351)
-+.+|.|+-|+ ||+|... |+.||||.+..... .+..+||+.|+.-+ |||||++++.-.++.+.||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFF------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhhHhH------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 45689999985 7999875 77999998754432 33459999999985 999999999999999999999999
Q ss_pred CCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---C--CCeEEeecc
Q psy6327 90 EKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---L--LNAKLADFG 164 (351)
Q Consensus 90 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~--~~~kl~Dfg 164 (351)
. .+|.+++... ....... +-...+..+.|+++||++||+.+|+||||||.||||+. + .+++|+|||
T Consensus 586 ~-~sL~dlie~~-~~d~~~~-------~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg 656 (903)
T KOG1027|consen 586 A-CSLQDLIESS-GLDVEMQ-------SDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG 656 (903)
T ss_pred h-hhHHHHHhcc-ccchhhc-------ccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence 7 9999999863 1111110 11334567889999999999999999999999999976 3 458999999
Q ss_pred ccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHhhhCcccc
Q psy6327 165 FSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 165 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
+++.+..... ...+..||-+|+|||++........ +|||||||++|+.++| .+||++.-..+..++.....-.-+
T Consensus 657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~a-vDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQA-VDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHL 735 (903)
T ss_pred cccccCCCcchhhcccCCCCcccccCHHHHhccccCcc-cchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeee
Confidence 9998865443 2446779999999999988776654 9999999999999985 999987654433333222111111
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.+ ....++.|||.+||.+||..||+|.++|.||+|.+.
T Consensus 736 ~~---~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 736 EP---LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred cc---CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 11 112289999999999999999999999999999854
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=292.83 Aligned_cols=248 Identities=22% Similarity=0.367 Sum_probs=208.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+.+...+||.|.||.||.+.+++-.-.+|||.++-+... ...+..|+.+|+.++|||+|+++|+|.-+--+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 466788999999999999999999999999987654433 2334589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
||..|+|.+|+++.....++. ...+.++.||..|++||..+++|||||-..|+|+..+..+|++|||+++
T Consensus 344 fM~yGNLLdYLRecnr~ev~a----------vvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPA----------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred cccCccHHHHHHHhchhhcch----------hHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999998754443332 1234578899999999999999999999999999999999999999999
Q ss_pred cccCCccccc-ccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 168 LLRTPKELSN-TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 168 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
.+........ +.-...-|.|||-+....++.+ +|||+||++|||+.| |-.||.+.+. ..........|.+..+.
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidl---SqVY~LLEkgyRM~~Pe 489 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDL---SQVYGLLEKGYRMDGPE 489 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHHhccccccCCC
Confidence 9765432221 1223557999999999999887 999999999999998 9999987652 23334445678888888
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHh
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQ 273 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell 273 (351)
.|++.+..|++.||+++|.+||++.|+-
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 9999999999999999999999999883
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.19 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=198.8
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG----- 79 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~----- 79 (351)
...+|.-++.+|.|+- .|..|.|...++.+|+|+...+... ....+...+|...+..++|+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 3456778889999999 8888999999999999998766333 33344455899999999999999999998543
Q ss_pred -CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 80 -TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 80 -~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
...|+|||+|. .+|...+. ..++...++ .++.|++.|++|||+.||+||||||+||++..++.+
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~----~elDH~tis----------~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVIL----MELDHETIS----------YILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHH----HhcchHHHH----------HHHHHHHHHHHHHHhcceeecccCcccceecchhhe
Confidence 46899999997 89988875 233333333 357789999999999999999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc-----------
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN----------- 227 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------- 227 (351)
||.|||+|+..... -..+.++.|..|+|||++.+-.+... +||||+||++.||++|+.-|.+.+.-+
T Consensus 158 Ki~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt 235 (369)
T KOG0665|consen 158 KILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT 235 (369)
T ss_pred eeccchhhcccCcc-cccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence 99999999875543 35567889999999999998887766 999999999999999999996543211
Q ss_pred --hHHHHhhhC---------------------cccccccc----ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 228 --RDVLKKQEG---------------------KEYLFNRK----YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 228 --~~~~~~~~~---------------------~~~~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
..+..+... ....++.. ..-+..++|++.+||..||++|.+++++|+|||++
T Consensus 236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111111000 00001100 01234689999999999999999999999999997
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=268.58 Aligned_cols=243 Identities=37% Similarity=0.605 Sum_probs=196.6
Q ss_pred cceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCChHHHH
Q psy6327 19 AYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYI 98 (351)
Q Consensus 19 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l 98 (351)
+||.||+|.+..+++.+++|++........ ...+.+|++.+++++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999999999999999876554332 345568999999999999999999999999999999999999999998
Q ss_pred HhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcccccc
Q psy6327 99 SKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT 178 (351)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 178 (351)
... ..++... ...++.+++.++.+||+.+++|+||+|.||++++++.++|+|||.+....... ....
T Consensus 79 ~~~--~~~~~~~----------~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 145 (244)
T smart00220 79 KKR--GRLSEDE----------ARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTT 145 (244)
T ss_pred Hhc--cCCCHHH----------HHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-cccc
Confidence 763 2234333 34567788889999999999999999999999999999999999998765432 3345
Q ss_pred cccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc-CCHhHHHHHHH
Q psy6327 179 FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE-ISIGAKQLIGR 257 (351)
Q Consensus 179 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~ 257 (351)
..++..|+|||.+....++.+ +|+||+|+++++|++|..||..... .................... ++.++.+++.+
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKA-VDVWSLGVILYELLTGKPPFPGDDQ-LLELFKKIGKPKPPFPPPEWKISPEAKDLIRK 223 (244)
T ss_pred ccCCcCCCCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhccCCCCccccccCCHHHHHHHHH
Confidence 568899999999987777764 9999999999999999999965321 22233333322222222212 88999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q psy6327 258 MLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 258 ~L~~dp~~Rpt~~ell~hp~~ 278 (351)
||..||++||++.++++||||
T Consensus 224 ~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 224 LLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HccCCchhccCHHHHhhCCCC
Confidence 999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=288.83 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=198.8
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC------CCCceeeeeEEEeCCE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS------HPNIIGVHRMVKAGTY 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~------hp~iv~~~~~~~~~~~ 81 (351)
.|.+....|+|-|++|..|.+...|..||||+|....... +.-+.|+++|++|+ --+.++++..|.-.++
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4899999999999999999999999999999997655433 33348999999996 3688999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccC-CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-CCeE
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNE-NIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-LNAK 159 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~-~~~k 159 (351)
+|||+|-+. .+|.+.++++... .+.- ..+-.|+.|++.||..|..+||+|.||||+|||++.. ..+|
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~i----------kaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHI----------KAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceee----------hHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence 999999996 9999999875322 2333 3334578888888999999999999999999999986 4589
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
|||||.|....... ...+.-+..|+|||++.+.+|+.. .|+||.||+||||.||+..|++.+. .+++.......-
T Consensus 578 LCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TN--N~MLrl~me~KG 652 (752)
T KOG0670|consen 578 LCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTN--NQMLRLFMELKG 652 (752)
T ss_pred eccCcccccccccc--ccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCc--HHHHHHHHHhcC
Confidence 99999998754322 233445778999999999999987 9999999999999999999977652 232221100000
Q ss_pred ccc----------------------------------------------------------ccccCCHhHHHHHHHhcCC
Q psy6327 240 LFN----------------------------------------------------------RKYEISIGAKQLIGRMLEP 261 (351)
Q Consensus 240 ~~~----------------------------------------------------------~~~~~s~~~~~li~~~L~~ 261 (351)
.+| ....+-.++++|+.+||..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 000 0001122688999999999
Q ss_pred CCCCCCCHHHHhcCccccC
Q psy6327 262 NPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 262 dp~~Rpt~~ell~hp~~~~ 280 (351)
||++|.|+.|+|.||||+.
T Consensus 733 dP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 733 DPEKRITVNQALKHPFITE 751 (752)
T ss_pred ChhhcCCHHHHhcCCcccC
Confidence 9999999999999999974
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=291.89 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=206.0
Q ss_pred eeeeeecCcccceEEEEEEecCC-c--eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRS-E--TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~-~--~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
.++.++||+|+||+|++|.+... | ..||||.+....... . -..+++|+.+|.+|+|||++++||+..+ .-+.+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~-mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-I-MDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-h-HHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 45678999999999999988643 3 467999987666543 2 3445599999999999999999999988 668899
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
||.+..|+|.+.+.+.....+. +.....|+.||+.|+.||.++++|||||-..|+|+-....+||+|||+
T Consensus 189 ~ELaplGSLldrLrka~~~~ll----------v~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILL----------VSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred hhhcccchHHHHHhhcccccee----------HHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccc
Confidence 9999999999999873333322 233456899999999999999999999999999999989999999999
Q ss_pred cccccCCccccc---ccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 166 SRLLRTPKELSN---TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 166 a~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
.+-+....+... ..--...|+|||.++...++.. +|+|++||++|||++ |+.||.+.. -.++++.+. ..-.+
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~--g~qIL~~iD-~~erL 334 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCR--GIQILKNID-AGERL 334 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCC--HHHHHHhcc-ccccC
Confidence 998765443321 1112347999999999999876 999999999999998 899997755 556666666 44556
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
+.+..+|+++.+++..||..+|.+|||+..|...-+.
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 6677899999999999999999999999998654443
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=275.77 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=194.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-----C---CCceeeeeEEE-
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-----H---PNIIGVHRMVK- 77 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h---p~iv~~~~~~~- 77 (351)
.+|-++++||.|-|++||+|.|..+.+.||+|+.+......+ ....||.+|+++. | .+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtE----aAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTE----AALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHH----HHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 469999999999999999999999999999999765444332 2338999999884 2 57999999985
Q ss_pred ---eCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEc
Q psy6327 78 ---AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILIS 153 (351)
Q Consensus 78 ---~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~ 153 (351)
.+.++|+|+|++ |.+|..+|+....+.++-..++. +++||+.||.|||. .||+|.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~----------I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKE----------ICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHH----------HHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 567999999999 79999999988888888766554 57788888889997 5999999999999994
Q ss_pred --------------------------------------------------------------------------------
Q psy6327 154 -------------------------------------------------------------------------------- 153 (351)
Q Consensus 154 -------------------------------------------------------------------------------- 153 (351)
T Consensus 223 ~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s 302 (590)
T KOG1290|consen 223 STEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQES 302 (590)
T ss_pred ccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccc
Confidence
Q ss_pred ----------------------------------C---------------------------------------------
Q psy6327 154 ----------------------------------R--------------------------------------------- 154 (351)
Q Consensus 154 ----------------------------------~--------------------------------------------- 154 (351)
.
T Consensus 303 ~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p 382 (590)
T KOG1290|consen 303 YNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNP 382 (590)
T ss_pred cccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCC
Confidence 0
Q ss_pred -------CCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-
Q psy6327 155 -------LLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR- 226 (351)
Q Consensus 155 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 226 (351)
+-.+||+|||.|+-... ....-+.|..|+|||++.+..|+.. +||||++|+++||+||...|....-.
T Consensus 383 ~~~~~~~di~vKIaDlGNACW~~k---hFT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePhsG~~ 458 (590)
T KOG1290|consen 383 DIPLPECDIRVKIADLGNACWVHK---HFTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPHSGEN 458 (590)
T ss_pred CCCCCccceeEEEeeccchhhhhh---hhchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCCCCCC
Confidence 00156666666654321 2223356889999999999999987 89999999999999999988533211
Q ss_pred ---chHHHHhh----hC--------ccc---cc---------------------cccccCC----HhHHHHHHHhcCCCC
Q psy6327 227 ---NRDVLKKQ----EG--------KEY---LF---------------------NRKYEIS----IGAKQLIGRMLEPNP 263 (351)
Q Consensus 227 ---~~~~~~~~----~~--------~~~---~~---------------------~~~~~~s----~~~~~li~~~L~~dp 263 (351)
+.+-+..+ .. +.+ .| ..+..+| .++.+||.-||+.+|
T Consensus 459 Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~P 538 (590)
T KOG1290|consen 459 YSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDP 538 (590)
T ss_pred CCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCc
Confidence 11111000 00 000 00 0011222 367899999999999
Q ss_pred CCCCCHHHHhcCccccCCcc
Q psy6327 264 KHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 264 ~~Rpt~~ell~hp~~~~~~~ 283 (351)
++||||.++|+|||++....
T Consensus 539 eKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 539 EKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred cccccHHHHhcCccccCCCC
Confidence 99999999999999986543
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=284.70 Aligned_cols=249 Identities=25% Similarity=0.418 Sum_probs=199.9
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
..+.++||+|-||.|.+|.-. .+..||+|.+....-.. ....+.+||++|.+|+||||+++.++|..++.+++|+||
T Consensus 540 L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred eehhhhhcCcccceeEEEEec-CceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 578999999999999999754 37899999986544333 245566999999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
++.|+|..++.++....+ +-...+.++.||+.|++||.+.+++||||.+.|+|++.++++||+|||.++.
T Consensus 617 mEnGDLnqFl~aheapt~----------~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTA----------ETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HhcCcHHHHHHhccCccc----------ccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence 999999999987422221 1123445889999999999999999999999999999999999999999997
Q ss_pred ccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCchHHHHhhh------Ccc
Q psy6327 169 LRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN--KKYPFGDPGTRNRDVLKKQE------GKE 238 (351)
Q Consensus 169 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~------~~~ 238 (351)
+...... ....+-...|||||.+..++++.. +|+|++|+++||+++ ...||++.+ +.+..+... ...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhcCCCCcc
Confidence 6544322 233445679999999999999886 999999999999865 789997655 333332211 112
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHh
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQ 273 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 273 (351)
...+.+.-++..+.+++.+||+.|.++||+++++-
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 22333446889999999999999999999999983
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=267.56 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=197.8
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-----EE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT-----YL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-----~~ 82 (351)
+.+--+.||.|+||+||.++|.++|+.+|.|++..-.. .-...+.+-+|+.+|...+|.|++..+++..-.. .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH-HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34456789999999999999999999999998854222 2222344449999999999999999998875443 47
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+++|.+. .+|..+|-+ ...++.+-++. +++||++||+|||+.+|.||||||.|+|++.+..+||||
T Consensus 133 YV~TELmQ-SDLHKIIVS--PQ~Ls~DHvKV----------FlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVS--PQALTPDHVKV----------FVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred HHHHHHHH-hhhhheecc--CCCCCcchhhh----------hHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecc
Confidence 88999986 889988876 46666655554 678899999999999999999999999999999999999
Q ss_pred ccccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHhh------
Q psy6327 163 FGFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLKKQ------ 234 (351)
Q Consensus 163 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~------ 234 (351)
||+++....... .....+-|-+|+|||++.+...++.++||||.|||+.||+..+..|...+.-.. +.+...
T Consensus 200 FGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~ 279 (449)
T KOG0664|consen 200 FGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ 279 (449)
T ss_pred cccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence 999998654332 234456688999999999888766679999999999999998888865442211 111110
Q ss_pred --------------hCc---cccccccccC------CHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 235 --------------EGK---EYLFNRKYEI------SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 235 --------------~~~---~~~~~~~~~~------s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
... .+.++.-..+ .-+..+++..+|..||++|.+..+++.|+++..
T Consensus 280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 101 1111111122 236788999999999999999999999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.04 Aligned_cols=240 Identities=21% Similarity=0.268 Sum_probs=181.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.++..+.||+|+||.||+|.+..++..||+|.+....... ..|+.++++++|||||++++++.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc-------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3566778999999999999999999999999875332111 257899999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhH---hCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLH---EVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|+++|+|.++++. ++.. ....++.|++.||+||| +.+|+||||||+||+++.++..++. ||
T Consensus 764 y~~~g~L~~~l~~-----l~~~----------~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 764 YIEGKNLSEVLRN-----LSWE----------RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred CCCCCcHHHHHhc-----CCHH----------HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 9999999999953 3322 23457889999999999 6799999999999999998887775 66
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh--h--Cc---
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ--E--GK--- 237 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--~--~~--- 237 (351)
....... .....||+.|+|||++.+..++.+ +||||+||++|||++|+.||.............. . ..
T Consensus 828 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 828 LPGLLCT----DTKCFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD 902 (968)
T ss_pred ccccccc----CCCccccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchh
Confidence 5543221 123368999999999988888776 9999999999999999999953221111111000 0 00
Q ss_pred ---ccccc----ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 238 ---EYLFN----RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 238 ---~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..... .......++.+++.+||+.||++|||+.|+++.
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00000 001122357789999999999999999999764
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=293.20 Aligned_cols=258 Identities=29% Similarity=0.423 Sum_probs=215.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|..+..+|+|+||.||+|+++++++..|+|+++...... ...+..|+-+++.++|||||.+++.|-....+++.|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 35899999999999999999999999999999987655443 333458999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|||.||+|.+...- .+.+++.++. ...++.+.||+|||++|-+|||||-.|||+++.|.+|++|||.+
T Consensus 92 EycgggslQdiy~~--Tgplselqia----------yvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV--TGPLSELQIA----------YVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred EecCCCcccceeee--cccchhHHHH----------HHHhhhhccchhhhcCCcccccccccceeecccCceeecccCch
Confidence 99999999997643 5666665443 25678899999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccc---cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchH-HHHhhhCcccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD-VLKKQEGKEYLFN 242 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~ 242 (351)
-.+...-.....+.|||.|||||+- +.+.|+.. +|+|++|+...|+.--++|.-+....... ...+....++...
T Consensus 160 aqitati~KrksfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhhhhhhhhcccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc
Confidence 8877766677788999999999985 45566765 99999999999999888887654422111 1122223334455
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.+..+++.+.+|++.+|.++|++|||++.+|+|||+..
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 56679999999999999999999999999999999864
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=264.44 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=195.1
Q ss_pred CCccc-eeeeeecCcccceEEEEEEecC---CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEe
Q psy6327 4 PDILE-CSYISKLGEGAYGNVYLVSDKR---SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKA 78 (351)
Q Consensus 4 ~~~~~-~~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~ 78 (351)
|.+.+ |..+++||+|+|++||++.+.. .+..||+|.+...... ..+.+|+++|..+. +.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 34444 8899999999999999999887 7899999988654432 23448999999995 9999999999999
Q ss_pred CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-CC
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-LN 157 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~-~~ 157 (351)
++...+|+||++..+-.++.... + +..+..|++.++.||.++|.+||+||||||.|+|.+.. +.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~l-----~----------~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRSL-----S----------LAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred CCeeEEEecccCccCHHHHHhcC-----C----------HHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCC
Confidence 99999999999999888887642 2 22344588999999999999999999999999999874 66
Q ss_pred eEEeeccccccccCCc--------------------------------------------ccccccccccceeccccccC
Q psy6327 158 AKLADFGFSRLLRTPK--------------------------------------------ELSNTFCGTTSYAAPEIIRN 193 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~ 193 (351)
-.|+|||+|....... .......|||+|+|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 8999999997211000 00012359999999999987
Q ss_pred CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHH------------------------------------HHhhh--
Q psy6327 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV------------------------------------LKKQE-- 235 (351)
Q Consensus 194 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------------------------------------~~~~~-- 235 (351)
.+--..++||||.|+|+..++++..||-....+.... .....
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 7766666999999999999999999993322111000 00000
Q ss_pred ------Cccc---cc-cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 236 ------GKEY---LF-NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 236 ------~~~~---~~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.... .. ......+..+.||+.+||..||.+|.|++++|.||||..
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0000 00 001123457899999999999999999999999999973
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=283.02 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=200.8
Q ss_pred eeeeecCcccceEEEEEEec----C---CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCE
Q psy6327 10 SYISKLGEGAYGNVYLVSDK----R---SETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~----~---~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~ 81 (351)
.+.+.||+|+||.|++|.-. . ....||||.+...... ...+.+..|+.+|+.+ +||||+.+++++..++.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 45668999999999998732 1 1567899987654444 2245556899999999 59999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhc-cCCCchHH---HHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC
Q psy6327 82 LYMIMDYAEKKDLEHYISKAC-NENIHENQ---ARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN 157 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~---~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~ 157 (351)
+++|+||+..|+|.++++... ...+.... ...-.......+.++.||+.|++||++.+++||||-..|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998754 00000000 00011334556788999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCcccc-ccccc--ccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHh
Q psy6327 158 AKLADFGFSRLLRTPKELS-NTFCG--TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 233 (351)
+||+|||+|+......... ....| ...|||||.+....++.+ +||||+||++||+++ |..||.+... ..+...
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~-~~~l~~- 533 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPP-TEELLE- 533 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCc-HHHHHH-
Confidence 9999999999654433322 22222 235999999999888876 899999999999998 9999976321 334444
Q ss_pred hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.....+....+..+++++.++++.||+.+|++||++.++.+
T Consensus 534 ~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 34445566666688999999999999999999999999854
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=263.87 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=179.5
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC----
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT---- 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~---- 80 (351)
++...++++.||+|.||.||+|... ++.||||+|+......-..+ ++|--+-.++|+||+++++.-+.+.
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~E----k~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNE----KNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhH----HHHHhccCccchhHHHhhchhccCCcccc
Confidence 4556778899999999999999765 69999999986654332222 3333344668999999999876555
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC---------CceeccCCCCCEe
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV---------GIVHRDIKCENIL 151 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~---------~i~H~Dlkp~NIl 151 (351)
.++||++|.+.|+|.++++. ..++. ....+++.-+++||+|||+- .|+|||||..|||
T Consensus 282 eywLVt~fh~kGsL~dyL~~---ntisw----------~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVL 348 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKA---NTISW----------NSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVL 348 (534)
T ss_pred ceeEEeeeccCCcHHHHHHh---ccccH----------HHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceE
Confidence 79999999999999999986 23333 34556778889999999954 5999999999999
Q ss_pred EcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCC-----CCCcchHHHHHHHHHHHHhCCCCCC-CC
Q psy6327 152 ISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPY-----NPKLADIWSLGVVLYRILNKKYPFG-DP 223 (351)
Q Consensus 152 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~-~~ 223 (351)
+..+++..|+|||+|..+..... .....+||.+|||||++.+... ..+++||||+|.++|||++...-+. +.
T Consensus 349 vK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~ 428 (534)
T KOG3653|consen 349 VKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP 428 (534)
T ss_pred EccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC
Confidence 99999999999999988764332 2335789999999999865332 2345899999999999998654442 11
Q ss_pred --------------CCCchH--HHHhhhCccccccccc---cCCHhHHHHHHHhcCCCCCCCCCHHH
Q psy6327 224 --------------GTRNRD--VLKKQEGKEYLFNRKY---EISIGAKQLIGRMLEPNPKHRPNAKD 271 (351)
Q Consensus 224 --------------~~~~~~--~~~~~~~~~~~~~~~~---~~s~~~~~li~~~L~~dp~~Rpt~~e 271 (351)
.....+ .........+.++..+ .-...+++.+..||..||+.|.|+.=
T Consensus 429 vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 429 VPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred CCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 000111 1111122222222221 12345788999999999999999753
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=270.62 Aligned_cols=204 Identities=32% Similarity=0.526 Sum_probs=176.4
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHh-----hhHHHHHHHHHhCC---CCCceeeeeEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYME-----KFAPREIDILLKVS---HPNIIGVHRMV 76 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~Ei~~l~~l~---hp~iv~~~~~~ 76 (351)
...+|+.++.||+|+||.|++|.+++....|++|.+.+.+.--+... -.+..||+||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 45679999999999999999999999999999999987776443321 12346999999997 99999999999
Q ss_pred EeCCEEEEEEecCC-CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 77 KAGTYLYMIMDYAE-KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 77 ~~~~~~~lv~e~~~-ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
++++++||+||... |.+|+++|.. ...+.|..++. +++|++.|+++||++||+|||||-+|+.++.+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~----------IFkQV~agi~hlh~~~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKL----------IFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN 706 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHH----------HHHHHHhccccccccCceecccccccEEEecC
Confidence 99999999999764 5699999987 56778877665 45667777889999999999999999999999
Q ss_pred CCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy6327 156 LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (351)
|-+||+|||.|...++ .....++||..|.|||++.+.+|-.+.-|||+||+++|.+...+.||.+
T Consensus 707 g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999999987544 3456788999999999999999988888999999999999999999853
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=277.35 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=199.9
Q ss_pred eeeeeecCcccceEEEEEEecCCc----eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSE----TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+-.++||+|+||+||++.+.-.| -+||+|++........ ...+.+|+.+|.+|.|||++++++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~--s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA--SIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh--hHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 344678999999999999875444 4678888754443332 344569999999999999999999997766 889
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|++|+++|+|.++++..+ .++-. ..-+.|..||++||.|||+++++||||-..|||+.....+||.|||
T Consensus 775 vtq~mP~G~LlDyvr~hr-~~igs----------q~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfg 843 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR-DNIGS----------QDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFG 843 (1177)
T ss_pred HHHhcccchHHHHHHHhh-ccccH----------HHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecc
Confidence 999999999999998742 33322 2345678899999999999999999999999999999999999999
Q ss_pred ccccccCCccccccccc--ccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 165 FSRLLRTPKELSNTFCG--TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
+++.............| .+-|||-|.+....++.. +||||+||++||++| |..|+.+.. ..++-...+. ...+
T Consensus 844 la~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~--~~eI~dlle~-geRL 919 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIP--AEEIPDLLEK-GERL 919 (1177)
T ss_pred hhhccCcccccccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCC--HHHhhHHHhc-cccC
Confidence 99988766554443333 568999999999998876 999999999999998 999997655 3333333333 3336
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+.++.++.++.-++.+||..|++.||+++++-.
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 667789999999999999999999999988764
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=232.51 Aligned_cols=209 Identities=27% Similarity=0.419 Sum_probs=165.2
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
+..||+|++|.|=+.++..+|...|+|.+....... . .+...+|+.+..+. .+|.+|.+||.+..+..++|.||.|+
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q-~-q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ-E-QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChH-H-HHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 567999999999999999999999999987654432 2 33444888887766 59999999999999999999999997
Q ss_pred CCChHHHHHhh--ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 91 KKDLEHYISKA--CNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 91 ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
.||..+-++. .+..++|..... ++..+..||.|||++ .++|||+||+||||+.+|++|+||||.+-
T Consensus 129 -tSldkfy~~v~~~g~~ipE~vlGk----------Ia~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 129 -TSLDKFYRKVLKKGGTIPEDVLGK----------IAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred -hhHHHHHHHHHhcCCcCchHHhhH----------hHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9998776432 256677766554 345567778899986 79999999999999999999999999998
Q ss_pred cccCCcccccccccccceecccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIR----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 235 (351)
.+..+-.. +-..|.-.|||||.+. ...|+-+ +||||||+++.||.+++.||..-........+...
T Consensus 198 ~L~dSiAk-t~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVDSIAK-TMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehhhhHH-HHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 76544322 1245888999999874 4456665 99999999999999999999876654444443333
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=253.54 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=179.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHH--hCCCCCceeeeeEEEeC----CE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILL--KVSHPNIIGVHRMVKAG----TY 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~--~l~hp~iv~~~~~~~~~----~~ 81 (351)
..++++.||+|.||.||+|.++ |..||||+|....- ....||.+|.. .|+|+||+.+++.-..+ ..
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3678999999999999999997 89999999864332 12226666665 45899999999876433 36
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC--------CceeccCCCCCEeEc
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV--------GIVHRDIKCENILIS 153 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~--------~i~H~Dlkp~NIll~ 153 (351)
++||++|.+.|||+|++.+ ..++-. ..++++..++.||.+||-. .|.|||||..|||+.
T Consensus 284 LwLvTdYHe~GSL~DyL~r---~tv~~~----------~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR---NTVTTE----------GMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred EEEeeecccCCcHHHHHhh---ccCCHH----------HHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 9999999999999999986 333332 3456778889999999943 499999999999999
Q ss_pred CCCCeEEeeccccccccCCc----ccccccccccceeccccccCCC----C-CCCcchHHHHHHHHHHHHhC--------
Q psy6327 154 RLLNAKLADFGFSRLLRTPK----ELSNTFCGTTSYAAPEIIRNSP----Y-NPKLADIWSLGVVLYRILNK-------- 216 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~-~~~~~DiwslG~il~~ll~g-------- 216 (351)
+++.+-|+|+|+|-...... ...+..+||-+|||||++.... + +.+.+||||||.++||++-.
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 99999999999997654432 2345789999999999985432 1 23458999999999999752
Q ss_pred --CCCCCCC---CCCchHHHHhhhCccc--cccccccCCH---hHHHHHHHhcCCCCCCCCCHHHH
Q psy6327 217 --KYPFGDP---GTRNRDVLKKQEGKEY--LFNRKYEISI---GAKQLIGRMLEPNPKHRPNAKDV 272 (351)
Q Consensus 217 --~~pf~~~---~~~~~~~~~~~~~~~~--~~~~~~~~s~---~~~~li~~~L~~dp~~Rpt~~el 272 (351)
..||.+. +....++.+..-.... ..+..+.-.+ .+-.+++.||..+|.-|.|+--+
T Consensus 431 ey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 431 EYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred hhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 5777543 2223344333333332 2333333333 34568899999999999987665
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=231.54 Aligned_cols=213 Identities=40% Similarity=0.682 Sum_probs=179.6
Q ss_pred cCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCCCCCh
Q psy6327 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDL 94 (351)
Q Consensus 15 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL 94 (351)
||+|++|.||++.+..+++.+++|++....... ....+.+|++.++.+.|++|+++++++......++++||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987665432 234456899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-CCCeEEeeccccccccCCc
Q psy6327 95 EHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-LLNAKLADFGFSRLLRTPK 173 (351)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~ 173 (351)
.+++.... ..++... ...++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 79 ~~~~~~~~-~~~~~~~----------~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 79 KDLLKENE-GKLSEDE----------ILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred HHHHHhcc-CCCCHHH----------HHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 99997631 2344433 3346778888888999999999999999999999 8999999999998765443
Q ss_pred ccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHH
Q psy6327 174 ELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252 (351)
Q Consensus 174 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (351)
.......+...|++||.+... ..+. .+|+|++|+++++| ..+.
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~~~~~~-~~D~~~lg~~~~~l-----------------------------------~~~~ 191 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGKGYYSE-KSDIWSLGVILYEL-----------------------------------PELK 191 (215)
T ss_pred chhhcccCCCCccChhHhcccCCCCc-hhhhHHHHHHHHHH-----------------------------------HHHH
Confidence 223445678899999998776 4444 49999999999999 6889
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCc
Q psy6327 253 QLIGRMLEPNPKHRPNAKDVQNHA 276 (351)
Q Consensus 253 ~li~~~L~~dp~~Rpt~~ell~hp 276 (351)
+++.+|++.||++||++.++++|+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhCC
Confidence 999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=225.31 Aligned_cols=200 Identities=42% Similarity=0.645 Sum_probs=166.6
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|++.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 57789999999999999999988999999998765543 1234556899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+++++|.+++..... .+++.. ...++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+..
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~----------~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 79 CEGGDLFDYLRKKGG-KLSEEE----------ARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred cCCCCHHHHHHhccc-CCCHHH----------HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 999999999976321 144433 334677888899999999999999999999999999999999999987
Q ss_pred ccCCc-ccccccccccceeccccc-cCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy6327 169 LRTPK-ELSNTFCGTTSYAAPEII-RNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222 (351)
Q Consensus 169 ~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (351)
..... .......++..|++||.+ ....++. ++|+|+||+++++|++|+.||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 65442 123445688899999998 5555555 49999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=276.92 Aligned_cols=201 Identities=15% Similarity=0.229 Sum_probs=142.3
Q ss_pred hCCC-CCceeeeeEE-------EeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy6327 63 KVSH-PNIIGVHRMV-------KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134 (351)
Q Consensus 63 ~l~h-p~iv~~~~~~-------~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~ 134 (351)
.+.| +||+++++++ .....++.++||+ +++|.+++... ...+++.. ++.++.||+.||.|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~al~~ 95 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFE----------CFHVFRQIVEIVNA 95 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHH----------HHHHHHHHHHHHHH
Confidence 3445 5788888877 2334678889988 58999999642 23345443 44578889999999
Q ss_pred hHhCCceeccCCCCCEeEcCC-------------------CCeEEeeccccccccCCc----------------cccccc
Q psy6327 135 LHEVGIVHRDIKCENILISRL-------------------LNAKLADFGFSRLLRTPK----------------ELSNTF 179 (351)
Q Consensus 135 lH~~~i~H~Dlkp~NIll~~~-------------------~~~kl~Dfg~a~~~~~~~----------------~~~~~~ 179 (351)
||++||+||||||+||||+.. +.+|++|||+++...... ......
T Consensus 96 lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 96 AHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred HHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 999999999999999999653 445666666665321100 001124
Q ss_pred ccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhc
Q psy6327 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRML 259 (351)
Q Consensus 180 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 259 (351)
+||++|||||++.+..++.+ +|||||||++|||++|.+|+.... ......... ...+..........+++.+||
T Consensus 176 ~gt~~Y~APE~~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~L 249 (793)
T PLN00181 176 MEMSWYTSPEEDNGSSSNCA-SDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR-VLPPQILLNWPKEASFCLWLL 249 (793)
T ss_pred CCCcceEChhhhccCCCCch-hhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh-hcChhhhhcCHHHHHHHHHhC
Confidence 68999999999998888765 999999999999999998875322 111111111 111111123456778999999
Q ss_pred CCCCCCCCCHHHHhcCccccCC
Q psy6327 260 EPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 260 ~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
++||.+||++.|+++||||...
T Consensus 250 ~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 250 HPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred CCChhhCcChHHHhhchhhhhh
Confidence 9999999999999999999753
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-33 Score=267.68 Aligned_cols=264 Identities=24% Similarity=0.410 Sum_probs=203.9
Q ss_pred eeeeecCcccceEEEEEEecCCceeEEEEecchh---hhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFK---RLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
...+.+|.|++|.|+.+........++.|.+..+ ..........+..|..+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999999998888877777777766532 1111111222446777788899999988877776666556669
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|||++ +|+.++... ..+... .+-.++.|++.|++|+|+.||.|||||++|+++..+|.+||+|||.+
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~----------e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPL----------EADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAA 467 (601)
T ss_pred hcccH-HHHHHHhcc--cccchh----------hhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcc
Confidence 99998 999999762 233332 34457889999999999999999999999999999999999999999
Q ss_pred ccccCCcc----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc---
Q psy6327 167 RLLRTPKE----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY--- 239 (351)
Q Consensus 167 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--- 239 (351)
..+..+.. ...+.+|+..|+|||++.+..|++...||||.|+++..|++|+.||..+...+............
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 88765543 35678899999999999999999999999999999999999999997665443321111111111
Q ss_pred --cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccccc
Q psy6327 240 --LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQT 286 (351)
Q Consensus 240 --~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 286 (351)
.......++...+.+|.+||++||.+|.|+.+|++.+||+....|..
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v 596 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV 596 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence 11112257889999999999999999999999999999998877654
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=224.46 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=185.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeE-EEeCCEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRM-VKAGTYLYM 84 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~-~~~~~~~~l 84 (351)
..|+|.+.||+|.||.+-+|.|+.+...+++|.++...... ..+.+|...--.|. |.||+.-|++ |++.+.+.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~----~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQ----ADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhH----HHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 35899999999999999999999999999999987654433 23337776655664 8999988875 788889999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC--CCCeEEee
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR--LLNAKLAD 162 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~--~~~~kl~D 162 (351)
++||++.|+|..-+.. ..+.|...+. ++.|+++||.|||++++||||||.+||||-+ ..++||||
T Consensus 100 ~qE~aP~gdL~snv~~---~GigE~~~K~----------v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcD 166 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA---AGIGEANTKK----------VFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCD 166 (378)
T ss_pred eeccCccchhhhhcCc---ccccHHHHHH----------HHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeee
Confidence 9999999999988864 5566665554 4667778888999999999999999999943 45799999
Q ss_pred ccccccccCCcccccccccccceeccccccCC---CC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCch---HHHHhhh
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS---PY-NPKLADIWSLGVVLYRILNKKYPFGDPGTRNR---DVLKKQE 235 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~ 235 (351)
||..+........ .--+..|.+||++... .+ ..+.+|+|.|||++|.+++|++||......+. +..+...
T Consensus 167 FG~t~k~g~tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~ 243 (378)
T KOG1345|consen 167 FGLTRKVGTTVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK 243 (378)
T ss_pred cccccccCceehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc
Confidence 9998764432211 1135678999986432 22 12238999999999999999999975443333 2222222
Q ss_pred Ccccccccc-ccCCHhHHHHHHHhcCCCCCCCCC---HHHHhcCccc
Q psy6327 236 GKEYLFNRK-YEISIGAKQLIGRMLEPNPKHRPN---AKDVQNHAWI 278 (351)
Q Consensus 236 ~~~~~~~~~-~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~ 278 (351)
......|.. ...|+.+..+.++-|.++|++|-- +..-....|.
T Consensus 244 rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 244 RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 222222222 247899999999999999999944 4444445555
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=224.84 Aligned_cols=257 Identities=19% Similarity=0.295 Sum_probs=196.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCce-----eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEE-EeCCE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSET-----LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMV-KAGTY 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~-~~~~~ 81 (351)
+++..-.+-+|.||.||.|.+++... .+.+|.++. -........+..|.-++..+.|||+..+.++. ++...
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh--cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 46777789999999999997664332 233343321 11222234455788888889999999999987 45567
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.+.++.++.-|+|..++...+.. +....+-+.+ .+.+.++.|++.|++|||++||+|.||-..|.+|++..++||+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~---~~~~aqtvtt-~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGD---DPSYAQTVTT-IQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccC---CCccccchhH-HHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 89999999999999999743221 1111111222 2345578899999999999999999999999999999999999
Q ss_pred eccccccccCCcccc--cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcc
Q psy6327 162 DFGFSRLLRTPKELS--NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|=.+++.+-+..... ...-....||+||.+.+..|+.. +|+||||+++|||+| |+.|+...+ ...........
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeID---PfEm~~ylkdG 514 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEID---PFEMEHYLKDG 514 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccC---HHHHHHHHhcc
Confidence 999998765433221 12223558999999999999886 999999999999998 999997654 33444555567
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
|....+.++|+++..++.-||..+|++||+++|+..
T Consensus 515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 788888899999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=209.11 Aligned_cols=163 Identities=21% Similarity=0.236 Sum_probs=123.6
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|.+++... ...+++..+. .++.|++.||.|||+++ ||+|||++.++.+|+ ||.+.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~----------~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIW----------AVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHH----------HHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc
Confidence 7899999753 3457776644 46778888888999999 999999999999999 999987543
Q ss_pred CcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc----cccccC
Q psy6327 172 PKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF----NRKYEI 247 (351)
Q Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 247 (351)
.. ..||+.|+|||++.+..++.+ +||||+||++|+|++|+.||..................... +....+
T Consensus 62 ~~-----~~g~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 62 EQ-----SRVDPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred cc-----CCCcccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHH
Confidence 22 268999999999998888765 99999999999999999999754322221111111111110 111233
Q ss_pred CH--hHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 248 SI--GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 248 s~--~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
+. .+.++|.+||..||.+||++.++++|+|+.
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 44 699999999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=209.07 Aligned_cols=259 Identities=35% Similarity=0.536 Sum_probs=198.2
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCC-CceeeeeEEEeCCEEEEEEe
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP-NIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp-~iv~~~~~~~~~~~~~lv~e 87 (351)
|.+.+.||.|+||.||.+.+. ..+++|.+.............+.+|+.++..+.|+ +++++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778999999999999999987 77889988766655543455566899999999988 79999999988888999999
Q ss_pred cCCCCChHHHHHhhcc-CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC-CeEEeeccc
Q psy6327 88 YAEKKDLEHYISKACN-ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL-NAKLADFGF 165 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~-~~kl~Dfg~ 165 (351)
|+.++++.+++..... ..+.+.... .++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~ 148 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEAL----------FILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGL 148 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHH----------HHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCc
Confidence 9999999977765211 144444433 4667777778899999999999999999999988 699999999
Q ss_pred cccccCCcc------cccccccccceeccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHhhh
Q psy6327 166 SRLLRTPKE------LSNTFCGTTSYAAPEIIRNS--PYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--NRDVLKKQE 235 (351)
Q Consensus 166 a~~~~~~~~------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~ 235 (351)
++....... .....+||+.|+|||.+.+. .......|+||+|++++++++|..||...... .........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence 986554432 34677899999999999873 33334499999999999999999998655421 122222222
Q ss_pred Ccccc-ccccccC------CHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 236 GKEYL-FNRKYEI------SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 236 ~~~~~-~~~~~~~------s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
..... ....... ...+.+++.+++..+|..|.+..+...++|...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred hcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 22211 1111111 257899999999999999999999888876654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=217.85 Aligned_cols=166 Identities=18% Similarity=0.177 Sum_probs=127.8
Q ss_pred ccceeeeeecCcccceEEEEEEecC-CceeEEEEecchhhh--hhHHHhhhHHHHHHHHHhCCCCCcee-eeeEEEeCCE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKR-SETLKACKAYDFKRL--KRDYMEKFAPREIDILLKVSHPNIIG-VHRMVKAGTY 81 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~hp~iv~-~~~~~~~~~~ 81 (351)
...|++.+.||+|+||+||+|.+.. +++.+|+|++..... ........+.+|+.+|++++|+|++. +++. +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 3459999999999999999999876 788889998653211 12233455779999999999999985 5442 45
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccC-CCCCEeEcCCCCeEE
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDI-KCENILISRLLNAKL 160 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dl-kp~NIll~~~~~~kl 160 (351)
.|+||||++|++|... .. . .. ..++.+++.||.|||++||+|||| ||+|||++.++.+||
T Consensus 93 ~~LVmE~~~G~~L~~~-~~--~---~~-------------~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP--H---GD-------------PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc--c---ch-------------HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEE
Confidence 7999999999999632 11 0 10 135678889999999999999999 999999998899999
Q ss_pred eeccccccccCCcccc--------cccccccceeccccccCC
Q psy6327 161 ADFGFSRLLRTPKELS--------NTFCGTTSYAAPEIIRNS 194 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~ 194 (351)
+|||+|+.+....... ....+++.|+|||.+...
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999765443211 245688899999998543
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-26 Score=208.48 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=187.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCc-eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC----CCCceeeeeEE-EeCCE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSE-TLKACKAYDFKRLKRDYMEKFAPREIDILLKVS----HPNIIGVHRMV-KAGTY 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----hp~iv~~~~~~-~~~~~ 81 (351)
.|++.++||+|+||.||.|.+..++ ..+|+|.......... ..+..|+.++..+. .+++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7999999999999999999988775 6788887654322221 13447889988886 26999999999 58889
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-----C
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-----L 156 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~-----~ 156 (351)
-|+||+.+ |.+|.++.+....+.++.. .++.++.|++.+|++||+.|++||||||+|+++... .
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~----------T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~ 164 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRK----------TVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVR 164 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHh----------HHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccc
Confidence 99999988 7999998876554555544 355678889999999999999999999999999865 3
Q ss_pred CeEEeecccccccc--CCc--------ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q psy6327 157 NAKLADFGFSRLLR--TPK--------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR 226 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~--~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (351)
.+.|.|||+++... ... .......||..|.++....+...+.. -|+||++.++.+++.|..||......
T Consensus 165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCcccccc
Confidence 58999999998322 111 11234559999999999988887766 89999999999999999999765532
Q ss_pred chHHHHhhhCcccccc-ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 227 NRDVLKKQEGKEYLFN-RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 227 ~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
................ .....+..+.++...+-..+...+|....+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 244 DLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred chHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 2211111111111111 22245567777777777789999998877754
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-28 Score=224.82 Aligned_cols=242 Identities=34% Similarity=0.508 Sum_probs=193.9
Q ss_pred ecCcccceEEEEEE---ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEecC
Q psy6327 14 KLGEGAYGNVYLVS---DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIMDYA 89 (351)
Q Consensus 14 ~LG~G~~g~V~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~ 89 (351)
.+|.|+||.|+++. -.+.|..+|.|+............ ....|..++..++ ||.+++++..++.++..++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 47999999999754 346688899998877665433322 2336888888887 999999999999999999999999
Q ss_pred CCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccc
Q psy6327 90 EKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL 169 (351)
Q Consensus 90 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 169 (351)
.||.|...+.. ...+.+...+. +...++-+++++|+.+++|||+|++||+++.+|++++.|||.++..
T Consensus 80 rgg~lft~l~~--~~~f~~~~~~~----------~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 80 RGGDLFTRLSK--EVMFDELDVAF----------YLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEA 147 (612)
T ss_pred ccchhhhcccc--CCchHHHHHHH----------HHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHh
Confidence 99999998876 44444444333 5566777888999999999999999999999999999999999865
Q ss_pred cCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCH
Q psy6327 170 RTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249 (351)
Q Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (351)
-..... |||..|||||++. .... ++|.||+|+++++|++|..||.. +....+......+| ..++.
T Consensus 148 v~~~~~----cgt~eymApEI~~--gh~~-a~D~ws~gvl~felltg~~pf~~------~~~~~Il~~~~~~p--~~l~~ 212 (612)
T KOG0603|consen 148 VKEKIA----CGTYEYRAPEIIN--GHLS-AADWWSFGVLAFELLTGTLPFGG------DTMKRILKAELEMP--RELSA 212 (612)
T ss_pred Hhhhhc----ccchhhhhhHhhh--ccCC-cccchhhhhhHHHHhhCCCCCch------HHHHHHhhhccCCc--hhhhH
Confidence 433222 8999999999998 3333 38999999999999999999975 44444444344333 37899
Q ss_pred hHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcc
Q psy6327 250 GAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEPT 283 (351)
Q Consensus 250 ~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 283 (351)
.+++++..++..+|..|.. +.++++|+||+...+
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 9999999999999999975 478999999986544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=188.58 Aligned_cols=172 Identities=19% Similarity=0.174 Sum_probs=130.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhh------HHHHHHHHHhCCCCCceeeeeEEEeC-
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF------APREIDILLKVSHPNIIGVHRMVKAG- 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~------~~~Ei~~l~~l~hp~iv~~~~~~~~~- 79 (351)
.+|+.++.||.|+||.||++.+ ++..+|+|.+..+.......... +++|+..+.++.||+|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4699999999999999999655 46689999997655444333222 56899999999999999998886533
Q ss_pred -------CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE
Q psy6327 80 -------TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI 152 (351)
Q Consensus 80 -------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll 152 (351)
+..++||||++|.+|.++.. +++ ..+.+++.+|..+|+.|++|||++|+||++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~--------------~~~~~i~~~l~~lH~~gi~H~Dikp~Nili 168 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE------ISE--------------DVKAKIKASIESLHQHGMVSGDPHKGNFIV 168 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh------ccH--------------HHHHHHHHHHHHHHHcCCccCCCChHHEEE
Confidence 35899999999999987632 111 124478888999999999999999999999
Q ss_pred cCCCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHH
Q psy6327 153 SRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214 (351)
Q Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 214 (351)
+.++ ++|+|||..+......... .++....++.. +|+||||+++..+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~d------------~~vler~y~~~-~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAKD------------RIDLERHYGIK-NEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhhHH------------HHHHHhHhccc-ccccceeEeehHHH
Confidence 9988 9999999887543222111 13334456644 89999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=190.18 Aligned_cols=240 Identities=22% Similarity=0.307 Sum_probs=147.4
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC----------CCCceeeeeEE--
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS----------HPNIIGVHRMV-- 76 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----------hp~iv~~~~~~-- 76 (351)
+...+.||.|+++.||.++|..+++.+|+|++...........+.+++|......+. |-.++-.++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 456778999999999999999999999999997666333322333434443333322 11222222221
Q ss_pred -------EeC---C-----EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCce
Q psy6327 77 -------KAG---T-----YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIV 141 (351)
Q Consensus 77 -------~~~---~-----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~ 141 (351)
+.. + +.+++|+-+. ++|.+++..-...... .... ....-+.+..|+...+++||+.|++
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~-~~~l----~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT-HSPL----AFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT-SHHH----HHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc-cchh----HHHHHHHHHHHHHHHHHHHhhcceE
Confidence 111 1 2477888885 9998886431111111 0111 1122234557888999999999999
Q ss_pred eccCCCCCEeEcCCCCeEEeeccccccccCCcccccccccccceeccccccCC--------CCCCCcchHHHHHHHHHHH
Q psy6327 142 HRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS--------PYNPKLADIWSLGVVLYRI 213 (351)
Q Consensus 142 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l 213 (351)
|+||+|+|+|++.+|.+.|+||+.....+..... ...+..|.+||..... .++. +.|.|+||+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~-~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTF-ATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-H-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeee-ccCHHHHHHHHHHH
Confidence 9999999999999999999999988764432221 2345779999976432 2333 47999999999999
Q ss_pred HhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCC
Q psy6327 214 LNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHR 266 (351)
Q Consensus 214 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 266 (351)
.||..||........ ..+.+....++|+.+++||..+|++||.+|
T Consensus 244 WC~~lPf~~~~~~~~--------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEAD--------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGST--------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccc--------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999975432111 111333333899999999999999999988
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=177.00 Aligned_cols=247 Identities=19% Similarity=0.225 Sum_probs=185.6
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~l 84 (351)
...|.++++||.|+||.+|.|....+|..||||.-....... .+..|..+.+.|+ ..+|..+..+..+..+-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-----chhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 456999999999999999999999999999999754333222 2237999999997 4788899999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC---CCeEEe
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL---LNAKLA 161 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~---~~~kl~ 161 (351)
||+.+ |.||.++..- +...++ +...+-++-|++.-++|+|.++++||||||+|+|..-+ ..+-++
T Consensus 89 VMdLL-GPsLEdLfnf-C~R~ft----------mkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNF-CSRRFT----------MKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred eeecc-CccHHHHHHH-Hhhhhh----------HHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEE
Confidence 99988 7999998753 344433 33455677899999999999999999999999999654 458899
Q ss_pred eccccccccCCc-------ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchH-HHHh
Q psy6327 162 DFGFSRLLRTPK-------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD-VLKK 233 (351)
Q Consensus 162 Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~ 233 (351)
|||+|+.+.+.. .......||..|.+--...+...+. +-|+-|+|.++.++.-|..||.+....... ...+
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSR-RDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSR-RDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhh-hhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence 999998765432 2334567999999877666555554 489999999999999999999876543322 2222
Q ss_pred hhCcccccc---ccccCCHhHHHHHHHhcCCCCCCCCCHH
Q psy6327 234 QEGKEYLFN---RKYEISIGAKQLIGRMLEPNPKHRPNAK 270 (351)
Q Consensus 234 ~~~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 270 (351)
+.+.....+ .....|.++.-.+.-|=..--++-|...
T Consensus 236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 222221111 1235678888888888777777777743
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=181.66 Aligned_cols=244 Identities=20% Similarity=0.258 Sum_probs=186.4
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 86 (351)
+|++.++||+|+||++|.+.+.-+++.||||.-+.+..... ++.|....+.|. .++|...|-+...+.+-.||+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQ-----LrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQ-----LRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcch-----HHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 59999999999999999999999999999997655544332 337888888885 799999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-----CCeEEe
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-----LNAKLA 161 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~-----~~~kl~ 161 (351)
|.+ |.||.|+.. .|++.++...+. .++.|++.-++|+|++.+|+|||||+|+||... ..+-++
T Consensus 104 dLL-GPSLEDLFD-~CgR~FSvKTV~----------miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 104 DLL-GPSLEDLFD-LCGRRFSVKTVA----------MIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred hhh-CcCHHHHHH-HhcCcccHHhHH----------HHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 988 799999874 567777665543 456677777789999999999999999999754 348999
Q ss_pred eccccccccCCcc-------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHh
Q psy6327 162 DFGFSRLLRTPKE-------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR-NRDVLKK 233 (351)
Q Consensus 162 Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~ 233 (351)
|||+|+.+..+.. ...+..||..||+---..+...+.+ -|+-|||-++.+++-|..||.+.... ..+..++
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK 250 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK 250 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence 9999998765432 3346789999999887777776654 89999999999999999999876543 3334444
Q ss_pred hhCccccccc---cccCCHhHHHHHHHhcCCCCCCCCCH
Q psy6327 234 QEGKEYLFNR---KYEISIGAKQLIGRMLEPNPKHRPNA 269 (351)
Q Consensus 234 ~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~ 269 (351)
+......-+. ...+|.++-.-+.-.=..+-.+-|..
T Consensus 251 IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 251 IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 4433322221 12466666666655555555566654
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=215.37 Aligned_cols=226 Identities=30% Similarity=0.475 Sum_probs=168.9
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
-|-..+|..++.+..|+||.||.+.|+.+.+.+|+| ++++.+-- |- ++.....|.+|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil--------Rn--ilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL--------RN--ILTFAGNPFVV------------ 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh--------hc--cccccCCccee------------
Confidence 355678999999999999999999999999999994 44332211 11 22223344444
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+-..+++. .+.++.. ++.+++|||+.||+|||+||+|.+|+.-|++|++|
T Consensus 136 ---------gDc~tllk~--~g~lPvd------------------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTD 186 (1205)
T KOG0606|consen 136 ---------GDCATLLKN--IGPLPVD------------------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTD 186 (1205)
T ss_pred ---------chhhhhccc--CCCCcch------------------hhHHhHhhccCCeecCCCCCCcceeeecccccccc
Confidence 555566654 3344431 24567899999999999999999999999999999
Q ss_pred ccccccccCCc---------------ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc
Q psy6327 163 FGFSRLLRTPK---------------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227 (351)
Q Consensus 163 fg~a~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (351)
||+++..-... -.....||||.|.|||++....|... +|+|++|+|+|+.+-|+.||.+.. .
T Consensus 187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdt--p 263 (1205)
T KOG0606|consen 187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDT--P 263 (1205)
T ss_pred hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCC--H
Confidence 99987642111 01234589999999999998888866 999999999999999999997654 3
Q ss_pred hHHHHhhhCccccccc-cccCCHhHHHHHHHhcCCCCCCCC---CHHHHhcCccccCCcc
Q psy6327 228 RDVLKKQEGKEYLFNR-KYEISIGAKQLIGRMLEPNPKHRP---NAKDVQNHAWIQNEPT 283 (351)
Q Consensus 228 ~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rp---t~~ell~hp~~~~~~~ 283 (351)
++.+.........++. ...++.+++++|.++|+.+|-.|. .+-++.+|+||+.-.+
T Consensus 264 eelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 264 EELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred HHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 4444444433333333 346788999999999999999995 4778999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=180.27 Aligned_cols=144 Identities=17% Similarity=0.206 Sum_probs=106.4
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHH-----------------------HhhhHHHHHHHHHhCCCCC
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY-----------------------MEKFAPREIDILLKVSHPN 68 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------------------~~~~~~~Ei~~l~~l~hp~ 68 (351)
...||+|+||.||+|.+. +|+.||+|++......... ......+|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999998754321100 1122345999999998877
Q ss_pred ceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHh-HhCCceeccCCC
Q psy6327 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYL-HEVGIVHRDIKC 147 (351)
Q Consensus 69 iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~l-H~~~i~H~Dlkp 147 (351)
+.....+.... .+|||||++|+++...... ...++... +..++.|++.+|.++ |+.||+||||||
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~--~~~~~~~~----------~~~i~~qi~~~L~~l~H~~giiHrDlkP 146 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLK--DAPLSESK----------ARELYLQVIQIMRILYQDCRLVHADLSE 146 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhh--cCCCCHHH----------HHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 74433332222 3899999998877655332 34455433 445778889999999 799999999999
Q ss_pred CCEeEcCCCCeEEeeccccccccC
Q psy6327 148 ENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 148 ~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
+|||+++ +.++|+|||+|.....
T Consensus 147 ~NIli~~-~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 147 YNLLYHD-GKLYIIDVSQSVEHDH 169 (190)
T ss_pred HHEEEEC-CcEEEEEccccccCCC
Confidence 9999984 7899999999976443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-25 Score=213.36 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=178.2
Q ss_pred CCcc-ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh--HHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 4 PDIL-ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR--DYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 4 ~~~~-~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
.|+. +|...+.||++-|=.|.+|++.+ | .+++|+|-.+...- ....+.+ +|++ ...+++||.+++..+..+..
T Consensus 19 sd~~~e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~k 94 (1431)
T KOG1240|consen 19 SDLSVECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDK 94 (1431)
T ss_pred hcCccceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhH
Confidence 3444 78889999999999999998874 3 38899986655322 2223333 5666 66678999999999988888
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+|=+|.. .+|+|.+.. +++-...-+.| ++.|++.||+-+|..||+|+|||.+||||+.=+.+-|
T Consensus 95 AAylvRqyvk-hnLyDRlST---RPFL~~iEKkW---------iaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~L 161 (1431)
T KOG1240|consen 95 AAYLVRQYVK-HNLYDRLST---RPFLVLIEKKW---------IAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYL 161 (1431)
T ss_pred HHHHHHHHHh-hhhhhhhcc---chHHHHHHHHH---------HHHHHHHHHHHHHHcCccccccccceEEEeeechhhh
Confidence 8999999996 999999975 34333333333 6889999999999999999999999999999888999
Q ss_pred eeccccccccCCccc-------ccccccccceeccccccCCC---------C-CCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy6327 161 ADFGFSRLLRTPKEL-------SNTFCGTTSYAAPEIIRNSP---------Y-NPKLADIWSLGVVLYRILN-KKYPFGD 222 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~---------~-~~~~~DiwslG~il~~ll~-g~~pf~~ 222 (351)
+||-.-+...-+.+. ..+...-.+|.|||.+.... . -.++.||||+||++.||++ |++||.-
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 999876543322221 12222345899999875311 1 1234899999999999998 7888831
Q ss_pred CCCCchHHHHhhhCcccccc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 223 PGTRNRDVLKKQEGKEYLFN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
. ..+.-.....+... ...--+...+.||..|++.||++|.++++.|+.
T Consensus 242 S-----QL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 242 S-----QLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred H-----HHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 11111111011000 000123478999999999999999999999974
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=174.69 Aligned_cols=145 Identities=18% Similarity=0.191 Sum_probs=108.1
Q ss_pred eeeecCcccceEEEEEEecCCceeEEEEecchhhhhh-----------------------HHHhhhHHHHHHHHHhCCCC
Q psy6327 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR-----------------------DYMEKFAPREIDILLKVSHP 67 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----------------------~~~~~~~~~Ei~~l~~l~hp 67 (351)
+.+.||+|+||.||+|.+. +|+.||+|++....... ........+|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987653210 01122335799999999999
Q ss_pred CceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCC
Q psy6327 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIK 146 (351)
Q Consensus 68 ~iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlk 146 (351)
++.....+.... .|+||||++|+++...... ...++... +..++.|++.++.++|+ +||+|||||
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~----------~~~i~~~l~~~l~~lH~~~givHrDlk 145 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEE----------AEELYEQVVEQMRRLYQEAGLVHGDLS 145 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHH----------HHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 875444443332 4899999998765443222 23344332 34567788999999999 999999999
Q ss_pred CCCEeEcCCCCeEEeeccccccccC
Q psy6327 147 CENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 147 p~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+|||++ ++.++|+|||+++....
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecCC
Confidence 9999999 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=172.62 Aligned_cols=189 Identities=16% Similarity=0.132 Sum_probs=137.0
Q ss_pred eeeeecCcccceEEEEEEecCCceeEEEEecchhhhh-hHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEe
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.....|++|+||+|+.+.. .+..++.+.+.....- .......+.+|+++|++|. |+++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999997755 5777776666544331 1122335679999999995 5889999886 34699999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccC-CCCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDI-KCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dl-kp~NIll~~~~~~kl~Dfg~a 166 (351)
|+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|
T Consensus 79 yI~G~~L~~~~~~---~----------------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A 139 (218)
T PRK12274 79 YLAGAAMYQRPPR---G----------------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLA 139 (218)
T ss_pred eecCccHHhhhhh---h----------------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCc
Confidence 9999998654321 0 0124567888899999999999999 799999999999999999999
Q ss_pred ccccCCccc----c---------cccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy6327 167 RLLRTPKEL----S---------NTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDP 223 (351)
Q Consensus 167 ~~~~~~~~~----~---------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (351)
......... . .-...++.|++|+.-.-- ..+-.+.+.++.|+-+|.++|+..++...
T Consensus 140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 865543321 0 011257788888864322 12212368889999999999999887643
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=177.26 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=186.9
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
|+....++-+|.+.-.|..|++++. |..+++|++......... .+.+..|.-.|+-..||||+.+++.+....++.+
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~ri-srdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARI-SRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred chhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchhh-cchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 3445567788999999999999887 445567877766654433 3334468888888899999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEcCCCCeEEe-
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILISRLLNAKLA- 161 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~~~~~~kl~- 161 (351)
+..||+.|+|+..+....+...+. .+|++|+.++++|+.|||+.. |.---|....++||++.+.+|+
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~----------sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism 334 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDH----------SQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM 334 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEec----------chHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec
Confidence 999999999999998754333333 346788999999999999964 4444688999999998776653
Q ss_pred -eccccccccCCcccccccccccceeccccccCCCCC--CCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 162 -DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYN--PKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 162 -Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|--++.. ..+..-+|.||+||.+..++.+ -+++|+|||++++|||.|.+.||.+.....-......++
T Consensus 335 ad~kfsfq-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg-- 405 (448)
T KOG0195|consen 335 ADTKFSFQ-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG-- 405 (448)
T ss_pred ccceeeee-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc--
Confidence 3222221 1122347899999999877654 345899999999999999999998876544334333333
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHh
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQ 273 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 273 (351)
.....++.++..+-.|+.-|++.||.+||.++.++
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 33344558999999999999999999999988763
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=182.13 Aligned_cols=190 Identities=27% Similarity=0.406 Sum_probs=136.2
Q ss_pred CCCCceeeeeEEEe---------------------------CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHH
Q psy6327 65 SHPNIIGVHRMVKA---------------------------GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQ 117 (351)
Q Consensus 65 ~hp~iv~~~~~~~~---------------------------~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~ 117 (351)
+|||||++.+.|.+ ...+|+||.-.+ .+|..++... ..+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~------- 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRT------- 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHH-------
Confidence 49999999877622 346899999886 9999999752 222222
Q ss_pred HHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE--cCCC--CeEEeeccccccccC-----Cc-ccccccccccceec
Q psy6327 118 IANALEYLHEIANALEYLHEVGIVHRDIKCENILI--SRLL--NAKLADFGFSRLLRT-----PK-ELSNTFCGTTSYAA 187 (351)
Q Consensus 118 i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll--~~~~--~~kl~Dfg~a~~~~~-----~~-~~~~~~~gt~~y~a 187 (351)
+.-++.|+++|+.|||.+||.|||+|.+|||+ ++++ .+.|+|||.+---+. +. ......-|...-||
T Consensus 343 ---~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 ---GRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred ---HHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 22367789999999999999999999999998 3443 478999997643211 11 11223347788999
Q ss_pred cccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCC
Q psy6327 188 PEIIRNSP-----YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPN 262 (351)
Q Consensus 188 PE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 262 (351)
||+....+ .+..+.|.|+.|.+.||++....||...+....+...-.+ ..+...+..+++.+++++..+|+.|
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe--~qLPalp~~vpp~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE--SQLPALPSRVPPVARQLVFDLLKRD 497 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh--hhCCCCcccCChHHHHHHHHHhcCC
Confidence 99986433 2334589999999999999999999775433222222111 1223344478999999999999999
Q ss_pred CCCCCCHH
Q psy6327 263 PKHRPNAK 270 (351)
Q Consensus 263 p~~Rpt~~ 270 (351)
|++|++..
T Consensus 498 pskRvsp~ 505 (598)
T KOG4158|consen 498 PSKRVSPN 505 (598)
T ss_pred ccccCCcc
Confidence 99999843
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=168.64 Aligned_cols=137 Identities=22% Similarity=0.267 Sum_probs=104.3
Q ss_pred eeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-----CCCCceeeeeEEEeCC---E
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-----SHPNIIGVHRMVKAGT---Y 81 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~hp~iv~~~~~~~~~~---~ 81 (351)
+-...||+|+||.||. ++.++.. +||++....... ...+.+|+.+++.+ .||||++++++++++. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~---~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGG---DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccch---HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 4467899999999995 7777666 699886543222 33456999999999 5799999999998873 4
Q ss_pred EE-EEEec--CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHH-HHhHhCCceeccCCCCCEeEcCC--
Q psy6327 82 LY-MIMDY--AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL-EYLHEVGIVHRDIKCENILISRL-- 155 (351)
Q Consensus 82 ~~-lv~e~--~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l-~~lH~~~i~H~Dlkp~NIll~~~-- 155 (351)
++ +|+|| +.+++|.+++++ ..+++.. .++.+++.++ +|||+++|+||||||+|||++..
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~---~~~~e~~------------~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~ 143 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQ---CRYEEDV------------AQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISE 143 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHc---ccccHhH------------HHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCC
Confidence 44 78999 557999999975 2344431 2345666666 89999999999999999999742
Q ss_pred --CCeEEeeccccc
Q psy6327 156 --LNAKLADFGFSR 167 (351)
Q Consensus 156 --~~~kl~Dfg~a~ 167 (351)
+.++|+||+.+.
T Consensus 144 ~~~~~~LiDg~G~~ 157 (210)
T PRK10345 144 SEVIPVVCDNIGES 157 (210)
T ss_pred CCCcEEEEECCCCc
Confidence 379999955443
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-23 Score=201.42 Aligned_cols=263 Identities=25% Similarity=0.425 Sum_probs=206.4
Q ss_pred ccceeeeeecCcccceEEEEEEec-CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK-RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~ 83 (351)
...|.+.+.||+|+|+.|-.+... .....+|.|.+.... ........+..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 345888999999999999988764 445566667665544 22222233335888888887 999999999999999999
Q ss_pred EEEecCCCCChHHHH-HhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhH-hCCceeccCCCCCEeEcCCC-CeEE
Q psy6327 84 MIMDYAEKKDLEHYI-SKACNENIHENQARIWIRQIANALEYLHEIANALEYLH-EVGIVHRDIKCENILISRLL-NAKL 160 (351)
Q Consensus 84 lv~e~~~ggsL~~~l-~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH-~~~i~H~Dlkp~NIll~~~~-~~kl 160 (351)
++++|..|+++.+.+ ... ....+..... .++.|+..++.|+| ..++.|+|+||+|.+++..+ .+++
T Consensus 98 ~~~~~s~g~~~f~~i~~~~-~~~~~~~~~~----------~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~ 166 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD-STGTSSSSAS----------RYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKI 166 (601)
T ss_pred cccCcccccccccccccCC-ccCCCCcchh----------hhhhhhccCccccCcccccccCCCCCccchhccCCCcccC
Confidence 999999999999998 432 1133333333 36778888888999 99999999999999999999 9999
Q ss_pred eeccccccccC-Ccc--ccccccc-ccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC
Q psy6327 161 ADFGFSRLLRT-PKE--LSNTFCG-TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 161 ~Dfg~a~~~~~-~~~--~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 236 (351)
+|||+|+.+.. .+. .....+| ++.|+|||...+..+.....|+||+|+++.-+++|..|+................
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~ 246 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN 246 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc
Confidence 99999987755 222 2345678 9999999999887777667999999999999999999998776555443333333
Q ss_pred c-cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 237 K-EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 237 ~-~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
. .........++....+++.+++..+|+.|.+.+++..+||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 2 2233444578999999999999999999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=166.59 Aligned_cols=146 Identities=20% Similarity=0.189 Sum_probs=109.2
Q ss_pred ceeeeeecCcccceEEEEEE-ecCCceeEEEEecchhhhhh---------------------HHHhhhHHHHHHHHHhCC
Q psy6327 8 ECSYISKLGEGAYGNVYLVS-DKRSETLKACKAYDFKRLKR---------------------DYMEKFAPREIDILLKVS 65 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~-~~~~~~~~aiK~~~~~~~~~---------------------~~~~~~~~~Ei~~l~~l~ 65 (351)
.|++.+.||+|+||.||+|. +..+|+.||+|++....... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999999 77889999999987543210 112234568999999997
Q ss_pred CC--CceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC-cee
Q psy6327 66 HP--NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG-IVH 142 (351)
Q Consensus 66 hp--~iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~-i~H 142 (351)
+. .+++++.. . ..++||||++|.+|...... ....... .+..++.|++.+|.+||+.| ++|
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~----------~~~~i~~qi~~~l~~LH~~g~iiH 172 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK--DVEPEEE----------EEFELYDDILEEMRKLYKEGELVH 172 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccc--cCCcchH----------HHHHHHHHHHHHHHHHHhcCCEEe
Confidence 53 33444442 2 34899999998888765422 2222221 23456788999999999999 999
Q ss_pred ccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 143 RDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 143 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
+||||+||+++ ++.++|+|||.+....
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999 7889999999987643
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=191.03 Aligned_cols=192 Identities=22% Similarity=0.330 Sum_probs=151.4
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC---CCCceeeeeEEEeCCEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS---HPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~l 84 (351)
.|.|-+.||+|+||.||.|.+.+ |+.+|+|+-.....=+-. --.+++.+|+ -+.|..+...+.-.+..++
T Consensus 699 ~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY------I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 699 KFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY------ICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee------ehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 38889999999999999999987 999999975433321111 1234455555 3666777777777777899
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-------CCC
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-------LLN 157 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-------~~~ 157 (351)
|+||.+.|+|.+++.. .+.+++..+.. ++.|++..++.||..+|||+||||+|+||.. .-.
T Consensus 772 v~ey~~~Gtlld~~N~--~~~m~e~lv~~----------~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINT--NKVMDEYLVMF----------FSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred eeeccccccHHHhhcc--CCCCCchhhhH----------HHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 9999999999999984 66667665544 5567777788999999999999999999953 234
Q ss_pred eEEeecccccccc--CCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q psy6327 158 AKLADFGFSRLLR--TPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP 219 (351)
Q Consensus 158 ~kl~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 219 (351)
++|+|||.+..+. ..+......++|-.+-.+|+..+.+|+.. +|.|.++.+++.|+.|+.-
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHHH
Confidence 8999999997654 23334566789999999999999999987 9999999999999998744
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=178.94 Aligned_cols=205 Identities=28% Similarity=0.435 Sum_probs=142.5
Q ss_pred HHHHHHHHhCCCCCceeeee-------EE-----EeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHH
Q psy6327 55 PREIDILLKVSHPNIIGVHR-------MV-----KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122 (351)
Q Consensus 55 ~~Ei~~l~~l~hp~iv~~~~-------~~-----~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~ 122 (351)
.+++-.+....|.+..-+.+ .+ ....++||.|++|.-.+|.++|.......-+ .+...+
T Consensus 292 ~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~---------s~s~~~ 362 (516)
T KOG1033|consen 292 FRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEER---------SLSLML 362 (516)
T ss_pred hhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCccccc---------chhHHH
Confidence 36666666665444333322 11 1234689999999999999999753222221 122344
Q ss_pred HHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCc------ccccccccccceeccccccCCCC
Q psy6327 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK------ELSNTFCGTTSYAAPEIIRNSPY 196 (351)
Q Consensus 123 ~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~ 196 (351)
.+++|++.|++| ++.+|+|+||.||+...+..+||+|||+.+...... ......+||++||+||++.+..|
T Consensus 363 ~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y 439 (516)
T KOG1033|consen 363 DIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY 439 (516)
T ss_pred HHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh
Confidence 577888889989 999999999999999999999999999998765433 23345679999999999999999
Q ss_pred CCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 197 NPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 197 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
+.+ +||||||++++|++. -..+|.. ...+..+....+......+. +.-.+|+..||.+.|.+||++.+.--|
T Consensus 440 ~~k-vdIyaLGlil~EL~~~f~T~~er-----~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 440 SEK-VDIYALGLILAELLIQFSTQFER-----IATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred hhh-cchhhHHHHHHHHHHHhccHHHH-----HHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhh
Confidence 987 999999999999997 2333321 11222222222211111122 345689999999999999977777667
Q ss_pred ccc
Q psy6327 276 AWI 278 (351)
Q Consensus 276 p~~ 278 (351)
+|.
T Consensus 513 ~~~ 515 (516)
T KOG1033|consen 513 EFL 515 (516)
T ss_pred hhc
Confidence 665
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-20 Score=171.79 Aligned_cols=203 Identities=24% Similarity=0.412 Sum_probs=150.5
Q ss_pred HHhCCCCCceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCc
Q psy6327 61 LLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGI 140 (351)
Q Consensus 61 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i 140 (351)
|+.+.|.|+.+++|.+.++...++|.+||.-|+|.|.+.. ..+..+. .. ...++++++.||.|+|...|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~----~F----~~s~~rdi~~Gl~ylh~s~i 69 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDY----FF----ILSFIRDISKGLAYLHNSPI 69 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccH----HH----HHHHHHHHHHHHHHHhcCcc
Confidence 4577899999999999999999999999999999999975 2222211 11 12478899999999999877
Q ss_pred -eeccCCCCCEeEcCCCCeEEeeccccccccC--CcccccccccccceeccccccCCCC------CCCcchHHHHHHHHH
Q psy6327 141 -VHRDIKCENILISRLLNAKLADFGFSRLLRT--PKELSNTFCGTTSYAAPEIIRNSPY------NPKLADIWSLGVVLY 211 (351)
Q Consensus 141 -~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~ 211 (351)
.|+.|+..|.+++....+||+|||+...... .........-..-|.|||.+..... ..++.|+||+|++++
T Consensus 70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ 149 (484)
T KOG1023|consen 70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY 149 (484)
T ss_pred eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence 9999999999999999999999999877642 1111122224567999999876421 234489999999999
Q ss_pred HHHhCCCCCCCCCCCch--HHHHhhhC--cccccccc---ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 212 RILNKKYPFGDPGTRNR--DVLKKQEG--KEYLFNRK---YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 212 ~ll~g~~pf~~~~~~~~--~~~~~~~~--~~~~~~~~---~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
|+++...||........ +....... .....|.- ....+++..++.+||..+|.+||++.++-.
T Consensus 150 ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 150 EILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 99999999976433222 23332222 11111111 145667999999999999999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=155.17 Aligned_cols=138 Identities=22% Similarity=0.295 Sum_probs=110.2
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhh-----hHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-----RDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
++.||+|++|.||+|.+ .|..+++|+....... .......+.+|+.++..+.|++|+....++......++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 5778888876533321 1122334568999999999999887777777777889999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++|++|.+++... .. ....++.+++.+|.++|+.+++|+|++|.|||++ ++.++|+|||.+
T Consensus 79 e~~~G~~L~~~~~~~--~~--------------~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 79 EYIEGEPLKDLINSN--GM--------------EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred EEeCCcCHHHHHHhc--cH--------------HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 999999999988642 10 2345677889999999999999999999999999 788999999988
Q ss_pred cc
Q psy6327 167 RL 168 (351)
Q Consensus 167 ~~ 168 (351)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 75
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=153.31 Aligned_cols=134 Identities=23% Similarity=0.275 Sum_probs=104.5
Q ss_pred ecCcccceEEEEEEecCCceeEEEEecchhhhh-----hHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-----RDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 14 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
.||+|+||.||++.. ++..+++|........ .......+.+|+.++..+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 5678889886443221 112234456899999999888765544455556667899999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~--~-----------------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--D-----------------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH--H-----------------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999875411 0 3577888999999999999999999999999 78999999999876
Q ss_pred c
Q psy6327 169 L 169 (351)
Q Consensus 169 ~ 169 (351)
.
T Consensus 139 ~ 139 (199)
T TIGR03724 139 S 139 (199)
T ss_pred C
Confidence 3
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=153.93 Aligned_cols=140 Identities=20% Similarity=0.164 Sum_probs=105.9
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH-------------------HHhhhHHHHHHHHHhCCCCC-
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD-------------------YMEKFAPREIDILLKVSHPN- 68 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------------------~~~~~~~~Ei~~l~~l~hp~- 68 (351)
|.+.+.||+|+||.||++... +|+.+|+|++........ .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999875 799999998764321100 01122457899999998774
Q ss_pred -ceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCC
Q psy6327 69 -IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKC 147 (351)
Q Consensus 69 -iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp 147 (351)
++..++. ...++||||++|++|..+... . ....++.+++.++.++|+.|++|+||+|
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~----------~~~~~~~~i~~~l~~lh~~gi~H~Dl~p 153 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------E----------DPEEVLDEILEEIVKAYKHGIIHGDLSE 153 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc--------c----------cHHHHHHHHHHHHHHHHHCCCCcCCCCc
Confidence 4444432 345899999999998765421 0 1224567888899999999999999999
Q ss_pred CCEeEcCCCCeEEeeccccccccC
Q psy6327 148 ENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 148 ~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
+||+++.++.++|+|||.+.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-19 Score=173.57 Aligned_cols=138 Identities=20% Similarity=0.218 Sum_probs=107.7
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhh-----hhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKR-----LKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
|...+.||+|+||.||++.+.... +++|+...+. .........+.+|+.+++.++|++++....+.......+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 355788999999999998875433 3333322211 122222345668999999999999988777777777789
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++|++|.+++.. ...++.+++.+|.+||+.|++||||||+|||+ +++.++|+||
T Consensus 413 lv~E~~~g~~L~~~l~~--------------------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 413 IVMEYIGGKDLKDVLEG--------------------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred EEEEecCCCcHHHHHHH--------------------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeC
Confidence 99999999999988752 23467789999999999999999999999999 5678999999
Q ss_pred cccccc
Q psy6327 164 GFSRLL 169 (351)
Q Consensus 164 g~a~~~ 169 (351)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=144.57 Aligned_cols=140 Identities=18% Similarity=0.231 Sum_probs=97.9
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhh---------------------hHHHHHHHHHhCCCC--C
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK---------------------FAPREIDILLKVSHP--N 68 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~---------------------~~~~Ei~~l~~l~hp--~ 68 (351)
.+.||+|+||.||+|.+. +++.||+|++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999987 7899999988653322111111 113566667666543 3
Q ss_pred ceeeeeEEEeCCEEEEEEecCCCCChHH-HHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCC
Q psy6327 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEH-YISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIK 146 (351)
Q Consensus 69 iv~~~~~~~~~~~~~lv~e~~~ggsL~~-~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlk 146 (351)
+.+.++.. ..++||||++|+++.. .+... ... ..+..++.+++.++.++|. .+|+|+|||
T Consensus 81 ~~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~---~~~-----------~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~ 142 (187)
T cd05119 81 VPKPIDLN----RHVLVMEFIGGDGIPAPRLKDV---RLL-----------EDPEELYDQILELMRKLYREAGLVHGDLS 142 (187)
T ss_pred CCceEecC----CCEEEEEEeCCCCccChhhhhh---hhc-----------ccHHHHHHHHHHHHHHHhhccCcCcCCCC
Confidence 44555432 3589999999854321 11110 000 2244577889999999999 999999999
Q ss_pred CCCEeEcCCCCeEEeeccccccccC
Q psy6327 147 CENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 147 p~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|+||+++ ++.++|+|||.+.....
T Consensus 143 p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred hhhEEEE-CCcEEEEECcccccccC
Confidence 9999999 88999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.7e-17 Score=142.12 Aligned_cols=138 Identities=18% Similarity=0.227 Sum_probs=102.1
Q ss_pred eecC-cccceEEEEEEecCCceeEEEEecchhhh-----h-----hHHHhhhHHHHHHHHHhCCCCCc--eeeeeEEEeC
Q psy6327 13 SKLG-EGAYGNVYLVSDKRSETLKACKAYDFKRL-----K-----RDYMEKFAPREIDILLKVSHPNI--IGVHRMVKAG 79 (351)
Q Consensus 13 ~~LG-~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~-----~~~~~~~~~~Ei~~l~~l~hp~i--v~~~~~~~~~ 79 (351)
..|| .||.|+||.+... +..+++|.+..... . .......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3577 8889999988764 67888888854221 1 11123345689999999998775 6677664332
Q ss_pred -C---EEEEEEecCCC-CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC
Q psy6327 80 -T---YLYMIMDYAEK-KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR 154 (351)
Q Consensus 80 -~---~~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~ 154 (351)
. ..++|||+++| .+|.+++.. ..+++. .+.+++.+|.+||++||+|+||||+|||++.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~--------------~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~ 177 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEE--------------QWQAIGQLIARFHDAGVYHADLNAHNILLDP 177 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH--------------HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC
Confidence 2 23599999997 699988864 333332 2356788899999999999999999999998
Q ss_pred CCCeEEeeccccccc
Q psy6327 155 LLNAKLADFGFSRLL 169 (351)
Q Consensus 155 ~~~~kl~Dfg~a~~~ 169 (351)
++.++|+|||.++..
T Consensus 178 ~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 178 DGKFWLIDFDRGELR 192 (239)
T ss_pred CCCEEEEECCCcccC
Confidence 889999999998763
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.2e-17 Score=132.15 Aligned_cols=132 Identities=21% Similarity=0.282 Sum_probs=105.6
Q ss_pred eeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC--CCceeeeeEEEeCCEEEEEEec
Q psy6327 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH--PNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~ 88 (351)
+++.||+|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.| +++++++.+....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999998754 6789998754432 2334589999999976 5899999998888899999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC---CceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV---GIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
++|+++..+ +.. ....++.+++.++..+|.. +++|+|++|+||+++..+.++++|||.
T Consensus 75 ~~g~~~~~~---------~~~----------~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 75 IEGETLDEV---------SEE----------EKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred cCCeecccC---------CHH----------HHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 998877654 111 1123566788888899985 699999999999999989999999998
Q ss_pred ccc
Q psy6327 166 SRL 168 (351)
Q Consensus 166 a~~ 168 (351)
++.
T Consensus 136 ~~~ 138 (155)
T cd05120 136 AGY 138 (155)
T ss_pred ccC
Confidence 875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-17 Score=153.26 Aligned_cols=254 Identities=21% Similarity=0.195 Sum_probs=187.3
Q ss_pred eeeeeecCc--ccceEEEEEEe--cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEE
Q psy6327 9 CSYISKLGE--GAYGNVYLVSD--KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 9 ~~~~~~LG~--G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~ 83 (351)
+.+...+|. |.+|.||.+.. ..++..+|+|.-............. .+|+...+.++ |+|.++.+..+++++..|
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k-~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRK-LREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccc-cchhhcccccCccccccccCcccccCCcce
Confidence 566788999 99999999888 8899999998743322211111111 27888888885 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHH----HHHHhHhCCceeccCCCCCEeEcCC-CCe
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN----ALEYLHEVGIVHRDIKCENILISRL-LNA 158 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~----~l~~lH~~~i~H~Dlkp~NIll~~~-~~~ 158 (351)
+-+|+|. .+|..+.... ...+++..... .+.+... ||.++|+.+++|-|+||.||++..+ ...
T Consensus 195 iqtE~~~-~sl~~~~~~~-~~~~p~~~l~~----------~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP-CNFLPDNLLWN----------SLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred eeecccc-chhHHhhhcc-cccCCchhhhh----------HHhhhhhcccccccccCCCcccccccchhheeccccccee
Confidence 9999995 8998888763 33356555443 4455555 8899999999999999999999998 889
Q ss_pred EEeeccccccccCCcccccc-----cccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh
Q psy6327 159 KLADFGFSRLLRTPKELSNT-----FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 233 (351)
+++|||+...+......... ..|...|++||+.++... . ..|++++|.++.+-.++..+............+.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~-~-~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT-F-ASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc-h-HhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 99999999887665432222 257789999999876543 3 3899999999999999877764331111111111
Q ss_pred hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.. .........+.++...+..|++.+|-.|++++.+++|+++..
T Consensus 341 ~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 341 GY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11 001111235666777999999999999999999999999863
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.2e-17 Score=159.66 Aligned_cols=263 Identities=23% Similarity=0.289 Sum_probs=192.2
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
...+.+.+-+-+|+++.++.+.-..+|...++|+......-.....+..+++-.++-.-.+|-++...-.+.-....+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45577888899999999999988888877777655432221111111222333333333457777665556667789999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
++|.+|++|...+.. .....+...+.. +..+..++++||+..+.|+|++|.|+|+..++..+++|||.
T Consensus 883 ~~~~~~~~~~Skl~~--~~~~saepaRs~----------i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHN--SGCLSAEPARSP----------ILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred hHHhccCCchhhhhc--CCCcccccccch----------hHHHHhhhhccccchhhcccccccchhhcccCCcccCcccc
Confidence 999999999999876 344555555543 33445566799999999999999999999999999999983
Q ss_pred ccccc-C-----C----------------------c---ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHH
Q psy6327 166 SRLLR-T-----P----------------------K---ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214 (351)
Q Consensus 166 a~~~~-~-----~----------------------~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 214 (351)
..... . . . .......||+.|.+||.+.+...... .|.|+.|+++++.+
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhh
Confidence 32211 0 0 0 00123568999999999988887765 89999999999999
Q ss_pred hCCCCCCCCCCCchHHHHhhhCccccccc-cccCCHhHHHHHHHhcCCCCCCCCCHH---HHhcCccccCCcc
Q psy6327 215 NKKYPFGDPGTRNRDVLKKQEGKEYLFNR-KYEISIGAKQLIGRMLEPNPKHRPNAK---DVQNHAWIQNEPT 283 (351)
Q Consensus 215 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~---ell~hp~~~~~~~ 283 (351)
+|.+||.+.. ....++.+......++. ....+.++++++.++|..+|.+|..+. ++..||||+...+
T Consensus 1030 ~g~pp~na~t--pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1030 TGIPPFNAET--PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred cCCCCCCCcc--hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 9999997655 45556666555554443 346789999999999999999999877 8999999987765
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-14 Score=137.20 Aligned_cols=231 Identities=17% Similarity=0.246 Sum_probs=153.4
Q ss_pred eeeeeecCcccceEEE-EEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 9 CSYISKLGEGAYGNVY-LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~-~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
|++ ....-++.+ +| .|..+.++.++.+.+++.... .....+.+-++-|+.++||||+++++.++.++.+|||+|
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence 444 333334444 44 577788899999988766554 223344578899999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhH-hCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLH-EVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH-~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
-+ -.|..++++.. . . ..+ --++||+.||.||| +.+++|++|....|+++..|.+||++|..+
T Consensus 90 rV--~Pl~~~lk~l~-----~-~--------~v~-~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v 152 (690)
T KOG1243|consen 90 RV--RPLETVLKELG-----K-E--------EVC-LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELV 152 (690)
T ss_pred cc--ccHHHHHHHhH-----H-H--------HHH-HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence 98 67777776632 1 1 111 13679999999997 678999999999999999999999999988
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
.....-........---.|..|+.+....+ ..|.|.|||++++++.| ++..... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~---s~D~~~Lg~li~el~ng--~~~~~~~---------------~~~~~~ 212 (690)
T KOG1243|consen 153 SKASGFNAPAKSLYLIESFDDPEEIDPSEW---SIDSWGLGCLIEELFNG--SLLTKTD---------------LSNTGK 212 (690)
T ss_pred eccccCCcccccchhhhcccChhhcCcccc---chhhhhHHHHHHHHhCc--ccCcchh---------------hhccCc
Confidence 654332221122222224666665533332 26999999999999998 3322110 011113
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHH----H-hcCccccCC
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKD----V-QNHAWIQNE 281 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~e----l-l~hp~~~~~ 281 (351)
++.....+..+-+--.+..||.... + +-|+||++.
T Consensus 213 ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~ 252 (690)
T KOG1243|consen 213 IPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRND 252 (690)
T ss_pred cchhHHHHHHHHhccccccccchhhHHHHHHhccccccch
Confidence 4444444444455555666766332 2 238888754
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.7e-16 Score=134.17 Aligned_cols=205 Identities=17% Similarity=0.258 Sum_probs=137.7
Q ss_pred HHHhCCCCCceeeeeEEEe-----CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy6327 60 ILLKVSHPNIIGVHRMVKA-----GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134 (351)
Q Consensus 60 ~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~ 134 (351)
-+.++-|.|||+++.++.+ .....++.||+..|+|..+|++....... ......-+|+.||+.||.|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a--------~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKA--------LFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhh--------hhHHHHHHHHHHHHhhhhh
Confidence 3455669999999999854 34588999999999999999864322111 1122334678899999999
Q ss_pred hHhC--CceeccCCCCCEeEcCCCCeEEeeccccccccCC-----cccccccccccceeccccccCCCCCCCcchHHHHH
Q psy6327 135 LHEV--GIVHRDIKCENILISRLLNAKLADFGFSRLLRTP-----KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLG 207 (351)
Q Consensus 135 lH~~--~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 207 (351)
||+. .|+|+++..+.|++..+|-+|++---.. ..... ......-.|-++|.|||.=.....+.. +|||++|
T Consensus 192 Lhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fg 269 (458)
T KOG1266|consen 192 LHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFG 269 (458)
T ss_pred hhccCCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhh
Confidence 9997 4999999999999998888887422111 11111 011122346789999998655555554 8999999
Q ss_pred HHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 208 VVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 208 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.+..+|..+..--.... ........+........ ..--++++.+||+..|..||++++++.||.+-+
T Consensus 270 mcAlemailEiq~tnse-S~~~~ee~ia~~i~~le-----n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 270 MCALEMAILEIQSTNSE-SKVEVEENIANVIIGLE-----NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HHHHHHHHheeccCCCc-ceeehhhhhhhheeecc-----CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 99999998765432211 11111111111111111 112367899999999999999999999998643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.6e-15 Score=141.61 Aligned_cols=150 Identities=15% Similarity=0.102 Sum_probs=95.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh-------------------------------HHHhhh---
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR-------------------------------DYMEKF--- 53 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------------------------------~~~~~~--- 53 (351)
+|.. +.||+|++|+||+|+.+++|+.||||+........ ....+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 78999999999999999889999999986432100 011111
Q ss_pred ---HHHHHHHHHhCC----CCCceeeeeEEEe-CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHH
Q psy6327 54 ---APREIDILLKVS----HPNIIGVHRMVKA-GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125 (351)
Q Consensus 54 ---~~~Ei~~l~~l~----hp~iv~~~~~~~~-~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~ 125 (351)
+.+|+..+.++. +.+.+.+-.++.+ .+..++||||++|+++.++-.-. ....+... +.... +-.++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~~---la~~~--v~~~~ 273 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDMKL---LAERG--VEVFF 273 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCHHH---HHHHH--HHHHH
Confidence 234554444442 3333444444432 44578999999999998753211 11111111 11111 11234
Q ss_pred HHHHHHHHHhHhCCceeccCCCCCEeEcCCC----CeEEeeccccccccC
Q psy6327 126 HEIANALEYLHEVGIVHRDIKCENILISRLL----NAKLADFGFSRLLRT 171 (351)
Q Consensus 126 ~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 171 (351)
.|+ ...|++|+|++|.||+++.++ .++++|||++..+..
T Consensus 274 ~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 444 358999999999999999887 899999999987654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.6e-14 Score=133.84 Aligned_cols=143 Identities=16% Similarity=0.104 Sum_probs=94.5
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhh---H----------------------------HH------hhhHH
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR---D----------------------------YM------EKFAP 55 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~----------------------------~~------~~~~~ 55 (351)
+.||+|++|+||+|+.+ +|+.||||+........ + .. +-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999865 78999999975421100 0 00 01233
Q ss_pred HHHHHHHhCC----CCCceeeeeEE-EeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHH
Q psy6327 56 REIDILLKVS----HPNIIGVHRMV-KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130 (351)
Q Consensus 56 ~Ei~~l~~l~----hp~iv~~~~~~-~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~ 130 (351)
+|+..+.++. |.+-+.+-.++ ...+..++||||++|++|.++....... ... . .++..++.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~~---~----------~ia~~~~~ 267 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LDR---K----------ALAENLAR 267 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CCH---H----------HHHHHHHH
Confidence 5666666652 33333333333 2234568999999999999876532111 111 1 12222232
Q ss_pred -HHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 131 -ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 131 -~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
.+..+|..|++|+|++|.||+++.++.++++|||++..+.
T Consensus 268 ~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 268 SFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 3567899999999999999999999999999999997754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.9e-15 Score=136.59 Aligned_cols=249 Identities=22% Similarity=0.267 Sum_probs=176.4
Q ss_pred ccceeeeeecCcccceEEEEEEec-CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK-RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~ 83 (351)
+.+|.++..||.|.|+.|+.+... .++..|++|........... ..+-..|+.+...+. |.+++..+..+..-...|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-DIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-hhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 457889999999999999987755 78889999987554443332 223337888888885 999999988888888888
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-CCeEEee
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-LNAKLAD 162 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~-~~~kl~D 162 (351)
+-.|||+++++...+.. ...+.+.. .+....|++.++.++|+..++|+|+||+||++..+ +..+++|
T Consensus 343 ip~e~~~~~s~~l~~~~--~~~~d~~~----------~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT--SQMLDEDP----------RLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred CchhhhcCcchhhhhHH--HHhcCcch----------hhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccc
Confidence 99999999998877632 23333332 23456788888999999999999999999999886 7789999
Q ss_pred ccccccccCCccccccccccccee-ccccc-cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYA-APEII-RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~-aPE~~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
||..+.+.-. .....+.-+++ .+|++ ....+.. +.|++|||..+++.++|..--.... ....... . .
T Consensus 411 ~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~-~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~-~--~ 479 (524)
T KOG0601|consen 411 FGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLS-KADIFSLGLSVDEAITGSPLSESGV----QSLTIRS-G--D 479 (524)
T ss_pred ccccccccee---cccccccccccccchhhcccccccc-ccccccccccccccccCcccCcccc----cceeeec-c--c
Confidence 9998752211 11222344455 25554 4444454 4999999999999998764432211 0110011 1 1
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
.+.....+.++..+.+.++.+|+..||.+.++..|.=|
T Consensus 480 ~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 480 TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 12222445788999999999999999999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.1e-13 Score=111.40 Aligned_cols=128 Identities=19% Similarity=0.129 Sum_probs=93.2
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEEEecCC
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-IGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~ 90 (351)
++.|+.|.++.||++... +..+++|........ ...+.+|+.+++.+.+.++ .+++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 567899999999998864 778999987543211 1223479999998865444 45555543 23479999999
Q ss_pred CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCc-----eeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 91 KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGI-----VHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 91 ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i-----~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|.++.+.- ... ...+.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.
T Consensus 75 G~~l~~~~-------~~~-------------~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 75 GSELLTED-------FSD-------------PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred CCcccccc-------ccC-------------HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 98876430 000 0134577888889999985 9999999999999 56799999998
Q ss_pred ccc
Q psy6327 166 SRL 168 (351)
Q Consensus 166 a~~ 168 (351)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=2e-12 Score=107.88 Aligned_cols=142 Identities=14% Similarity=0.145 Sum_probs=97.6
Q ss_pred eeecCcccceEEEEEEecC------CceeEEEEecchhhhh-----------------------hHHHhhhHHHHHHHHH
Q psy6327 12 ISKLGEGAYGNVYLVSDKR------SETLKACKAYDFKRLK-----------------------RDYMEKFAPREIDILL 62 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~-----------------------~~~~~~~~~~Ei~~l~ 62 (351)
...||.|--+.||.|.... .+..+|+|++...... ........++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998653 3578999998643210 0011122348999999
Q ss_pred hCC--CCCceeeeeEEEeCCEEEEEEecCCCCChHH-HHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHh-HhC
Q psy6327 63 KVS--HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEH-YISKACNENIHENQARIWIRQIANALEYLHEIANALEYL-HEV 138 (351)
Q Consensus 63 ~l~--hp~iv~~~~~~~~~~~~~lv~e~~~ggsL~~-~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~l-H~~ 138 (351)
++. .-+++..+.+ ..-+|||||+.++.+.. .++. ..+++.. ...+..+++.+|..| |..
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~----------~~~i~~~i~~~l~~l~H~~ 144 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEE----------MKNAYYQVLSMMKQLYKEC 144 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHH----------HHHHHHHHHHHHHHHHHhC
Confidence 996 3566677765 34679999997654421 2222 1222222 223456788888888 899
Q ss_pred CceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 139 GIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 139 ~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
|++|+||++.||++++ +.+.|+|||.+-....
T Consensus 145 glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 145 NLVHADLSEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CeecCCCCHHHEEEEC-CcEEEEECCCceeCCC
Confidence 9999999999999975 6799999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.9e-12 Score=100.94 Aligned_cols=147 Identities=21% Similarity=0.231 Sum_probs=104.4
Q ss_pred eeeecCcccceEEEEEEecCCceeEEEEecchhh-----hhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKR-----LKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
.+..|-+|+-+.|+.+.+. |+...||.=..+. +......+..++|+.++.++.--+|.--.-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5788999999999998765 7776666543333 34444456667899999998744554333344444455789
Q ss_pred EecCCC-CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC---eEEe
Q psy6327 86 MDYAEK-KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN---AKLA 161 (351)
Q Consensus 86 ~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~---~kl~ 161 (351)
|||++| .++.+++.............. .++..|-+.+.-||.++|+|+||..+||++..++. +.++
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~----------~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lI 158 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLA----------ELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILI 158 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHH----------HHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEE
Confidence 999985 488999877544443332222 35566667777999999999999999999977543 5899
Q ss_pred eccccccc
Q psy6327 162 DFGFSRLL 169 (351)
Q Consensus 162 Dfg~a~~~ 169 (351)
|||++...
T Consensus 159 dfgls~~s 166 (229)
T KOG3087|consen 159 DFGLSSVS 166 (229)
T ss_pred eecchhcc
Confidence 99998754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1e-11 Score=100.40 Aligned_cols=135 Identities=24% Similarity=0.286 Sum_probs=96.7
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhh-----hhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKR-----LKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
..+++|+-+.+|.+... |..+.+|.=..+. +..........+|+.++.++.--.|.--.=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999998654 3334444433333 3333334445689999999875555444444445566779999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|++|..|.+.+... . ..++..+-.-+.-||..||+|+||.++||.++.++ +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-----~--------------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-----R--------------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-----c--------------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99999999898763 1 12445555666789999999999999999998865 9999999998
Q ss_pred cc
Q psy6327 168 LL 169 (351)
Q Consensus 168 ~~ 169 (351)
+-
T Consensus 140 ~s 141 (204)
T COG3642 140 FS 141 (204)
T ss_pred cc
Confidence 63
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.1e-12 Score=122.61 Aligned_cols=155 Identities=21% Similarity=0.339 Sum_probs=114.3
Q ss_pred HHHHHHHHhHhC-CceeccCCCCCEeEcCCCCeEEeeccccccccCCccc---------ccccccccceeccccccCCCC
Q psy6327 127 EIANALEYLHEV-GIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL---------SNTFCGTTSYAAPEIIRNSPY 196 (351)
Q Consensus 127 qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~ 196 (351)
+++.|+.|+|.. ++||++|.|++|.++..+.+||+.|+++-....+... ..-..-...|.|||.+.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 455788899975 8999999999999999999999999988654442111 011123568999999988665
Q ss_pred CCCcchHHHHHHHHHHHH-hCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 197 NPKLADIWSLGVVLYRIL-NKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 197 ~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
... +|+||+|+++|.+. .|+.-+...+......+......-..+-...+++.++++=+.++|..++..||++.+++..
T Consensus 187 ~~~-sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 TPA-SDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccc-ccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 555 99999999999999 4555554443222222222222222333345799999999999999999999999999999
Q ss_pred ccccCCc
Q psy6327 276 AWIQNEP 282 (351)
Q Consensus 276 p~~~~~~ 282 (351)
|||.+..
T Consensus 266 ~ff~D~~ 272 (700)
T KOG2137|consen 266 PFFSDPG 272 (700)
T ss_pred cccCCch
Confidence 9998754
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-10 Score=107.10 Aligned_cols=214 Identities=14% Similarity=0.213 Sum_probs=153.2
Q ss_pred eEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE----eCCEEEEEEecCCC-CChH
Q psy6327 21 GNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK----AGTYLYMIMDYAEK-KDLE 95 (351)
Q Consensus 21 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~----~~~~~~lv~e~~~g-gsL~ 95 (351)
.+.|+|....+|..|++|.+...+....... . .-+++++++.|+|||++.+++. .+..+++|++|.++ ++|.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~--t-~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKD--T-SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccc--h-HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 5689999999999999999855444332111 1 4688999999999999999986 34579999999885 5777
Q ss_pred HHHHhhc-------------cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 96 HYISKAC-------------NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 96 ~~l~~~~-------------~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++.-... +...+|... ..|+.|+..||.++|+.|+.-+-|.|.+|+++.+.+++|+.
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~l----------W~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~ 436 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVL----------WSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISG 436 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHH----------HHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEec
Confidence 7652211 112233332 24778888888999999999999999999999998999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
.|....+..... |-+.. ..+-|.=.||.++.-|.||..--...+.....-...+
T Consensus 437 C~i~Dvl~~d~~--------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------- 490 (655)
T KOG3741|consen 437 CGIMDVLQEDPT--------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------- 490 (655)
T ss_pred ccceeeecCCCC--------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh--------
Confidence 998877654431 11111 1236999999999999999654322221111101111
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....|.+++++|.-+...++.+ -++.+++.+
T Consensus 491 -~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 -TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1257889999999999999987 688888875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.7e-10 Score=97.97 Aligned_cols=151 Identities=18% Similarity=0.261 Sum_probs=98.9
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC--CCceeeeeEEEeC---CEEEEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH--PNIIGVHRMVKAG---TYLYMIM 86 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~~---~~~~lv~ 86 (351)
++.||.|.++.||++.... |..+++|........ .....+.+|+.+++.+.+ .++.+++.+.... +..++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 4678999999999998643 678999987544321 113344589999999975 4467777776654 3678999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI-------------------------------------- 128 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi-------------------------------------- 128 (351)
||++|.++.+.+.. ..++......+..++..++..+|++
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99999888765421 2233333333333333333333221
Q ss_pred -HHHHHHhH-------hCCceeccCCCCCEeEcC--CCCeEEeecccccc
Q psy6327 129 -ANALEYLH-------EVGIVHRDIKCENILISR--LLNAKLADFGFSRL 168 (351)
Q Consensus 129 -~~~l~~lH-------~~~i~H~Dlkp~NIll~~--~~~~kl~Dfg~a~~ 168 (351)
...+..+. ...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 11122222 346899999999999998 56689999998865
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.3e-09 Score=90.68 Aligned_cols=129 Identities=23% Similarity=0.292 Sum_probs=78.0
Q ss_pred EEEEEEecCCceeEEEEecchhhh-----------------------hhHHHhhhHHHHHHHHHhCCCC--CceeeeeEE
Q psy6327 22 NVYLVSDKRSETLKACKAYDFKRL-----------------------KRDYMEKFAPREIDILLKVSHP--NIIGVHRMV 76 (351)
Q Consensus 22 ~V~~~~~~~~~~~~aiK~~~~~~~-----------------------~~~~~~~~~~~Ei~~l~~l~hp--~iv~~~~~~ 76 (351)
.||.|... +|..+|+|+...... .........++|...|.++..- ++++.+.+.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888764 567889998854221 1112234456899999999754 567777553
Q ss_pred EeCCEEEEEEecCC--CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHH-HhHhCCceeccCCCCCEeEc
Q psy6327 77 KAGTYLYMIMDYAE--KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE-YLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 77 ~~~~~~~lv~e~~~--ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~-~lH~~~i~H~Dlkp~NIll~ 153 (351)
. -+|||||++ |..+..+... .+....... ++.+++..+. .+|..||+|+||.+.||+++
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~----------~~~~il~~~~~~~~~~givHGDLs~~NIlv~ 141 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLKDV----DLSPEEPKE----------LLEEILEEIIKMLHKAGIVHGDLSEYNILVD 141 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHHHC----GGGGSTHHH----------HHHHHHHHHHHHHHCTTEEESS-STTSEEEE
T ss_pred --C--CEEEEEecCCCccchhhHHhc----cccchhHHH----------HHHHHHHHHHHHHHhcCceecCCChhhEEee
Confidence 2 369999998 6666554432 111112222 3344444333 46899999999999999999
Q ss_pred CCCCeEEeecccccccc
Q psy6327 154 RLLNAKLADFGFSRLLR 170 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~ 170 (351)
++ .+.|+|||.+....
T Consensus 142 ~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 142 DG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TT-CEEE--GTTEEETT
T ss_pred cc-eEEEEecCcceecC
Confidence 87 89999999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.6e-09 Score=95.55 Aligned_cols=242 Identities=17% Similarity=0.223 Sum_probs=148.1
Q ss_pred eeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCcee--------eeeEEEeCC
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIG--------VHRMVKAGT 80 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~--------~~~~~~~~~ 80 (351)
...+.||+|+-+.+|..-...+ . +.|++......... .-+..|... .||-+-. ++|- ..+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~-VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--Q-VAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGK 83 (637)
T ss_pred CCCccccCCccceeeecchhhc--h-hheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCC-Cccc
Confidence 4467799999999997544322 2 34777655543321 233344444 3554433 1221 1223
Q ss_pred EEEEEEecCCCCC-hHHHHHh-hccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 81 YLYMIMDYAEKKD-LEHYISK-ACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 81 ~~~lv~e~~~ggs-L~~~l~~-~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
.+-++|..+.|.. +.++... .....+++-. . --++...+.++.+...||..|.+-+|+.++|+|+++++.+
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~-w------~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V 156 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCA-W------DFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKV 156 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccc-c------HHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceE
Confidence 3778888888652 2222211 1112222211 1 1245678899999999999999999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccceecccccc-----CCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCC-----c
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR-----NSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTR-----N 227 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~-----~ 227 (351)
.|.|=..-.. +..+......+|.+.|.+||... +..-+.. .|.|.||+++++++.| ++||++.-.. .
T Consensus 157 ~LVdsDsfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 157 VLVDSDSFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred EEEcccceee-ccCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 9998664433 23334455678999999999865 2222333 8999999999999986 9999653210 0
Q ss_pred hH--H-----HHhhhCcccccc-----ccccCCHhHHHHHHHhcCC--CCCCCCCHH
Q psy6327 228 RD--V-----LKKQEGKEYLFN-----RKYEISIGAKQLIGRMLEP--NPKHRPNAK 270 (351)
Q Consensus 228 ~~--~-----~~~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~--dp~~Rpt~~ 270 (351)
.+ + ...........+ ...-+++++..|..+|+.. ++.-|||+.
T Consensus 235 ~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 235 LETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred chhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 00 0 000001111111 1123678899999999875 367899965
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=6e-09 Score=91.79 Aligned_cols=136 Identities=13% Similarity=0.083 Sum_probs=87.9
Q ss_pred eEEEEEEecCCceeEEEEecchhhhhh---H-----HHhhhHHHHHHHHHhCCCCCc--eeeeeEEEe-----CCEEEEE
Q psy6327 21 GNVYLVSDKRSETLKACKAYDFKRLKR---D-----YMEKFAPREIDILLKVSHPNI--IGVHRMVKA-----GTYLYMI 85 (351)
Q Consensus 21 g~V~~~~~~~~~~~~aiK~~~~~~~~~---~-----~~~~~~~~Ei~~l~~l~hp~i--v~~~~~~~~-----~~~~~lv 85 (351)
..|+++.. .|+.+.+|......... . .......+|...+..|...+| +....+++. ....++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 33555533 46788899764322110 0 001124488888888853333 344444432 2357899
Q ss_pred EecCCCC-ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-------CCC
Q psy6327 86 MDYAEKK-DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-------LLN 157 (351)
Q Consensus 86 ~e~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-------~~~ 157 (351)
||++++. +|.+++........++... ..++.+++..+.-||..||+|+|++++|||++. +..
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~----------~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLK----------RMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHH----------HHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCce
Confidence 9999976 8999986432223232222 235667888888999999999999999999975 467
Q ss_pred eEEeecccccc
Q psy6327 158 AKLADFGFSRL 168 (351)
Q Consensus 158 ~kl~Dfg~a~~ 168 (351)
+.|+||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.6e-08 Score=83.87 Aligned_cols=105 Identities=24% Similarity=0.241 Sum_probs=75.9
Q ss_pred hHHHHHHHHHhCCC--CCceeeeeEEEeC----CEEEEEEecCCCC-ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHH
Q psy6327 53 FAPREIDILLKVSH--PNIIGVHRMVKAG----TYLYMIMDYAEKK-DLEHYISKACNENIHENQARIWIRQIANALEYL 125 (351)
Q Consensus 53 ~~~~Ei~~l~~l~h--p~iv~~~~~~~~~----~~~~lv~e~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~ 125 (351)
...+|...+..|.. -.+++.+.+.+.. ...++|+|+++|. +|.+++..... .+..... .++
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~----------~ll 124 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRR----------ELL 124 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHH----------HHH
Confidence 34478888877753 3344555555442 2468999999974 79999875221 2222222 356
Q ss_pred HHHHHHHHHhHhCCceeccCCCCCEeEcCCC---CeEEeeccccccc
Q psy6327 126 HEIANALEYLHEVGIVHRDIKCENILISRLL---NAKLADFGFSRLL 169 (351)
Q Consensus 126 ~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~---~~kl~Dfg~a~~~ 169 (351)
.+++..+.-||..||+|+|+++.|||++.++ .+.++||+.++..
T Consensus 125 ~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 125 RALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 6777888899999999999999999999887 7999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.2e-08 Score=86.05 Aligned_cols=138 Identities=22% Similarity=0.239 Sum_probs=95.0
Q ss_pred eeeeecCcccceEEEEEEecCCceeEEEEecchhhhh-------hH------------HHhhhHHHHHHHHHhCCCC--C
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-------RD------------YMEKFAPREIDILLKVSHP--N 68 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~------------~~~~~~~~Ei~~l~~l~hp--~ 68 (351)
.+...||-|.-|.||.|.+. .|..+|+|.-.....+ .+ ......++|..+|..|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999987 6778888865332211 00 1122345899999999744 6
Q ss_pred ceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCC
Q psy6327 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCE 148 (351)
Q Consensus 69 iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~ 148 (351)
|.+.+++ +...+||||++|-.|...-- ...... .++..|++-+.-.-..||+|+|+++-
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~----------~il~~il~~~~~~~~~GiVHGDlSef 231 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPD----------EILDKILEEVRKAYRRGIVHGDLSEF 231 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-------cccCHH----------HHHHHHHHHHHHHHHcCccccCCchh
Confidence 7777665 45689999999877654321 011111 12333444444445899999999999
Q ss_pred CEeEcCCCCeEEeeccccccc
Q psy6327 149 NILISRLLNAKLADFGFSRLL 169 (351)
Q Consensus 149 NIll~~~~~~kl~Dfg~a~~~ 169 (351)
||+++++|.+.++||--+...
T Consensus 232 NIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred eEEEecCCCEEEEeCcccccC
Confidence 999999999999999766543
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.4e-09 Score=101.24 Aligned_cols=243 Identities=21% Similarity=0.177 Sum_probs=163.3
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCC-ceeeeeEEEeCCEEEEEEe
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN-IIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~~~~lv~e 87 (351)
+....-+++|+++.+++.+...+.... .+.+... . ..+-++++|.+++||| .+..++-+..+...+++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l-------~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-L-------SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-h-------hhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 345667889999999998776555444 4444322 1 1225899999999999 7888888888899999999
Q ss_pred cCCCC-ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKK-DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
++.++ +..... ...+..... .+ -....+.-.++++++|+.--+|+| ||+... +..+..||+..
T Consensus 315 i~s~~rs~~~~~------~~se~~~~~--~~---~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~ 378 (829)
T KOG0576|consen 315 ICSTGRSSALEM------TVSEIALEQ--YQ---FAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVP 378 (829)
T ss_pred hhcCCccccccC------ChhhHhhhh--hh---hhhhhhhhcccccccccccccCcc----cccccc-cccccccccCC
Confidence 99877 222111 112211111 11 112344556788899998878998 777766 66899999998
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc--ccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK--EYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~ 244 (351)
..+.... ...+..+++.++|||+.....+... .|.|++|.--.+|.-|.+|-..+-. ........ .+.....
T Consensus 379 ~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~----~~~~~g~~p~s~~L~~~ 452 (829)
T KOG0576|consen 379 PQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPA----VLPMIGNGPNSPMLTDK 452 (829)
T ss_pred cccCccc-ccccCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCcc----ccCCCCCCCCccccchh
Confidence 8765443 4566779999999999999888876 8999999877788888777644211 00001100 0111110
Q ss_pred ccCCHhH-HHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 245 YEISIGA-KQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 245 ~~~s~~~-~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
...+... .++...|+..-|-.|+....++-|.+|.+-+
T Consensus 453 ~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 453 SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 1112222 2588899999999999999999888887543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.67 E-value=4e-07 Score=78.55 Aligned_cols=146 Identities=18% Similarity=0.133 Sum_probs=85.0
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCC--CceeeeeEEEeCCEEEEEEecCC
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP--NIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
..||+|..+.||+. .+..+++|........ ..+.+|.++++.+..- .+.+.+.+.+..+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~-----~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDK-----ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCH-----HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999974 2446778877542211 2235899999998643 35778888888888899999999
Q ss_pred CCC-hHHHH--------------Hh----hccC---CCchHH-HHHHHHHHHHHHHHHHHHHH-HHHHhH----hCCcee
Q psy6327 91 KKD-LEHYI--------------SK----ACNE---NIHENQ-ARIWIRQIANALEYLHEIAN-ALEYLH----EVGIVH 142 (351)
Q Consensus 91 ggs-L~~~l--------------~~----~~~~---~~~~~~-~~~~~~~i~~~~~~~~qi~~-~l~~lH----~~~i~H 142 (351)
|.+ +...+ .+ -... ...... ...+..++...-.....+.. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 864 21111 11 0000 001001 01111111100000000111 122222 224789
Q ss_pred ccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 143 RDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 143 ~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+|+.|.||++++++ +.++||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.4e-07 Score=76.45 Aligned_cols=138 Identities=18% Similarity=0.162 Sum_probs=83.4
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHH------hhhHHHHHHHHHhCCC---CCceeeeeEE--
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM------EKFAPREIDILLKVSH---PNIIGVHRMV-- 76 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~------~~~~~~Ei~~l~~l~h---p~iv~~~~~~-- 76 (351)
+|.+++.+-......|.+. .-+|..+.+|....+....... .....+++..+.++.. -....++-+.
T Consensus 32 ~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 32 NYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 4666666666555555544 3346788888775443221111 1112244554444432 2223323222
Q ss_pred ---EeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 77 ---KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 77 ---~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
.-....+++|||++|..|.+... +++. +...+..++.-+|+.|++|+|..|.|++++
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~--------------~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED------IDED--------------LAEKIVEAIKQLHKHGFYHGDPHPGNFLVS 169 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh------cCHH--------------HHHHHHHHHHHHHHcCCccCCCCcCcEEEE
Confidence 22244668999999998877542 1111 223455667789999999999999999999
Q ss_pred CCCCeEEeecccccc
Q psy6327 154 RLLNAKLADFGFSRL 168 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~ 168 (351)
+++ ++++||+..+.
T Consensus 170 ~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 170 NNG-IRIIDTQGKRM 183 (229)
T ss_pred CCc-EEEEECccccc
Confidence 755 99999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.2e-07 Score=90.46 Aligned_cols=145 Identities=17% Similarity=0.142 Sum_probs=91.9
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhh---H----------------------------H------HhhhHH
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR---D----------------------------Y------MEKFAP 55 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~----------------------------~------~~~~~~ 55 (351)
..|+.++-|+||+|+... |+.||||+....-... + . .+-.+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 568899999999999764 9999999874322100 0 0 011223
Q ss_pred HHHHHHHhCC-----CCCceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHH
Q psy6327 56 REIDILLKVS-----HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130 (351)
Q Consensus 56 ~Ei~~l~~l~-----hp~iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~ 130 (351)
+|+..+.++. .|+|.--.=+++-.+.-.++|||++|..+.+...-.. ...+..... ..+.. .++.|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~--~f~~q~-- 281 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVR--AFLRQL-- 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHH--HHHHHH--
Confidence 5666666553 3443222222233455689999999999998853221 333322211 11111 133332
Q ss_pred HHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 131 ~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
=..|++|.|..|.||+++.+|.+.+.|||....+.+
T Consensus 282 -----~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 -----LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -----HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 247999999999999999999999999999887654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.3e-07 Score=75.24 Aligned_cols=142 Identities=13% Similarity=0.108 Sum_probs=92.2
Q ss_pred cCcccceEEEEEEecCCceeEEEEecchh---hhhhHHHhhhHHHHHHHHHhCCC--CCceeeeeE--EEeC--CEEEEE
Q psy6327 15 LGEGAYGNVYLVSDKRSETLKACKAYDFK---RLKRDYMEKFAPREIDILLKVSH--PNIIGVHRM--VKAG--TYLYMI 85 (351)
Q Consensus 15 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~--~~~~--~~~~lv 85 (351)
-|+||-+-|+..... |+.+-+|.-... ......-...+.+|+..+.+|.. -.+.+.... ...+ -..+||
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 467899999987654 335777764210 00101124455689999998863 224444411 1121 247899
Q ss_pred EecCCC-CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC--eEEee
Q psy6327 86 MDYAEK-KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN--AKLAD 162 (351)
Q Consensus 86 ~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~--~kl~D 162 (351)
+|-+.| .+|.+++.+....+.+..... .++.+++..+.-||+.|+.|+|+.+.|||++.++. ++++|
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~----------~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQ----------AMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHH----------HHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEE
Confidence 997754 588888865322222332222 35667888888999999999999999999986667 99999
Q ss_pred cccccc
Q psy6327 163 FGFSRL 168 (351)
Q Consensus 163 fg~a~~ 168 (351)
|.-++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 987664
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.3e-07 Score=76.01 Aligned_cols=142 Identities=17% Similarity=0.227 Sum_probs=91.3
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhH---------------------HHhhhHHHHHHHHHhCC--CCC
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD---------------------YMEKFAPREIDILLKVS--HPN 68 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---------------------~~~~~~~~Ei~~l~~l~--hp~ 68 (351)
...|+.|--+.||+|.. .++..+|+|++......-. ........|...|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 44678899999999875 4688999999976443221 11223446888888874 445
Q ss_pred ceeeeeEEEeCCEEEEEEecCCCCCh-HHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCC
Q psy6327 69 IIGVHRMVKAGTYLYMIMDYAEKKDL-EHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIK 146 (351)
Q Consensus 69 iv~~~~~~~~~~~~~lv~e~~~ggsL-~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlk 146 (351)
+.+-+.+.. -.|||||+..... .-.|+. ..+.... +..+..+++..+.-|-. .++||+||+
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD---v~~e~~e----------~~~~~~~~v~~~~~l~~~a~LVHgDLS 194 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKD---VPLELEE----------AEGLYEDVVEYMRRLYKEAGLVHGDLS 194 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCccc---CCcCchh----------HHHHHHHHHHHHHHHHHhcCcccccch
Confidence 556665543 4689999953310 111111 1111111 22334455556656655 899999999
Q ss_pred CCCEeEcCCCCeEEeeccccccccCC
Q psy6327 147 CENILISRLLNAKLADFGFSRLLRTP 172 (351)
Q Consensus 147 p~NIll~~~~~~kl~Dfg~a~~~~~~ 172 (351)
.-|||+. ++.+.|+|||-|.....+
T Consensus 195 EyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 195 EYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred hhheEEE-CCeEEEEECccccccCCC
Confidence 9999999 688999999988765433
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.1e-06 Score=86.91 Aligned_cols=201 Identities=16% Similarity=0.223 Sum_probs=138.0
Q ss_pred HHHHHHHHhCCCCCceeeeeEEEeCCE----EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHH
Q psy6327 55 PREIDILLKVSHPNIIGVHRMVKAGTY----LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130 (351)
Q Consensus 55 ~~Ei~~l~~l~hp~iv~~~~~~~~~~~----~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~ 130 (351)
..|+..+..+.|+|++.++.+.-.... ..+..++|..-++...+.. -...+....+. +..+..+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~----------~~~~~~~ 297 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRI----------LHQKLLE 297 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHH----------HHHHHhh
Confidence 357777888899999999988754432 3355678988899888876 45555555443 4567788
Q ss_pred HHHHhHhCCceeccCCCC---CEeEcCCCCeEEe--eccccccccCCcccccccccccceeccccccCCCCCCC-cchHH
Q psy6327 131 ALEYLHEVGIVHRDIKCE---NILISRLLNAKLA--DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPK-LADIW 204 (351)
Q Consensus 131 ~l~~lH~~~i~H~Dlkp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~Diw 204 (351)
|+.++|+....|.-|... +--.+..+.+.++ ||+.+......... ....-+..+.|||......+... ..|+|
T Consensus 298 GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 298 GLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred hHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHH
Confidence 888999996666665555 3344455666666 88888765543322 23335667889998876665533 26999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 205 SLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 205 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.+|.....+..|..+-.-... .. .+... .......+++.+|+.-++++|+++.+++.|||.+..
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~-----~~-------~~l~~-~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAV-----PV-------SLLDV-LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HHHHHHhhhhhcCcccccccc-----hh-------hhhcc-ccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 999999999987765422110 00 00000 112267889999999999999999999999998644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.38 E-value=8e-06 Score=70.53 Aligned_cols=150 Identities=19% Similarity=0.239 Sum_probs=82.5
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCC--CceeeeeEE---EeCCEEEEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP--NIIGVHRMV---KAGTYLYMIM 86 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--~iv~~~~~~---~~~~~~~lv~ 86 (351)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.|... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998765 48889986544 1123344788888887522 356666643 3445689999
Q ss_pred ecCCCCChHH----------------HHHhhccC-----CCchHHH--HHHHHHHHHHH-H--------HHHHHHH-HHH
Q psy6327 87 DYAEKKDLEH----------------YISKACNE-----NIHENQA--RIWIRQIANAL-E--------YLHEIAN-ALE 133 (351)
Q Consensus 87 e~~~ggsL~~----------------~l~~~~~~-----~~~~~~~--~~~~~~i~~~~-~--------~~~qi~~-~l~ 133 (351)
++++|.++.. .+..-... ....... ........... . ....+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988887 12111011 1111000 00001111000 0 0111222 233
Q ss_pred HhH-------hCCceeccCCCCCEeEc-CCCCeEEeecccccc
Q psy6327 134 YLH-------EVGIVHRDIKCENILIS-RLLNAKLADFGFSRL 168 (351)
Q Consensus 134 ~lH-------~~~i~H~Dlkp~NIll~-~~~~~kl~Dfg~a~~ 168 (351)
.++ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333 24599999999999999 556668999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.6e-06 Score=66.54 Aligned_cols=132 Identities=16% Similarity=0.142 Sum_probs=89.0
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEEEe
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-IGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e 87 (351)
-...+.||+|.+|.||++.+. |..+|+|+=..+.. ...+..|+++|..++-.++ .++|.+.+ .++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence 445778999999999999886 66889987543333 2334489999999986665 46666654 345599
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCC-CCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIK-CENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlk-p~NIll~~~~~~kl~Dfg~a 166 (351)
|++|-+|.+.-... + +..+. .+++.---|-..||-|..|. |..+++..++.+-|+||..|
T Consensus 93 ~i~G~~L~~~~~~~-----~----rk~l~----------~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~A 153 (201)
T COG2112 93 YIDGRPLGKLEIGG-----D----RKHLL----------RVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSA 153 (201)
T ss_pred hhcCcchhhhhhcc-----c----HHHHH----------HHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccch
Confidence 99988888765421 1 11111 22333224667899999886 44444444458999999999
Q ss_pred cccc
Q psy6327 167 RLLR 170 (351)
Q Consensus 167 ~~~~ 170 (351)
+...
T Consensus 154 t~k~ 157 (201)
T COG2112 154 TFKK 157 (201)
T ss_pred hhcc
Confidence 8543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.7e-05 Score=69.40 Aligned_cols=76 Identities=13% Similarity=0.027 Sum_probs=52.9
Q ss_pred ecCcccc-eEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEecCCC
Q psy6327 14 KLGEGAY-GNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIMDYAEK 91 (351)
Q Consensus 14 ~LG~G~~-g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~g 91 (351)
.|..|.. ..||++... +..+.+|...... ...+.+|+.+++.+. +-.+.+++.+....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3445555 789988653 3577788764332 122347999988884 45567888888777778999999998
Q ss_pred CChHHH
Q psy6327 92 KDLEHY 97 (351)
Q Consensus 92 gsL~~~ 97 (351)
.+|...
T Consensus 77 ~~l~~~ 82 (244)
T cd05150 77 VPAAAL 82 (244)
T ss_pred ccHhHh
Confidence 877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.7e-05 Score=81.40 Aligned_cols=82 Identities=17% Similarity=0.265 Sum_probs=56.5
Q ss_pred eeeecCcccceEEEEEEecCCc--eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCc--eeeeeEEEeC---CEE
Q psy6327 11 YISKLGEGAYGNVYLVSDKRSE--TLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNI--IGVHRMVKAG---TYL 82 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~i--v~~~~~~~~~---~~~ 82 (351)
-+..++.|.+..+|+......+ ..+++|+......... ...+.+|+.+++.+. |+++ .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~--~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS--AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc--HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998765432 4667776543322111 234558999999995 6655 7888877654 468
Q ss_pred EEEEecCCCCCh
Q psy6327 83 YMIMDYAEKKDL 94 (351)
Q Consensus 83 ~lv~e~~~ggsL 94 (351)
|+||||++|..+
T Consensus 120 flVME~v~G~~~ 131 (822)
T PLN02876 120 FYIMEYLEGRIF 131 (822)
T ss_pred eEEEEecCCccc
Confidence 999999997643
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=98.23 E-value=9.9e-08 Score=98.27 Aligned_cols=227 Identities=17% Similarity=0.076 Sum_probs=141.4
Q ss_pred EecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE--eCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHH
Q psy6327 38 KAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK--AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWI 115 (351)
Q Consensus 38 K~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~ 115 (351)
|.++.+.+.+... +....|...++...|+++.....-.. +....|.+++|+.+|.+++.|-+.....-+... ..+
T Consensus 1261 ke~d~e~LsePlk-emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~--~~v 1337 (2724)
T KOG1826|consen 1261 KEYDFENLSEPLK-EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR--SPV 1337 (2724)
T ss_pred hhhhHHHHhhHHH-HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh--chH
Confidence 4444444443322 22224555566678999887766553 344578999999999999999764332222221 111
Q ss_pred HHHHHHHHHHHHH-HHHHHHhHhC-----CceeccCCCCCEeEcCCCCeEEeeccccccccCCcccccccccccceeccc
Q psy6327 116 RQIANALEYLHEI-ANALEYLHEV-----GIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189 (351)
Q Consensus 116 ~~i~~~~~~~~qi-~~~l~~lH~~-----~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE 189 (351)
. ..+++ .....-+|+. -.+|++||+-|.+|..+.++|++++|+.+.........+..++++.|++|+
T Consensus 1338 ~-------~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~ql 1410 (2724)
T KOG1826|consen 1338 H-------LRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQL 1410 (2724)
T ss_pred H-------HHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHH
Confidence 1 11222 3334444543 268999999999999999999999999996666666777888999999999
Q ss_pred cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCH
Q psy6327 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNA 269 (351)
Q Consensus 190 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 269 (351)
+...-.++.+ +|+|..|+.+|....|..+|.... . ...+.+....-.+..+.-.|.++-.....+|-+.-..||.-
T Consensus 1411 i~N~ik~t~r-sdilr~s~~ly~rs~~n~~fi~fl--q-~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q 1486 (2724)
T KOG1826|consen 1411 IKNEIKFTKR-SDILRRSLSLYLRSDGNAYFIFFL--Q-PALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQ 1486 (2724)
T ss_pred HHHHHhhhhH-HHHHHHHHHHHHHhcccHHHHHHH--H-HHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchh
Confidence 9888777765 999999999999998888873211 0 01111110111111111123344444445555555677776
Q ss_pred HHHhcCccc
Q psy6327 270 KDVQNHAWI 278 (351)
Q Consensus 270 ~ell~hp~~ 278 (351)
...+..+.+
T Consensus 1487 ~isls~d~~ 1495 (2724)
T KOG1826|consen 1487 YISLSRDHF 1495 (2724)
T ss_pred hhhcccccc
Confidence 666665544
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.1e-05 Score=77.09 Aligned_cols=143 Identities=18% Similarity=0.176 Sum_probs=87.2
Q ss_pred eecCcccceEEEEEEecCCceeEEEEecchhhhhh---H-------------------------HHhh------hHHHHH
Q psy6327 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR---D-------------------------YMEK------FAPREI 58 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~-------------------------~~~~------~~~~Ei 58 (351)
+.||.-+.|+||+|+.+. |+.||||+-...-... + ...+ .+.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568999999999999776 9999999864322110 0 0011 122344
Q ss_pred HHHHhC----CCCC------ceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHH
Q psy6327 59 DILLKV----SHPN------IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128 (351)
Q Consensus 59 ~~l~~l----~hp~------iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi 128 (351)
+...+. .|-+ |.++|..+. +...|+||||+|..+.|+-.=. ...++... +...+.++ |+.||
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~---i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAID-KRGISPHD---ILNKLVEA--YLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHH-HcCCCHHH---HHHHHHHH--HHHHH
Confidence 444333 2444 444544443 3467999999998887663211 22333222 11122221 22332
Q ss_pred HHHHHHhHhCCceeccCCCCCEeEcC----CCCeEEeeccccccccC
Q psy6327 129 ANALEYLHEVGIVHRDIKCENILISR----LLNAKLADFGFSRLLRT 171 (351)
Q Consensus 129 ~~~l~~lH~~~i~H~Dlkp~NIll~~----~~~~kl~Dfg~a~~~~~ 171 (351)
=..|.+|+|-.|.||+++. ++.+.+-|||+...+..
T Consensus 318 -------f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 -------FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -------HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3468999999999999984 57799999999876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.1e-05 Score=64.67 Aligned_cols=128 Identities=21% Similarity=0.309 Sum_probs=87.5
Q ss_pred cceeeeeecCcccc-eEEEEEEecCCceeEEEEecch---hhh-------hhH--------HHhhhHHHHHHHHHhCC--
Q psy6327 7 LECSYISKLGEGAY-GNVYLVSDKRSETLKACKAYDF---KRL-------KRD--------YMEKFAPREIDILLKVS-- 65 (351)
Q Consensus 7 ~~~~~~~~LG~G~~-g~V~~~~~~~~~~~~aiK~~~~---~~~-------~~~--------~~~~~~~~Ei~~l~~l~-- 65 (351)
.++++++.||.|+- |.||++... |+.||+|.+.. ... ... ....-+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57899999999999 999999765 88999999321 111 100 11223447888877775
Q ss_pred -CCCc--eeeeeEEEeC------------------CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHH
Q psy6327 66 -HPNI--IGVHRMVKAG------------------TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124 (351)
Q Consensus 66 -hp~i--v~~~~~~~~~------------------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~ 124 (351)
+.++ |+.+|+..-. ....||-||.+... .+.. .-
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~--------------~~ 169 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI--------------RD 169 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch--------------hH
Confidence 5566 8999987211 13467888776443 0010 12
Q ss_pred HHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 125 ~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
+.+|.+-|..+|..||+-+|+++.|.. .-||+|||.+
T Consensus 170 ~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 345666677899999999999999984 4589999964
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.19 E-value=4e-05 Score=66.54 Aligned_cols=149 Identities=18% Similarity=0.227 Sum_probs=83.0
Q ss_pred eeecCcccceEEEEEEecC-CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCC-ceeeeeEEEeCCEEEEEEecC
Q psy6327 12 ISKLGEGAYGNVYLVSDKR-SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN-IIGVHRMVKAGTYLYMIMDYA 89 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~~~~lv~e~~ 89 (351)
++.|..|-...+|++.... .+..+.+|+....... .....+|+.+++.+...+ .++++..... .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 5668888889999987543 3567888876532211 111237898988885333 4455544332 3799999
Q ss_pred CCCChHHH--------------HHhhccCCCc-------------hHHHHHHHHHHHHH---------------HHHHHH
Q psy6327 90 EKKDLEHY--------------ISKACNENIH-------------ENQARIWIRQIANA---------------LEYLHE 127 (351)
Q Consensus 90 ~ggsL~~~--------------l~~~~~~~~~-------------~~~~~~~~~~i~~~---------------~~~~~q 127 (351)
+|.++... +.+-.....+ ......|...+... ...+.+
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98765321 1111111110 01222232222110 011122
Q ss_pred HHHHHHH-hH----hCCceeccCCCCCEeEcC-CCCeEEeecccccc
Q psy6327 128 IANALEY-LH----EVGIVHRDIKCENILISR-LLNAKLADFGFSRL 168 (351)
Q Consensus 128 i~~~l~~-lH----~~~i~H~Dlkp~NIll~~-~~~~kl~Dfg~a~~ 168 (351)
.+..|.. +. ..+++|+|+.+.|||++. ++.+.++||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2222211 21 236999999999999998 57799999988764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.00013 Score=61.33 Aligned_cols=135 Identities=21% Similarity=0.253 Sum_probs=87.5
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhh-------------hhHHHhhhHHHHHHHHHhCC------CCCceee
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL-------------KRDYMEKFAPREIDILLKVS------HPNIIGV 72 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~~~Ei~~l~~l~------hp~iv~~ 72 (351)
...||+|+.-.||.- ..+. ...||+...... .........++|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp-~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDP-NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CCCC-CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457999999999963 3332 345777765550 00011222335666655555 8899999
Q ss_pred eeEEEeCCEEEEEEecCCC------CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCC
Q psy6327 73 HRMVKAGTYLYMIMDYAEK------KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIK 146 (351)
Q Consensus 73 ~~~~~~~~~~~lv~e~~~g------gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlk 146 (351)
+|+.+++.-.-+|+|.+.+ .+|.++++. ..+++ ... .+ +-+-..+|-+.+|+.+|++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~-------~~------L~~f~~~l~~~~Iv~~dl~ 145 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELR-------QA------LDEFKRYLLDHHIVIRDLN 145 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHH-------HH------HHHHHHHHHHcCCeecCCC
Confidence 9999999989999997542 478888854 33443 211 11 1223348889999999999
Q ss_pred CCCEeEcCC--C--CeEEee-cccc
Q psy6327 147 CENILISRL--L--NAKLAD-FGFS 166 (351)
Q Consensus 147 p~NIll~~~--~--~~kl~D-fg~a 166 (351)
|.||++... + .+.|+| ||..
T Consensus 146 ~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 146 PHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cccEEEEecCCCceEEEEEeCCCCc
Confidence 999999653 2 466776 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.5e-05 Score=66.28 Aligned_cols=74 Identities=8% Similarity=0.081 Sum_probs=44.8
Q ss_pred eeecCcccce-EEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCC---CceeeeeEEEeC---CEEEE
Q psy6327 12 ISKLGEGAYG-NVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP---NIIGVHRMVKAG---TYLYM 84 (351)
Q Consensus 12 ~~~LG~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---~iv~~~~~~~~~---~~~~l 84 (351)
++.|+.|+.. .||... ..+.+|...... . ...+.+|+.++..|... .+.+++...... ...++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-~----~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-Y----AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-h----HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 4567777776 599762 346677644311 1 22355899999888532 344455443322 24588
Q ss_pred EEecCCCCChH
Q psy6327 85 IMDYAEKKDLE 95 (351)
Q Consensus 85 v~e~~~ggsL~ 95 (351)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00012 Score=65.94 Aligned_cols=152 Identities=14% Similarity=0.196 Sum_probs=84.5
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCC--CceeeeeE------EEeCC
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP--NIIGVHRM------VKAGT 80 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--~iv~~~~~------~~~~~ 80 (351)
..-++.|..|....+|++... +..+++|+... ... ..+..|+.++..|.+. .+.+++.. ....+
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~----~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSA----EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred hhheecccCccccceEEEEeC--CCcEEEEEcCC--CCh----HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 334677888888899987543 34688888753 111 2233688888877432 24444432 23445
Q ss_pred EEEEEEecCCCCChHH-----------HHHhhc--cCCCc----hHHHHHHHHHHHHHH------HHHHHHHHHHHHhHh
Q psy6327 81 YLYMIMDYAEKKDLEH-----------YISKAC--NENIH----ENQARIWIRQIANAL------EYLHEIANALEYLHE 137 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~-----------~l~~~~--~~~~~----~~~~~~~~~~i~~~~------~~~~qi~~~l~~lH~ 137 (351)
..++|++|++|.++.. .+.+-. ...+. ......|.......+ .....+..++.++..
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999999876532 111000 00000 001111211111100 011112233444443
Q ss_pred -------CCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 138 -------VGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 138 -------~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999877678999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00022 Score=66.44 Aligned_cols=80 Identities=15% Similarity=0.044 Sum_probs=53.1
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhh--hh--HHHhhhHHHHHHHHHhCC---CCCceeeeeEEEeCCEEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL--KR--DYMEKFAPREIDILLKVS---HPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~--~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~l 84 (351)
.+.||.|.+..||++...+.++.+.||.-..... .. .........|...|+.+. ..++++++.+.. ...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 5779999999999999865446889997431110 00 011223346888888763 346777887743 55789
Q ss_pred EEecCCCCC
Q psy6327 85 IMDYAEKKD 93 (351)
Q Consensus 85 v~e~~~ggs 93 (351)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00036 Score=63.21 Aligned_cols=155 Identities=15% Similarity=0.181 Sum_probs=82.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCC--CceeeeeE------EEe
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP--NIIGVHRM------VKA 78 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--~iv~~~~~------~~~ 78 (351)
.+...++.++.|....+|.+.. .+| .+.+|.+.... .. ..+..|+.++..|... .+.+++.. ...
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~----~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KA----EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-CH----HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 3445577788888889998763 334 57788764321 11 1122567777766422 23444332 123
Q ss_pred CCEEEEEEecCCCCChH-----------HHHHhhc--cCCCch-----HHHHHHHHHHHH---HH-----HHHHHHHHHH
Q psy6327 79 GTYLYMIMDYAEKKDLE-----------HYISKAC--NENIHE-----NQARIWIRQIAN---AL-----EYLHEIANAL 132 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~-----------~~l~~~~--~~~~~~-----~~~~~~~~~i~~---~~-----~~~~qi~~~l 132 (351)
.+..+++++|++|.++. ..+.... ...++. .....|...... .+ .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 46689999999985432 1111100 011100 001111111000 00 0111223344
Q ss_pred HHhH-------hCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 133 EYLH-------EVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 133 ~~lH-------~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+++. ..+++|+|+.+.||++++++...|+||+.+..
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 4443 25899999999999999887678999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=60.17 Aligned_cols=102 Identities=13% Similarity=0.068 Sum_probs=73.9
Q ss_pred HHHHHHHhCCC-CCceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy6327 56 REIDILLKVSH-PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134 (351)
Q Consensus 56 ~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~ 134 (351)
.|.-+++.+.+ +++++++|++. .++|.||...+++...- ..+.......| ....+++.++++.+++
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~-----~~l~~~~~~~w----~~R~~iA~~lL~~l~~ 74 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIY-----RPLSQFLQSPW----EQRAKIALQLLELLEE 74 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccc-----cccccccccCH----HHHHHHHHHHHHHHHH
Confidence 68889999975 69999999984 36788999877665320 00000000111 2234678888999999
Q ss_pred hHh---CCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 135 LHE---VGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 135 lH~---~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
++. ..+.-+|++|+|+-+++++++|++|...+....
T Consensus 75 l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 75 LDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred HhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 987 458889999999999999999999998876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0004 Score=62.76 Aligned_cols=76 Identities=18% Similarity=0.142 Sum_probs=48.8
Q ss_pred eeecCcccceEEEEEEecC------CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCC-ceeeeeEEEeCCEEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKR------SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN-IIGVHRMVKAGTYLYM 84 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~~~~l 84 (351)
++.|..|-...||++.... .++.+++|........ .....+|..++..+...+ ..+++.++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4567778888999987543 2578889986543211 112237888888885333 3456665542 25
Q ss_pred EEecCCCCChH
Q psy6327 85 IMDYAEKKDLE 95 (351)
Q Consensus 85 v~e~~~ggsL~ 95 (351)
|+||++|.++.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999987764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0003 Score=61.94 Aligned_cols=144 Identities=13% Similarity=0.128 Sum_probs=77.0
Q ss_pred ecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEEEecCCCC
Q psy6327 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-IGVHRMVKAGTYLYMIMDYAEKK 92 (351)
Q Consensus 14 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~gg 92 (351)
.+..|-.+.+|+.. .++..+++|........ ..-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45668888999886 34667888865432111 00113479999998864333 44444432 26899999987
Q ss_pred ChHH--------------HHHhhccCCCch------HHHHHHHHHHHHHHHHHHHHHHHHHHhHh--------CCceecc
Q psy6327 93 DLEH--------------YISKACNENIHE------NQARIWIRQIANALEYLHEIANALEYLHE--------VGIVHRD 144 (351)
Q Consensus 93 sL~~--------------~l~~~~~~~~~~------~~~~~~~~~i~~~~~~~~qi~~~l~~lH~--------~~i~H~D 144 (351)
.+.. .+.+-...+... .....+..++... .....+...+..+-. ..++|+|
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPA-RRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccc-cCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 6532 111111111110 0001111111000 000011111222211 2589999
Q ss_pred CCCCCEeEcCCCCeEEeecccccc
Q psy6327 145 IKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 145 lkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+.|.||++++++ +.|+||..|..
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999876 88999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0011 Score=59.74 Aligned_cols=165 Identities=12% Similarity=0.124 Sum_probs=94.0
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC--CCCceeeeeEEEeCC
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS--HPNIIGVHRMVKAGT 80 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~ 80 (351)
+|......+++....|..-.+|...+. ++.++++ .+.... .........+|..+++.+. --.+...++++.++.
T Consensus 21 ip~~~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~-~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~ 96 (321)
T COG3173 21 IPGYAGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGD-PVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY 96 (321)
T ss_pred CcCcCCCceeeeccCCcccceEEEecC--CceEEEe-cCCccc-cchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC
Confidence 566677777887766666667766554 7788888 331111 1111222347888888885 334556667766655
Q ss_pred --EEEEEEecCCCCChHHHHHhhccC------------------------------CCchHHHHHHHHHHHHHHH---H-
Q psy6327 81 --YLYMIMDYAEKKDLEHYISKACNE------------------------------NIHENQARIWIRQIANALE---Y- 124 (351)
Q Consensus 81 --~~~lv~e~~~ggsL~~~l~~~~~~------------------------------~~~~~~~~~~~~~i~~~~~---~- 124 (351)
..|.||+|++|..+.+........ .....+...|..+...+.. .
T Consensus 97 ~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 97 LGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred CCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 789999999974433222110000 0011122222222210000 0
Q ss_pred HHHHHHHHHHhHhC--------CceeccCCCCCEeEcCCCCeEEeeccccccccC
Q psy6327 125 LHEIANALEYLHEV--------GIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171 (351)
Q Consensus 125 ~~qi~~~l~~lH~~--------~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 171 (351)
.-....-..+++.+ .++|+|+.+.||++++++-+-+.||+.+...++
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 00111223455433 489999999999999988899999999987443
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.62 E-value=5.4e-05 Score=67.19 Aligned_cols=137 Identities=17% Similarity=0.194 Sum_probs=90.6
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh-------hHHH------------hhhHHHHHHHHHhCC-C-C
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-------RDYM------------EKFAPREIDILLKVS-H-P 67 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~------------~~~~~~Ei~~l~~l~-h-p 67 (351)
+.+.+.||-|.-+.||.+.+. .|...++|.-...+.+ .+.. .-...+|...|+.|. | -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456788999999999998875 4667777754332211 0000 011236888888885 2 3
Q ss_pred CceeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCC
Q psy6327 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKC 147 (351)
Q Consensus 68 ~iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp 147 (351)
.|++.+++ +..++|||++.|-.|...-.- ...+ .+...+..-+.-|-.+|+||+|..-
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~-------------~ly~~lm~~Iv~la~~GlIHgDFNE 230 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPP-------------TLYDDLMGLIVRLANHGLIHGDFNE 230 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec-----CChH-------------HHHHHHHHHHHHHHHcCceecccch
Confidence 44555554 457899999998887654311 0101 1222333445577889999999999
Q ss_pred CCEeEcCCCCeEEeecccccc
Q psy6327 148 ENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 148 ~NIll~~~~~~kl~Dfg~a~~ 168 (351)
-||++++++.++++||--+-.
T Consensus 231 FNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 231 FNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred heeEEecCCCEEEeechHhhc
Confidence 999999999999999975543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0022 Score=58.33 Aligned_cols=31 Identities=26% Similarity=0.373 Sum_probs=26.5
Q ss_pred CCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 138 VGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 138 ~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
.++||+|+.|.||+++++...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4799999999999999765568999998764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0021 Score=57.87 Aligned_cols=78 Identities=10% Similarity=0.028 Sum_probs=53.6
Q ss_pred eeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC---CCceeeeeEEEe---CCEEE
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH---PNIIGVHRMVKA---GTYLY 83 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h---p~iv~~~~~~~~---~~~~~ 83 (351)
.-++.||.|..+.||...... + .+.+|... .... ...+..|...|+.|.- -.++++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMAR-SFST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEec-cccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 346679999999999875432 3 45556532 2111 2344589999998852 467888887754 36689
Q ss_pred EEEecCCCCCh
Q psy6327 84 MIMDYAEKKDL 94 (351)
Q Consensus 84 lv~e~~~ggsL 94 (351)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0013 Score=60.47 Aligned_cols=149 Identities=17% Similarity=0.251 Sum_probs=82.4
Q ss_pred eeecCcccceEEEEEEecC----CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKR----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-IGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~ 86 (351)
+..|..|-.-.+|++.... .++.+.+|+..... ... ... .+|..+++.+..-++ .++++.+..+ .|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~-idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELF-FDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Cee-ech-HHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 4456568889999986432 34678888775432 111 112 379999998864444 4566666443 579
Q ss_pred ecCCCCChHHH--------------HHhhccCCC-------chHHHHHHHHHHHHH----------HHHHHHHHHHHHH-
Q psy6327 87 DYAEKKDLEHY--------------ISKACNENI-------HENQARIWIRQIANA----------LEYLHEIANALEY- 134 (351)
Q Consensus 87 e~~~ggsL~~~--------------l~~~~~~~~-------~~~~~~~~~~~i~~~----------~~~~~qi~~~l~~- 134 (351)
+|++|.+|... +++....+. ....+..|..++... +..+...+..|..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987776421 111111111 111222333222110 0011111111211
Q ss_pred h----HhCCceeccCCCCCEeEcC-CCCeEEeecccccc
Q psy6327 135 L----HEVGIVHRDIKCENILISR-LLNAKLADFGFSRL 168 (351)
Q Consensus 135 l----H~~~i~H~Dlkp~NIll~~-~~~~kl~Dfg~a~~ 168 (351)
+ +...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 1235899999999999986 46799999988753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0033 Score=57.55 Aligned_cols=149 Identities=15% Similarity=0.201 Sum_probs=80.6
Q ss_pred eeecCcccceEEEEEEecCC---ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEEEe
Q psy6327 12 ISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-IGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e 87 (351)
++.|..|=...+|++..... +..+.+|+...... . ... ..+|..+++.+..-++ +++++++..+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~-~Id-R~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--Y-VID-RERELQAIKYLSAAGFGAKLLGVFGNG----MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--e-Eec-hHHHHHHHHHHHhcCCCCceeEEeCCc----Eeeh
Confidence 44455588888998865432 33788887643221 1 111 1379999998865444 4566666432 5899
Q ss_pred cCCCCChHH--------------HHHhhccCCCc-------hHHHHHHHHHHHHH---------------HHHHHHHHHH
Q psy6327 88 YAEKKDLEH--------------YISKACNENIH-------ENQARIWIRQIANA---------------LEYLHEIANA 131 (351)
Q Consensus 88 ~~~ggsL~~--------------~l~~~~~~~~~-------~~~~~~~~~~i~~~---------------~~~~~qi~~~ 131 (351)
|++|.+|.. .+++....+.+ ...+..|..++... ..-+.+-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998776522 11221111111 11222222222110 0011111112
Q ss_pred HHH-hHhC----CceeccCCCCCEeEcC-CCCeEEeecccccc
Q psy6327 132 LEY-LHEV----GIVHRDIKCENILISR-LLNAKLADFGFSRL 168 (351)
Q Consensus 132 l~~-lH~~----~i~H~Dlkp~NIll~~-~~~~kl~Dfg~a~~ 168 (351)
+.. +... -.+|.|+.+.|||+++ ++.++++||..|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 222 2122 2799999999999975 47899999998753
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0015 Score=61.56 Aligned_cols=158 Identities=16% Similarity=0.207 Sum_probs=97.8
Q ss_pred HHHHHHHhCCCCCceeeeeEEEeC-CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy6327 56 REIDILLKVSHPNIIGVHRMVKAG-TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134 (351)
Q Consensus 56 ~Ei~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~ 134 (351)
-..++++.+.|+|...++++.+.. ....+|||++. .+|.+++.... +... . +
T Consensus 31 gr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~---l~~~-------------s----------~ 83 (725)
T KOG1093|consen 31 GRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN---LKDE-------------S----------L 83 (725)
T ss_pred hhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc---cchh-------------h----------h
Confidence 678889999999999999987643 45889999995 99999987632 1110 0 1
Q ss_pred hHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHH
Q psy6327 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214 (351)
Q Consensus 135 lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 214 (351)
+ .+++.|- || ++.+| -+++. . ....| + ++|||++|.++.++.
T Consensus 84 ~-~~~~~~~-----~~-------~~~td-~~~t~----~---~~~~~----------------p-KsdVwsl~~i~~el~ 125 (725)
T KOG1093|consen 84 L-AHGVLHL-----NI-------IYITD-HFLTK----Y---PSPIG----------------P-KSDVWSLGFIILELY 125 (725)
T ss_pred c-cccccee-----hh-------hhccc-ccccc----C---CCCCC----------------c-chhhhhHHHHHHHHH
Confidence 1 1222222 22 33333 11110 0 01111 1 499999999999999
Q ss_pred hCCCCCCCCCCCchHHHHhhhCccccc----------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 215 NKKYPFGDPGTRNRDVLKKQEGKEYLF----------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 215 ~g~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
-|..-+.... ..+....+..-.... .....++....++..+|+-..|..||...++..++-|..
T Consensus 126 L~~~l~~~~~--~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 126 LGISLEAELT--ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HhhHHHHHHH--HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 9877664322 112211111100000 111246677788999999999999999999999988854
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.007 Score=55.40 Aligned_cols=77 Identities=14% Similarity=0.128 Sum_probs=47.5
Q ss_pred ecCcccceEEEEEEecCCceeEEEEecchhhhh--h--HHHhhhHHHHHHHHHhCC--CC-CceeeeeEEEeCCEEEEEE
Q psy6327 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK--R--DYMEKFAPREIDILLKVS--HP-NIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 14 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~--~~~~~~~~~Ei~~l~~l~--hp-~iv~~~~~~~~~~~~~lv~ 86 (351)
.||.|....||++.+...++.++||.-..-... . .....+...|...|+... -| .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998644467888865321110 0 111222336888887764 34 45566554 344556999
Q ss_pred ecCCCC
Q psy6327 87 DYAEKK 92 (351)
Q Consensus 87 e~~~gg 92 (351)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999643
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0071 Score=55.02 Aligned_cols=142 Identities=18% Similarity=0.240 Sum_probs=86.1
Q ss_pred eeeecCcccceEEEEEEecCCceeEEEEecchhhhh-----------------------hHHHhhhHHHHHHHHHhCCCC
Q psy6327 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-----------------------RDYMEKFAPREIDILLKVSHP 67 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----------------------~~~~~~~~~~Ei~~l~~l~hp 67 (351)
+-..|..|.-+.||.|... +|..+|||++....+. ..-..-....|+.-|++|+..
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788999999998754 6777999998653320 011122345788888888755
Q ss_pred CceeeeeEEEeCCEEEEEEecCCCCCh-HHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCC
Q psy6327 68 NIIGVHRMVKAGTYLYMIMDYAEKKDL-EHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIK 146 (351)
Q Consensus 68 ~iv~~~~~~~~~~~~~lv~e~~~ggsL-~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlk 146 (351)
+|.-.--+.- ....|||+++....- .-.|+ ...++...++....+++..+..++ |.+++||.||+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY---------~~c~LVHADLS 292 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLY---------QKCRLVHADLS 292 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHH---------HHhceeccchh
Confidence 5432211111 124689999952211 11122 344444444444444433333222 56789999999
Q ss_pred CCCEeEcCCCCeEEeecccccc
Q psy6327 147 CENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 147 p~NIll~~~~~~kl~Dfg~a~~ 168 (351)
--|+|+.+ |.+.++|-+-+-.
T Consensus 293 EfN~Lyhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 293 EFNLLYHD-GKLYIIDVSQSVE 313 (520)
T ss_pred hhhheEEC-CEEEEEEcccccc
Confidence 99999987 6799999886644
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.019 Score=53.56 Aligned_cols=84 Identities=18% Similarity=0.091 Sum_probs=52.6
Q ss_pred eeeecCcccceEEEEEEecCCceeEEEEecchhhh-hhH---HHhhhHHHHHHHHHhCC---CCCceeeeeEEEeCCEEE
Q psy6327 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL-KRD---YMEKFAPREIDILLKVS---HPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~---~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~ 83 (351)
-.+.||.|....||+..+. +..+.||.-..... ... ........|+..|+.+. ..++++++.+..+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 3778999999999998863 44578887542111 000 01112225677776664 3578888888873 357
Q ss_pred EEEecCCC--CChHHHH
Q psy6327 84 MIMDYAEK--KDLEHYI 98 (351)
Q Consensus 84 lv~e~~~g--gsL~~~l 98 (351)
++|||+++ ..+.+-+
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 88999986 2454444
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.033 Score=50.36 Aligned_cols=29 Identities=28% Similarity=0.515 Sum_probs=25.6
Q ss_pred CCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 138 VGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 138 ~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999988 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.053 Score=49.13 Aligned_cols=30 Identities=13% Similarity=0.234 Sum_probs=27.6
Q ss_pred CceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 139 GIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 139 ~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
++||+|+.++|||+++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999988899999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.012 Score=54.57 Aligned_cols=78 Identities=17% Similarity=0.129 Sum_probs=49.0
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhH---HHhhhHHHHHHHHHhCC--CC-CceeeeeEEEeCCEEEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD---YMEKFAPREIDILLKVS--HP-NIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~--hp-~iv~~~~~~~~~~~~~lv 85 (351)
++.||.|.-.-||++.+...+..++||.-..-..... ....+...|...|+.+. -| .++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6789999999999998854456788886432111100 11222336888888764 34 45666665 33456789
Q ss_pred EecCCC
Q psy6327 86 MDYAEK 91 (351)
Q Consensus 86 ~e~~~g 91 (351)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.011 Score=53.69 Aligned_cols=73 Identities=27% Similarity=0.437 Sum_probs=49.9
Q ss_pred eCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEcCCC
Q psy6327 78 AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLL 156 (351)
Q Consensus 78 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~ 156 (351)
+..+.|++|++. |++|.- ++. . ...+++.++.+.+..++-+..+ ..-|||+.-.||||+ .|
T Consensus 297 e~~y~yl~~kdh-gt~is~-ik~---~------------~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-IKA---D------------RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred CceEEEEEEecC-Cceeee-eec---c------------cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 344678888876 566542 221 1 1233445555555555455443 588999999999999 89
Q ss_pred CeEEeecccccc
Q psy6327 157 NAKLADFGFSRL 168 (351)
Q Consensus 157 ~~kl~Dfg~a~~ 168 (351)
++.|+||-+++.
T Consensus 359 nvtLIDfklsRl 370 (488)
T COG5072 359 NVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEeeeeec
Confidence 999999999985
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.06 Score=48.15 Aligned_cols=76 Identities=11% Similarity=0.099 Sum_probs=45.9
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC---CCCceeeeeEEEeCCEEEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS---HPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~lv 85 (351)
.+-.+.|+.|....+|... .+++.+.+|.-. ... ...+..|..-|+.|. --.+++.+.+....+..|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC-hhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3446778989999999876 567788898755 111 233446777777773 45677899988877777999
Q ss_pred EecCCCC
Q psy6327 86 MDYAEKK 92 (351)
Q Consensus 86 ~e~~~gg 92 (351)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.11 Score=45.94 Aligned_cols=30 Identities=23% Similarity=0.320 Sum_probs=27.5
Q ss_pred CceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 139 GIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 139 ~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
-++|+|+.|+|++.++.+.++|+||..|..
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 589999999999999999999999988764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.14 Score=47.72 Aligned_cols=77 Identities=13% Similarity=0.147 Sum_probs=46.5
Q ss_pred eeeecCcccceEEEEEEecCC-cee-----EEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEE
Q psy6327 11 YISKLGEGAYGNVYLVSDKRS-ETL-----KACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-IGVHRMVKAGTYLY 83 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~-~~~-----~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~ 83 (351)
.++.|..|-...+|++..... +.. |.++.... . ...... ..+|+.+++.|...++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~--~-~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST--Y-NSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC--C-CceEec-cHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 355666689999999875432 122 34443211 1 111111 1379999999975444 667777753 5
Q ss_pred EEEecCCCCChH
Q psy6327 84 MIMDYAEKKDLE 95 (351)
Q Consensus 84 lv~e~~~ggsL~ 95 (351)
++.||++|.+|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 899999987764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.092 Score=47.88 Aligned_cols=29 Identities=24% Similarity=0.431 Sum_probs=26.1
Q ss_pred ceeccCCCCCEeEcCCCC-eEEeecccccc
Q psy6327 140 IVHRDIKCENILISRLLN-AKLADFGFSRL 168 (351)
Q Consensus 140 i~H~Dlkp~NIll~~~~~-~kl~Dfg~a~~ 168 (351)
+||+|+.|.||+++.+.. ..++|||-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999999875 89999997753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.24 Score=45.29 Aligned_cols=29 Identities=24% Similarity=0.257 Sum_probs=24.4
Q ss_pred CCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 138 VGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 138 ~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
.+++|+|+.+.|||++ + .+.|+||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4689999999999995 3 578999997753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.19 Score=44.75 Aligned_cols=31 Identities=26% Similarity=0.308 Sum_probs=26.1
Q ss_pred CceeccCCCCCEeEcCCCC-eEEeeccccccc
Q psy6327 139 GIVHRDIKCENILISRLLN-AKLADFGFSRLL 169 (351)
Q Consensus 139 ~i~H~Dlkp~NIll~~~~~-~kl~Dfg~a~~~ 169 (351)
.++|+|++|.|||+++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 469999988763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.087 Score=50.14 Aligned_cols=76 Identities=13% Similarity=0.114 Sum_probs=47.2
Q ss_pred eeeecCcccceEEEEEEecCC--------ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc-eeeeeEEEeCCE
Q psy6327 11 YISKLGEGAYGNVYLVSDKRS--------ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-IGVHRMVKAGTY 81 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~--------~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~ 81 (351)
-++.|..|-.-.+|++..... ++.|.+|+...... . ... ...|..+++.+...+| .++++.+..
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te--~-lId-R~~E~~v~~~ls~~gi~P~l~~~f~g--- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD--E-LYN-PISEFEVYKTMSKYRIAPQLLNTFSG--- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc--c-eeC-HHHHHHHHHHHHHCCCCCceEEEeCC---
Confidence 466677788888999875422 46788887643321 1 111 2268888888864444 356665542
Q ss_pred EEEEEecCCCCCh
Q psy6327 82 LYMIMDYAEKKDL 94 (351)
Q Consensus 82 ~~lv~e~~~ggsL 94 (351)
..|.||++|-+|
T Consensus 182 -g~I~efi~g~~l 193 (442)
T PTZ00296 182 -GRIEEWLYGDPL 193 (442)
T ss_pred -CEEEEeeCCccC
Confidence 357899997644
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.03 Score=46.41 Aligned_cols=29 Identities=21% Similarity=0.310 Sum_probs=25.7
Q ss_pred CceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 139 GIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 139 ~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
-.+|+|+.|.||++++++ ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 369999999999998877 99999998865
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.0079 Score=56.60 Aligned_cols=73 Identities=22% Similarity=0.264 Sum_probs=59.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG 79 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 79 (351)
...+|.....+|.|+||+|+.+....++..+|||.+..+..... ...+.+|+.-+..+.|++++++...|..+
T Consensus 47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s--~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREES--RSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhccccccccccccCccccCCccccccchhhHHHHhcccchhhh--hhhhhccccchhhhcccchhhheeceecC
Confidence 34567788899999999999999999999999999887765443 33444888889999999999988877543
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.19 Score=46.72 Aligned_cols=63 Identities=22% Similarity=0.234 Sum_probs=39.8
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
...++-+|..|.++..+++. ...++...+.+..-...|+ +..+--.+.+|.|+.|.||++...
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~Al---------lkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNAL---------LKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHH---------HHHHHhhcceecccCCCcEEEEec
Confidence 45677889999999999975 3344433332222222221 123345689999999999999653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 351 | ||||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-34 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-34 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-34 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-34 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-33 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-33 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-33 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-33 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-33 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-33 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-33 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-33 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-33 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-33 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-33 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-33 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-33 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-33 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-33 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-33 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-33 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-33 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-33 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-33 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-33 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-33 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-33 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-33 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-33 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-32 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-32 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-32 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-32 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-32 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-32 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-31 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-31 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-31 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-31 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-31 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-31 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-31 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-31 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-30 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-30 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-30 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-30 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-30 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-30 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-30 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-30 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-30 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-30 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-29 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-29 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-29 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-29 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-29 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-29 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-28 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-28 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-28 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-28 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-28 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-28 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-28 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-28 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-28 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-28 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-28 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-28 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-28 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-28 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-28 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-28 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-28 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-28 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-28 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-28 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-28 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-28 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-28 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-27 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-27 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-27 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-27 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-27 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-27 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-27 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-27 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-27 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-27 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-27 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-27 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-27 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-27 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-26 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-26 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-26 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-26 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-26 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-26 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-26 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-26 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-26 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-25 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-25 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-25 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-25 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-25 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-25 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-25 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-25 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-25 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-25 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-25 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-25 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-25 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-25 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-25 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-25 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-25 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-24 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-24 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-24 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-24 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-24 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-24 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-24 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-24 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-24 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-24 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-24 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-24 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-23 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-23 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-23 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-23 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-23 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-23 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-23 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-23 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-23 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-23 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-23 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-23 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-23 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-23 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-23 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-23 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-23 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-23 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-22 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-22 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-22 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-22 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-22 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-22 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-22 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-22 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-22 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-22 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-22 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-22 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-22 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-21 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-21 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-21 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-21 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-20 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-20 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-20 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-20 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-20 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-20 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-20 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-20 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-20 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-20 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-20 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-20 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-20 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-20 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-20 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-20 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-20 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-20 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-20 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-20 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-20 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-20 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-20 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-20 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-20 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-20 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-20 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-20 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-20 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-20 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-20 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-20 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-20 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-20 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-20 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-20 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-20 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-20 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-20 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-20 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-20 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-20 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-20 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-20 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-20 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-20 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-20 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-20 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-20 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-20 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-19 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-19 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-19 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-19 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-19 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-19 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-19 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-19 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-19 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-19 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-19 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-19 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-19 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-19 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-19 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-19 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-19 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-19 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-19 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-19 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-19 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-19 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-19 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-19 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-19 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-19 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-19 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-19 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-19 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-19 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-19 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-19 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-19 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-19 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-19 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-19 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-19 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-19 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-19 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-19 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-19 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-19 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-19 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-19 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-19 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-19 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-18 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-18 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-18 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-18 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-18 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-18 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-18 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-18 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-17 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-16 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-16 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-15 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-15 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-14 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-10 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-07 |
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-76
Identities = 91/320 (28%), Positives = 146/320 (45%), Gaps = 16/320 (5%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ K+GEG++G LV K + R+ E+ + RE+ +L + HPNI+
Sbjct: 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-SRREVAVLANMKHPNIVQ 87
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ LY++MDY E DL I+ E+Q W QI AL+++H+
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR--- 144
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
I+HRDIK +NI +++ +L DFG +R+L + EL+ GT Y +PEI
Sbjct: 145 -------KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
N PYN K +DIW+LG VLY + K+ F + VLK G + Y S
Sbjct: 198 ENKPYNNK-SDIWALGCVLYELCTLKHAFEAG-SMKNLVLKIISGSFPPVSLHY--SYDL 253
Query: 252 KQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKVFMQKYTV 311
+ L+ ++ + NP+ RP+ + +I + ++ + K SK Q
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE-KFLSPQLIAEEFCLKTFSKFGSQPIPA 312
Query: 312 VQALTSSNNVDVTEENKEKK 331
+ + N++ V K K
Sbjct: 313 KRPASGQNSISVMPAQKITK 332
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 7e-76
Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 16/274 (5%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +G G+YG + K + K D+ + + E+++L ++ HPNI+
Sbjct: 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHPNIVR 69
Query: 72 VHR--MVKAGTYLYMIMDYAEKKDLEHYISKA--CNENIHENQARIWIRQIANALEYLHE 127
+ + + T LY++M+Y E DL I+K + + E + Q+ AL+ H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
++HRD+K N+ + N KL DFG +R+L + TF GT Y +
Sbjct: 130 -----RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK-QEGKEYLFNRKYE 246
PE + YN K +DIWSLG +LY + PF +++ K +EGK +Y
Sbjct: 185 PEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFT--AFSQKELAGKIREGKFRRIPYRY- 240
Query: 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
S ++I RML HRP+ +++ + I
Sbjct: 241 -SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-74
Identities = 76/285 (26%), Positives = 123/285 (43%), Gaps = 17/285 (5%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
K+G G + VY + A K L +EID+L +++HPN+I
Sbjct: 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYIS--KACNENIHENQARIWIRQIANALEYLHEIA 129
+ L ++++ A+ DL I K I E + Q+ +ALE++H
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-- 154
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
++HRDIK N+ I+ KL D G R + +++ GT Y +PE
Sbjct: 155 --------RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY--LFNRKYEI 247
I + YN K +DIWSLG +LY + + PF + KK E +Y L + Y
Sbjct: 207 RIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY-- 263
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEER 292
S +QL+ + P+P+ RP+ V + A + T ++
Sbjct: 264 SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 5e-72
Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 43/285 (15%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I +G G +G V+ + K + K A RE+ L K+ H NI+
Sbjct: 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK-------AEREVKALAKLDHVNIVH 68
Query: 72 VH----------------RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWI 115
+ L++ M++ +K LE +I K E + + A
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 116 RQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL 175
QI ++Y+H +++RD+K NI + K+ DFG L+ +
Sbjct: 129 EQITKGVDYIHSK----------KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 176 SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235
GT Y +PE I + Y + D+++LG++L +L+ + ++ ++
Sbjct: 179 -TRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFE---TSKFFTDLRD 233
Query: 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
G + + K L+ ++L P+ RPN ++ +
Sbjct: 234 GI---ISDIF--DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-71
Identities = 76/315 (24%), Positives = 128/315 (40%), Gaps = 54/315 (17%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I+ LG+GA+G V + A K K + E+ +L ++H ++
Sbjct: 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVMLLASLNHQYVVR 66
Query: 72 VH-------------RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQI 118
+ VK + L++ M+Y E L I N N ++ RQI
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQI 125
Query: 119 ANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL--------- 169
AL Y+H GI+HRD+K NI I N K+ DFG ++ +
Sbjct: 126 LEALSYIHSQ----------GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 170 -----RTPKELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDP 223
+ + GT Y A E++ + YN K D++SLG++ + ++ YPF
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK-IDMYSLGIIFFEMI---YPFSTG 231
Query: 224 GTRNRDVLKKQEGKEYLFNRKYE--ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
R ++LKK F ++ K++I +++ +P RP A+ + N W+
Sbjct: 232 MERV-NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV- 289
Query: 282 PTCQTMTAEEREALK 296
+ +EALK
Sbjct: 290 ---KHQDEVIKEALK 301
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 6e-71
Identities = 63/269 (23%), Positives = 126/269 (46%), Gaps = 17/269 (6%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G + + +SD ++ + A K L + + + EI I ++H +++G H
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ +++++++ ++ L + + + E +AR YL +I +Y
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEAR----------YYLRQIVLGCQY 130
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH ++HRD+K N+ ++ L K+ DFG + + E CGT +Y APE++
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQL 254
++ + D+WS+G ++Y +L K PF + + + EY + I+ A L
Sbjct: 191 GHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKNEYSIPK--HINPVAASL 245
Query: 255 IGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283
I +ML+ +P RP ++ N + +
Sbjct: 246 IQKMLQTDPTARPTINELLNDEFFTSGYI 274
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 8e-71
Identities = 78/266 (29%), Positives = 133/266 (50%), Gaps = 16/266 (6%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G++ VY + A K D K + + M + E+ I ++ HP+I+ ++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ Y+Y++++ ++ Y+ EN+AR ++H+I + Y
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEAR----------HFMHQIITGMLY 127
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH GI+HRD+ N+L++R +N K+ADFG + L+ P E T CGT +Y +PEI S
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQL 254
+ + +D+WSLG + Y +L + PF +N L K +Y +SI AK L
Sbjct: 188 AHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKN--TLNKVVLADYEMPS--FLSIEAKDL 242
Query: 255 IGRMLEPNPKHRPNAKDVQNHAWIQN 280
I ++L NP R + V +H ++
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-70
Identities = 63/269 (23%), Positives = 126/269 (46%), Gaps = 17/269 (6%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G + + +SD ++ + A K L + + + EI I ++H +++G H
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ +++++++ ++ L + + + E +AR YL +I +Y
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEAR----------YYLRQIVLGCQY 156
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH ++HRD+K N+ ++ L K+ DFG + + E CGT +Y APE++
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQL 254
++ + D+WS+G ++Y +L K PF + + + EY + I+ A L
Sbjct: 217 GHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKNEYSIPK--HINPVAASL 271
Query: 255 IGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283
I +ML+ +P RP ++ N + +
Sbjct: 272 IQKMLQTDPTARPTINELLNDEFFTSGYI 300
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-69
Identities = 87/266 (32%), Positives = 133/266 (50%), Gaps = 19/266 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G +GNVYL +K+S+ + A K +L++ +E RE++I + HPNI+ ++
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
T +Y+I++YA + + K E + Y+ E+ANAL Y
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTAT----------YITELANALSY 124
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
H ++HRDIK EN+L+ K+ADFG+S P CGT Y PE+I
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPEMIEGR 182
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQL 254
++ K D+WSLGV+ Y L K PF + K+ E+ F ++ GA+ L
Sbjct: 183 MHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRISRVEFTFPDF--VTEGARDL 237
Query: 255 IGRMLEPNPKHRPNAKDVQNHAWIQN 280
I R+L+ NP RP ++V H WI
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITA 263
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-68
Identities = 81/267 (30%), Positives = 134/267 (50%), Gaps = 22/267 (8%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
+G+G + V L + A K D +L ++K RE+ I+ ++HPNI+ +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+++ LY+IM+YA ++ Y+ + + E +AR RQI +A++Y H+
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK------ 133
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
IVHRD+K EN+L+ +N K+ADFGFS +L FCG YAAPE+ +
Sbjct: 134 ----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD-AFCGAPPYAAPELFQGK 188
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ--EGKEYLFNRKYEISIGAK 252
Y+ D+WSLGV+LY +++ PF + L+++ GK + + +S +
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLRGK---YRIPFYMSTDCE 242
Query: 253 QLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
L+ R L NP R + + WI
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMKDRWIN 269
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-68
Identities = 79/265 (29%), Positives = 133/265 (50%), Gaps = 19/265 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G +GNVYL +K+++ + A K +L+++ +E REI+I + HPNI+ ++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+Y+++++A + +L + K + E ++ ++ E+A+AL Y
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSAT----------FMEELADALHY 129
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
HE ++HRDIK EN+L+ K+ADFG+S P T CGT Y PE+I
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLDYLPPEMIEGK 187
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQL 254
++ K D+W GV+ Y L PF P ++ + F +S G+K L
Sbjct: 188 THDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTE--THRRIVNVDLKFPPF--LSDGSKDL 242
Query: 255 IGRMLEPNPKHRPNAKDVQNHAWIQ 279
I ++L +P R K V H W++
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-67
Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 43/294 (14%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I LG G +G V+ +K + A K + + RE+ L K+ HP I+
Sbjct: 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK--VMREVKALAKLEHPGIVR 67
Query: 72 ------------VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIA 119
+ YLY+ M K++L+ +++ C E
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS--------- 118
Query: 120 NALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF 179
L +IA A+E+LH G++HRD+K NI + K+ DFG + +E
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 180 ------------CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227
GT Y +PE I + Y+ K DI+SLG++L+ +L YPF R
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV 234
Query: 228 RDVLKKQEGK-EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
R + + K LF +KY ++ ML P+P RP A ++ +A ++
Sbjct: 235 RTLTDVRNLKFPPLFTQKYP---CEYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-67
Identities = 80/294 (27%), Positives = 123/294 (41%), Gaps = 31/294 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLK---RDYMEKFAPREIDILLKVSH--PNI 69
LG G +G+VY A K + R+ P E+ +L KVS +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 70 IGVHRMVKAGTYLYMIMDYAE-KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I + + +I++ E +DL +I++ + E AR + Q+ A+ + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC 168
Query: 129 ANALEYLHEVGIVHRDIKCENILI-SRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
G++HRDIK ENILI KL DFG LL + F GT Y+
Sbjct: 169 ----------GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSP 216
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247
PE IR Y+ + A +WSLG++LY ++ PF + G+ + +
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-------EHDEEIIRGQ---VFFRQRV 266
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLK 301
S + LI L P RP +++QNH W+Q+ Q +L G K
Sbjct: 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK 320
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 6e-67
Identities = 84/273 (30%), Positives = 125/273 (45%), Gaps = 22/273 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+LG+GA+ V K + A K + K+L +K RE I K+ HPNI+ +H
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLH 71
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
++ ++ Y++ D +L I E E A I+QI ++ Y H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN----- 124
Query: 134 YLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
GIVHR++K EN+L S+ A KLADFG + + E + F GT Y +PE+
Sbjct: 125 -----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEV 178
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
++ PY+ DIW+ GV+LY +L PF D + + + Y + ++
Sbjct: 179 LKKDPYSKP-VDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVT 235
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
AK LI ML NPK R A WI N
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 6e-67
Identities = 90/321 (28%), Positives = 147/321 (45%), Gaps = 31/321 (9%)
Query: 3 FPDILECSYI--SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----- 55
+P L YI LG GA G V L ++++ A K ++ + P
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 56 REIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWI 115
EI+IL K++HP II + A Y Y++++ E +L + N+ + E +++
Sbjct: 64 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVG--NKRLKEATCKLYF 120
Query: 116 RQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL---LNAKLADFGFSRLLRTP 172
Q+ A++YLHE GI+HRD+K EN+L+S K+ DFG S++L
Sbjct: 121 YQMLLAVQYLHEN----------GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 169
Query: 173 KELSNTFCGTTSYAAPEIIRNS---PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD 229
L T CGT +Y APE++ + YN D WSLGV+L+ L+ PF + T
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRT-QVS 227
Query: 230 VLKKQEGKEYLFNRKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTM 287
+ + +Y F + E+S A L+ ++L +PK R ++ H W+Q+E +
Sbjct: 228 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 287
Query: 288 TAEEREALKIGKLKSKVFMQK 308
E + L +
Sbjct: 288 QDLLSEENESTALPQVLAQPS 308
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-66
Identities = 79/267 (29%), Positives = 126/267 (47%), Gaps = 17/267 (6%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEGAYG V L ++ +E A K D + D E +EI I ++H N++ +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIK-KEICINKMLNHENVVKFYG 72
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ G Y+ ++Y +L I + + E A+ + Q+ + YLH I
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI------ 124
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR--TPKELSNTFCGTTSYAAPEIIR 192
GI HRDIK EN+L+ N K++DFG + + R + L N CGT Y APE+++
Sbjct: 125 ----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252
++ + D+WS G+VL +L + P+ P ++ +E K YL K I
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK-IDSAPL 239
Query: 253 QLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
L+ ++L NP R D++ W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-66
Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 32/274 (11%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM----EKFAPREIDILLKV-SH 66
+S+LG G+YG V+ V K L A K R + E+ KV H
Sbjct: 62 LSRLGHGSYGEVFKVRSKEDGRLYAVK-----RSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P + + + + G LY+ + L+ + ++ E Q ++R AL +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLH 174
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
G+VH D+K NI + KL DFG L T G Y
Sbjct: 175 SQ----------GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYM 223
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRIL-NKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245
APE+++ Y AD++SLG+ + + N + P G G + L++
Sbjct: 224 APELLQG-SYGTA-ADVFSLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAG-- 276
Query: 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+S + ++ MLEP+PK R A+ + ++
Sbjct: 277 -LSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 6e-66
Identities = 79/267 (29%), Positives = 126/267 (47%), Gaps = 17/267 (6%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEGAYG V L ++ +E A K D + D E +EI I ++H N++ +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIK-KEICINKMLNHENVVKFYG 72
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ G Y+ ++Y +L I + + E A+ + Q+ + YLH I
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI------ 124
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR--TPKELSNTFCGTTSYAAPEIIR 192
GI HRDIK EN+L+ N K++DFG + + R + L N CGT Y APE+++
Sbjct: 125 ----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAK 252
++ + D+WS G+VL +L + P+ P ++ +E K YL K I
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK-IDSAPL 239
Query: 253 QLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
L+ ++L NP R D++ W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 8e-66
Identities = 80/283 (28%), Positives = 126/283 (44%), Gaps = 29/283 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFA-----PREIDILLKVSHPNI 69
LG GA+G V+ DK K +++ D + EI IL +V H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 70 IGVHRMVKAGTYLYMIMDYAEK-KDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I V + + + ++M+ DL +I + + + E A RQ+ +A+ YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
I+HRDIK ENI+I+ KL DFG + L +L TFCGT Y AP
Sbjct: 150 ----------DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTFCGTIEYCAP 198
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248
E++ +PY ++WSLGV LY ++ ++ PF ++ + E + Y +S
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPF-------CELEETVEAA---IHPPYLVS 248
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEE 291
L+ +L+P P+ R + + W+ T EE
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 9e-66
Identities = 76/274 (27%), Positives = 116/274 (42%), Gaps = 33/274 (12%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLK---RDYMEKFAPREIDILLKVS----HP 67
LG+G +G V+ A K R+ P E+ +L KV HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEK-KDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
+I + + ++++ +DL YI++ + E +R + Q+ A+++ H
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 127 EIANALEYLHEVGIVHRDIKCENILI-SRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
G+VHRDIK ENILI R AKL DFG LL E F GT Y
Sbjct: 157 SR----------GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGTRVY 204
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245
+ PE I Y+ A +WSLG++LY ++ PF + E + +
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF-------ERDQEILEAE---LHFPA 254
Query: 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+S LI R L P P RP+ +++ W+Q
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-65
Identities = 83/275 (30%), Positives = 132/275 (48%), Gaps = 23/275 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
LG+G++G V D+ ++ A K + K RE+++L K+ HPNI+ +
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHPNIMKLF 87
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+++ + Y++ + +L I K + E+ A I+Q+ + + Y+H+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH----- 140
Query: 134 YLHEVGIVHRDIKCENILI-SRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
IVHRD+K ENIL+ S+ + K+ DFG S + GT Y APE+
Sbjct: 141 -----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEV 194
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
+R Y+ K D+WS GV+LY +L+ PF D+LK+ E +Y F+ IS
Sbjct: 195 LRG-TYDEK-CDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAFDLPQWRTIS 250
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283
AK LI +ML +P R A H WIQ +
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-65
Identities = 83/273 (30%), Positives = 131/273 (47%), Gaps = 23/273 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
KLG GA+G+V+LV ++ S + K + R + ME+ EI++L + HPNII +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIE-AEIEVLKSLDHPNIIKIF 86
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIH--ENQARIWIRQIANALEYLHEIANA 131
+ + +Y++M+ E +L I A E ++Q+ NAL Y H
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143
Query: 132 LEYLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
+VH+D+K ENIL ++ K+ DFG + L + E S GT Y AP
Sbjct: 144 -------HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTALYMAP 195
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE-I 247
E+ + K DIWS GVV+Y +L PF +V +K KE + + +
Sbjct: 196 EVFKRD-VTFK-CDIWSAGVVMYFLLTGCLPFTGTS--LEEVQQKATYKEPNYAVECRPL 251
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ A L+ +ML +P+ RP+A V +H W +
Sbjct: 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-65
Identities = 82/275 (29%), Positives = 126/275 (45%), Gaps = 21/275 (7%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+LG+GA+ V + A + K+L +K RE I + HPNI+ +H
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE-REARICRLLKHPNIVRLH 76
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + Y+I D +L I E E A I+QI A+ + H++
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM----- 129
Query: 134 YLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
G+VHR++K EN+L S+L A KLADFG + + ++ F GT Y +PE+
Sbjct: 130 -----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
+R PY D+W+ GV+LY +L PF D + ++ + Y F ++
Sbjct: 185 LRKDPYGKP-VDLWACGVILYILLVGYPPFWDE--DQHRLYQQIKAGAYDFPSPEWDTVT 241
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283
AK LI +ML NP R A + H WI + T
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRST 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 3e-65
Identities = 67/290 (23%), Positives = 109/290 (37%), Gaps = 35/290 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I KLGEG + V LV A K + + A RE D+ +HPNI+
Sbjct: 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREADMHRLFNHPNILR 90
Query: 72 ----VHRMVKAGTYLYMIMDYAEKKDLEHYIS--KACNENIHENQARIWIRQIANALEYL 125
R A ++++ + ++ L + I K + E+Q + I LE +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSN-------- 177
H G HRD+K NIL+ L D G E S
Sbjct: 151 HA----------KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 178 -TFCGTTSYAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233
T SY APE+ + + + D+WSLG VLY ++ + P+ + V
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDER-TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
Query: 234 QEGKEYL-FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
+ + + + ++ S QL+ M+ +P RP+ + + P
Sbjct: 260 VQNQLSIPQSPRH--SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-65
Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 21/269 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
+G G +G L+ DK ++ L A K + + ++ REI + HPNI+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ----REIINHRSLRHPNIVRFKE 83
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
++ T+L +IM+YA +L I E++AR + +Q+ + + Y H +
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM------ 135
Query: 135 LHEVGIVHRDIKCENILI--SRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR 192
I HRD+K EN L+ S K+ DFG+S+ + GT +Y APE++
Sbjct: 136 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLL 190
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN--RDVLKKQEGKEYLFNRKYEISIG 250
Y+ K+AD+WS GV LY +L YPF DP R +++ +Y IS
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
LI R+ +P R + +++ H+W
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-65
Identities = 76/292 (26%), Positives = 132/292 (45%), Gaps = 42/292 (14%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP------------------- 55
+G+G+YG V L ++ T A K K+L R P
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 56 ----REIDILLKVSHPNIIGVHRMVKAGT--YLYMIMDYAEKKDLEHYISKACNENIHEN 109
+EI IL K+ HPN++ + ++ +LYM+ + + + + + + E+
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSED 137
Query: 110 QARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL 169
QAR + + + +EYLH I+HRDIK N+L+ + K+ADFG S
Sbjct: 138 QARFYFQDLIKGIEYLHYQ----------KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 170 RTPKELSNTFCGTTSYAAPEIIRNS--PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227
+ L + GT ++ APE + + ++ K D+W++GV LY + + PF D
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 228 RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+ K + + F + +I+ K LI RML+ NP+ R +++ H W+
Sbjct: 248 --LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 4e-65
Identities = 71/281 (25%), Positives = 117/281 (41%), Gaps = 23/281 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP--REIDILLKVSHPNIIG 71
+G+G + V ++ + A K D + RE I + HP+I+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIH--ENQARIWIRQIANALEYLHEIA 129
+ + LYM+ ++ + DL I K + E A ++RQI AL Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149
Query: 130 NALEYLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYA 186
I+HRD+K +L S+ +A KL FG + L ++ GT +
Sbjct: 150 ---------NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY- 245
APE+++ PY D+W GV+L+ +L+ PF + + +Y N +
Sbjct: 201 APEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYG---TKERLFEGIIKGKYKMNPRQW 256
Query: 246 -EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQ 285
IS AK L+ RML +P R + NH W++
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-65
Identities = 83/273 (30%), Positives = 124/273 (45%), Gaps = 22/273 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+LG+GA+ V K + A K + K+L +K RE I K+ HPNI+ +H
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLH 94
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
++ ++ Y++ D +L I E E A I+QI ++ Y H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN----- 147
Query: 134 YLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
GIVHR++K EN+L S+ A KLADFG + + + F GT Y +PE+
Sbjct: 148 -----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH-GFAGTPGYLSPEV 201
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
++ PY+ DIW+ GV+LY +L PF D + + + Y + ++
Sbjct: 202 LKKDPYSKP-VDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVT 258
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
AK LI ML NPK R A WI N
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 5e-65
Identities = 70/273 (25%), Positives = 130/273 (47%), Gaps = 25/273 (9%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+G G++G V + K + +A K ++ +++F +EI+I+ + HPNII ++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFK-QEIEIMKSLDHPNIIRLY 72
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ T +Y++M+ +L + E+ A ++ + +A+ Y H++
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL----- 125
Query: 134 YLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
+ HRD+K EN L ++ ++ KL DFG + + K + T GT Y +P++
Sbjct: 126 -----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKVGTPYYVSPQV 179
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
+ Y P+ D WS GV++Y +L PF P + +V+ K + F K +S
Sbjct: 180 LEG-LYGPE-CDEWSAGVMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVS 235
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
A+ LI R+L +PK R + H W + +
Sbjct: 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 6e-65
Identities = 87/296 (29%), Positives = 143/296 (48%), Gaps = 31/296 (10%)
Query: 2 KFPDILECSYI--SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---- 55
+P L YI LG GA G V L ++++ A + ++ + P
Sbjct: 128 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNV 187
Query: 56 -REIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIW 114
EI+IL K++HP II + A Y Y++++ E +L + N+ + E +++
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVG--NKRLKEATCKLY 244
Query: 115 IRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL---LNAKLADFGFSRLLRT 171
Q+ A++YLHE GI+HRD+K EN+L+S K+ DFG S++L
Sbjct: 245 FYQMLLAVQYLHEN----------GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-G 293
Query: 172 PKELSNTFCGTTSYAAPEIIRNS---PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR 228
L T CGT +Y APE++ + YN D WSLGV+L+ L+ PF + T+
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQV- 351
Query: 229 DVLKKQEGKEYLFNRKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
+ + +Y F + E+S A L+ ++L +PK R ++ H W+Q+E
Sbjct: 352 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 7e-65
Identities = 60/283 (21%), Positives = 119/283 (42%), Gaps = 31/283 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN--IIG 71
++G G V+ V +++ + A K + + ++ + EI L K+ + II
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIY-AIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHSDKIIR 92
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ Y+YM+M+ DL ++ K ++I + + + + + A+ +H+
Sbjct: 93 LYDYEITDQYIYMVMECGNI-DLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR--TPKELSNTFCGTTSYAAPE 189
GIVH D+K N LI KL DFG + ++ T + ++ GT +Y PE
Sbjct: 147 -------GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 190 IIRNSPYNPKL----------ADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239
I++ + + +D+WSLG +LY + K PF L +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQISKLHAIIDPNH 257
Query: 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
+ ++ L+ +PK R + ++ H ++Q +
Sbjct: 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 8e-65
Identities = 83/266 (31%), Positives = 133/266 (50%), Gaps = 19/266 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG G +G V + + + A K + ++++ + REI L HP+II +++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
++ T +M+M+Y +L YI K + + E +AR +QI +A++Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH------ 130
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
+VHRD+K EN+L+ +NAK+ADFG S ++ E T CG+ +YAAPE+I
Sbjct: 131 ----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSCGSPNYAAPEVISGR 185
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK-QEGKEYLFNRKYEISIGAKQ 253
Y DIWS GV+LY +L PF D + KK + G F ++
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIRGGV---FYIPEYLNRSVAT 240
Query: 254 LIGRMLEPNPKHRPNAKDVQNHAWIQ 279
L+ ML+ +P R KD++ H W +
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 9e-65
Identities = 85/273 (31%), Positives = 139/273 (50%), Gaps = 23/273 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
KLG GAYG V L DK + +A K + K E+ +L + HPNI+ ++
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL-EEVAVLKLLDHPNIMKLY 102
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ Y++M+ + +L I +E A + I+Q+ + + YLH+
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH----- 155
Query: 134 YLHEVGIVHRDIKCENILI-SRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
IVHRD+K EN+L+ S+ +A K+ DFG S + ++ GT Y APE+
Sbjct: 156 -----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIAPEV 209
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
+R Y+ K D+WS+GV+L+ +L PFG G ++++L+K E +Y F+ +S
Sbjct: 210 LR-KKYDEK-CDVWSIGVILFILLAGYPPFG--GQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
GAK LI +ML+ + + R +A+ H WI+
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-64
Identities = 84/273 (30%), Positives = 133/273 (48%), Gaps = 23/273 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
LG+G++G V D+ ++ A K + K RE+++L K+ HPNI+ +
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHPNIMKLF 87
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+++ + Y++ + +L I K + E+ A I+Q+ + + Y+H+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH----- 140
Query: 134 YLHEVGIVHRDIKCENILI-SRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
IVHRD+K ENIL+ S+ + K+ DFG S + GT Y APE+
Sbjct: 141 -----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEV 194
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
+R + Y+ K D+WS GV+LY +L+ PF G D+LK+ E +Y F+ IS
Sbjct: 195 LRGT-YDEK-CDVWSAGVILYILLSGTPPFY--GKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
AK LI +ML +P R A H WIQ
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-64
Identities = 87/335 (25%), Positives = 139/335 (41%), Gaps = 34/335 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGV 72
+G G+Y K + A K D + EI+ILL+ HPNII +
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITL 81
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
+ G Y+Y++ + + +L I + + E +A + I +EYLH
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQ---- 135
Query: 133 EYLHEVGIVHRDIKCENIL-ISRLLNA---KLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
G+VHRD+K NIL + N ++ DFGF++ LR L T C T ++ AP
Sbjct: 136 ------GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ--EGKEYLFNRKY- 245
E++ Y+ DIWSLGV+LY +L PF + + + + GK + + Y
Sbjct: 190 EVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK-FSLSGGYW 247
Query: 246 -EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE---PTCQTMTAEEREALKIGKLK 301
+S AK L+ +ML +P R A V H WI + P Q + +K
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAA 307
Query: 302 SKVFMQKYTVVQALTSSNNVDVTEENKEKKYPDSG 336
+ + + L + + KK +
Sbjct: 308 TYSALNRNQ-SPVLEPVGRSTLAQRRGIKKITSTA 341
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 1e-63
Identities = 74/307 (24%), Positives = 129/307 (42%), Gaps = 43/307 (14%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF--APREIDILLKVSHPNIIG 71
+G+G+YG V + + ++ ++A K + ++++ + E+ ++ K+ HPNI
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN----------- 120
++ + + Y+ ++M+ L ++ +++ + + QI
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 121 -----------------ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA--KLA 161
+ +I +AL YLH GI HRDIK EN L S + KL
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 162 DFGFSRLLRTPKELS----NTFCGTTSYAAPEIIRNS--PYNPKLADIWSLGVVLYRILN 215
DFG S+ T GT + APE++ + Y PK D WS GV+L+ +L
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK-CDAWSAGVLLHLLLM 271
Query: 216 KKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQ 273
PF PG + D + + K+ F +S A+ L+ +L N R +A
Sbjct: 272 GAVPF--PGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
Query: 274 NHAWIQN 280
H WI
Sbjct: 330 QHPWISQ 336
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-63
Identities = 90/300 (30%), Positives = 145/300 (48%), Gaps = 22/300 (7%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
LG+G++G V L DK + A K +++K+ ++ RE+ +L ++ HPNI+ ++
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ Y Y++ + +L I + E A IRQ+ + + Y+H+
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKN----- 145
Query: 134 YLHEVGIVHRDIKCENILI-SRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
IVHRD+K EN+L+ S+ +A ++ DFG S K++ GT Y APE+
Sbjct: 146 -----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-KDKIGTAYYIAPEV 199
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
+ + Y+ K D+WS GV+LY +L+ PF G D+LKK E +Y F ++S
Sbjct: 200 LHGT-YDEK-CDVWSTGVILYILLSGCPPFN--GANEYDILKKVEKGKYTFELPQWKKVS 255
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKVFMQK 308
AK LI +ML P R +A+D +H WIQ Q I ++ QK
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQK 315
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-63
Identities = 59/283 (20%), Positives = 121/283 (42%), Gaps = 31/283 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN--IIG 71
++G G V+ V +++ + A K + + ++ + EI L K+ + II
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIY-AIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHSDKIIR 73
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ Y+YM+M+ DL ++ K ++I + + + + + A+ +H+
Sbjct: 74 LYDYEITDQYIYMVMECGNI-DLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR--TPKELSNTFCGTTSYAAPE 189
GIVH D+K N LI KL DFG + ++ T + ++ GT +Y PE
Sbjct: 128 -------GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 190 IIRNSPYNPKL----------ADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239
I++ + + +D+WSLG +LY + K PF + + + +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN-H 238
Query: 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
+ ++ L+ +PK R + ++ H ++Q +
Sbjct: 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-63
Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+LG GA VY K ++ A K K + + + EI +LL++SHPNII +
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR----TEIGVLLRLSHPNIIKLK 114
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + T + ++++ +L I + E A ++QI A+ YLHE
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHEN----- 167
Query: 134 YLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
GIVHRD+K EN+L + +A K+ADFG S+++ + T CGT Y APEI
Sbjct: 168 -----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK-TVCGTPGYCAPEI 221
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
+R Y P+ D+WS+G++ Y +L PF D ++ + ++ EY F + E+S
Sbjct: 222 LRGCAYGPE-VDMWSVGIITYILLCGFEPFYDE-RGDQFMFRRILNCEYYFISPWWDEVS 279
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
+ AK L+ +++ +PK R H W+ +
Sbjct: 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 6e-63
Identities = 57/302 (18%), Positives = 100/302 (33%), Gaps = 46/302 (15%)
Query: 14 KLGEGAYGNVYLVSDKRS------------ETLKACKAYDFKRLKRDYMEKFAPREIDIL 61
L +G + + L E + + ++ E+ I+
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 62 LKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISK------ACNENIHENQARIWI 115
+ + + ++ +Y+I +Y E + + I + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 116 RQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL 175
+ + N+ Y+H +E I HRD+K NIL+ + KL+DFG S +
Sbjct: 158 KSVLNSFSYIH---------NEKNICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKK 206
Query: 176 SNTFCGTTSYAAPEIIRN-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGT--------- 225
GT + PE N S YN DIWSLG+ LY + PF +
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 226 -------RNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
+R+ + +S + L NP R ++D H W+
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326
Query: 279 QN 280
+
Sbjct: 327 AD 328
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 1e-62
Identities = 85/283 (30%), Positives = 125/283 (44%), Gaps = 31/283 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY------MEKFAPREIDILLKVS-H 66
LG G V K + A K D + + +E+DIL KVS H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
PNII + + T+ +++ D +K +L Y+++ + E + R +R + + LH
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH 141
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
++ IVHRD+K ENIL+ +N KL DFGFS L P E CGT SY
Sbjct: 142 KL----------NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYL 190
Query: 187 APEIIRNS------PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240
APEII S Y + D+WS GV++Y +L PF + +L+ Y
Sbjct: 191 APEIIECSMNDNHPGYGKE-VDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQ 247
Query: 241 FNRKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
F + S K L+ R L P+ R A++ H + Q
Sbjct: 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-62
Identities = 59/283 (20%), Positives = 118/283 (41%), Gaps = 31/283 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN--IIG 71
++G G V+ V +++ + A K + + ++ + EI L K+ + II
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIY-AIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHSDKIIR 120
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ Y+YM+M+ DL ++ K ++I + + + + + A+ +H+
Sbjct: 121 LYDYEITDQYIYMVMECGNI-DLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR--TPKELSNTFCGTTSYAAPE 189
GIVH D+K N LI KL DFG + ++ T + ++ G +Y PE
Sbjct: 175 -------GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 190 IIRNSPYNPKL----------ADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239
I++ + + +D+WSLG +LY + K PF L +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQISKLHAIIDPNH 285
Query: 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
+ ++ L+ +PK R + ++ H ++Q +
Sbjct: 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-62
Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 25/276 (9%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD-YMEKFAPREIDILLKVSHPNIIGVH 73
LGEG+YG V V D + +A K K+L+R E +EI +L ++ H N+I +
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 74 RMVKAGT--YLYMIMDYAEKKDLE--HYISKACNENIHENQARIWIRQIANALEYLHEIA 129
++ +YM+M+Y E + + + QA + Q+ + LEYLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHSQ- 128
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR--TPKELSNTFCGTTSYAA 187
GIVH+DIK N+L++ K++ G + L + T G+ ++
Sbjct: 129 ---------GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 188 PEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246
PEI ++ DIWS GV LY I YPF + + Y +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--LFENIGKGSYAI--PGD 235
Query: 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
L+ MLE P R + + ++ H+W + +
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-62
Identities = 91/310 (29%), Positives = 139/310 (44%), Gaps = 32/310 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP----------REIDILLK 63
KLG GAYG V L +K + KA K + + EI +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
+ HPNII + + + Y Y++ ++ E +L I E A ++QI + +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGIC 160
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILI-SRLLNA--KLADFGFSRLLRTPKELSNTFC 180
YLH+ IVHRDIK ENIL+ ++ K+ DFG S +L
Sbjct: 161 YLHKH----------NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-RDRL 209
Query: 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240
GT Y APE+++ YN K D+WS GV++Y +L PFG G ++D++KK E +Y
Sbjct: 210 GTAYYIAPEVLKKK-YNEK-CDVWSCGVIMYILLCGYPPFG--GQNDQDIIKKVEKGKYY 265
Query: 241 FNRKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIG 298
F+ IS AK+LI ML + R A++ N WI+ + ++ +
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALS 325
Query: 299 KLKSKVFMQK 308
++ QK
Sbjct: 326 NMRKFEGSQK 335
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-62
Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 23/301 (7%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH-PNIIGV 72
+LG G + V K + A K +R +D + EI +L P +I +
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL-HEIAVLELAKSCPRVINL 94
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
H + + + + +I++YA ++ E + EN I+QI + YLH+
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---- 150
Query: 133 EYLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
IVH D+K +NIL S K+ DFG SR + EL GT Y APE
Sbjct: 151 ------NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR-EIMGTPEYLAPE 203
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EI 247
I+ P D+W++G++ Y +L PF G N++ ++ + +
Sbjct: 204 ILNYDPITTA-TDMWNIGIIAYMLLTHTSPFV--GEDNQETYLNISQVNVDYSEETFSSV 260
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKVFMQ 307
S A I +L NP+ RP A+ +H+W+Q EE + + +
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS--QTQDHSVRS 318
Query: 308 K 308
Sbjct: 319 S 319
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-61
Identities = 79/279 (28%), Positives = 137/279 (49%), Gaps = 32/279 (11%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGV 72
LGEG++ K+S A K KR++ + +EI L HPNI+ +
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQ-----KEITALKLCEGHPNIVKL 71
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
H + + +++M+ +L I K ++ E +A +R++ +A+ ++H++
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDV---- 125
Query: 133 EYLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
G+VHRD+K EN+L N K+ DFGF+RL + T C T YAAPE
Sbjct: 126 ------GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD-----PGTRNRDVLKK-QEGKEYLFNR 243
++ + Y+ D+WSLGV+LY +L+ + PF T +++KK ++G + F
Sbjct: 180 LLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-FSFEG 237
Query: 244 KY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ +S AK LI +L +P R ++ + W+Q+
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-61
Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 34/282 (12%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR-----DYMEKFAPREIDILLKVS-HP 67
+G G V + + A K + + + + + RE IL +V+ HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+II + ++ ++++++ D K +L Y+++ + E + R +R + A+ +LH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHA 218
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
IVHRD+K ENIL+ + +L+DFGFS L P E CGT Y A
Sbjct: 219 N----------NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRELCGTPGYLA 267
Query: 188 PEIIRNS------PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ--EGKEY 239
PEI++ S Y + D+W+ GV+L+ +L PF R + ++ + EG+ Y
Sbjct: 268 PEILKCSMDETHPGYGKE-VDLWACGVILFTLLAGSPPFWH---RRQILMLRMIMEGQ-Y 322
Query: 240 LFNRKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
F+ + S K LI R+L+ +P+ R A+ H + +
Sbjct: 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-61
Identities = 86/266 (32%), Positives = 136/266 (51%), Gaps = 20/266 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEG++G V L + +++ A K + LK+ M REI L + HP+II ++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
++ T + M+++YA +L YI + + + E++ R + +QI A+EY H
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH------ 127
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
IVHRD+K EN+L+ LN K+ADFG S ++ T CG+ +YAAPE+I
Sbjct: 128 ----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVINGK 182
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK-QEGKEYLFNRKYEISIGAKQ 253
Y D+WS G+VLY +L + PF D N + KK + +S GA+
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--LFKKVNSCV---YVMPDFLSPGAQS 237
Query: 254 LIGRMLEPNPKHRPNAKDVQNHAWIQ 279
LI RM+ +P R ++++ W
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 4e-61
Identities = 76/308 (24%), Positives = 134/308 (43%), Gaps = 43/308 (13%)
Query: 3 FPDILECSYISK--LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDI 60
F L+ +S+ LG G+ G V A K R+ D+ + A EI +
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVK-----RMLIDFCD-IALMEIKL 61
Query: 61 LLKVS-HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIA 119
L + HPN+I + +LY+ ++ +L+ + E+ + + + +++
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCNL-NLQDLV-----ESKNVSDENLKLQKEY 115
Query: 120 NALEYLHEIANALEYLHEVGIVHRDIKCENILIS-------------RLLNAKLADFGFS 166
N + L +IA+ + +LH + I+HRD+K +NIL+S L ++DFG
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 167 RLLR----TPKELSNTFCGTTSYAAPEIIRNS-------PYNPKLADIWSLGVVLYRILN 215
+ L + + N GT+ + APE++ S DI+S+G V Y IL+
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSMGCVFYYILS 234
Query: 216 KKY-PFGDPGTRNRDVLKKQ-EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQ 273
K PFGD +R ++++ E + A LI +M++ +P RP A V
Sbjct: 235 KGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294
Query: 274 NHAWIQNE 281
H +
Sbjct: 295 RHPLFWPK 302
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-61
Identities = 81/266 (30%), Positives = 133/266 (50%), Gaps = 19/266 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG G +G V + + + A K + ++++ + REI L HP+II +++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
++ + ++M+M+Y +L YI K N + E ++R +QI + ++Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRH------ 135
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
+VHRD+K EN+L+ +NAK+ADFG S ++ E T CG+ +YAAPE+I
Sbjct: 136 ----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSCGSPNYAAPEVISGR 190
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK-QEGKEYLFNRKYEISIGAKQ 253
Y DIWS GV+LY +L PF D + KK +G F ++
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LFKKICDGI---FYTPQYLNPSVIS 245
Query: 254 LIGRMLEPNPKHRPNAKDVQNHAWIQ 279
L+ ML+ +P R KD++ H W +
Sbjct: 246 LLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-61
Identities = 66/306 (21%), Positives = 115/306 (37%), Gaps = 54/306 (17%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
LG+GA NV+ K++ L A K ++ R ++ RE ++L K++H NI+ +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQM-REFEVLKKLNHKNIVKLF 73
Query: 74 RMVKAGT--YLYMIMDYAEKKDLEHYISKACNEN-IHENQARIWIRQIANALEYLHEIAN 130
+ + T + +IM++ L + + N + E++ I +R + + +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 131 ALEYLHEVGIVHRDIKCENILISRL----LNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
GIVHR+IK NI+ KL DFG +R L E + GT Y
Sbjct: 132 --------GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLYGTEEYL 182
Query: 187 APEIIRNS--------PYNPKLADIWSLGVVLYRILNKKYPFGDP--GTRNRDVLKKQEG 236
P++ + Y D+WS+GV Y PF RN++V+ K
Sbjct: 183 HPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 237 KEYLFNRKY-------------------EISIGAK----QLIGRMLEPNPKHRPNAKDVQ 273
+ +S G + ++ +LE + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 274 NHAWIQ 279
Sbjct: 302 AETSDI 307
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-60
Identities = 82/349 (23%), Positives = 154/349 (44%), Gaps = 31/349 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPNII 70
+LG G + V +K + A K ++ + RE+ IL +V HPNII
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+H + + T + +I++ +L ++++ E++ E +A +I+QI + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK-- 134
Query: 131 ALEYLHEVGIVHRDIKCENILI----SRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
I H D+K ENI++ + + KL DFG + + E GT +
Sbjct: 135 --------KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPEFV 185
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY- 245
APEI+ P + AD+WS+GV+ Y +L+ PF G ++ L Y F+ ++
Sbjct: 186 APEIVNYEPLGLE-ADMWSIGVITYILLSGASPFL--GDTKQETLANITAVSYDFDEEFF 242
Query: 246 -EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKV 304
+ S AK I ++L + R ++ H WI T Q + + K +
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT-QQAMVRRESVVNLENFKKQY 301
Query: 305 FMQK----YTVVQALTSSNNVDVTEEN-KEKKYPDSGESVSDQSILVRK 348
++ +++V + + + + + + ES ++++I RK
Sbjct: 302 VRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRK 350
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-60
Identities = 73/316 (23%), Positives = 136/316 (43%), Gaps = 30/316 (9%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPNII 70
+LG G + V +K + A K ++ + RE+ IL +V H N+I
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+H + + T + +I++ +L ++++ E++ E +A +I+QI + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK-- 134
Query: 131 ALEYLHEVGIVHRDIKCENILISR----LLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
I H D+K ENI++ + + KL DFG + + E GT +
Sbjct: 135 --------KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPEFV 185
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY- 245
APEI+ P + AD+WS+GV+ Y +L+ PF G ++ L Y F+ ++
Sbjct: 186 APEIVNYEPLGLE-ADMWSIGVITYILLSGASPFL--GDTKQETLANITSVSYDFDEEFF 242
Query: 246 -EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKV 304
S AK I ++L + R ++ H WI Q + + + +
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN-QQAMVRRESVVNLENFRKQY 301
Query: 305 FMQK----YTVVQALT 316
++ +++V
Sbjct: 302 VRRRWKLSFSIVSLCN 317
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-60
Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 25/276 (9%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPNII 70
+LG G + V K + A K +RL RE++IL ++ HPNII
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+H + + T + +I++ +L ++++ E++ E++A +++QI + + YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK-- 127
Query: 131 ALEYLHEVGIVHRDIKCENILISR----LLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
I H D+K ENI++ KL DFG + + E GT +
Sbjct: 128 --------RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK-NIFGTPEFV 178
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY- 245
APEI+ P + AD+WS+GV+ Y +L+ PF G ++ L Y F+ +Y
Sbjct: 179 APEIVNYEPLGLE-ADMWSIGVITYILLSGASPFL--GETKQETLTNISAVNYDFDEEYF 235
Query: 246 -EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
S AK I R+L +PK R H+WI+
Sbjct: 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-60
Identities = 89/339 (26%), Positives = 145/339 (42%), Gaps = 40/339 (11%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKA-YDFKRLKRDYMEKFAPREIDILLKVS-HPNIIG 71
LG G G V + +KR++ A K D + +R E+++ + S P+I+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR---------EVELHWRASQCPHIVR 119
Query: 72 VHR----MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+ + L ++M+ + +L I ++ E +A ++ I A++YLH
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 128 IANALEYLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTS 184
I I HRD+K EN+L S+ NA KL DFGF++ + L+ T C T
Sbjct: 180 I----------NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT-TPCYTPY 228
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GDPGTRNRDVLKKQ--EGKEYLF 241
Y APE++ Y+ D+WSLGV++Y +L PF + G +K + G+ Y F
Sbjct: 229 YVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEF 286
Query: 242 NRKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGK 299
E+S K LI +L+ P R + NH WI L K
Sbjct: 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVL---K 343
Query: 300 LKSKVFMQKYTVVQALTSSNNVDVTEENKEKKYPDSGES 338
+ + + + ++ VD E+ K KK D+
Sbjct: 344 EDKERWEDVKEEMTSALATMRVD-YEQIKIKKIEDASNP 381
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-60
Identities = 83/305 (27%), Positives = 140/305 (45%), Gaps = 26/305 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPNII 70
+LG G + V +K + A K +R K RE+ IL ++ HPN+I
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+H + + T + +I++ +L ++++ E++ E +A +++QI N + YLH +
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL-- 133
Query: 131 ALEYLHEVGIVHRDIKCENILISR----LLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
I H D+K ENI++ K+ DFG + + E GT +
Sbjct: 134 --------QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGTPEFV 184
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY- 245
APEI+ P + AD+WS+GV+ Y +L+ PF G ++ L Y F +Y
Sbjct: 185 APEIVNYEPLGLE-ADMWSIGVITYILLSGASPFL--GDTKQETLANVSAVNYEFEDEYF 241
Query: 246 -EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKV 304
S AK I R+L +PK R +D H WI+ + T Q ++ + A+ + K K
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS-RKASAVNMEKFKKFA 300
Query: 305 FMQKY 309
+K
Sbjct: 301 ARKKS 305
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 8e-60
Identities = 76/333 (22%), Positives = 142/333 (42%), Gaps = 22/333 (6%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+LG GA+G V+ +K + + K + Y K EI I+ ++ HP +I +H
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLH 114
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + +I+++ +L I+ + + E + ++RQ L+++HE
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH----- 168
Query: 134 YLHEVGIVHRDIKCENILISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
IVH DIK ENI+ + K+ DFG + L P E+ T +AAPEI+
Sbjct: 169 -----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIV 222
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EISI 249
P D+W++GV+ Y +L+ PF G + + L+ + ++ F+ +S
Sbjct: 223 DREPVGFY-TDMWAIGVLGYVLLSGLSPFA--GEDDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKVFMQKY 309
AK I +L+ P+ R D H W++ + + T KI + + +
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWP 339
Query: 310 TVVQALTSSNNVDVTEENKEKKYPDSGESVSDQ 342
A+ N +++ ++Y +
Sbjct: 340 APQPAIGRIANFSSLRKHRPQEYQIYDSYFDRK 372
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-60
Identities = 82/279 (29%), Positives = 123/279 (44%), Gaps = 33/279 (11%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGV 72
LG G G V +R+ A K R +E+D + S P+I+ +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR--------QEVDHHWQASGGPHIVCI 87
Query: 73 HR----MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
M L +IM+ E +L I + ++ E +A +R I A+++LH
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 129 ANALEYLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSY 185
I HRD+K EN+L S+ +A KL DFGF++ T L T C T Y
Sbjct: 148 ----------NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-TQNALQ-TPCYTPYY 195
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GDPGTRNRDVLKKQEGK-EYLFNR 243
APE++ Y+ D+WSLGV++Y +L PF + G +K++ +Y F
Sbjct: 196 VAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254
Query: 244 KY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
E+S AKQLI +L+ +P R NH WI
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 9e-60
Identities = 68/290 (23%), Positives = 107/290 (36%), Gaps = 42/290 (14%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNII 70
L EG + VY D S A K + + +E+ + K+S HPNI+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLSGHPNIV 89
Query: 71 --------GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
G ++ + + + +E + + Q A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK--------- 173
+++H + I+HRD+K EN+L+S KL DFG + +
Sbjct: 150 QHMHR--------QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 174 ---ELSNTFCGTTSYAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227
E T T Y PEII N P K DIW+LG +LY + +++PF D
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK-QDIWALGCILYLLCFRQHPFEDGA--- 257
Query: 228 RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAW 277
L+ GK Y LI ML+ NP+ R + +V +
Sbjct: 258 --KLRIVNGK-YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 1e-59
Identities = 73/300 (24%), Positives = 129/300 (43%), Gaps = 32/300 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
LG G +G V+ + S+ K K + ++ +EI IL H NI+ +H
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK----KEISILNIARHRNILHLH 67
Query: 74 RMVKAGTYLYMIMDYAEKKDL-EHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
++ L MI ++ D+ E + ++E + ++ Q+ AL++LH
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---- 121
Query: 133 EYLHEVGIVHRDIKCENILISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
I H DI+ ENI+ ++ K+ +FG +R L+ P + Y APE+
Sbjct: 122 ------NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEYYAPEV 174
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
++ + D+WSLG ++Y +L+ PF N+ +++ EY F+ + EIS
Sbjct: 175 HQHDVVSTA-TDMWSLGTLVYVLLSGINPFL--AETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKVFMQK 308
I A + R+L K R A + H W++ + E I LK + +
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK-------IERVSTKVIRTLKHRRYYHT 284
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 1e-59
Identities = 46/299 (15%), Positives = 75/299 (25%), Gaps = 43/299 (14%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGV-- 72
L G V+LV D A K + + ++ +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 73 ------------------------HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHE 108
+ A ++M A DLE S +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV-DLELLFSTLDFVYVFR 188
Query: 109 NQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168
I ++ L G+VH +N+ I L D
Sbjct: 189 GDEGILAL-----HILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL-- 241
Query: 169 LRTPKELSNTFCGTTSYAAPEII--RNSPYNPKLADIWSLGVVLYRILNKKYPFGDP--- 223
+YA E + + + + W LG+ +YR+ PFG
Sbjct: 242 -WKVGTRGPASSVPVTYAPREFLNASTATFTHA-LNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 224 --GTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
G+ R L+ F + K LIGR L + + R +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 5e-59
Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 32/280 (11%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGV 72
LG GA G + A K R+ + FA RE+ +L + HPN+I
Sbjct: 31 VLGHGAEGTIVYR-GMFDNRDVAVK-----RILPECFS-FADREVQLLRESDEHPNVIRY 83
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
K + Y+ ++ L+ Y+ + + + ++Q + L +LH +
Sbjct: 84 FCTEKDRQFQYIAIELCAA-TLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSL---- 137
Query: 133 EYLHEVGIVHRDIKCENILIS-----RLLNAKLADFGFSRLLRTPK---ELSNTFCGTTS 184
IVHRD+K NILIS + A ++DFG + L + + GT
Sbjct: 138 ------NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 185 YAAPEIIRNSPYNP--KLADIWSLGVVLYRILNKKY-PFGDPGTRNRDVLKKQEGKEYLF 241
+ APE++ DI+S G V Y ++++ PFG R ++L + L
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL- 250
Query: 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
+ + + A++LI +M+ +P+ RP+AK V H + +
Sbjct: 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-58
Identities = 64/283 (22%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKVSHPNIIGV 72
LG G +G V+ + + A K + +K ++ ++ EI ++ ++ H N+I +
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK----NEISVMNQLDHANLIQL 151
Query: 73 HRMVKAGTYLYMIMDYAEKKDL-EHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ ++ + ++M+Y + +L + I + + N+ E ++++QI + ++H++
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQM--- 206
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
I+H D+K ENIL K+ DFG +R + P+E GT + APE
Sbjct: 207 -------YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPE 258
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EI 247
++ + D+WS+GV+ Y +L+ PF G + + L + + +I
Sbjct: 259 VVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFL--GDNDAETLNNILACRWDLEDEEFQDI 315
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAE 290
S AK+ I ++L R +A + H W+ + ++A+
Sbjct: 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQ 358
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 8e-58
Identities = 66/344 (19%), Positives = 119/344 (34%), Gaps = 63/344 (18%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
LG+GA NV+ K++ L A K ++ R ++ RE ++L K++H NI+ +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQM-REFEVLKKLNHKNIVKLF 73
Query: 74 RMVKAGT--YLYMIMDYAEKKDLEHYISKACNEN-IHENQARIWIRQIANALEYLHEIAN 130
+ + T + +IM++ L + + N + E++ I +R + + +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 131 ALEYLHEVGIVHRDIKCENILISRL----LNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
GIVHR+IK NI+ KL DFG +R L E + GT Y
Sbjct: 132 --------GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLYGTEEYL 182
Query: 187 APEIIRNS--------PYNPKLADIWSLGVVLYRILNKKYPFGD--PGTRNRDVLKKQEG 236
P++ + Y D+WS+GV Y PF RN++V+ K
Sbjct: 183 HPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 237 KEYLF-----------------------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQ 273
+ + + + ++ +LE + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 274 NHAW---------IQNEPTCQTMTAEEREALKIGKLKSKVFMQK 308
+ + V+ Q
Sbjct: 302 AETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQT 345
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 7e-57
Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 49/299 (16%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKVS-HPNIIGV 72
LGEGA+ V + + A K + + R + RE+++L + H N++ +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF----REVEMLYQCQGHRNVLEL 76
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
+ Y++ + + +I K + +E +A + ++ +A+AL++LH
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNK---- 130
Query: 133 EYLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELS-------NTFCGT 182
GI HRD+K ENIL + K+ DF ++ + S T CG+
Sbjct: 131 ------GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 183 TSYAAPEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPF---GDPGTRNRDVLKKQ 234
Y APE++ S Y+ + D+WSLGV+LY +L+ PF
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 235 EGKEYLFNR----KYE--------ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
+ LF KYE IS AK LI ++L + K R +A V H W+Q
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-56
Identities = 77/345 (22%), Positives = 146/345 (42%), Gaps = 27/345 (7%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKVSHPNIIGV 72
+LG GA+G V+ V+++ + A K ++ + +EI + + HP ++ +
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR----KEIQTMSVLRHPTLVNL 219
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
H + + MI ++ +L ++ + + E++A ++RQ+ L ++HE
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---- 274
Query: 133 EYLHEVGIVHRDIKCENILI-SRLLNA-KLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
VH D+K ENI+ ++ N KL DFG + L PK+ GT +AAPE+
Sbjct: 275 ------NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEV 327
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EIS 248
P D+WS+GV+ Y +L+ PFG G + + L+ + ++ + IS
Sbjct: 328 AEGKPVGYY-TDMWSVGVLSYILLSGLSPFG--GENDDETLRNVKSCDWNMDDSAFSGIS 384
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ--NEPTCQTMTAEEREALKIGKLKSKVFM 306
K I ++L +P R H W+ N P + R +K+K +
Sbjct: 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTK-YD 443
Query: 307 QKYTVVQALTSSNNVDVTEENKEKKYPDSGESVSDQSILVRKLGE 351
+ L +N +++ ++Y R + +
Sbjct: 444 AWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVK 488
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 194 bits (493), Expect = 2e-56
Identities = 72/297 (24%), Positives = 114/297 (38%), Gaps = 46/297 (15%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+LG G +G V + + A K + L E++ EI I+ K++HPN++
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWC-LEIQIMKKLNHPNVVSAR 78
Query: 74 RMVKAGTYL------YMIMDYAEKKDLEHYISKACNEN-IHENQARIWIRQIANALEYLH 126
+ L + M+Y E DL Y+++ N + E R + I++AL YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 127 EIANALEYLHEVGIVHRDIKCENILISR---LLNAKLADFGFSRLLRTPKELSNTFCGTT 183
E I+HRD+K ENI++ L K+ D G+++ L EL F GT
Sbjct: 139 EN----------RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFVGTL 187
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243
Y APE++ Y D WS G + + + PF P + K K
Sbjct: 188 QYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPF-LPNWQPVQWHGKVREKSNEHIV 245
Query: 244 KYEISIG---------------------AKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
Y+ G ++ + ML + + R N Q
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-56
Identities = 58/291 (19%), Positives = 114/291 (39%), Gaps = 43/291 (14%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNII 70
+ K+G G +G+V+ + + A K E+ A RE+ + H +++
Sbjct: 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVV 74
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
++ + +Y L IS+ + +A + L ++
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD--------LLLQVGR 126
Query: 131 ALEYLHEVGIVHRDIKCENILISR-------------------LLNAKLADFGFSRLLRT 171
L Y+H + +VH DIK NI ISR + K+ D G + +
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 172 PKELSNTFCGTTSYAAPEIIR-NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV 230
P G + + A E+++ N + PK ADI++L + + + RN D
Sbjct: 187 P----QVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLP-----RNGDQ 236
Query: 231 LKK-QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ ++G+ + S +L+ M+ P+P+ RP+A + H+ + +
Sbjct: 237 WHEIRQGRLPRIPQVL--SQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-54
Identities = 71/272 (26%), Positives = 131/272 (48%), Gaps = 27/272 (9%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LGEG++ V L + + A K + + + ++ + RE D++ ++ HP + ++
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ LY + YA+ +L YI K + E R Y EI +ALEY
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRF----------YTAEIVSALEY 145
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIR 192
LH GI+HRD+K ENIL++ ++ ++ DFG +++L + +N+F GT Y +PE++
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL-KKQEGKEYLFNRKYEISIGA 251
K +D+W+LG ++Y+++ PF N ++ +K EY F + A
Sbjct: 206 EKSAC-KSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYDF--PEKFFPKA 259
Query: 252 KQLIGRMLEPNPKHRP------NAKDVQNHAW 277
+ L+ ++L + R ++ H +
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-54
Identities = 38/310 (12%), Positives = 75/310 (24%), Gaps = 61/310 (19%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREI---------------- 58
LG+ +D+ + F K E+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 59 ---------DILLKVSHPNIIGV----HRMVKAGTYLYMIMDYAEKKDLEHYISKACNEN 105
D++ +I V M + + + + + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 106 IHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165
L+ ++ L LH G+VH ++ +I++ + L F
Sbjct: 201 KSLVHHA--------RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 166 SRLLRTPKELSNTFCGTTSYAAPEII-----------RNSPYNPKLADIWSLGVVLYRIL 214
+ + PE+ R + D W+LG+V+Y I
Sbjct: 253 LV----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS-FDAWALGLVIYWIW 307
Query: 215 NKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274
P E++F I + L+ L + R
Sbjct: 308 CADLPITKDAALGG--------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
Query: 275 HAWIQNEPTC 284
+ T
Sbjct: 360 TPEYEQLRTE 369
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-51
Identities = 71/330 (21%), Positives = 117/330 (35%), Gaps = 70/330 (21%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I +G G +G V+ +K + A K R+ + RE+ L K+ HP I+
Sbjct: 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVR 68
Query: 72 VH-----------RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQA--------- 111
+ +L + + + +
Sbjct: 69 YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ 128
Query: 112 --------------------RIWIRQ--------IANALEYLHEIANALEYLHEVGIVHR 143
+ W+ + L +IA A+E+LH G++HR
Sbjct: 129 PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHR 188
Query: 144 DIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF------------CGTTSYAAPEII 191
D+K NI + K+ DFG + +E GT Y +PE I
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK-EYLFNRKYEISIG 250
+ Y+ K DI+SLG++L+ +L Y F R R + + K LF +KY
Sbjct: 249 HGNNYSHK-VDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQKYP---Q 301
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
++ ML P+P RP A D+ +A +N
Sbjct: 302 EHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 8e-50
Identities = 76/313 (24%), Positives = 120/313 (38%), Gaps = 53/313 (16%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGV 72
LG G G V + +KR++ A K R RE+++ + S P+I+ +
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------REVELHWRASQCPHIVRI 76
Query: 73 HR----MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+ L ++M+ + +L I ++ E +A ++ I A++YLH I
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 129 ANALEYLHEVGIVHRDIKCENIL-ISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSY 185
I HRD+K EN+L S+ NA KL DFGF
Sbjct: 137 ----------NIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------- 166
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD--PGTRNRDVLKKQEGKEYLFNR 243
A E Y+ D+WSLGV++Y +L PF + + + +Y F
Sbjct: 167 -AKETTGEK-YDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223
Query: 244 KY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLK 301
E+S K LI +L+ P R + NH WI LK K +
Sbjct: 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 283
Query: 302 SKVFMQKYTVVQA 314
+ ++ T A
Sbjct: 284 WEDVKEEMTSALA 296
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-49
Identities = 64/268 (23%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
+G+G++G V +V ++ + A K + ++ + +E+ I+ + HP ++ +
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ ++M++D DL +++ + N + E ++ ++ E+ AL+Y
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKL----------FICELVMALDY 130
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
L I+HRD+K +NIL+ + + DF + +L + T GT Y APE+ +
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAGTKPYMAPEMFSSR 189
Query: 195 P---YNPKLADIWSLGVVLYRILNKKYPF-GDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250
Y+ D WSLGV Y +L + P+ T +++++ E + S
Sbjct: 190 KGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS--AWSQE 246
Query: 251 AKQLIGRMLEPNPKHR-PNAKDVQNHAW 277
L+ ++LEPNP R DVQN +
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPY 274
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 33/276 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G +G V + + + ACK + KR+K+ E A E IL KV+ ++ +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
+ L +++ DL+ +I E +A Y EI LE
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF----------YAAEICCGLED 301
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH IV+RD+K ENIL+ + +++D G + + + GT Y APE+++N
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE-------- 246
Y D W+LG +LY ++ + PF + R K+ +E + E
Sbjct: 361 RYT-FSPDWWALGCLLYEMIAGQSPF-----QQRK---KKIKREEVERLVKEVPEEYSER 411
Query: 247 ISIGAKQLIGRMLEPNPKHR-----PNAKDVQNHAW 277
S A+ L ++L +P R +A++V+ H
Sbjct: 412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-49
Identities = 61/273 (22%), Positives = 117/273 (42%), Gaps = 21/273 (7%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
++G G++ VY D + A ++L + ++F E ++L + HPNI+ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPNIVRFY 91
Query: 74 R----MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
VK + ++ + L+ Y+ + + + R W RQI L++LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT-- 147
Query: 130 NALEYLHEVGIVHRDIKCENILISRLL-NAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
I+HRD+KC+NI I+ + K+ D G + L R + GT + AP
Sbjct: 148 ------RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAP 199
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248
E+ Y+ D+++ G+ + + +YP+ + + ++ +
Sbjct: 200 EMYEEK-YDES-VDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
K++I + N R + KD+ NHA+ Q E
Sbjct: 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-49
Identities = 81/276 (29%), Positives = 134/276 (48%), Gaps = 41/276 (14%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREID-------ILLKVSHP 67
LG G++G V+L+ + + Y K LK++ + + ++++ +L V+HP
Sbjct: 14 LGTGSFGRVHLIRSRHNGRY-----YAMKVLKKEIVVRL--KQVEHTNDERLMLSIVTHP 66
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
II + + ++MIMDY E +L + K+ + A+ Y E
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKF----------YAAE 114
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
+ ALEYLH I++RD+K ENIL+ + + K+ DFGF++ + +++ T CGT Y A
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIA 171
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL-KKQEGKEYLFNRKYE 246
PE++ PYN K D WS G+++Y +L PF D N +K E F
Sbjct: 172 PEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELRFPP--F 225
Query: 247 ISIGAKQLIGRMLEPNPKHR----PN-AKDVQNHAW 277
+ K L+ R++ + R N +DV+NH W
Sbjct: 226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-49
Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK-----FAPREIDILLKVSHPNI 69
+G GA+G V LV K + + Y K L + M K F E DI+ + P +
Sbjct: 77 IGRGAFGEVQLVRHKSTRKV-----YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ + + YLYM+M+Y DL + +S ++ E AR Y E+
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARF----------YTAEVV 178
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGTTSYAAP 188
AL+ +H +G +HRD+K +N+L+ + + KLADFG ++ + +T GT Y +P
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 189 EIIRNSPYNP---KLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL--KKQEGKEYL-FN 242
E++++ + + D WS+GV LY +L PF + K K L F
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA---DSLVGTYSKIMNHKNSLTFP 295
Query: 243 RKYEISIGAKQLIGRMLEPNPKHR--PN-AKDVQNHAW 277
+IS AK LI L + + R N ++++ H +
Sbjct: 296 DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLF 332
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-49
Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG G++G V LV K S A K D +++ + + E IL V+ P ++ +
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEY 134
K + LYM+M+Y ++ ++ + E AR Y +I EY
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF----------YAAQIVLTFEY 156
Query: 135 LHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS 194
LH + +++RD+K EN+LI + ++ DFGF++ + K + T CGT APEII +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWTLCGTPEALAPEIILSK 213
Query: 195 PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL-KKQEGKEYLFNRKYEISIGAKQ 253
YN K D W+LGV++Y + PF + +K + F S K
Sbjct: 214 GYN-KAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVSGKVRFPS--HFSSDLKD 267
Query: 254 LIGRMLEPNPKHR----PN-AKDVQNHAW 277
L+ +L+ + R N D++NH W
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-49
Identities = 43/295 (14%), Positives = 90/295 (30%), Gaps = 40/295 (13%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF--APREIDILLKVSHPNI 69
LGEGA+ VY + K + + K K +F + ++ L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNEN---IHENQARIWIRQIANALEYLH 126
+ + ++ + L + I+ N + + +
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI----------SFAM 179
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNA-----------KLADFGFSRLLRT--PK 173
+ +E +H+ I+H DIK +N ++ L D G S ++
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 174 ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233
+ C T+ + E++ N P+N + D + + +Y +L Y + +
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMK--VKNEGGECKPE 296
Query: 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH---AWIQNEPTCQ 285
+ + + ML H + D+ Q T +
Sbjct: 297 GLFRRLPHLDMW------NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK 345
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 71/278 (25%), Positives = 125/278 (44%), Gaps = 34/278 (12%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG G +G V+ K + L ACK + KRLK+ + A E IL KV I+ +
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNEN--IHENQARIWIRQIANALEYLHEIANAL 132
+ T L ++M D+ ++I +N E +A Y +I + L
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF----------YTAQIVSGL 302
Query: 133 EYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR 192
E+LH+ I++RD+K EN+L+ N +++D G + L+ + + + GT + APE++
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 193 NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR------KY- 245
Y+ D ++LGV LY ++ + PF R R ++ + L R Y
Sbjct: 363 GEEYD-FSVDYFALGVTLYEMIAARGPF-----RARG---EKVENKELKQRVLEQAVTYP 413
Query: 246 -EISIGAKQLIGRMLEPNPKHR-----PNAKDVQNHAW 277
+ S +K +L+ +P+ R + ++ H
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-48
Identities = 83/278 (29%), Positives = 141/278 (50%), Gaps = 40/278 (14%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY----------MEKFAPREIDILLKV 64
LG+G++G V+LV K+ A + Y K LK+ ME+ DIL++V
Sbjct: 32 LGQGSFGKVFLV--KKISGSDARQLYAMKVLKKATLKVRDRVRTKMER------DILVEV 83
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
+HP I+ +H + LY+I+D+ DL +SK E + Y
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKF----------Y 131
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
L E+A AL++LH +GI++RD+K ENIL+ + KL DFG S+ ++ + +FCGT
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244
Y APE++ + + AD WS GV+++ +L PF ++R K L +
Sbjct: 192 YMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQG---KDRKETMTMILKAKLGMPQ 247
Query: 245 YEISIGAKQLIGRMLEPNPKHR----PN-AKDVQNHAW 277
+ +S A+ L+ + + NP +R P+ ++++ H++
Sbjct: 248 F-LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-48
Identities = 62/285 (21%), Positives = 114/285 (40%), Gaps = 54/285 (18%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
++G G++G V+ + DK++ A K E F E+ +S P I+ ++
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRL--------EVFRVEELVACAGLSSPRIVPLY 116
Query: 74 RMVKAGTYLYMIMDYAE----KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
V+ G ++ + M+ E + ++ + E++A ++ Q LE
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQM------GCLPEDRALYYLGQA---LE------ 161
Query: 130 NALEYLHEVGIVHRDIKCENILISRL-LNAKLADFGFSRLLRTPKELS-----NTFCGTT 183
LEYLH I+H D+K +N+L+S A L DFG + L+ + GT
Sbjct: 162 -GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP---------GTRNRDVLKKQ 234
++ APE++ P + K DIWS ++ +LN +P+ + + +
Sbjct: 221 THMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP 279
Query: 235 EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+ Q I L P HR +A +++
Sbjct: 280 PS----------CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 79/283 (27%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK-----FAPREIDILLKVSHPNI 69
+G GA+ V +V K++ + Y K + + M K E D+L+ I
Sbjct: 69 IGRGAFSEVAVVKMKQTGQV-----YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+H + YLY++M+Y DL +SK E I AR YL EI
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSK-FGERIPAEMARF----------YLAEIV 172
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGTTSYAAP 188
A++ +H +G VHRDIK +NIL+ R + +LADFG +L S GT Y +P
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 189 EIIRN-------SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ--EGKEY 239
EI++ Y D W+LGV Y + + PF + + KE+
Sbjct: 233 EILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYA---DSTAETYGKIVHYKEH 288
Query: 240 LFNRKY--EISIGAKQLIGRMLEPNPKHR---PNAKDVQNHAW 277
L + A+ I R+L P+ R A D + H +
Sbjct: 289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 38/304 (12%), Positives = 76/304 (25%), Gaps = 50/304 (16%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREI---------------- 58
LG+ +D+ + F K E+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 59 ---------DILLKVSHPNIIGV----HRMVKAGTYLYMIMDYAEKKDLEHYISKACNEN 105
D++ +I V M + + + + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 106 IHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165
L+ ++ L LH G+VH ++ +I++ + L F
Sbjct: 206 KSLVHHA--------RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 166 SRLL-RTPKELSNTFCGTTSYAAPEIIRNSPYNPKL----ADIWSLGVVLYRILNKKYPF 220
+ A ++ ++P L D W+LG+ +Y I P
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 221 GDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
D E++F I + L+ L + R +
Sbjct: 318 TDDAALGGS--------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
Query: 281 EPTC 284
T
Sbjct: 370 LRTE 373
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 77/281 (27%), Positives = 137/281 (48%), Gaps = 31/281 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVH 73
+G G+Y V LV K+++ + A K + + D + E + + +HP ++G+H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + L+ +++Y DL ++ + + E AR Y EI+ AL
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARF----------YSAEISLALN 124
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
YLHE GI++RD+K +N+L+ + KL D+G + P + ++TFCGT +Y APEI+R
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR------KY-- 245
Y D W+LGV+++ ++ + PF G+ + Q ++YLF +
Sbjct: 185 EDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDN---PDQNTEDYLFQVILEKQIRIPR 240
Query: 246 EISIGAKQLIGRMLEPNPKHR------PNAKDVQNHAWIQN 280
+S+ A ++ L +PK R D+Q H + +N
Sbjct: 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-47
Identities = 80/280 (28%), Positives = 132/280 (47%), Gaps = 46/280 (16%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY-----------MEKFAPREIDILLK 63
LG+G +G V LV +K + A K L+++ E +L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKI-----LRKEVIIAKDEVAHTVTES------RVLQN 61
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
HP + + + L +M+YA +L ++S+ E +AR
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARF---------- 109
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
Y EI +ALEYLH +V+RDIK EN+++ + + K+ DFG + + TFCGT
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ-EGKEYLFN 242
Y APE++ ++ Y + D W LGVV+Y ++ + PF + ++ + L + +E F
Sbjct: 170 EYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEIRFP 225
Query: 243 RKYEISIGAKQLIGRMLEPNPKHR----PN-AKDVQNHAW 277
R +S AK L+ +L+ +PK R P+ AK+V H +
Sbjct: 226 R--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-47
Identities = 83/280 (29%), Positives = 132/280 (47%), Gaps = 42/280 (15%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY------------MEKFAPREIDILL 62
LG+G YG V+ V ++ K + K LK+ E+ +IL
Sbjct: 25 LGKGGYGKVFQV--RKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER------NILE 76
Query: 63 KVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
+V HP I+ + + G LY+I++Y +L + + E+ A
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACF--------- 125
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
YL EI+ AL +LH+ GI++RD+K ENI+++ + KL DFG + +++TFCGT
Sbjct: 126 -YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGT 184
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
Y APEI+ S +N + D WSLG ++Y +L PF NR + K L
Sbjct: 185 IEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTG---ENRKKTIDKILKCKLNL 240
Query: 243 RKYEISIGAKQLIGRMLEPNPKHR----PN-AKDVQNHAW 277
Y ++ A+ L+ ++L+ N R P A +VQ H +
Sbjct: 241 PPY-LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-47
Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 35/279 (12%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK-----FAPREIDILLKVSHPNI 69
+G GA+G V +V K ++ + + K L + M K E D+L+ I
Sbjct: 82 IGRGAFGEVAVVKLKNADKV-----FAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+H + LY++MDY DL +SK + + E AR YL E+
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARF----------YLAEMV 185
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGTTSYAAP 188
A++ +H++ VHRDIK +NIL+ + +LADFG +L+ S+ GT Y +P
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 189 EIIRNSPYNP----KLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL--KKQEGKEYLFN 242
EI++ D WSLGV +Y +L + PF + K KE
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA---ESLVETYGKIMNHKERFQF 302
Query: 243 RKY--EISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAW 277
++S AK LI R++ + +D + H +
Sbjct: 303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 76/281 (27%), Positives = 137/281 (48%), Gaps = 31/281 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVH 73
+G G+Y V LV K+++ + A + + + D + E + + +HP ++G+H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALE 133
+ + L+ +++Y DL ++ + + E AR Y EI+ AL
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARF----------YSAEISLALN 167
Query: 134 YLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN 193
YLHE GI++RD+K +N+L+ + KL D+G + P + ++TFCGT +Y APEI+R
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 194 SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR------KY-- 245
Y D W+LGV+++ ++ + PF G+ + Q ++YLF +
Sbjct: 228 EDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDN---PDQNTEDYLFQVILEKQIRIPR 283
Query: 246 EISIGAKQLIGRMLEPNPKHR------PNAKDVQNHAWIQN 280
+S+ A ++ L +PK R D+Q H + +N
Sbjct: 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-46
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 44/279 (15%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY-----------MEKFAPREIDILLK 63
+G+G++G V L K E A K L++ E+ ++LLK
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKV-----LQKKAILKKKEEKHIMSER------NVLLK 94
Query: 64 -VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
V HP ++G+H + LY ++DY +L +++ + E +AR
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARF--------- 143
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
Y EIA+AL YLH + IV+RD+K ENIL+ + L DFG + ++TFCGT
Sbjct: 144 -YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGT 202
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
Y APE++ PY+ + D W LG VLY +L PF RN + + L
Sbjct: 203 PEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYS---RNTAEMYDNILNKPLQL 258
Query: 243 RKYEISIGAKQLIGRMLEPNPKHR----PNAKDVQNHAW 277
+ I+ A+ L+ +L+ + R + ++++H +
Sbjct: 259 KPN-ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-46
Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 29/274 (10%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS---HPNIIG 71
+G G +G VY + + A K D KR+K E A E +L VS P I+
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ L I+D DL +++S+ E R Y EI
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRF----------YAAEIILG 304
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
LE++H +V+RD+K NIL+ + +++D G + K+ + GT Y APE++
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVL 362
Query: 192 -RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ--EGKEYLFNRKYEIS 248
+ Y+ AD +SLG +L+++L PF T+++ + + L S
Sbjct: 363 QKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---PDSFS 418
Query: 249 IGAKQLIGRMLEPNPKHR-----PNAKDVQNHAW 277
+ L+ +L+ + R A++V+ +
Sbjct: 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-46
Identities = 79/279 (28%), Positives = 116/279 (41%), Gaps = 37/279 (13%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHR 74
LG+G YG VY D ++ A K + Y + EI + + H NI+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLH-EEIALHKHLKHKNIVQYLG 86
Query: 75 MVKAGTYLYMIMDYAEKKDLEHYISKACNE-NIHENQARIWIRQIANALEYLHEIANALE 133
++ + M+ L + +E + +QI LE L+
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI---LE-------GLK 136
Query: 134 YLHEVGIVHRDIKCENILISRLL-NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR 192
YLH+ IVHRDIK +N+LI+ K++DFG S+ L + TF GT Y APEII
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 193 NSP--YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF---NRKY-- 245
P Y ADIWSLG + + K PF + G E + +F K
Sbjct: 197 KGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELG----------EPQAAMFKVGMFKVHP 245
Query: 246 ----EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+S AK I + EP+P R A D+ +++
Sbjct: 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-45
Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 33/226 (14%)
Query: 8 ECSYISKLGEGAYGNVYL-------VSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDI 60
+ + K+G G++G V+ V A K + + + +F RE+ I
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWHGSDV---------AVKILMEQDFHAERVNEFL-REVAI 87
Query: 61 LLKVSHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYI-SKACNENIHENQARIWIR 116
+ ++ HPNI+ G V L ++ +Y + L + E + E +
Sbjct: 88 MKRLRHPNIVLFMGA---VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS 176
+A + YLH IVHR++K N+L+ + K+ DFG SRL + S
Sbjct: 145 DVAKGMNYLHN--------RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 196
Query: 177 NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222
+ GT + APE++R+ P N K +D++S GV+L+ + + P+G+
Sbjct: 197 KSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGN 241
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 43/277 (15%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY-----------MEKFAPREIDILLK 63
LG+G++G V+L K++ A KA LK+D +EK +L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKA-----LKKDVVLMDDDVECTMVEK------RVLSL 73
Query: 64 V-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
HP + + + L+ +M+Y DL ++I ++A
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATF--------- 122
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
Y EI L++LH GIV+RD+K +NIL+ + + K+ADFG + +NTFCGT
Sbjct: 123 -YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT 181
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL-KKQEGKEYLF 241
Y APEI+ YN D WS GV+LY +L + PF ++ + L +
Sbjct: 182 PDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIRMDNPFY 237
Query: 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAK-DVQNHAW 277
R + AK L+ ++ P+ R + D++ H
Sbjct: 238 PR--WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 45/283 (15%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY-----------MEKFAPREIDILLK 63
LG+G++G V L K ++ L A K LK+D +EK +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKI-----LKKDVVIQDDDVECTMVEK------RVLAL 76
Query: 64 V-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
P + +H + LY +M+Y DL ++I + E A
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVF--------- 125
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
Y EIA L +L GI++RD+K +N+++ + K+ADFG + + TFCGT
Sbjct: 126 -YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT 184
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
Y APEII PY K D W+ GV+LY +L + PF + D L + + +
Sbjct: 185 PDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSIMEHNVAY 240
Query: 243 RKYEISIGAKQLIGRMLEPNPKHR----PN-AKDVQNHAWIQN 280
K +S A + ++ +P R P +D++ HA+ +
Sbjct: 241 PKS-MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 77/282 (27%), Positives = 120/282 (42%), Gaps = 48/282 (17%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY-----------MEKFAPREIDILLK 63
LG+G++G V L K + L A K LK+D EK IL
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKV-----LKKDVILQDDDVECTMTEK------RILSL 79
Query: 64 V-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
+HP + + + L+ +M++ DL +I K+ E +AR
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARF--------- 128
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
Y EI +AL +LH+ GI++RD+K +N+L+ + KLADFG + + TFCGT
Sbjct: 129 -YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGT 187
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL-KKQEGKEYLF 241
Y APEI++ Y D W++GV+LY +L PF N D L + E ++
Sbjct: 188 PDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEA---ENEDDLFEAILNDEVVY 243
Query: 242 NRKYEISIGAKQLIGRMLEPNPKHR------PNAKDVQNHAW 277
+ A ++ + NP R + H +
Sbjct: 244 PT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 5e-44
Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 23/273 (8%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
Y+ LG+G +G V LV +K + A K + + E +L HP +
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ + L +M+YA +L ++S+ E++AR Y EI +
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARF----------YGAEIVS 259
Query: 131 ALEYLH-EVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
AL+YLH E +V+RD+K EN+++ + + K+ DFG + TFCGT Y APE
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
++ ++ Y + D W LGVV+Y ++ + PF + ++ + L + E + + +
Sbjct: 320 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELILMEEIRFPRT-LGP 374
Query: 250 GAKQLIGRMLEPNPKHR----PN-AKDVQNHAW 277
AK L+ +L+ +PK R AK++ H +
Sbjct: 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-44
Identities = 88/285 (30%), Positives = 138/285 (48%), Gaps = 44/285 (15%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY------------MEKFAPREIDILL 62
LG GAYG V+LV ++ K Y K LK+ E+ +L
Sbjct: 62 LGTGAYGKVFLV--RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER------QVLE 113
Query: 63 KVSH-PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
+ P ++ +H + T L++I+DY +L ++S+ E E++ +I
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQI-------- 163
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL-LRTPKELSNTFC 180
Y+ EI ALE+LH++GI++RDIK ENIL+ + L DFG S+ + E + FC
Sbjct: 164 --YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 181 GTTSYAAPEIIRNSPYN-PKLADIWSLGVVLYRILNKKYPF-GDPGTRNRDVL-KKQEGK 237
GT Y AP+I+R K D WSLGV++Y +L PF D ++ + ++
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281
Query: 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHR----PN-AKDVQNHAW 277
E + E+S AK LI R+L +PK R P A +++ H +
Sbjct: 282 EPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-43
Identities = 74/299 (24%), Positives = 121/299 (40%), Gaps = 62/299 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ KLGEG+YG+VY K + + A K + ++ + +EI I+ + P+++
Sbjct: 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII-----KEISIMQQCDSPHVVK 88
Query: 72 VHRMVKAGTYLYMIMDYAEK---KDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+ T L+++M+Y D+ +K E+ +IA L
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED-----------EIATIL---QST 134
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
LEYLH + +HRDIK NIL++ +AKLADFG + L NT GT + AP
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 194
Query: 189 EIIRNSPYNPKLADIWSLGV-------------------VLYRILNKKYPFGDPGTRNRD 229
E+I+ YN ADIWSLG+ ++ I P
Sbjct: 195 EVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP---------- 243
Query: 230 VLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMT 288
+K E S + + L +P+ R A + H ++++ +
Sbjct: 244 TFRKPE----------LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILR 292
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-43
Identities = 64/283 (22%), Positives = 116/283 (40%), Gaps = 46/283 (16%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI---I 70
LG+G +G V+ + ET + + R + F +E+ ++ + HPN+ I
Sbjct: 17 VLGKGCFGQAIKVTHR--ETGEVMVMKELIRFDEETQRTFL-KEVKVMRCLEHPNVLKFI 73
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARI-WIRQIANALEYLHEIA 129
GV + L I +Y + L I ++ W ++++ A + IA
Sbjct: 74 GV---LYKDKRLNFITEYIKGGTLRGII--------KSMDSQYPWSQRVSFAKD----IA 118
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL--------------RTPKEL 175
+ + YLH + I+HRD+ N L+ N +ADFG +RL+ + ++
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 176 SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235
T G + APE+I Y+ K D++S G+VL I+ + D R D
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237
Query: 236 GKEYLFNRKYEISIGA----KQLIGRMLEPNPKHRPNAKDVQN 274
G F + + R + +P+ RP+ +++
Sbjct: 238 G----FLDR-YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 79/291 (27%), Positives = 120/291 (41%), Gaps = 57/291 (19%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ K+G+G++G V+ D R++ + A K D + + + + +EI +L + P +
Sbjct: 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED--IQQEITVLSQCDSPYVTK 84
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ T L++IM+Y + + E Q I I L EI
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQ----IATI------LREILKG 131
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
L+YLH +HRDIK N+L+S KLADFG + L + NTF GT + APE+I
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 192 RNSPYNPKLADIWSLGV-------------------VLYRILNKKYPFGDPGTRNRDVLK 232
+ S Y+ K ADIWSLG+ VL+ I P L+
Sbjct: 192 KQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP----------TLE 240
Query: 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283
K K+ + L P RP AK++ H +I
Sbjct: 241 GNYSKPL------------KEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 71/316 (22%), Positives = 124/316 (39%), Gaps = 70/316 (22%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK-------AYDFKRLKRDYMEKFAPREIDILLKV 64
IS+LG G G V+ VS K S + A K ++ R E+ +L +
Sbjct: 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR---------ELQVLHEC 88
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
+ P I+G + + + + M++ + L+ + KA I E + L Y
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTY 146
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
L E + I+HRD+K NIL++ KL DFG S L ++N+F GT S
Sbjct: 147 LRE---------KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRS 195
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244
Y +PE ++ + Y+ + +DIWS+G+ L + +YP P + +++ + +
Sbjct: 196 YMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254
Query: 245 YEI----------------------------------------SIGAKQLIGRMLEPNPK 264
S+ + + + L NP
Sbjct: 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 314
Query: 265 HRPNAKDVQNHAWIQN 280
R + K + HA+I+
Sbjct: 315 ERADLKQLMVHAFIKR 330
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-42
Identities = 63/274 (22%), Positives = 120/274 (43%), Gaps = 31/274 (11%)
Query: 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYD--FKRLKRDYMEKFAPREIDILL 62
D E +G GA+G V +A D K+++ + K E+ L
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAK---------WRAKDVAIKQIESESERKAFIVELRQLS 56
Query: 63 KVSHPNIIGVHRMVKAGTY-LYMIMDYAEKKDLEHYISKACN-ENIHENQARIWIRQIAN 120
+V+HPNI+ ++ A + ++M+YAE L + + A A W Q +
Sbjct: 57 RVNHPNIV---KLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILI-SRLLNAKLADFGFSRLLRTPKELSNTF 179
+ YLH + ++HRD+K N+L+ + K+ DFG + ++T
Sbjct: 114 GVAYLHS-------MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNN 163
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK-QEGKE 238
G+ ++ APE+ S Y+ K D++S G++L+ ++ ++ PF + G ++ G
Sbjct: 164 KGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR 222
Query: 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272
+ I + L+ R +P RP+ +++
Sbjct: 223 PPLIKNLPKPI--ESLMTRCWSKDPSQRPSMEEI 254
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-42
Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 45/283 (15%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY-----------MEKFAPREIDILLK 63
LG+G++G V L K ++ L A K LK+D +EK +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKI-----LKKDVVIQDDDVECTMVEK------RVLAL 397
Query: 64 V-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
P + +H + LY +M+Y DL ++I + E A
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVF--------- 446
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
Y EIA L +L GI++RD+K +N+++ + K+ADFG + + TFCGT
Sbjct: 447 -YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT 505
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
Y APEII PY K D W+ GV+LY +L + PF + D L + + +
Sbjct: 506 PDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSIMEHNVAY 561
Query: 243 RKYEISIGAKQLIGRMLEPNPKHR----PN-AKDVQNHAWIQN 280
K +S A + ++ +P R P +D++ HA+ +
Sbjct: 562 PKS-MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-42
Identities = 40/222 (18%), Positives = 90/222 (40%), Gaps = 20/222 (9%)
Query: 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV 64
D + ++++KL E G ++ + ++ K + F E L
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQGNDI--VVKVLKVRDWSTRKSRDFN-EECPRLRIF 64
Query: 65 SHPNIIGVHRMVKA--GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
SHPN++ V ++ + +I + L + + + N + ++QA + +A +
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
+LH E I + +++I + A+++ + S
Sbjct: 125 AFLHT--------LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYA 171
Query: 183 TSYAAPEIIRNSPYNP--KLADIWSLGVVLYRILNKKYPFGD 222
++ APE ++ P + + AD+WS V+L+ ++ ++ PF D
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-42
Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 29/286 (10%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+G GA V + A K + ++ + E +EI + + HPNI+
Sbjct: 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE--LLKEIQAMSQCHHPNIVS 77
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ L+++M + I K + IA L E+
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATIL---REVLEG 133
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS-----NTFCGTTSYA 186
LEYLH+ G +HRD+K NIL+ + ++ADFG S L T +++ TF GT +
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 187 APEII-RNSPYNPKLADIWSLGVVLYRILNKKYPFGD-PGTRNRDVLK----------KQ 234
APE++ + Y+ K ADIWS G+ + P+ P + VL +
Sbjct: 194 APEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQNDPPSLET 249
Query: 235 EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
++ +KY +++I L+ +P+ RP A ++ H + Q
Sbjct: 250 GVQDKEMLKKY--GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-41
Identities = 70/296 (23%), Positives = 125/296 (42%), Gaps = 56/296 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
K+GEG+ G V L +K S A K D L++ + E+ I+ H N++
Sbjct: 50 YVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+++ G L+++M++ + L +S+ ++E Q I + + A
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQ----IATV------CEAVLQA 153
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
L YLH G++HRDIK ++IL++ KL+DFGF + + GT + APE+I
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 192 RNSPYNPKLADIWSLGV-------------------VLYRILNKKYPFGDPGTRNRDVLK 232
S Y + DIWSLG+ + R+ + P LK
Sbjct: 214 SRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP----------KLK 262
Query: 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMT 288
++S + + RML +P+ R A+++ +H ++ + +
Sbjct: 263 NSH----------KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLV 308
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 70/304 (23%), Positives = 128/304 (42%), Gaps = 65/304 (21%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +LG+GA+G VY +K + L A K + K + +E + EI+IL HP I+
Sbjct: 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYI-VEIEILATCDHPYIVK 80
Query: 72 VHRMVKAGTYLYMIMDYAEK---KDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+ L++++++ + + + E QI ++
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-----------QIQVVC---RQM 126
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
AL +LH I+HRD+K N+L++ + +LADFG S + ++F GT + AP
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186
Query: 189 EII-----RNSPYNPKLADIWSLGV-------------------VLYRILNKKYPFGDPG 224
E++ +++PY+ K ADIWSLG+ VL +I P
Sbjct: 187 EVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP----- 240
Query: 225 TRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTC 284
L + S+ + + L+ NP+ RP+A + H ++ + +
Sbjct: 241 -----TLLTPS----------KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285
Query: 285 QTMT 288
+ +
Sbjct: 286 KALR 289
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 35/305 (11%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNII 70
+ +G G YG VY ++ L A K D + D E+ +EI++L K S H NI
Sbjct: 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIK-QEINMLKKYSHHRNIA 84
Query: 71 GVH------RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
+ L+++M++ + I + E WI I
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE----WIAYI------ 134
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
EI L +LH+ ++HRDIK +N+L++ KL DFG S L NTF GT
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 185 YAAPEIIRN-----SPYNPKLADIWSLGVVLYRILNKKYPFGD-PGTRNRDVLKK--QEG 236
+ APE+I + Y+ K +D+WSLG+ + P D R L +
Sbjct: 195 WMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPRNP 250
Query: 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALK 296
L ++K+ S + I L N RP + + H +I+++P + + + ++ +
Sbjct: 251 APRLKSKKW--SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHID 308
Query: 297 IGKLK 301
K K
Sbjct: 309 RTKKK 313
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 56/288 (19%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
K+G+GA G VY D + A + + L++ ++ EI ++ + +PNI+
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVN 81
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
G L+++M+Y L +++ C + E Q I + E A
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQ----IAAV------CRECLQA 128
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
LE+LH ++HRDIK +NIL+ + KL DFGF + + +T GT + APE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 192 RNSPYNPKLADIWSLGV-------------------VLYRILNKKYPFGDPGTRNRDVLK 232
Y PK DIWSLG+ LY I P L+
Sbjct: 189 TRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP----------ELQ 237
Query: 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
E +F + + R LE + + R +AK++ H +++
Sbjct: 238 NPEKLSAIF----------RDFLNRCLEMDVEKRGSAKELLQHQFLKI 275
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 72/303 (23%), Positives = 129/303 (42%), Gaps = 50/303 (16%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY--MEKFAPREIDILLKVSHPNI 69
I K+GEG+YG V+ ++ + + A K + D ++K A REI +L ++ HPN+
Sbjct: 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ + + + L+++ +Y + + H + + E+ + Q A+ + H+
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHK-- 120
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
H +HRD+K ENILI++ KL DFGF+RLL P + + T Y +PE
Sbjct: 121 ------H--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172
Query: 190 IIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------------QEG 236
++ Y P + D+W++G V +L+ + PG + D L Q+
Sbjct: 173 LLVGDTQYGPPV-DVWAIGCVFAELLSGVPLW--PGKSDVDQLYLIRKTLGDLIPRHQQV 229
Query: 237 KEYLFNRKY-----------------EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
IS A L+ L +P R + + +H + +
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
Query: 280 NEP 282
N
Sbjct: 290 NIR 292
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 68/306 (22%), Positives = 133/306 (43%), Gaps = 57/306 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF-------APREIDILLKV 64
+ K+GEG YG V+ ++ + + A LKR ++ A REI +L ++
Sbjct: 7 LEKIGEGTYGTVFKAKNRETHEIVA--------LKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
H NI+ +H ++ + L ++ ++ ++ DL+ Y +CN ++ + ++ Q+ L+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQL---LK- 112
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP-KELSNTFCGTT 183
L + H ++HRD+K +N+LI+R KLA+FG +R P + S T
Sbjct: 113 ------GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TL 165
Query: 184 SYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF--GDP------------GTRNR 228
Y P+++ + Y+ + D+WS G + + N P G+ GT
Sbjct: 166 WYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 229 DV------------LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276
+ L N +++ + L+ +L+ NP R +A++ H
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 277 WIQNEP 282
+ +
Sbjct: 285 YFSDFC 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-41
Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 37/283 (13%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK-------AYDFKRLKRDYMEKFAPREIDILLK- 63
+ ++G G G V+ + +++ + A K + KR+ ++D++LK
Sbjct: 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM---------DLDVVLKS 80
Query: 64 VSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
P I+ T +++ M+ + K I E I AL
Sbjct: 81 HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLK--KRMQGPIPERILGKMTVAIVKALY 138
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGT 182
YL E + G++HRD+K NIL+ KL DFG S RL+ + + G
Sbjct: 139 YLKE---------KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGC 187
Query: 183 TSYAAPEII-----RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237
+Y APE I Y+ + AD+WSLG+ L + ++P+ + T + K + +
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE 246
Query: 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
L S + + L + + RP + H++I+
Sbjct: 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-41
Identities = 76/313 (24%), Positives = 127/313 (40%), Gaps = 42/313 (13%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ ++G G++G VY D R+ + A K + + + + +E+ L K+ HPN I
Sbjct: 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 72 VHRMVKAGTYLYMIMDYAE--KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+++M+Y DL K E +IA H
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-----------EIAAVT---HGAL 164
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
L YLH ++HRD+K NIL+S KL DFG + ++ P N+F GT + APE
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-APA---NSFVGTPYWMAPE 220
Query: 190 II---RNSPYNPKLADIWSLGVVLYRILNKKYPFGD-PGTRNRDVLKK--QEGKEYLFNR 243
+I Y+ K D+WSLG+ + +K P + L Q L +
Sbjct: 221 VILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPALQSG 276
Query: 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMT---------AEEREA 294
+ S + + L+ P+ RP ++ + H ++ E + E +
Sbjct: 277 HW--SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 334
Query: 295 LKIGKLKSKVFMQ 307
L+ K+K K+ Q
Sbjct: 335 LQYRKMK-KILFQ 346
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 62/298 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK-------AYDFKRLKRDYMEKFAPREIDILLKV 64
+ ++G GAYG+V + K S + A K + K+L ++D++++
Sbjct: 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM---------DLDVVMRS 77
Query: 65 S-HPNIIGVHRMVKAGTYLYMIMDY--AEKKDLEHYISKACNENIHENQARIWIRQIANA 121
S P I+ + + ++ M+ Y+ ++ I E A
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT--- 178
L +L E + I+HRDIK NIL+ R N KL DFG S +L ++
Sbjct: 138 LNHLKE---------NLKIIHRDIKPSNILLDRSGNIKLCDFGIS------GQLVDSIAK 182
Query: 179 --FCGTTSYAAPEII----RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV-- 230
G Y APE I Y+ + +D+WSLG+ LY + ++P+ + +
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQ 241
Query: 231 --------LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
L E +E+ S + L + RP K++ H +I
Sbjct: 242 VVKGDPPQLSNSEEREF--------SPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 72/304 (23%), Positives = 131/304 (43%), Gaps = 54/304 (17%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF---APREIDILLKVSHPN 68
+ KLGEG Y VY K ++ L A K ++ ++ E A RE+ +L + H N
Sbjct: 7 LDKLGEGTYATVYKGKSKLTDNLVA-----LKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I+ +H ++ L ++ +Y +K DL+ Y+ C I+ + ++++ Q+ L Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCHR- 118
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP-KELSNTFCGTTSYAA 187
++HRD+K +N+LI+ KLADFG +R P K N T Y
Sbjct: 119 -------Q--KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168
Query: 188 PEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------------- 233
P+I+ S Y+ ++ D+W +G + Y + + F PG+ + L
Sbjct: 169 PDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLF--PGSTVEEQLHFIFRILGTPTEETW 225
Query: 234 ---------------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
+ E L + + L+ ++L+ ++R +A+D H +
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285
Query: 279 QNEP 282
+
Sbjct: 286 LSLG 289
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 77/308 (25%), Positives = 135/308 (43%), Gaps = 62/308 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF-------APREIDILLKV 64
+ K+GEG YG VY D + + A LKR ++ A REI +L ++
Sbjct: 26 LEKVGEGTYGVVYKAKDSQGRIV----A-----LKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
HPNI+ + ++ + L ++ ++ EK DL+ + + ++Q +I++ Q+ L
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQL---LR- 130
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP-KELSNTFCGTT 183
+ + H+ I+HRD+K +N+LI+ KLADFG +R P + ++ T
Sbjct: 131 ------GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TL 183
Query: 184 SYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK--------- 233
Y AP+++ S Y+ + DIWS+G + ++ K F PG + D L K
Sbjct: 184 WYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLF--PGVTDDDQLPKIFSILGTPN 240
Query: 234 ----------QEGKEYLFNRKYEISIG---------AKQLIGRMLEPNPKHRPNAKDVQN 274
K+ F + L+ ML +P R +A+D N
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300
Query: 275 HAWIQNEP 282
H + ++
Sbjct: 301 HPYFKDLD 308
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACK-----AYDFKRLKRDYMEKFAPREIDILL 62
E Y ++G+G +G V+ + +++ A K + + + ++F RE+ I+
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ-REVFIMS 78
Query: 63 KVSHPNIIGVHRMVKAGTY-LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
++HPNI+ ++ M+M++ DL H + I + + IA
Sbjct: 79 NLNHPNIV---KLYGLMHNPPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALG 134
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILIS-----RLLNAKLADFGFSRLLRTPKELS 176
+EY+ IVHRD++ NI + + AK+ADFG S+
Sbjct: 135 IEYMQN--------QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV---HSV 183
Query: 177 NTFCGTTSYAAPEII--RNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222
+ G + APE I Y K AD +S ++LY IL + PF +
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDE 230
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 73/294 (24%), Positives = 122/294 (41%), Gaps = 44/294 (14%)
Query: 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACK-------AYDFKRLKRDYMEKFAPR 56
D LE I +LG GAYG V + S + A K + + KRL
Sbjct: 6 ADDLE--PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLM--------- 54
Query: 57 EIDILLKVS-HPNIIGVHRMVKAGTYLYMIMDYAE---KKDLEHYISKACNENIHENQAR 112
++DI ++ P + + + +++ M+ + K + I K + I E+
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDK--GQTIPEDILG 112
Query: 113 IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRT 171
I ALE+LH ++ ++HRD+K N+LI+ L K+ DFG S L+
Sbjct: 113 KIAVSIVKALEHLHS---------KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163
Query: 172 PKELSNTFCGTTSYAAPEII----RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227
+ + G Y APE I Y+ K +DIWSLG+ + + ++P+ GT
Sbjct: 164 VAK--DIDAGCKPYMAPERINPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPF 220
Query: 228 RDVLKKQEGKE-YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ + + E L K+ S + L+ N K RP ++ H +
Sbjct: 221 QQLKQVVEEPSPQLPADKF--SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 74/313 (23%), Positives = 129/313 (41%), Gaps = 48/313 (15%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF-APREIDILLKVSHPNII 70
+ +GEG+YG V +K + + A K F D M K A REI +L ++ H N++
Sbjct: 30 LGLVGEGSYGMVMKCRNKDTGRIVAIK--KFLESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ + K Y++ ++ + + + + + + ++ QI N + + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHS--- 142
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
H I+HRDIK ENIL+S+ KL DFGF+R L P E+ + T Y APE+
Sbjct: 143 -----H--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195
Query: 191 IRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------------QEG- 236
+ Y + D+W++G ++ + + F PG + D L QE
Sbjct: 196 LVGDVKYGKAV-DVWAIGCLVTEMFMGEPLF--PGDSDIDQLYHIMMCLGNLIPRHQELF 252
Query: 237 ------KEYLFNRKYE----------ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
E +S L + L +P RP ++ +H + Q
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312
Query: 281 EPTCQTMTAEERE 293
+ + + E +
Sbjct: 313 DGFAERFSQELQL 325
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-40
Identities = 75/320 (23%), Positives = 131/320 (40%), Gaps = 74/320 (23%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKR------LKRDYMEKF-------APREI 58
++++GEGAYG V+ KA D K LKR ++ RE+
Sbjct: 16 VAEIGEGAYGKVF-------------KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 59 DILL---KVSHPNIIGVHRMV-----KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQ 110
+L HPN++ + + T L ++ ++ ++ DL Y+ K +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 111 ARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170
+ + Q+ L++LH H +VHRD+K +NIL++ KLADFG +R+
Sbjct: 122 IKDMMFQLLRGLDFLHS--------H--RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 171 TPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV 230
L++ T Y APE++ S Y + D+WS+G + + +K F G+ + D
Sbjct: 172 FQMALTSVVV-TLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLF--RGSSDVDQ 227
Query: 231 LKK-------------------------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKH 265
L K + + + +I K L+ + L NP
Sbjct: 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287
Query: 266 RPNAKDVQNHAWIQNEPTCQ 285
R +A +H + Q+ C+
Sbjct: 288 RISAYSALSHPYFQDLERCK 307
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 56/324 (17%), Positives = 114/324 (35%), Gaps = 69/324 (21%)
Query: 12 ISKLGEGA--YGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
++ +G+G V L K + + + + + + E+ + +HPNI
Sbjct: 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ-GELHVSKLFNHPNI 88
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ A L+++ + + I + ++E IA L +
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IAY---ILQGVL 138
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL-------RTPKELSNTFCGT 182
AL+Y+H +G VHR +K +ILIS L+ + + R +
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 183 TSYAAPEIIRNS--PYNPKLADIWSLGV-------------------VLYRILNKKYP-- 219
+ +PE+++ + Y+ K +DI+S+G+ +L LN P
Sbjct: 199 LPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257
Query: 220 -----------------------FGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIG 256
D T + + + ++R + S +
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF--SPHFHHFVE 315
Query: 257 RMLEPNPKHRPNAKDVQNHAWIQN 280
+ L+ NP RP+A + NH++ +
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQ 339
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 72/308 (23%), Positives = 129/308 (41%), Gaps = 53/308 (17%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF---APREIDILLKVSHPN 68
+ KLG G Y VY +K + A K +K D E A REI ++ ++ H N
Sbjct: 10 LEKLGNGTYATVYKGLNKTTGVYVA-----LKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I+ ++ ++ L ++ ++ + DL+ Y+ + + + + + + ++
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYMD---SRTVGNTPRGLELNLVKY---FQWQL 117
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP-KELSNTFCGTTSYAA 187
L + HE I+HRD+K +N+LI++ KL DFG +R P S+ T Y A
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRA 176
Query: 188 PEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------------- 233
P+++ S Y+ + DIWS G +L ++ K F PGT + + LK
Sbjct: 177 PDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLF--PGTNDEEQLKLIFDIMGTPNESLW 233
Query: 234 ------------------QEGKEYLFNRKYE-ISIGAKQLIGRMLEPNPKHRPNAKDVQN 274
++ ++ L E + + +L+ NP R +AK +
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293
Query: 275 HAWIQNEP 282
H W
Sbjct: 294 HPWFAEYY 301
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 36/233 (15%)
Query: 5 DILECSYISKLGEGAYGNVYLVSDKRSE----TLKACKAYDFKRLKRDYMEKFAPREIDI 60
D E + +G G +G VY E + D + + +E +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVR-----QEAKL 59
Query: 61 LLKVSHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQ 117
+ HPNII GV L ++M++A L +S + I + W Q
Sbjct: 60 FAMLKHPNIIALRGV---CLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQ 113
Query: 118 IANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL--------NAKLADFGFSRLL 169
IA + YLH+ V I+HRD+K NILI + + K+ DFG +R
Sbjct: 114 IARGMNYLHD-------EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166
Query: 170 RTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222
+ + G ++ APE+IR S ++ +D+WS GV+L+ +L + PF
Sbjct: 167 H--RTTKMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRG 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 63/311 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF-------APREIDILLKV 64
I+KLGEG YG VY D + A +KR +E A RE+ +L ++
Sbjct: 39 ITKLGEGTYGEVYKAIDTVTNETVA--------IKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
H NII + ++ L++I +YAE DL+ Y+ K N ++ + ++ Q+ N + +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNF 147
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNA-----KLADFGFSRLLRTP-KELSNT 178
H +HRD+K +N+L+S + K+ DFG +R P ++ ++
Sbjct: 148 CHS--------R--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 179 FCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF-GD-------------- 222
T Y PEI+ S Y+ + DIWS+ + +L K F GD
Sbjct: 198 II-TLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255
Query: 223 -------PGTRN----RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKD 271
PG + K GK + L+ MLE +P R +AK+
Sbjct: 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315
Query: 272 VQNHAWIQNEP 282
H + +
Sbjct: 316 ALEHPYFSHND 326
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 73/311 (23%), Positives = 124/311 (39%), Gaps = 60/311 (19%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK----RDYMEKF---APREIDILLKV 64
++++G GAYG VY D S A K ++ RE+ +L ++
Sbjct: 14 VAEIGVGAYGTVYKARDPHSGHFVA-----LKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 65 S---HPNIIGVHRMV-----KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIR 116
HPN++ + + + ++ ++ ++ DL Y+ KA + + +R
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS 176
Q L++LH + IVHRD+K ENIL++ KLADFG +R+ L+
Sbjct: 128 QFLRGLDFLHA--------N--CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT 177
Query: 177 NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK--- 233
T Y APE++ S Y + D+WS+G + + +K F G D L K
Sbjct: 178 PVVV-TLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLF--CGNSEADQLGKIFD 233
Query: 234 ----------------------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKD 271
G + + E+ QL+ ML NP R +A
Sbjct: 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293
Query: 272 VQNHAWIQNEP 282
H+++ +
Sbjct: 294 ALQHSYLHKDE 304
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 72/322 (22%), Positives = 131/322 (40%), Gaps = 61/322 (18%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G G YG+VY K + K Y K+++ + A REI +L ++ HPN+I +
Sbjct: 28 KVGRGTYGHVYKAKRKDGKD---DKDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 84
Query: 74 RMV--KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ A ++++ DYAE DL H I ++ ++ + + L++I +
Sbjct: 85 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKS---LLYQILDG 140
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNA----KLADFGFSRLLRTP-KELSNTFCG--TTS 184
+ YLH ++HRD+K NIL+ K+AD GF+RL +P K L++ T
Sbjct: 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 185 YAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF-GD-------------------- 222
Y APE++ + Y + DIW++G + +L + F
Sbjct: 201 YRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259
Query: 223 ----------PGTRN------------RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLE 260
+ R+ +Y+ K + A L+ ++L
Sbjct: 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 319
Query: 261 PNPKHRPNAKDVQNHAWIQNEP 282
+P R ++ + +P
Sbjct: 320 MDPIKRITSEQAMQDPYFLEDP 341
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-39
Identities = 74/306 (24%), Positives = 124/306 (40%), Gaps = 56/306 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF-------APREIDILLKV 64
+ LGEG + VY DK + + A K++K + + A REI +L ++
Sbjct: 15 LDFLGEGQFATVYKARDKNTNQIVA-----IKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
SHPNIIG+ + + ++ D+ E DLE I K + + + + ++ L+
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYMLMT---LQ- 123
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP-KELSNTFCGTT 183
LEYLH+ I+HRD+K N+L+ KLADFG ++ +P + ++ T
Sbjct: 124 ------GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TR 176
Query: 184 SYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK--------- 233
Y APE++ + Y + D+W++G +L +L + PG + D L +
Sbjct: 177 WYRAPELLFGARMYGVGV-DMWAVGCILAELLLRVPFL--PGDSDLDQLTRIFETLGTPT 233
Query: 234 -----------------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276
L + LI + NP R A
Sbjct: 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293
Query: 277 WIQNEP 282
+ N P
Sbjct: 294 YFSNRP 299
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 73/305 (23%), Positives = 130/305 (42%), Gaps = 61/305 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF-------APREIDILLKV 64
+ K+GEG YG VY + ET A LK+ +EK REI IL ++
Sbjct: 7 LEKIGEGTYGVVYKAQNNYGETF----A-----LKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 65 SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
H NI+ ++ ++ L ++ ++ ++ DL+ + C + A+ ++ Q+ L
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL-DVCEGGLESVTAKSFLLQL---LN- 111
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP-KELSNTFCGTT 183
+ Y H+ ++HRD+K +N+LI+R K+ADFG +R P ++ ++ T
Sbjct: 112 ------GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TL 164
Query: 184 SYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK--------- 233
Y AP+++ S Y+ + DIWS+G + ++N F PG D L +
Sbjct: 165 WYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLF--PGVSEADQLMRIFRILGTPN 221
Query: 234 ------------------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+ + L+ +ML+ +P R AK H
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
Query: 276 AWIQN 280
A+ +
Sbjct: 282 AYFKE 286
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 60/219 (27%), Positives = 87/219 (39%), Gaps = 25/219 (11%)
Query: 12 ISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLKRD--YMEKFAPREIDILLKVSH 66
+G G G+VY D R LK L D + + RE ++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSE----TLSSDPVFRTRMQ-REARTAGRLQE 93
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P+++ +H + LY+ M DL + + Q + A+ +
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR---------QGPL---APPRAVAIVR 141
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE-LSNTFCGTTSY 185
+I +AL+ H G HRD+K ENIL+S A L DFG + K GT Y
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GDP 223
APE S + ADI++L VLY L P+ GD
Sbjct: 202 MAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-38
Identities = 58/293 (19%), Positives = 107/293 (36%), Gaps = 40/293 (13%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
+ G +G V+ A K + +D E+ L + H NI
Sbjct: 27 QLLEVKARGRFGCVWKAQLLNEYV--AVKIFP----IQDKQSWQNEYEVYSLPGMKHENI 80
Query: 70 IG----VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
+ R L++I + EK L ++ + N+ +A L YL
Sbjct: 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYL 137
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL--SNTFCGTT 183
HE L+ H+ I HRDIK +N+L+ L A +ADFG + K ++ GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 184 SYAAPEIIRNSP-----YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238
Y APE++ + + D++++G+VL+ + ++ P +++ G+
Sbjct: 198 RYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256
Query: 239 YLFN-------------------RKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272
+K+ + I + + + R +A V
Sbjct: 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-37
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM------EKFAPREIDILLKVS 65
+ KLG G VYL D A KA + ++F RE+ ++S
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFE-REVHNSSQLS 69
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
H NI+ + + + Y++M+Y E L YI + + A+ +
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES---------HGPLSVDT---AINFT 117
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR-TPKELSNTFCGTTS 184
++I + +++ H++ IVHRDIK +NILI K+ DFG ++ L T +N GT
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GD 222
Y +PE + + DI+S+G+VLY +L + PF G+
Sbjct: 178 YFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGE 215
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 54/286 (18%), Positives = 105/286 (36%), Gaps = 53/286 (18%)
Query: 14 KLGEGAYGNVYL------VSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP 67
+G+G +G VY V A + D +R D ++ F RE+ + H
Sbjct: 40 LIGKGRFGQVYHGRWHGEV---------AIRLIDIERDNEDQLKAFK-REVMAYRQTRHE 89
Query: 68 NII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
N++ G + +L +I + + L + A + N+ R ++I + Y
Sbjct: 90 NVVLFMGA---CMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGY 145
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT-----F 179
LH GI+H+D+K +N+ + DFG + +
Sbjct: 146 LHA----------KGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 180 CGTTSYAAPEIIRNS---------PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV 230
G + APEIIR P++ +D+++LG + Y + +++PF +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPF--KTQPAEAI 251
Query: 231 LKKQEGKEYLFN-RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+ Q G N + + ++ + RP + +
Sbjct: 252 I-WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 62/285 (21%), Positives = 110/285 (38%), Gaps = 44/285 (15%)
Query: 8 ECSYISKLGEGAYGNVYL------VSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDIL 61
+ + ++G G++G VY V A K + ++ F E+ +L
Sbjct: 25 QITVGQRIGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK-NEVGVL 74
Query: 62 LKVSHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQI 118
K H NI+ G A L ++ + E L H++ + + RQ
Sbjct: 75 RKTRHVNILLFMGY---STAPQ-LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQT 129
Query: 119 ANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS-- 176
A ++YLH I+HRD+K NI + K+ DFG +
Sbjct: 130 ARGMDYLHAK----------SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 177 NTFCGTTSYAAPEIIRNSPYNP--KLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ 234
G+ + APE+IR NP +D+++ G+VLY ++ + P+ NRD + +
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIEM 237
Query: 235 EGKEYLFNRKYEISIGA----KQLIGRMLEPNPKHRPNAKDVQNH 275
G+ L ++ K+L+ L+ RP+ +
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-36
Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 24/225 (10%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +G+G YG V+ A K + RD F E+ + + H NI+G
Sbjct: 13 LECVGKGRYGEVWRG--SWQGENVAVKIFS----SRDEKSWFRETELYNTVMLRHENILG 66
Query: 72 ----VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+ T L++I Y E L Y+ + + IA+ L +LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLH- 122
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR----TPKELSNTFCGTT 183
+ I HRD+K +NIL+ + +AD G + + +N GT
Sbjct: 123 -IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 184 SYAAPEIIRNSPYNP-----KLADIWSLGVVLYRILNKKYPFGDP 223
Y APE++ + K DIW+ G+VL+ + + G
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-36
Identities = 60/295 (20%), Positives = 103/295 (34%), Gaps = 44/295 (14%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
+ ++G+G YG V++ K A K + + F EI + + H NI+
Sbjct: 41 MVKQIGKGRYGEVWMG--KWRGEKVAVKVFF----TTEEASWFRETEIYQTVLMRHENIL 94
Query: 71 G----VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
G + + T LY+I DY E L Y+ + + + L +LH
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLH 151
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL----SNTFCGT 182
+ I HRD+K +NIL+ + +AD G + + NT GT
Sbjct: 152 --TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 183 TSYAAPEII------RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN---RDVLKK 233
Y PE++ + AD++S G++L+ + + G D++
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
Query: 234 QEGKEYLFN---------------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQ 273
E + E +L+ NP R A V+
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-36
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 26/227 (11%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
+G+G +G V+ K A K + R+ F EI + + H NI+
Sbjct: 46 LQESIGKGRFGEVWRG--KWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENIL 99
Query: 71 G----VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
G ++ T L+++ DY E L Y+++ + A+ L +LH
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLH 156
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL----SNTFCGT 182
+ + I HRD+K +NIL+ + +AD G + + + N GT
Sbjct: 157 --MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 183 TSYAAPEIIRNS------PYNPKLADIWSLGVVLYRILNKKYPFGDP 223
Y APE++ +S + ADI+++G+V + I + G
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIH 260
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-36
Identities = 71/323 (21%), Positives = 128/323 (39%), Gaps = 77/323 (23%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF-------APREIDILLKV 64
++K+G+G +G V+ +++ A LK+ ME A REI IL +
Sbjct: 22 LAKIGQGTFGEVFKARHRKTGQKVA--------LKKVLMENEKEGFPITALREIKILQLL 73
Query: 65 SHPNIIGVHRMV--------KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIR 116
H N++ + + + +Y++ D+ E DL +S ++ + ++
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQ 131
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP-KEL 175
+ N L Y+H I+HRD+K N+LI+R KLADFG +R
Sbjct: 132 MLLNGLYYIHR----------NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 176 SNTFCGTTS------YAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF--GD---- 222
N + T+ Y PE++ Y P + D+W G ++ + + P G+
Sbjct: 182 PNRY---TNRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRS-PIMQGNTEQH 236
Query: 223 -----------------PGTRNRDVLKKQEGKEYLFNR------KYEISIGAKQLIGRML 259
P N ++ +K E + + Y A LI ++L
Sbjct: 237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296
Query: 260 EPNPKHRPNAKDVQNHAWIQNEP 282
+P R ++ D NH + ++P
Sbjct: 297 VLDPAQRIDSDDALNHDFFWSDP 319
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-34
Identities = 66/238 (27%), Positives = 102/238 (42%), Gaps = 35/238 (14%)
Query: 1 MKFPDILECSY--ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY------MEK 52
M P L Y LG G V+L D R A K L+ D +
Sbjct: 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV-----LRADLARDPSFYLR 58
Query: 53 FAPREIDILLKVSHPNIIGVH----RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHE 108
F RE ++HP I+ V+ AG Y++M+Y + L +
Sbjct: 59 FR-REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-------- 109
Query: 109 NQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168
+ + ++ A+E + + AL + H+ GI+HRD+K NI+IS K+ DFG +R
Sbjct: 110 -EGPMTPKR---AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 169 LRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GD 222
+ + GT Y +PE R + + +D++SLG VLY +L + PF GD
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGD 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-34
Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 57/271 (21%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLK----ACK----AYDFKRLKRDYMEKFAPREIDILLK 63
+ G G +YL D+ + K + D + E L +
Sbjct: 85 KGCIAHGGLGWIYLALDRN---VNGRPVVLKGLVHSGD-----AEAQAMAM-AERQFLAE 135
Query: 64 VSHPNIIGV-----HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQI 118
V HP+I+ + H Y++M+Y + L+ ++ + +
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----------GQKLPVAE- 183
Query: 119 ANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLL-RTPKELSN 177
A+ YL EI AL YLH +G+V+ D+K ENI+++ KL D G +
Sbjct: 184 --AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINSF-----G 235
Query: 178 TFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GDPGTRNRDVLKKQEG 236
GT + APEI+R P DI+++G L + G + +
Sbjct: 236 YLYGTPGFQAPEIVRTGP-TVA-TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKT 293
Query: 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRP 267
+ L+ R ++P+P+ R
Sbjct: 294 YDSYGR-----------LLRRAIDPDPRQRF 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 43/225 (19%), Positives = 79/225 (35%), Gaps = 31/225 (13%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
+ +G G YG VY S A K + + + I + + H NI
Sbjct: 16 KLLELIGRGRYGAVYKGSLDERPV--AVKVFS----FANRQNFINEKNIYRVPLMEHDNI 69
Query: 70 IG-----VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
++M+Y L Y+S + + L Y
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAY 126
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL--------S 176
LH ++ ++ I HRD+ N+L+ ++DFG S L + + +
Sbjct: 127 LHTELPRGDH-YKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 177 NTFCGTTSYAAPEIIRNS-------PYNPKLADIWSLGVVLYRIL 214
+ GT Y APE++ + + D+++LG++ + I
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQ-VDMYALGLIYWEIF 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 71/299 (23%), Positives = 123/299 (41%), Gaps = 55/299 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+G G++G VY S L A K++ +D ++F RE+ I+ K+ H NI+
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVA-----IKKVLQD--KRFKNRELQIMRKLDHCNIVR 111
Query: 72 VHRMVKAGT------YLYMIMDYAEKKDLEHYI--SKACNENIHENQARIWIRQIANALE 123
+ + YL +++DY + + + + ++
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKL---------- 160
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNA-KLADFGFSRLLRTPKELSNTFCGT 182
Y++++ +L Y+H GI HRDIK +N+L+ KL DFG ++ L E + ++ +
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICS 219
Query: 183 TSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF-GDP------------GTRNR 228
Y APE+I + Y + D+WS G VL +L + F GD GT R
Sbjct: 220 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278
Query: 229 DVLKK--QEGKEYLFNRKYEISIG----------AKQLIGRMLEPNPKHRPNAKDVQNH 275
+ +++ E+ F + A L R+LE P R + H
Sbjct: 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 82/355 (23%), Positives = 139/355 (39%), Gaps = 83/355 (23%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYD-FKRL---KRDYMEKFAPREIDILLKVSHP 67
S LGEGAYG V + K + + A K + F + R REI IL H
Sbjct: 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL------REIKILKHFKHE 69
Query: 68 NIIGVHRMVKAGTY-----LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
NII + + + ++ +Y+I + + DL IS + H I+
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDH-------IQYF---- 117
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
+++ A++ LH ++HRD+K N+LI+ + K+ DFG +R++ ++ G
Sbjct: 118 --IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 183 TS----------YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK 232
S Y APE++ S + D+WS G +L + ++ F PG R L
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF--PGRDYRHQLL 233
Query: 233 K-------------------QEGKEYL----------FNRKY-EISIGAKQLIGRMLEPN 262
+EY+ + + ++ L+ RML +
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293
Query: 263 PKHRPNAKDVQNHAWIQN------EPTCQTMTAE------EREALKIGKLKSKVF 305
P R AK+ H ++Q EP + + +EAL LK ++
Sbjct: 294 PAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIW 348
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 73/299 (24%), Positives = 132/299 (44%), Gaps = 50/299 (16%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHP 67
+G G +G V L + E A K LK Y EK E I+ + HP
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKT-----LKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
NII + +V + ++ +Y E L+ ++ ++ A+ + Q+ + L
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--------RKHDAQFTVIQL---VGMLRG 155
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS--- 184
IA+ ++YL ++G VHRD+ NILI+ L K++DFG R+L E + T G
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYLF-- 241
+ +PE I + +D+WS G+VL+ +++ + P+ N+DV+K + L
Sbjct: 216 WTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPY--WEMSNQDVIKAVDEGYRLPPP 272
Query: 242 ----NRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQN--HAWIQNEPTCQTMTAEE 291
Y++ ML+ + +RP + + + I+N + + +T+
Sbjct: 273 MDCPAALYQL----------MLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 321
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 71/300 (23%), Positives = 123/300 (41%), Gaps = 51/300 (17%)
Query: 14 KLGEGAYGNVYL----VSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSH 66
+G G +G VY S + E A K LK Y EK E I+ + SH
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-----LKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
NII + ++ + +I +Y E L+ ++ E + Q+ + L
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFL--------REKDGEFSVLQL---VGMLR 154
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS-- 184
IA ++YL + VHRD+ NIL++ L K++DFG SR+L E + T G
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 185 -YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYLF- 241
+ APE I + +D+WS G+V++ ++ + P+ N +V+K L
Sbjct: 215 RWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPY--WELSNHEVMKAINDGFRLPT 271
Query: 242 -----NRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQN--HAWIQNEPTCQTMTAEE 291
+ Y++ M++ RP D+ + I+ + +T+ +
Sbjct: 272 PMDCPSAIYQL----------MMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFD 321
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-30
Identities = 71/302 (23%), Positives = 129/302 (42%), Gaps = 58/302 (19%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+G G++G V+ S+ + A K++ +D ++F RE+ I+ V HPN++
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEV----A--IKKVLQD--KRFKNRELQIMRIVKHPNVVD 96
Query: 72 VHRMV------KAGTYLYMIMDYAE---KKDLEHYISKACNENIHENQARIWIRQIANAL 122
+ K +L ++++Y + HY + + ++
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK--LKQTMPMLLIKL--------- 145
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA-KLADFGFSRLLRTPKELSNTFCG 181
Y++++ +L Y+H +GI HRDIK +N+L+ KL DFG +++L + + C
Sbjct: 146 -YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC- 203
Query: 182 TTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF-GDP------------GTRN 227
+ Y APE+I + Y + DIWS G V+ ++ + F G+ GT +
Sbjct: 204 SRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262
Query: 228 RDVLKKQ--EGKEYLFNRKYEISIG----------AKQLIGRMLEPNPKHRPNAKDVQNH 275
R+ +K E+ F + A LI R+LE P R A + H
Sbjct: 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322
Query: 276 AW 277
+
Sbjct: 323 PF 324
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 66/344 (19%), Positives = 112/344 (32%), Gaps = 66/344 (19%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF--------APREIDILLK 63
+ G+YG V D + A K + REI +L
Sbjct: 27 QRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 64 VSHPNIIGVHRMVKAGTY-----LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQI 118
HPNI+G+ + LY++ + DL + I + ++ I
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DL-AQVIHDQRIVISPQHIQYFMYHI 143
Query: 119 ANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT 178
L LHE G+VHRD+ NIL++ + + DF +R ++
Sbjct: 144 LLGLHVLHE----------AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH- 192
Query: 179 FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK----- 233
+ Y APE++ KL D+WS G V+ + N+K F G+ + L K
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF--RGSTFYNQLNKIVEVV 250
Query: 234 -------------QEGKEYL-----------FNRKY-EISIGAKQLIGRMLEPNPKHRPN 268
++YL + A LI +MLE NP+ R +
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
Query: 269 AKDVQNHAWI------QNEPTCQTMTAE-EREALKIGKLKSKVF 305
+ H + + + + + +
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIFT 354
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 57/269 (21%), Positives = 111/269 (41%), Gaps = 30/269 (11%)
Query: 14 KLGEGAYGNVYLVSDKRSET---LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
++G G +G V+ + T +K+C+ LK ++ +E IL + SHPNI+
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-----QEARILKQYSHPNIV 175
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ + +Y++M+ + D ++ AR+ ++ + L+ + + A
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFL--------RTEGARLRVKTL---LQMVGDAAA 224
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY----A 186
+EYL +HRD+ N L++ K++DFG SR + G
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA--DGVYAASGGLRQVPVKWT 282
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245
APE + Y+ + +D+WS G++L+ + P+ P N+ + E K
Sbjct: 283 APEALNYGRYSSE-SDVWSFGILLWETFSLGASPY--PNLSNQQTREFVE-KGGRLPCPE 338
Query: 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQN 274
+L+ + P RP+ +
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 49/237 (20%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 14 KLGEGAYGNVY----LVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSH 66
LG GA+G VY + ++ + A K L+ K E ++ V +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-----LREATSPKANKEILDEAYVMASVDN 76
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P++ + + T + +I L Y+ E++ I + + L +
Sbjct: 77 PHVCRLLGICLTST-VQLITQLMPFGCLLDYV--------REHKDNIGSQYL---LNWCV 124
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
+IA + YL + +VHRD+ N+L+ + K+ DFG ++LL +
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-----AEEKEYHAEGG 179
Query: 187 -------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQE 235
A E I + Y + +D+WS GV ++ ++ P+ G ++ E
Sbjct: 180 KVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPY--DGIPASEISSILE 233
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 29/230 (12%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHP 67
+G G G V L + + A KA LK Y E+ E I+ + HP
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKA-----LKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
NII + +V G ++ +Y E L+ ++ + + I Q+ + L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--------RTHDGQFTIMQL---VGMLRG 159
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS--- 184
+ + YL ++G VHRD+ N+L+ L K++DFG SR+L + + T G
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
+ APE I ++ +D+WS GVV++ +L + P+ NRDV+
Sbjct: 220 WTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPY--WNMTNRDVISS 266
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
KLG G YG VY K+ A K LK D M E+F +E ++ ++ HPN++
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFL-KEAAVMKEIKHPNLVQ 280
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + Y+I ++ +L Y+ + + + L +I++A
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSA 330
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK-ELSNTFCGTTSYAAPEI 190
+EYL + +HR++ N L+ K+ADFG SRL+ + APE
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
+ + ++ K +D+W+ GV+L+ I P+ PG V +
Sbjct: 391 LAYNKFSIK-SDVWAFGVLLWEIATYGMSPY--PGIDLSQVYEL 431
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 35/242 (14%)
Query: 11 YISKLGEGAYGNVYL----VSDKRSETL---KACKAYDFKRLKRDYMEKFAPREIDILLK 63
I LGEG +G V L + K+ K D +EI+IL
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-----KEIEILRN 79
Query: 64 VSHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
+ H NI+ G+ G + +IM++ L+ Y+ K N+ +I ++Q
Sbjct: 80 LYHENIVKYKGIC-TEDGGNGIKLIMEFLPSGSLKEYLPK--------NKNKINLKQQ-- 128
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC 180
L+Y +I ++YL VHRD+ N+L+ K+ DFG ++ + T KE
Sbjct: 129 -LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 181 GTTS---YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237
S + APE + S + +D+WS GV L+ +L + D + + K G
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLT----YCDSDSSPMALFLKMIGP 242
Query: 238 EY 239
+
Sbjct: 243 TH 244
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-28
Identities = 49/229 (21%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
++G G +G V+L ++ A K ++ M E F E ++++K+SHP ++
Sbjct: 15 EIGSGQFGLVHL-GYWLNKDKVAIKT-----IREGAMSEEDFI-EEAEVMMKLSHPKLVQ 67
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + + ++ ++ E L Y+ + + L ++
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYL--------RTQRGLFAAETL---LGMCLDVCEG 116
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS------Y 185
+ YL E ++HRD+ N L+ K++DFG +R + L + + +T +
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV-----LDDQYTSSTGTKFPVKW 171
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
A+PE+ S Y+ K +D+WS GV+++ + ++ K P+ N +V++
Sbjct: 172 ASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPY--ENRSNSEVVED 217
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 68/308 (22%), Positives = 123/308 (39%), Gaps = 68/308 (22%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNII 70
+ KLG G Y V+ + + K LK +K REI IL + PNII
Sbjct: 41 VRKLGRGKYSEVFEAINITNNEKVV-----VKILKPVKKKK-IKREIKILENLRGGPNII 94
Query: 71 GVHRMVKAGT--YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+ +VK ++ ++ D + + +I Y++EI
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF---------------YMYEI 139
Query: 129 ANALEYLHEVGIVHRDIKCENILI---SRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
AL+Y H +GI+HRD+K N++I R L +L D+G + +E N + +
Sbjct: 140 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKL--RLIDWGLAEFYHPGQEY-NVRVASRYF 196
Query: 186 AAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK-------QEGK 237
PE++ + Y+ L D+WSLG +L ++ +K PF G N D L + ++
Sbjct: 197 KGPELLVDYQMYDYSL-DMWSLGCMLASMIFRKEPFF-HGHDNYDQLVRIAKVLGTEDLY 254
Query: 238 EYL------FNRKYEISIGAKQ----------------------LIGRMLEPNPKHRPNA 269
+Y+ + ++ +G + ++L + + R A
Sbjct: 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 314
Query: 270 KDVQNHAW 277
++ H +
Sbjct: 315 REAMEHPY 322
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-28
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 33/229 (14%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
KLG G YG VY K+ A K LK D M E+F +E ++ ++ HPN++
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFL-KEAAVMKEIKHPNLVQ 73
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + Y+I ++ +L Y+ + + + L +I++A
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSA 123
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS------Y 185
+EYL + +HRD+ N L+ K+ADFG SRL+ +T+ +
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKW 178
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
APE + + ++ K +D+W+ GV+L+ I P+ PG V +
Sbjct: 179 TAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY--PGIDLSQVYEL 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 32/239 (13%)
Query: 11 YISKLGEGAYGNVYL----VSDKRSETLKACKAYDFKRLKRDYMEKFAP--REIDILLKV 64
++ +LG+G +G+V + + + A K L+ E REI+IL +
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-----LQHSTEEHLRDFEREIEILKSL 68
Query: 65 SHPNIIGVHRMVKAGTY--LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
H NI+ + + L +IM+Y L Y+ K ++ RI ++ L
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--------HKERIDHIKL---L 117
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
+Y +I +EYL +HRD+ NIL+ K+ DFG +++L KE
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 183 TS---YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238
S + APE + S ++ +D+WS GVVLY + + + + G +
Sbjct: 178 ESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 91/343 (26%), Positives = 142/343 (41%), Gaps = 71/343 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYD-FKRL---KRDYMEKFAPREIDILLKVSHP 67
+S +GEGAYG V D ++ A K F+ +R REI ILL+ H
Sbjct: 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL------REIKILLRFRHE 85
Query: 68 NIIGVHRMVKAGTY-----LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
NIIG++ +++A T +Y++ D E DL + N H I
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDH-------ICYF---- 133
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG- 181
L++I L+Y+H ++HRD+K N+L++ + K+ DFG +R+ + +
Sbjct: 134 --LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 182 --TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------ 233
T Y APEI+ NS K DIWS+G +L +L+ + F PG D L
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF--PGKHYLDQLNHILGILG 249
Query: 234 ------------QEGKEYL----------FNRKY-EISIGAKQLIGRMLEPNPKHRPNAK 270
+ + YL +NR + A L+ +ML NP R +
Sbjct: 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309
Query: 271 DVQNHAWIQN------EPTCQTM--TAEEREALKIGKLKSKVF 305
H +++ EP + E + L KLK +F
Sbjct: 310 QALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 352
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 52/229 (22%), Positives = 104/229 (45%), Gaps = 35/229 (15%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
+LG G +G V R + A K +K M ++F E +++ +SH ++
Sbjct: 31 ELGTGQFGVVKY-GKWRGQYDVAIKM-----IKEGSMSEDEFI-EEAKVMMNLSHEKLVQ 83
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + +++I +Y L +Y+ E + R +Q+ LE ++ A
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYL--------REMRHRFQTQQL---LEMCKDVCEA 132
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS------Y 185
+EYL +HRD+ N L++ K++DFG SR + L + + + +
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-----LDDEYTSSVGSKFPVRW 187
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
+ PE++ S ++ K +DIW+ GV+++ I + K P+ N + +
Sbjct: 188 SPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEH 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 50/229 (21%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
+LG G +G V L + + A K +K M ++F +E ++K+SHP ++
Sbjct: 15 ELGSGQFGVVKL-GKWKGQYDVAVKM-----IKEGSMSEDEFF-QEAQTMMKLSHPKLVK 67
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + +Y++ +Y L +Y+ + + Q+ LE +++
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYL--------RSHGKGLEPSQL---LEMCYDVCEG 116
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS------Y 185
+ +L +HRD+ N L+ R L K++DFG +R + L + + + +
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-----LDDQYVSSVGTKFPVKW 171
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
+APE+ Y+ K +D+W+ G++++ + + K P+ N +V+ K
Sbjct: 172 SAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPY--DLYTNSEVVLK 217
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 51/248 (20%), Positives = 100/248 (40%), Gaps = 43/248 (17%)
Query: 4 PDILECSYISKLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYMEK----FAPR 56
P L + +G G +G VY L+ + + A K+ L R F
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-----LNRITDIGEVSQFL-T 75
Query: 57 EIDILLKVSHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARI 113
E I+ SHPN++ G+ +++ +++ Y + DL ++I
Sbjct: 76 EGIIMKDFSHPNVLSLLGI--CLRSEGSPLVVLPYMKHGDLRNFI--------RNETHNP 125
Query: 114 WIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK 173
++ + + + ++A ++YL VHRD+ N ++ K+ADFG +R +
Sbjct: 126 TVKDL---IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--- 179
Query: 174 ELSNTFCGTTSYA-------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGT 225
+ + A A E ++ + K +D+WS GV+L+ ++ + P+ P
Sbjct: 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY--PDV 236
Query: 226 RNRDVLKK 233
D+
Sbjct: 237 NTFDITVY 244
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 48/241 (19%), Positives = 92/241 (38%), Gaps = 38/241 (15%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYMEKFAP-----REIDILLKVS 65
KLG+G++G V + A K LK D + + RE++ + +
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKC-----LKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
H N+I ++ +V + M+ + A L + ++Q + + Y
Sbjct: 80 HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRL--------RKHQGHFLLGTL---SRYA 127
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT--- 182
++A + YL +HRD+ N+L++ K+ DFG R L +
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 183 ---TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKE 238
APE ++ ++ +D W GV L+ + + P+ G +L K + +
Sbjct: 188 FAWC---APESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPW--IGLNGSQILHKIDKEG 241
Query: 239 Y 239
Sbjct: 242 E 242
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-27
Identities = 61/239 (25%), Positives = 98/239 (41%), Gaps = 50/239 (20%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYM----EKFAPREIDILLKVSH 66
LGEG +G VY + K + A K K+D EKF E I+ + H
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKT-----CKKDCTLDNKEKFM-SEAVIMKNLDH 72
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P+I+ + +++ ++IM+ +L HY+ N+ + + + + Y
Sbjct: 73 PHIVKLIGIIEEEP-TWIIMELYPYGELGHYL--------ERNKNSLKVLTL---VLYSL 120
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
+I A+ YL + VHRDI NIL++ KL DFG SR + Y
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE----------DEDYYK 170
Query: 187 -----------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
+PE I + +D+W V ++ IL+ K PF N+DV+
Sbjct: 171 ASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPF--FWLENKDVIGV 226
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 49/237 (20%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 14 KLGEGAYGNVY----LVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSH 66
LG GA+G VY + ++ + A K L+ K E ++ V +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-----LREATSPKANKEILDEAYVMASVDN 76
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P++ + + T + +I L Y+ E++ I + + L +
Sbjct: 77 PHVCRLLGICLTST-VQLITQLMPFGCLLDYV--------REHKDNIGSQYL---LNWCV 124
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYA 186
+IA + YL + +VHRD+ N+L+ + K+ DFG ++LL +
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-----AEEKEYHAEGG 179
Query: 187 -------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQE 235
A E I + Y + +D+WS GV ++ ++ P+ G ++ E
Sbjct: 180 KVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPY--DGIPASEISSILE 233
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 61/283 (21%), Positives = 113/283 (39%), Gaps = 57/283 (20%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHP 67
+GEG +G+V+ +S + A K K + +E + + HP
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKT-----CKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+I+ + ++ +++IM+ +L ++ + + + + + Y ++
Sbjct: 452 HIVKLIGVITENP-VWIIMELCTLGELRSFL--------QVRKFSLDLASL---ILYAYQ 499
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS--- 184
++ AL YL VHRDI N+L+S KL DFG SR + +T+ +
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-----DSTYYKASKGKL 554
Query: 185 ---YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYL 240
+ APE I + +D+W GV ++ IL PF G +N DV+ + E E L
Sbjct: 555 PIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGERL 611
Query: 241 ------FNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQN 274
Y + M + +P RP +++
Sbjct: 612 PMPPNCPPTLYSL----------MTKCWAYDPSRRPRFTELKA 644
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 32/239 (13%)
Query: 11 YISKLGEGAYGNVYL----VSDKRSETLKACKAYDFKRLKRDYMEKFAP--REIDILLKV 64
++ +LG+G +G+V + + + A K L+ E REI+IL +
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-----LQHSTEEHLRDFEREIEILKSL 99
Query: 65 SHPNIIGVHRMVKAGTY--LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
H NI+ + + L +IM+Y L Y+ K ++ RI ++ L
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--------HKERIDHIKL---L 148
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
+Y +I +EYL +HRD+ NIL+ K+ DFG +++L KE
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208
Query: 183 TS---YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238
S + APE + S ++ +D+WS GVVLY + + + + G +
Sbjct: 209 ESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND 262
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-27
Identities = 58/241 (24%), Positives = 93/241 (38%), Gaps = 35/241 (14%)
Query: 11 YISKLGEGAYGNVYL-----VSDKRSET--LKACKAYDFKRLKRDYMEKFAPREIDILLK 63
I LGEG +G V L +D E +KA KA + + + +EIDIL
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-----QEIDILRT 89
Query: 64 VSHPNIIGVHRMV--KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
+ H +II L ++M+Y L Y+ + I + Q+
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----------SIGLAQL--- 136
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCG 181
L + +I + YLH +HRD+ N+L+ K+ DFG ++ + E
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196
Query: 182 TTS---YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238
S + APE ++ + +D+WS GV LY +L D + G
Sbjct: 197 GDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLT----HCDSSQSPPTKFLELIGIA 251
Query: 239 Y 239
Sbjct: 252 Q 252
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 41/249 (16%)
Query: 11 YISKLGEGAYGNVYL----VSDKRSETLKACKAYDFKRLKRDYMEKFAP--REIDILLKV 64
YIS+LG+G +G+V L + L A K L+ ++ REI IL +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ-----LQHSGPDQQRDFQREIQILKAL 81
Query: 65 SHPNIIGVHRMVKAGTY--LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
I+ + L ++M+Y L ++ ++AR+ ++ L
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--------QRHRARLDASRL---L 130
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
Y +I +EYL VHRD+ NIL+ + K+ADFG ++LL K+
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 183 TS---YAAPEIIRNSPYNPKLADIWSLGVVLYRIL-------------NKKYPFGDPGTR 226
S + APE + ++ ++ + +D+WS GVVLY + +
Sbjct: 191 QSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249
Query: 227 NRDVLKKQE 235
+L+ E
Sbjct: 250 LSRLLELLE 258
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 79/341 (23%), Positives = 137/341 (40%), Gaps = 72/341 (21%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK--AYDFKRL---KRDYMEKFAPREIDILLKVSH 66
+S +G GAYG+V D ++ A K + F+ + KR Y RE+ +L + H
Sbjct: 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY------RELRLLKHMKH 87
Query: 67 PNIIGVHRMVKAGTY------LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
N+IG+ + +Y++ DL + + + H ++ +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDH-------VQFL-- 137
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC 180
+++I L+Y+H I+HRD+K N+ ++ K+ DFG +R T E++ +
Sbjct: 138 ----IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTG-YV 190
Query: 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------- 233
T Y APEI+ N + + DIWS+G ++ +L + F PGT + D LK
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLKLILRLVGT 248
Query: 234 -----------QEGKEYL----------FNRKY-EISIGAKQLIGRMLEPNPKHRPNAKD 271
+ + Y+ F + + A L+ +ML + R A
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308
Query: 272 VQNHAWIQN------EPTCQTMTAE-EREALKIGKLKSKVF 305
HA+ EP E L I + KS +
Sbjct: 309 ALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLTY 349
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 79/342 (23%), Positives = 136/342 (39%), Gaps = 74/342 (21%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK----AYDFKRL-KRDYMEKFAPREIDILLKVSH 66
+ +G GAYG+V DKRS A K + + KR Y RE+ +L + H
Sbjct: 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY------RELLLLKHMQH 82
Query: 67 PNIIGVHRMVKAGTY------LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
N+IG+ + + Y++M + + DL+ + E + + + Q+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL----KFSEEKIQYLVYQMLK 137
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC 180
L+Y+H G+VHRD+K N+ ++ K+ DFG +R E++ +
Sbjct: 138 GLKYIHS----------AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTG-YV 184
Query: 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------- 233
T Y APE+I + + + DIWS+G ++ +L K F G D L +
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF--KGKDYLDQLTQILKVTGV 242
Query: 234 -----------QEGKEYL----------FNRKY-EISIGAKQLIGRMLEPNPKHRPNAKD 271
+ K Y+ F + + S A L+ +MLE + R A
Sbjct: 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302
Query: 272 VQNHAWIQN------EPTCQTM--TAEEREALKIGKLKSKVF 305
H + + E Q + E E L + + K ++
Sbjct: 303 ALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIY 344
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 76/341 (22%), Positives = 131/341 (38%), Gaps = 72/341 (21%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK--AYDFKRL---KRDYMEKFAPREIDILLKVSH 66
+ +G GAYG V D R+ A K F+ KR Y RE+ +L + H
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY------RELRLLKHMRH 83
Query: 67 PNIIGVHRMVKAGTY------LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
N+IG+ + Y++M + DL + I+ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDR-------IQFL-- 133
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC 180
++++ L Y+H GI+HRD+K N+ ++ K+ DFG +R + E++ +
Sbjct: 134 ----VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTG-YV 186
Query: 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------- 233
T Y APE+I N + DIWS+G ++ ++ K F G+ + D LK+
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF--KGSDHLDQLKEIMKVTGT 244
Query: 234 -----------QEGKEYL----------FNRKY-EISIGAKQLIGRMLEPNPKHRPNAKD 271
E K Y+ F S A L+ +ML + + R A +
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304
Query: 272 VQNHAWIQ------NEPTCQTMTAE-EREALKIGKLKSKVF 305
H + + +EP Q + + + K +
Sbjct: 305 ALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTY 345
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 53/233 (22%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHP 67
+GEG +G+V+ +S + A K K + +E + + HP
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKT-----CKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
+I+ + ++ +++IM+ +L ++ + + + + + Y ++
Sbjct: 77 HIVKLIGVITENP-VWIIMELCTLGELRSFL--------QVRKYSLDLASL---ILYAYQ 124
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS--- 184
++ AL YL VHRDI N+L+S KL DFG SR + +T+ +
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-----DSTYYKASKGKL 179
Query: 185 ---YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
+ APE I + +D+W GV ++ IL PF G +N DV+ +
Sbjct: 180 PIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 60/313 (19%), Positives = 115/313 (36%), Gaps = 71/313 (22%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL---KRDYMEKFAPREIDILLKVSHPN 68
+ LG G G V+ D + A K K REI I+ ++ H N
Sbjct: 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL------REIKIIRRLDHDN 69
Query: 69 IIGVHRMVKAGTY--------------LYMIMDYAEKKDLEHYISKACNENIHENQARIW 114
I+ V ++ +Y++ +Y E DL + + + H AR++
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEH---ARLF 125
Query: 115 IRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI-SRLLNAKLADFGFSRLLRTPK 173
+ Q+ L+Y+H ++HRD+K N+ I + L K+ DFG +R++
Sbjct: 126 MYQLLRGLKYIHS----------ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 174 ELSNTFCG---TTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV 230
T Y +P ++ + K D+W+ G + +L K F G +
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF--AGAHELEQ 233
Query: 231 LKK---------QEGKEYLFN--RKYEISIGAKQ-----------------LIGRMLEPN 262
++ +E ++ L + Y + + + ++L +
Sbjct: 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFS 293
Query: 263 PKHRPNAKDVQNH 275
P R A++ +H
Sbjct: 294 PMDRLTAEEALSH 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 60/292 (20%), Positives = 118/292 (40%), Gaps = 59/292 (20%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYM-----EKFAPREIDILLKVS 65
LG+G +G+V L + S A K LK D + E+F RE + +
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKM-----LKADIIASSDIEEFL-REAACMKEFD 83
Query: 66 HPNII---GV---HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIA 119
HP++ GV R +I+ + + DL ++ I EN + ++ +
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA---SRIGENPFNLPLQTL- 139
Query: 120 NALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF 179
+ ++ +IA +EYL +HRD+ N +++ + +ADFG SR + + + +
Sbjct: 140 --VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS----GDYY 193
Query: 180 CGTTSYA------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLK 232
+ A E + ++ Y +D+W+ GV ++ I+ + + P+ G N ++
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY--AGIENAEIYN 250
Query: 233 K-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
G Y++ M + +PK RP+ ++
Sbjct: 251 YLIGGNRLKQPPECMEEVYDL----------MYQCWSADPKQRPSFTCLRME 292
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 52/232 (22%), Positives = 102/232 (43%), Gaps = 31/232 (13%)
Query: 14 KLGEGAYGNVY--LVSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDILLKVSHP 67
+LG G +G+V + ++ + A K LK+ + RE I+ ++ +P
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKV-----LKQGTEKADTEEMM-REAQIMHQLDNP 70
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
I+ + + +A L ++M+ A L ++ + I + + E LH+
Sbjct: 71 YIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVG--------KREEIPVSNV---AELLHQ 118
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS--- 184
++ ++YL E VHRD+ N+L+ AK++DFG S+ L
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQE 235
+ APE I ++ + +D+WS GV ++ L+ + P+ + +V+ E
Sbjct: 179 WYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAFIE 227
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 48/238 (20%), Positives = 97/238 (40%), Gaps = 43/238 (18%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDILLKVSH 66
+G G +G VY L+ + + A K+ L R F E I+ SH
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKS-----LNRITDIGEVSQFL-TEGIIMKDFSH 149
Query: 67 PNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
PN++ G+ +++ +++ Y + DL ++I ++ + +
Sbjct: 150 PNVLSLLGI--CLRSEGSPLVVLPYMKHGDLRNFI--------RNETHNPTVKDL---IG 196
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
+ ++A +++L VHRD+ N ++ K+ADFG +R + +
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNK 253
Query: 184 SYA-------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
+ A A E ++ + K +D+WS GV+L+ ++ + P+ P D+
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY--PDVNTFDITVY 308
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 70/355 (19%), Positives = 131/355 (36%), Gaps = 87/355 (24%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK----AYDFKRL-KRDYMEKFAPREIDILLKVSH 66
+ +G GA G V D E A K + + KR Y RE+ ++ V+H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY------RELVLMKCVNH 83
Query: 67 PNIIGVHRMVKAGTY------LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
NIIG+ + +Y++M+ + +L + + ++
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NL-CQVIQMELDHER------------- 128
Query: 121 ALEY-LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF 179
+ Y L+++ +++LH GI+HRD+K NI++ K+ DFG +R T ++ +
Sbjct: 129 -MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-Y 186
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------ 233
T Y APE+I Y + DIWS+G ++ ++ F PGT + D K
Sbjct: 187 VVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLF--PGTDHIDQWNKVIEQLG 243
Query: 234 -----------QEGKEYL----------FNRKY-------------EISIGAKQLIGRML 259
+ Y+ F + + + A+ L+ +ML
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303
Query: 260 EPNPKHRPNAKDVQNHAWIQ------NEPTCQTMTAE---EREALKIGKLKSKVF 305
+ R + + H +I + + I + K ++
Sbjct: 304 VIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIY 358
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 52/235 (22%), Positives = 100/235 (42%), Gaps = 37/235 (15%)
Query: 14 KLGEGAYGNVY--LVSDKRSETLKACKAYDFKRLKRDYMEKFAP----REIDILLKVSHP 67
+LG G +G V K+ A K LK + + E +++ ++ +P
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKI-----LKNEANDPALKDELLAEANVMQQLDNP 78
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
I+ + + +A + ++M+ AE L Y+ + N ++ + + Q++ ++YL E
Sbjct: 79 YIVRMIGICEAES-WMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT----- 182
VHRD+ N+L+ AK++DFG S+ LR +
Sbjct: 136 S----------NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 183 -TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQE 235
APE I ++ K +D+WS GV+++ + + P+ G + +V E
Sbjct: 186 WY---APECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPY--RGMKGSEVTAMLE 234
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 44/236 (18%), Positives = 94/236 (39%), Gaps = 38/236 (16%)
Query: 14 KLGEGAYGNVY---LVSDKRSETL----KACKAYDFKRLKRDYMEKFAPREIDILLKVSH 66
LG G +G V+ + + S + K + ++ + + + + H
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-----DHMLAIGSLDH 74
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
+I+ + + + L ++ Y L ++ +++ + + + L +
Sbjct: 75 AHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHV--------RQHRGALGPQLL---LNWGV 122
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS-- 184
+IA + YL E G+VHR++ N+L+ ++ADFG + LL + +
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL----PPDDKQLLYSEAK 178
Query: 185 ----YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQE 235
+ A E I Y + +D+WS GV ++ ++ P+ G R +V E
Sbjct: 179 TPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPY--AGLRLAEVPDLLE 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-26
Identities = 30/260 (11%), Positives = 71/260 (27%), Gaps = 47/260 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKVSHPNII 70
+ G + D + A D + + D +++ L ++ P +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKPGVA 94
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
V +V ++ ++ L+ A+ + +A
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA-----------DTSPSPVG---AIRAMQSLAA 140
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
A + H G+ + +S + LA
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDAN 180
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL---FNRKYEI 247
+ DI +G LY +L ++P + G R+ +++ + +I
Sbjct: 181 PQ--------DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232
Query: 248 SIGAKQLIGRMLEPNPKHRP 267
+ R ++ + R
Sbjct: 233 PFQISAVAARSVQGDGGIRS 252
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 51/231 (22%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 14 KLGEGAYGNVY--LVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPN 68
+LG G +G+V + ++ + A K LK+ + RE I+ ++ +P
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKV-----LKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I+ + + +A L ++M+ A L ++ + I + + E LH++
Sbjct: 398 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFL--------VGKREEIPVSNV---AELLHQV 445
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS---Y 185
+ ++YL E VHR++ N+L+ AK++DFG S+ L +
Sbjct: 446 SMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQE 235
APE I ++ + +D+WS GV ++ L+ + P+ + +V+ E
Sbjct: 506 YAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAFIE 553
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 56/231 (24%), Positives = 105/231 (45%), Gaps = 43/231 (18%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACK-AYDFKRLKRDYM-EKFAPREIDILLKVSHPNII- 70
+G+G +G+V L + K A K +K D + F E ++ ++ H N++
Sbjct: 28 TIGKGEFGDVML------GDYRGNKVA--VKCIKNDATAQAFL-AEASVMTQLRHSNLVQ 78
Query: 71 --GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
GV V+ LY++ +Y K L Y+ + + L++ ++
Sbjct: 79 LLGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL----------LKFSLDV 126
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSN-----TFCGTT 183
A+EYL VHRD+ N+L+S AK++DFG ++ + ++ T
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----- 181
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
APE +R ++ K +D+WS G++L+ I + + P+ P +DV+ +
Sbjct: 182 ---APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPY--PRIPLKDVVPR 226
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
KLG+G +G V++ T A K LK M E F +E ++ K+ H ++
Sbjct: 274 KLGQGCFGEVWM-GTWNGTTRVAIKT-----LKPGTMSPEAFL-QEAQVMKKLRHEKLVQ 326
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ +V +Y++ +Y K L ++ + + Q QIA+ + Y+ +
Sbjct: 327 LYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 382
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY------ 185
VHRD++ NIL+ L K+ADFG +RL+ N +
Sbjct: 383 -------NYVHRDLRAANILVGENLVCKVADFGLARLIE-----DNEYTARQGAKFPIKW 430
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
APE + K +D+WS G++L + K + P+ PG NR+VL +
Sbjct: 431 TAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPY--PGMVNREVLDQ 476
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
KLG+G +G V++ T A K LK M E F +E ++ K+ H ++
Sbjct: 191 KLGQGCFGEVWM-GTWNGTTRVAIKT-----LKPGTMSPEAFL-QEAQVMKKLRHEKLVQ 243
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ +V +Y++ +Y K L ++ + + Q QIA+ + Y+ +
Sbjct: 244 LYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 299
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY------ 185
VHRD++ NIL+ L K+ADFG +RL+ N +
Sbjct: 300 -------NYVHRDLRAANILVGENLVCKVADFGLARLIE-----DNEYTARQGAKFPIKW 347
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
APE + K +D+WS G++L + K + P+ PG NR+VL +
Sbjct: 348 TAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPY--PGMVNREVLDQ 393
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 71/315 (22%), Positives = 115/315 (36%), Gaps = 72/315 (22%)
Query: 10 SYISKLGEGAYGNVYL-----VSDKRSETL---KACKAYDFKRLKRDYMEKFAPREIDIL 61
+LGEGA+G V+L + ++ + L KA K + ++D+ RE ++L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQ-----REAELL 97
Query: 62 LKVSHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQI 118
+ H +I+ GV G L M+ +Y DL ++ +
Sbjct: 98 TMLQHQHIVRFFGV---CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 119 ANALEYLH---EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL 175
+ L ++A + YL + VHRD+ N L+ + L K+ DFG SR +
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY----- 209
Query: 176 SNTFCGTTSY-------------AAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFG 221
+T Y PE I + + +D+WS GVVL+ I K P+
Sbjct: 210 ------STDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW- 261
Query: 222 DPGTRNRDVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDV 272
N + + +G+ Y I M P+ R + KDV
Sbjct: 262 -YQLSNTEAIDCITQGRELERPRACPPEVYAI----------MRGCWQREPQQRHSIKDV 310
Query: 273 QNH--AWIQNEPTCQ 285
A Q P
Sbjct: 311 HARLQALAQAPPVYL 325
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 69/319 (21%), Positives = 120/319 (37%), Gaps = 76/319 (23%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK--AYDFKRL---KRDYMEKFAPREIDILLKVSH 66
+ +G GA G V D + A K + F+ KR Y RE+ ++ V+H
Sbjct: 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY------RELVLMKCVNH 120
Query: 67 PNIIGVHRMVKAGTY------LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
NII + + +Y++M+ + +L I + + + Q+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLC 175
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC 180
+++LH GI+HRD+K NI++ K+ DFG +R T ++ +
Sbjct: 176 GIKHLHS----------AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YV 224
Query: 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------- 233
T Y APE+I Y + DIWS+G ++ ++ K F PG D K
Sbjct: 225 VTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILF--PGRDYIDQWNKVIEQLGT 281
Query: 234 ----------QEGKEYL----------FNRKY-------------EISIGAKQLIGRMLE 260
+ Y+ F + + + A+ L+ +ML
Sbjct: 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341
Query: 261 PNPKHRPNAKDVQNHAWIQ 279
+P R + D H +I
Sbjct: 342 IDPAKRISVDDALQHPYIN 360
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-25
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 70/300 (23%)
Query: 11 YISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDIL 61
+LG+G++G VY V ET A K + + F E ++
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-----VNEAASMRERIEFL-NEASVM 82
Query: 62 LKVSHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQI 118
+ + +++ GV V G +IM+ + DL+ Y+ ++ + N +
Sbjct: 83 KEFNCHHVVRLLGV---VSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPS-L 137
Query: 119 ANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT 178
+ ++ EIA+ + YL+ VHRD+ N +++ K+ DFG +R +
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-------- 189
Query: 179 FCGTTSYA-------------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPG 224
T Y +PE +++ + +D+WS GVVL+ I + P+ G
Sbjct: 190 ---ETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY--QG 243
Query: 225 TRNRDVLKKQEGKEYLF------NRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
N VL+ L + +E+ M NPK RP+ ++ +
Sbjct: 244 LSNEQVLRFVMEGGLLDKPDNCPDMLFEL----------MRMCWQYNPKMRPSFLEIISS 293
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-25
Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 58/291 (19%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDYM-----EKFAPREIDILLKVS 65
LGEG +G+V L + + A K +K D E+F E + S
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKT-----MKLDNSSQREIEEFL-SEAACMKDFS 94
Query: 66 HPNII---GV--HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
HPN+I GV + +I+ + + DL Y+ + I ++ +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY---SRLETGPKHIPLQTL-- 149
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC 180
L+++ +IA +EYL +HRD+ N ++ + +ADFG S+ + + + +
Sbjct: 150 -LKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS----GDYYR 204
Query: 181 GTTS------YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
+ A E + + Y K +D+W+ GV ++ I + P+ PG +N ++
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY--PGVQNHEMYDY 261
Query: 234 -QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
G E + YEI M +P RP ++
Sbjct: 262 LLHGHRLKQPEDCLDELYEI----------MYSCWRTDPLDRPTFSVLRLQ 302
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 56/231 (24%), Positives = 106/231 (45%), Gaps = 43/231 (18%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACK-AYDFKRLKRDYM-EKFAPREIDILLKVSHPNII- 70
+G+G +G+V L + K A K +K D + F E ++ ++ H N++
Sbjct: 200 TIGKGEFGDVML------GDYRGNKVA--VKCIKNDATAQAFL-AEASVMTQLRHSNLVQ 250
Query: 71 --GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
GV +V+ LY++ +Y K L Y+ + + L++ ++
Sbjct: 251 LLGV--IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL----------LKFSLDV 298
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSN-----TFCGTT 183
A+EYL VHRD+ N+L+S AK++DFG ++ + ++ T
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----- 353
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
APE +R ++ K +D+WS G++L+ I + + P+ P +DV+ +
Sbjct: 354 ---APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPY--PRIPLKDVVPR 398
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK--FAPREIDILLKVSHPNIIG 71
KLG G +G V++ + + T A K +K M F E +++ + H ++
Sbjct: 195 KLGAGQFGEVWMATYNK-HTKVAVKT-----MKPGSMSVEAFL-AEANVMKTLQHDKLVK 247
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+H +V +Y+I ++ K L ++ + + QIA + ++ +
Sbjct: 248 LHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 303
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS------Y 185
+HRD++ NIL+S L K+ADFG +R++ N + +
Sbjct: 304 -------NYIHRDLRAANILVSASLVCKIADFGLARVI-----EDNEYTAREGAKFPIKW 351
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
APE I + K +D+WS G++L I+ + P+ PG N +V++
Sbjct: 352 TAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPY--PGMSNPEVIRA 397
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 64/298 (21%), Positives = 116/298 (38%), Gaps = 58/298 (19%)
Query: 10 SYISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDI 60
++ +LGE +G VY + A K LK F E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-----LKDKAEGPLREEFR-HEAML 65
Query: 61 LLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISK----ACNENIHENQARIWIR 116
++ HPN++ + +V L MI Y DL ++ + + +++
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS 176
+ + + + +IA +EYL +VH+D+ N+L+ LN K++D G R + +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY-----A 180
Query: 177 NTFCGTTSYA-------APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD---PGTR 226
+ + APE I ++ +DIWS GVVL+ + + +G G
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFS----YGLQPYCGYS 235
Query: 227 NRDVLKKQEGKEYLF------NRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
N+DV++ ++ L Y + M+E P RP KD+ +
Sbjct: 236 NQDVVEMIRNRQVLPCPDDCPAWVYAL----------MIECWNEFPSRRPRFKDIHSR 283
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 52/238 (21%), Positives = 100/238 (42%), Gaps = 43/238 (18%)
Query: 14 KLGEGAYGNVY---LVSDKRSETLKACKAYDFKRLKRDY----MEKFAPREIDILLKVSH 66
+G+G +G VY + ++ A K+ L R +E F RE ++ ++H
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKS-----LSRITEMQQVEAFL-REGLLMRGLNH 81
Query: 67 PNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
PN++ G+ M+ ++++ Y DL +I Q ++ + +
Sbjct: 82 PNVLALIGI--MLPPEGLPHVLLPYMCHGDLLQFI--------RSPQRNPTVKDL---IS 128
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
+ ++A +EYL E VHRD+ N ++ K+ADFG +R + +
Sbjct: 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL---DREYYSVQQH 185
Query: 184 SYA-------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
+A A E ++ + K +D+WS GV+L+ +L + P+ D+
Sbjct: 186 RHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPY--RHIDPFDLTHF 240
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 69/306 (22%), Positives = 118/306 (38%), Gaps = 60/306 (19%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDI---LLKVSHPN 68
G+G +G V L +K + A K++ +D F RE+ I L + HPN
Sbjct: 28 ERMAGQGTFGTVQLGKEKSTGMSVA-----IKKVIQDPR--FRNRELQIMQDLAVLHHPN 80
Query: 69 IIGVHRMVKAGT-------YLYMIMDYAEKKDLEHYISKACNEN--IHENQARIWIRQIA 119
I+ + YL ++M+Y L ++++ Q+
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 120 NALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA-KLADFGFSRLLRTPKELSNT 178
++ LH + V + HRDIK N+L++ KL DFG ++ L +
Sbjct: 140 RSIGCLHLPS--------VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 179 FCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF-GDP------------G 224
C + Y APE+I + Y + DIWS+G + ++ + F GD G
Sbjct: 192 IC-SRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249
Query: 225 TRNRDVLKK---QEGKEYLFNRK------------YEISIGAKQLIGRMLEPNPKHRPNA 269
+R+VL+K L+N K + + A L+ +L+ P+ R
Sbjct: 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 270 KDVQNH 275
+ H
Sbjct: 310 YEALCH 315
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 73/312 (23%), Positives = 119/312 (38%), Gaps = 71/312 (22%)
Query: 10 SYISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEKFAP--REIDILL 62
+LGEGA+G V+L +S + + L A KA LK + RE ++L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA-----LKDPTLAARKDFQREAELLT 72
Query: 63 KVSHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIA 119
+ H +I+ GV G L M+ +Y + DL ++ + + + +
Sbjct: 73 NLQHEHIVKFYGV---CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 120 NALEYL----HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL 175
L + +IA+ + YL VHRD+ N L+ L K+ DFG SR +
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY----- 184
Query: 176 SNTFCGTTSY-------------AAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFG 221
+T Y PE I + + +D+WS GV+L+ I K P+
Sbjct: 185 ------STDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW- 236
Query: 222 DPGTRNRDVLKKQEGKEYLF------NRKYEISIGAKQLIGRMLE---PNPKHRPNAKDV 272
N +V++ L Y++ ML P+ R N K++
Sbjct: 237 -FQLSNTEVIECITQGRVLERPRVCPKEVYDV----------MLGCWQREPQQRLNIKEI 285
Query: 273 QN--HAWIQNEP 282
HA + P
Sbjct: 286 YKILHALGKATP 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 45/242 (18%), Positives = 88/242 (36%), Gaps = 48/242 (19%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDF--KRLKRDYM---EKFAPREIDILLKVSHPN 68
LG+G + ++ + + K L + + E F ++ K+SH +
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF-EAASMMSKLSHKH 73
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
++ + + G ++ ++ + L+ Y+ +N+ I I LE ++
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYL--------KKNKNCINILWK---LEVAKQL 122
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLN--------AKLADFGFSRLLRTPKELSNTFC 180
A A+ +L E ++H ++ +NIL+ R + KL+D G S +
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL---------- 172
Query: 181 GTTSY-------AAPEIIRNS-PYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVL 231
PE I N N D WS G L+ I + P ++ L
Sbjct: 173 -PKDILQERIPWVPPECIENPKNLNLA-TDKWSFGTTLWEICSGGDKPL--SALDSQRKL 228
Query: 232 KK 233
+
Sbjct: 229 QF 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 71/399 (17%), Positives = 136/399 (34%), Gaps = 125/399 (31%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK--AYDFKRL---KRDYMEKFAPREIDILLKVSH 66
+G G+YG+V DK + + A K F+ L KR REI IL +++H
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL------REIAILNRLNH 111
Query: 67 PNIIGVHRMVKAGTY-----LYMIMDYAEKKDLEHYI-SKACNENIHENQARIWIRQIAN 120
+++ V +V LY++++ A+ D + + +H I+ +
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELH-------IKTL-- 161
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC 180
L+ + ++Y+H GI+HRD+K N L+++ + K+ DFG +R + P+ ++
Sbjct: 162 ----LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 181 GTTS---------------------------YAAPEIIRNSPYNPKLADIWSLGVVLYRI 213
+ Y APE+I + D+WS+G + +
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 214 LNKKYPFGDP--------------------------------------------GTRNRD 229
LN GT + +
Sbjct: 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEE 337
Query: 230 VLKK---QEGKEYL----------FNRKY-EISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
++ ++ K Y+ ++ S A L+ RML NP R + H
Sbjct: 338 DIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397
Query: 276 AWIQN------EPTCQ---TMTAEEREALKIGKLKSKVF 305
+ + E + + + +L+
Sbjct: 398 PFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFV 436
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 9e-24
Identities = 81/387 (20%), Positives = 128/387 (33%), Gaps = 133/387 (34%)
Query: 5 DILECSY--ISKLGEGAYGNVYLVSDKRSE---TLKACKAYDFKRLKRDYMEKFAPREID 59
D+ Y I KLG G + V+L D + + +K K+ Y E A EI
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS------AEHYTET-ALDEIR 85
Query: 60 ILLKVSH--PNIIGVHRMVKA----------GTYLYMIMDYAEKKDLEHYISKACNENIH 107
+L V + PN +V+ GT++ M+ + L +I K+ + +
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLP 144
Query: 108 ENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI--------------- 152
+ I+Q+ L+YLH + I+H DIK ENIL+
Sbjct: 145 LPCVKKIIQQVLQGLDYLHT---------KCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195
Query: 153 ----------------------------------SRLLNAKLADFGFSRLLRTPKELSNT 178
+ L K+AD G + +
Sbjct: 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TE 252
Query: 179 FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF----GDPGTRNRDVL--- 231
T Y + E++ S YN ADIWS + + + Y F G+ TR+ D +
Sbjct: 253 DIQTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI 311
Query: 232 -------------KKQEGKEYLFNR---------------------KYEIS----IGAKQ 253
+ KE+ F + KYE S G
Sbjct: 312 IELLGKVPRKLIVAGKYSKEF-FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTD 370
Query: 254 LIGRMLEPNPKHRPNAKDVQNHAWIQN 280
+ MLE P+ R A + H W+ +
Sbjct: 371 FLLPMLELIPEKRATAAECLRHPWLNS 397
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 66/303 (21%), Positives = 110/303 (36%), Gaps = 60/303 (19%)
Query: 10 SYISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDI 60
+ I LG GA+G VY + + S A K L E+ F E I
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFL-MEALI 86
Query: 61 LLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
+ K +H NI+ + +++M+ DL+ ++ + + + + +
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRE--TRPRPSQPSSLAMLDL-- 142
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRL---LNAKLADFGFSRLLRTPKELSN 177
L +IA +YL E +HRDI N L++ AK+ DFG +R +
Sbjct: 143 -LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-----RA 196
Query: 178 TFCGTTSYA-------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRD 229
++ A PE + K D WS GV+L+ I + P+ P N++
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY--PSKSNQE 253
Query: 230 VLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH--AWI 278
VL+ G + Y I M + P+ RPN +
Sbjct: 254 VLEFVTSGGRMDPPKNCPGPVYRI----------MTQCWQHQPEDRPNFAIILERIEYCT 303
Query: 279 QNE 281
Q+
Sbjct: 304 QDP 306
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 62/299 (20%), Positives = 112/299 (37%), Gaps = 56/299 (18%)
Query: 10 SYISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDI 60
S+ LG GA+G V + + A K LK E+ +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-----LKPSAHLTEREALM-SELKV 79
Query: 61 LLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIA 119
L + +H NI+ + G +I +Y DL +++ + + I + +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 120 NALEYL------HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK 173
AL+ +++A + +L +HRD+ NIL++ K+ DFG +R ++
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN-- 197
Query: 174 ELSNTFCGTTSYA------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPG-T 225
+ + + APE I N Y + +D+WS G+ L+ + + P+ PG
Sbjct: 198 --DSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPY--PGMP 252
Query: 226 RNRDVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
+ K +EG E+ Y+I M +P RP K +
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDI----------MKTCWDADPLKRPTFKQIVQL 301
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-23
Identities = 74/310 (23%), Positives = 116/310 (37%), Gaps = 79/310 (25%)
Query: 3 FPDILECSYISKLGEGAYGNVY-------LVSDKRSETLKACKAYDFKRLKRDYMEKFAP 55
F + +K+GEG +G VY V+ K+ L A + LK+ +
Sbjct: 27 FDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK---LAAMVDITTEELKQQFD----- 78
Query: 56 REIDILLKVSHPN--------IIGVHRM-VKAGTYLYMIMDYAEKKDLEHYISKACNENI 106
+EI ++ K H N G V Y+YM L +S
Sbjct: 79 QEIKVMAKCQHENLVELLGFSSDGDDLCLV----YVYM-----PNGSLLDRLSCLDGTPP 129
Query: 107 HENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166
R +IA AN + +LHE +HRDIK NIL+ AK++DFG +
Sbjct: 130 LSWHMRC---KIA------QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 167 RLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKL---ADIWSLGVVLYRILNKKYPFG 221
R + +++ GTT+Y APE +R ++ +DI+S GVVL I+
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALRG-----EITPKSDIYSFGVVLLEIIT------ 229
Query: 222 DPGTRNRDVLKKQEG-----KEYLFNRK--YEI---------SIGAKQLIG---RMLEPN 262
G D ++ + +E K + S + + + L
Sbjct: 230 --GLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEK 287
Query: 263 PKHRPNAKDV 272
RP+ K V
Sbjct: 288 KNKRPDIKKV 297
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 61/305 (20%), Positives = 114/305 (37%), Gaps = 66/305 (21%)
Query: 11 YISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDIL 61
LGEG +G V + + T A K LK + E ++L
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-----LKENASPSELRDLL-SEFNVL 80
Query: 62 LKVSHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQI 118
+V+HP++I G L +I++YA+ L ++ ++ +
Sbjct: 81 KQVNHPHVIKLYGA---CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 119 ANA------------LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166
+ + + +I+ ++YL E+ +VHRD+ NIL++ K++DFG S
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 167 RLLRTPKELSNTFCGTTSYA------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYP 219
R + +++ + A E + + Y + +D+WS GV+L+ I+ P
Sbjct: 198 RDVYE----EDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNP 252
Query: 220 FGDPGTRNRDVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAK 270
+ PG + + G + Y + ML+ P RP
Sbjct: 253 Y--PGIPPERLFNLLKTGHRMERPDNCSEEMYRL----------MLQCWKQEPDKRPVFA 300
Query: 271 DVQNH 275
D+
Sbjct: 301 DISKD 305
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 44/246 (17%)
Query: 11 YISKLGEGAYGNVY--LVSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDILLKV 64
+ +GEG +G V + A K R+K + FA E+++L K+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIK-----RMKEYASKDDHRDFA-GELEVLCKL 82
Query: 65 -SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHY-------ISKACNENIHENQARIWIR 116
HPNII + + YLY+ ++YA +L + + + + + +
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS 176
Q+ L + ++A ++YL + +HRD+ NIL+ AK+ADFG SR
Sbjct: 143 QL---LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQ 192
Query: 177 NTFCGTTSYA------APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD---PGTRN 227
+ T A E + S Y +D+WS GV+L+ I G G
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEI----VSLGGTPYCGMTC 247
Query: 228 RDVLKK 233
++ +K
Sbjct: 248 AELYEK 253
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 75/349 (21%), Positives = 125/349 (35%), Gaps = 95/349 (27%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
LG G++G V V D S A K++ +D ++ RE+DI+ + H NII
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFA-----LKKVLQD--PRYKNRELDIMKVLDHVNIIK 64
Query: 72 VHRMVKAGT--------------------------------------YLYMIMDYAE--- 90
+ YL +IM+Y
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 91 KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENI 150
K L+ +I +I N I Y++++ A+ ++H +GI HRDIK +N+
Sbjct: 125 HKVLKSFIRS--GRSIPMNLISI----------YIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 151 LI-SRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGV 208
L+ S+ KL DFG ++ L + C + Y APE++ + Y P + D+WS+G
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYTPSI-DLWSIGC 230
Query: 209 VLYRILNKKYPF-GDP------------GTRNRDVLKK--QEGKEYLFNRKYEISI---- 249
V ++ K F G+ GT ++ + + E F
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290
Query: 250 ------GAKQLIGRMLEPNPKHRPNAKDVQNHAW------IQNEPTCQT 286
A L+ ++L P R N + H +
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNN 339
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 87/376 (23%), Positives = 151/376 (40%), Gaps = 103/376 (27%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK----AYDFKRL-KRDYMEKFAPREIDILLKVS- 65
+ KLG+GAYG V+ D+R+ + A K A+ +R + REI IL ++S
Sbjct: 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF------REIMILTELSG 67
Query: 66 HPNIIGVHRMVKAGTY--LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
H NI+ + +++A +Y++ DY E DL I E +H + +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVH-------KQYV----- 114
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTT 183
++++ ++YLH G++HRD+K NIL++ + K+ADFG SR + ++N +
Sbjct: 115 -VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 184 S---------------------YAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPF- 220
+ Y APEI+ S Y + D+WSLG +L IL K F
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFP 232
Query: 221 ---------------GDPGTRNRDVLKKQEGKEYLFNRKY-------------------- 245
P + + ++ K + + K
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 246 -------EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ------NEPTCQ---TMTA 289
+ + A L+ ++L+ NP R +A D H ++ EP C T+
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPI 352
Query: 290 EEREALKIGKLKSKVF 305
+ I ++ V+
Sbjct: 353 NDNVKHSIDDYRNLVY 368
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 71/348 (20%), Positives = 134/348 (38%), Gaps = 83/348 (23%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-----SH 66
+ KLG G + V+L D + T A K R + Y E A EI +L +V +
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEA-AEDEIKLLQRVNDADNTK 79
Query: 67 PNIIGVHRMVK----------AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIR 116
+ +G + ++K G ++ M+ + ++L I K + I + +
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL------LNAKLADFGFSRLLR 170
Q+ L+Y+H GI+H DIK EN+L+ + + K+AD G +
Sbjct: 139 QLLLGLDYMHR---------RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 171 TPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF----GDPGTR 226
E T Y +PE++ +P+ ADIWS +++ ++ + F G T+
Sbjct: 190 ---EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 227 NRD---------------VLKKQEGKEYLFNRKYE--------------ISIGAKQ---- 253
+ D +L+ + FN + + +
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 254 -------LIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREA 294
+ ML+ +P+ R +A + NH W+++ + + +RE
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDREL 353
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 68/300 (22%), Positives = 116/300 (38%), Gaps = 59/300 (19%)
Query: 10 SYISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDI 60
LG GA+G V + + A K LK E+ I
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-----LKEGATHSEHRALM-SELKI 83
Query: 61 LLKV-SHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIR 116
L+ + H N++ G K G L +I+++ + +L Y+ NE + A +
Sbjct: 84 LIHIGHHLNVVNLLGA--CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 117 QIANALEYL----HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTP 172
+ LE+L ++A +E+L +HRD+ NIL+S K+ DFG +R +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK- 200
Query: 173 KELSNTFCGTTSYA------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPG- 224
+ APE I + Y + +D+WS GV+L+ I + P+ PG
Sbjct: 201 ---DPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY--PGV 254
Query: 225 TRNRDVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
+ + ++ +EG +Y Y+ ML+ P RP ++ H
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQT----------MLDCWHGEPSQRPTFSELVEH 304
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-23
Identities = 59/232 (25%), Positives = 109/232 (46%), Gaps = 41/232 (17%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM--EKFAPREIDILLKVSHPNIIG 71
+LG G +G V++ T A K+ LK+ M + F E +++ ++ H ++
Sbjct: 20 RLGAGQFGEVWMGYYNG-HTKVAVKS-----LKQGSMSPDAFL-AEANLMKQLQHQRLVR 72
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ +V +Y+I +Y E L ++ + N+ L+ +IA
Sbjct: 73 LYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKL----------LDMAAQIAEG 121
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR----TPKELSN-----TFCGT 182
+ ++ E +HRD++ NIL+S L+ K+ADFG +RL+ T +E + T
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---- 177
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKK 233
APE I + K +D+WS G++L I+ + P+ PG N +V++
Sbjct: 178 ----APEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPY--PGMTNPEVIQN 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-23
Identities = 80/396 (20%), Positives = 131/396 (33%), Gaps = 127/396 (32%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK--AYDFKRL---KRDYMEKFAPREIDILLKVSH 66
+G G+YG VYL DK +E A K F+ L KR REI IL ++
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL------REITILNRLKS 84
Query: 67 PNIIGVHRMVKAGTY-----LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
II ++ ++ LY++++ A+ DL +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DL-KKL-------FKTPIF---------- 125
Query: 122 LEYLH------EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL 175
L H + ++HE GI+HRD+K N L+++ + K+ DFG +R + + K+
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 176 SNTFCGTTS----------------------YAAPEIIRNSPYNPKLADIWSLGVVLYRI 213
+ + Y APE+I K DIWS G + +
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 214 LNKKYPFGDP-----------------------------------------GTRNRDVLK 232
LN + GT D LK
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305
Query: 233 K---QEGKEYL----------FNRKY-EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
E +Y+ +KY IS L+ ML+ NP R +H ++
Sbjct: 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
Query: 279 QN------EPTCQ---TMTAEEREALKIGKLKSKVF 305
++ E + ++ L +L+
Sbjct: 366 KDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFL 401
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-23
Identities = 64/315 (20%), Positives = 110/315 (34%), Gaps = 84/315 (26%)
Query: 10 SYISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDI 60
Y+ +GEGA+G V+ + T+ A K LK + F RE +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-----LKEEASADMQADFQ-REAAL 103
Query: 61 LLKVSHPNII---GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQ 117
+ + +PNI+ GV G + ++ +Y DL ++ + +
Sbjct: 104 MAEFDNPNIVKLLGV---CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 118 IANA------------LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165
+ L ++A + YL E VHRD+ N L+ + K+ADFG
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 166 SRLLRTPKELSNTFCGTTSY-------------AAPEIIRNSPYNPKLADIWSLGVVLYR 212
SR + + Y PE I + Y + +D+W+ GVVL+
Sbjct: 221 SRNIY-----------SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWE 268
Query: 213 ILNKKYPFGD---PGTRNRDVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE--- 260
I + +G G + +V+ ++G E Y + M
Sbjct: 269 IFS----YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNL----------MRLCWS 314
Query: 261 PNPKHRPNAKDVQNH 275
P RP+ +
Sbjct: 315 KLPADRPSFCSIHRI 329
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 65/303 (21%), Positives = 109/303 (35%), Gaps = 60/303 (19%)
Query: 10 SYISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDI 60
+ I LG GA+G VY + + S A K L E+ F E I
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFL-MEALI 127
Query: 61 LLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIAN 120
+ K +H NI+ + +++++ DL+ ++ + + + + +
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE--TRPRPSQPSSLAMLDL-- 183
Query: 121 ALEYLHEIANALEYLHEVGIVHRDIKCENILISRL---LNAKLADFGFSRLLRTPKELSN 177
L +IA +YL E +HRDI N L++ AK+ DFG +R +
Sbjct: 184 -LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-----RA 237
Query: 178 TFCGTTSYA-------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRD 229
+ A PE + K D WS GV+L+ I + P+ P N++
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY--PSKSNQE 294
Query: 230 VLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH--AWI 278
VL+ G + Y I M + P+ RPN +
Sbjct: 295 VLEFVTSGGRMDPPKNCPGPVYRI----------MTQCWQHQPEDRPNFAIILERIEYCT 344
Query: 279 QNE 281
Q+
Sbjct: 345 QDP 347
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 66/300 (22%), Positives = 121/300 (40%), Gaps = 59/300 (19%)
Query: 10 SYISKLGEGAYGNVY------LVSDKRSETL----KACKAYDFKRLKRDYMEKFAPREID 59
+ LGEGA+G V + DK E + K K ++ D + E++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-----SEME 92
Query: 60 ILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHY-------ISKACNENIHENQA 111
++ + H NII + LY+I++YA K +L Y + + +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 112 RIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171
++ + + + +++A +EYL +HRD+ N+L++ K+ADFG +R +
Sbjct: 153 QMTFKDL---VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 172 PKELSNTFCGTTSYA------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPG 224
+ + TT+ APE + + Y + +D+WS GV+++ I P+ PG
Sbjct: 210 ----IDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY--PG 262
Query: 225 TRNRDVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
++ K +EG N Y + M + P RP K +
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNELYMM----------MRDCWHAVPSQRPTFKQLVED 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-22
Identities = 55/221 (24%), Positives = 86/221 (38%), Gaps = 49/221 (22%)
Query: 13 SKLGEGAYGNVY--LVSDKRSETLKACKAYDFKRLKRD----YMEKFAPREIDILLKVSH 66
+G G +G VY ++ D A KR + E EI+ L H
Sbjct: 45 FLIGHGVFGKVYKGVLRDG---AKVAL-----KRRTPESSQGIEEFET--EIETLSFCRH 94
Query: 67 PNII--------GVHRM-VKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIR- 116
P+++ + + Y YM E +L+ ++ + + + W +
Sbjct: 95 PHLVSLIGFCDERNEMILI----YKYM-----ENGNLKRHLYGSDLPTMSMS----WEQR 141
Query: 117 -QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE- 174
+I A L YLH I+HRD+K NIL+ K+ DFG S+ +
Sbjct: 142 LEIC------IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
Query: 175 -LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRIL 214
LS GT Y PE K +D++S GVVL+ +L
Sbjct: 196 HLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVL 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-22
Identities = 69/300 (23%), Positives = 120/300 (40%), Gaps = 61/300 (20%)
Query: 11 YISKLGEGAYGNVY------LVSDKRSETLK-ACKAYDFKRLKRDYMEK----FAPREID 59
LGEG +G V + DK E + A K LK D EK E++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM-----LKDDATEKDLSDLV-SEME 138
Query: 60 ILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHY-------ISKACNENIHENQA 111
++ + H NII + LY+I++YA K +L Y + + +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 112 RIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRT 171
++ + + + +++A +EYL +HRD+ N+L++ K+ADFG +R +
Sbjct: 199 QMTFKDL---VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 172 PKELSNTFCGTTSYA------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPG 224
+ + TT+ APE + + Y + +D+WS GV+++ I P+ PG
Sbjct: 256 ----IDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY--PG 308
Query: 225 TRNRDVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
++ K +EG N Y + M + P RP K +
Sbjct: 309 IPVEELFKLLKEGHRMDKPANCTNELYMM----------MRDCWHAVPSQRPTFKQLVED 358
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 36/215 (16%)
Query: 10 SYISKLGEGAYGNVY--LVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP 67
S + LG G +G VY ++D +K K + + + E++++ H
Sbjct: 33 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ-----TEVEMISMAVHR 87
Query: 68 N--------IIGVHRM-VKAGTYLYMIMDYAEKKDLEHYISKACNENIHEN-QARIWIRQ 117
N + R+ V Y YM + + + + R I
Sbjct: 88 NLLRLRGFCMTPTERLLV----YPYM-----ANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 118 -IANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE-L 175
A L YLH+ + I+HRD+K NIL+ A + DFG ++L+ +
Sbjct: 139 GSARGLAYLHDHCD-------PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191
Query: 176 SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVL 210
+ GT + APE + + K D++ GV+L
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVML 225
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 61/296 (20%), Positives = 114/296 (38%), Gaps = 54/296 (18%)
Query: 10 SYISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDI 60
+ LG GA+G V + + + A K LK E+ I
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-----LKSTAHADEKEALM-SELKI 102
Query: 61 LLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIA 119
+ + H NI+ + G + +I +Y DL +++ + + + + A A
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-RRKSRVLETDPAFAIANSTA 161
Query: 120 NALEYLH---EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS 176
+ + LH ++A + +L +HRD+ N+L++ AK+ DFG +R +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN----D 217
Query: 177 NTFCGTTS------YAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTR-NR 228
+ + + + APE I + Y + +D+WS G++L+ I + P+ PG N
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPY--PGILVNS 274
Query: 229 DVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
K ++G + Y I M P HRP + + +
Sbjct: 275 KFYKLVKDGYQMAQPAFAPKNIYSI----------MQACWALEPTHRPTFQQICSF 320
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 72/298 (24%), Positives = 119/298 (39%), Gaps = 55/298 (18%)
Query: 10 SYISKLGEGAYGNVY------LVSDKRSETLK-ACKAYDFKRLKRDYMEK----FAPREI 58
LGEGA+G V L DK + K A K LK D EK E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-----LKSDATEKDLSDLI-SEM 125
Query: 59 DILLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYI----SKACNENIHENQARI 113
+++ + H NII + LY+I++YA K +L Y+ + + +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 114 WIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK 173
+ + +++A +EYL +HRD+ N+L++ K+ADFG +R +
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-- 243
Query: 174 ELSNTFCGTTSYA------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTR 226
+ + TT+ APE + + Y + +D+WS GV+L+ I P+ PG
Sbjct: 244 --IDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY--PGVP 298
Query: 227 NRDVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKDVQNH 275
++ K +EG N Y + M + P RP K +
Sbjct: 299 VEELFKLLKEGHRMDKPSNCTNELYMM----------MRDCWHAVPSQRPTFKQLVED 346
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-21
Identities = 66/304 (21%), Positives = 119/304 (39%), Gaps = 61/304 (20%)
Query: 10 SYISKLGEGAYGNVYL-----VSDKRSETLKACKAYDFKRLKRDYMEK----FAPREIDI 60
+ LG GA+G V +S A K LK E+ +
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-----LKEKADSSEREALM-SELKM 101
Query: 61 LLKV-SHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYI-----SKACNENIHENQARIW 114
+ ++ SH NI+ + +Y+I +Y DL +Y+ + +E +ENQ R+
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 115 IRQIANALEYL------HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168
+ N L + +++A +E+L VHRD+ N+L++ K+ DFG +R
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 169 LRTPKELSNTFCGTTSYA------APEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFG 221
+ + + + + APE + Y K +D+WS G++L+ I + P+
Sbjct: 222 IMS----DSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPY- 275
Query: 222 DPG-TRNRDVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHRPNAKD 271
PG + + K Q G Y Y I M + + RP+ +
Sbjct: 276 -PGIPVDANFYKLIQNGFKMDQPFYATEEIYII----------MQSCWAFDSRKRPSFPN 324
Query: 272 VQNH 275
+ +
Sbjct: 325 LTSF 328
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 57/331 (17%), Positives = 102/331 (30%), Gaps = 82/331 (24%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +G+G++G V D + A K R ++ + + A EI IL + +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMV---RNEKRFHRQ-AAEEIRILEHLRKQDKDN 157
Query: 72 VHRMVKAGTY------LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
++ + M + +L I K + R + I L+ L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNA--KLADFGFSRLLRTPKELSNTFCGTT 183
H+ I+H D+K ENIL+ + + K+ DFG S + T+ +
Sbjct: 217 HKN----------RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QRVYTYIQSR 263
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLY-------------------RIL---------- 214
Y APE+I + Y + D+WSLG +L ++
Sbjct: 264 FYRAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322
Query: 215 -----NKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQ---------------- 253
K G + + N +
Sbjct: 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382
Query: 254 -----LIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+ + LE +P R H W++
Sbjct: 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 31/242 (12%)
Query: 5 DILECSY--ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-RDYMEKFAPREIDIL 61
+ Y S +G+G++G V D+ + A K +K + A E+ +L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKI-----IKNKKAFLNQAQIEVRLL 104
Query: 62 LKVSHPNIIGVHRMVKAGTY------LYMIMDYAEKKDLEHYISKACNENIHENQARIWI 115
++ + + +V + L ++ + +L + + N R +
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFA 163
Query: 116 RQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA--KLADFGFSRLLRTPK 173
+Q+ AL +L E+ I+H D+K ENIL+ + K+ DFG S L
Sbjct: 164 QQMCTALLFLAT--------PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--- 212
Query: 174 ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233
+ + + Y +PE++ PY+ + D+WSLG +L + + F G D + K
Sbjct: 213 QRIYQYIQSRFYRSPEVLLGMPYDLAI-DMWSLGCILVEMHTGEPLF--SGANEVDQMNK 269
Query: 234 QE 235
Sbjct: 270 IV 271
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 53/247 (21%), Positives = 89/247 (36%), Gaps = 34/247 (13%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGV 72
K+G G++G +YL ++ ++ A K + K E I + I V
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----LYESKIYRILQGGTGIPNV 68
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
G Y ++MD LE C+ + + L ++ N +
Sbjct: 69 RWFGVEGDYNVLVMDL-LGPSLEDLF-NFCSRKL----------SLKTVLMLADQMINRV 116
Query: 133 EYLHEVGIVHRDIKCENILISRLLNAK---LADFGFSRLLRTPKELS-------NTFCGT 182
E++H +HRDIK +N L+ A + DFG ++ R GT
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
YA+ + + D+ SLG VL L P+ + K++ E +
Sbjct: 177 ARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPW-----QGLKAGTKKQKYEKISE 230
Query: 243 RKYEISI 249
+K SI
Sbjct: 231 KKVATSI 237
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 44/219 (20%), Positives = 77/219 (35%), Gaps = 33/219 (15%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G G++G++YL +D + A K E I + +G+
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLE-----CVKTKHPQLHIESKIYKMMQ--GGVGIP 68
Query: 74 RMVKAGT---YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ G Y M+M+ LE + C+ + L ++ +
Sbjct: 69 TIRWCGAEGDYNVMVMEL-LGPSLEDLFNF-CSRKF----------SLKTVLLLADQMIS 116
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAK---LADFGFSRLLRTPKELS-------NTFC 180
+EY+H +HRD+K +N L+ + DFG ++ R +
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP 219
GT YA+ + + D+ SLG VL P
Sbjct: 177 GTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLP 214
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 62/341 (18%), Positives = 111/341 (32%), Gaps = 93/341 (27%)
Query: 12 ISKLGEGAYGNVYLVSD-KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
+ LGEGA+G V D K A K + Y E A EI +L ++ +
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEA-ARSEIQVLEHLNTTDPN 74
Query: 71 GVHRMVKAGTY------LYMIMDYAEK--KDLEHYISKACNENIHENQARIWIRQIANAL 122
R V+ + + ++ E +I + + IR++A
Sbjct: 75 STFRCVQMLEWFEHHGHICIVF---ELLGLSTYDFIKENGFLPFRLDH----IRKMA--- 124
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL------- 175
++I ++ +LH + H D+K ENIL + + + R RT
Sbjct: 125 ---YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 176 -SNTFCGTTSYA--------APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD---P 223
S T+ APE+I ++ D+WS+G +L +Y G P
Sbjct: 182 GSATYDDEHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILI-----EYYLGFTVFP 235
Query: 224 GTRNRDVLKKQEG---------------KEYLFNRKYEISIGAKQ--------------- 253
+++ L E ++Y + + + +
Sbjct: 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295
Query: 254 ------------LIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
LI +MLE +P R ++ H +
Sbjct: 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 40/201 (19%), Positives = 68/201 (33%), Gaps = 38/201 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD----------YMEKFAPREIDIL 61
+G+G +G +YL SE++ + K D Y P +I
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 62 LKVSHPNIIGVHRMV-------KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIW 114
++ +GV + +Y +MIMD DL+ +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG-SDLQKIYEA-NAKRFSRKT---- 153
Query: 115 IRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK--LADFGFSRLLRTP 172
+ Q++ I + LEY+HE VH DIK N+L++ + L D+G +
Sbjct: 154 VLQLSL------RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 173 KELS-------NTFCGTTSYA 186
GT +
Sbjct: 208 GVHKAYAADPKRCHDGTIEFT 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 65/334 (19%), Positives = 112/334 (33%), Gaps = 79/334 (23%)
Query: 12 ISKLGEGAYGNVYLVSD-KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
+ LGEG +G V D R ++ A K R Y E A EI++L K+ +
Sbjct: 24 VGNLGEGTFGKVVECLDHARGKSQVALKII---RNVGKYREA-ARLEINVLKKIKEKDKE 79
Query: 71 GVHRMVKAGTYLY------MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
V + + + K + ++ + + +R +A
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPH----VRHMA----- 129
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL--------S 176
+++ +AL +LHE + H D+K ENIL L + S ++ K S
Sbjct: 130 -YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 177 NTFCGTTSYA--------APEIIRNSPYNPKLADIWSLGVVLY----------------- 211
TF PE+I + D+WS+G +L+
Sbjct: 189 ATFDHEHHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREH 247
Query: 212 -----RIL------------NKKYPFGDPGTR---NRDVLKKQEGKEYLFNRKYEISIGA 251
+IL +KY + + D +E + L + + S+
Sbjct: 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307
Query: 252 KQ---LIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
Q L+ RMLE +P R + H +
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 29/200 (14%), Positives = 69/200 (34%), Gaps = 36/200 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK------------RDYMEKFAPREID 59
S G +Y + + T + LK + P +++
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 60 ILLKVSHPNIIGVHRMVKAGT----YLYMIMDYAEKKDLEHYISKACNENIHENQARIWI 115
K+ ++ + + G Y ++++ + L+ + +++ ++ +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL-DVSPKHVLSERS---V 161
Query: 116 RQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK--LADFGFSRLLRTPK 173
Q+A + +ALE+LHE VH ++ ENI + ++ LA +GF+
Sbjct: 162 LQVAC------RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 174 E-------LSNTFCGTTSYA 186
+ + G +
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 40/223 (17%), Positives = 75/223 (33%), Gaps = 39/223 (17%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
++GEG++G ++ ++ + A K R E + G+
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFE-----PRRSDAPQLRDEYRTYKLL--AGCTGIP 69
Query: 74 RMVKAGT---YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQ--IANALEYLHEI 128
+ G + +++D LE + C R+ + ++
Sbjct: 70 NVYYFGQEGLHNVLVIDL-LGPSLEDLL-DLCG------------RKFSVKTVAMAAKQM 115
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAK-----LADFGFSRLLRTPKELS------- 176
++ +HE +V+RDIK +N LI R + + DFG + R P
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 177 NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP 219
GT Y + + + D+ +LG V L P
Sbjct: 176 KNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLP 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 48/242 (19%), Positives = 88/242 (36%), Gaps = 27/242 (11%)
Query: 40 YDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYIS 99
+ R KR+ + + + I V + + + E +S
Sbjct: 115 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174
Query: 100 KACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159
E + + + Y ++A +E+L +HRD+ NIL+S K
Sbjct: 175 D-VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233
Query: 160 LADFGFSRLLRTPKELSNTFCGT--TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK- 216
+ DFG +R + + + APE I + Y + +D+WS GV+L+ I +
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLG 292
Query: 217 KYPFGDPG-TRNRDVLKK-QEGK-----EYLFNRKYEISIGAKQLIGRMLE---PNPKHR 266
P+ PG + + ++ +EG +Y Y+ ML+ P R
Sbjct: 293 ASPY--PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT----------MLDCWHGEPSQR 340
Query: 267 PN 268
P
Sbjct: 341 PT 342
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 37/199 (18%), Positives = 65/199 (32%), Gaps = 37/199 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK--------RDYMEKFAPREIDILLK 63
K+G G +G +YL A + + + Y I ++
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 64 VSHPNIIGVHRMV-------KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIR 116
+ +G+ K +Y +M+M+ DL+ N ++ +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLG-IDLQKISG--QNGTFKKST----VL 154
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK--LADFGFSRLLRTPKE 174
Q+ + + LEY+HE VH DIK N+L+ + LAD+G S
Sbjct: 155 QLGI------RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 175 L-------SNTFCGTTSYA 186
GT +
Sbjct: 209 HKQYQENPRKGHNGTIEFT 227
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 41/223 (18%), Positives = 77/223 (34%), Gaps = 39/223 (17%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
K+G G +G + L + + A K K E ++ + G+
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQL-----HLEYRFYKQL--GSGDGIP 68
Query: 74 RMVKAGT---YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQ--IANALEYLHEI 128
++ G Y M+++ LE C+ R + L ++
Sbjct: 69 QVYYFGPCGKYNAMVLEL-LGPSLEDLF-DLCD------------RTFSLKTVLMIAIQL 114
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAK-----LADFGFSRLLRTPKELS------- 176
+ +EY+H +++RD+K EN LI R N + DF ++ P+
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 177 NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP 219
+ GT Y + + + D+ +LG + L P
Sbjct: 175 KSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLP 216
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 38/234 (16%), Positives = 67/234 (28%), Gaps = 81/234 (34%)
Query: 115 IRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE 174
I+ EI AL YL ++ + H D+K ENIL+ K +
Sbjct: 139 IKLYC------IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192
Query: 175 L--------------SNTFCGTTSYA--------APEIIRNSPYNPKLADIWSLGVVLY- 211
+ TF + APE+I N ++ D+WS G VL
Sbjct: 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAE 251
Query: 212 ------------------------------------RILNKKYPFGDPGTRNRDVLKKQE 235
+ KY ++ L E
Sbjct: 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKY-----VNKDELKLAWPE 306
Query: 236 GKEYLFNRKYEISIGAKQ----------LIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+ + K+ + +L+ +P RP+ ++ H +++
Sbjct: 307 NASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 1e-10
Identities = 28/204 (13%), Positives = 54/204 (26%), Gaps = 56/204 (27%)
Query: 12 ISKLGEGAYGNVYLVSDK---------RSETLKACKAYDFKRLKRDYMEKFAPREIDILL 62
K+GEG +G V+ E K + E +E+ +L
Sbjct: 25 CEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 63 KVSHPNIIGVHRMVKA---------------------------------GTYLYMIMDYA 89
G + L++++++
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 90 EK-KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCE 148
DLE +K + A+ + Q+ +L + HRD+
Sbjct: 145 FGGIDLEQMRTKLSS----LATAKSILHQLTASLAVAE---------ASLRFEHRDLHWG 191
Query: 149 NILISRLLNAKLADFGFSRLLRTP 172
N+L+ + KL + P
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 3e-06
Identities = 54/376 (14%), Positives = 111/376 (29%), Gaps = 112/376 (29%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEK-FAPREIDILLKVSHPNIIGV 72
+ GE Y ++S + +D K ++ D + + EID ++
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDN---FDCKDVQ-DMPKSILSKEEIDHIIMSKDA----- 60
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWI-RQIANALEYLHEIANA 131
V L+ + +++ ++ ++ + N ++ I E
Sbjct: 61 ---VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK------FLMSPIKT--EQRQPSMMT 109
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL-----LRTP-KEL-SNTF----- 179
Y+ + ++ D N A + SRL LR EL
Sbjct: 110 RMYIEQRDRLYND------------NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 180 ---CGTTSYAAPEIIRNSPYNPKLAD--IW-SLGVV------------LYRILNKKY--- 218
G T A ++ + K+ W +L L ++ +
Sbjct: 158 VLGSGKTWVAL-DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 219 PFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
+ R + E + L ++ YE + L+ L +VQN A
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCL----LV---LL----------NVQN-AKA 258
Query: 279 QN--EPTCQTM--TAEEREALKIGKLKSKVFMQKYTVVQALTSSNNVDVTEENKEKKYPD 334
N +C+ + T R V L+++ ++ ++
Sbjct: 259 WNAFNLSCKILLTT---RFK---------------QVTDFLSAATTTHISLDHHSMTLTP 300
Query: 335 SGESVSDQSILVRKLG 350
E S+L++ L
Sbjct: 301 D-EVK---SLLLKYLD 312
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 5e-05
Identities = 44/298 (14%), Positives = 91/298 (30%), Gaps = 79/298 (26%)
Query: 20 YGNVYLVSDKRSETLKACKAYDFKRLKRDYM----EKFAPREI----------DILLKVS 65
Y +L+S ++E + +RD + + FA + LL++
Sbjct: 91 YK--FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR 148
Query: 66 HPNIIGVHRMVKAG-TYL--YMIMDYAEKKDLE---HYIS-KACN--ENIHENQARIWIR 116
+ + ++ +G T++ + + Y + ++ +++ K CN E + E ++ +
Sbjct: 149 PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL------NAKLAD-FGFS-RL 168
N +N +H + R + + LL NAK + F S ++
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI 268
Query: 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR 228
L T T R ++ D S + L+ +
Sbjct: 269 LLT------T-------------RFK----QVTDFLSAATTTHISLDH----------HS 295
Query: 229 DVLKKQEGKEYLFNRKYEISIG-----AKQ-------LIGRMLEPNPKHRPNAKDVQN 274
L E K L + + +I + N K V
Sbjct: 296 MTLTPDEVKS-LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 8e-04
Identities = 56/371 (15%), Positives = 114/371 (30%), Gaps = 100/371 (26%)
Query: 43 KRLKRDYMEKFAPREIDILLKVSHPNII----------------GVHRMVKAGTYLYMIM 86
L+R K + +LL V + V + A T ++ +
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291
Query: 87 DYA----EKKDLEHYISK------------ACN----------ENIHENQARI--W---- 114
D+ +++ + K E+I + A W
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351
Query: 115 ----IRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-----------LNAK 159
I ++L L E A + + + IL+S + + K
Sbjct: 352 CDKLTTIIESSLNVL-EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVL---YRILNK 216
L +S + + PKE + + P I KL + ++L + Y I K
Sbjct: 411 LHK--YSLVEKQPKES--------TISIPSIYLE--LKVKLENEYALHRSIVDHYNIP-K 457
Query: 217 KYPFGDPGTRNRDV---------LKK--QEGKEYLFNRKY-EIS-IGAK-QLIGRMLEPN 262
+ D D LK + LF + + + K + +
Sbjct: 458 TFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNAS 517
Query: 263 PKHRPNAKDVQNH-AWIQ-NEPTCQTMTAEEREALKIGKLKSKVFMQKYT-VVQ-ALTSS 318
+ ++ + +I N+P + + + L K++ + KYT +++ AL +
Sbjct: 518 GSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLP--KIEENLICSKYTDLLRIALMAE 575
Query: 319 NNVDVTEENKE 329
+ E +K+
Sbjct: 576 DEAIFEEAHKQ 586
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.04 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.79 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.42 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.27 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.92 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.75 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.74 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.68 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.58 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.47 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.15 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.01 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.67 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.41 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.35 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-68 Score=478.13 Aligned_cols=261 Identities=26% Similarity=0.492 Sum_probs=227.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++++.||+|+||+||+|.++.+|+.||+|++...........+.+.+|+.+|++|+|||||++++++++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999876655444455667999999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
||||+||+|.+++.+ .+.+++..++. |+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 111 mEy~~gG~L~~~i~~--~~~l~e~~~~~----------~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 111 LSYAKNGELLKYIRK--IGSFDETCTRF----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp ECCCTTEEHHHHHHH--HSSCCHHHHHH----------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 999999999999987 57788877654 567788888899999999999999999999999999999999
Q ss_pred cccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 166 SRLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 166 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+.+.... ....+.+|||.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+ ..+....+....+.++.
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~p~ 255 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGN--EGLIFAKIIKLEYDFPE 255 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCT
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCc
Confidence 99875432 34567899999999999999888765 999999999999999999997654 45566666555555543
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHH------HhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKD------VQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e------ll~hp~~~~~~~ 283 (351)
.+|+++++||.+||++||++|||+.| |++||||++..+
T Consensus 256 --~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 256 --KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp --TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred --ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 68999999999999999999999988 588999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-68 Score=484.46 Aligned_cols=264 Identities=29% Similarity=0.529 Sum_probs=221.3
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
|..+.+|++++.||+|+||+||+|.++.+|+.||||++......... ...+.+|+.+|++|+|||||++++++++++.+
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE-REESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHH-HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 56678999999999999999999999999999999999876655443 34556999999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|||||||+||+|.++|.......+++..++ .|+.||+.||+|||++||+||||||+||||+.++.+||+|
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~----------~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~D 168 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQIL----------DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGD 168 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHH----------HHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECS
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcc
Confidence 999999999999999987555666776544 4677888888899999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
||+|+..........+.+||+.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+ ..+.+..+....+ .+
T Consensus 169 FGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~~-~~ 244 (350)
T 4b9d_A 169 FGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGS--MKNLVLKIISGSF-PP 244 (350)
T ss_dssp TTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCC-CC
T ss_pred cccceeecCCcccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCC-CC
Confidence 9999987655445567789999999999999888865 999999999999999999997654 3444444433332 23
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.+..+|+++++||.+||++||++|||+.|+|+||||+..
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 345789999999999999999999999999999999754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-67 Score=477.48 Aligned_cols=257 Identities=26% Similarity=0.461 Sum_probs=222.6
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|+++++||+|+||+||+|.++.+|+.||||++....... .+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4999999999999999999999999999999997654433 3445699999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
||+||+|.+++.. ..+++..++. |+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus 152 y~~gg~L~~~l~~---~~l~e~~~~~----------~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 152 FLEGGALTDIVTH---TRMNEEQIAA----------VCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHHH----------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCCcHHHHHHc---CCCCHHHHHH----------HHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCce
Confidence 9999999999975 5677766544 67788888899999999999999999999999999999999999
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-cccccccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG-KEYLFNRKYE 246 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 246 (351)
.+........+.+||+.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+ ..+.+..+.. ..+..+....
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~~~~~~ 295 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLKNLHK 295 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCCCSCGGG
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCCCcccc
Confidence 88766666778899999999999998888765 999999999999999999997654 3344443332 2333444557
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
+|+++++||.+||++||++|||+.|+|+||||+....
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 9999999999999999999999999999999986543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-67 Score=465.32 Aligned_cols=258 Identities=34% Similarity=0.577 Sum_probs=207.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|++++.||+|+||+||+|.++.+|+.||+|++.............+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876665555556677999999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||| +|+|.+++.+ .+.+++..++. ++.||+.||+|||++||+||||||+|||++.++++||+|||+
T Consensus 92 mEy~-~g~L~~~l~~--~~~l~e~~~~~----------~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ--RDKMSEQEARR----------FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp EECC-CEEHHHHHHH--SCSCCHHHHHH----------HHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred EeCC-CCCHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCC
Confidence 9999 6899999987 57788876554 667788888899999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
|+..... ....+.+||+.|||||++.+..++..++||||+||++|+|++|+.||.+.+ .......+....+.++ .
T Consensus 159 a~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~~~~i~~~~~~~p--~ 233 (275)
T 3hyh_A 159 SNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVLFKNISNGVYTLP--K 233 (275)
T ss_dssp C----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCC--T
T ss_pred CeecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCCCC--C
Confidence 9875433 334567899999999999998887666999999999999999999997644 4455555554444443 3
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.+|+++++||.+||++||++|||++|+++||||+..
T Consensus 234 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 234 FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 689999999999999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-66 Score=480.37 Aligned_cols=257 Identities=26% Similarity=0.462 Sum_probs=222.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|+++++||+|+||.||+|.++.+|+.||||++....... .+.+.+|+.+|+.|+|||||+++++|.+++.+|||||
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 4999999999999999999999999999999997654333 3456699999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
||+||+|.++++. ..+++..++ .++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+
T Consensus 229 y~~gG~L~~~i~~---~~l~e~~~~----------~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 229 FLEGGALTDIVTH---TRMNEEQIA----------AVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred CCCCCcHHHHHhc---cCCCHHHHH----------HHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccce
Confidence 9999999999975 567776654 467788888999999999999999999999999999999999999
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-cccccccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG-KEYLFNRKYE 246 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 246 (351)
.+........+.+||+.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+ ....+..+.. ..........
T Consensus 296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~~~~~~ 372 (423)
T 4fie_A 296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLKNLHK 372 (423)
T ss_dssp ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSCTTS
T ss_pred ECCCCCccccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCCccccc
Confidence 88766666778899999999999999888865 999999999999999999997654 3344443332 2233444557
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
+|+++++||.+||+.||++|||+.|+|+||||+....
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 9999999999999999999999999999999986543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-66 Score=466.44 Aligned_cols=261 Identities=30% Similarity=0.494 Sum_probs=215.5
Q ss_pred CccceeeeeecCcccceEEEEEEec---CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
+..+|++++.||+|+||+||+|.+. .+++.||+|++......... ...+.+|+.+|++++|||||++++++++++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 4568999999999999999999874 56889999999765543322 2234589999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
+|||||||+||+|.+++.+ .+.+++..++. ++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 101 ~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~----------~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~ 168 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSK--EVMFTEEDVKF----------YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLT 168 (304)
T ss_dssp EEEEECCCTTCEEHHHHHH--HCCCCHHHHHH----------HHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEE
T ss_pred EEEEEEcCCCCCHHHHHHh--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEec
Confidence 9999999999999999987 56788876554 67788888889999999999999999999999999999
Q ss_pred eccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
|||+|+..........+.+||+.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+ ..+....+....+.+
T Consensus 169 DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~~~~ 245 (304)
T 3ubd_A 169 DFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKD--RKETMTMILKAKLGM 245 (304)
T ss_dssp SSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCC
T ss_pred ccccceeccCCCccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcC--HHHHHHHHHcCCCCC
Confidence 99999876655556677899999999999999988865 999999999999999999997654 445555554444443
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEPT 283 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 283 (351)
+ ..+|+++++||.+||++||++||| ++|+++||||++..+
T Consensus 246 p--~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 246 P--QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp C--TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred C--CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 3 468999999999999999999998 579999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-65 Score=451.67 Aligned_cols=254 Identities=21% Similarity=0.416 Sum_probs=210.5
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe----CCEEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA----GTYLYM 84 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~~l 84 (351)
|++.++||+|+||+||+|.++.++..||+|++......... .+.+.+|+.+|++|+|||||++++++.+ +..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH-HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH-HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 47788899999999999999999999999999766655443 3456699999999999999999999865 456899
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEcC-CCCeEEe
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILISR-LLNAKLA 161 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~~-~~~~kl~ 161 (351)
|||||+||+|.+++.+ ...+++..++ .++.||+.||+|||++| |+||||||+|||++. ++.+||+
T Consensus 107 vmEy~~gg~L~~~l~~--~~~l~~~~~~----------~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR--FKVMKIKVLR----------SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEE
Confidence 9999999999999987 5677776544 46778888899999998 999999999999985 7899999
Q ss_pred eccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
|||+|+.... ....+.+|||.|||||++.+ .|+.+ +|||||||++|+|++|++||.+... .......+.......
T Consensus 175 DFGla~~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~~i~~~~~~~ 249 (290)
T 3fpq_A 175 DLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVKPA 249 (290)
T ss_dssp CTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTTCCCG
T ss_pred eCcCCEeCCC--CccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCc-HHHHHHHHHcCCCCC
Confidence 9999986433 34456789999999999875 56654 9999999999999999999976442 233333443333333
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
..+..+++++++||.+||++||++|||+.|+|+||||+.
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 334468899999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-64 Score=455.04 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=211.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
++..|++.++||+|+||.||+|.++.+|+.||||++..+... .+|+.+|+.|+|||||++++++.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 345689999999999999999999999999999999754332 279999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC-CeEEeec
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL-NAKLADF 163 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~-~~kl~Df 163 (351)
|||||+||+|.+++++ .+.+++..+. .|+.||+.||+|||++||+||||||+||||+.++ .+||+||
T Consensus 128 vmEy~~gg~L~~~l~~--~~~l~e~~~~----------~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DF 195 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQ--MGCLPEDRAL----------YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 195 (336)
T ss_dssp EECCCTTCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCC
T ss_pred EEeccCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeC
Confidence 9999999999999987 5678876654 4677888889999999999999999999999887 6999999
Q ss_pred cccccccCCcc-----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 164 GFSRLLRTPKE-----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 164 g~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|+|+.+..... .....+||+.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+... ....+....
T Consensus 196 Gla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~~~~ 272 (336)
T 4g3f_A 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKIASEP 272 (336)
T ss_dssp TTCEEC------------CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHHHHSC
T ss_pred CCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHHcCC
Confidence 99987654322 1234689999999999999888875 999999999999999999997655332 222222222
Q ss_pred -ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHH-------------hcCccccCC
Q psy6327 239 -YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV-------------QNHAWIQNE 281 (351)
Q Consensus 239 -~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el-------------l~hp~~~~~ 281 (351)
.....+..+|+++.+||.+||++||++|||+.|+ ++|||+...
T Consensus 273 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 2223445799999999999999999999999997 579999754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-62 Score=439.53 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=197.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-----
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT----- 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----- 80 (351)
+.+|++++.||+|+||+||+|.++.+|+.||+|++..... ....+.+.+|+.+|++|+|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 4679999999999999999999999999999999865442 223445669999999999999999999986543
Q ss_pred -------EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 81 -------YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 81 -------~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
.+|+|||||+||+|.+++.. ...+++... ..++.++.||+.||+|||++||+||||||+|||++
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~--~~~~~~~~~-------~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~ 152 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERER-------SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHT--CCSGGGSCH-------HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHh--cCCCChhHH-------HHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC
Confidence 47999999999999999976 333333211 12446788999999999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCcc------------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy6327 154 RLLNAKLADFGFSRLLRTPKE------------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFG 221 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (351)
.++.+||+|||+|+....... ...+.+||+.|||||++.+..|+.+ +|||||||++|+|++ ||.
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCC
Confidence 999999999999987654322 1234689999999999999888865 999999999999996 775
Q ss_pred CCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 222 DPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.... ............+ .+.....++.+.+||.+||++||++|||+.|+++||||++..
T Consensus 229 ~~~~-~~~~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 229 TQME-RVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp SHHH-HHHHHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred CccH-HHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 3211 1112222222211 122234677889999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-61 Score=447.53 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=210.4
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe------CCE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA------GTY 81 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------~~~ 81 (351)
+|++++.||+|+||+||+|.++.+|+.||||++......... .+.+.+|+.+|+.|+|||||++++++.. .+.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN-AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH-HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH-HHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 599999999999999999999999999999999755443333 3445589999999999999999999754 367
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
+|||||||+ |+|.+++.+ .+.+++..++. |+.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~----------~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~ 200 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS--SQPLTLEHVRY----------FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIG 200 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS--SSCCCHHHHHH----------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeCCC-CCHHHHHHh--cCCCCHHHHHH----------HHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEe
Confidence 999999996 789999976 57788876554 67788888889999999999999999999999999999
Q ss_pred eccccccccCC----cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc
Q psy6327 162 DFGFSRLLRTP----KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 162 Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
|||+|+.+... .....+.+||+.|||||++.+..+...++||||+||++|+|++|++||.+.+ ..+.+..+...
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~~l~~I~~~ 278 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVHQLQLIMMV 278 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHHHHHHHHHh
Confidence 99999876433 2234567999999999999887665556999999999999999999997654 23333222110
Q ss_pred ccc------------------------cc-----ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 238 EYL------------------------FN-----RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 238 ~~~------------------------~~-----~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
... .+ ....+|++++|||.+||++||++|||+.|+|+||||+...
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 000 00 0124789999999999999999999999999999998643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-61 Score=463.62 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=218.0
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHH---HHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
..+.+|++++.||+|+||.||+|.++.+|+.||+|++.............+. +++.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4578899999999999999999999999999999999876654332222222 4467777889999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.+|||||||+||+|.++|.+ .+.+++..++. |+.||+.||+|||++||+||||||+||||+.+|++||
T Consensus 266 ~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~----------y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ--HGVFSEADMRF----------YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HCCCCHHHHHH----------HHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEe
Confidence 99999999999999999987 57788877655 6677888888999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHhhhCcc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLKKQEGKE 238 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~ 238 (351)
+|||+|+.+... ...+.+|||.|||||++..+ .|+. ++|+|||||++|+|++|.+||.+.+.... .....+....
T Consensus 334 ~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~-~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~ 410 (689)
T 3v5w_A 334 SDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410 (689)
T ss_dssp CCCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC
T ss_pred cccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Confidence 999999876543 34567999999999999754 5555 59999999999999999999976543332 2333333333
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEPT 283 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 283 (351)
+.+ +..+|+++++||.+||+.||.+|++ ++||++||||++..+
T Consensus 411 ~~~--p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 411 VEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp CCC--CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred CCC--CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 333 3479999999999999999999998 799999999987543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-60 Score=437.43 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=202.9
Q ss_pred CCCccc-eeeeeecCcccceEEEEEEec---CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEE
Q psy6327 3 FPDILE-CSYISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVK 77 (351)
Q Consensus 3 ~~~~~~-~~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~ 77 (351)
+|.+.+ |++.++||+|+||+||+|.++ .+++.||+|.+...... ..+.+|+++|+.+ +|||||++++++.
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-----IRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH-----HHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH-----HHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 466655 999999999999999999875 46889999988544321 2345899999998 6999999999999
Q ss_pred eCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-C
Q psy6327 78 AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-L 156 (351)
Q Consensus 78 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~-~ 156 (351)
+.+++|+|||||+||+|.+++. .+++..++ .++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~----------~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~ 155 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-----SLSFQEVR----------EYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK 155 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-----TCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT
T ss_pred ECCEEEEEEeCCCcccHHHHHc-----CCCHHHHH----------HHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC
Confidence 9999999999999999999984 36665544 467788889999999999999999999999876 7
Q ss_pred CeEEeeccccccccCCc----------------------------ccccccccccceeccccccCCCCCCCcchHHHHHH
Q psy6327 157 NAKLADFGFSRLLRTPK----------------------------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGV 208 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 208 (351)
.+||+|||+|+...... ....+.+||+.|+|||++.+.+....++||||+||
T Consensus 156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 99999999998654321 11234689999999999988765455699999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHhhh--------------------------------------Cc-------------
Q psy6327 209 VLYRILNKKYPFGDPGTRNRDVLKKQE--------------------------------------GK------------- 237 (351)
Q Consensus 209 il~~ll~g~~pf~~~~~~~~~~~~~~~--------------------------------------~~------------- 237 (351)
++|+|++|+.||..... ..+.+..+. ..
T Consensus 236 il~ell~G~~Pf~~~~~-~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~ 314 (361)
T 4f9c_A 236 IFLSLLSGRYPFYKASD-DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQG 314 (361)
T ss_dssp HHHHHHHTCSSSSCCSS-HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------
T ss_pred HHHHHHHCCCCCCCCCC-HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccc
Confidence 99999999999964332 111111100 00
Q ss_pred -cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 238 -EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 238 -~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.........+|++++|||.+||++||++|||++|+|+||||++.
T Consensus 315 ~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 315 HATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp -------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 00011223588999999999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-59 Score=453.30 Aligned_cols=260 Identities=24% Similarity=0.432 Sum_probs=221.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|++++.||+|+||.||+|.++.+|+.||+|++....... ...+.+|+.+|+.|+|||||+++++|.+.+.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999986544332 34556899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC--CCeEEeec
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL--LNAKLADF 163 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~--~~~kl~Df 163 (351)
||||+||+|.++|... ...+++..++. |+.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 233 ~E~~~gg~L~~~i~~~-~~~l~e~~~~~----------~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 233 YEFMSGGELFEKVADE-HNKMSEDEAVE----------YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp EECCCCCBHHHHHTCT-TSCEEHHHHHH----------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EeecCCCcHHHHHHHh-CCCCCHHHHHH----------HHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeec
Confidence 9999999999999642 45677766544 67788888899999999999999999999854 88999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc-
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN- 242 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 242 (351)
|+|+.+... ......+||+.|||||++.+..|+.+ +|||||||++|+|++|.+||.+.+ ..+.+..+....+.++
T Consensus 302 G~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~--~~~~~~~i~~~~~~~~~ 377 (573)
T 3uto_A 302 GLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMDD 377 (573)
T ss_dssp SSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTTCCCCCS
T ss_pred cceeEccCC-CceeeeEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHhCCCCCCc
Confidence 999987543 33456789999999999999988765 999999999999999999997654 5556666555544433
Q ss_pred -ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 243 -RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 243 -~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
....+|+++++||.+||+.||.+|||+.|+|+||||+...+
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 33478999999999999999999999999999999986543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-59 Score=416.83 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=194.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.++++.++||+|+||+||+|.+.. .+|||++......... .+.+.+|+.+|++++|||||++++++.+ +.+||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQ-FQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHH-HHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHH-HHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 568899999999999999998753 4899998654443333 3456699999999999999999998865 4589999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|||+||+|.+++... ...+++.. ++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 111 Ey~~gGsL~~~l~~~-~~~l~~~~----------~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ-ETKFQMFQ----------LIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp ECCSSCBHHHHHHTS-CCCCCHHH----------HHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EcCCCCCHHHHHhhc-CCCCCHHH----------HHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence 999999999999753 34566544 4457889999999999999999999999999999999999999999
Q ss_pred ccccCCc--ccccccccccceeccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc--
Q psy6327 167 RLLRTPK--ELSNTFCGTTSYAAPEIIRNS---PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY-- 239 (351)
Q Consensus 167 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-- 239 (351)
+...... ......+||+.|||||++.+. +|+.+ +|||||||++|||+||+.||.+.+. ...........+
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k-sDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~~~~~~~~~~~ 256 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ-SDVYSYGIVLYELMTGELPYSHINN--RDQIIFMVGRGYAS 256 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHTTCCC
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcH-HHhHhHHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCC
Confidence 8764322 234567899999999998643 45554 9999999999999999999976542 222222211111
Q ss_pred --cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 240 --LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 240 --~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
....+..+|+++.+|+.+||+.||++|||+.|+++
T Consensus 257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11233468999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=418.84 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=206.4
Q ss_pred cceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|.+.++||+|+||+||+|.+. .++..||||++.... ....+.+.+|+.+|++|+|||||++++++.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 46999999999999999999864 468899999986432 2224456699999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhc-----------cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCE
Q psy6327 82 LYMIMDYAEKKDLEHYISKAC-----------NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENI 150 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~-----------~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NI 150 (351)
+|||||||+||+|.+++.+.. ...+++.. ++.++.||+.||+|||+++|+||||||+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~----------~~~i~~qia~gl~yLH~~~iiHRDlKp~NI 159 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQ----------MLHIAQQIAAGMVYLASQHFVHRDLATRNC 159 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHH----------HHHHHHHHHHHHHHHHhCCcccCccCHhhE
Confidence 999999999999999997632 23455543 456788999999999999999999999999
Q ss_pred eEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCc
Q psy6327 151 LISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRN 227 (351)
Q Consensus 151 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 227 (351)
|++.++.+||+|||+|+....... .....+||+.|||||++.+..++.+ +|||||||++|||+| |+.||.+.+ .
T Consensus 160 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~--~ 236 (299)
T 4asz_A 160 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLS--N 236 (299)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSC--H
T ss_pred EECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCC--H
Confidence 999999999999999987654332 2334579999999999999998875 999999999999998 999997654 4
Q ss_pred hHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 228 RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
.+....+.... ..+.+..+|+++.+|+.+||+.||++|||+.++ ++|++
T Consensus 237 ~~~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 237 NEVIECITQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred HHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 44444443322 233445799999999999999999999999999 45554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-59 Score=417.99 Aligned_cols=254 Identities=23% Similarity=0.386 Sum_probs=208.7
Q ss_pred ccceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
..+++++++||+|+||+||+|... .+++.||||.+..... ....+.+.+|+.+|++|+|||||++++++.+++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC--C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC--hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 457899999999999999999853 4678999999864432 222345669999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhc--------------cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKAC--------------NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIK 146 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlk 146 (351)
.+|||||||++|+|.++|.... ...+++. .++.++.||+.||+|||+++|+|||||
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~----------~~~~i~~qia~gl~yLH~~~iiHRDLK 172 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP----------DFVHLVAQIAAGMEYLSSHHVVHKDLA 172 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHH----------HHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHH----------HHHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999996532 1234433 345678899999999999999999999
Q ss_pred CCCEeEcCCCCeEEeeccccccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy6327 147 CENILISRLLNAKLADFGFSRLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDP 223 (351)
Q Consensus 147 p~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 223 (351)
|+|||+++++.+||+|||+|+...... ......+||+.|||||++.+..++.+ +|||||||++|||+| |..||.+.
T Consensus 173 ~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred ccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998765432 23445689999999999999998876 999999999999998 89999765
Q ss_pred CCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 224 GTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
+ ..+....+.... ..+.+..+|.++.+|+.+||+.||++|||+.||+++
T Consensus 252 ~--~~~~~~~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 252 S--NQDVVEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp C--HHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C--HHHHHHHHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4 455555544332 344556899999999999999999999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=419.62 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=199.5
Q ss_pred cceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|.+.++||+|+||+||+|.++ .+++.||||++.... ....+.+.+|+.+|++|+|||||++++++.+.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 46889999999999999999864 468999999986432 2224456799999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhcc-------------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCC
Q psy6327 82 LYMIMDYAEKKDLEHYISKACN-------------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCE 148 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~-------------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~ 148 (351)
+|||||||++|+|.+++.+... .++++ ..++.++.||+.||+|||+++|+||||||+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~----------~~~~~i~~qia~gl~yLH~~~iiHRDLKp~ 187 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL----------GQLLAVASQVAAGMVYLAGLHFVHRDLATR 187 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCH----------HHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCH----------HHHHHHHHHHHHHHHHHhcCCeecccccHh
Confidence 9999999999999999976321 12333 345568899999999999999999999999
Q ss_pred CEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCC
Q psy6327 149 NILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGT 225 (351)
Q Consensus 149 NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 225 (351)
|||++.++.+||+|||+|+....... .....+||+.|||||++.+..++.+ +|||||||++|||+| |+.||.+.+
T Consensus 188 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~- 265 (329)
T 4aoj_A 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLS- 265 (329)
T ss_dssp GEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSC-
T ss_pred hEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCC-
Confidence 99999999999999999987644332 2345679999999999999988865 999999999999999 999997654
Q ss_pred CchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 226 RNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..+....+... ...+.+..+|+++.+|+.+||+.||++|||+.|++++
T Consensus 266 -~~~~~~~i~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 266 -NTEAIDCITQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp -HHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred -HHHHHHHHHcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44444443322 2234445799999999999999999999999999764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=417.52 Aligned_cols=264 Identities=21% Similarity=0.320 Sum_probs=206.0
Q ss_pred cceeeeeecCcccceEEEEEEecCC-----ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC-CCceeeeeEEEe-C
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS-----ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH-PNIIGVHRMVKA-G 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~-~ 79 (351)
.+|++.+.||+|+||+||+|.+..+ ++.||+|.+........ .+.+.+|+.+|+++.| ||||++++++.+ +
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~--~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHH--HHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 4689999999999999999987654 46899998865433222 3445689999999965 999999999865 4
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHH----HHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQAR----IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~----~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
+.+|||||||++|+|.++|++......+..... ........++.++.||+.||+|||+++|+||||||+|||++++
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 678999999999999999976433211110000 0001123456688899999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q psy6327 156 LNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 232 (351)
+.+||+|||+|+.+..... .....+||+.|||||++.+..|+.+ +|||||||++|||+| |..||.+.... .....
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~-~~~~~ 299 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKID-EEFCR 299 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHH
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHH-HHHHH
Confidence 9999999999997654332 3345689999999999999988875 999999999999998 99999875532 22322
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
... ....++.+..+++++.+|+.+||+.||++|||+.||++|
T Consensus 300 ~i~-~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH-cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 222 223334445789999999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=402.58 Aligned_cols=260 Identities=30% Similarity=0.566 Sum_probs=221.6
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
+.+.+|++++.||+|+||.||+|.+..+|+.||+|++.......... ..+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHH-HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHH-HHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 45678999999999999999999999999999999997665544333 34558999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++||+|.+++.. ...+++..+. .++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 91 lv~e~~~~~~L~~~l~~--~~~l~~~~~~----------~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVA--HGRMKEKEAR----------SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp EEECCCTTCBHHHHHHH--HCCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECST
T ss_pred EEEECCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeec
Confidence 99999999999999977 4567766544 46778888899999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++..... ......+||+.|+|||++.+..++..++||||+||++|+|++|+.||.+.+ ............+..+
T Consensus 159 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~p- 234 (328)
T 3fe3_A 159 GFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--LKELRERVLRGKYRIP- 234 (328)
T ss_dssp TCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCC-
T ss_pred cCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCC-
Confidence 999876543 334567899999999999988887656999999999999999999997654 3444444444443333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..++.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 235 -~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 235 -FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp -TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred -CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 3689999999999999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=400.96 Aligned_cols=262 Identities=29% Similarity=0.484 Sum_probs=222.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++++.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 46789999999999999999999999999999999976544332223445589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||++||+|.+++.. ...+++..++ .++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 83 v~E~~~gg~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR--ERVFTEERAR----------FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp EEECCTTCBHHHHHHH--HSCCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeecc
Confidence 9999999999999976 4567766544 467788888999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+++............+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+ .......+......++
T Consensus 151 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~p-- 225 (337)
T 1o6l_A 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILMEEIRFP-- 225 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCC--
T ss_pred chhhcccCCCcccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCC--
Confidence 99875555555667889999999999998888765 999999999999999999997644 3344444433333333
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEPT 283 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 283 (351)
..+++++++||.+||+.||++|| ++.++++||||++..+
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 36899999999999999999999 8999999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=406.07 Aligned_cols=262 Identities=29% Similarity=0.483 Sum_probs=217.3
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 83 (351)
.+.+|++++.||+|+||.||+|.++.+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 457899999999999999999999999999999999776544433344556899999998 6999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++||+|.+++.. ...+++..++. ++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 101 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~----------~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK--SRRFDEARARF----------YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHH----------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccc
Confidence 99999999999999987 46677766544 6778888889999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++............+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+ ..+....+......++
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~~~~~p- 244 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILNDEVVYP- 244 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCC-
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCC-
Confidence 999875555555667889999999999988887765 999999999999999999997654 4455555554444444
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNA------KDVQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~hp~~~~~~~ 283 (351)
..++.++.+||.+||+.||.+||++ .++++||||++..+
T Consensus 245 -~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 245 -TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred -CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 3689999999999999999999998 89999999987644
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-55 Score=392.10 Aligned_cols=263 Identities=25% Similarity=0.437 Sum_probs=220.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++..++..|+||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46999999999999999999999999999999987655433 234558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++||+|.+++.. ..+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~----------~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE---TCMDEGQIA----------AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp ECCTTCBHHHHHHH---SCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ECCCCCCHHHHHhh---cCCCHHHHH----------HHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999975 346655433 46778888999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
.............+||+.|+|||++.+..++.+ +|||||||++|+|++|..||....... ...............+..
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (297)
T 3fxz_A 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEK 241 (297)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCCCSCGGG
T ss_pred eecCCcccccCCccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCCccc
Confidence 887666555667789999999999998888765 999999999999999999997654221 111111222223344557
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccccC
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTM 287 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 287 (351)
++..+.+||.+||+.||++|||+.|+++||||+........
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~ 282 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSL 282 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGG
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCccccc
Confidence 89999999999999999999999999999999876554443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-55 Score=405.23 Aligned_cols=264 Identities=28% Similarity=0.539 Sum_probs=220.3
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 83 (351)
.+.+|++++.||+|+||.||+|.++.+++.||+|++.............+.+|..++.++ +||||+++++++.+.+.+|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 467899999999999999999999999999999999877665554455566899999887 7999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++||+|..++.+ ...+++..++. ++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 130 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~----------~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR--QRKLPEEHARF----------YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHH----------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEcCCCCcHHHHHHH--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeec
Confidence 99999999999999987 46677766554 6778888888999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-------chHHHHhhhC
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR-------NRDVLKKQEG 236 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~ 236 (351)
|+++............+||+.|+|||++.+..++.. +|||||||++|+|++|..||...... .......+..
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 999875555556677899999999999998888765 99999999999999999999643211 1122333333
Q ss_pred ccccccccccCCHhHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCcc
Q psy6327 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNA------KDVQNHAWIQNEPT 283 (351)
Q Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~hp~~~~~~~ 283 (351)
....++ ..++.++++||.+||+.||.+||++ .|+++||||++..+
T Consensus 277 ~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 277 KQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp CCCCCC--TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred cccCCC--CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 333333 3689999999999999999999985 79999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=395.61 Aligned_cols=267 Identities=28% Similarity=0.520 Sum_probs=223.0
Q ss_pred CCCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 2 KFPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 2 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.-..+.+|++++.||+|+||.||+|.++.+++.||+|++.............+.+|+.+++++ +||||+++++++.+.+
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 345678899999999999999999999999999999999876655544455566899999988 7999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.+|+||||++||+|.+++.. ...+++..++ .++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL 151 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQR--QRKLPEEHAR----------FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKL 151 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEE
Confidence 99999999999999999976 4567776544 46778888899999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-------chHHHHh
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR-------NRDVLKK 233 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~ 233 (351)
+|||+++............+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||...... .......
T Consensus 152 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 152 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp CCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred EeccccccccCCCCcccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 999999875544555667789999999999998888765 99999999999999999999653211 1122233
Q ss_pred hhCccccccccccCCHhHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCcc
Q psy6327 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNA------KDVQNHAWIQNEPT 283 (351)
Q Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~hp~~~~~~~ 283 (351)
+......++ ..++.++++||.+||+.||.+||++ .++++||||++..+
T Consensus 231 i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 231 ILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp HHHCCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred HHcCCCCCC--CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 333333333 3689999999999999999999995 79999999987644
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-55 Score=399.08 Aligned_cols=262 Identities=28% Similarity=0.445 Sum_probs=220.5
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 83 (351)
.+.+|++.+.||+|+||.||+|.++.+++.||+|++.............+.+|..++..+ +||||+++++++.+.+.+|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 467899999999999999999999999999999999766543222233445899999877 8999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++||+|.+++.. ...+++..+. .++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 95 lv~E~~~gg~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS--CHKFDLSRAT----------FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEC
Confidence 99999999999999986 4567765544 46778888999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++............+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+ .......+......++
T Consensus 163 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~p- 238 (345)
T 1xjd_A 163 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMDNPFYP- 238 (345)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCC-
T ss_pred hhhhhcccCCCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHhCCCCCC-
Confidence 999875544445667889999999999998888765 999999999999999999997654 3444444443333333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHH-HHhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAK-DVQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~-ell~hp~~~~~~~ 283 (351)
..++.++++||.+||+.||++||++. ++++||||++..+
T Consensus 239 -~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 239 -RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred -cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 36899999999999999999999998 9999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=391.41 Aligned_cols=259 Identities=30% Similarity=0.518 Sum_probs=220.0
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++++.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 46789999999999999999999999999999999976554332233445689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||++||+|.+++.. ...+++..++ .++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 84 v~e~~~gg~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK--SQRFPNPVAK----------FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp EECCCCSCBHHHHHHH--TSSCCHHHHH----------HHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEeCCCCCCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecC
Confidence 9999999999999986 4567766544 467788889999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+++.... .....+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+ .......+......++
T Consensus 152 ~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~p-- 223 (318)
T 1fot_A 152 FAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSN--TMKTYEKILNAELRFP-- 223 (318)
T ss_dssp SCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHCCCCCC--
T ss_pred cceecCC---ccccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCC--
Confidence 9987543 2346689999999999998888766 999999999999999999997654 3344444443333333
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEPT 283 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 283 (351)
..++.++++||.+||+.||.+|| +++++++||||++..+
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 36899999999999999999999 8999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=393.61 Aligned_cols=266 Identities=29% Similarity=0.537 Sum_probs=220.3
Q ss_pred CCCCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 1 MKFPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 1 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
|..|-+.+|++++.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+++
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 78899999999999999999999999999999999999986554322 2345669999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+||||++||+|.+++.. ...+++.... .++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~----------~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 146 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQ----------RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKI 146 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBT--TTBCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred eEEEEEEcCCCCcHHHHHhh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEE
Confidence 99999999999999999975 4556665543 46778888899999999999999999999999999999
Q ss_pred eeccccccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 161 ADFGFSRLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 161 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
+|||+++...... ......+||+.|+|||++.+..+...++|||||||++|+|++|..||............... ..
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~ 225 (323)
T 3tki_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KK 225 (323)
T ss_dssp CCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT-TC
T ss_pred EEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-cc
Confidence 9999998654322 23346789999999999988877555699999999999999999999876544333333322 23
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
...+....++..+.+||.+||+.||++|||+.|+++||||+..
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 3333345789999999999999999999999999999999754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-54 Score=406.61 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=218.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.++.+|+.+|+|++......... ...+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHH-HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHH-HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 3599999999999999999999999999999999776654433 344569999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc---CCCCeEEeec
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS---RLLNAKLADF 163 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~---~~~~~kl~Df 163 (351)
|||+||+|.+++.. ...+++..+. .++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 90 E~~~gg~L~~~i~~--~~~~~e~~~~----------~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 90 DLVTGGELFEDIVA--REYYSEADAS----------HCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp CCCBCCBHHHHHHH--CSCCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred EeCCCCCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccC
Confidence 99999999999987 4667776544 4677888889999999999999999999998 4578999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc-
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN- 242 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 242 (351)
|+++............+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+.+ .......+....+.++
T Consensus 158 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 158 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDED--QHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp SSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCCCCT
T ss_pred ceeEEecCCCceeecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhCCCCCCc
Confidence 999887665555567789999999999988888765 999999999999999999997654 4444444444443333
Q ss_pred -ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 243 -RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 243 -~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
....+++++++||.+||+.||++|||+.|+|+||||+.
T Consensus 235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 33478999999999999999999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=396.06 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=221.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 83 (351)
.+.+|++++.||+|+||.||+|.++.+++.||+|++.............+.+|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 467899999999999999999999999999999999776543332234455899999988 7999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++||+|.+++.. ...+++..++ .++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DF 165 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAV----------FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 165 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeC
Confidence 99999999999999986 4567766544 46778888899999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++............+||+.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+ .......+......++
T Consensus 166 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~~~~~p- 241 (353)
T 2i0e_A 166 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEHNVAYP- 241 (353)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCC-
T ss_pred CcccccccCCcccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCC--HHHHHHHHHhCCCCCC-
Confidence 999875544455667889999999999998888765 999999999999999999997644 4445555444444433
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 283 (351)
..+|.++++||.+||+.||.+||+ +.++++||||++..+
T Consensus 242 -~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 242 -KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp -TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred -CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 378999999999999999999995 699999999987543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=395.97 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=217.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH---HHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD---YMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.|++.+.||+|+||.||+|.++.+|+.||+|++........ .....+.+|+.++++++||||+++++++.+....|+
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 49999999999999999999999999999999976544321 112345689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC----CeEE
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL----NAKL 160 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~----~~kl 160 (351)
||||++||+|.+++.. ...+++..+. .++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 93 v~e~~~gg~L~~~l~~--~~~l~~~~~~----------~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 93 ILELVSGGELFDFLAQ--KESLSEEEAT----------SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp EEECCCSCBHHHHHTT--CSCCBHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEcCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 9999999999999976 4567776544 4677888889999999999999999999998876 7999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
+|||+++..... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+ .......+....+.
T Consensus 161 ~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~ 236 (361)
T 2yab_A 161 IDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDT--KQETLANITAVSYD 236 (361)
T ss_dssp CCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTTCCC
T ss_pred EecCCceEcCCC-CccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCC
Confidence 999999876543 23456679999999999988887765 999999999999999999997654 44555555544444
Q ss_pred ccc--cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 241 FNR--KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 241 ~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
++. ...+|.++++||.+||..||.+|||+.|+++||||+...
T Consensus 237 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 237 FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 332 347899999999999999999999999999999998643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=396.39 Aligned_cols=260 Identities=33% Similarity=0.562 Sum_probs=217.8
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
..+.+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+..+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34678999999999999999999999999999999997665544433455679999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+ +|+|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 lv~E~~-~g~l~~~l~~--~~~l~~~~~~----------~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVE--KKRMTEDEGR----------RFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp EEECCC-CEEHHHHHHH--HCSCCHHHHH----------HHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCS
T ss_pred EEEECC-CCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEe
Confidence 999999 6899999876 4567766544 46778888889999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|++...... ......+||+.|+|||++.+..+...++|||||||++|+|++|..||.+... ...........+. .
T Consensus 153 G~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~--~ 227 (336)
T 3h4j_B 153 GLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI--PNLFKKVNSCVYV--M 227 (336)
T ss_dssp SCTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS--TTCBCCCCSSCCC--C
T ss_pred ccceeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH--HHHHHHHHcCCCC--C
Confidence 999876543 3345668999999999999888755569999999999999999999976542 2222222222222 2
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
+..+|+++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 33689999999999999999999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=404.54 Aligned_cols=263 Identities=28% Similarity=0.449 Sum_probs=220.4
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
...+|++++.||+|+||.||+|.++.+++.||+|++.............+.+|+.+++.++||||+++++++.+...+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 35689999999999999999999999999999999976554333334456689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||||+||+|.+++.. ..+++..++ .++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 147 V~E~~~gg~L~~~l~~---~~~~e~~~~----------~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN---YDVPEKWAR----------FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp EECCCTTEEHHHHHHH---CCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEeCCCCCcHHHHHHc---CCCCHHHHH----------HHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999975 456765544 367788888999999999999999999999999999999999
Q ss_pred ccccccCCcc-cccccccccceeccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc--
Q psy6327 165 FSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSP----YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK-- 237 (351)
Q Consensus 165 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-- 237 (351)
+++....... ...+.+||+.|+|||++.+.. ++. ++|||||||++|+|++|..||.+.+ .......+...
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~-~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR-ECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIMNHKN 290 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEET-HHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTHHH
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCC-cceEecchHHHHHHHhCCCCCCCCC--hhhHHHHHHhccc
Confidence 9987654432 345678999999999997655 444 4999999999999999999997654 34444444332
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCcc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~~ 283 (351)
...++....+|.++++||.+||+.+|.+ ||++.||++||||++..+
T Consensus 291 ~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 291 SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 2344555579999999999999999998 999999999999998655
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=392.94 Aligned_cols=260 Identities=28% Similarity=0.459 Sum_probs=221.0
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
..+.+|++++.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45788999999999999999999999999999999997665433333344568999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++||+|.+++.+ ...+++..++ .++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 118 lv~e~~~gg~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRR--IGRFSEPHAR----------FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp EEEECCTTCBHHHHHHH--HCCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEcCCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccc
Confidence 99999999999999987 4567766544 46778888899999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++..... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+ .......+......++
T Consensus 186 g~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~p- 258 (350)
T 1rdq_E 186 GFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKVRFP- 258 (350)
T ss_dssp TTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCC-
T ss_pred ccceeccCC---cccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCC--HHHHHHHHHcCCCCCC-
Confidence 999876432 345689999999999998887765 999999999999999999997644 3444444443433333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 283 (351)
..++.++.+||.+||+.||.+||+ +.++++||||++..+
T Consensus 259 -~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 368999999999999999999998 999999999987644
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=389.60 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=187.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC----EE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT----YL 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----~~ 82 (351)
.+|.+.++||+|+||+||+|.+ +|+.||||++....... ...+.|+..+.+++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~----~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhh----HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688999999999999999987 58999999986543322 22335777778899999999999997653 68
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC--------CceeccCCCCCEeEcC
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV--------GIVHRDIKCENILISR 154 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~--------~i~H~Dlkp~NIll~~ 154 (351)
|||||||+||+|.++++. ..++... ++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 77 ~lV~Ey~~~gsL~~~l~~---~~l~~~~----------~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~ 143 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR---YTVTVEG----------MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp EEEEECCTTCBHHHHHHH---CCBCHHH----------HHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred EEEecCCCCCcHHHHHHh---CCCCHHH----------HHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC
Confidence 999999999999999975 3455443 345778899999999987 9999999999999999
Q ss_pred CCCeEEeeccccccccCCccc----ccccccccceeccccccCCC------CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy6327 155 LLNAKLADFGFSRLLRTPKEL----SNTFCGTTSYAAPEIIRNSP------YNPKLADIWSLGVVLYRILNKKYPFGDPG 224 (351)
Q Consensus 155 ~~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (351)
++++||+|||+|+........ ....+||+.|||||++.+.. ++. ++|||||||++|||+||.+||....
T Consensus 144 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~-k~DVwS~Gvvl~El~tg~~~~~~~~ 222 (303)
T 3hmm_A 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHH-HHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred CCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccCh-hHhhhhHHHHHHHHHHCCCCCCccc
Confidence 999999999999876544322 23468999999999987653 333 4899999999999999988764322
Q ss_pred CC-------------chHHHHhhhCccc--ccccc---ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 225 TR-------------NRDVLKKQEGKEY--LFNRK---YEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 225 ~~-------------~~~~~~~~~~~~~--~~~~~---~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.. ............. ..+.. ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 223 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 10 1112222222211 11111 1234578899999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=392.78 Aligned_cols=263 Identities=24% Similarity=0.436 Sum_probs=218.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 35679999999999999999999999999999999976654433334455689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+.||+|.+++.. ...+++..++ .++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 93 v~e~~~gg~L~~~l~~--~~~l~~~~~~----------~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQ--NVHFKEETVK----------LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp EECCCTTEEHHHHHHT--TCCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccc
Confidence 9999999999999986 5567776544 367788888999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHhhhCcccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRN---SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLKKQEGKEYL 240 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~ 240 (351)
+++..... ......+||+.|+|||++.. ..++.. +|||||||++|+|++|..||........ ...........
T Consensus 161 ~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~- 237 (384)
T 4fr4_A 161 IAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV- 237 (384)
T ss_dssp TCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC-
T ss_pred eeeeccCC-CceeccCCCccccCCeeeccCCCCCCCcc-ceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc-
Confidence 99876433 34456789999999999864 345554 9999999999999999999976543332 22233322222
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCC-HHHHhcCccccCCcc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPN-AKDVQNHAWIQNEPT 283 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~ell~hp~~~~~~~ 283 (351)
..+..++.++.+||.+||+.||.+||+ ++++++||||++..+
T Consensus 238 -~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 238 -TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred -CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 233468999999999999999999998 899999999986543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=390.43 Aligned_cols=257 Identities=30% Similarity=0.490 Sum_probs=215.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|+||.||+|.++.+++.||+|++......... ...+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 599999999999999999999999999999999776554433 3345689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC---CCeEEeecc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL---LNAKLADFG 164 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~---~~~kl~Dfg 164 (351)
|+.||+|.+++.. ...+++.... .++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 109 ~~~gg~L~~~l~~--~~~~~~~~~~----------~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 109 LVTGGELFEDIVA--REFYSEADAS----------HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp CCCSCBHHHHHTT--CSCCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred cCCCCCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence 9999999999976 4556665543 467788889999999999999999999999864 459999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc--
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN-- 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 242 (351)
++....... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+ .......+....+.++
T Consensus 177 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~ 252 (362)
T 2bdw_A 177 LAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPSP 252 (362)
T ss_dssp TCBCCTTCC-SCCCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCTT
T ss_pred cceEecCCc-ccccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCcc
Confidence 998765432 3345689999999999988887765 999999999999999999997654 3344444433333332
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
....+++++++||.+||+.||++|||+.++|+||||+..
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 334689999999999999999999999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=379.46 Aligned_cols=262 Identities=24% Similarity=0.437 Sum_probs=209.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|++++.||+|+||+||+|.+..+++.||+|++......... ...+.+|+.++++++||||+++++++.+++..++|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH-HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc-chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 46899999999999999999999999999999999765543332 23445899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++ ++|.+.+... ...+++..+. .++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~e~~~-~~l~~~~~~~-~~~l~~~~~~----------~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 80 FEFCD-QDLKKYFDSC-NGDLDPEIVK----------SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EECCS-EEHHHHHHHT-TTCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCC-CCHHHHHHhC-CCCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 99998 5666666542 4566765544 4677888889999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---c-----
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---K----- 237 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~----- 237 (351)
++............+||+.|+|||++.+......++||||+||++|+|++|..||..... .......+.. .
T Consensus 148 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-~~~~~~~i~~~~~~~~~~~ 226 (292)
T 3o0g_A 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTT
T ss_pred ceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHHhCCCChhh
Confidence 988766555566778999999999998776444559999999999999998888643322 2222221100 0
Q ss_pred -------------------cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 238 -------------------EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 238 -------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.........++.++++||.+||+.||++|||+.|+++||||++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 00001112578999999999999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=394.66 Aligned_cols=262 Identities=30% Similarity=0.505 Sum_probs=213.4
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHH-HHhCCCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDI-LLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
.+.+|++++.||+|+||.||+|.++.+++.||+|++.............+.+|..+ ++.++||||+++++++.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 45789999999999999999999999999999999987665444334444467776 56789999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++||+|.+++.+ ...+++..++ .++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 116 lv~E~~~gg~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR--ERCFLEPRAR----------FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999976 4567766544 36778888999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++............+||+.|+|||++.+..++.. +|+|||||++|+|++|..||...+ ..+....+......++
T Consensus 184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~~~~~~- 259 (373)
T 2r5t_A 184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNILNKPLQLK- 259 (373)
T ss_dssp CBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSB--HHHHHHHHHHSCCCCC-
T ss_pred ccccccccCCCccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcccCCC-
Confidence 999875554555667889999999999998887765 999999999999999999997644 3444444443333333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNA----KDVQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~hp~~~~~~~ 283 (351)
..++.++++||.+||+.||.+||++ .++++||||++..+
T Consensus 260 -~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 260 -PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp -SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred -CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 4689999999999999999999996 69999999987644
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=400.63 Aligned_cols=264 Identities=28% Similarity=0.435 Sum_probs=218.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|+++++||+|+||.||+|.++.+++.||+|++.............+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999999765544433344567899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
||||+||+|.+++.+. ...+++..++. ++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 153 ~Ey~~gg~L~~~l~~~-~~~l~e~~~~~----------~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKF-EDRLPEEMARF----------YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp ECCCTTCBHHHHHHTT-TTCCCHHHHHH----------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHHc-cCCCCHHHHHH----------HHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 9999999999999763 35677765544 677888888899999999999999999999999999999999
Q ss_pred cccccCCcc-cccccccccceecccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc-
Q psy6327 166 SRLLRTPKE-LSNTFCGTTSYAAPEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE- 238 (351)
Q Consensus 166 a~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 238 (351)
++....... .....+||+.|+|||++. ...++. ++|||||||++|+|++|+.||.+.+ ..+....+....
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~-~~DvwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP-ECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKE 298 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECT-HHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTHHH
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCC-cCeeHHHHHHHHHHHhCCCCCCCCC--hhHHHHhhhhccc
Confidence 987654333 234568999999999987 345555 4999999999999999999997654 334444443222
Q ss_pred -cccccc-ccCCHhHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCcc
Q psy6327 239 -YLFNRK-YEISIGAKQLIGRMLEPNPKH--RPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 239 -~~~~~~-~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~~ 283 (351)
+.++.. ..+|+++++||.+||+.+|++ |++++|+++||||++..+
T Consensus 299 ~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 299 RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 222222 358999999999999999988 999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=382.48 Aligned_cols=260 Identities=29% Similarity=0.487 Sum_probs=210.0
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH-----------------------HHhhhHHHHHHHH
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD-----------------------YMEKFAPREIDIL 61 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------------------~~~~~~~~Ei~~l 61 (351)
.+.+|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 35689999999999999999999999999999999876543211 1124456899999
Q ss_pred HhCCCCCceeeeeEEEe--CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC
Q psy6327 62 LKVSHPNIIGVHRMVKA--GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG 139 (351)
Q Consensus 62 ~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~ 139 (351)
++++||||+++++++.+ ....|+||||+++++|.+++. ...+++.... .++.|++.||.|||++|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~----------~~~~qi~~~l~~lH~~~ 157 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQAR----------FYFQDLIKGIEYLHYQK 157 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHH----------HHHHHHHHHHHHHHHTT
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHH----------HHHHHHHHHHHHHHHCC
Confidence 99999999999999986 678999999999999988654 3456665543 46778888999999999
Q ss_pred ceeccCCCCCEeEcCCCCeEEeeccccccccCCcccccccccccceeccccccCCCC--CCCcchHHHHHHHHHHHHhCC
Q psy6327 140 IVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPY--NPKLADIWSLGVVLYRILNKK 217 (351)
Q Consensus 140 i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~ 217 (351)
|+||||||+|||++.++.+||+|||+++............+||+.|+|||++.+... ...++|||||||++|+|++|.
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 999999999999999999999999999887655544556789999999999976553 234589999999999999999
Q ss_pred CCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 218 YPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 218 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
.||.+.. ..............++....+++++.+||.+||+.||++|||+.|+++||||+
T Consensus 238 ~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 238 CPFMDER--IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp CSSCCSS--HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CCCCCcc--HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 9997644 23333333333344444557899999999999999999999999999999995
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=389.43 Aligned_cols=260 Identities=27% Similarity=0.452 Sum_probs=213.7
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH--HHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD--YMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
.|++.+.||+|+||.||+|.++.+++.||+|++........ .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 59999999999999999999999999999999876543221 1133456899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhcc--CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC---eEE
Q psy6327 86 MDYAEKKDLEHYISKACN--ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN---AKL 160 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~---~kl 160 (351)
||||+|++|.+++..... ..+++..+ ..++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~----------~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVA----------SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHH----------HHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEE
Confidence 999999999988865322 23555443 346778889999999999999999999999987654 999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
+|||+++............+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.. ......+....+.
T Consensus 175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~---~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK---ERLFEGIIKGKYK 250 (351)
T ss_dssp CCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSH---HHHHHHHHHTCCC
T ss_pred ecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcH---HHHHHHHHcCCCC
Confidence 999999887665555566789999999999988888765 999999999999999999997632 2333333322222
Q ss_pred cc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 241 FN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 241 ~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.+ ....++.++++||.+||+.||++|||+.++++||||+..
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 22 224689999999999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=380.57 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=204.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|+++++||+|+||+||+|.+. +++.||+|++......... ...+.+|+.++++++||||+++++++.++...++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI-PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CH-HHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchh-hHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 356999999999999999999985 5899999998755433322 33455899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++ ++|.+++... ...+++..+. .++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 98 ~e~~~-~~l~~~~~~~-~~~~~~~~~~----------~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 98 FEFME-KDLKKVLDEN-KTGLQDSQIK----------IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp EECCS-EEHHHHHHTC-TTCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EcCCC-CCHHHHHHhc-cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcC
Confidence 99998 6888888653 3446665543 4677888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH-hhhCccc-----
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK-KQEGKEY----- 239 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~----- 239 (351)
++............+||+.|+|||++.+......++|||||||++|+|++|+.||.+.......... .......
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 9887655555566789999999999877543344599999999999999999999765533221110 0000000
Q ss_pred --------------------cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 240 --------------------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 240 --------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.......+++++.+||.+||++||++|||+.|+++||||++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 0001124688999999999999999999999999999998653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=390.28 Aligned_cols=260 Identities=29% Similarity=0.511 Sum_probs=207.6
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+..+|++++.||+|+||.||+|.+..+++.||+|++....... ..+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4567999999999999999999999999999999986544332 234589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC--eEEee
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN--AKLAD 162 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~--~kl~D 162 (351)
||||++||+|.+++.. ...+++..+. .++.|++.||.|||++||+||||||+|||++.++. +||+|
T Consensus 94 v~e~~~~~~L~~~l~~--~~~~~~~~~~----------~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~D 161 (361)
T 3uc3_A 94 IMEYASGGELYERICN--AGRFSEDEAR----------FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD 161 (361)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECC
T ss_pred EEEeCCCCCHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEee
Confidence 9999999999999976 4567766544 46778888899999999999999999999987665 99999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHhhhCcccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--NRDVLKKQEGKEYL 240 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~ 240 (351)
||+++..... ......+||+.|+|||++.+..++.+++|||||||++|+|++|+.||.+.... ............+.
T Consensus 162 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 240 (361)
T 3uc3_A 162 FGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240 (361)
T ss_dssp CCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC
T ss_pred cCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC
Confidence 9999753322 23345679999999999988887766689999999999999999999765422 22333444445555
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.+....+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 241 IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 56666789999999999999999999999999999999654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=403.00 Aligned_cols=261 Identities=28% Similarity=0.485 Sum_probs=211.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 35679999999999999999999999999999999976654443334445589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
||||++||+|.+++.. ...+++.... .++.||+.||+|||+ +||+||||||+|||++.++.+||+||
T Consensus 226 v~e~~~~~~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR--ERVFSEDRAR----------FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EECCCSSCBHHHHHHH--HSCCCHHHHH----------HHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCC
T ss_pred EEeeCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccC
Confidence 9999999999999976 4566665544 467788889999998 99999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++............+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+ .......+......++
T Consensus 294 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~p- 369 (446)
T 4ejn_A 294 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEEIRFP- 369 (446)
T ss_dssp CCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCC-
T ss_pred CCceeccCCCcccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHHHhCCCCCC-
Confidence 999875555555567889999999999988888765 999999999999999999997654 3444444433333333
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
..+++++.+||.+||+.||.+|| |+.|+++||||++..
T Consensus 370 -~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 370 -RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 36899999999999999999999 999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-53 Score=394.87 Aligned_cols=265 Identities=29% Similarity=0.417 Sum_probs=216.9
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
...+|++++.||+|+||.||+|.++.+|+.||+|++.............+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 35679999999999999999999999999999999976554444344556789999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||++||+|.+++.+. ...+++..++. ++.||+.||+|||++||+||||||+|||++.++++||+|||
T Consensus 139 VmE~~~gg~L~~~l~~~-~~~l~~~~~~~----------~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKF-GERIPAEMARF----------YLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCCHHHHHH----------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEcCCCCCcHHHHHHhc-CCCCCHHHHHH----------HHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999763 34677765443 57788888899999999999999999999999999999999
Q ss_pred ccccccCCcc-cccccccccceeccccccC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC
Q psy6327 165 FSRLLRTPKE-LSNTFCGTTSYAAPEIIRN-------SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 165 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 236 (351)
+++....... .....+||+.|+|||++.. ..++. ++|||||||++|+|++|+.||...+ .......+..
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~ 284 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP-ECDWWALGVFAYEMFYGQTPFYADS--TAETYGKIVH 284 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECT-HHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHT
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCCh-HHhhhHHhHHHHHHHhCCCCCCCCC--HHHHHHHHHh
Confidence 9987654433 2345689999999999873 44555 4999999999999999999997654 3344433332
Q ss_pred cc--cccc-ccccCCHhHHHHHHHhcCCCCCCC---CCHHHHhcCccccCCccc
Q psy6327 237 KE--YLFN-RKYEISIGAKQLIGRMLEPNPKHR---PNAKDVQNHAWIQNEPTC 284 (351)
Q Consensus 237 ~~--~~~~-~~~~~s~~~~~li~~~L~~dp~~R---pt~~ell~hp~~~~~~~~ 284 (351)
.. ..++ ....+|.++++||.+||+ +|.+| |+++|+++||||++..+.
T Consensus 285 ~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 21 1222 124689999999999999 99998 589999999999877653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=385.84 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=214.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ...+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc----HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 4699999999999999999999999999999998654322 234568999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC--CCCeEEeecc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR--LLNAKLADFG 164 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~--~~~~kl~Dfg 164 (351)
|||+||+|.+++... ...+++..+ ..++.|++.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~----------~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 81 EFISGLDIFERINTS-AFELNEREI----------VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp CCCCCCBHHHHHTSS-SCCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EeCCCCCHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 999999999999652 235666544 346778888999999999999999999999987 7899999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc--
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN-- 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 242 (351)
+++...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... .......+....+.++
T Consensus 150 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~ 225 (321)
T 1tki_A 150 QARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFDEE 225 (321)
T ss_dssp TCEECCTTC-EEEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCCCHH
T ss_pred CCeECCCCC-ccccccCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHcCCCCCChh
Confidence 998765432 3345679999999999988777654 999999999999999999997654 3444444433333332
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
....+|.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 234789999999999999999999999999999999865
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=383.41 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=214.4
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH---HHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD---YMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.|++.+.||+|+||.||+|.+..+++.+|+|++........ .....+.+|+.+++.++||||+++++++.+....++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 49999999999999999999999999999999876543221 112345689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC----CeEE
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL----NAKL 160 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~----~~kl 160 (351)
||||++|++|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~----------~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 92 ILELVAGGELFDFLAE--KESLTEEEAT----------EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp EEECCCSCBHHHHHTT--SSCCBHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred EEEcCCCCCHHHHHHh--cCCcCHHHHH----------HHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 9999999999999976 4566765543 4677888899999999999999999999998877 7999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
+|||+++...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... ............+.
T Consensus 160 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 160 IDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDT--KQETLANVSAVNYE 235 (326)
T ss_dssp CCCTTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHTCCC
T ss_pred EECCCCeECCCCC-ccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHHhcCCC
Confidence 9999998765432 2345679999999999988887765 999999999999999999997644 33333333322222
Q ss_pred cc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 241 FN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 241 ~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
++ ....++..+++||.+||+.||++|||+.|+++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 22 2246899999999999999999999999999999998653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=401.22 Aligned_cols=260 Identities=30% Similarity=0.529 Sum_probs=221.0
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|.+.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35679999999999999999999999999999999976654433334456699999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||++||+|.+++.+ ...+++..+. .++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 94 v~E~~~gg~L~~~l~~--~~~l~~~~~~----------~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 94 VMEYVSGGELFDYICK--NGRLDEKESR----------RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEECCSSEEHHHHTTS--SSSCCHHHHH----------HHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEecc
Confidence 9999999999999976 5667776544 467788888999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+++..... ......+||+.|+|||++.+..+...++|||||||++|+|++|..||.+.. .......+....+.. +
T Consensus 162 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~--p 236 (476)
T 2y94_A 162 LSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--VPTLFKKICDGIFYT--P 236 (476)
T ss_dssp SCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--SHHHHHHHHTTCCCC--C
T ss_pred chhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCCcCC--C
Confidence 99876443 334566899999999999988776556999999999999999999997654 344444444443333 3
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 237 ~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 237 QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 4689999999999999999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=387.21 Aligned_cols=268 Identities=20% Similarity=0.327 Sum_probs=214.4
Q ss_pred CCCccceeeeeecCcc--cceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 3 FPDILECSYISKLGEG--AYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
.++..+|++++.||+| +||.||+|.++.+++.||+|++........ ....+.+|+.+++.++||||+++++++.+++
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE-MVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH-HHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 4678889999999999 999999999999999999999977654443 3455668999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+|||||++|+|.+++.......+++..+. .++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~----------~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl 169 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIA----------YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 169 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEE
Confidence 99999999999999999987555667765544 46778888999999999999999999999999999999
Q ss_pred eeccccccccCCc-------ccccccccccceeccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q psy6327 161 ADFGFSRLLRTPK-------ELSNTFCGTTSYAAPEIIRN--SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL 231 (351)
Q Consensus 161 ~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 231 (351)
+|||.+....... ......+||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.........
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 248 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLE 248 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999986543221 12233579999999999987 45665 49999999999999999999976543222111
Q ss_pred HhhhCc-------------------------------------------cccccccccCCHhHHHHHHHhcCCCCCCCCC
Q psy6327 232 KKQEGK-------------------------------------------EYLFNRKYEISIGAKQLIGRMLEPNPKHRPN 268 (351)
Q Consensus 232 ~~~~~~-------------------------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt 268 (351)
..... ....+....+++++.+||.+||+.||++|||
T Consensus 249 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 327 (389)
T 3gni_B 249 -KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327 (389)
T ss_dssp -C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred -HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence 10000 0011122357889999999999999999999
Q ss_pred HHHHhcCccccCCcc
Q psy6327 269 AKDVQNHAWIQNEPT 283 (351)
Q Consensus 269 ~~ell~hp~~~~~~~ 283 (351)
+.|+|+||||+....
T Consensus 328 a~ell~hp~f~~~~~ 342 (389)
T 3gni_B 328 ASTLLNHSFFKQIKR 342 (389)
T ss_dssp HHHHTTSGGGGGC--
T ss_pred HHHHhcCHHHHHHhh
Confidence 999999999986543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=381.05 Aligned_cols=264 Identities=25% Similarity=0.397 Sum_probs=196.1
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
....+|++++.||+|+||.||+|.++.+++.||+|++....... ....+.+|+.++++++||||+++++++.+++..|
T Consensus 2 s~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp -----------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred CcccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 35678999999999999999999999999999999986544221 1234458999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhcc----CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 84 MIMDYAEKKDLEHYISKACN----ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~----~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
+||||++ |+|.+++..... ..+++..+ ..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~----------~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~k 148 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLV----------KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLK 148 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHH----------HHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEE
Confidence 9999998 799999876432 23454443 34677889999999999999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--- 236 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--- 236 (351)
|+|||+++............+||+.|+|||++.+......++|||||||++|+|++|..||.+.. ..+....+..
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~ 226 (317)
T 2pmi_A 149 LGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFDIMG 226 (317)
T ss_dssp ECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHC
T ss_pred ECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhC
Confidence 99999998776554455566899999999999765433345999999999999999999997654 2222211100
Q ss_pred c-------------cc----------------cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 237 K-------------EY----------------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 237 ~-------------~~----------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
. .+ .......++.++.+||.+||+.||++|||+.|+++||||++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0 00 0011125788999999999999999999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=406.21 Aligned_cols=263 Identities=26% Similarity=0.394 Sum_probs=218.9
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
...+|++++.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 34679999999999999999999999999999999977655443334455689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||++||+|.+++.......+++..+. .++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~----------~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFG 331 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAV----------FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLG 331 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHH----------HHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecc
Confidence 9999999999999986444447765544 467788889999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--NRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 242 (351)
+++...... .....+||+.|+|||++.+..++.. +|||||||++|+|++|..||...... .......+......+
T Consensus 332 la~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~- 408 (576)
T 2acx_A 332 LAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY- 408 (576)
T ss_dssp TCEECCTTC-CEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC-
T ss_pred cceecccCc-cccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC-
Confidence 998765432 2345689999999999998887765 99999999999999999999765422 122333332222222
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNE 281 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~ 281 (351)
+..+|.++++||.+||+.||.+|| ++.|+++||||++.
T Consensus 409 -p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 409 -SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred -CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 246899999999999999999999 78999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=404.01 Aligned_cols=265 Identities=26% Similarity=0.395 Sum_probs=220.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|.+++.||+|+||.||+|.++.+|+.||+|++.............+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999999776554433334556899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 86 MDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
|||++||+|.+++.... ...+++..+. .++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~----------~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAI----------FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHH----------HHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeec
Confidence 99999999999997643 2356665543 46778888999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHhhhCccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--NRDVLKKQEGKEYLF 241 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 241 (351)
|+++............+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...... .......+......+
T Consensus 334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~ 412 (543)
T 3c4z_A 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412 (543)
T ss_dssp TTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC
T ss_pred ceeeeccCCCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC
Confidence 999887655544556789999999999998888765 99999999999999999999765421 223333333333323
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEPT 283 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 283 (351)
+..+|.++++||.+||+.||++||+ +.++++||||++..+
T Consensus 413 --p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 413 --PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred --CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 3478999999999999999999996 589999999987543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=381.26 Aligned_cols=260 Identities=30% Similarity=0.459 Sum_probs=205.6
Q ss_pred ccceeeeeecCcccceEEEEEEec---CCceeEEEEecchhhhhh-HHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLKR-DYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
..+|++++.||+|+||.||+|.+. .+++.+|+|++....... ......+.+|+.+++.++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999999985 689999999987654322 1223345589999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.|+||||++|++|.+++.. ...+++.... .++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~----------~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER--EGIFMEDTAC----------FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHh--CCCCCHHHHH----------HHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEE
Confidence 9999999999999999976 4556665443 467788889999999999999999999999999999999
Q ss_pred eccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
|||+++............+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... .......+......+
T Consensus 164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~ 240 (327)
T 3a62_A 164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGEN--RKKTIDKILKCKLNL 240 (327)
T ss_dssp CCSCC----------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCCC
T ss_pred eCCcccccccCCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCC
Confidence 99999865544444566789999999999988877764 999999999999999999997654 334444433333332
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEP 282 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~ 282 (351)
+..++.++++||.+||+.||.+|| ++.++++||||++..
T Consensus 241 --p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 241 --PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp --CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred --CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 346899999999999999999999 889999999998654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=376.61 Aligned_cols=264 Identities=25% Similarity=0.411 Sum_probs=205.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|++++.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP-VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 467999999999999999999999999999999986554333 3344556899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~e~~~~~~l~~~~~~--~~~~~~~~~~----------~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 81 FEYCDHTVLHELDRY--QRGVPEHLVK----------SITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148 (311)
T ss_dssp EECCSEEHHHHHHHT--SSCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEeCCCchHHHHHhh--hcCCCHHHHH----------HHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence 999999999998875 4556665543 4677888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---------
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--------- 236 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--------- 236 (351)
++............+||+.|+|||++.+......++||||+||++|+|++|..||.+... .+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 226 (311)
T 4agu_A 149 ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD--VDQLYLIRKTLGDLIPRH 226 (311)
T ss_dssp CEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHH
T ss_pred chhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhccccccc
Confidence 988765555556678999999999997644434459999999999999999999976542 221111100
Q ss_pred ------ccc----cc----------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccc
Q psy6327 237 ------KEY----LF----------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTC 284 (351)
Q Consensus 237 ------~~~----~~----------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 284 (351)
..+ .. .....++.++.+||.+||+.||++|||+.|+++||||++....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 000 00 0113578899999999999999999999999999999976544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=376.31 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=202.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|++++.||+|+||.||+|.+ .+++.+|+|++........ ....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGC-CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccc-cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 46799999999999999999998 6789999999865543221 123445899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++ ++|.+++... ...+++... ..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~e~~~-~~l~~~~~~~-~~~~~~~~~----------~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 79 FEHLD-QDLKKLLDVC-EGGLESVTA----------KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EECCS-EEHHHHHHTS-TTCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEecC-CCHHHHHHhc-ccCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 99998 5999998753 345665543 34678889999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---c-----
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---K----- 237 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~----- 237 (351)
++............+||+.|+|||++.+......++|||||||++|+|++|..||.... ..+....+.. .
T Consensus 147 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 147 ARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp HHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTT
T ss_pred ccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHCCCChhh
Confidence 98765544444556799999999999765533445999999999999999999997654 2222211100 0
Q ss_pred --------cc--c---------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 238 --------EY--L---------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 238 --------~~--~---------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.+ . ......++.++.+||.+||+.||++|||+.|+++||||++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00 0 00112478999999999999999999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=378.82 Aligned_cols=258 Identities=29% Similarity=0.504 Sum_probs=193.9
Q ss_pred cceeee---eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEE
Q psy6327 7 LECSYI---SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 7 ~~~~~~---~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~ 82 (351)
.+|.+. +.||+|+||.||+|.++.+++.||+|++.... .....+|+.+++.+. ||||+++++++.++...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 347765 78999999999999999999999999986432 223348999999997 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC---CeE
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL---NAK 159 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~---~~k 159 (351)
|+||||++||+|.+++.. ...+++..+. .++.|++.||.|||++||+||||||+|||++.++ .+|
T Consensus 82 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~----------~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~k 149 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKK--KKHFSETEAS----------YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIK 149 (325)
T ss_dssp EEEECCCCSCBHHHHHHH--CSCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEE
T ss_pred EEEEEccCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEE
Confidence 999999999999999987 5667776544 4677888889999999999999999999998765 799
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC-----CchHHHHhh
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGT-----RNRDVLKKQ 234 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~~~~ 234 (351)
|+|||+++............+||+.|+|||++.+..++.+ +|||||||++|+|++|..||..... ...+....+
T Consensus 150 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i 228 (325)
T 3kn6_A 150 IIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228 (325)
T ss_dssp ECCCTTCEECCC----------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH
T ss_pred EeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH
Confidence 9999999876665555567789999999999988888765 9999999999999999999976432 123344444
Q ss_pred hCccccccc--cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 235 EGKEYLFNR--KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 235 ~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
....+.++. ...+++++++||.+||+.||.+|||+.++++||||++...
T Consensus 229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 444433332 2368999999999999999999999999999999987544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=384.70 Aligned_cols=255 Identities=31% Similarity=0.519 Sum_probs=212.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv 85 (351)
.+|++.+.||+|+||.||+|.++.+++.||+|++...... ..+|+.++.++ +||||+++++++.++...|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 4599999999999999999999999999999998654322 22788898888 799999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC----CCeEEe
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL----LNAKLA 161 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~----~~~kl~ 161 (351)
||||+||+|.+++.. ...+++..+. .++.||+.||.|||++||+||||||+|||+.+. +.+||+
T Consensus 95 ~E~~~gg~L~~~i~~--~~~~~~~~~~----------~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 95 TELMKGGELLDKILR--QKFFSEREAS----------AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp ECCCCSCBHHHHHHT--CTTCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred EeCCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEE
Confidence 999999999999976 4567765544 467788888999999999999999999998543 349999
Q ss_pred eccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC-CchHHHHhhhCcccc
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGT-RNRDVLKKQEGKEYL 240 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~ 240 (351)
|||+++............+||+.|+|||++.+..++.+ +|||||||++|+|++|..||..... ...+....+....+.
T Consensus 163 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241 (342)
T ss_dssp CCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred ECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence 99999987665555667789999999999987777654 9999999999999999999976432 233444444433333
Q ss_pred cc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 241 FN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 241 ~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
++ ....+|+++++||.+||+.||++|||+.++++||||.+.
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 33 224689999999999999999999999999999999653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=369.61 Aligned_cols=261 Identities=30% Similarity=0.551 Sum_probs=194.0
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++.+.||+|+||.||+|.+..+++.+|+|.+.............+.+|+.++++++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 46789999999999999999999999999999999976554433334556689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++++|.+++... ...+++... ..++.|++.||.|||++|++|+||||+||+++.++.+||+|||
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~----------~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR-VKPFSENEA----------RHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp EEECCTTEEHHHHHHTC-SSCCCHHHH----------HHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCcHHHHHhhc-cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeec
Confidence 99999999999999753 345666544 3467788889999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
++..............||+.|+|||++.+..++.+ +||||||+++|+|++|..||...... ..........+ ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~--~~~ 232 (278)
T 3cok_A 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVK--NTLNKVVLADY--EMP 232 (278)
T ss_dssp TCEECC----------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC-------CCSSCC--CCC
T ss_pred ceeeccCCCCcceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHH--HHHHHHhhccc--CCc
Confidence 99876654444456679999999999988777765 99999999999999999999765432 22222222222 223
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..++.++.+||.+||+.||++|||+.++++||||+..
T Consensus 233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred cccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 4689999999999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=369.00 Aligned_cols=266 Identities=29% Similarity=0.525 Sum_probs=219.6
Q ss_pred CCCCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 1 MKFPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 1 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
|..|-+.+|++++.||+|+||.||+|.+..+++.+|+|++........ ...+.+|+.+++.++||||+++++++.+++
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTH--HHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhh--hHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 666778899999999999999999999999999999999876543322 344568999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+||||+++++|.+++.. ...+++... ..++.|++.||.|||++|++|+||||+||+++.++.+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~----------~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 146 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEP--DIGMPEPDA----------QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKI 146 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBT--TTBCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEEecCCCcHHHHHhh--ccCCCHHHH----------HHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEE
Confidence 99999999999999999865 345665543 346778889999999999999999999999999999999
Q ss_pred eeccccccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 161 ADFGFSRLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 161 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
+|||.+....... ......+||+.|+|||++.+..+...++||||||+++|+|++|..||.............. ...
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~ 225 (276)
T 2yex_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-EKK 225 (276)
T ss_dssp CCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-TTC
T ss_pred eeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-hcc
Confidence 9999998654322 2234567999999999998877655559999999999999999999987654333332222 222
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
...+....++..+.+||.+||+.||++|||+.|+++||||+..
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 2233344789999999999999999999999999999999865
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=412.08 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=225.0
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 83 (351)
.+.+|++++.||+|+||.||+|.++.+++.||+|++.............+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 357899999999999999999999999999999999765543333344455899999988 6999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++||+|.+++.. ...+++..++ .|+.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DF 486 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAV----------FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 486 (674)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCC
T ss_pred EEEeCcCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeec
Confidence 99999999999999987 4567776544 46778888899999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|+++............+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+ ..+....+......++.
T Consensus 487 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~~p~ 563 (674)
T 3pfq_A 487 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEHNVAYPK 563 (674)
T ss_dssp TTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHSSCCCCCT
T ss_pred ceeeccccCCcccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCC--HHHHHHHHHhCCCCCCc
Confidence 999875555555667889999999999998888765 999999999999999999997654 55666666665555443
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNA-----KDVQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~~ 283 (351)
.++.++++||.+||+.||++||++ +||++||||++..+
T Consensus 564 --~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 564 --SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp --TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred --cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 789999999999999999999997 99999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=381.24 Aligned_cols=262 Identities=28% Similarity=0.405 Sum_probs=200.5
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++++.||+|+||.||+|.+..+++.||+|++......... ...+.+|+.++++++||||+++++++.++...|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV-PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccccc-chhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 466899999999999999999999999999999999765443332 2334489999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc-----CCCCeE
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS-----RLLNAK 159 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~-----~~~~~k 159 (351)
||||++ |+|.+++.. ...+++..+. .++.||+.||.|||++||+||||||+|||++ ..+.+|
T Consensus 111 v~e~~~-~~L~~~~~~--~~~~~~~~~~----------~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK--NPDVSMRVIK----------SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp EEECCS-EEHHHHHHH--CTTCCHHHHH----------HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred EEecCC-CCHHHHHhh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEE
Confidence 999998 699999976 4556665443 4677888899999999999999999999995 445599
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc--
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK-- 237 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-- 237 (351)
|+|||+++............+||+.|+|||++.+......++|||||||++|+|++|..||.... ..+....+...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 178 IGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--EIDQLFKIFEVLG 255 (329)
T ss_dssp ECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHC
T ss_pred ECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--HHHHHHHHHHHhC
Confidence 99999998776555555667789999999999876543445999999999999999999997654 22222211100
Q ss_pred -c--ccc-----------------------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 238 -E--YLF-----------------------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 238 -~--~~~-----------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
. ..+ .....+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 0 000 00112789999999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=375.00 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=213.6
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|...+.||+|+||.||+|.+..+|+.||+|++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 788899999999999999999999999999987544332 23345899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
++|++|.+++.. ..+++... ..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 124 ~~~~~L~~~l~~---~~l~~~~~----------~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 190 (321)
T 2c30_A 124 LQGGALTDIVSQ---VRLNEEQI----------ATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 190 (321)
T ss_dssp CCSCBHHHHHTT---CCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHh---cCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeee
Confidence 999999999864 45665443 34678888999999999999999999999999999999999999987
Q ss_pred ccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh-CccccccccccC
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE-GKEYLFNRKYEI 247 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 247 (351)
...........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... ......... ...........+
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2c30_A 191 ISKDVPKRKSLVGTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRDSPPPKLKNSHKV 267 (321)
T ss_dssp CCSSSCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCCCTTGGGS
T ss_pred cccCccccccccCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCCCCcCccccC
Confidence 7655445566789999999999988887765 999999999999999999997644 223322222 222223334568
Q ss_pred CHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 248 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
++.+.+||.+||+.||++|||+.++++||||....
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 99999999999999999999999999999997643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=370.89 Aligned_cols=258 Identities=33% Similarity=0.560 Sum_probs=214.4
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++.+.||+|+||.||+|.+..++..+|+|++.............+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 46789999999999999999999999999999999977665554445566789999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++++|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~l~~--~~~~~~~~~~----------~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK--LSKFDEQRTA----------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCC
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecc
Confidence 9999999999999976 3556665443 467788889999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
++...... ......||+.|+|||++.+..++.+ +||||||+++|+|++|..||.... .............. .+
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~--~~ 227 (279)
T 3fdn_A 155 WSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANT--YQETYKRISRVEFT--FP 227 (279)
T ss_dssp EESCC----------CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCC--CC
T ss_pred ccccCCcc--cccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCc--HHHHHHHHHhCCCC--CC
Confidence 98654332 2345679999999999988877765 999999999999999999997644 33333333332222 23
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..++.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 3689999999999999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=367.74 Aligned_cols=260 Identities=30% Similarity=0.479 Sum_probs=216.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.+..+++.+|+|++.......... ..+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHH-HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHH-HHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 56999999999999999999999999999999997766544433 44558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC---eEEeec
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN---AKLADF 163 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~---~kl~Df 163 (351)
||++|++|.+.+.. ...+++.... .++.|++.||.|||++||+||||||+||+++.++. +||+||
T Consensus 85 e~~~~~~l~~~~~~--~~~~~~~~~~----------~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Df 152 (284)
T 3kk8_A 85 DLVTGGELFEDIVA--REFYSEADAS----------HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 152 (284)
T ss_dssp CCCCSCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred ecCCCCCHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeec
Confidence 99999999999876 4556665543 46778888999999999999999999999986655 999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc--cc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY--LF 241 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~ 241 (351)
|++....... ......||+.|+|||++.+..++.+ +||||||+++|+|++|..||.+.. ............+ ..
T Consensus 153 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 153 GLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPS 228 (284)
T ss_dssp TTCEECCSSC-BCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCT
T ss_pred eeeEEcccCc-cccCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCc--hhHHHHHHHhccccCCc
Confidence 9998765433 2345679999999999998887765 999999999999999999997654 3333333332222 22
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
+....+++++.+||.+||+.||++|||+.|+++||||++...
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 333478999999999999999999999999999999987544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=385.67 Aligned_cols=258 Identities=25% Similarity=0.451 Sum_probs=213.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|++++.||+|+||.||+|.++.+++.+|+|++....... ...+.+|+.+++.++||||+++++++.+....++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh---HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 45999999999999999999999999999999986543222 234568999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC--CCCeEEeecc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR--LLNAKLADFG 164 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~--~~~~kl~Dfg 164 (351)
||++||+|.+++... ...+++..+ +.++.||+.||.|||++||+||||||+|||++. .+.+||+|||
T Consensus 128 E~~~gg~L~~~l~~~-~~~l~~~~~----------~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 128 EFLSGGELFDRIAAE-DYKMSEAEV----------INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp ECCCCCBHHHHTTCT-TCCBCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EcCCCCcHHHHHHhh-cCCCCHHHH----------HHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecc
Confidence 999999999999752 235666543 356778889999999999999999999999974 4679999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc--c
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF--N 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~ 242 (351)
+++...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.. .......+....+.+ .
T Consensus 197 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~ 272 (387)
T 1kob_A 197 LATKLNPDE-IVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDWEFDED 272 (387)
T ss_dssp TCEECCTTS-CEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHCCCCCCSS
T ss_pred cceecCCCc-ceeeeccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCcc
Confidence 998765432 2344579999999999988887765 999999999999999999997654 333443333332222 2
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
....++.++++||.+||+.||++|||+.|+++||||++..
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 2346899999999999999999999999999999998653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=387.20 Aligned_cols=259 Identities=30% Similarity=0.445 Sum_probs=194.9
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCC--EE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGT--YL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~--~~ 82 (351)
+.+|++++.||+|+||.||+|.+..+|+.||+|++......... .....+|+.+++.+. ||||+++++++...+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD-AQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHH-HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHH-HHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 35799999999999999999999999999999998644333333 334448999999997 999999999997544 79
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+|||||+ ++|..++.. ..+++.... .++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~----------~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~D 152 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA---NILEPVHKQ----------YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVAD 152 (388)
T ss_dssp EEEEECCS-EEHHHHHHH---TCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred EEEecccC-cCHHHHHHc---CCCCHHHHH----------HHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecC
Confidence 99999997 799999875 355554433 4677889999999999999999999999999999999999
Q ss_pred ccccccccCC---------------------cccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy6327 163 FGFSRLLRTP---------------------KELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFG 221 (351)
Q Consensus 163 fg~a~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (351)
||+|+..... .......+||++|+|||++.+......++||||+||++|+|++|++||.
T Consensus 153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 9999865321 1123456899999999999874433445999999999999999999997
Q ss_pred CCCCCchHHHHhhhC---ccc------------------------------------------cccccccCCHhHHHHHH
Q psy6327 222 DPGTRNRDVLKKQEG---KEY------------------------------------------LFNRKYEISIGAKQLIG 256 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~---~~~------------------------------------------~~~~~~~~s~~~~~li~ 256 (351)
+.+ .......+.. .+. .......+++++.+||.
T Consensus 233 ~~~--~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 233 GSS--TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp CSS--HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred CCC--HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 654 2222221110 000 00011267899999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 257 RMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 257 ~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
+||+.||++|||+.|+|+||||+..
T Consensus 311 ~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HhhccCcccCCCHHHHhCCHHHHHh
Confidence 9999999999999999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=380.64 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=199.6
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|++++.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 467999999999999999999999999999999986544221 122333799999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++ |+|.+++... ...+++..+. .++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~e~~~-~~l~~~~~~~-~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDC-GNIINMHNVK----------LFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp EECCS-EEHHHHHHHT-TTCCCHHHHH----------HHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSE
T ss_pred ecccc-cCHHHHHHhc-CCCCCHHHHH----------HHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcc
Confidence 99997 6999998763 3445655443 4677888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh---Ccc----
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---GKE---- 238 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~~---- 238 (351)
++............+||+.|+|||++.+......++|||||||++|+|++|..||.+.+. .+....+. ...
T Consensus 147 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 147 ARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EEQLHFIFRILGTPTEET 224 (324)
T ss_dssp EECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTT
T ss_pred cccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHh
Confidence 987665555555668999999999987754434459999999999999999999976542 22211110 000
Q ss_pred ---------------------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 239 ---------------------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 239 ---------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
........+++++.+||.+||+.||.+|||+.|+|+||||.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0011123578899999999999999999999999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=375.68 Aligned_cols=257 Identities=32% Similarity=0.533 Sum_probs=198.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 49999999999999999999999999999999864431 2345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---CCCeEEeecc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---LLNAKLADFG 164 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~~~~kl~Dfg 164 (351)
|++|++|.+++.. ...+++... ..++.|++.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 129 ~~~~~~L~~~l~~--~~~~~~~~~----------~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 129 LVTGGELFDRIVE--KGYYSERDA----------ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp CCCSCBHHHHHTT--CSSCCHHHH----------HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred eCCCCCHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 9999999999976 455666544 346778889999999999999999999999975 7889999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc--c
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF--N 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~ 242 (351)
+++..... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.... ......+....+.. +
T Consensus 197 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~i~~~~~~~~~~ 273 (349)
T 2w4o_A 197 LSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGD-QFMFRRILNCEYYFISP 273 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCH-HHHHHHHHTTCCCCCTT
T ss_pred cccccCcc-cccccccCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCccc-HHHHHHHHhCCCccCCc
Confidence 99875432 23345679999999999988887765 99999999999999999999765432 22333333333322 2
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTC 284 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 284 (351)
....++.++.+||.+||+.||++|||+.|+++||||++....
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 234689999999999999999999999999999999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=366.21 Aligned_cols=260 Identities=24% Similarity=0.454 Sum_probs=220.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 45699999999999999999999999999999999776554444455666899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++.. ...+++... ..++.|++.||.|||++|++|+||||+|||++.++.+||+|||+
T Consensus 94 ~e~~~~~~L~~~~~~--~~~~~~~~~----------~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 161 (294)
T 2rku_A 94 LELCRRRSLLELHKR--RKALTEPEA----------RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161 (294)
T ss_dssp EECCTTCBHHHHHHH--HCSCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccC
Confidence 999999999999876 456666544 34677888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
++.............||+.|+|||++.+..++.+ +||||||+++|+|++|..||.... ..+.........+. .+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~--~~~ 236 (294)
T 2rku_A 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKKNEYS--IPK 236 (294)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCCC--CCT
T ss_pred ceecccCccccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhhccCC--Ccc
Confidence 9876655445556779999999999988777665 999999999999999999997654 33333333333332 234
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.++..+.+||.+||+.||++|||+.|+++||||....
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 6899999999999999999999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=376.16 Aligned_cols=265 Identities=26% Similarity=0.421 Sum_probs=208.1
Q ss_pred CCCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 2 KFPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 2 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
-|..+.+|++++.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch-HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 4678899999999999999999999999999999999986544333 234445589999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.|+||||+++++|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 99 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~----------~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~ 166 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF--PNGLDYQVVQ----------KYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLC 166 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS--TTCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCcchHHHHHhh--ccCCCHHHHH----------HHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEE
Confidence 9999999999999888765 4556665443 467788889999999999999999999999999999999
Q ss_pred eccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-----
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG----- 236 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----- 236 (351)
|||+++............+||+.|+|||++.+......++|||||||++|+|++|+.||..... .........
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~ 244 (331)
T 4aaa_A 167 DFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD--IDQLYHIMMCLGNL 244 (331)
T ss_dssp CCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSC
T ss_pred eCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCC
Confidence 9999987766555556678999999999998764334459999999999999999999976542 221111100
Q ss_pred ------------------------ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 237 ------------------------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 237 ------------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..........+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 000001112578999999999999999999999999999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=393.02 Aligned_cols=259 Identities=30% Similarity=0.509 Sum_probs=212.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|+++++||+|+||+||+|.+..+++.||+|++......... ...+.+|+.++++++||||+++++++.+....|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH-HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 3599999999999999999999999999999998765433222 234558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc---CCCCeEEeec
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS---RLLNAKLADF 163 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~---~~~~~kl~Df 163 (351)
|||.||+|.+++.. ...+++..+. .++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 101 e~~~~~~L~~~~~~--~~~~~~~~~~----------~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 101 ELYTGGELFDEIIK--RKRFSEHDAA----------RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp CCCCSCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred EcCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence 99999999999976 4566765544 4677888889999999999999999999995 4567999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc--cc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY--LF 241 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~ 241 (351)
|+++...... .....+||+.|+|||++.+. ++. ++||||+||++|+|++|.+||.+.. ..+....+....+ ..
T Consensus 169 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~-~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 169 GLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDE-KCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAFDL 243 (486)
T ss_dssp SCTTTBCCC-----CCTTGGGGCCGGGGGSC-CCH-HHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCSCS
T ss_pred CcCeECCCCC-ccCCCcCCCCCCCHHHhCCC-CCc-hhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCC
Confidence 9998765432 33456799999999998764 555 4999999999999999999997654 4444444443333 33
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
+....+|+++++||.+||+.||.+|||+.++|+||||+....
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 444578999999999999999999999999999999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=365.19 Aligned_cols=257 Identities=30% Similarity=0.537 Sum_probs=216.8
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++.+.||+|+||.||+|.+..++..+|+|++.............+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999999876554443334556689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++++|.+++.. ...+++.... .++.|++.||.|||++||+|+||||+||+++.++.+||+|||
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~----------~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 92 MLEFAPRGELYKELQK--HGRFDEQRSA----------TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEeCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999986 3556665443 467788889999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
++...... ......||+.|+|||++.+..++.+ +||||||+++|+|++|..||.... .............. .+
T Consensus 160 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~--~~ 232 (284)
T 2vgo_A 160 WSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPS--HTETHRRIVNVDLK--FP 232 (284)
T ss_dssp TCEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCCC--CC
T ss_pred ccccCccc--ccccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCC--HhHHHHHHhccccC--CC
Confidence 98765432 2345679999999999998887765 999999999999999999997654 33333333333332 23
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
..++.++++||.+||+.||.+|||+.++++||||+.
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 468999999999999999999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=373.19 Aligned_cols=260 Identities=24% Similarity=0.463 Sum_probs=219.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|.+.+.||+|+||.||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 45799999999999999999999999999999999776554444455666899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 120 ~e~~~~~~L~~~~~~--~~~l~~~~~~----------~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 187 (335)
T 2owb_A 120 LELCRRRSLLELHKR--RKALTEPEAR----------YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187 (335)
T ss_dssp ECCCTTCBHHHHHHH--HCSCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHhc--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccC
Confidence 999999999999876 4566665443 4677888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
++.............||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... ..+.........+. .+.
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~--~~~ 262 (335)
T 2owb_A 188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKKNEYS--IPK 262 (335)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCC--CCT
T ss_pred ceecccCcccccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHhcCCCC--CCc
Confidence 9877655455556789999999999988877665 999999999999999999997644 23333333222222 233
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.++..+.+||.+||+.||++|||+.|+++||||+...
T Consensus 263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 6899999999999999999999999999999998654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=397.40 Aligned_cols=257 Identities=31% Similarity=0.516 Sum_probs=215.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 59999999999999999999999999999999876554333234455699999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE---cCCCCeEEeecc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI---SRLLNAKLADFG 164 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll---~~~~~~kl~Dfg 164 (351)
||.||+|.+++.. ...+++..+. .++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 107 ~~~~~~L~~~~~~--~~~~~~~~~~----------~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 107 VYTGGELFDEIIS--RKRFSEVDAA----------RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp CCCSCBHHHHHHT--CSCCBHHHHH----------HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred cCCCCCHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 9999999999976 4567765543 467788889999999999999999999999 457889999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc--cc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL--FN 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~ 242 (351)
+++...... .....+||+.|+|||++.+ .++. ++|||||||++|+|++|.+||.+.. .......+....+. .+
T Consensus 175 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~ 249 (484)
T 3nyv_A 175 LSTHFEASK-KMKDKIGTAYYIAPEVLHG-TYDE-KCDVWSTGVILYILLSGCPPFNGAN--EYDILKKVEKGKYTFELP 249 (484)
T ss_dssp HHHHBCCCC-SHHHHTTGGGTCCHHHHHT-CCCT-HHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCSG
T ss_pred eeEEccccc-ccccCCCCccccCceeecC-CCCC-cceeHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCCCCCc
Confidence 998765433 3345679999999999876 4555 4999999999999999999997654 44444444443333 33
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
....+|+++++||.+||++||.+|||+.|+|+||||+..
T Consensus 250 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 250 QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 445789999999999999999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=375.19 Aligned_cols=273 Identities=25% Similarity=0.404 Sum_probs=210.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh--HHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR--DYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+|++.+.||+|+||.||+|.+..++..+|+|++....... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 35999999999999999999999999999999987654321 1223455689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCC-------------chH---------------HHHHHHHHHHHHHHHHHHHHHHHHHhH
Q psy6327 85 IMDYAEKKDLEHYISKACNENI-------------HEN---------------QARIWIRQIANALEYLHEIANALEYLH 136 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~-------------~~~---------------~~~~~~~~i~~~~~~~~qi~~~l~~lH 136 (351)
||||++||+|.+++........ +.. ...........+..++.|++.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999853111100 000 000111233445668899999999999
Q ss_pred hCCceeccCCCCCEeEcCCC--CeEEeeccccccccCCcc----cccccccccceeccccccC--CCCCCCcchHHHHHH
Q psy6327 137 EVGIVHRDIKCENILISRLL--NAKLADFGFSRLLRTPKE----LSNTFCGTTSYAAPEIIRN--SPYNPKLADIWSLGV 208 (351)
Q Consensus 137 ~~~i~H~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ 208 (351)
++||+||||||+|||++.++ .+||+|||+++....... ......||+.|+|||++.+ ..++. ++|||||||
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwslG~ 264 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP-KCDAWSAGV 264 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT-HHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc-HHHHHHHHH
Confidence 99999999999999998766 899999999986543221 2345679999999999865 44554 599999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHhhhCccc--cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 209 VLYRILNKKYPFGDPGTRNRDVLKKQEGKEY--LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 209 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
++|+|++|..||.... ..+.......... ..+....+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 265 il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVN--DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHCCCCCCCCC--hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999997654 3333333322222 2233345899999999999999999999999999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=394.45 Aligned_cols=259 Identities=34% Similarity=0.541 Sum_probs=211.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH----------HHhhhHHHHHHHHHhCCCCCceeeeeEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD----------YMEKFAPREIDILLKVSHPNIIGVHRMV 76 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 76 (351)
..|+++++||+|+||+||+|.++.+++.+|+|++........ .....+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 459999999999999999999999999999999876543321 1234456899999999999999999999
Q ss_pred EeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 77 KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 77 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
.+....|+|||||+||+|.+++.. ...+++..+. .++.||+.||.|||++||+||||||+|||++.++
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~----------~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAA----------NIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC
Confidence 999999999999999999999976 4567765543 4677888899999999999999999999998775
Q ss_pred ---CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh
Q psy6327 157 ---NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 157 ---~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 233 (351)
.+||+|||+++...... .....+||+.|+|||++.+ .++. ++||||+||++|+|++|.+||.+.. .......
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~ 258 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNE-KCDVWSCGVIMYILLCGYPPFGGQN--DQDIIKK 258 (504)
T ss_dssp CCSSEEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH
T ss_pred CCccEEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCc-hHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH
Confidence 69999999998765432 3445679999999999874 4665 4999999999999999999997654 4445554
Q ss_pred hhCccccc--cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 234 QEGKEYLF--NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 234 ~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
+....+.+ +....+|+++++||.+||++||.+|||+.|+|+||||+...
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 259 VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 44444333 23357899999999999999999999999999999997643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=383.22 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=199.5
Q ss_pred ccceeee-eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHH-hCCCCCceeeeeEEEe----C
Q psy6327 6 ILECSYI-SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILL-KVSHPNIIGVHRMVKA----G 79 (351)
Q Consensus 6 ~~~~~~~-~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~-~l~hp~iv~~~~~~~~----~ 79 (351)
+.+|.+. +.||+|+||.||+|.++.+++.||+|++... ....+|+.++. ..+||||+++++++.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4568877 6899999999999999999999999998532 12347888875 4579999999999876 6
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---CC
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---LL 156 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~~ 156 (351)
..+|+|||||+||+|.+++.......+++..+. .++.||+.||.|||++||+||||||+|||++. ++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~----------~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHH----------HHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCc
Confidence 689999999999999999986444457765544 46778888899999999999999999999997 78
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc--hHHHHhh
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN--RDVLKKQ 234 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~ 234 (351)
.+||+|||+++..... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||....... ......+
T Consensus 202 ~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i 279 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279 (400)
T ss_dssp CEEECCCTTCEECC------------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred cEEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence 8999999999875432 23356789999999999988888765 999999999999999999997654221 1122222
Q ss_pred hCcccccc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 235 EGKEYLFN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 235 ~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
....+.++ ....++.++.+||.+||+.||++|||+.|+++||||....
T Consensus 280 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 280 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp HHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 22222222 2346899999999999999999999999999999997643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=371.84 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=214.8
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH---HHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD---YMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.|++.+.||+|+||.||+|.+..+|+.+|+|++........ .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 49999999999999999999999999999999876543221 112345689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC----CeEE
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL----NAKL 160 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~----~~kl 160 (351)
||||++|++|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~----------~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQ--KESLSEEEAT----------SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp EECCCCSCBHHHHHHT--CSCEEHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEcCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEE
Confidence 9999999999999976 4556665443 4677888899999999999999999999999887 7999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
+|||++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... ............+.
T Consensus 161 ~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~ 236 (321)
T 2a2a_A 161 IDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDT--KQETLANITSVSYD 236 (321)
T ss_dssp CCCTTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTTCCC
T ss_pred ccCccceecCccc-cccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhcccc
Confidence 9999998765432 2345679999999999988887765 999999999999999999997644 34444444333332
Q ss_pred ccc--cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 241 FNR--KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 241 ~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
++. ...++..+.+||.+||+.||++|||+.|+++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 237 FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 222 246899999999999999999999999999999998653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=362.75 Aligned_cols=260 Identities=31% Similarity=0.529 Sum_probs=208.2
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+..+++.+|+|++.............+.+|+.+++.++||||+++++++...+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 46799999999999999999999999999999998765543333344566899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++.. ...+++... ..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~----------~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~ 157 (276)
T 2h6d_A 90 MEYVSGGELFDYICK--HGRVEEMEA----------RRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL 157 (276)
T ss_dssp EECCCSCBHHHHHHH--HCSCCHHHH----------HHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred EeccCCCcHHHHHhc--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccc
Confidence 999999999999976 345665543 34677888999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
+...... .......||+.|+|||++.+..+...++||||||+++|+|++|..||.... .............. .+.
T Consensus 158 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~--~~~ 232 (276)
T 2h6d_A 158 SNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--VPTLFKKIRGGVFY--IPE 232 (276)
T ss_dssp GGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCC--CCT
T ss_pred ccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCccc--Cch
Confidence 9876443 223455799999999999887765456999999999999999999997643 33333333332222 234
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.++..+.++|.+||+.||++|||+.++++||||+...
T Consensus 233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 233 YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 6799999999999999999999999999999997653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=374.86 Aligned_cols=254 Identities=31% Similarity=0.504 Sum_probs=211.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH-----HHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD-----YMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|++++.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 469999999999999999999999999999999976553221 112234479999999999999999999999999
Q ss_pred EEEEEecCCCC-ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 82 LYMIMDYAEKK-DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 82 ~~lv~e~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.++||||+.+| +|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~----------~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL 171 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR--HPRLDEPLAS----------YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKL 171 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT--CCCCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCccHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEE
Confidence 99999999766 99999976 4566665543 46778888999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
+|||+++...... .....+||+.|+|||++.+..+...++|||||||++|+|++|..||..... . . ...
T Consensus 172 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~----~--~~~ 240 (335)
T 3dls_A 172 IDFGSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----T----V--EAA 240 (335)
T ss_dssp CCCTTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----G----T--TTC
T ss_pred eecccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----H----H--hhc
Confidence 9999998765432 334567999999999998888755568999999999999999999965221 1 1 111
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
...+..++.++.+||.+||++||++|||+.++++||||+....
T Consensus 241 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 283 (335)
T 3dls_A 241 IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283 (335)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence 2233468999999999999999999999999999999986543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=376.02 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=202.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-----
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT----- 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----- 80 (351)
+.+|++++.||+|+||.||+|.++.+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTT--HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 457999999999999999999999999999999986544222 2344569999999999999999999985543
Q ss_pred ----------------------------------------------------EEEEEEecCCCCChHHHHHhhccCCCch
Q psy6327 81 ----------------------------------------------------YLYMIMDYAEKKDLEHYISKACNENIHE 108 (351)
Q Consensus 81 ----------------------------------------------------~~~lv~e~~~ggsL~~~l~~~~~~~~~~ 108 (351)
..++|||||+|++|.+++... .....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~ 160 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR--CSLED 160 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--CSGGG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--cCccc
Confidence 489999999999999999763 22222
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCc------------ccc
Q psy6327 109 NQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPK------------ELS 176 (351)
Q Consensus 109 ~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~------------~~~ 176 (351)
... ..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 161 ~~~-------~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 161 REH-------GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp SCH-------HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred hhh-------HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 111 1244678899999999999999999999999999999999999999998765442 123
Q ss_pred cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHH
Q psy6327 177 NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIG 256 (351)
Q Consensus 177 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 256 (351)
...+||+.|+|||++.+..++.+ +|||||||++|+|++|..|+.. ............. .......++++.+||.
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 307 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQME----RVRIITDVRNLKF-PLLFTQKYPQEHMMVQ 307 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHHH----HHHHHHHHHTTCC-CHHHHHHCHHHHHHHH
T ss_pred cccCCCcCccChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChhH----HHHHHHHhhccCC-CcccccCChhHHHHHH
Confidence 44679999999999998887765 9999999999999998877532 1122222222111 1122356788999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccccC
Q psy6327 257 RMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 257 ~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
+||+.||++|||+.|+++||||++
T Consensus 308 ~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 308 DMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHccCCCCcCCCHHHHhhchhhhc
Confidence 999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=369.45 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=201.7
Q ss_pred cceeee-eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEE
Q psy6327 7 LECSYI-SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 7 ~~~~~~-~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~l 84 (351)
..|++. +.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.++.++ +||||+++++++.+.+..|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 358885 78999999999999999999999999986543221 23445899999995 79999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC---eEEe
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN---AKLA 161 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~---~kl~ 161 (351)
||||++|++|.+++.. ...+++.... .++.|++.||+|||++||+||||||+|||++.++. +||+
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~----------~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHK--RRHFNELEAS----------VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred EEEcCCCCcHHHHHhc--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEE
Confidence 9999999999999987 4556665543 46778889999999999999999999999988765 9999
Q ss_pred eccccccccCCcc-------cccccccccceeccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc--
Q psy6327 162 DFGFSRLLRTPKE-------LSNTFCGTTSYAAPEIIRN-----SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN-- 227 (351)
Q Consensus 162 Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-- 227 (351)
|||++........ .....+||+.|+|||++.+ ..++.+ +|||||||++|+|++|..||.......
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCccccccccc
Confidence 9999976542211 1234569999999999875 345554 999999999999999999997654321
Q ss_pred -----------hHHHHhhhCccccccc--cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 228 -----------RDVLKKQEGKEYLFNR--KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 228 -----------~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
...........+.++. ...++.++++||.+||+.||++|||+.|+++||||++..
T Consensus 236 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp C----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 1222233323333322 236899999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=375.97 Aligned_cols=265 Identities=23% Similarity=0.386 Sum_probs=206.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe------
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA------ 78 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------ 78 (351)
.+.+|++++.||+|+||.||+|.+..+|+.||+|++......... ...+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS-CHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc-hHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 467899999999999999999999999999999998665443322 2234489999999999999999999977
Q ss_pred --CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 79 --GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 79 --~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
.+..|+||||++ ++|.+.+... ...+++..+ ..++.|++.||.|||++||+||||||+|||++.++
T Consensus 94 ~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~----------~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~ 161 (351)
T 3mi9_A 94 RCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEI----------KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 161 (351)
T ss_dssp ---CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred cCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC
Confidence 457899999998 5888877653 345665543 34677888899999999999999999999999999
Q ss_pred CeEEeeccccccccCCc----ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q psy6327 157 NAKLADFGFSRLLRTPK----ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 232 (351)
.+||+|||+++...... ......+||+.|+|||++.+......++|||||||++|+|++|.+||.... ......
T Consensus 162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~ 239 (351)
T 3mi9_A 162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLA 239 (351)
T ss_dssp CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHH
T ss_pred CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHH
Confidence 99999999998764222 223456789999999998765543445999999999999999999997654 222221
Q ss_pred hhhC---ccc--ccccc-------------------------ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 233 KQEG---KEY--LFNRK-------------------------YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 233 ~~~~---~~~--~~~~~-------------------------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.+.. ... .++.. ...++.+.+||.+||+.||++|||+.|+|+||||+..+
T Consensus 240 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 1110 000 00000 01377899999999999999999999999999998765
Q ss_pred cc
Q psy6327 283 TC 284 (351)
Q Consensus 283 ~~ 284 (351)
..
T Consensus 320 ~~ 321 (351)
T 3mi9_A 320 MP 321 (351)
T ss_dssp CC
T ss_pred Cc
Confidence 43
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=372.98 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=210.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 38999999999999999999999999999999876544444444556699999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
|+. |+|.+++... ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 135 ~~~-g~l~~~l~~~-~~~l~~~~~~----------~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 135 YCL-GSASDLLEVH-KKPLQEVEIA----------AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 202 (348)
T ss_dssp CCS-EEHHHHHHHH-TSCCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred cCC-CCHHHHHHHh-cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCce
Confidence 997 7888888643 3556665433 467788889999999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceecccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
.... ....+||+.|+|||++. ...++. ++|||||||++|+|++|..||.... ..................
T Consensus 203 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~-~~DiwslG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~ 275 (348)
T 1u5q_A 203 IMAP----ANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPALQS 275 (348)
T ss_dssp SSSS----BCCCCSCGGGCCHHHHHTTSSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCCC
T ss_pred ecCC----CCcccCCcceeCHhhhccccCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCC
Confidence 7543 23467999999999985 455555 4999999999999999999997654 222222222222222223
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
..+++.+.+||.+||+.||++|||+.++++||||.....
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 468999999999999999999999999999999976543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=365.81 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=200.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv 85 (351)
.+|+++++||+|+||+||+|.+..+++.||+|++.............+ .|+..+..+ +||||+++++++.+++..|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHH-HHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHH-HHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 459999999999999999999999999999998765444333333344 555555555 899999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+ +++|.+++... ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 136 ~e~~-~~~L~~~~~~~-~~~l~~~~~~----------~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW-GASLPEAQVW----------GYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EECC-CCBHHHHHHHH-CSCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred Eecc-CCCHHHHHHhc-CCCCCHHHHH----------HHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEcccee
Confidence 9999 58999998764 3456665543 4677888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
+....... ......||+.|+|||++.+ .++. ++|||||||++|+|++|..|+... .................
T Consensus 204 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~el~~g~~~~~~~-----~~~~~~~~~~~~~~~~~ 275 (311)
T 3p1a_A 204 LVELGTAG-AGEVQEGDPRYMAPELLQG-SYGT-AADVFSLGLTILEVACNMELPHGG-----EGWQQLRQGYLPPEFTA 275 (311)
T ss_dssp CEECC-------CCCCCGGGCCGGGGGT-CCST-HHHHHHHHHHHHHHHHTCCCCSSH-----HHHHHHTTTCCCHHHHT
T ss_pred eeecccCC-CCcccCCCccccCHhHhcC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHhccCCCccccc
Confidence 98764432 3345569999999999876 5655 499999999999999997766432 12222222222222334
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.+++++.+||.+||++||++|||+.|+++||||+.
T Consensus 276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 276 GLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 68999999999999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=369.27 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=203.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH--HHhhhHHHHHHHHHhCC---CCCceeeeeEEEeCC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD--YMEKFAPREIDILLKVS---HPNIIGVHRMVKAGT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~ 80 (351)
..+|++++.||+|+||+||+|.+..+++.||+|++........ .......+|+.+++.+. ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 3579999999999999999999999999999999875432111 11122336777777664 999999999997755
Q ss_pred -----EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 81 -----YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 81 -----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
..++||||+. ++|.+++.......+++..+. .++.|++.||+|||++||+||||||+|||++.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~----------~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~ 156 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIK----------DLMRQFLRGLDFLHANCIVHRDLKPENILVTSG 156 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHH----------HHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHH----------HHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC
Confidence 6899999997 799999987544457766544 467788888999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh
Q psy6327 156 LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 235 (351)
+.+||+|||+++..... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||...+ .......+.
T Consensus 157 ~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~ 232 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIF 232 (308)
T ss_dssp SCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSS--HHHHHHHHH
T ss_pred CCEEEeeCccccccCCC-cccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence 99999999999876433 23355679999999999988888776 999999999999999999997654 222222211
Q ss_pred C---ccc----------------------cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 236 G---KEY----------------------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 236 ~---~~~----------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. ... .......+++++.+||.+||++||++|||+.|+|+||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0 000 000113578999999999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=390.16 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=197.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC------
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG------ 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------ 79 (351)
..+|++++.||+|+||.||+|.+..+++.||+|++......... ...+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHH-HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHH-HHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 46799999999999999999999999999999999755333332 34455899999999999999999999644
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
..+|+||||++ ++|.+.+. ..+++..+. .++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 140 ~~~~lv~E~~~-~~l~~~~~----~~l~~~~~~----------~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 140 QDVYLVMELMD-ANLCQVIQ----MELDHERMS----------YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp CEEEEEEECCS-EEHHHHHT----SCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeCCC-CCHHHHHh----hcCCHHHHH----------HHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEE
Confidence 57899999998 55777664 335554433 4677889999999999999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--- 236 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--- 236 (351)
|+|||+++..... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+. .+....+..
T Consensus 205 l~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~--~~~~~~i~~~lg 280 (464)
T 3ttj_A 205 ILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLG 280 (464)
T ss_dssp ECCCCCC-----C-CCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHC
T ss_pred EEEEEeeeecCCC-cccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcC
Confidence 9999999876442 23456789999999999999888865 9999999999999999999976542 222211100
Q ss_pred c-------------------c-----ccccc--c-----------ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 237 K-------------------E-----YLFNR--K-----------YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 237 ~-------------------~-----~~~~~--~-----------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
. . ..++. + ...++++++||.+||+.||++|||+.|+|+||||+
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 0 0 00000 0 00156799999999999999999999999999997
Q ss_pred C
Q psy6327 280 N 280 (351)
Q Consensus 280 ~ 280 (351)
.
T Consensus 361 ~ 361 (464)
T 3ttj_A 361 V 361 (464)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=390.09 Aligned_cols=262 Identities=27% Similarity=0.372 Sum_probs=190.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE-----eCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK-----AGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-----~~~~ 81 (351)
.+|++++.||+|+||+||+|.++.+++.||+|++....... ...+.+.+|+.+|+.++||||+++++++. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL-IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCH-HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 56999999999999999999999999999999986543322 22345569999999999999999999984 3357
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
+|+||||+. ++|.+++.. ...+++..++ .++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~----------~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT--PVYLTELHIK----------TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS--SCCCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccc-cchhhhccc--CCCCCHHHHH----------HHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeec
Confidence 999999985 899999976 4567776544 467788888999999999999999999999999999999
Q ss_pred eccccccccCCc---------------------------ccccccccccceecccccc-CCCCCCCcchHHHHHHHHHHH
Q psy6327 162 DFGFSRLLRTPK---------------------------ELSNTFCGTTSYAAPEIIR-NSPYNPKLADIWSLGVVLYRI 213 (351)
Q Consensus 162 Dfg~a~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l 213 (351)
|||+++...... ......+||++|+|||++. ...++. ++|||||||++|+|
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~DiwSlG~il~el 277 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE-AIDVWSIGCIFAEL 277 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCT-HHHHHHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCc-HhHHHHHHHHHHHH
Confidence 999998764322 1234567899999999864 444554 59999999999999
Q ss_pred Hh-----------CCCCCCCCCCCc------------------hHHHHhh---hC-------------------------
Q psy6327 214 LN-----------KKYPFGDPGTRN------------------RDVLKKQ---EG------------------------- 236 (351)
Q Consensus 214 l~-----------g~~pf~~~~~~~------------------~~~~~~~---~~------------------------- 236 (351)
++ |+++|.+.+... .+.+..+ ..
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 677775533100 0000000 00
Q ss_pred -ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 237 -KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 237 -~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
..........++.++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 358 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp CCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 00001112356899999999999999999999999999999987643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=365.58 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=213.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.+..+|+.||+|.+..... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 469999999999999999999999999999999875432 223458999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|.+++... ...+++... ..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus 104 e~~~~~~L~~~~~~~-~~~~~~~~~----------~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 172 (314)
T 3com_A 104 EYCGAGSVSDIIRLR-NKTLTEDEI----------ATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA 172 (314)
T ss_dssp ECCTTEEHHHHHHHH-TCCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ecCCCCCHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccc
Confidence 999999999999742 455666543 346778888999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
..............||+.|+|||++.+..++.+ +||||||+++|+|++|..||....... ............+..+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 250 (314)
T 3com_A 173 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMR-AIFMIPTNPPPTFRKPEL 250 (314)
T ss_dssp EECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCSSGGG
T ss_pred hhhhhhccccCccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhcCCCcccCCccc
Confidence 876655444556679999999999988887766 999999999999999999997654211 111122222233334456
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccccc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQT 286 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 286 (351)
++..+.+||.+||+.||.+|||+.++++||||+.......
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~ 290 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGG
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchH
Confidence 8999999999999999999999999999999987765443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=366.83 Aligned_cols=257 Identities=30% Similarity=0.520 Sum_probs=211.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|++.+.||+|+||.||+|.+..+|+.+|+|++....... ...+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 5999999999999999999999999999999987543222 3345689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE---cCCCCeEEeecc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI---SRLLNAKLADFG 164 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll---~~~~~~kl~Dfg 164 (351)
|++|++|.+++.. ...+++.... .++.|++.||.|||++||+|+||||+||++ +.++.+||+|||
T Consensus 87 ~~~~~~L~~~l~~--~~~~~~~~~~----------~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 87 LVSGGELFDRILE--RGVYTEKDAS----------LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp CCCSCBHHHHHHH--HSCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred cCCCccHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 9999999999976 4556665443 467788889999999999999999999999 678899999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc--c
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF--N 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~ 242 (351)
++...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... .......+....+.+ +
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~ 229 (304)
T 2jam_A 155 LSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEET--ESKLFEKIKEGYYEFESP 229 (304)
T ss_dssp TTCCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHCCCCCCTT
T ss_pred cceecCCC--ccccccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCCCCcc
Confidence 99764332 2344579999999999988877765 999999999999999999997654 333333333332222 2
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTC 284 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 284 (351)
....++.++.+||.+||+.||++|||+.++++||||++....
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence 234689999999999999999999999999999999876443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=361.11 Aligned_cols=254 Identities=27% Similarity=0.489 Sum_probs=211.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.+..++..+|+|++....... ...+.+|+.++++++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 35999999999999999999999999999999987654433 234558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE---cCCCCeEEeec
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI---SRLLNAKLADF 163 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll---~~~~~~kl~Df 163 (351)
||++|++|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 86 e~~~~~~L~~~~~~--~~~~~~~~~~----------~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 86 ELCTGGELFERVVH--KRVFRESDAA----------RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp ECCCSCBHHHHHHH--HCSCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 99999999999976 4556665543 467788889999999999999999999999 77889999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
|++....... ......||+.|+|||++.+. ++.+ +||||||+++|+|++|..||.... ...............+.
T Consensus 154 g~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~ 228 (277)
T 3f3z_A 154 GLAARFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPE-CDEWSAGVMMYVLLCGYPPFSAPT--DSEVMLKIREGTFTFPE 228 (277)
T ss_dssp TTCEECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTT-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCH
T ss_pred ccceeccCcc-chhccCCCCCccChHHhccc-CCch-hhehhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCc
Confidence 9998765433 34456799999999998654 5554 999999999999999999997654 33444444333333332
Q ss_pred --cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 244 --KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 244 --~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
...+++.+.+||.+||+.||++|||+.++++||||++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 2368999999999999999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=393.00 Aligned_cols=255 Identities=31% Similarity=0.532 Sum_probs=207.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|+++++||+|+||+||+|.++.++..+|+|++......... ...+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 599999999999999999999999999999998765433322 3345589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC---CCeEEeecc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL---LNAKLADFG 164 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~---~~~kl~Dfg 164 (351)
||+||+|.+++.. ...+++..+. .++.||+.||.|||++||+||||||+|||++.. +.+||+|||
T Consensus 117 ~~~~g~L~~~~~~--~~~~~~~~~~----------~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 117 CYKGGELFDEIIH--RMKFNEVDAA----------VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 9999999999976 4566665543 467788889999999999999999999999764 459999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc--c
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF--N 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~ 242 (351)
+++...... .....+||+.|+|||++.+ .++. ++||||+||++|+|++|.+||.+.. .......+....+.+ +
T Consensus 185 ~a~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~ 259 (494)
T 3lij_A 185 LSAVFENQK-KMKERLGTAYYIAPEVLRK-KYDE-KCDVWSIGVILFILLAGYPPFGGQT--DQEILRKVEKGKYTFDSP 259 (494)
T ss_dssp TCEECBTTB-CBCCCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCSG
T ss_pred CCeECCCCc-cccccCCCcCeeCHHHHcc-cCCC-chhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCch
Confidence 998765433 3445679999999999864 5665 4999999999999999999997654 444555444443333 3
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
....+|+++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 33478999999999999999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=379.90 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=204.3
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
+...+.||+|+||.||+|.+..+|+.||+|++....... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 344678999999999999999999999999987644322 34456999999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE--cCCCCeEEeecccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI--SRLLNAKLADFGFS 166 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll--~~~~~~kl~Dfg~a 166 (351)
++|++|.+++... ...+++... +.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 168 ~~~~~L~~~l~~~-~~~l~~~~~----------~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 168 VDGGELFDRIIDE-SYNLTELDT----------ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp CTTCEEHHHHHHT-GGGCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CCCCcHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 9999999998653 234555443 3467889999999999999999999999999 55678999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc--ccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF--NRK 244 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~ 244 (351)
+...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... .......+....+.+ ...
T Consensus 237 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~ 312 (373)
T 2x4f_A 237 RRYKPRE-KLKVNFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDN--DAETLNNILACRWDLEDEEF 312 (373)
T ss_dssp EECCTTC-BCCCCCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCSCSGGG
T ss_pred eecCCcc-ccccccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCChhhh
Confidence 8765433 2345579999999999988777665 999999999999999999997654 334444333333222 223
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..+++++++||.+||+.||.+|||+.|+++||||++.
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 4689999999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=381.03 Aligned_cols=264 Identities=27% Similarity=0.352 Sum_probs=200.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----C
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG-----T 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~ 80 (351)
..+|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL-IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcCh-HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 456999999999999999999999999999999986543322 2344556999999999999999999999766 5
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.+|+||||+. ++|.+++.. ...+++..+. .++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~----------~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT--PIFLTEEHIK----------TILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS--SCCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCC-cCHHHHHhc--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEE
Confidence 7999999997 799999976 4567765544 46778888899999999999999999999999999999
Q ss_pred eeccccccccCCcc----------------------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCC
Q psy6327 161 ADFGFSRLLRTPKE----------------------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKY 218 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 218 (351)
+|||+++....... .....+||++|+|||++........++||||+||++|+|++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 99999987654321 23567899999999986544433345999999999999998544
Q ss_pred CC-----------CCCCCC---------------chHHH------------------------HhhhCcccccc-----c
Q psy6327 219 PF-----------GDPGTR---------------NRDVL------------------------KKQEGKEYLFN-----R 243 (351)
Q Consensus 219 pf-----------~~~~~~---------------~~~~~------------------------~~~~~~~~~~~-----~ 243 (351)
|| .+.+.. ..+.+ ..........+ .
T Consensus 251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (432)
T 3n9x_A 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330 (432)
T ss_dssp TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence 44 332210 00000 00000000000 1
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
...+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 1358999999999999999999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=362.70 Aligned_cols=257 Identities=31% Similarity=0.494 Sum_probs=202.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|++.+.||+|+||.||+|.+..++..+|+|++........ ...+.+|+.++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 359999999999999999999999999999999876543221 334558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc---CCCCeEEe
Q psy6327 87 DYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS---RLLNAKLA 161 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~---~~~~~kl~ 161 (351)
||+++|+|.+++.... ...+++..+ ..++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~----------~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYV----------AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHH----------HHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEE
Confidence 9999999999986532 245665543 35678888999999999999999999999994 45789999
Q ss_pred eccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc-
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL- 240 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~- 240 (351)
|||+++..... .......||+.|+|||++.+ .++. ++|||||||++|+|++|..||.... ..............
T Consensus 170 Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~-~~Di~slG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~ 244 (285)
T 3is5_A 170 DFGLAELFKSD-EHSTNAAGTALYMAPEVFKR-DVTF-KCDIWSAGVVMYFLLTGCLPFTGTS--LEEVQQKATYKEPNY 244 (285)
T ss_dssp CCCCCCC-----------CTTGGGCCHHHHTT-CCCH-HHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCC
T ss_pred eeecceecCCc-ccCcCcccccCcCChHHhcc-CCCc-ccCeehHHHHHHHHHhCCCCCCCCC--HHHHHhhhccCCccc
Confidence 99999875443 23345679999999999864 4554 4999999999999999999997654 22333222222221
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
......+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 245 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 1222357999999999999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=374.09 Aligned_cols=264 Identities=26% Similarity=0.375 Sum_probs=205.6
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh--HHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR--DYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
..+|++++.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 456999999999999999999999999999999987544322 122344568999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||++ ++|.+++... ...+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 89 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~----------~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 89 LVFDFME-TDLEVIIKDN-SLVLTPSHIK----------AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp EEEECCS-EEHHHHHTTC-CSSCCSSHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEcCC-CCHHHHHHhc-CcCCCHHHHH----------HHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEec
Confidence 9999998 5899888653 3456655543 46778888999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---cc--
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---KE-- 238 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~~-- 238 (351)
|+++............+||+.|+|||++.+......++|||||||++|+|++|.+||.+.. ..+....+.. ..
T Consensus 157 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTE 234 (346)
T ss_dssp GGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCT
T ss_pred ccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHcCCCCh
Confidence 9998876655555667899999999999765533445999999999999999999997654 2222221110 00
Q ss_pred cccc---------------------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 239 YLFN---------------------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 239 ~~~~---------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
..++ ....++.++.+||.+||+.||++|||+.|+++||||++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 0000 01356789999999999999999999999999999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=358.91 Aligned_cols=257 Identities=21% Similarity=0.397 Sum_probs=208.6
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe----CCEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA----GTYL 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~ 82 (351)
..|++.+.||+|+||.||+|.+..++..+|+|.+......... ...+.+|+.++++++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH-HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHH-HHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3489999999999999999999999999999998766554443 3455689999999999999999999865 4679
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEc-CCCCeE
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILIS-RLLNAK 159 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~-~~~~~k 159 (351)
++||||+++++|.+++.. ...+++... ..++.|++.||.|||+++ |+|+||||+|||++ .++.+|
T Consensus 105 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~----------~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR--FKVMKIKVL----------RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHH----------HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred EEEEEecCCCCHHHHHHH--ccCCCHHHH----------HHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEE
Confidence 999999999999999976 355665543 346778888999999999 99999999999998 788999
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
|+|||++...... ......||+.|+|||++.+ .++. ++|||||||++|+|++|..||..... .............
T Consensus 173 l~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 173 IGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVK 247 (290)
T ss_dssp ECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCT-HHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTTCC
T ss_pred EeeCCCccccccc--ccccccCCcCcCCHHHHhc-cCCC-cchHHHHHHHHHHHHhCCCCCCCcCc-HHHHHHHHhccCC
Confidence 9999999764432 2345679999999998874 4555 49999999999999999999976442 2233333333322
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
........++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 333344678899999999999999999999999999999853
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=372.01 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=209.9
Q ss_pred eeee-eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEE
Q psy6327 9 CSYI-SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 9 ~~~~-~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 86 (351)
|.+. +.||+|+||.||+|.+..+++.||+|++......... ...+.+|+.+++.+. ||||+++++++.+.+..|+||
T Consensus 30 y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH-HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 6776 8899999999999999999999999998765433322 233458999999995 799999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---CCCeEEeec
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---LLNAKLADF 163 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~~~~kl~Df 163 (351)
||+.||+|.+++.......+++..+. .++.|++.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~----------~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPELAEMVSENDVI----------RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECCTTEEGGGGGSSCC-CCCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 99999999999865445666665543 46778888999999999999999999999987 789999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh--Cccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE--GKEYLF 241 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~ 241 (351)
|+++...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... .......+. ...+..
T Consensus 179 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 179 GMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGED--NQETYLNISQVNVDYSE 254 (327)
T ss_dssp GGCEEC----------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCT
T ss_pred ccccccCCcc-ccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHhcccccCc
Confidence 9998765432 2345679999999999988887765 999999999999999999997654 233322222 222333
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQ 285 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 285 (351)
.....++..+.+||.+||+.||.+|||+.++|+||||++..+..
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 33347899999999999999999999999999999998765543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=372.86 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=210.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhh-----hhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL-----KRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.+|++.+.||+|+||.||+|.+..+|+.||||++..... ........+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 359999999999999999999999999999999865431 1122244566899999999 7999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+||||++|++|.+++.. ...+++.... .++.||+.||.|||+.||+|+||||+|||++.++.+||
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~----------~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE--KVALSEKETR----------SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEEeCCCCcHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999976 4556665443 46778888999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS------PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ 234 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 234 (351)
+|||++....... .....+||+.|+|||++.+. .++.+ +|||||||++|+|++|..||.... .......+
T Consensus 242 ~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~--~~~~~~~i 317 (365)
T 2y7j_A 242 SDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKE-VDLWACGVILFTLLAGSPPFWHRR--QILMLRMI 317 (365)
T ss_dssp CCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH
T ss_pred EecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCch-hhHHhHHHHHHHHHHCCCCCCCCC--HHHHHHHH
Confidence 9999998765432 33456899999999998632 35554 999999999999999999997643 33333333
Q ss_pred hCcccc--ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 235 EGKEYL--FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 235 ~~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
....+. .+....++..+.+||.+||+.||++|||+.++++||||+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 322222 223346899999999999999999999999999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=374.11 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=203.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-----CCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-----HPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----hp~iv~~~~~~~~~~~ 81 (351)
.+|+++++||+|+||.||+|.+..+++.||+|++...... .....+|+.+++.+. ||||+++++++...+.
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHH----HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhh----hhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 4699999999999999999999999999999998642221 233347999999986 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-------
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR------- 154 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~------- 154 (351)
.++||||+ +++|.+++.......+++..+. .++.||+.||+|||++||+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~----------~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIK----------LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 99999999 8999999987555556665543 46778888999999999999999999999975
Q ss_pred ------------------CCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhC
Q psy6327 155 ------------------LLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK 216 (351)
Q Consensus 155 ------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 216 (351)
++.+||+|||+++.... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g 255 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHC
Confidence 78899999999986433 2345679999999999998888876 9999999999999999
Q ss_pred CCCCCCCCCCchHHHHhhhCcccc--------------------------cc------------------ccccCCHhHH
Q psy6327 217 KYPFGDPGTRNRDVLKKQEGKEYL--------------------------FN------------------RKYEISIGAK 252 (351)
Q Consensus 217 ~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~------------------~~~~~s~~~~ 252 (351)
+.||.... ..+....+...... ++ .....++.+.
T Consensus 256 ~~pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 256 SLLFRTHE--HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp SCSCCCSS--HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred CCCCCCCc--HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 99997644 22222111100000 00 0012347788
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 253 QLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 253 ~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
+||.+||+.||.+|||+.|+|+||||+
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999999995
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=373.35 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=199.9
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC------
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG------ 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------ 79 (351)
...|++++.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH-HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH-HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 356999999999999999999999999999999986543332 2344456999999999999999999999765
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
..+|+||||+ |++|.+++.. ..+++..+. .++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~----------~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQ----------FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHH----------HHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEE
Confidence 3469999999 7999999975 456665443 4677888999999999999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccceeccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG-- 236 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-- 236 (351)
|+|||+++..... ....+||+.|+|||++.+ ..++. ++||||+||++|+|++|+.||.+.+. .+....+..
T Consensus 169 l~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~ 242 (367)
T 1cm8_A 169 ILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQ-TVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVT 242 (367)
T ss_dssp ECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCT-THHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHH
T ss_pred EEeeecccccccc---cCcCcCCCCcCCHHHHhCCCCCCh-hhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhc
Confidence 9999999875432 345679999999999887 45555 49999999999999999999976542 222211100
Q ss_pred -c--------------------------cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 237 -K--------------------------EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 237 -~--------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
. ..........++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 000011135689999999999999999999999999999998643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=381.07 Aligned_cols=258 Identities=31% Similarity=0.527 Sum_probs=199.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh-----hHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-----RDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|.+.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.++++++||||+++++++.. ..
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 4699999999999999999999999999999999765532 11223346689999999999999999999864 45
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC---Ce
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL---NA 158 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~---~~ 158 (351)
.|+||||+++|+|.+++.. ...+++.... .++.|++.||+|||++||+||||||+|||++.++ .+
T Consensus 214 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~----------~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVG--NKRLKEATCK----------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp EEEEEECCTTCBGGGGTSS--SCCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCE
T ss_pred eEEEEEcCCCCcHHHHHhc--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceE
Confidence 8999999999999998865 4566665544 4677888889999999999999999999997544 59
Q ss_pred EEeeccccccccCCcccccccccccceeccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN---SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 235 (351)
||+|||+++..... ......+||+.|+|||++.+ ..++. ++|||||||++|+|++|..||....... .......
T Consensus 282 kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~ 358 (419)
T 3i6u_A 282 KITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQIT 358 (419)
T ss_dssp EECCSSTTTSCC------------CTTCCTTTTC----CTTHH-HHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHH
T ss_pred EEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCc-hhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHh
Confidence 99999999876533 33456789999999999864 34444 4999999999999999999997654322 2222222
Q ss_pred Cccccc--cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 236 GKEYLF--NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 236 ~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
...+.+ .....+++.+.+||.+||+.||++|||+.|+++||||++
T Consensus 359 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 359 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 222222 223468999999999999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=367.93 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=202.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe------C
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA------G 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~------~ 79 (351)
.+|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+|+.+++++ +||||+++++++.. .
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 4699999999999999999999999999999998654332 23345899999999 79999999999976 5
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
...|+||||+++++|.+++.......+++.... .++.||+.||.|||++||+|+||||+|||++.++.+|
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~----------~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA----------YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHH----------HHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEE
Confidence 689999999999999999987544566665433 4677888899999999999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccceecccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ 234 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 234 (351)
|+|||++..............||+.|+|||++. ...++.+ +|||||||++|+|++|..||.+.. ........
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~ 246 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMH--PMRALFLI 246 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTT-HHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHH
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCcc-chHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHh
Confidence 999999987655444445667999999999986 3445554 999999999999999999997654 22222222
Q ss_pred hCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 235 EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
............++..+.+||.+||..||.+|||+.++++||||++.+
T Consensus 247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 211222222346899999999999999999999999999999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=357.66 Aligned_cols=255 Identities=21% Similarity=0.299 Sum_probs=203.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~l 84 (351)
..+|++++.||+|+||.||+|.+..+++.||+|++......... ...+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 35699999999999999999999999999999998765443333 33445899999999 89999999999999999999
Q ss_pred EEecCCCCChHHHHHhhcc--CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-------
Q psy6327 85 IMDYAEKKDLEHYISKACN--ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL------- 155 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~------- 155 (351)
||||++|++|.+++..... ..+++..+ ..++.||+.||.|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~----------~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAEL----------KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHH----------HHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccc
Confidence 9999999999999976422 44565443 3567788899999999999999999999999843
Q ss_pred ------------CCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy6327 156 ------------LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP 223 (351)
Q Consensus 156 ------------~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (351)
..+||+|||.+....... ...||+.|+|||++.+......++|||||||++|+|++|.+|+...
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cccccccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 479999999998765432 3459999999999987644434599999999999999999887432
Q ss_pred CCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 224 GTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. ......... ....+..+++++.+||.+||+.||++|||+.++++||||++.
T Consensus 235 ~-----~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 235 D-----QWHEIRQGR-LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp H-----HHHHHHTTC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred h-----HHHHHHcCC-CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2 111221111 122234689999999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=371.94 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=204.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC----EE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT----YL 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----~~ 82 (351)
.+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 45999999999999999999999999999999997765555444556679999999999999999999986543 45
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||||++|++|.+++.. ...+++... +.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 92 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~----------~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D 159 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT--EGPMTPKRA----------IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD 159 (311)
T ss_dssp EEEEECCCEEEHHHHHHH--HCSCCHHHH----------HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECC
T ss_pred EEEEecCCCCCHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEee
Confidence 999999999999999976 455666554 34677888899999999999999999999999999999999
Q ss_pred ccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh--Cc
Q psy6327 163 FGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE--GK 237 (351)
Q Consensus 163 fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--~~ 237 (351)
||+++....... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ........ ..
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~--~~~~~~~~~~~~ 236 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDP 236 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCCC
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCCC
Confidence 999987644322 2334679999999999988887765 9999999999999999999976542 22222221 11
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
.........++.++.+||.+||+.||++||++.+++.|+|++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 111222346899999999999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=357.54 Aligned_cols=260 Identities=31% Similarity=0.471 Sum_probs=212.5
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhh------hhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEe
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL------KRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKA 78 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~ 78 (351)
..+|++.+.||+|+||.||+|.++.+++.||+|++..... ........+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4579999999999999999999999999999999865431 11222345568999999995 9999999999999
Q ss_pred CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
.+..++||||+++++|.+++.. ...+++... ..++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~----------~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 163 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKET----------RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI 163 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred CCeEEEEEeccCCCcHHHHHhc--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcE
Confidence 9999999999999999999976 455666544 3467788889999999999999999999999999999
Q ss_pred EEeeccccccccCCcccccccccccceecccccc------CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR------NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 232 (351)
||+|||++....... ......||+.|+|||++. ...++. ++||||||+++|+|++|..||.... ......
T Consensus 164 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~ 239 (298)
T 1phk_A 164 KLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGK-EVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLR 239 (298)
T ss_dssp EECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHH
T ss_pred EEecccchhhcCCCc-ccccccCCccccCHHHhccccccccccCCc-ccccHhHHHHHHHHHHCCCCCcCcc--HHHHHH
Confidence 999999998765432 334567999999999985 334444 4999999999999999999997654 333333
Q ss_pred hhhCccccc--cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 233 KQEGKEYLF--NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 233 ~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
......+.+ +....++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 240 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 333222222 2334689999999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=368.64 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=202.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC--CCceeeeeEEEeCCEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH--PNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~~~~~~l 84 (351)
..|++++.||+|+||.||+|.+. +++.||+|++......... ...+.+|+.+++.+.| |||+++++++.++...|+
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHH-HHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 45999999999999999999884 6889999998765544433 3445589999999976 999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||+ .+++|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 87 v~e~-~~~~L~~~l~~--~~~~~~~~~~----------~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG 152 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK--KKSIDPWERK----------SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG 152 (343)
T ss_dssp EECC-CSEEHHHHHHH--SCCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred EEeC-CCCCHHHHHHh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecc
Confidence 9995 57999999987 4566665543 4677888999999999999999999999997 5789999999
Q ss_pred ccccccCCcc--cccccccccceeccccccC-----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q psy6327 165 FSRLLRTPKE--LSNTFCGTTSYAAPEIIRN-----------SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL 231 (351)
Q Consensus 165 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 231 (351)
+++....... .....+||+.|+|||++.+ ..++. ++|||||||++|+|++|..||..... .....
T Consensus 153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~-~~~~~ 230 (343)
T 3dbq_A 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP-KSDVWSLGCILYYMTYGKTPFQQIIN-QISKL 230 (343)
T ss_dssp SSCCC------------CCCCSSCCHHHHHHCC-----------CCH-HHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHH
T ss_pred cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCc-hhhHHHHHHHHHHHHhCCCcchhhhh-HHHHH
Confidence 9987654332 2345679999999999864 44444 49999999999999999999976432 22223
Q ss_pred HhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 232 KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
............+...+.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 33333333333444678899999999999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=373.55 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=203.8
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC--CCCceeeeeEEEeCCEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS--HPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~~~~lv 85 (351)
.|++++.||+|+||.||+|.+.. ++.||+|++......... ...+.+|+.+++.+. ||||+++++++...+.+|+|
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~-~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHH-HHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 49999999999999999999875 899999998765544333 344569999999996 59999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|| +.+++|.+++.. ...+++... ..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 135 ~E-~~~~~L~~~l~~--~~~~~~~~~----------~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~ 200 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK--KKSIDPWER----------KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGI 200 (390)
T ss_dssp EE-CCSEEHHHHHHH--CSSCCHHHH----------HHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSS
T ss_pred Ee-cCCCCHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCc
Confidence 99 557999999987 445665443 34678889999999999999999999999996 47899999999
Q ss_pred cccccCCcc--cccccccccceeccccccC-----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q psy6327 166 SRLLRTPKE--LSNTFCGTTSYAAPEIIRN-----------SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 166 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 232 (351)
++....... .....+||+.|+|||++.+ ..++. ++|||||||++|+|++|..||..... ......
T Consensus 201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~-~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~~~ 278 (390)
T 2zmd_A 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP-KSDVWSLGCILYYMTYGKTPFQQIIN-QISKLH 278 (390)
T ss_dssp SCCC---------CCSCCCGGGCCHHHHHCC------------CCH-HHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHH
T ss_pred cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCC-hhhHHHHHHHHHHHHHCCCcchhhhH-HHHHHH
Confidence 987654322 2345689999999999865 23444 49999999999999999999976432 222333
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
...........+...+.++.+||.+||+.||++|||+.|+++||||+...
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 33333333334445688999999999999999999999999999998543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=361.28 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=206.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
...|++++.||+|+||.||+|.+..+++.+|+|++....... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 456999999999999999999999999999999986543322 23445899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++... ...+++... ..++.|++.||.|||++|++|+||||+|||++.++.+||+|||+
T Consensus 95 ~e~~~~~~l~~~~~~~-~~~~~~~~~----------~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL-DRGLTEPQI----------QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGV 163 (302)
T ss_dssp EECCTTEEHHHHHHHH-TSCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred EEeCCCCcHHHHHHhh-ccCCCHHHH----------HHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999998753 345666543 34677888899999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceecccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh-hCccc
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ-EGKEY 239 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~ 239 (351)
+..............||+.|+|||++. ...++. ++||||||+++|+|++|..||..... ....... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~ 240 (302)
T 2j7t_A 164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKSDPP 240 (302)
T ss_dssp HHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTT-HHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCC
T ss_pred CccccccccccccccCChhhcCCeeeccccCCCCCCch-hhhHHHHHHHHHHHhcCCCCCccCCH--HHHHHHHhccCCc
Confidence 865433223334567999999999984 445554 49999999999999999999976542 2222222 22222
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
....+..++..+.+||.+||+.||++|||+.++++||||+....
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 23344578999999999999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=358.91 Aligned_cols=258 Identities=29% Similarity=0.478 Sum_probs=210.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHH---HhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDY---MEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
.+|++.+.||+|+||.||+|.+..+++.+|+|++......... ....+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 3599999999999999999999999999999998765433211 1344568999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC----CeE
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL----NAK 159 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~----~~k 159 (351)
+||||+++++|.+++.. ...+++... ..++.|++.||.|||++|++|+||||+||+++.++ .+|
T Consensus 85 lv~e~~~~~~L~~~l~~--~~~~~~~~~----------~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~k 152 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE--KESLTEDEA----------TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIK 152 (283)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEE
T ss_pred EEEeecCCCcHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceE
Confidence 99999999999999976 455666543 34677888999999999999999999999998876 799
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
|+|||++....... ......||+.|+|||++.+..++.+ +||||||+++|+|++|..||.... ............+
T Consensus 153 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~ 228 (283)
T 3bhy_A 153 LIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGET--KQETLTNISAVNY 228 (283)
T ss_dssp ECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCC
T ss_pred EEecccceeccCCC-cccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcc--hHHHHHHhHhccc
Confidence 99999998764432 2344569999999999988877765 999999999999999999997654 3334433333332
Q ss_pred ccc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 240 LFN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 240 ~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
..+ ....++..+.+||.+||+.||++|||+.++++||||+.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 222 22468999999999999999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=360.46 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=204.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.+..++..+|+|.+.............+.+|+.++++++||||+++++++.+++..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 35999999999999999999999999999999986655544444566679999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++|++|.+++.. ...+++... +.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 91 e~~~g~~L~~~l~~--~~~~~~~~~----------~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 91 EYIEGPTLSEYIES--HGPLSVDTA----------INFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp ECCCSCBHHHHHHH--HCSCCHHHH----------HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 99999999999987 456666554 346778888999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc--ccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL--FNR 243 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~ 243 (351)
+....... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.... ............. ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAV-SIAIKHIQDSVPNVTTDV 236 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHH-HHHHHHHSSCCCCHHHHS
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhccCCCcchhc
Confidence 87654332 2345679999999999998887765 99999999999999999999765421 1112222222111 122
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
...+++.+.++|.+||+.||.+||+..+.+.+.|.
T Consensus 237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 34689999999999999999999965555555553
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=373.28 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=207.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++++.||+|+||.||+|.+..++..+|+|++..... ......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 3569999999999999999999999999999999865432 22244556999999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||++|++|.+++.. ...+++.... .++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 110 ~e~~~~~~L~~~l~~--~~~~~~~~~~----------~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK--AGRIPEQILG----------KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp ECCCTTCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EECCCCCCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECC
Confidence 999999999999977 3456655433 4677888889999996 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHH--------------
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV-------------- 230 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------------- 230 (351)
++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+......
T Consensus 178 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 178 VSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp CCHHHHHH--C----CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred CCcccccc--cccCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 99765322 2345679999999999988887765 999999999999999999997644211110
Q ss_pred --------------------------HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 231 --------------------------LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 231 --------------------------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
................++.++.+||.+||+.||++|||+.|+++||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 001111111111223478899999999999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=377.54 Aligned_cols=264 Identities=17% Similarity=0.146 Sum_probs=194.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC--CCCCceeee-------eEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV--SHPNIIGVH-------RMVK 77 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l--~hp~iv~~~-------~~~~ 77 (351)
.+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999876654444455666785554444 699987754 5554
Q ss_pred eC-----------------CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCc
Q psy6327 78 AG-----------------TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGI 140 (351)
Q Consensus 78 ~~-----------------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i 140 (351)
.. ..+|+||||++ |+|.+++.... ..+....... ....+.++.||+.||+|||++||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~----~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEG----ILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHH----HHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhh----hhhHHHHHHHHHHHHHHHHHCCC
Confidence 33 44899999998 89999998642 2222222100 01113456899999999999999
Q ss_pred eeccCCCCCEeEcCCCCeEEeeccccccccCCcccccccccccceeccccccC--CCCCCCcchHHHHHHHHHHHHhCCC
Q psy6327 141 VHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN--SPYNPKLADIWSLGVVLYRILNKKY 218 (351)
Q Consensus 141 ~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~ 218 (351)
+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.+ +|||||||++|+|++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~-~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHA-LNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHH-HHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCcc-ccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999875432 224457799999999987 566654 999999999999999999
Q ss_pred CCCCCCCCchHHH-----HhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 219 PFGDPGTRNRDVL-----KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 219 pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
||........... .......+.++....+++.+.+||.+||+.||++|||+.++++||||++
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 9976643221111 1111223334444578999999999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=361.33 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=200.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+ ++..+|+|++.......... ..+.+|+.++++++||||+++++++.+....++|
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERV-NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHH-HHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHH-HHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 46799999999999999999976 58899999987655444333 3455899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhcc-CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEcCCCCeEEee
Q psy6327 86 MDYAEKKDLEHYISKACN-ENIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|||+++|+|.+++..... ..+++.. ++.++.|++.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~----------~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERR----------RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHH----------HHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHH----------HHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 999999999999975211 1144433 4457888999999999999 99999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
||+++.............||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... ................
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~--~~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLN--PAQVVAAVGFKCKRLE 259 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSC--HHHHHHHHHHSCCCCC
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCC
Confidence 9999876554444556789999999999998888765 999999999999999999997654 3333333322223334
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc--Ccccc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN--HAWIQ 279 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~--hp~~~ 279 (351)
.+..+++++.+||.+||+.||.+|||+.++++ .++++
T Consensus 260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 44578999999999999999999999999987 45554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=371.27 Aligned_cols=262 Identities=33% Similarity=0.529 Sum_probs=208.7
Q ss_pred ccceeeeeecCcccceEEEEEEec---CCceeEEEEecchhhhh-hHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLK-RDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
+.+|++++.||+|+||.||+|.+. .+++.||+|++...... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999984 58999999998654321 111122334799999999 6999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+||||+++++|.+++.. ...+++.... .++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQ----------IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HSCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEeecCCCCCHHHHHHH--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEE
Confidence 99999999999999999976 3556665443 46778889999999999999999999999999999999
Q ss_pred eeccccccccCCc-ccccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc--hHHHHhhhC
Q psy6327 161 ADFGFSRLLRTPK-ELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRN--RDVLKKQEG 236 (351)
Q Consensus 161 ~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~ 236 (351)
+|||+++...... ......+||+.|+|||++.+.. ....++|||||||++|+|++|..||....... .........
T Consensus 201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 280 (355)
T 1vzo_A 201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280 (355)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc
Confidence 9999998654322 2334567999999999998533 22345999999999999999999997544222 222222222
Q ss_pred ccccccccccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCC
Q psy6327 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNE 281 (351)
Q Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~ 281 (351)
.. .+.+..++..+.+||.+||+.||.+|| |+.++++||||+..
T Consensus 281 ~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 281 SE--PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cC--CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 22 223347899999999999999999999 99999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=367.24 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=205.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----CE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG-----TY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~ 81 (351)
.+|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.++++++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 469999999999999999999999999999999864332 22234456899999999999999999999655 47
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.|+||||+. ++|.+++.. ..+++..+. .++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~---~~~~~~~~~----------~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT---QHLSNDHIC----------YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH---CCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEcccC-cCHHHHHHh---CCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEE
Confidence 899999997 699999875 456665443 467788899999999999999999999999999999999
Q ss_pred eccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh---
Q psy6327 162 DFGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE--- 235 (351)
Q Consensus 162 Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--- 235 (351)
|||+++........ ....+||+.|+|||++.+......++|||||||++|+|++|+.||.+.... +....+.
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~ 248 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGIL 248 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--GHHHHHHHHH
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHHHh
Confidence 99999876543322 245689999999998766553344599999999999999999999765432 2221111
Q ss_pred Cccc--------------------------cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 236 GKEY--------------------------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 236 ~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.... .......++.++.+||.+||++||++|||+.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0000 000113578999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=362.85 Aligned_cols=257 Identities=22% Similarity=0.373 Sum_probs=203.7
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEe--C
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKA--G 79 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~--~ 79 (351)
+....+|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++. ||||+++++++.+ .
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 445678999999999999999999999999999999986432 223458999999997 9999999999987 6
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC-Ce
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL-NA 158 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~-~~ 158 (351)
...++||||+++++|.+++.. +++.. +..++.|++.||.|||++||+||||||+|||++.++ .+
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~----------~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~ 170 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQT-----LTDYD----------IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL 170 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGG-----CCHHH----------HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred CceEEEEeccCchhHHHHHHh-----CCHHH----------HHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEE
Confidence 789999999999999998853 44443 334678899999999999999999999999999766 89
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh-----
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK----- 233 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~----- 233 (351)
||+|||+++...... .....+||+.|+|||++.+......++|||||||++|+|++|..||.............
T Consensus 171 kl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~ 249 (330)
T 3nsz_A 171 RLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249 (330)
T ss_dssp EECCCTTCEECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred EEEeCCCceEcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence 999999998765433 34456799999999998874433445999999999999999999995433211111100
Q ss_pred -------hhCcc----------------------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 234 -------QEGKE----------------------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 234 -------~~~~~----------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..... ........++.++.+||.+||++||.+|||+.|+|+||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred CchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 00000 0001112379999999999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=375.20 Aligned_cols=254 Identities=24% Similarity=0.301 Sum_probs=202.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC------CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV------SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l------~hp~iv~~~~~~~~~~ 80 (351)
.+|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+|+.+++.+ +|+||+++++++...+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccch----HHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 3599999999999999999999999999999998654322 22334788887776 5789999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC--e
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN--A 158 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~--~ 158 (351)
..++||||+. ++|.+++.......+++..+. .++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~----------~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVR----------KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHH----------HHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCE
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHH----------HHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcce
Confidence 9999999996 799999987555557665543 46778888999999999999999999999999887 9
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc-
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK- 237 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~- 237 (351)
||+|||+++.... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+.+. .+.+..+...
T Consensus 242 kL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~--~~~l~~i~~~~ 315 (429)
T 3kvw_A 242 KVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDE--GDQLACMIELL 315 (429)
T ss_dssp EECCCTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHH
T ss_pred EEeecccceecCC---cccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHc
Confidence 9999999976432 2345689999999999998888765 9999999999999999999976542 2221111000
Q ss_pred --c-------------------c-----------------------------------cccccccCCHhHHHHHHHhcCC
Q psy6327 238 --E-------------------Y-----------------------------------LFNRKYEISIGAKQLIGRMLEP 261 (351)
Q Consensus 238 --~-------------------~-----------------------------------~~~~~~~~s~~~~~li~~~L~~ 261 (351)
. + ........++++.+||.+||++
T Consensus 316 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~ 395 (429)
T 3kvw_A 316 GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395 (429)
T ss_dssp CCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCS
T ss_pred CCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCC
Confidence 0 0 0000012377899999999999
Q ss_pred CCCCCCCHHHHhcCccccCC
Q psy6327 262 NPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 262 dp~~Rpt~~ell~hp~~~~~ 281 (351)
||++|||+.|+|+||||+..
T Consensus 396 dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 396 DPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp STTTSCCHHHHHTSTTTC--
T ss_pred ChhhCCCHHHHhCChhhccC
Confidence 99999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=370.14 Aligned_cols=262 Identities=23% Similarity=0.386 Sum_probs=214.2
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHh--------------hhHHHHHHHHHhCCCCCcee
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYME--------------KFAPREIDILLKVSHPNIIG 71 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~--------------~~~~~Ei~~l~~l~hp~iv~ 71 (351)
..+|++.+.||+|+||.||+|.+ +++.||+|.+........... ..+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999998 899999999976554321111 45568999999999999999
Q ss_pred eeeEEEeCCEEEEEEecCCCCChHHH------HHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceecc
Q psy6327 72 VHRMVKAGTYLYMIMDYAEKKDLEHY------ISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRD 144 (351)
Q Consensus 72 ~~~~~~~~~~~~lv~e~~~ggsL~~~------l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~D 144 (351)
+++++.+.+..|+||||+++++|.++ +.......+++... ..++.|++.||.|||+ +||+|+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~----------~~i~~qi~~~l~~lH~~~~i~H~d 177 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI----------KCIIKSVLNSFSYIHNEKNICHRD 177 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHH----------HHHHHHHHHHHHHHHHTSCEECCC
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHH----------HHHHHHHHHHHHHHhccCCEeecC
Confidence 99999999999999999999999998 65433455665544 3467888899999999 9999999
Q ss_pred CCCCCEeEcCCCCeEEeeccccccccCCcccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy6327 145 IKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDP 223 (351)
Q Consensus 145 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (351)
|||+|||++.++.+||+|||++...... ......||+.|+|||++.+. .++..++|||||||++|+|++|..||...
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876443 34456799999999999877 55543599999999999999999999765
Q ss_pred CCCchHHHHhhhCcccccccc-----------------ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 224 GTRNRDVLKKQEGKEYLFNRK-----------------YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
... .............++.. ..++.++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 256 ~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 256 ISL-VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp SCS-HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CcH-HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 431 34444444333333321 46899999999999999999999999999999998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=370.89 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=199.9
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-------
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA------- 78 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------- 78 (351)
..+|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+|+.+++.++||||+++++++..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 35799999999999999999999999999999988643222 1279999999999999999999843
Q ss_pred -------------------------------CCEEEEEEecCCCCChHHHHHhh--ccCCCchHHHHHHHHHHHHHHHHH
Q psy6327 79 -------------------------------GTYLYMIMDYAEKKDLEHYISKA--CNENIHENQARIWIRQIANALEYL 125 (351)
Q Consensus 79 -------------------------------~~~~~lv~e~~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~ 125 (351)
....++||||++ |+|.+.+... ....+++..+. .++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~----------~i~ 147 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLIS----------IYI 147 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHH----------HHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHH----------HHH
Confidence 345899999998 6888877642 23456655443 467
Q ss_pred HHHHHHHHHhHhCCceeccCCCCCEeEc-CCCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHH
Q psy6327 126 HEIANALEYLHEVGIVHRDIKCENILIS-RLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIW 204 (351)
Q Consensus 126 ~qi~~~l~~lH~~~i~H~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 204 (351)
.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...... .....+||+.|+|||++.+......++|||
T Consensus 148 ~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 148 YQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 8888999999999999999999999998 57899999999998764433 344567899999999988765334459999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---------------------------ccccccccccCCHhHHHHHHH
Q psy6327 205 SLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---------------------------KEYLFNRKYEISIGAKQLIGR 257 (351)
Q Consensus 205 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~s~~~~~li~~ 257 (351)
|+||++|+|++|+.||.+.+ ..+....+.. ..+....+..++.++.+||.+
T Consensus 227 slG~il~ell~g~~pf~~~~--~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGET--SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence 99999999999999997654 2222221110 000011123478899999999
Q ss_pred hcCCCCCCCCCHHHHhcCccccC
Q psy6327 258 MLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 258 ~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
||+.||.+|||+.|+++||||+.
T Consensus 305 ~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 305 ILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HccCChhhCCCHHHHhcCHHHHH
Confidence 99999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=357.30 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=213.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
..|++++.||+|+||.||+|.+..+++.||+|++........ ...+.+|+.+++.++||||+++++++.+....|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH--HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 349999999999999999999999999999999876543322 344568999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++|++|.+++.. ..+++... +.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++
T Consensus 100 e~~~~~~L~~~~~~---~~~~~~~~----------~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 100 EYLGGGSALDLLEP---GPLDETQI----------ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp ECCTTEEHHHHHTT---SCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeCCCCcHHHHHhc---CCCCHHHH----------HHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccc
Confidence 99999999999864 45665443 346788899999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
..............||+.|+|||++.+..++.+ +||||||+++|+|++|..||.... ............ .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~ 242 (303)
T 3a7i_A 167 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELH--PMKVLFLIPKNN-PPTLEGN 242 (303)
T ss_dssp EECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSC-CCCCCSS
T ss_pred eecCccccccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcC--HHHHHHHhhcCC-CCCCccc
Confidence 877655444556789999999999988887765 999999999999999999997644 222222221111 1122346
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
++..+.+||.+||+.||.+|||+.++++||||...
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 89999999999999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=361.58 Aligned_cols=258 Identities=31% Similarity=0.527 Sum_probs=202.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh-----hHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-----RDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.++++++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 3599999999999999999999999999999998765432 1122344668999999999999999999998766
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC---e
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN---A 158 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~---~ 158 (351)
.|+||||+++++|.+++.. ...+++.... .++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 89 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~----------~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG--NKRLKEATCK----------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp EEEEEECCTTEETHHHHST--TCCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCE
T ss_pred eEEEEecCCCCcHHHHHhc--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeE
Confidence 8999999999999999975 4566665543 46778888999999999999999999999987654 9
Q ss_pred EEeeccccccccCCcccccccccccceecccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 235 (351)
||+|||+++...... ......||+.|+|||++. ...++. ++|||||||++|+|++|..||........ ......
T Consensus 157 kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~ 233 (322)
T 2ycf_A 157 KITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQIT 233 (322)
T ss_dssp EECCCTTCEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTT-HHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHH
T ss_pred EEccCccceeccccc-ccccccCCcCccCchhhccCCCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHH
Confidence 999999998764332 233557999999999974 344554 49999999999999999999976543221 111111
Q ss_pred Cccc--cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 236 GKEY--LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 236 ~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
...+ .......++..+.+||.+||+.||++|||+.++++||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 1111 11222468999999999999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=357.93 Aligned_cols=262 Identities=27% Similarity=0.442 Sum_probs=209.6
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh-HHHhhhHHHHHHHHHhCCCCCceeeeeEE--EeCCEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR-DYMEKFAPREIDILLKVSHPNIIGVHRMV--KAGTYL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~--~~~~~~ 82 (351)
+.+|++.+.||+|+||.||+|.+..+++.+|+|++....... ......+.+|+.++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 467999999999999999999999999999999997665432 12234566999999999999999999998 455679
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||||++++ |.+++.......+++.... .++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~----------~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAH----------GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHH----------HHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeec
Confidence 9999999865 8888876555666665443 4677888899999999999999999999999999999999
Q ss_pred ccccccccCC--cccccccccccceeccccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 163 FGFSRLLRTP--KELSNTFCGTTSYAAPEIIRNSPY-NPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 163 fg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
||++...... ........||+.|+|||++.+... ...++||||||+++|+|++|..||.... ............+
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--IYKLFENIGKGSY 230 (305)
T ss_dssp CTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCCC
T ss_pred cccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHHhcCCC
Confidence 9999876432 222345679999999999876432 2335999999999999999999997644 3333333333333
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
. .+..++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 231 ~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 231 A--IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp C--CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred C--CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 2 3346899999999999999999999999999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=370.45 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=194.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-----
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT----- 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----- 80 (351)
+.+|++++.||+|+||.||+|.+..+++.||+|++........ ....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT-HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH-HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH-HHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 5679999999999999999999999999999999875433332 2344558999999999999999999997654
Q ss_pred -EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 81 -YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 81 -~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
..|+||||++ ++|.+++. ..+++..+ ..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~----------~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ----MELDHERM----------SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH----SCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred cceEEEEEcCC-CCHHHHHh----hccCHHHH----------HHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEE
Confidence 8999999997 67888885 33555443 34678889999999999999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc-
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE- 238 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 238 (351)
|+|||+++..... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+ .......+....
T Consensus 168 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~ 243 (371)
T 2xrw_A 168 ILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD--HIDQWNKVIEQLG 243 (371)
T ss_dssp ECCCCC-----------------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHC-CC
T ss_pred EEEeecccccccc-cccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhC
Confidence 9999999875432 22345679999999999998888765 999999999999999999997654 222222111100
Q ss_pred ---------------------c--------------cccc----cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 239 ---------------------Y--------------LFNR----KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 239 ---------------------~--------------~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
. .++. ....+.++++||.+||+.||++|||+.|+|+||||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 0 0000 001256899999999999999999999999999997
Q ss_pred C
Q psy6327 280 N 280 (351)
Q Consensus 280 ~ 280 (351)
.
T Consensus 324 ~ 324 (371)
T 2xrw_A 324 V 324 (371)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=369.42 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=186.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC------C
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG------T 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~ 80 (351)
.+|++++.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+.+++.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHH-HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 569999999999999999999999999999999865433222 234455899999999999999999998654 5
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+|+||+ +++|.+++.. ..+++..+. .++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~----------~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQ----------FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHH----------HHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEE
Confidence 689999999 6999999864 456665443 46778889999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--- 236 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--- 236 (351)
+|||+++..... ....+||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.+. .+....+..
T Consensus 174 ~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g 247 (367)
T 2fst_X 174 LDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQ-TVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVG 247 (367)
T ss_dssp CC------------------CCCTTCCHHHHTTCCSCCT-THHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHC
T ss_pred eecccccccccc---CCCcCcCcCccChHHHcCCcCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhC
Confidence 999999875432 345679999999999887 44554 49999999999999999999976542 222111100
Q ss_pred cc-------------------------cc-ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 237 KE-------------------------YL-FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 237 ~~-------------------------~~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.+ .. .......++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 00 00 001124688999999999999999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=356.81 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=196.2
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++++.||+|+||.||+|.+..+++.||+|++........ ......++...++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH-HHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4679999999999999999999999999999999865543332 233344566668888999999999999999999999
Q ss_pred EecCCCCChHHHHHhh--ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEcCCCCeEEee
Q psy6327 86 MDYAEKKDLEHYISKA--CNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|||++ |+|.+++... ....+++.... .++.|++.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~----------~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILG----------KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHH----------HHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHH----------HHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEee
Confidence 99997 6888887642 23456665443 4677888899999998 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccc----cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEII----RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
||+++...... ......||+.|+|||++ .+..++. ++||||+||++|+|++|..||..................
T Consensus 154 fg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 154 FGISGYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSV-KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp C----------------CCCCCCSCHHHHSCCTTC--CCH-HHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred cCCcccccccc-cccccCCCccccChhhcChhhcCcCCCc-HHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 99998764432 23345799999999996 3444554 499999999999999999999765433333333333322
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.. .....++.++.+||.+||+.||++|||+.|+++||||+.
T Consensus 232 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 232 PQ-LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CC-CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CC-cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 22 223468999999999999999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=355.62 Aligned_cols=264 Identities=27% Similarity=0.501 Sum_probs=212.7
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE--eCCE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK--AGTY 81 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~~ 81 (351)
+...+|++++.||+|+||.||+|.+..+++.+|+|.+......... .+.+.+|+.++++++||||+++++++. ....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHH-HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 3467899999999999999999999999999999999765544333 345568999999999999999999874 4678
Q ss_pred EEEEEecCCCCChHHHHHhhcc--CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC-----ceeccCCCCCEeEcC
Q psy6327 82 LYMIMDYAEKKDLEHYISKACN--ENIHENQARIWIRQIANALEYLHEIANALEYLHEVG-----IVHRDIKCENILISR 154 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~-----i~H~Dlkp~NIll~~ 154 (351)
.|+||||++|++|.+++..... ..+++.. ++.++.|++.||.|||+++ |+|+||||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~----------~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~ 151 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEF----------VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 151 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHH----------HHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHH----------HHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC
Confidence 9999999999999999976432 2355544 3456788889999999999 999999999999999
Q ss_pred CCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh
Q psy6327 155 LLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ 234 (351)
Q Consensus 155 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 234 (351)
++.+||+|||+++.............||+.|+|||++.+..++.+ +||||||+++|+|++|..||.... ........
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i 228 (279)
T 2w5a_A 152 KQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFS--QKELAGKI 228 (279)
T ss_dssp SSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH
T ss_pred CCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccC--HHHHHHHH
Confidence 999999999999876554433445679999999999988877754 999999999999999999997654 33333333
Q ss_pred hCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 235 EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
..... ...+..++.++.++|.+||+.||++|||+.|+++|+|+....
T Consensus 229 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 229 REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred hhccc-ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 22222 123346899999999999999999999999999999997543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=378.44 Aligned_cols=255 Identities=15% Similarity=0.152 Sum_probs=197.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHH---HHHHhCCCCCceeee-------eEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREI---DILLKVSHPNIIGVH-------RMV 76 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei---~~l~~l~hp~iv~~~-------~~~ 76 (351)
.+|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+ .++++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 5699999999999999999999999999999999755443333345566899 455556799999998 776
Q ss_pred EeCC-----------------EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC
Q psy6327 77 KAGT-----------------YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG 139 (351)
Q Consensus 77 ~~~~-----------------~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~ 139 (351)
++.+ ..|+||||+ +|+|.+++... ..+++... ......++.++.||+.||+|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHK---SLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTH---HHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccc---cccHHHHHHHHHHHHHHHHHHHhCC
Confidence 6553 289999999 58999999863 23333110 0112334568899999999999999
Q ss_pred ceeccCCCCCEeEcCCCCeEEeeccccccccCCcccccccccccceeccccccCC-----------CCCCCcchHHHHHH
Q psy6327 140 IVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS-----------PYNPKLADIWSLGV 208 (351)
Q Consensus 140 i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~ 208 (351)
|+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.+ +|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS-FDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH-HHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChh-hhHHHHHH
Confidence 99999999999999999999999999986332 3345678 999999999877 66654 99999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 209 VLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 209 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
++|+|++|+.||....... ... ........+++++.+||.+||+.||++|||+.|+++||||+.
T Consensus 302 il~elltg~~Pf~~~~~~~--~~~------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG--GSE------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHSSCCC------C--CSG------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCCCccccccc--chh------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999997544211 111 112223478999999999999999999999999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=356.05 Aligned_cols=254 Identities=22% Similarity=0.333 Sum_probs=204.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
...+|++.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+|+.++++++||||+++++++.+++..++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 4678999999999999999999999999999999874322 2224455699999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||++|++|.+++... ...+++.. ++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 153 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM-DSQYPWSQ----------RVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFG 153 (310)
T ss_dssp EEECCTTCBHHHHHHHC-CTTSCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCT
T ss_pred EEEecCCCcHHHHHHhc-cCCCCHHH----------HHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecc
Confidence 99999999999999763 34555544 34567888999999999999999999999999999999999999
Q ss_pred ccccccCCcccc--------------cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHH
Q psy6327 165 FSRLLRTPKELS--------------NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV 230 (351)
Q Consensus 165 ~a~~~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 230 (351)
+++......... ...+||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~ 232 (310)
T 3s95_A 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232 (310)
T ss_dssp TCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred cceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence 998764332211 15679999999999998887765 999999999999999999997643322111
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..... .......+..+++.+.++|.+||+.||++|||+.++++
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 233 GLNVR-GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp SBCHH-HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhh-ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 10000 00011123468899999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=354.74 Aligned_cols=258 Identities=29% Similarity=0.400 Sum_probs=202.1
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|.....||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 33455899999999999999999999999998654322 234456899999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhcc-CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-CCCeEEeecccc
Q psy6327 89 AEKKDLEHYISKACN-ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-LLNAKLADFGFS 166 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-~~~~kl~Dfg~a 166 (351)
+++++|.+++..... ..+++.. +..++.|++.||.|||++||+|+||||+||+++. ++.+||+|||++
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~----------~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQT----------IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHH----------HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred CCCCCHHHHHHhhccCCCccHHH----------HHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccc
Confidence 999999999976422 1233333 2346778999999999999999999999999987 899999999999
Q ss_pred ccccCCcccccccccccceeccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSP--YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
..............||+.|+|||++.+.. ++. ++||||||+++|+|++|..||............. .........+
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 248 (295)
T 2clq_A 171 KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFKVHPEIP 248 (295)
T ss_dssp EESCC-----CCCCCCGGGCCHHHHHHGGGGCSH-HHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HHHCCCCCCC
T ss_pred cccCCCCCcccccCCCccccChhhhcCCCCCCCc-HHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-cccccccccc
Confidence 87655444445667999999999987653 444 4999999999999999999997544222222111 1111112233
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..++.++.+||.+||+.||++|||+.++++||||+..
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 4689999999999999999999999999999999854
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=372.13 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=197.5
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe------C
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA------G 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------~ 79 (351)
..+|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++.. .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3469999999999999999999999999999999854321 12379999999999999999999843 2
Q ss_pred CEEEEEEecCCCCChHHHHHhh--ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC-C
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKA--CNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL-L 156 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~-~ 156 (351)
..+++||||++ ++|.+.+... ....+++..+ ..++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 126 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~----------~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~ 194 (420)
T 1j1b_A 126 VYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYV----------KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194 (420)
T ss_dssp EEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHH----------HHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT
T ss_pred eeEEeehhccc-ccHHHHHHHHhhccCCCCHHHH----------HHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC
Confidence 24789999998 5777766532 2345555443 3467888999999999999999999999999965 5
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNS-PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 235 (351)
.+||+|||+++...... .....+||+.|+|||++.+. .++. ++|||||||++|+|++|+.||.+.+. .+.+..+.
T Consensus 195 ~~kl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~ 270 (420)
T 1j1b_A 195 VLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEII 270 (420)
T ss_dssp EEEECCCTTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCT-HHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred eEEeccchhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCc-hhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH
Confidence 68999999998764332 23456799999999998765 4554 59999999999999999999976542 22221110
Q ss_pred C-----------------cccccc----------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 236 G-----------------KEYLFN----------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 236 ~-----------------~~~~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. ..+.++ ....++.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 271 ~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 271 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0 011111 123568999999999999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=358.19 Aligned_cols=263 Identities=23% Similarity=0.354 Sum_probs=188.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcch--hHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 467999999999999999999999999999999986544322 133455899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhh------ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 86 MDYAEKKDLEHYISKA------CNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~------~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
|||++|++|.+++... ....+++.. +..++.|++.||.|||++|++|+||||+||+++.++.+|
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~----------~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDEST----------IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHH----------HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHH----------HHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence 9999999999999742 123455544 345678889999999999999999999999999999999
Q ss_pred EeeccccccccCCcc-----cccccccccceeccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh
Q psy6327 160 LADFGFSRLLRTPKE-----LSNTFCGTTSYAAPEIIRN-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 233 (351)
|+|||++........ ......||+.|+|||++.+ ..++. ++|||||||++|+|++|..||......... ...
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~ 239 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDF-KADIWSFGITAIELATGAAPYHKYPPMKVL-MLT 239 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCT-HHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-HHH
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCc-hhhHHHHHHHHHHHHhCCCCCccCchhhHH-HHH
Confidence 999999976543321 2234579999999999876 34454 599999999999999999999765432221 111
Q ss_pred hhCcccc-------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 234 QEGKEYL-------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 234 ~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
....... ......++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 1111111 111235788999999999999999999999999999998643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=368.63 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=194.6
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC------C
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG------T 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~ 80 (351)
.+|++++.||+|+||.||+|.+..++. +|+|++...... ..+|+.+++.++||||+++++++... .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 359999999999999999999988777 788776533221 12799999999999999999998543 3
Q ss_pred EEEEEEecCCCCChHHHHHhh--ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc-CCCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKA--CNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS-RLLN 157 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~-~~~~ 157 (351)
.+++||||+++ ++...+... ....+++..++ .++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~----------~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~ 180 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIK----------LYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV 180 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHH----------HHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHH----------HHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc
Confidence 48999999985 444444321 23456655433 4678889999999999999999999999999 7899
Q ss_pred eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-
Q psy6327 158 AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG- 236 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~- 236 (351)
+||+|||+++...... .....+||+.|+|||++.+......++||||+||++|+|++|+.||.+.+. .+....+..
T Consensus 181 ~kL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~l~~i~~~ 257 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG--IDQLVEIIKV 257 (394)
T ss_dssp EEECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHH
T ss_pred EEEeeCCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence 9999999998764433 334567899999999987765334459999999999999999999976542 221111100
Q ss_pred -------------ccc---c----------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 237 -------------KEY---L----------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 237 -------------~~~---~----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
..+ . ......+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 000 0 011224789999999999999999999999999999998643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=353.23 Aligned_cols=262 Identities=27% Similarity=0.415 Sum_probs=201.1
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
...+.+|++.+.||+|+||.||+|.+..+|+.+|+|++.............+.+|+.++++++||||+++++++...+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 45677899999999999999999999999999999998765444444445566899999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 83 YMIMDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
++||||+++++|.+++.... ...+++... +.++.|++.||.|||++|++|+||||+||+++.++.+||
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~----------~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl 177 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTV----------WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKL 177 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHH----------HHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEE
Confidence 99999999999999997532 334555443 356788899999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
+|||++..............||+.|+|||++.+..++.+ +||||||+++|+|++|..||.+................+.
T Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256 (310)
T ss_dssp CCC------------------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC
T ss_pred EeccceeeecCCCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC
Confidence 999999876554444456679999999999988877765 9999999999999999999976554433444444433333
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
......++.++.+||.+||+.||++|||+.+++++
T Consensus 257 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 23334689999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=357.70 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=201.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC--EEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT--YLYM 84 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--~~~l 84 (351)
.+|++.+.||+|+||.||+|.+..+++.||+|++........ ...+.+|+.++++++||||+++++++.... ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 469999999999999999999999999999999875443322 233458999999999999999999997665 7899
Q ss_pred EEecCCCCChHHHHHhhccC-CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE----cCCCCeE
Q psy6327 85 IMDYAEKKDLEHYISKACNE-NIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI----SRLLNAK 159 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll----~~~~~~k 159 (351)
||||++|++|.+++...... .+++... +.++.|++.||.|||++||+||||||+|||+ +..+.+|
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~----------~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEF----------LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHH----------HHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEE
Confidence 99999999999999764322 2555443 3467888899999999999999999999999 7777899
Q ss_pred EeeccccccccCCcccccccccccceecccccc--------CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--chH
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR--------NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--NRD 229 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~ 229 (351)
|+|||+++...... .....+||+.|+|||++. +..++.+ +|||||||++|+|++|..||...... ...
T Consensus 157 L~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 157 LTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp ECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred EccCCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 99999998765443 334567999999999986 4556655 99999999999999999999643321 122
Q ss_pred HHHhhhCccc-------------------ccc----ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q psy6327 230 VLKKQEGKEY-------------------LFN----RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276 (351)
Q Consensus 230 ~~~~~~~~~~-------------------~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 276 (351)
.........+ ..+ ....++..+.+||.+||+.||++|||++|+|+||
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 2222211111 001 1123456789999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=363.69 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=199.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE----
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL---- 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~---- 82 (351)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHH-HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchh-HHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 469999999999999999999999999999999875443332 344455899999999999999999999877654
Q ss_pred --EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 83 --YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 83 --~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
|+||||+. ++|.+++. ..+++..+. .++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~----------~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQ----------YLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHH----------HHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEE
Confidence 99999997 78888773 346655443 46778888999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--- 236 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--- 236 (351)
+|||+++..... ....+||+.|+|||++.+ ..++. ++|||||||++|+|++|..||.+.+. .+....+..
T Consensus 186 ~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~ 259 (371)
T 4exu_A 186 LDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQ-TVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTG 259 (371)
T ss_dssp CSTTCC-----------CTTCCCTTSCHHHHSCCSCCCT-THHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHC
T ss_pred EecCcccccccC---cCCcccCccccCHHHhcCCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhC
Confidence 999999865432 345678999999999887 45555 49999999999999999999976542 222211100
Q ss_pred c--------------------------cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 237 K--------------------------EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 237 ~--------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. .........+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 00001113578999999999999999999999999999999854
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=370.73 Aligned_cols=259 Identities=28% Similarity=0.454 Sum_probs=185.6
Q ss_pred eeee-eecCcccceEEEEEEec--CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE--eCCEEE
Q psy6327 9 CSYI-SKLGEGAYGNVYLVSDK--RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK--AGTYLY 83 (351)
Q Consensus 9 ~~~~-~~LG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~~~~ 83 (351)
|.+. ++||+|+||.||+|.++ .+++.||+|++....... .+.+|+.+|+.++||||+++++++. ....+|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-----SACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH-----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH-----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 6664 47999999999999965 578999999987544332 2348999999999999999999995 477999
Q ss_pred EEEecCCCCChHHHHHhhccC-------CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE----
Q psy6327 84 MIMDYAEKKDLEHYISKACNE-------NIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI---- 152 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~-------~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll---- 152 (351)
+||||+. ++|.+++...... .+++.. +..++.||+.||.|||++||+||||||+|||+
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~----------~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~ 165 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGM----------VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG 165 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHH----------HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHH----------HHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC
Confidence 9999997 6898888643211 244433 44578889999999999999999999999999
Q ss_pred cCCCCeEEeeccccccccCCc---ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC---
Q psy6327 153 SRLLNAKLADFGFSRLLRTPK---ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--- 226 (351)
Q Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--- 226 (351)
+.++.+||+|||+++...... ......+||+.|+|||++.+......++|||||||++|+|++|.+||......
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 245 (405)
T 3rgf_A 166 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245 (405)
T ss_dssp TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence 667899999999998765432 22345689999999999987554444599999999999999999999654321
Q ss_pred ----chHHHHhhh---Ccc-------------------------c--------cccccccCCHhHHHHHHHhcCCCCCCC
Q psy6327 227 ----NRDVLKKQE---GKE-------------------------Y--------LFNRKYEISIGAKQLIGRMLEPNPKHR 266 (351)
Q Consensus 227 ----~~~~~~~~~---~~~-------------------------~--------~~~~~~~~s~~~~~li~~~L~~dp~~R 266 (351)
..+.+..+. ... + ........+..+.+||.+||++||.+|
T Consensus 246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R 325 (405)
T 3rgf_A 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 325 (405)
T ss_dssp -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence 011111100 000 0 000011237789999999999999999
Q ss_pred CCHHHHhcCccccCCcc
Q psy6327 267 PNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 267 pt~~ell~hp~~~~~~~ 283 (351)
||+.|+|+||||+..+.
T Consensus 326 ~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 326 ITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp CCHHHHHTSGGGTSSSC
T ss_pred CCHHHHhcChhhccCCC
Confidence 99999999999987654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=351.77 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=209.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.+..+++.||+|++......... ...+.+|+.++++++||||+++++++...+..++||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH-HHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 4699999999999999999999999999999998765443222 234558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC---CCeEEeec
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL---LNAKLADF 163 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~---~~~kl~Df 163 (351)
||+++++|.+++.. ...+++... ..++.|++.||.|||++|++|+||||+||+++.+ +.+||+||
T Consensus 101 e~~~~~~L~~~l~~--~~~~~~~~~----------~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 101 ELYTGGELFDEIIK--RKRFSEHDA----------ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp CCCCSCBHHHHHHH--HSSCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EccCCCCHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEecc
Confidence 99999999999876 345665543 3467888899999999999999999999999764 46999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc--cc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY--LF 241 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~ 241 (351)
|++....... ......||+.|+|||++.+. ++. ++||||||+++|+|++|..||.... ............+ ..
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~-~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 169 GLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDE-KCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAFDL 243 (287)
T ss_dssp TGGGTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCT-HHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCS
T ss_pred CcceeecCCC-ccccccCcccccChHHhcCC-CCC-chhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCc
Confidence 9998754432 23345689999999998764 554 4999999999999999999997654 3333333333322 22
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
+....++.++.+||.+||+.||++|||+.++++||||+.
T Consensus 244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 333478999999999999999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=354.56 Aligned_cols=263 Identities=25% Similarity=0.439 Sum_probs=207.9
Q ss_pred cceeeeeecCcccceEEEEEEec-CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC---CCCCceeeeeEEE-----
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV---SHPNIIGVHRMVK----- 77 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~----- 77 (351)
.+|++++.||+|+||.||+|.+. .+++.||+|++......... ...+.+|+.+++.+ .||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-CchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 56999999999999999999995 77899999998754432211 22334777777766 8999999999987
Q ss_pred eCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC
Q psy6327 78 AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN 157 (351)
Q Consensus 78 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~ 157 (351)
.....++||||++ |+|.+++.......+++.... .++.|++.||.|||++||+||||||+|||++.++.
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~----------~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIK----------DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHH----------HHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC
Confidence 5678999999998 799999987544556665433 46778889999999999999999999999999999
Q ss_pred eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC-
Q psy6327 158 AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG- 236 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~- 236 (351)
+||+|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... .......+..
T Consensus 159 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~ 234 (326)
T 1blx_A 159 IKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDV 234 (326)
T ss_dssp EEECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHH
T ss_pred EEEecCcccccccCCC-CccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHH
Confidence 9999999998754332 3345679999999999988887765 999999999999999999997654 2222211110
Q ss_pred --c----------------------cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcccc
Q psy6327 237 --K----------------------EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQ 285 (351)
Q Consensus 237 --~----------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 285 (351)
. .........++..+++||.+||+.||++|||+.++++||||++...+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 0 000011235789999999999999999999999999999998766543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=358.86 Aligned_cols=259 Identities=27% Similarity=0.377 Sum_probs=180.7
Q ss_pred CCccceeeee-ecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe----
Q psy6327 4 PDILECSYIS-KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA---- 78 (351)
Q Consensus 4 ~~~~~~~~~~-~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~---- 78 (351)
.-..+|.+++ .||+|+||.||+|.++.+++.||+|++...... ..+....++.+.||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA-------RQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH-------HHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH-------HHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 3446799976 599999999999999999999999998543211 1123334567789999999999976
Q ss_pred CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---C
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---L 155 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~ 155 (351)
+...++||||++||+|.+++.......+++..+. .++.|++.||.|||++||+||||||+|||++. +
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~----------~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~ 167 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAA----------EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKD 167 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHH----------HHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHH----------HHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCC
Confidence 5568999999999999999987544567776544 46778888889999999999999999999976 4
Q ss_pred CCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch--HHHHh
Q psy6327 156 LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR--DVLKK 233 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~ 233 (351)
+.+||+|||+++..... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||........ .....
T Consensus 168 ~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (336)
T 3fhr_A 168 AVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244 (336)
T ss_dssp CCEEECCCTTCEEC------------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC---------------
T ss_pred ceEEEeccccceecccc--ccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh
Confidence 55999999999865432 2345678999999999987777765 9999999999999999999965442211 11111
Q ss_pred hhCccc--cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 234 QEGKEY--LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 234 ~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.....+ ..+....++.++.+||.+||+.||++|||+.|+++||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 245 IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 111111 1222346899999999999999999999999999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=367.69 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=200.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC--------CCCceeeeeEEE-
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS--------HPNIIGVHRMVK- 77 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--------hp~iv~~~~~~~- 77 (351)
.+|+++++||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+. ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH----YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc----chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 469999999999999999999999999999999864322 2334458999999885 788999999987
Q ss_pred ---eCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEc
Q psy6327 78 ---AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILIS 153 (351)
Q Consensus 78 ---~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~ 153 (351)
.+...|+||||+ +++|.+.+.......+++..+. .++.||+.||+|||++ ||+||||||+|||++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~----------~i~~qi~~aL~~lH~~~givHrDikp~NIll~ 181 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK----------KIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHH----------HHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHH----------HHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe
Confidence 566899999999 5777777766444567765544 4677888899999998 999999999999998
Q ss_pred CCC-------------------------------------------------CeEEeeccccccccCCcccccccccccc
Q psy6327 154 RLL-------------------------------------------------NAKLADFGFSRLLRTPKELSNTFCGTTS 184 (351)
Q Consensus 154 ~~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~ 184 (351)
.++ .+||+|||+++..... ....+||+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~ 258 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQ 258 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGG
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCc
Confidence 765 7999999999875432 345579999
Q ss_pred eeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch----HHHHhh---hCcc---------c---------
Q psy6327 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR----DVLKKQ---EGKE---------Y--------- 239 (351)
Q Consensus 185 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~~~~---~~~~---------~--------- 239 (351)
|+|||++.+..++.+ +|||||||++|+|++|..||...+.... .....+ .... +
T Consensus 259 y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 259 YRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred ccCChhhcCCCCCcH-HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 999999998888765 9999999999999999999975442211 111000 0000 0
Q ss_pred -------------------cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 240 -------------------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 240 -------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
........+..+.+||.+||+.||++|||+.|+|+||||++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00011234567899999999999999999999999999963
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=356.99 Aligned_cols=260 Identities=27% Similarity=0.395 Sum_probs=202.6
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----C
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG-----T 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~ 80 (351)
..+|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 457999999999999999999999999999999985432 222233445899999999999999999988654 6
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+||||+. ++|.+++.. ..+++... ..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~----------~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST---QMLSDDHI----------QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH---CCCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred eEEEEEeccC-ccHHHHHhh---cCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEE
Confidence 7999999997 799999875 45665543 346778889999999999999999999999999999999
Q ss_pred eeccccccccCCccc----------ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHH
Q psy6327 161 ADFGFSRLLRTPKEL----------SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV 230 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 230 (351)
+|||+++........ ....+||+.|+|||++........++|||||||++|+|++|..||.+.+.. ..
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 231 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--HQ 231 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 999999876532211 223578999999998865333334599999999999999999999765421 11
Q ss_pred HHhh---hCcc---------------------------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 231 LKKQ---EGKE---------------------------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 231 ~~~~---~~~~---------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
...+ .... ........++.++.+||.+||+.||++|||+.++++||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 1100 0000 000111368899999999999999999999999999999986
Q ss_pred Ccc
Q psy6327 281 EPT 283 (351)
Q Consensus 281 ~~~ 283 (351)
...
T Consensus 312 ~~~ 314 (353)
T 2b9h_A 312 YHD 314 (353)
T ss_dssp TCC
T ss_pred cCC
Confidence 543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=357.24 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=199.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE-----
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY----- 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~----- 81 (351)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHH-HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchH-HHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 469999999999999999999999999999999865443332 33445589999999999999999999987653
Q ss_pred -EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 82 -LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 82 -~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.|+||||+. ++|.+++. ..+++..+ ..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~----------~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKI----------QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEE
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHH----------HHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEE
Confidence 599999997 78888774 34565443 346778889999999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN-SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--- 236 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--- 236 (351)
+|||+++..... ....+||+.|+|||++.+ ..++. ++|||||||++|+|++|..||.+.+. .+....+..
T Consensus 168 ~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~ 241 (353)
T 3coi_A 168 LDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQ-TVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTG 241 (353)
T ss_dssp CSTTCTTC-----------CCSBCCSCHHHHSCCSCCCT-THHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHHHHHHHC
T ss_pred eecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhC
Confidence 999999865432 345678999999999877 44554 49999999999999999999976542 111111100
Q ss_pred --------------------------ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 237 --------------------------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 237 --------------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
..........++.++.+||.+||+.||++|||+.++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0000111235789999999999999999999999999999998543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=358.96 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=204.3
Q ss_pred cceeeeeecCcccceEEEEEEec-------CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-------RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA 78 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 78 (351)
.+|++.+.||+|+||.||+|.+. .++..||+|++...... .....+.+|+.+++.+ +||||+++++++.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH--HHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 57999999999999999999864 45678999998654322 2234456899999999 89999999999999
Q ss_pred CCEEEEEEecCCCCChHHHHHhhcc--------------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceecc
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACN--------------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRD 144 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~D 144 (351)
.+.+|+||||++||+|.+++..... ..++. ..++.++.||+.||.|||++||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~i~~qi~~aL~~LH~~~ivHrD 228 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF----------KDLVSCTYQLARGMEYLASQKCIHRD 228 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCH----------HHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCH----------HHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 9999999999999999999986421 12232 23456788999999999999999999
Q ss_pred CCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy6327 145 IKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFG 221 (351)
Q Consensus 145 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 221 (351)
|||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.
T Consensus 229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp CCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred cchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999987654332 2234457899999999988887765 999999999999999 999997
Q ss_pred CCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 222 DPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
+.. ........... .....+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 308 ~~~--~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 308 GIP--VEELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TCC--GGGHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC--HHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 654 23333333222 2233345789999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=354.41 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=202.9
Q ss_pred ccceeeeeecCcccceEEEEEEecCCce---eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSET---LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
..+|++.+.||+|+||.||+|.+..++. .||+|++...... .....+.+|+.++++++||||+++++++.+++..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 4569999999999999999999986554 5999998654322 2234556899999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||||++|++|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 126 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 194 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH-DGQFTIMQ----------LVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSD 194 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT-TTCSCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEeeCCCCCcHHHHHHhc-ccCCCHHH----------HHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECC
Confidence 9999999999999999653 34555544 345678889999999999999999999999999999999999
Q ss_pred ccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcc
Q psy6327 163 FGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 163 fg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
||+++........ .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.. ...........
T Consensus 195 fg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~~~- 270 (325)
T 3kul_A 195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMT--NRDVISSVEEG- 270 (325)
T ss_dssp CSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSC--HHHHHHHHHTT-
T ss_pred CCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcC-
Confidence 9999876543322 223446789999999988887765 999999999999999 999997654 33444433322
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...+.+..++..+.+||.+||+.||++|||+.++++
T Consensus 271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 334445578999999999999999999999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=352.50 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=196.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE---------
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK--------- 77 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--------- 77 (351)
.+|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh---HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 469999999999999999999999999999999865432 22344558999999999999999999873
Q ss_pred -----eCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE
Q psy6327 78 -----AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI 152 (351)
Q Consensus 78 -----~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll 152 (351)
.....|+||||++ |+|.+++.. ..+++.... .++.|++.||+|||++||+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~----------~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 153 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHAR----------LFMYQLLRGLKYIHSANVLHRDLKPANLFI 153 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHH----------HHHHHHHHHHHHHHhCCEecCCCCHHHEEE
Confidence 4578999999998 699999864 456655433 467788899999999999999999999999
Q ss_pred c-CCCCeEEeeccccccccCCc---ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch
Q psy6327 153 S-RLLNAKLADFGFSRLLRTPK---ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR 228 (351)
Q Consensus 153 ~-~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 228 (351)
+ .++.+||+|||+++...... .......||+.|+|||++........++|||||||++|+|++|+.||.... ..
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~ 231 (320)
T 2i6l_A 154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH--EL 231 (320)
T ss_dssp ETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HH
T ss_pred cCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC--HH
Confidence 7 56789999999998764322 123345679999999998763333345999999999999999999997654 22
Q ss_pred HHHHhhhCcc----------------------------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 229 DVLKKQEGKE----------------------------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 229 ~~~~~~~~~~----------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.......... ........++.++.+||.+||+.||++|||+.|+++||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 2221111000 000111358999999999999999999999999999999986
Q ss_pred Ccc
Q psy6327 281 EPT 283 (351)
Q Consensus 281 ~~~ 283 (351)
...
T Consensus 312 ~~~ 314 (320)
T 2i6l_A 312 YSF 314 (320)
T ss_dssp TCC
T ss_pred ccC
Confidence 543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=354.50 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=201.1
Q ss_pred cceeeeeecCcccceEEEEEEe-cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCC------CceeeeeEEEeC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSD-KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP------NIIGVHRMVKAG 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp------~iv~~~~~~~~~ 79 (351)
.+|++++.||+|+||.||+|.+ ..+++.||+|++..... ....+.+|+.+++.++|+ +++++++++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR----YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc----hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 4699999999999999999998 56899999999864321 233445899999888654 599999999999
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-----
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR----- 154 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~----- 154 (351)
+..++||||+ +++|.+++.......+++..+ ..++.|++.||+|||++||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~----------~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHI----------RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHH----------HHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccc
Confidence 9999999999 799999998754445665543 346778889999999999999999999999987
Q ss_pred --------------CCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy6327 155 --------------LLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220 (351)
Q Consensus 155 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 220 (351)
++.+||+|||+++.... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSC
T ss_pred ccCCccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCC
Confidence 66799999999986433 2345679999999999988887765 99999999999999999999
Q ss_pred CCCCCCchHHHHhh---hCcc------------c---------------------------cccccccCCHhHHHHHHHh
Q psy6327 221 GDPGTRNRDVLKKQ---EGKE------------Y---------------------------LFNRKYEISIGAKQLIGRM 258 (351)
Q Consensus 221 ~~~~~~~~~~~~~~---~~~~------------~---------------------------~~~~~~~~s~~~~~li~~~ 258 (351)
...+. .+..... .... + ........++++.+||.+|
T Consensus 235 ~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 235 PTHDS--KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp CCSCH--HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCh--HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 76542 2211111 0000 0 0000112356789999999
Q ss_pred cCCCCCCCCCHHHHhcCccccCC
Q psy6327 259 LEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 259 L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
|+.||.+|||+.|+++||||+..
T Consensus 313 L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 313 LEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp TCSSTTTSCCHHHHTTSGGGGGG
T ss_pred hCcCcccccCHHHHhcCHHHHHH
Confidence 99999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=362.30 Aligned_cols=264 Identities=21% Similarity=0.323 Sum_probs=203.9
Q ss_pred cceeeeeecCcccceEEEEEE-----ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVS-----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.+|++.+.||+|+||.||+|. +..+++.||+|++........ ...+.+|+.+++++ +||||+++++++.+.+
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHH--HHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 579999999999999999998 567789999999865433222 34456899999999 7999999999987754
Q ss_pred -EEEEEEecCCCCChHHHHHhhccCCCchHHHHHH---------------------------------------------
Q psy6327 81 -YLYMIMDYAEKKDLEHYISKACNENIHENQARIW--------------------------------------------- 114 (351)
Q Consensus 81 -~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~--------------------------------------------- 114 (351)
..++|||||+||+|.+++........+.......
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 5899999999999999998643211100000000
Q ss_pred ---------HHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcc--ccccccccc
Q psy6327 115 ---------IRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTT 183 (351)
Q Consensus 115 ---------~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~ 183 (351)
......++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....... ......||+
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 012234566888999999999999999999999999999999999999999987643322 334567899
Q ss_pred ceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCC
Q psy6327 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPN 262 (351)
Q Consensus 184 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 262 (351)
.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.............. .....+..+++++.++|.+||+.|
T Consensus 260 ~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~d 336 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--TRMRAPDYTTPEMYQTMLDCWHGE 336 (359)
T ss_dssp GGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT--CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred eeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC--CCCCCCCCCCHHHHHHHHHHccCC
Confidence 9999999988887765 999999999999998 999997765332222222222 223334468999999999999999
Q ss_pred CCCCCCHHHHhcC
Q psy6327 263 PKHRPNAKDVQNH 275 (351)
Q Consensus 263 p~~Rpt~~ell~h 275 (351)
|.+|||+.|+++|
T Consensus 337 P~~Rps~~ell~~ 349 (359)
T 3vhe_A 337 PSQRPTFSELVEH 349 (359)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999876
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=360.54 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=198.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CC-----CceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HP-----NIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp-----~iv~~~~~~~~~~ 80 (351)
.+|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+. |+ +|+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA----FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH----HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 579999999999999999999999999999999864332 1233447888888875 44 4999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhH--hCCceeccCCCCCEeEc--CCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLH--EVGIVHRDIKCENILIS--RLL 156 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~NIll~--~~~ 156 (351)
..|+||||+. ++|.+++.......+++...+ .++.|++.||.||| +.||+||||||+|||++ .++
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~----------~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTR----------KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHH----------HHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHH----------HHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 9999999996 699999987544556665543 46778888888999 57999999999999995 467
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 236 (351)
.+||+|||+++.... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+. .+....+..
T Consensus 199 ~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~--~~~~~~i~~ 272 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANE--VDQMNKIVE 272 (382)
T ss_dssp CEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred cEEEEeccCceeccc---ccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence 899999999987643 2345679999999999998888765 9999999999999999999976542 222211110
Q ss_pred ---c----------------------ccc------------ccccc-------------------------cCCHhHHHH
Q psy6327 237 ---K----------------------EYL------------FNRKY-------------------------EISIGAKQL 254 (351)
Q Consensus 237 ---~----------------------~~~------------~~~~~-------------------------~~s~~~~~l 254 (351)
. .+. .+... ..++++.+|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 352 (382)
T 2vx3_A 273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352 (382)
T ss_dssp HHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred HhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence 0 000 00000 001378999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 255 IGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 255 i~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
|.+||++||++|||+.|+|+||||+..
T Consensus 353 i~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 353 ILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHhcCCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=361.79 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=204.5
Q ss_pred cceeeeeecCcccceEEEEEE-----ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVS-----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|++++.||+|+||.||+|. +..++..||+|++....... ....+.+|+.++++++||||+++++++.....
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 569999999999999999999 55678899999986432222 23345589999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhcc-----CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 82 LYMIMDYAEKKDLEHYISKACN-----ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~-----~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
.|+||||++||+|.+++..... ..++.. .++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~----------~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHH----------HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHH----------HHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC
Confidence 9999999999999999987432 224433 3445788899999999999999999999999999554
Q ss_pred ---CeEEeeccccccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q psy6327 157 ---NAKLADFGFSRLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDV 230 (351)
Q Consensus 157 ---~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 230 (351)
.+||+|||+++...... .......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.... ....
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~--~~~~ 295 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKS--NQEV 295 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCC--HHHH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCC--HHHH
Confidence 59999999998653222 23345668999999999988887765 999999999999998 999997654 3344
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
........ ....+..++..+.+||.+||+.||++|||+.+++++.+.
T Consensus 296 ~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 296 LEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHcCC-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 44333322 223344789999999999999999999999999998765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=352.37 Aligned_cols=260 Identities=19% Similarity=0.322 Sum_probs=187.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCce---eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE-
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSET---LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL- 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~- 82 (351)
.+|++.+.||+|+||.||+|.+..++. .||+|++......... ...+.+|+.++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH-HHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH-HHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 469999999999999999999887765 8999998765443333 34455999999999999999999999877655
Q ss_pred -----EEEEecCCCCChHHHHHhhccC----CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 83 -----YMIMDYAEKKDLEHYISKACNE----NIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 83 -----~lv~e~~~ggsL~~~l~~~~~~----~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
++||||+++|+|.+++...... .+++.. ++.++.|++.||.|||++||+||||||+|||++
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~----------~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT----------LVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA 171 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHH----------HHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc
Confidence 9999999999999999754322 345443 345678889999999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q psy6327 154 RLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDV 230 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 230 (351)
.++.+||+|||+++....... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.. ....
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~--~~~~ 248 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIE--NAEI 248 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCC--GGGH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccC--hHHH
Confidence 999999999999987644332 2233457889999999988887765 999999999999999 999997655 3333
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCC-------HHHHhcCccccCC
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPN-------AKDVQNHAWIQNE 281 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-------~~ell~hp~~~~~ 281 (351)
........ .......+++++.+||.+||+.||++||| ++++++|||+...
T Consensus 249 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 249 YNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred HHHHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 33333222 22334478999999999999999999999 7778889999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=350.04 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=192.7
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++++.||+|+||.||+|.+..+|+.||+|++........ ....+.++..+++.++||||+++++++.+.+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH-HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 46789999999999999999999999999999999876543332 23334455667888899999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEcCCCCeEEeec
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
||||+ ++.+..+... ....+++.... .++.|++.||.|||++ ||+|+||||+|||++.++.+||+||
T Consensus 102 v~e~~-~~~~~~l~~~-~~~~~~~~~~~----------~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKR-MQGPIPERILG----------KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp EECCC-SEEHHHHHHH-HTSCCCHHHHH----------HHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEecc-CCcHHHHHHH-hccCCCHHHHH----------HHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEEC
Confidence 99999 4666655543 24566665443 4677888899999995 9999999999999999999999999
Q ss_pred cccccccCCcccccccccccceecccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|++....... ......||+.|+|||++. ...++. ++|||||||++|+|++|..||..................
T Consensus 170 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 170 GISGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDI-RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP 247 (318)
T ss_dssp TTC---------------CCTTCCHHHHC--------CCT-HHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC
T ss_pred CCchhccCCc-cccccCCCccccChhhcccccccccCCcc-ccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC
Confidence 9997654432 233457999999999985 344454 499999999999999999999764432222223333333
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
...+....++.++.+||.+||+.||.+|||+.++++||||+.
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 344444568999999999999999999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=346.51 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=198.7
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++..++..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35779999999999999999999999999999999976655555555667799999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||++|++|.+++.. ...+++... +.++.|++.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 112 v~e~~~~~~L~~~l~~--~~~~~~~~~----------~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR--QGPLAPPRA----------VAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EEECCCCEEHHHHHHH--HCSCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred EEEecCCCCHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCc
Confidence 9999999999999986 355665543 3467788889999999999999999999999999999999999
Q ss_pred ccccccCCc-ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc-ccc
Q psy6327 165 FSRLLRTPK-ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY-LFN 242 (351)
Q Consensus 165 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~ 242 (351)
++....... .......||+.|+|||++.+..++.+ +||||||+++|+|++|..||..... ............ ...
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 256 (309)
T 2h34_A 180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQL--SVMGAHINQAIPRPST 256 (309)
T ss_dssp C----------------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHH--HHHHHHHHSCCCCGGG
T ss_pred cCccccccccccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchH--HHHHHHhccCCCCccc
Confidence 998754432 22345679999999999988887765 9999999999999999999976432 222222222111 122
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCC-CHHHHhc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRP-NAKDVQN 274 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rp-t~~ell~ 274 (351)
....++.++.++|.+||+.||++|| |++++++
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 3346899999999999999999999 7888765
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=347.93 Aligned_cols=256 Identities=24% Similarity=0.408 Sum_probs=195.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--------
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA-------- 78 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-------- 78 (351)
.+|++++.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 57999999999999999999999999999999985432 123445589999999999999999998854
Q ss_pred -----CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 79 -----GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 79 -----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
.+..|+||||++|++|.+++... ...+++.. +..++.|++.||.|||++||+|+||||+|||++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDE----------YWRLFRQILEALSYIHSQGIIHRDLKPMNIFID 150 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcc-ccccchHH----------HHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc
Confidence 46789999999999999999752 22333333 335678899999999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCc--------------ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q psy6327 154 RLLNAKLADFGFSRLLRTPK--------------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP 219 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 219 (351)
.++.+||+|||++....... .......||+.|+|||++.+......++|||||||++|+|++ |
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence 99999999999998754321 123355799999999999865433345999999999999998 5
Q ss_pred CCCCCCCchHHHHhhhCcccccc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 220 FGDPGTRNRDVLKKQEGKEYLFN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 220 f~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
|.... ...............++ .....+..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 228 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 228 FSTGM-ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp CSSHH-HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred cCCch-hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 53211 12222333332222222 223567889999999999999999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=358.99 Aligned_cols=259 Identities=21% Similarity=0.285 Sum_probs=187.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-----
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT----- 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----- 80 (351)
+.+|++.+.||+|+||.||+|.+..+++.||+|++....... ....+++..++.++||||+++++++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 467999999999999999999999999999999885433222 22237888888999999999999986533
Q ss_pred --EEEEEEecCCCCChHHHHHhh--ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhH--hCCceeccCCCCCEeEcC
Q psy6327 81 --YLYMIMDYAEKKDLEHYISKA--CNENIHENQARIWIRQIANALEYLHEIANALEYLH--EVGIVHRDIKCENILISR 154 (351)
Q Consensus 81 --~~~lv~e~~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~NIll~~ 154 (351)
..++||||++ ++|...+... ....+++... ..++.|++.||.||| ++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~----------~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 98 DIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILI----------KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE 166 (360)
T ss_dssp CEEEEEEEECCS-CBHHHHHHHHHTTTCCCCHHHH----------HHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET
T ss_pred ceeEEEEeeccc-ccHHHHHHHHhhcccCCCHHHH----------HHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC
Confidence 3899999998 5665555432 1334454443 346778888899999 999999999999999997
Q ss_pred -CCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh
Q psy6327 155 -LLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 155 -~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 233 (351)
++.+||+|||+++...... ......||+.|+|||++.+......++|||||||++|+|++|+.||.... .......
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~ 243 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN--SAGQLHE 243 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH
T ss_pred CCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC--hHHHHHH
Confidence 8999999999998765433 33456789999999998766643445999999999999999999997654 2222221
Q ss_pred hhC---------------c--ccc-------------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 234 QEG---------------K--EYL-------------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 234 ~~~---------------~--~~~-------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
+.. . ... .......+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 110 0 000 001112567899999999999999999999999999998653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=356.23 Aligned_cols=259 Identities=25% Similarity=0.338 Sum_probs=194.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhh--------hhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE-
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL--------KRDYMEKFAPREIDILLKVSHPNIIGVHRMVK- 77 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~- 77 (351)
.+|++.+.||+|+||.||+|.+.. +..||+|++..... ......+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 569999999999999999999865 89999999854322 12223355669999999999999999999984
Q ss_pred ----eCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 78 ----AGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 78 ----~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
.....|+||||+. |+|.+++... ...+++.... .++.||+.||.|||++||+||||||+|||++
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~----------~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQ----------YFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHH----------HHHHHHHHHHHHHHHCcCEecCCChHHEEEc
Confidence 3447999999998 7888888753 3456655443 4677888899999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh
Q psy6327 154 RLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 233 (351)
.++.+||+|||+++..... ......+||+.|+|||++.+......++|||||||++|+|++|+.||..... ......
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~ 245 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF--YNQLNK 245 (362)
T ss_dssp TTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH
T ss_pred CCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 9999999999999854432 2334567999999999988743334459999999999999999999976542 222111
Q ss_pred hhC------------------------cc------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 234 QEG------------------------KE------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 234 ~~~------------------------~~------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
+.. .. ........+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 100 00 0001122568899999999999999999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=341.90 Aligned_cols=251 Identities=21% Similarity=0.394 Sum_probs=205.5
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+..+|++++.||+|+||.||+|.+. ++..+|+|++....... ..+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence 4568999999999999999999987 46779999987654433 234589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++++|.+++... ...+++... +.++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 83 v~e~~~~~~L~~~l~~~-~~~~~~~~~----------~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 151 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQ-RGLFAAETL----------LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG 151 (269)
T ss_dssp EEECCTTCBHHHHHHTT-TTCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred EEEeCCCCcHHHHHHhc-CcccCHHHH----------HHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccc
Confidence 99999999999999753 334555443 3467788999999999999999999999999999999999999
Q ss_pred ccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
+++....... ......||+.|+|||++.+..++.+ +||||+|+++|+|++ |..||.... ........... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~--~~~~~~~~~~~-~~~~ 227 (269)
T 4hcu_A 152 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTG-FRLY 227 (269)
T ss_dssp GGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTT-CCCC
T ss_pred ccccccccccccccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHhcC-ccCC
Confidence 9986543321 2334557889999999988887765 999999999999999 999997654 33444333332 2223
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.+..++..+.+++.+||+.||++|||+.++++|
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 334679999999999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=342.41 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=194.7
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh-HHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR-DYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
+..+|++.+.||+|+||.||+|.+. +..+|+|++....... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 4678999999999999999999875 8899999986544332 122345668999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC---ceeccCCCCCEeEcC------
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG---IVHRDIKCENILISR------ 154 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~NIll~~------ 154 (351)
+||||++|++|.+++.. ..+++... ..++.|++.||.|||++| |+||||||+|||++.
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~----------~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG---KRIPPDIL----------VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp EEEECCTTEEHHHHHTS---SCCCHHHH----------HHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred EEEEcCCCCCHHHHhhc---CCCCHHHH----------HHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence 99999999999999863 45666543 346778888999999999 899999999999986
Q ss_pred --CCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q psy6327 155 --LLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 155 --~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 232 (351)
++.+||+|||+++...... .....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.... ......
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~ 224 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGID--GLAVAY 224 (271)
T ss_dssp CSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSC--HHHHHH
T ss_pred ccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC--HHHHHH
Confidence 6779999999998654432 234579999999999988877765 999999999999999999997654 333443
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.........+.+..+++.+.++|.+||+.||.+|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 4444444445556789999999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=343.05 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=203.4
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHH----hhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM----EKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
..+|++.+.||+|+||.||+|.+..+++.||+|++.......... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 356999999999999999999999999999999986544332211 145568999999999999999999997776
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEcCCCC--
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILISRLLN-- 157 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~~~~~-- 157 (351)
++||||+++++|.+++... ...+++... +.++.|++.||.|||++| |+||||||+|||++.++.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~----------~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~ 164 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVK----------LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT-TSCCCHHHH----------HHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTC
T ss_pred -eEEEEecCCCCHHHHHhcc-cCCccHHHH----------HHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCC
Confidence 6999999999999988653 345565443 346778889999999999 999999999999988776
Q ss_pred ---eEEeeccccccccCCcccccccccccceecccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q psy6327 158 ---AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR--NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK 232 (351)
Q Consensus 158 ---~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 232 (351)
+||+|||+++.... ......||+.|+|||++. ...++. ++|||||||++|+|++|..||............
T Consensus 165 ~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 240 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTE-KADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240 (287)
T ss_dssp SCCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECH-HHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred ceeEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCc-hhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence 99999999975433 234567999999999984 333444 499999999999999999999876654444344
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...........+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 433333344445578999999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=353.05 Aligned_cols=252 Identities=29% Similarity=0.485 Sum_probs=207.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH---HHhhhHHHHHHHHHhCC--CCCceeeeeEEEeCC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD---YMEKFAPREIDILLKVS--HPNIIGVHRMVKAGT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~ 80 (351)
..+|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++. ||||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 3469999999999999999999999999999999976554321 11233447999999996 599999999999999
Q ss_pred EEEEEEecCCC-CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc-CCCCe
Q psy6327 81 YLYMIMDYAEK-KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS-RLLNA 158 (351)
Q Consensus 81 ~~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~-~~~~~ 158 (351)
..++|||++.+ ++|.+++.. ...+++.... .++.|++.||.|||++||+||||||+|||++ +++.+
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~----------~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE--RGALQEELAR----------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH--HCSCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred cEEEEEEcCCCCccHHHHHhc--cCCCCHHHHH----------HHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCE
Confidence 99999999986 899999986 4566665443 4677888999999999999999999999999 67899
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
||+|||+++..... ......||+.|+|||++.+..+...++|||||||++|+|++|..||.... .... ..
T Consensus 190 kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~~----~~ 259 (320)
T 3a99_A 190 KLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EIIR----GQ 259 (320)
T ss_dssp EECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHHH----CC
T ss_pred EEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----hhhc----cc
Confidence 99999999876543 23456799999999999877775555899999999999999999996421 1111 11
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
......+++++.+||.+||+.||++|||+.++++||||++.
T Consensus 260 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 260 --VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp --CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 12234689999999999999999999999999999999865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=338.04 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=204.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++++.||+|+||.||+|.+. ++..+|+|++....... ..+.+|+.++++++||||+++++++.+....++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 457999999999999999999776 56779999987655443 2345899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++++|.+++... ...+++... +.++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 82 ~e~~~~~~L~~~l~~~-~~~~~~~~~----------~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSH-GKGLEPSQL----------LEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGM 150 (268)
T ss_dssp EECCTTCBHHHHHHHH-GGGCCHHHH----------HHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred EEccCCCcHHHHHHHc-CCCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcc
Confidence 9999999999999764 334555443 35677888999999999999999999999999999999999999
Q ss_pred cccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 166 SRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 166 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
+........ ......+|+.|+|||++.+..++.+ +||||||+++|+|++ |..||.... ............ ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~ 226 (268)
T 3sxs_A 151 TRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYT--NSEVVLKVSQGH-RLYR 226 (268)
T ss_dssp EEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHTTC-CCCC
T ss_pred ceecchhhhhcccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccC--hHHHHHHHHcCC-CCCC
Confidence 987654332 2234456788999999988887766 999999999999999 999997654 333333333222 2223
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34579999999999999999999999999876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=340.87 Aligned_cols=250 Identities=18% Similarity=0.289 Sum_probs=204.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--CEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--TYL 82 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~ 82 (351)
+..+|++.+.||+|+||.||+|.+. +..+|+|++......... .+.+.+|+.++++++||||+++++++.+. ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHH-HHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHH-HHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 4678999999999999999999985 889999998766544433 34456899999999999999999999877 788
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEcCCCCeEE
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~~~~~~kl 160 (351)
++||||++||+|.+++.......+++... +.++.|++.||.|||++| ++||||||+|||++.++.++|
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l 154 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQA----------VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARI 154 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHH----------HHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEE
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHH----------HHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeE
Confidence 99999999999999998744334666544 346778888999999999 999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCC--cchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPK--LADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
+|||++..... ....||+.|+|||++.+..++.. ++|||||||++|+|++|..||.... ............
T Consensus 155 ~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~ 227 (271)
T 3kmu_A 155 SMADVKFSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--NMEIGMKVALEG 227 (271)
T ss_dssp EGGGSCCTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--HHHHHHHHHHSC
T ss_pred Eeccceeeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--hHHHHHHHHhcC
Confidence 99998765322 34568999999999987665542 4899999999999999999997654 333333333233
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.....+..++.++.++|.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 333444578999999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=358.99 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=204.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ... ....+.+|+.++++++||||+++++++...+..|+|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPD-LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHH-HHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHH-HHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 357999999999999999999999999999999986432 222 233455899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+++|+|.+++... ...++... ++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 191 ~e~~~~g~L~~~l~~~-~~~~~~~~----------~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE-GARLRVKT----------LLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp EECCTTCBHHHHHHHH-GGGCCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHH----------HHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 9999999999999763 23455433 345788899999999999999999999999999999999999999
Q ss_pred cccccCCcccc--cccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 166 SRLLRTPKELS--NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 166 a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
++......... ....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.... .......... ....+
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~--~~~~~~~~~~-~~~~~ 335 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLS--NQQTREFVEK-GGRLP 335 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSC--HHHHHHHHHT-TCCCC
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc-CCCCC
Confidence 98654332211 22346788999999988877765 999999999999998 999997654 3333333322 23334
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+..+++++.+||.+||+.||++|||+.++++
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 45578999999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=346.41 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=199.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC--CCCceeeeeEEEeCCEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS--HPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~~~~l 84 (351)
.+|++++.||+|+||.||+|.+. +++.+|+|++......... ...+.+|+.+++++. ||||+++++++.+.+..|+
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHH-HHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccc-hHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 45999999999999999999986 4889999998765544333 344558999999997 5999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||| +.+++|.+++.. ...+++... ..++.|++.||.|||++||+||||||+|||+++ +.+||+|||
T Consensus 106 v~e-~~~~~L~~~l~~--~~~~~~~~~----------~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK--KKSIDPWER----------KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp EEC-CCSEEHHHHHHH--CSSCCHHHH----------HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred EEe-cCCCcHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecc
Confidence 999 557999999986 456665443 346778889999999999999999999999975 889999999
Q ss_pred ccccccCCcc--cccccccccceeccccccC-----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q psy6327 165 FSRLLRTPKE--LSNTFCGTTSYAAPEIIRN-----------SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL 231 (351)
Q Consensus 165 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 231 (351)
+++....... ......||+.|+|||++.+ ..++. ++|||||||++|+|++|..||...... ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~-~~~~ 249 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP-KSDVWSLGCILYYMTYGKTPFQQIINQ-ISKL 249 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCH-HHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCc-hHHHHHHHHHHHHHHhCCCchhhHHHH-HHHH
Confidence 9987644322 2235579999999999875 23443 499999999999999999999765422 2222
Q ss_pred HhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 232 KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
............+...+.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 22222223333344568899999999999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=357.78 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=200.1
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-----------CCCceeeee
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-----------HPNIIGVHR 74 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hp~iv~~~~ 74 (351)
..+|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+|+.+++++. ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc----hhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35799999999999999999999999999999998744322 233458999988876 899999999
Q ss_pred EEEeCC----EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCC
Q psy6327 75 MVKAGT----YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCEN 149 (351)
Q Consensus 75 ~~~~~~----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~N 149 (351)
++...+ ..++||||+ +++|.+++.......+++..+ ..++.||+.||.|||++ ||+||||||+|
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~----------~~i~~qi~~aL~~lH~~~~ivH~Dikp~N 162 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV----------KQISKQLLLGLDYMHRRCGIIHTDIKPEN 162 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHH----------HHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHH----------HHHHHHHHHHHHHHHhcCCEEecCCChHH
Confidence 997654 899999999 899999998765556666543 34677889999999998 99999999999
Q ss_pred EeEcC------CCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy6327 150 ILISR------LLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP 223 (351)
Q Consensus 150 Ill~~------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (351)
||++. .+.+||+|||+++..... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---
T ss_pred eEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCC
Confidence 99953 347999999999875432 344579999999999998887765 99999999999999999999754
Q ss_pred CCCc----hHHHHhhh---Cccc-------------------------------------cccccccCCHhHHHHHHHhc
Q psy6327 224 GTRN----RDVLKKQE---GKEY-------------------------------------LFNRKYEISIGAKQLIGRML 259 (351)
Q Consensus 224 ~~~~----~~~~~~~~---~~~~-------------------------------------~~~~~~~~s~~~~~li~~~L 259 (351)
.... ........ ...+ ....+..++.++.+||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 3110 11110000 0000 00111245678899999999
Q ss_pred CCCCCCCCCHHHHhcCccccCCc
Q psy6327 260 EPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 260 ~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
+.||++|||+.|+++||||++..
T Consensus 319 ~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CSSTTTCBCHHHHHTCGGGTTCT
T ss_pred ccCccccCCHHHHhhChhhhccc
Confidence 99999999999999999998653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=352.24 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=199.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCc-eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCC------ceeeeeEEEeC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSE-TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN------IIGVHRMVKAG 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~------iv~~~~~~~~~ 79 (351)
.+|++++.||+|+||.||+|.+..++ ..||+|++..... ....+.+|+.+++.+.|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK----YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc----chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 46999999999999999999998776 7999999864322 2334458999999887655 89999999999
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE-------
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI------- 152 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll------- 152 (351)
+..++||||+ +++|.+++.......+++..+ ..++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~----------~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHV----------RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHH----------HHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHH----------HHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 9999999999 588888887654456666544 3467788899999999999999999999999
Q ss_pred ------------cCCCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy6327 153 ------------SRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220 (351)
Q Consensus 153 ------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 220 (351)
+.++.+||+|||+++.... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCC
Confidence 5678899999999986433 2345679999999999988887765 99999999999999999999
Q ss_pred CCCCCCchHHHHh---hhCccc---------------------------------------cccccccCCHhHHHHHHHh
Q psy6327 221 GDPGTRNRDVLKK---QEGKEY---------------------------------------LFNRKYEISIGAKQLIGRM 258 (351)
Q Consensus 221 ~~~~~~~~~~~~~---~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~ 258 (351)
..... ...... .....+ ........+.++.+||.+|
T Consensus 240 ~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 240 QTHEN--REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp CCSSH--HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCH--HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 76542 211111 100000 0000112245789999999
Q ss_pred cCCCCCCCCCHHHHhcCccccCC
Q psy6327 259 LEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 259 L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
|+.||++|||+.|+++||||++.
T Consensus 318 L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 318 LEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TCSSTTTSCCHHHHTTSGGGGGC
T ss_pred hcCChhhCcCHHHHhcChhhcCC
Confidence 99999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=352.85 Aligned_cols=264 Identities=19% Similarity=0.337 Sum_probs=204.2
Q ss_pred cceeeeeecCcccceEEEEEEe-----cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSD-----KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.+|++.+.||+|+||.||+|.+ ..++..||+|++...... .....+.+|+.+++++ +||||+++++++...+
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 5689999999999999999997 346778999998644322 2234556999999999 8999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHH------------HHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARI------------WIRQIANALEYLHEIANALEYLHEVGIVHRDIKCE 148 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~------------~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~ 148 (351)
..|+||||+++|+|.+++..... .+++..... .......++.++.||+.||.|||++||+||||||+
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKRE-KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTT-CC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred ccEEEEecCCCCcHHHHHhhccc-cccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 99999999999999999976422 211111000 00122345568889999999999999999999999
Q ss_pred CEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCC
Q psy6327 149 NILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGT 225 (351)
Q Consensus 149 NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 225 (351)
|||++.++.+||+|||++........ ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+...
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999999999987644322 2334567899999999988887765 999999999999998 9999977653
Q ss_pred CchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q psy6327 226 RNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276 (351)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 276 (351)
.. ....... .....+.+..+++++.+||.+||+.||.+|||+.++++|.
T Consensus 281 ~~-~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 281 DA-NFYKLIQ-NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SH-HHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH-HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 22 2222222 2233334457899999999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=342.87 Aligned_cols=251 Identities=23% Similarity=0.386 Sum_probs=208.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+..++..+|+|.+...... ...+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 45699999999999999999999999999999998654332 23345899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++|++|.+++.......+++... +.++.|++.||.|||++||+|+||||+||+++.++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~----------~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHH----------HHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHH----------HHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999998755555666543 34677888999999999999999999999999999999999999
Q ss_pred cccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 166 SRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 166 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
+........ ......+|+.|+|||++.+..++.+ +||||||+++|+|++ |..||..... ......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~~~-~~~~~~ 233 (288)
T 3kfa_A 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEK-DYRMER 233 (288)
T ss_dssp GGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHT-TCCCCC
T ss_pred ceeccCCccccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhc-cCCCCC
Confidence 987654332 2334557889999999988887765 999999999999999 9999976553 222222222 223344
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 4578999999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=350.85 Aligned_cols=253 Identities=22% Similarity=0.381 Sum_probs=204.5
Q ss_pred cceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|++++.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.++++++||||+++++++.+++.
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 56999999999999999999987 4569999999865432 2224456699999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhcc----------------------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC
Q psy6327 82 LYMIMDYAEKKDLEHYISKACN----------------------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVG 139 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~----------------------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~ 139 (351)
.|+||||+++|+|.+++..... ..+++ ..++.++.||+.||.|||++|
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~----------~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC----------AEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCH----------HHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCH----------HHHHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999976321 23333 334567889999999999999
Q ss_pred ceeccCCCCCEeEcCCCCeEEeeccccccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-C
Q psy6327 140 IVHRDIKCENILISRLLNAKLADFGFSRLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-K 216 (351)
Q Consensus 140 i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g 216 (351)
|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.+ +|||||||++|+|++ |
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g 273 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTT
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcC
Confidence 9999999999999999999999999998654332 22334568999999999988887765 999999999999999 9
Q ss_pred CCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 217 KYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 217 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..||.+.. ............. ...+..++.++.+||.+||+.||++|||+.+++++
T Consensus 274 ~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 274 LQPYYGMA--HEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CCTTTTSC--HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCCCC--hHHHHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99997654 3333333333222 22334789999999999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=346.46 Aligned_cols=254 Identities=20% Similarity=0.341 Sum_probs=205.0
Q ss_pred cceeeeeecCcccceEEEEEEe-----cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSD-----KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.+|++.+.||+|+||.||+|.+ ..+++.||+|.+....... ....+.+|+.+++++ +||||+++++++..++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH--HHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 4699999999999999999984 5678999999987543322 234556899999999 8999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccC----------------CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceecc
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNE----------------NIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRD 144 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~----------------~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~D 144 (351)
..++||||+++|+|.+++...... .+++. .++.++.|++.||.|||++||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~qi~~~l~~lH~~~i~H~d 170 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE----------DLLSFSYQVAKGMAFLASKNCIHRD 170 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHH----------HHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHH----------HHHHHHHHHHHHHHHHHHCCeecCC
Confidence 999999999999999999864322 23433 3455788899999999999999999
Q ss_pred CCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy6327 145 IKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFG 221 (351)
Q Consensus 145 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 221 (351)
|||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSST
T ss_pred CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987654432 2334567899999999988877765 999999999999998 999997
Q ss_pred CCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 222 DPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....... ..... ........+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~-~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 250 GMPVDSK-FYKMI-KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp TCCSSHH-HHHHH-HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchhH-HHHHh-ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 6553322 21111 1122233344789999999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=349.38 Aligned_cols=252 Identities=30% Similarity=0.477 Sum_probs=200.6
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH---HHhhhHHHHHHHHHhC----CCCCceeeeeEEEeC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD---YMEKFAPREIDILLKV----SHPNIIGVHRMVKAG 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l----~hp~iv~~~~~~~~~ 79 (351)
.+|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++ +||||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 469999999999999999999999999999999976544221 1123334799999998 899999999999999
Q ss_pred CEEEEEEec-CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc-CCCC
Q psy6327 80 TYLYMIMDY-AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS-RLLN 157 (351)
Q Consensus 80 ~~~~lv~e~-~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~-~~~~ 157 (351)
+..++|||| +.+++|.+++.. ...+++... +.++.|++.||.|||++||+||||||+||+++ .++.
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~----------~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITE--KGPLGEGPS----------RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHH--HCSCCHHHH----------HHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE
T ss_pred CeEEEEEEecCCCCCHHHHHHh--cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe
Confidence 999999999 789999999987 455666544 34678888999999999999999999999999 7899
Q ss_pred eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc
Q psy6327 158 AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+||+|||+++..... ......||+.|+|||++.+..+...++|||||||++|+|++|+.||... ..... .
T Consensus 179 ~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~----~ 248 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----QEILE----A 248 (312)
T ss_dssp EEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHHH----T
T ss_pred EEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----HHHhh----h
Confidence 999999999876543 2345679999999999987776654599999999999999999999642 11111 1
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.. .....++..+.+||.+||+.||++|||+.|+++||||+...
T Consensus 249 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 249 EL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 11 22346899999999999999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=345.43 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=204.9
Q ss_pred ccceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
..+|++.+.||+|+||.||+|.+. .++..+|+|++..... . ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-P-SELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-H-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-H-HHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 357999999999999999999873 4568999999864432 2 22344568999999999999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhcc----------------------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACN----------------------ENIHENQARIWIRQIANALEYLHEIANALEYLHEV 138 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~----------------------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~ 138 (351)
..++||||++|++|.+++..... ..+++ ..++.++.|++.||.|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~i~~qi~~~l~~lH~~ 169 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM----------GDLISFAWQISQGMQYLAEM 169 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECH----------HHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCH----------HHHHHHHHHHHHHHHHHHHC
Confidence 99999999999999999986422 11333 23456788999999999999
Q ss_pred CceeccCCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-
Q psy6327 139 GIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN- 215 (351)
Q Consensus 139 ~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~- 215 (351)
||+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.+ +|||||||++|+|++
T Consensus 170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTL 248 (314)
T ss_dssp TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTT
T ss_pred CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999987654332 2234457899999999988777765 999999999999999
Q ss_pred CCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 216 KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 216 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
|..||.+... .......... .....+..+++++.+||.+||+.||++|||+.+++++
T Consensus 249 g~~p~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 249 GGNPYPGIPP--ERLFNLLKTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SCCSSTTCCG--GGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCH--HHHHHHhhcC-CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999976553 2333333222 2223344789999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=339.19 Aligned_cols=251 Identities=21% Similarity=0.343 Sum_probs=201.9
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+..+|++++.||+|+||.||+|.+. ++..||+|++....... ..+.+|+.++++++||||+++++++.+.+..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 3457999999999999999999876 67789999987654443 234589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++++|.+++... ...+++... +.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 97 v~e~~~~~~L~~~l~~~-~~~~~~~~~----------~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 97 ITEYMANGCLLNYLREM-RHRFQTQQL----------LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp EECCCTTCBHHHHHHCG-GGCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred EEeccCCCcHHHHHHHh-ccCCCHHHH----------HHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccc
Confidence 99999999999999763 344555443 4567888999999999999999999999999999999999999
Q ss_pred ccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
+++....... ......+|+.|+|||++.+..++.+ +||||||+++|+|++ |..||.... ........... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~-~~~~ 241 (283)
T 3gen_A 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQG-LRLY 241 (283)
T ss_dssp GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHTT-CCCC
T ss_pred ccccccccccccccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccC--hhHHHHHHhcc-cCCC
Confidence 9986543322 2234457889999999988887765 999999999999998 999997654 33333333322 2223
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 334678999999999999999999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=348.69 Aligned_cols=249 Identities=17% Similarity=0.219 Sum_probs=200.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv 85 (351)
.+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+ +||||+++++++..+...++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 469999999999999999999999999999999865432 23455899999999 899999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC-----eEE
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN-----AKL 160 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~-----~kl 160 (351)
|||+ +++|.+++... ...+++... +.++.|++.||+|||++||+||||||+|||++.++. +||
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~----------~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl 151 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC-DRTFSLKTV----------LMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHI 151 (330)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred EEeC-CCCHHHHHHHc-CCCCCHHHH----------HHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEE
Confidence 9999 89999999763 355666543 456788889999999999999999999999998877 999
Q ss_pred eeccccccccCCccc-------ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HHHH
Q psy6327 161 ADFGFSRLLRTPKEL-------SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLK 232 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~ 232 (351)
+|||+++........ ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+...... ....
T Consensus 152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~ 230 (330)
T 2izr_A 152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230 (330)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence 999999876443321 246689999999999998887765 9999999999999999999987553322 2222
Q ss_pred hhhCccccccc---cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 233 KQEGKEYLFNR---KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 233 ~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+.......+. ...++ ++.+||.+||+.||.+||++.++++
T Consensus 231 ~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 231 KIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22211111111 11244 9999999999999999999998875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=347.80 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=182.6
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHH-HHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREID-ILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
..+|++++.||+|+||.||+|.+..+|+.||+|++....... ...... +|+. +++.++||||+++++++...+..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~-~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLL-MDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHH-HHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHH-HHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 467999999999999999999999999999999986543222 222333 5555 6777899999999999999999999
Q ss_pred EEecCCCCChHHHHHhh---ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC-CceeccCCCCCEeEcCCCCeEE
Q psy6327 85 IMDYAEKKDLEHYISKA---CNENIHENQARIWIRQIANALEYLHEIANALEYLHEV-GIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~NIll~~~~~~kl 160 (351)
||||++ ++|.+++... ....+++.... .++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 99 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~----------~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 99 CMELMS-TSFDKFYKYVYSVLDDVIPEEILG----------KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EECCCS-EEHHHHHHHHHHTTCCCCCHHHHH----------HHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred EEeecC-CChHHHHHHHHhhhcccCcHHHHH----------HHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 999998 5888887632 23455554433 4677888899999999 9999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccc----cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEII----RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 236 (351)
+|||+++...... ......||+.|+|||++ .+..++. ++|||||||++|+|++|..||................
T Consensus 168 ~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (327)
T 3aln_A 168 CDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDV-RSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245 (327)
T ss_dssp CCCSSSCC-------------------------------CCS-HHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS
T ss_pred ccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCc-hhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC
Confidence 9999998764432 22344799999999998 3445555 4999999999999999999997643221111111111
Q ss_pred cccccc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 237 KEYLFN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 237 ~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
....++ ....++..+.+||.+||+.||++|||+.++++||||..
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 111111 12358999999999999999999999999999999964
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=353.90 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=205.2
Q ss_pred cceeeeeecCcccceEEEEEEecC-------CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKR-------SETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA 78 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 78 (351)
.+|.+.+.||+|+||.||+|.+.. .+..||+|++....... ....+.+|+.+++++ +||||+++++++..
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHH--HHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 469999999999999999999753 34689999986543222 234455899999999 89999999999999
Q ss_pred CCEEEEEEecCCCCChHHHHHhhcc--------------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceecc
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACN--------------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRD 144 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~D 144 (351)
++..++||||+++|+|.+++..... ..+++... +.++.||+.||.|||++||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~----------~~i~~qi~~aL~~LH~~~ivH~D 216 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL----------VSCAYQVARGMEYLASKKCIHRD 216 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHH----------HHHHHHHHHHHHHHHhCCEecCC
Confidence 9999999999999999999987432 23555443 35677888999999999999999
Q ss_pred CCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy6327 145 IKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFG 221 (351)
Q Consensus 145 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 221 (351)
|||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.
T Consensus 217 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 217 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred CCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987654332 2334567899999999988887765 999999999999999 999997
Q ss_pred CCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 222 DPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
... ........... .....+..+++++.+||.+||+.||++|||+.+++++
T Consensus 296 ~~~--~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 296 GVP--VEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TCC--HHHHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC--HHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 654 33333333322 2233345789999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=348.18 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=191.8
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC----C
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG----T 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~----~ 80 (351)
+..+|++.++||+|+||.||+|.+. ++.||+|++....... ....+|+.++++++||||+++++++... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS----WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHH----HHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 3467999999999999999999876 7999999986544322 2233699999999999999999999764 3
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC----------CceeccCCCCCE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV----------GIVHRDIKCENI 150 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~----------~i~H~Dlkp~NI 150 (351)
.+++||||+++|+|.+++.. ..+++... +.++.|++.||.|||+. ||+||||||+||
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~----------~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Ni 162 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA---NVVSWNEL----------CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH---CCBCHHHH----------HHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGE
T ss_pred eEEEEEecCCCCCHHHHHHh---cCCCHHHH----------HHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhE
Confidence 58999999999999999975 34665543 34677888888899998 999999999999
Q ss_pred eEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCC----CCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy6327 151 LISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYN----PKLADIWSLGVVLYRILNKKYPFGDPG 224 (351)
Q Consensus 151 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~----~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (351)
|++.++.+||+|||+++....... .....+||+.|+|||++.+.... ..++|||||||++|+|++|+.||.+..
T Consensus 163 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp EECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred EECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999987654332 23346799999999998764221 123799999999999999999997543
Q ss_pred CCch--------------HHHHhhhCcccc--ccc---cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 225 TRNR--------------DVLKKQEGKEYL--FNR---KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 225 ~~~~--------------~~~~~~~~~~~~--~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.... ............ .+. ....+.++.+||.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2111 111111111111 111 1123456999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=339.50 Aligned_cols=250 Identities=17% Similarity=0.197 Sum_probs=202.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv 85 (351)
.+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+ +|+|++++++++..+...++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 459999999999999999999999999999998864332 23455899999999 799999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC-----eEE
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN-----AKL 160 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~-----~kl 160 (351)
|||+ +++|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++. +||
T Consensus 85 ~e~~-~~~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC-GRKFSVKT----------VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHH----------HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEec-CCCHHHHHHHh-ccCCCHHH----------HHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 9999 89999999763 33466544 3456788889999999999999999999999987765 999
Q ss_pred eeccccccccCCcc-------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HHHH
Q psy6327 161 ADFGFSRLLRTPKE-------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLK 232 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~ 232 (351)
+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ....
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence 99999987654332 2345679999999999988887665 9999999999999999999987543222 2222
Q ss_pred hhhCccc---cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 233 KQEGKEY---LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 233 ~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
....... .......+++++.+||.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 232 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 2211111 11122368999999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=347.78 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=196.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeE----EEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLK----ACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
...+|++++.||+|+||.||+|.+..+++.+ |+|.+..... ......+.+|+.++++++||||+++++++.++.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 4567999999999999999999998887655 7776643221 122345568999999999999999999998766
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.++|+||+.+|+|.+++... ...+++... +.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~----------~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl 158 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREH-KDNIGSQYL----------LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 158 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHS-TTSCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEE
T ss_pred -eEEEEEecCCCcHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEE
Confidence 78899999999999999763 345565443 356778899999999999999999999999999999999
Q ss_pred eeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 161 ADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+|||+++........ .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||..... .........
T Consensus 159 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~- 234 (327)
T 3poz_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK- 234 (327)
T ss_dssp CCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHT-
T ss_pred ccCcceeEccCCcccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHHHc-
Confidence 999999876543322 234457889999999998888765 999999999999999 9999976553 223222222
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....+.+..++.++.+++.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 22233445689999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=344.60 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=196.3
Q ss_pred ccceeeeeecCcccceEEEEEE----ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--C
Q psy6327 6 ILECSYISKLGEGAYGNVYLVS----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA--G 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~ 79 (351)
..+|++++.||+|+||.||+|. +..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.. .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3579999999999999999998 677899999999864322 223445689999999999999999999854 3
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
...++||||+++|+|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~k 154 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKH-KERIDHIK----------LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 154 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHC-GGGCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred CceEEEEEeCCCCCHHHHHHhc-ccccCHHH----------HHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEE
Confidence 5689999999999999999763 23355543 345778899999999999999999999999999999999
Q ss_pred EeeccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch--------
Q psy6327 160 LADFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-------- 228 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------- 228 (351)
|+|||+++....... ......|++.|+|||++.+..++.+ +||||||+++|+|++|..||........
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~ 233 (295)
T 3ugc_A 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233 (295)
T ss_dssp ECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCC
T ss_pred EccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccc
Confidence 999999987654322 2233457888999999988887765 9999999999999999999864321000
Q ss_pred ------HHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 229 ------DVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 229 ------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...... ......+.+..+++++.+||.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 234 GQMIVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp THHHHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cchhHHHHHHHH-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011111 112233344578999999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=341.77 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=199.1
Q ss_pred cceeeeeecCcccceEEEEEE----ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC--C
Q psy6327 7 LECSYISKLGEGAYGNVYLVS----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG--T 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~ 80 (351)
..|++++.||+|+||.||+|. +..+++.||+|++....... ....+.+|+.+++.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 459999999999999999998 67789999999987544222 124456899999999999999999999876 6
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..++||||+++++|.+++... ...+++... +.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~----------~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl 167 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQ----------LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKI 167 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHH-TTTCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred eEEEEEEeCCCCcHHHHHHhc-cccCCHHHH----------HHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEE
Confidence 689999999999999999653 344555443 346778899999999999999999999999999999999
Q ss_pred eeccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------------C
Q psy6327 161 ADFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPG------------T 225 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------------~ 225 (351)
+|||++........ ......||+.|+|||++.+..++.+ +|||||||++|+|++|..|+.... .
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246 (302)
T ss_dssp CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred CcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence 99999987655432 2345568899999999988877755 999999999999999999874321 0
Q ss_pred CchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 226 RNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
................+.+..+++++.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0111111111122233344578999999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=346.87 Aligned_cols=253 Identities=20% Similarity=0.287 Sum_probs=198.7
Q ss_pred CccceeeeeecCcccceEEEEEEecCCcee----EEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETL----KACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
...+|++++.||+|+||.||+|.+..++.. +|+|.+....... ....+.+|+.++++++||||+++++++.+ .
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLCPG-S 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEECB-S
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC-C
Confidence 346799999999999999999999888876 6666654332111 12334489999999999999999999874 4
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..++||||+.+|+|.+++... ...+++... +.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~----------~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl 156 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQH-RGALGPQLL----------LNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQV 156 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSS-GGGSCTTHH----------HHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEE
T ss_pred ccEEEEEeCCCCCHHHHHHHc-cccCCHHHH----------HHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEE
Confidence 588999999999999999753 245555443 346778888999999999999999999999999999999
Q ss_pred eeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 161 ADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||..... ..........
T Consensus 157 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~ 233 (325)
T 3kex_A 157 ADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKG 233 (325)
T ss_dssp CSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHHTT
T ss_pred CCCCcccccCcccccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHHcC
Confidence 99999987654332 2345567889999999988887765 999999999999999 9999987553 2333333322
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
. ....+..++.++.++|.+||+.||.+|||+.+++++
T Consensus 234 ~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 E-RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp C-BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred C-CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 223334688899999999999999999999999886
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=353.10 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=193.4
Q ss_pred ccceeeeeecCcccceEEEEEEec---CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDK---RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
..+|++.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 357999999999999999999887 5678899999865432 22234566999999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||+++|+|.+++... ...+++.. ++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 122 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~----------~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH-DAQFTVIQ----------LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT-TTCSCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCCHHH----------HHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECc
Confidence 9999999999999999753 33455543 345778899999999999999999999999999999999999
Q ss_pred ccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcc
Q psy6327 163 FGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 163 fg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
||+++........ .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.... .......... .
T Consensus 191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~--~~~~~~~i~~-~ 266 (373)
T 2qol_A 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMS--NQDVIKAVDE-G 266 (373)
T ss_dssp C----------------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCC--HHHHHHHHHT-T
T ss_pred CccccccccCCccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc-C
Confidence 9999876543221 122345778999999988887765 999999999999998 999997654 3344433332 2
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...+....++..+.+||.+||+.||++|||+.++++
T Consensus 267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 334445578999999999999999999999999876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=344.57 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=201.0
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeE--EEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLK--ACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~--aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~ 81 (351)
+..+|++.+.||+|+||.||+|.+..++..+ |+|.+.... .......+.+|+.+++++ +||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 3468999999999999999999999888866 888875322 222234456899999999 89999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhc--------------cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCC
Q psy6327 82 LYMIMDYAEKKDLEHYISKAC--------------NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKC 147 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp 147 (351)
.|+||||+++++|.+++.... ...+++.. ++.++.|++.||.|||++||+||||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~i~~qi~~aL~~LH~~~ivH~dlkp 170 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ----------LLHFAADVARGMDYLSQKQFIHRDLAA 170 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHH----------HHHHHHHHHHHHHHHHhCCccCCCCcc
Confidence 999999999999999997632 12344443 445788889999999999999999999
Q ss_pred CCEeEcCCCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCC
Q psy6327 148 ENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTR 226 (351)
Q Consensus 148 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 226 (351)
+|||++.++.+||+|||+++..... .......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||....
T Consensus 171 ~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~-- 246 (327)
T 1fvr_A 171 RNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMT-- 246 (327)
T ss_dssp GGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred ceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCc--
Confidence 9999999999999999999753321 12233457889999999988777765 999999999999998 999997654
Q ss_pred chHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 227 NRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.......... ......+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 247 CAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3333333322 22333445789999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=364.87 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=207.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.++.++..||+|.+...... ...+.+|+.+|++++||||+++++++......|+||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 4689999999999999999999999999999998754432 233558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++|+|.+++.......+++.. ++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~----------~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVV----------LLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EccCCCCHHHHHHhcCcCCCCHHH----------HHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccc
Confidence 999999999999875444555543 3457788999999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+....... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||..... ........ ..+..+.+
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~~~-~~~~~~~~ 441 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLE-KDYRMERP 441 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHH-TTCCCCCC
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH-cCCCCCCC
Confidence 87643322 2234456789999999988887765 999999999999999 9999976553 33333332 23334445
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..++..+.+||.+||+.||++|||+.++++
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 578999999999999999999999999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=343.62 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=204.5
Q ss_pred cceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|++.+.||+|+||.||+|.+. .+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH--HHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 46999999999999999999877 468899999986443222 23345689999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhcc--------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 82 LYMIMDYAEKKDLEHYISKACN--------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~--------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
.++||||+++|+|.+++..... ..++. ..++.++.|++.||.|||++||+||||||+|||++
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~----------~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL----------SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCH----------HHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCH----------HHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence 9999999999999999976321 12233 23456788999999999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q psy6327 154 RLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDV 230 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 230 (351)
.++.+||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.... ....
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~--~~~~ 249 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLS--NEQV 249 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSC--HHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCC--HHHH
Confidence 999999999999986544322 2234567899999999988877765 999999999999999 899997654 3333
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
........ .......++..+.+||.+||+.||++|||+.+++++
T Consensus 250 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 250 LRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 33333222 223344789999999999999999999999999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=337.22 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=190.0
Q ss_pred cceeeeeecCcccceEEEEEEecCC---ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
.+|++.+.||+|+||.||+|.+..+ +..+|+|.+..... ......+.+|+.++++++||||+++++++. ++..|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 5699999999999999999998653 56799998764322 223445568999999999999999999985 45689
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+++++|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR-KYSLDLAS----------LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHH----------HHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence 999999999999999753 23455544 3346788899999999999999999999999999999999999
Q ss_pred cccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 164 GFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 164 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
|+++....... ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.. ..+....+.... ..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~--~~~~~~~i~~~~-~~ 236 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGE-RL 236 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTC-CC
T ss_pred ccccccCcccccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCC--HHHHHHHHHcCC-CC
Confidence 99987654322 2234457889999999988777765 999999999999996 999997654 233333333222 22
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
+.+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3345789999999999999999999999999764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=347.55 Aligned_cols=254 Identities=20% Similarity=0.336 Sum_probs=203.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCce-----eEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSET-----LKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+....... ....+.+|+.+++.+ +||||+++++++..++
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 569999999999999999999876664 79999886543222 234456899999999 8999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhcc------------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACN------------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCE 148 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~------------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~ 148 (351)
..|+||||+++|+|.+++..... ..+++. .++.++.|++.||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 193 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR----------DLLHFSSQVAQGMAFLASKNCIHRDVAAR 193 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHH----------HHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHH----------HHHHHHHHHHHHHHHHhcCCcccCCcccc
Confidence 99999999999999999976421 223333 34567889999999999999999999999
Q ss_pred CEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCC
Q psy6327 149 NILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGT 225 (351)
Q Consensus 149 NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 225 (351)
|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+...
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccch
Confidence 99999999999999999986543322 2334567889999999988887765 999999999999998 9999976553
Q ss_pred CchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 226 RNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.. ..............+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 273 ~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 273 NS--KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp SH--HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hH--HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 22 2222211222233344679999999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=349.35 Aligned_cols=254 Identities=18% Similarity=0.188 Sum_probs=193.3
Q ss_pred cceeeeeecCcccceEEEEEEecC---CceeEEEEecchhhhhh--------HHHhhhHHHHHHHHHhCCCCCceeeeeE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKR---SETLKACKAYDFKRLKR--------DYMEKFAPREIDILLKVSHPNIIGVHRM 75 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~--------~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 75 (351)
.+|++.+.||+|+||.||+|.+.. ++..+|+|++....... ......+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 469999999999999999999987 88999999986543211 1112234578999999999999999999
Q ss_pred EEe----CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEe
Q psy6327 76 VKA----GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENIL 151 (351)
Q Consensus 76 ~~~----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIl 151 (351)
+.. ....|+||||+ |++|.+++... ..+++... +.++.||+.||+|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~----------~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 183 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTV----------LQLGIRMLDVLEYIHENEYVHGDIKAANLL 183 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHH----------HHHHHHHHHHHHHHHhCCeeCCCcCHHHEE
Confidence 987 78999999999 99999999763 35665543 457788889999999999999999999999
Q ss_pred EcCCC--CeEEeeccccccccCCcc-------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy6327 152 ISRLL--NAKLADFGFSRLLRTPKE-------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222 (351)
Q Consensus 152 l~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (351)
++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||..
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGG
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCccc
Confidence 99877 999999999987643221 1245579999999999998877765 9999999999999999999965
Q ss_pred CCCCchHHHHhhhCccccccc-------cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 223 PGTRNRDVLKKQEGKEYLFNR-------KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...................+. ...++.++.+||.+||+.||++|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp GTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 332222222111111111111 1168899999999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=339.15 Aligned_cols=246 Identities=20% Similarity=0.306 Sum_probs=195.2
Q ss_pred ccceeeeeecCcccceEEEEEEecCCc-------eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSE-------TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA 78 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 78 (351)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.+....... .+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY---SESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGG---HHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHH---HHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 356999999999999999999998777 579999986543322 3345689999999999999999999999
Q ss_pred CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC-
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN- 157 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~- 157 (351)
++..++||||++|++|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 152 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKN-KNCINILW----------KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHT-GGGCCHHH----------HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBG
T ss_pred CCCCEEEEECCCCCCHHHHHHhC-CCCCCHHH----------HHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcc
Confidence 99999999999999999999763 22355443 3456788999999999999999999999999998877
Q ss_pred -------eEEeeccccccccCCcccccccccccceeccccccC-CCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCch
Q psy6327 158 -------AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN-SPYNPKLADIWSLGVVLYRILNKK-YPFGDPGTRNR 228 (351)
Q Consensus 158 -------~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~ 228 (351)
+||+|||++...... ....||+.|+|||++.+ ..++. ++|||||||++|+|++|. +||.... ..
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~il~el~~g~~~~~~~~~--~~ 225 (289)
T 4fvq_A 153 KTGNPPFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNL-ATDKWSFGTTLWEICSGGDKPLSALD--SQ 225 (289)
T ss_dssp GGTBCCEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCH-HHHHHHHHHHHHHHHTTTCCTTTTSC--HH
T ss_pred cccccceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCc-hhHHHHHHHHHHHHHcCCCCCccccc--hH
Confidence 999999998764332 33458999999999987 44554 599999999999999954 5554332 22
Q ss_pred HHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 229 DVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
........ .. ..+...+.++.+||.+||+.||++|||+.++++|
T Consensus 226 ~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 226 RKLQFYED-RH--QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHHT-TC--CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhc-cC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22222221 11 2223568899999999999999999999999886
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=343.56 Aligned_cols=255 Identities=25% Similarity=0.311 Sum_probs=197.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE----eCCE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK----AGTY 81 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~----~~~~ 81 (351)
-.+|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH---HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 4579999999999999999999999999999998865322 22344568999999999999999999986 3457
Q ss_pred EEEEEecCCCCChHHHHHhhc--cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 82 LYMIMDYAEKKDLEHYISKAC--NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
.++||||+.+|+|.+++.... ...+++... +.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~----------~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~k 174 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI----------LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV 174 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHH----------HHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEE
Confidence 899999999999999997632 344565443 34678888999999999999999999999999999999
Q ss_pred EeeccccccccCCccc---------ccccccccceeccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc
Q psy6327 160 LADFGFSRLLRTPKEL---------SNTFCGTTSYAAPEIIRNSP---YNPKLADIWSLGVVLYRILNKKYPFGDPGTRN 227 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (351)
|+|||+++........ .....||+.|+|||++.+.. ++. ++|||||||++|+|++|..||.......
T Consensus 175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~ 253 (317)
T 2buj_A 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE-RTDVWSLGCVLYAMMFGEGPYDMVFQKG 253 (317)
T ss_dssp ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECT-HHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCc-hhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence 9999998765322111 12345799999999987554 344 5999999999999999999995321111
Q ss_pred hHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 228 RDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
......... ....+....++.++.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 254 DSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp SCHHHHHHC-C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhHHhhc-cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 111111111 22334445789999999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=357.01 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=189.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv 85 (351)
.+|.+.+.||+|+||+|+. ....+++.||||++...... ...+|+.+++.+ +||||+++++++.+....|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3589999999999999763 44567899999998654332 233899999999 799999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---C--CCeEE
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---L--LNAKL 160 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~--~~~kl 160 (351)
||||. |+|.+++.... ....+.. ++.++.||+.||.|||++||+||||||+|||++. + ..+||
T Consensus 97 ~E~~~-g~L~~~l~~~~-~~~~~~~----------~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKD-FAHLGLE----------PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EECCS-EEHHHHHHSSS-CCCCSSC----------HHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred EECCC-CCHHHHHHhcC-CCccchh----------HHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 99997 79999997642 2233222 2346788999999999999999999999999953 2 35789
Q ss_pred eeccccccccCCc---ccccccccccceeccccccC---CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHh
Q psy6327 161 ADFGFSRLLRTPK---ELSNTFCGTTSYAAPEIIRN---SPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 161 ~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 233 (351)
+|||+++...... ......+||+.|+|||++.+ ..++. ++|||||||++|+|++ |..||...... .....
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~-~~DiwSlG~il~ellt~g~~pf~~~~~~--~~~~~ 241 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTY-TVDIFSAGCVFYYVISEGSHPFGKSLQR--QANIL 241 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCT-HHHHHHHHHHHHHHHTTSCBTTBSTTTH--HHHHH
T ss_pred ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCc-HHHHHHHHHHHHHHHcCCCCCcchhhHH--HHHHH
Confidence 9999998765432 22345679999999999974 33343 5999999999999999 99999654322 11111
Q ss_pred hhCccc-cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 234 QEGKEY-LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 234 ~~~~~~-~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
...... ........+..+++||.+||+.||.+|||+.++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 111111 111222346678999999999999999999999999999753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=346.67 Aligned_cols=256 Identities=23% Similarity=0.285 Sum_probs=200.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQG---IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSH---HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHH---HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 357999999999999999999964 68899999876543322 33456899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhcc--CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 86 MDYAEKKDLEHYISKACN--ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
|||+++|+|.+++..... ..+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~----------~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQ----------RLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHH----------HHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999865322 1344443 3457788999999999999999999999999999999999999
Q ss_pred cccccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchH-HHH----hhhC
Q psy6327 164 GFSRLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD-VLK----KQEG 236 (351)
Q Consensus 164 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~----~~~~ 236 (351)
|+++...... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ... ....
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 9998654322 22344569999999999988887765 99999999999999999999764432111 000 0000
Q ss_pred --------ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q psy6327 237 --------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276 (351)
Q Consensus 237 --------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 276 (351)
...........+..+.+++.+||+.||++|||+.|++++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0011111224567889999999999999999999998763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=354.99 Aligned_cols=245 Identities=22% Similarity=0.412 Sum_probs=199.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-EEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT-YLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-~~~l 84 (351)
..+|++.+.||+|+||.||+|.+. ++.||+|++..... .+.+.+|+.+|++++||||+++++++.... ..|+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTT-----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchH-----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 467999999999999999999875 78999999865432 334558999999999999999999986654 7999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++|+|.+++.......+++.. ++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~----------~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDC----------LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHH----------HHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 99999999999999875433355543 34577889999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNR 243 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (351)
+++..... .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||..... .+....... .+..+.
T Consensus 335 ~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~-~~~~~~ 407 (450)
T 1k9a_A 335 LTKEASST---QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEK-GYKMDA 407 (450)
T ss_dssp TCEECC---------CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCT--TTHHHHHHT-TCCCCC
T ss_pred Cccccccc---ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc-CCCCCC
Confidence 99864332 223357889999999998888765 999999999999998 9999976553 333333332 233444
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+..+++++.+||.+||+.||++|||+.++++
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5578999999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=331.79 Aligned_cols=251 Identities=21% Similarity=0.391 Sum_probs=204.6
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+..+|++.+.||+|+||.||+|.+. ++..+|+|++....... +.+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence 4568999999999999999999986 57789999987655433 234589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++++|.+++... ...+++... +.++.|++.||.|||++|++|+||||+||+++.++.+||+|||
T Consensus 81 v~e~~~~~~L~~~~~~~-~~~~~~~~~----------~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg 149 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQ-RGLFAAETL----------LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG 149 (267)
T ss_dssp EECCCTTCBHHHHHHHT-TTCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTT
T ss_pred EEeCCCCCcHHHHHhhC-cccCCHHHH----------HHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccc
Confidence 99999999999999763 234555443 3467788899999999999999999999999999999999999
Q ss_pred ccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
++........ ......||+.|+|||++.+..++.+ +||||||+++|+|++ |..||.... ........... ....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~i~~~-~~~~ 225 (267)
T 3t9t_A 150 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTG-FRLY 225 (267)
T ss_dssp GGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTT-CCCC
T ss_pred cccccccccccccccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCCCC--HHHHHHHHhcC-CcCC
Confidence 9987543221 2234557889999999988777654 999999999999999 899997654 33333333322 2222
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.+..++..+.+++.+||+.||++|||+.+++++
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 334679999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=335.84 Aligned_cols=246 Identities=23% Similarity=0.419 Sum_probs=203.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--------
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA-------- 78 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-------- 78 (351)
.+|++++.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 46999999999999999999999999999999986543 223489999999999999999999864
Q ss_pred --------CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCE
Q psy6327 79 --------GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENI 150 (351)
Q Consensus 79 --------~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NI 150 (351)
....++||||+++++|.+++.......+++... +.++.|++.||.|||++||+|+||||+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 153 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA----------LELFEQITKGVDYIHSKKLINRDLKPSNI 153 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHH----------HHHHHHHHHHHHHHHhCCeeeccCCHHHE
Confidence 456899999999999999998755566666543 34677888899999999999999999999
Q ss_pred eEcCCCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHH
Q psy6327 151 LISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDV 230 (351)
Q Consensus 151 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 230 (351)
|++.++.+||+|||++....... ......||+.|+|||++.+..++.+ +||||||+++|+|++|..||... ...
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~----~~~ 227 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET----SKF 227 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH----HHH
T ss_pred EEcCCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH----HHH
Confidence 99999999999999998765433 2344569999999999988877765 99999999999999999987431 122
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
........ ....++..+.+||.+||+.||.+|||+.++++|++.-
T Consensus 228 ~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 228 FTDLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22222111 1235789999999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=341.64 Aligned_cols=255 Identities=21% Similarity=0.323 Sum_probs=202.5
Q ss_pred ccceeeeeecCcccceEEEEEEe-----cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSD-----KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAG 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~ 79 (351)
..+|++.+.||+|+||.||+|.+ ..+++.||+|++....... ....+.+|+.+++++ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH--HHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 35799999999999999999984 4678999999986543322 234456899999999 699999999998765
Q ss_pred -CEEEEEEecCCCCChHHHHHhhccCC--------------CchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceecc
Q psy6327 80 -TYLYMIMDYAEKKDLEHYISKACNEN--------------IHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRD 144 (351)
Q Consensus 80 -~~~~lv~e~~~ggsL~~~l~~~~~~~--------------~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~D 144 (351)
...++||||+++++|.+++....... +++. .++.++.|++.||.|||++||+|||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~qi~~al~~lH~~~i~H~d 173 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE----------HLICYSFQVAKGMEFLASRKCIHRD 173 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHH----------HHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHH----------HHHHHHHHHHHHHHHHHhCCccccc
Confidence 45999999999999999997643211 3333 3445778899999999999999999
Q ss_pred CCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy6327 145 IKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFG 221 (351)
Q Consensus 145 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 221 (351)
|||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999999987644322 2334568999999999988887765 999999999999998 999997
Q ss_pred CCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 222 DPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....... ....... ......+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 253 ~~~~~~~-~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 253 GVKIDEE-FCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TCCCSHH-HHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchhHH-HHHHhcc-CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7553322 2222211 11223334689999999999999999999999999886
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=342.15 Aligned_cols=256 Identities=24% Similarity=0.391 Sum_probs=203.3
Q ss_pred CccceeeeeecCcccceEEEEEE----ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE--e
Q psy6327 5 DILECSYISKLGEGAYGNVYLVS----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK--A 78 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~ 78 (351)
+..+|++++.||+|+||.||+|. +..+++.||+|++...... ..+.+.+|+.++++++||||+++++++. +
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---QQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH---HHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 45679999999999999999998 5788999999998654322 2344569999999999999999999886 5
Q ss_pred CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCe
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNA 158 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~ 158 (351)
....|+||||+++++|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~ 166 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH-RARLDASR----------LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 166 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH-GGGCCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred CceEEEEEeecCCCCHHHHHHhc-ccCCCHHH----------HHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCE
Confidence 67899999999999999999764 23455544 34567788889999999999999999999999999999
Q ss_pred EEeeccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC---------
Q psy6327 159 KLADFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR--------- 226 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------- 226 (351)
||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||......
T Consensus 167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 245 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245 (327)
T ss_dssp EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred EEcccccceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhccccc
Confidence 9999999987654332 2334568899999999988877665 99999999999999999998543210
Q ss_pred ---chHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 227 ---NRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...............+.+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp -CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011111111222333445789999999999999999999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=358.79 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=188.1
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEe
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
|.+.+.||+|+||+||.+ ...+|+.||+|.+..... ..+.+|+.+++++ +||||+++++++.+++..|+|||
T Consensus 17 ~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp EEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGH------HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred eeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 556788999999999865 456799999999865432 2234899999876 89999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC------------
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL------------ 155 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~------------ 155 (351)
||+ |+|.+++.... ........ .....++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 90 ~~~-gsL~~~l~~~~--~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 90 LCN-LNLQDLVESKN--VSDENLKL---QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp CCS-EEHHHHHHTC-----------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred cCC-CCHHHHHhccC--CCchhhhh---ccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 996 69999997632 11111000 0112235688999999999999999999999999999754
Q ss_pred -CCeEEeeccccccccCCccc----ccccccccceeccccccC-------CCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy6327 156 -LNAKLADFGFSRLLRTPKEL----SNTFCGTTSYAAPEIIRN-------SPYNPKLADIWSLGVVLYRILN-KKYPFGD 222 (351)
Q Consensus 156 -~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~-g~~pf~~ 222 (351)
+.+||+|||+++........ ....+||+.|+|||++.+ ..++. ++|||||||++|+|++ |..||.+
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTR-SIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCT-HHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcch-hhhhHhHHHHHHHHHhCCCCCCCC
Confidence 47999999999876543321 234679999999999875 34444 5999999999999999 9999976
Q ss_pred CCCCchHHHHhhhCcc-ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 223 PGTRNRDVLKKQEGKE-YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 223 ~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
................ ........++.++.+||.+||+.||.+|||+.++++||||+.
T Consensus 243 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred chhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 5432222211111100 001111245688999999999999999999999999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=344.51 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=199.8
Q ss_pred cceeeeeecCcccceEEEEEE-----ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVS-----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|++++.||+|+||.||+|. +..++..||+|.+....... ....+.+|+.++++++||||+++++++.....
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchh--hHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 579999999999999999999 55678899999986432222 23345589999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhcc-----CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC--
Q psy6327 82 LYMIMDYAEKKDLEHYISKACN-----ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-- 154 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~-----~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-- 154 (351)
.|+||||++|++|.+++..... ..++... ++.++.|++.||.|||++||+||||||+|||++.
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~----------~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD----------LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHH----------HHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC
Confidence 9999999999999999987432 1233333 4457888999999999999999999999999984
Q ss_pred -CCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q psy6327 155 -LLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDV 230 (351)
Q Consensus 155 -~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 230 (351)
+..+||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.... ....
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~--~~~~ 254 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKS--NQEV 254 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCC--HHHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcC--HHHH
Confidence 45699999999976543322 2334568999999999988877765 999999999999998 999997654 3333
Q ss_pred HHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 231 LKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
........ .......++..+.+||.+||+.||.+|||+.+++++.|.
T Consensus 255 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 255 LEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCC-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 33333222 223344789999999999999999999999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=347.62 Aligned_cols=255 Identities=16% Similarity=0.163 Sum_probs=194.5
Q ss_pred cceeeeeecCcccceEEEEEEecCC-----ceeEEEEecchhhhhhH--------HHhhhHHHHHHHHHhCCCCCceeee
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS-----ETLKACKAYDFKRLKRD--------YMEKFAPREIDILLKVSHPNIIGVH 73 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~--------~~~~~~~~Ei~~l~~l~hp~iv~~~ 73 (351)
.+|++.+.||+|+||.||+|.+..+ ++.||+|++........ ........|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 3799999999999999999998765 58899999865432111 1111233577778888999999999
Q ss_pred eEEEeC----CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCC
Q psy6327 74 RMVKAG----TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCEN 149 (351)
Q Consensus 74 ~~~~~~----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~N 149 (351)
+++... ...|+||||+ |++|.+++... ...+++... +.++.||+.||.|||++||+||||||+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~----------~~i~~qi~~~l~~lH~~~iiHrDlkp~N 182 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTV----------LQLSLRILDILEYIHEHEYVHGDIKASN 182 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeEEecCCHHH
Confidence 998664 5689999999 99999999763 356666554 4567888899999999999999999999
Q ss_pred EeEc--CCCCeEEeeccccccccCCccc-------ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy6327 150 ILIS--RLLNAKLADFGFSRLLRTPKEL-------SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220 (351)
Q Consensus 150 Ill~--~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 220 (351)
||++ .++.+||+|||+++.+...... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTT
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCc
Confidence 9999 8899999999999876433221 134569999999999988887765 99999999999999999999
Q ss_pred CCCCCCchHHHHhhhCccccc-------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 221 GDPGTRNRDVLKKQEGKEYLF-------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+................... .....++.++.+|+.+||+.||++||++.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 262 EDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp GGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 754322221111110000000 011367999999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=333.91 Aligned_cols=236 Identities=28% Similarity=0.436 Sum_probs=185.2
Q ss_pred ccceeee-eecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHH-HhCCCCCceeeeeEEEe----C
Q psy6327 6 ILECSYI-SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDIL-LKVSHPNIIGVHRMVKA----G 79 (351)
Q Consensus 6 ~~~~~~~-~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l-~~l~hp~iv~~~~~~~~----~ 79 (351)
+.+|.++ +.||+|+||.||+|.+..+++.||+|++.... ...+|+.++ +.++||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH--------HHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4668888 77999999999999999999999999985321 233788888 55689999999999987 7
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---CC
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---LL 156 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~~ 156 (351)
...++||||++||+|.+++.......+++.... .++.|++.||+|||++||+||||||+|||++. ++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~----------~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 157 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 157 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHH----------HHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCC
Confidence 789999999999999999987544567765544 46778888899999999999999999999998 78
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchH--HHHhh
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD--VLKKQ 234 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~ 234 (351)
.+||+|||++..... ..++. ++|||||||++|+|++|..||......... .....
T Consensus 158 ~~kl~Dfg~a~~~~~----------------------~~~~~-~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 214 (299)
T 3m2w_A 158 ILKLTDFGFAKETTG----------------------EKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214 (299)
T ss_dssp CEEECCCTTCEECTT----------------------CGGGG-HHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS
T ss_pred cEEEecccccccccc----------------------ccCCc-hhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH
Confidence 899999999875432 22333 499999999999999999999654321100 00111
Q ss_pred hCcccccc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 235 EGKEYLFN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 235 ~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
....+..+ ....++.++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 11111111 1146899999999999999999999999999999997654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=336.68 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=195.9
Q ss_pred ccceeeeeecCcccceEEEEEEecC-Cc--eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKR-SE--TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
..+|++++.||+|+||.||+|.+.. ++ ..||+|++...........+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4579999999999999999998643 33 368999987655444344555669999999999999999999998766 8
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||+++++|.+++... ...+++.. +..++.|++.||.|||++|++|+||||+|||++.++.+||+|
T Consensus 96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH-QGHFLLGT----------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred eeeEecccCCCHHHHHHhc-cCCcCHHH----------HHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcc
Confidence 8999999999999999764 24455544 334677889999999999999999999999999999999999
Q ss_pred ccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcc
Q psy6327 163 FGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 163 fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
||++........ ......+|+.|+|||++.+..++.+ +||||||+++|+|++ |..||.... ............
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~ 241 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKIDKEG 241 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTSC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCC--HHHHHHHHHccC
Confidence 999987654332 2234567889999999988777654 999999999999999 999997654 344444444444
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...+....++.++.++|.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 4445556789999999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=334.25 Aligned_cols=252 Identities=22% Similarity=0.362 Sum_probs=199.4
Q ss_pred Cccceeeee-ecCcccceEEEEEE--ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYIS-KLGEGAYGNVYLVS--DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~-~LG~G~~g~V~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
+..+|++.+ .||+|+||.||+|. +..+++.+|+|++........ ....+.+|+.+++.++||||+++++++ ..+.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-LKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH-HHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHH-HHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 446799988 99999999999994 467789999999876543322 234456899999999999999999999 5567
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++||||+++++|.+++.. ...+++... +.++.|++.||.|||++||+|+||||+|||++.++.+||+
T Consensus 92 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~----------~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~ 159 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ--NRHVKDKNI----------IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS 159 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH--CTTCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred cEEEEEeCCCCCHHHHHHh--CcCCCHHHH----------HHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEc
Confidence 8999999999999999986 455665543 3567888899999999999999999999999999999999
Q ss_pred eccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 162 DFGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 162 Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
|||++......... .....+|+.|+|||++.+..++.+ +||||||+++|+|++ |..||.... ...........
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~ 236 (291)
T 1xbb_A 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKG 236 (291)
T ss_dssp CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTT
T ss_pred cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcC
Confidence 99999876543322 223346789999999987777654 999999999999999 999997654 33333333322
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
. ....+..++..+.++|.+||+.||++|||+.++++
T Consensus 237 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 237 E-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 22334478999999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=334.25 Aligned_cols=255 Identities=18% Similarity=0.213 Sum_probs=195.6
Q ss_pred CCCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeE-EEeCC
Q psy6327 2 KFPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRM-VKAGT 80 (351)
Q Consensus 2 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~-~~~~~ 80 (351)
.+.--.+|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++|++++..+.. +....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 4hgt_A 4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp -------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred ccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence 344456799999999999999999999999999999986544332 334589999999998776665554 47888
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE---cCCCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI---SRLLN 157 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll---~~~~~ 157 (351)
..++||||+ +++|.+++... ...+++... +.++.|++.||.|||++||+||||||+|||+ +.++.
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~----------~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~ 146 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTV----------LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TSCCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC
T ss_pred ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHH----------HHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe
Confidence 999999999 89999999753 345665543 4567888999999999999999999999999 78899
Q ss_pred eEEeeccccccccCCcc-------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-H
Q psy6327 158 AKLADFGFSRLLRTPKE-------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-D 229 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~ 229 (351)
+||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ .
T Consensus 147 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 225 (296)
T 4hgt_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence 99999999987654322 2235679999999999998887765 9999999999999999999976443211 1
Q ss_pred HHHhhhCcccccc---ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 230 VLKKQEGKEYLFN---RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 230 ~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
............+ ....+++++.+||.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 226 KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1111111111111 12367999999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=342.26 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=194.8
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeE----EEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLK----ACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
...+|++++.||+|+||.||+|.+..+++.+ |+|.+...... .....+.+|+.+++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3567999999999999999999998888766 55554322211 11344558999999999999999999998776
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.++|+||+.+|+|.+++... ...+++... +.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~----------~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL 158 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREH-KDNIGSQYL----------LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 158 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHT-TTCCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEE
T ss_pred -ceEEEEecCCCcHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEE
Confidence 78999999999999999764 345665443 346778899999999999999999999999999999999
Q ss_pred eeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 161 ADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||..... .........
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~- 234 (327)
T 3lzb_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK- 234 (327)
T ss_dssp CCTTC----------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHT-
T ss_pred ccCcceeEccCccccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc-
Confidence 99999987644332 2234457889999999998887765 999999999999999 9999976553 233332222
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....+.+..++.++.+||.+||+.||.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22334445789999999999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=341.68 Aligned_cols=253 Identities=21% Similarity=0.354 Sum_probs=201.5
Q ss_pred cceeeeeecCcccceEEEEEEec-------CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-------RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA 78 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 78 (351)
.+|++.+.||+|+||.||+|.+. .++..||+|++....... ....+.+|+.+++++ +||||+++++++..
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHH--HHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 57999999999999999999875 467889999986543222 234455899999999 89999999999999
Q ss_pred CCEEEEEEecCCCCChHHHHHhhcc--------------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceecc
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACN--------------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRD 144 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~D 144 (351)
.+..|+||||+++|+|.+++..... ..++.. .++.++.||+.||.|||++||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~i~~qi~~aL~~LH~~~ivH~D 182 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK----------DLVSCTYQLARGMEYLASQKCIHRD 182 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHH----------HHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHH----------HHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 9999999999999999999976422 113332 3456788999999999999999999
Q ss_pred CCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy6327 145 IKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFG 221 (351)
Q Consensus 145 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 221 (351)
|||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcC
Confidence 999999999999999999999987654332 2234457889999999988777765 999999999999999 999997
Q ss_pred CCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 222 DPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
+.. ........... .....+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 262 ~~~--~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 262 GIP--VEELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TCC--HHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC--HHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 654 33333322221 1223344789999999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=356.61 Aligned_cols=248 Identities=22% Similarity=0.428 Sum_probs=201.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+|++++||||+++++++. ....|+||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 46899999999999999999986 4678999998754432 234558999999999999999999986 55689999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++|+|.+++.......++... ++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~----------~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPK----------LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred eecCCCcHHHHHHhccCCCCCHHH----------HHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 999999999999764333444433 4457889999999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+....... ......+|+.|+|||++....++.+ +|||||||++|+|++ |+.||.+.. ..+...... ..+..+.+
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~-~~~~~~~~ 407 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALE-RGYRMPRP 407 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHH-HTCCCCCC
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH-cCCCCCCC
Confidence 87643221 1233456789999999988887765 999999999999999 999997654 334433333 22344555
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..+++++.+||.+||+.||++|||+.++++
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 678999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=336.24 Aligned_cols=256 Identities=19% Similarity=0.279 Sum_probs=193.3
Q ss_pred CccceeeeeecCcccceEEEEEEecC---CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKR---SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT- 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~- 80 (351)
+..+|++.+.||+|+||.||+|.+.. ++..||+|.+.......... ..+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHH-HHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHH-HHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34679999999999999999998765 56789999987655444333 34558999999999999999999997655
Q ss_pred ----EEEEEEecCCCCChHHHHHhh----ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE
Q psy6327 81 ----YLYMIMDYAEKKDLEHYISKA----CNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI 152 (351)
Q Consensus 81 ----~~~lv~e~~~ggsL~~~l~~~----~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll 152 (351)
..++||||+++++|.+++... ....+++.. ++.++.|++.||.|||++||+||||||+|||+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~----------~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli 180 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT----------LLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHH----------HHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHH----------HHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 359999999999999998542 123455544 34567888999999999999999999999999
Q ss_pred cCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchH
Q psy6327 153 SRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRD 229 (351)
Q Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 229 (351)
+.++.+||+|||+++....... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||..... ..
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~--~~ 257 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQN--HE 257 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCG--GG
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCH--HH
Confidence 9999999999999987644321 2234457889999999988887765 999999999999999 9999976542 23
Q ss_pred HHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 230 VLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
........ .....+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 258 MYDYLLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33322222 1223345789999999999999999999999999865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=347.29 Aligned_cols=259 Identities=22% Similarity=0.277 Sum_probs=198.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+. +++.||+|++........ ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred hhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence 356999999999999999999854 689999999875443221 23456899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccC--CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC---CceeccCCCCCEeEcCCCCeEE
Q psy6327 86 MDYAEKKDLEHYISKACNE--NIHENQARIWIRQIANALEYLHEIANALEYLHEV---GIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~--~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~NIll~~~~~~kl 160 (351)
|||+++|+|.+++...... .+++... ..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~----------~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKR----------QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHH----------HHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHH----------HHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999764322 2554433 35678889999999999 9999999999999999999999
Q ss_pred eeccccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------CCchHHHHh
Q psy6327 161 ADFGFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPG------TRNRDVLKK 233 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~~~ 233 (351)
+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... .........
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999987654332 3345569999999999988877765 999999999999999999995211 000001000
Q ss_pred hhC---------ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 234 QEG---------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 234 ~~~---------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
... ...........+..+.+++.+||+.||.+|||+.++++|-.-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 000 000011112345689999999999999999999999988543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=339.14 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=196.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCc----eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSE----TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.++++++||||+++++++...+.
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 356899999999999999999987553 46999998654322 223345689999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++||||+++++|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 189 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREK-DGEFSVLQ----------LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 189 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHT-TTCSCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred cEEEEeCCCCCcHHHHHHhC-CCCCCHHH----------HHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEEC
Confidence 99999999999999999763 34555544 34567888999999999999999999999999999999999
Q ss_pred eccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 162 DFGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 162 Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
|||+++........ .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.... ...........
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~--~~~~~~~~~~~ 266 (333)
T 1mqb_A 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAINDG 266 (333)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTT
T ss_pred CCCcchhhccccccccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHCC
Confidence 99999876543221 223346889999999988887765 999999999999998 999997654 33444333322
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...+.+..++..+.++|.+||+.||++||++.+++++
T Consensus 267 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 267 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2334445789999999999999999999999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=332.89 Aligned_cols=253 Identities=19% Similarity=0.213 Sum_probs=199.2
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeE-EEeCCEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRM-VKAGTYL 82 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~-~~~~~~~ 82 (351)
.-..+|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+.+++.+.|++++..+.. ...+...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-----HHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 34467999999999999999999999999999999986544322 34589999999998776655554 4778899
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE---cCCCCeE
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI---SRLLNAK 159 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll---~~~~~~k 159 (351)
++||||+ +++|.+++... ...+++.. ++.++.|++.||+|||++||+||||||+|||+ +.++.+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~----------~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKT----------VLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEec-CCCHHHHHHhh-ccCCCHHH----------HHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEE
Confidence 9999999 89999999743 34566544 34567888999999999999999999999999 4788999
Q ss_pred EeeccccccccCCcc-------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc-hHHH
Q psy6327 160 LADFGFSRLLRTPKE-------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN-RDVL 231 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~ 231 (351)
|+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ....
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh
Confidence 999999987654432 1245679999999999998887765 999999999999999999997644221 1122
Q ss_pred HhhhCcccccc---ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 232 KKQEGKEYLFN---RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 232 ~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..........+ ....+|+++.+||.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 228 ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 21111111111 12468999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=332.38 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=195.6
Q ss_pred ceeeeeecCcccceEEEEEEecCCce---eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE-E
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSET---LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL-Y 83 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~-~ 83 (351)
.|.+.++||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 47778999999999999999765444 79999886432 222234456899999999999999999999766554 9
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+.+++|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~----------~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Df 168 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKD----------LISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF 168 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHH----------HHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcC
Confidence 999999999999999753 34455443 3456788999999999999999999999999999999999999
Q ss_pred cccccccCCc----ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCCCchHHHHhhhCcc
Q psy6327 164 GFSRLLRTPK----ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP-FGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 164 g~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~~~~~~~~ 238 (351)
|+++...... .......||+.|+|||.+.+..++.+ +|||||||++|+|++|..| |.... ...........
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~- 244 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLAQG- 244 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHHTT-
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhhcC-
Confidence 9998654322 22334568999999999988887765 9999999999999995555 54333 22222222222
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...+.+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 223344568999999999999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=351.90 Aligned_cols=254 Identities=25% Similarity=0.361 Sum_probs=197.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC--EEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT--YLYM 84 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--~~~l 84 (351)
..|++.+.||+|+||.||+|.+..+++.||+|++........ ...+.+|+.++++++||||+++++++...+ ..++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 469999999999999999999999999999999875443322 233458999999999999999999998755 7899
Q ss_pred EEecCCCCChHHHHHhhccC-CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE----cCCCCeE
Q psy6327 85 IMDYAEKKDLEHYISKACNE-NIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI----SRLLNAK 159 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll----~~~~~~k 159 (351)
||||++||+|.+++...... .+++... +.++.|++.||+|||++||+||||||+|||+ +.++.+|
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~----------~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEF----------LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEE
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHH----------HHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEE
Confidence 99999999999999764322 2565543 3467788899999999999999999999999 6777899
Q ss_pred EeeccccccccCCcccccccccccceeccccccC--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC--CchH
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN--------SPYNPKLADIWSLGVVLYRILNKKYPFGDPGT--RNRD 229 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~ 229 (351)
|+|||+++...... .....+||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||..... ....
T Consensus 157 L~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 234 (396)
T 4eut_A 157 LTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGA-TVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (396)
T ss_dssp ECCGGGCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHH-HHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred EecCCCceEccCCC-ccccccCCccccCHHHhhccccccccccCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence 99999998765433 3345679999999999865 33444 48999999999999999999964332 1222
Q ss_pred HHHhhhCccc-------------------ccccc----ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 230 VLKKQEGKEY-------------------LFNRK----YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 230 ~~~~~~~~~~-------------------~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.........+ ..+.. ..++..+.++|.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2222211111 00111 234567889999999999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=331.06 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=197.5
Q ss_pred ccceeeeeecCcccceEEEEEEecC---CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKR---SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
..+|++.+.||+|+||.||+|.+.. ++..+|+|.+....... ....+.+|+.+++.++||||+++++++.++ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH--HHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch--HHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 4579999999999999999998653 45679999987543222 234556899999999999999999998765 46
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+||||+++++|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 88 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 156 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERN-KNSLKVLT----------LVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGD 156 (281)
T ss_dssp EEEEECCTTCBHHHHHHHH-TTTCCHHH----------HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECC
T ss_pred EEEEecCCCCCHHHHHHhc-cccCCHHH----------HHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCc
Confidence 8999999999999999763 33455544 334678889999999999999999999999999999999999
Q ss_pred ccccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 163 FGFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 163 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
||++........ ......+|+.|+|||++.+..++.+ +||||||+++|+|++ |+.||..... .......... ..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~~~-~~ 232 (281)
T 3cc6_A 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLEKG-DR 232 (281)
T ss_dssp CCGGGCC---------CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHHHT-CC
T ss_pred cCCCcccccccccccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHhcC-CC
Confidence 999987654322 2234457889999999988777765 999999999999998 9999975442 2222222211 12
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.+.+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 23344689999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=334.30 Aligned_cols=250 Identities=21% Similarity=0.382 Sum_probs=185.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.++||+|+||.||+|.+.. .+|+|++......... .+.+.+|+.++++++||||++++++. .....++||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHH-HHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHH-HHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 459999999999999999998753 4899998765544333 34456899999999999999999965 455689999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++|++|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 99 e~~~~~~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS-ETKFEMKK----------LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp ECCCEEEHHHHHTTC----CCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred EecCCCcHHHHHhhc-cCCCCHHH----------HHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence 999999999999643 34455443 3456788899999999999999999999999999999999999999
Q ss_pred ccccCC--cccccccccccceecccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc--
Q psy6327 167 RLLRTP--KELSNTFCGTTSYAAPEIIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY-- 239 (351)
Q Consensus 167 ~~~~~~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-- 239 (351)
+..... ........||+.|+|||++. +..++. ++||||||+++|+|++|..||...... ............
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF-QSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSLSP 245 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCH-HHHHHHHHHHHHHHHHSSCTTSSCCCH-HHHHHHHHHTSCCC
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCc-ccchHHHHHHHHHHHHCCCCccccchH-HHHHHHhcccccCc
Confidence 865432 12234567999999999986 444554 499999999999999999999765432 222222211111
Q ss_pred -cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 240 -LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 240 -~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11123468899999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=331.66 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=202.3
Q ss_pred Cccceeeee-ecCcccceEEEEEEec--CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYIS-KLGEGAYGNVYLVSDK--RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~-~LG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
...+|.+++ .||+|+||.||+|.+. .++..+|+|++..... ......+.+|+.++++++||||+++++++. .+.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 83 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEA 83 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc--hhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCC
Confidence 345677877 9999999999999854 5688899999865432 222344568999999999999999999994 456
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++||||+++++|.+++... ...+++... +.++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~----------~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 152 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNV----------AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKIS 152 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEEC
T ss_pred cEEEEEeCCCCCHHHHHHhC-CccCCHHHH----------HHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEEC
Confidence 89999999999999999642 344665443 3567888899999999999999999999999999999999
Q ss_pred eccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 162 DFGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 162 Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
|||+++........ .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.... ...........
T Consensus 153 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~i~~~ 229 (287)
T 1u59_A 153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQG 229 (287)
T ss_dssp CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTT
T ss_pred cccceeeeccCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHhcC
Confidence 99999876543321 233457899999999987777765 999999999999998 999997654 33333333322
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAW 277 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 277 (351)
. ....+..+++++.++|.+||+.||++|||+.+++++.+
T Consensus 230 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 230 K-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp C-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred C-cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 2 22333478999999999999999999999999998743
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=335.27 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=191.7
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
+-+..+|++.+.||+|+||.||+|.+. ++.+|+|.+..... .+.+.+|+.++++++||||+++++++.+. .
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 74 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESE-----RKAFIVELRQLSRVNHPNIVKLYGACLNP--V 74 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTH-----HHHHHHHHHHHHHCCCTTBCCEEEBCTTT--T
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhH-----HHHHHHHHHHHhcCCCCCcCeEEEEEcCC--c
Confidence 346678999999999999999999875 78899999864321 23445899999999999999999988743 7
Q ss_pred EEEEecCCCCChHHHHHhhccC-CCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh---CCceeccCCCCCEeEcCCCC-
Q psy6327 83 YMIMDYAEKKDLEHYISKACNE-NIHENQARIWIRQIANALEYLHEIANALEYLHE---VGIVHRDIKCENILISRLLN- 157 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~NIll~~~~~- 157 (351)
++||||++||+|.+++...... .++.. .++.++.|++.||.|||+ +||+||||||+|||++.++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~----------~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 144 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAA----------HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHH----------HHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTE
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHH----------HHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCE
Confidence 8999999999999999753211 12332 234567889999999999 89999999999999998886
Q ss_pred eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc
Q psy6327 158 AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 158 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+||+|||++...... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.................
T Consensus 145 ~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 220 (307)
T 2eva_A 145 LKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220 (307)
T ss_dssp EEECCCCC---------------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT
T ss_pred EEEcccccccccccc---cccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC
Confidence 799999999765432 234469999999999988877765 9999999999999999999976554333332222211
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...+....++..+.++|.+||+.||++|||+.+++++
T Consensus 221 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 221 -TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp -CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1223334789999999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=343.76 Aligned_cols=248 Identities=16% Similarity=0.212 Sum_probs=196.6
Q ss_pred cceeeeeecCcccceEEEEEEecC--------CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCcee-------
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKR--------SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG------- 71 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~------- 71 (351)
.+|++.+.||+|+||.||+|.+.. .++.||+|.+... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 579999999999999999999987 4899999998643 23458999999999999987
Q ss_pred --------eeeEEEe-CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCcee
Q psy6327 72 --------VHRMVKA-GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVH 142 (351)
Q Consensus 72 --------~~~~~~~-~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H 142 (351)
+++++.. +...|+||||+ +++|.+++.......+++..+ +.++.||+.||.|||++||+|
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~----------~~i~~qi~~~L~~LH~~~ivH 182 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV----------LQVACRLLDALEFLHENEYVH 182 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHH----------HHHHHHHHHHHHHHHHTTCBC
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHH----------HHHHHHHHHHHHHHHhCCccC
Confidence 5677765 78999999999 899999998754466666554 456788889999999999999
Q ss_pred ccCCCCCEeEcCCC--CeEEeeccccccccCCcc-------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHH
Q psy6327 143 RDIKCENILISRLL--NAKLADFGFSRLLRTPKE-------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRI 213 (351)
Q Consensus 143 ~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 213 (351)
|||||+|||++.++ .+||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|
T Consensus 183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el 261 (352)
T 2jii_A 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKW 261 (352)
T ss_dssp SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHH
Confidence 99999999999988 899999999987654322 1234579999999999988877765 9999999999999
Q ss_pred HhCCCCCCCCCCCchHHHHhhh---Ccccccc----ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 214 LNKKYPFGDPGTRNRDVLKKQE---GKEYLFN----RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 214 l~g~~pf~~~~~~~~~~~~~~~---~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
++|..||............... .....+. ....++.++.+||.+||+.||++|||+.++++
T Consensus 262 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 262 LYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 9999999765432322222211 1111111 11257999999999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=329.34 Aligned_cols=248 Identities=23% Similarity=0.433 Sum_probs=200.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.+. ++..+|+|.+....... ..+.+|+.+++.++||||+++++++..+ ..++||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 86 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIIT 86 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccH----HHHHHHHHHHHhCCCcCcceEEEEEcCC-CcEEEE
Confidence 56999999999999999999975 56789999986544332 3355899999999999999999998754 589999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++++|.+++.......+++.. ++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~----------~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINK----------LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHH----------HHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 999999999999764333455543 3457888999999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
........ ......+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.. ........... .....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~-~~~~~~ 232 (279)
T 1qpc_A 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERG-YRMVRP 232 (279)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTT-CCCCCC
T ss_pred ccccCcccccccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccC--HHHHHHHHhcc-cCCCCc
Confidence 87654332 2234457889999999987777655 999999999999999 999997654 33333333322 223334
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..++.++.++|.+||+.||++|||+.++++
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 578999999999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=334.00 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=188.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHh--CCCCCceeeeeEEEe----C
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK--VSHPNIIGVHRMVKA----G 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~----~ 79 (351)
..+|++++.||+|+||.||+|.+ +++.||+|++...... ...+|.+++.. ++||||+++++++.. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~------~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEK------SWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHH------HHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccch------hhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 45799999999999999999987 5899999998654322 12256666655 789999999998643 3
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhH--------hCCceeccCCCCCEe
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLH--------EVGIVHRDIKCENIL 151 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH--------~~~i~H~Dlkp~NIl 151 (351)
...++||||+++|+|.++++. ..+++.. ++.++.|++.||+||| ++||+||||||+|||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~----------~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nil 145 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL---TTLDTVS----------CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL 145 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT---CCBCHHH----------HHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEE
T ss_pred ceeEEehhhccCCCHHHHHhh---cccCHHH----------HHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEE
Confidence 568999999999999999964 4566544 3457788899999999 999999999999999
Q ss_pred EcCCCCeEEeeccccccccCCccc----ccccccccceeccccccCCCCCC-----CcchHHHHHHHHHHHHhC------
Q psy6327 152 ISRLLNAKLADFGFSRLLRTPKEL----SNTFCGTTSYAAPEIIRNSPYNP-----KLADIWSLGVVLYRILNK------ 216 (351)
Q Consensus 152 l~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g------ 216 (351)
++.++.+||+|||+++........ ....+||+.|+|||++.+..... .++|||||||++|+|++|
T Consensus 146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 999999999999999765443322 23457999999999998763221 248999999999999999
Q ss_pred ----CCCCCCCCCCc--hHHHHhhh-C--ccccccc---cccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 217 ----KYPFGDPGTRN--RDVLKKQE-G--KEYLFNR---KYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 217 ----~~pf~~~~~~~--~~~~~~~~-~--~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..||....... ........ . .....+. ...++.++.+||.+||+.||++|||+.++++
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 88886543221 11121111 1 1111111 1235678999999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=336.78 Aligned_cols=248 Identities=26% Similarity=0.387 Sum_probs=188.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHh--CCCCCceeeeeEEEeC----C
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK--VSHPNIIGVHRMVKAG----T 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~~----~ 80 (351)
.+|++++.||+|+||.||+|.+. ++.||+|++....... ..+|..++.. ++||||+++++++... .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~------~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEAS------WFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHH------HHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccch------hhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 46999999999999999999875 8999999985433211 1245555544 4899999999999877 7
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC--------CceeccCCCCCEeE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV--------GIVHRDIKCENILI 152 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~--------~i~H~Dlkp~NIll 152 (351)
..|+||||+++|+|.++++. ..+++.. ++.++.|++.||.|||++ ||+||||||+|||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~----------~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS---TTLDAKS----------MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH---CCBCHHH----------HHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred ceEEEEeccCCCcHHHHhhc---cCCCHHH----------HHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 89999999999999999975 3455544 345678889999999999 99999999999999
Q ss_pred cCCCCeEEeeccccccccCCccc----ccccccccceeccccccCCCCCCC-----cchHHHHHHHHHHHHhC-------
Q psy6327 153 SRLLNAKLADFGFSRLLRTPKEL----SNTFCGTTSYAAPEIIRNSPYNPK-----LADIWSLGVVLYRILNK------- 216 (351)
Q Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwslG~il~~ll~g------- 216 (351)
+.++.+||+|||+++........ ....+||+.|+|||++.+...... ++|||||||++|+|++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 99999999999999766443322 235679999999999987766543 37999999999999999
Q ss_pred ---CCCCCCCCCCc---hHHHHhhhCcc--ccccc---cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 217 ---KYPFGDPGTRN---RDVLKKQEGKE--YLFNR---KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 217 ---~~pf~~~~~~~---~~~~~~~~~~~--~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..||....... ........... ...+. ...++.++.+||.+||+.||.+|||+.++++|
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 66775432211 11111111111 11111 12466789999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=332.17 Aligned_cols=254 Identities=20% Similarity=0.308 Sum_probs=195.7
Q ss_pred CCccceeeeeecCcccceEEEEEEecCC---ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEE-EeC
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMV-KAG 79 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~-~~~ 79 (351)
+....|++.+.||+|+||.||+|.+..+ ...+|+|.+.... .......+.+|+.++++++||||+++++++ ..+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 3455799999999999999999996543 3468889876432 222234456899999999999999999985 556
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
+..++||||+++|+|.+++... ...++... ++.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k 168 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKD----------LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVK 168 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCT-TCCCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred CceEEEEeCCCCCCHHHHHHhc-ccCCCHHH----------HHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEE
Confidence 7889999999999999999753 33445443 334677889999999999999999999999999999999
Q ss_pred EeeccccccccCCcc----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhh
Q psy6327 160 LADFGFSRLLRTPKE----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQ 234 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 234 (351)
|+|||+++....... ......||+.|+|||++.+..++.+ +||||||+++|+|++ |.+||...... ......
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~ 245 (298)
T 3f66_A 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL 245 (298)
T ss_dssp ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHH
T ss_pred ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHH
Confidence 999999987644322 2234567889999999988887765 999999999999999 66777654432 222222
Q ss_pred hCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 235 EGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.... ....+..++..+.++|.+||+.||.+|||+.++++
T Consensus 246 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 246 LQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2221 12223468999999999999999999999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=353.36 Aligned_cols=248 Identities=23% Similarity=0.403 Sum_probs=197.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.++||+|+||.||+|.+.. +..||+|++....... ..+.+|+.+|++++||||+++++++.+ +..|+||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 458999999999999999999875 4569999987654332 234589999999999999999999876 6689999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+++|+|.+++.......++... ++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~----------~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQ----------LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHH----------HHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence 999999999999764444555544 3457888999999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+....... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.. ..+....... .+..+.+
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~-~~~~~~~ 403 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVER-GYRMPCP 403 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT-TCCCCCC
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc-CCCCCCC
Confidence 87643321 2234457889999999988887765 999999999999999 999997654 3344444332 2334445
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..+++.+.+||.+||+.||++|||+.++++
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 578999999999999999999999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=338.53 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=196.5
Q ss_pred eeeeeecCcccceEEEEEE----ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--CCEE
Q psy6327 9 CSYISKLGEGAYGNVYLVS----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA--GTYL 82 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~ 82 (351)
|++++.||+|+||.||++. +..+++.||+|++..... ......+.+|+.++++++||||+++++++.+ ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 5999999999999997764 456899999999875432 2224455689999999999999999999987 4789
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||+++++|.+++.. ..+++... +.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 111 ~lv~e~~~~~~L~~~l~~---~~~~~~~~----------~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~D 177 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPR---HSIGLAQL----------LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGD 177 (318)
T ss_dssp EEEECCCTTCBHHHHGGG---SCCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEecccCCcHHHHHhh---CCCCHHHH----------HHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECC
Confidence 999999999999999975 33555443 45678889999999999999999999999999999999999
Q ss_pred ccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-----------
Q psy6327 163 FGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR----------- 228 (351)
Q Consensus 163 fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------- 228 (351)
||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||........
T Consensus 178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256 (318)
T ss_dssp GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred ccccccccccccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence 999987654432 2334568899999999988877754 9999999999999999999964321100
Q ss_pred -HHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 229 -DVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 229 -~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.............+.+..++.++.+||.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0011111112233344578999999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=329.67 Aligned_cols=246 Identities=22% Similarity=0.412 Sum_probs=192.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-CEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG-TYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-~~~~ 83 (351)
+..+|++.+.||+|+||.||+|.+. |+.+|+|.+..... .+.+.+|+.++++++||||+++++++.+. +..|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 4578999999999999999999874 88999999864431 23445899999999999999999997544 5789
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+++++|.+++.......+++.. ++.++.|++.||.|||++|++|+||||+||+++.++.+||+||
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~----------~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Df 161 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDC----------LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 161 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHH----------HHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeec
Confidence 999999999999999764322244433 3457788999999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
|++...... .....+++.|+|||++.+..++.+ +||||||+++|+|++ |..||..... ......... .....
T Consensus 162 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~-~~~~~ 234 (278)
T 1byg_A 162 GLTKEASST---QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEK-GYKMD 234 (278)
T ss_dssp CC---------------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTT-TCCCC
T ss_pred ccccccccc---ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhc-CCCCC
Confidence 999865432 223457899999999988777765 999999999999998 9999976542 333333322 22333
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+..+++.+.++|.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 44578999999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=336.84 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=181.1
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEE--------Ee
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMV--------KA 78 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~--------~~ 78 (351)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++++. ||||+++++++ ..
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch---HHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 69999999999999999999999999999998854332 22344558999999996 99999999998 34
Q ss_pred CCEEEEEEecCCCCChHHHHHhhc-cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEcCC
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKAC-NENIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILISRL 155 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~~~ 155 (351)
....++||||+. |+|.+++.... ...+++... +.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~----------~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTV----------LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHH----------HHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHH----------HHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC
Confidence 556899999996 89999886532 344665543 456788899999999999 9999999999999999
Q ss_pred CCeEEeeccccccccCCccc------------ccccccccceeccccc---cCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy6327 156 LNAKLADFGFSRLLRTPKEL------------SNTFCGTTSYAAPEII---RNSPYNPKLADIWSLGVVLYRILNKKYPF 220 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf 220 (351)
+.+||+|||+++........ .....||+.|+|||++ .+..++. ++|||||||++|+|++|..||
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGE-KQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSH-HHHHHHHHHHHHHHHHSSCCC
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCCh-HHhHHHHHHHHHHHHhCCCCC
Confidence 99999999999876543221 1245699999999998 4445554 499999999999999999999
Q ss_pred CCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q psy6327 221 GDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 276 (351)
...... . ........+.....+..+.+||.+||+.||.+|||+.|+++|.
T Consensus 254 ~~~~~~--~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 254 EDGAKL--R----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cchhHH--H----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 754321 1 1112223344456788899999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=343.09 Aligned_cols=252 Identities=19% Similarity=0.276 Sum_probs=188.2
Q ss_pred cceeeeeecCcccceEEEEEEecCC---ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE-eCCEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK-AGTYL 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-~~~~~ 82 (351)
..|++.+.||+|+||.||+|.+..+ +..+|+|.+..... ......+.+|+.++++++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4588899999999999999987543 35689998754322 122344568999999999999999999864 55688
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||+++|+|.+++... ...++... ++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~D 235 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE-THNPTVKD----------LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 235 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred EEEEECCCCCCHHHHHhhc-ccCCCHHH----------HHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEee
Confidence 9999999999999999753 23344433 345678899999999999999999999999999999999999
Q ss_pred ccccccccCCcc----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 163 FGFSRLLRTPKE----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 163 fg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
||+++....... ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |.+||........ .......
T Consensus 236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~~~~ 312 (373)
T 3c1x_A 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQG 312 (373)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHHHTT
T ss_pred ccccccccccccccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHHHcC
Confidence 999986543221 1233457889999999988887765 999999999999999 7888876553322 2222222
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
. ....+..++..+.++|.+||+.||++|||+.+++++
T Consensus 313 ~-~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 313 R-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 222334689999999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=339.03 Aligned_cols=258 Identities=21% Similarity=0.319 Sum_probs=186.9
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE-----eC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK-----AG 79 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-----~~ 79 (351)
++.+|++++.||+|+||.||+|.+ +++.||+|++......... ...|+..+..++||||+++++.+. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~----~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFI----NEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHH----HHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHH----HHHHHHHHHhccCcchhhheecccccccCCC
Confidence 567899999999999999999976 6899999998654432211 124555555689999999998653 33
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhC---------CceeccCCCCCE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEV---------GIVHRDIKCENI 150 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~---------~i~H~Dlkp~NI 150 (351)
...++||||+++|+|.+++... ..+... ++.++.||+.||.|||++ ||+||||||+||
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~----------~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Ni 151 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH---TSDWVS----------SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC---CBCHHH----------HHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGE
T ss_pred ceEEEEEecCCCCcHHHHHhhc---ccchhH----------HHHHHHHHHHHHHHHHhhhccccccccceeecccccceE
Confidence 4789999999999999999752 233322 345788999999999999 999999999999
Q ss_pred eEcCCCCeEEeeccccccccCCc--------ccccccccccceeccccccCC-------CCCCCcchHHHHHHHHHHHHh
Q psy6327 151 LISRLLNAKLADFGFSRLLRTPK--------ELSNTFCGTTSYAAPEIIRNS-------PYNPKLADIWSLGVVLYRILN 215 (351)
Q Consensus 151 ll~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~ 215 (351)
|++.++.+||+|||+++...... ......+||+.|+|||++.+. .++. ++|||||||++|+|++
T Consensus 152 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~DiwslG~il~ell~ 230 (336)
T 3g2f_A 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK-QVDMYALGLIYWEIFM 230 (336)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH-HHHHHHHHHHHHHHHT
T ss_pred EEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc-ccchHHHHHHHHHHHh
Confidence 99999999999999998764322 122345799999999998763 2333 4899999999999999
Q ss_pred CCCCCCCCCCCch---------------HHHHh-h--hCccccccc----cccCCHhHHHHHHHhcCCCCCCCCCHHHHh
Q psy6327 216 KKYPFGDPGTRNR---------------DVLKK-Q--EGKEYLFNR----KYEISIGAKQLIGRMLEPNPKHRPNAKDVQ 273 (351)
Q Consensus 216 g~~pf~~~~~~~~---------------~~~~~-~--~~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 273 (351)
|..||........ ..... . ......++. ...++.++.+||.+||+.||++|||+.|++
T Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l 310 (336)
T 3g2f_A 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310 (336)
T ss_dssp TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence 9777643221100 00000 0 111111111 112445799999999999999999999995
Q ss_pred c------CccccCCc
Q psy6327 274 N------HAWIQNEP 282 (351)
Q Consensus 274 ~------hp~~~~~~ 282 (351)
+ ++|-++..
T Consensus 311 ~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 311 ERMAELMMIWERNKS 325 (336)
T ss_dssp HHHHHHHHCCCC---
T ss_pred HHHHHHHHHHHhccc
Confidence 4 67777654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=365.08 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=199.4
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe------C
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA------G 79 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------~ 79 (351)
+.+|++.+.||+|+||.||+|.+..+|+.||+|++..... . .....+.+|+.++++++||||+++++++.. +
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~-~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-P-KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-H-HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-H-HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 4679999999999999999999999999999999865322 2 223445689999999999999999999755 6
Q ss_pred CEEEEEEecCCCCChHHHHHhhcc-CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCC-
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACN-ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLN- 157 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~- 157 (351)
+..|+||||++||+|.+++..... ..+++.... .++.|++.||+|||++||+||||||+|||++.++.
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~----------~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR----------TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHH----------HHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHH----------HHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCc
Confidence 778999999999999999976322 246665543 46778888999999999999999999999997665
Q ss_pred --eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-------
Q psy6327 158 --AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR------- 228 (351)
Q Consensus 158 --~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------- 228 (351)
+||+|||++....... ......||+.|+|||++.+..++.+ +||||+||++|+|++|..||........
T Consensus 161 ~~vKL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~ 238 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238 (676)
T ss_dssp CEEEECSCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred eeEEEccccccccccccc-ccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence 8999999998765432 3345679999999999998888776 9999999999999999999964310000
Q ss_pred -----HHHHhhhCccccc----c----ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 229 -----DVLKKQEGKEYLF----N----RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 229 -----~~~~~~~~~~~~~----~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
............+ + ....++..+.+||.+||++||++|||+.++++||||+.
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000000001111 1 11236788999999999999999999999999999853
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=360.04 Aligned_cols=244 Identities=22% Similarity=0.374 Sum_probs=194.3
Q ss_pred eecCcccceEEEEEEe--cCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecCC
Q psy6327 13 SKLGEGAYGNVYLVSD--KRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 13 ~~LG~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (351)
+.||+|+||.||+|.+ +.+++.||||++........ ....+.+|+.+|++++|||||++++++..+ ..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-LKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG-GHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccC
Confidence 4799999999999954 56789999999876543332 234456999999999999999999999755 4789999999
Q ss_pred CCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 91 KKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 91 ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
+|+|.+++.. ...+++... +.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 453 ~g~L~~~l~~--~~~l~~~~~----------~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 453 LGPLNKYLQQ--NRHVKDKNI----------IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp TEEHHHHHHH--CTTCCHHHH----------HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred CCCHHHHHhh--CCCCCHHHH----------HHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 9999999976 456666543 4567888999999999999999999999999999999999999998765
Q ss_pred CCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccccccc
Q psy6327 171 TPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246 (351)
Q Consensus 171 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (351)
.... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.. ..+....+... .....+..
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~~-~~~~~p~~ 596 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKG-ERMGCPAG 596 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTT-CCCCCCTT
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcC-CCCCCCCC
Confidence 4332 2233457889999999988888765 999999999999998 999997654 33444433332 23334457
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
++.++.+||.+||+.||++|||+.++++
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 8999999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=342.35 Aligned_cols=244 Identities=17% Similarity=0.186 Sum_probs=190.8
Q ss_pred cceeeeeecCcccceEEEEE-----EecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC---CCCceeeeeEEEe
Q psy6327 7 LECSYISKLGEGAYGNVYLV-----SDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS---HPNIIGVHRMVKA 78 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~-----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~ 78 (351)
.+|++.+.||+|+||.||+| .+..+++.||+|++..... ..+.+|+.+++.++ |+||+++++++..
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 45999999999999999999 4677899999999865432 22347888888887 9999999999999
Q ss_pred CCEEEEEEecCCCCChHHHHHhhc---cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKAC---NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR- 154 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~---~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~- 154 (351)
.+..|+|||||+||+|.+++.... ...+++..+ +.++.||+.||+|||++||+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~----------~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV----------ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHH----------HHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHH----------HHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence 999999999999999999997532 345665543 457788899999999999999999999999988
Q ss_pred ----------CCCeEEeecccccccc--CCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy6327 155 ----------LLNAKLADFGFSRLLR--TPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGD 222 (351)
Q Consensus 155 ----------~~~~kl~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (351)
++.+||+|||+|+... .........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCcccc
Confidence 8999999999997653 22334456789999999999998888765 9999999999999999999954
Q ss_pred CCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 223 PGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....... . ...+ .....++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 288 ~~~~~~~----~---~~~~-~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 288 NEGGECK----P---EGLF-RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp EETTEEE----E---CSCC-TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred CCCCcee----e---chhc-cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 3211100 0 0001 111346788999999999999999765544443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=355.07 Aligned_cols=248 Identities=23% Similarity=0.403 Sum_probs=202.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.++||+|+||.||+|.+.. +..||+|++....... +.+.+|+.+|++++||||+++++++.+ ...|+||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 468999999999999999999875 4569999987654332 235589999999999999999999876 5689999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||+.+|+|.+++.......++... ++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~----------~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQ----------LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHH----------HHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 999999999999764444555543 3457888999999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+....... ......++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+.. ..+....... .+..+.+
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~--~~~~~~~i~~-~~~~~~~ 486 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVER-GYRMPCP 486 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCC--HHHHHHHHHT-TCCCCCC
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc-CCCCCCC
Confidence 87643221 1233456889999999988887765 999999999999999 999997654 3444444332 2334445
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..++..+.+||.+||+.||++|||+.+|++
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 578999999999999999999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=332.85 Aligned_cols=253 Identities=24% Similarity=0.398 Sum_probs=198.3
Q ss_pred ccceeeeeecCcccceEEEEEE----ecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-
Q psy6327 6 ILECSYISKLGEGAYGNVYLVS----DKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT- 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~- 80 (351)
..+|++++.||+|+||.||+|. +..+++.||+|++..... .....+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---HHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 3569999999999999999998 567899999999865322 22344568999999999999999999986543
Q ss_pred -EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 81 -YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 81 -~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
..++||||+++++|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 185 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKH-KERIDHIK----------LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 185 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHS-TTSSCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred CceEEEEECCCCCCHHHHHHhc-ccCCCHHH----------HHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEE
Confidence 689999999999999999763 23455544 345678889999999999999999999999999999999
Q ss_pred EeeccccccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC---------c
Q psy6327 160 LADFGFSRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR---------N 227 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~ 227 (351)
|+|||+++........ .....+++.|+|||++.+..++.+ +|||||||++|+|++|..||...... .
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCC
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccc
Confidence 9999999876544321 233457888999999988777654 99999999999999999998542100 0
Q ss_pred -h----HHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 228 -R----DVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 228 -~----~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
. ....... .....+.+..++.++.+||.+||+.||++|||+.++++
T Consensus 265 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 265 GQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp THHHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhhHHHHHHHhh-cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0011111 11123334578999999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.53 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=194.1
Q ss_pred eeeee-ecCcccceEEEEEEec--CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 9 CSYIS-KLGEGAYGNVYLVSDK--RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 9 ~~~~~-~LG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+.+ .||+|+||.||+|.++ .++..||||++....... ....+.+|+.+|++++||||+++++++..+ ..|+|
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv 413 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 413 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST--THHHHHHHHHHHTTCCCTTBCCEEEEEESS-SEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEeccC-CeEEE
Confidence 44455 7999999999999875 456789999986543221 133455899999999999999999999764 58999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+.+|+|.+++... ...+++.. ++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 414 ~E~~~~g~L~~~l~~~-~~~l~~~~----------~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK-REEIPVSN----------VAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp EECCTTCBHHHHHTTC-TTTSCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred EEeCCCCcHHHHHhhc-cCCCCHHH----------HHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 9999999999999653 34456544 345778899999999999999999999999999999999999999
Q ss_pred cccccCCccc---ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 166 SRLLRTPKEL---SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 166 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
++........ .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.... ..+....+... ...
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~~-~~~ 558 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQG-KRM 558 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCC--SHHHHHHHHTT-CCC
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcC-CCC
Confidence 9876433221 123345689999999988888765 999999999999998 999997655 34444444332 233
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+.+..+++++.+||.+||+.||++|||+.++++
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 444578999999999999999999999999853
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=326.97 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=194.5
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhh-hhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL-KRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
|...+.||+|+||.||+|.+ +++.+|+|++..... ........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 34458899999999999986 588999999865332 222234456689999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhcc-CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 88 YAEKKDLEHYISKACN-ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|+++++|.+++..... ..+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~----------~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 180 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHM----------RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred ecCCCcHHHHHHhccCCCCCCHHH----------HHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccc
Confidence 9999999999975322 3355443 3356788899999999999999999999999999999999999999
Q ss_pred ccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch--HHHHhhhCccc---
Q psy6327 167 RLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR--DVLKKQEGKEY--- 239 (351)
Q Consensus 167 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~--- 239 (351)
+....... ......||+.|+|||++.+. ++. ++||||||+++|+|++|..||........ ...........
T Consensus 181 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (307)
T 2nru_A 181 RASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITP-KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIE 258 (307)
T ss_dssp EECCSCSSCEECSSCCSCGGGCCHHHHTTE-ECT-HHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHH
T ss_pred cccccccccccccccCCCcCcCChHHhcCC-CCc-cchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhh
Confidence 87544322 23445799999999998754 454 49999999999999999999976543211 11111111100
Q ss_pred ------cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 240 ------LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 240 ------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
........+..+.+++.+||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 259 DYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011122346778999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=342.37 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=199.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC-CCceeeeeEEEeCCEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH-PNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~l 84 (351)
..+|++.++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|.| ++|..+..++......++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 35699999999999999999999999999999987654432 234589999999986 666677777788899999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeE---cCCCCeEEe
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILI---SRLLNAKLA 161 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll---~~~~~~kl~ 161 (351)
||||+ +++|.+++... ...+++..+ +.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 81 vme~~-g~sL~~ll~~~-~~~l~~~~~----------~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 148 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC-SRKLSLKTV----------LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (483)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred EEECC-CCCHHHHHHhh-cCCCCHHHH----------HHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEE
Confidence 99999 89999999753 345665543 4567888999999999999999999999999 578999999
Q ss_pred eccccccccCCcc-------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHh
Q psy6327 162 DFGFSRLLRTPKE-------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNR-DVLKK 233 (351)
Q Consensus 162 Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~ 233 (351)
|||+++....... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... .....
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence 9999987654332 1236679999999999998887765 9999999999999999999987553222 22221
Q ss_pred hhCccc---cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 234 QEGKEY---LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 234 ~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+..... .......++.++.+||.+||+.||++||++.+|++
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 228 ISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111111 11112368999999999999999999999988764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=331.44 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=193.9
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||.||+|.+.. .+|+|++......... ...+.+|+.++++++||||+++++++.+....++|
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQ-LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCC-CCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHH-HHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 4679999999999999999998864 4899988755433222 23344899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++|++|.+++... ...+++... +.++.|++.||.|||++|++||||||+|||++ ++.+||+|||+
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~----------~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA-KIVLDVNKT----------RQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CBCCCSEEHHHHTTSS-CCCCCSHHH----------HHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred eecccCCcHHHHHHhc-CCCCCHHHH----------HHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999753 234565543 34678888899999999999999999999998 57899999999
Q ss_pred cccccCC-----cccccccccccceeccccccCC---------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q psy6327 166 SRLLRTP-----KELSNTFCGTTSYAAPEIIRNS---------PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL 231 (351)
Q Consensus 166 a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 231 (351)
++..... ........||+.|+|||++.+. .++. ++|||||||++|+|++|..||.... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~--~~~~~ 252 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSK-HSDVFALGTIWYELHAREWPFKTQP--AEAII 252 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCH-HHHHHHHHHHHHHHHHSSCSSSSCC--HHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCc-hhhHHHHHHHHHHHHhCCCCCCCCC--HHHHH
Confidence 8764321 1222345689999999998752 2343 4999999999999999999997654 33333
Q ss_pred HhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 232 KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...............++.++.++|.+||..||++|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 253 WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 33333222222333688999999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=344.74 Aligned_cols=254 Identities=15% Similarity=0.132 Sum_probs=187.6
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC-CCcee---------------
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH-PNIIG--------------- 71 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~--------------- 71 (351)
.|+..+.||+|+||+||+|.+..+|+.||||++...........+.+++|+.+++.+.| +|...
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 48888999999999999999999999999999874444333334556789999999976 32211
Q ss_pred ------eeeEEEe-----CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCc
Q psy6327 72 ------VHRMVKA-----GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGI 140 (351)
Q Consensus 72 ------~~~~~~~-----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i 140 (351)
+..++.. ....+++|+++ +++|.+++.......-... .......+.++.|++.||+|||++||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHK-----SLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSH-----HHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCC-----CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1111111 22467888877 5999999853211000000 11223445677899999999999999
Q ss_pred eeccCCCCCEeEcCCCCeEEeeccccccccCCcccccccccccceeccccc----------cCCCCCCCcchHHHHHHHH
Q psy6327 141 VHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII----------RNSPYNPKLADIWSLGVVL 210 (351)
Q Consensus 141 ~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~DiwslG~il 210 (351)
+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....++. ++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF-AFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH-HHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCc-hhhHHHHHHHH
Confidence 99999999999999999999999999865432 455678 999999998 4444554 49999999999
Q ss_pred HHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 211 YRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 211 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
|+|++|+.||...... .. ....+.....+|+++.+||.+||+.||++|||+.++++||||+.
T Consensus 308 ~elltg~~Pf~~~~~~--~~------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 308 YWIWCADLPNTDDAAL--GG------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHSSCCCCTTGGG--SC------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHCCCCCCCcchh--hh------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999999754321 11 11223333478999999999999999999999999999999963
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=326.89 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=192.9
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHh--CCCCCceeeeeEEEeCC----
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK--VSHPNIIGVHRMVKAGT---- 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~~~---- 80 (351)
.+|++.+.||+|+||.||+|.+ +++.||+|++..... ..+.+|+.++.. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGH------HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhH------HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 4699999999999999999987 489999999864432 223478888887 68999999999998776
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhH--------hCCceeccCCCCCEeE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLH--------EVGIVHRDIKCENILI 152 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH--------~~~i~H~Dlkp~NIll 152 (351)
..|+||||+++|+|.+++.+ ..+++... +.++.|++.||.||| ++||+||||||+|||+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~----------~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR---YTVTVEGM----------IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH---CCBCHHHH----------HHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred eeEEEEeecCCCcHHHHHhc---cCccHHHH----------HHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence 89999999999999999975 34555443 456778889999999 8999999999999999
Q ss_pred cCCCCeEEeeccccccccCCcc----cccccccccceeccccccCCCCCC-----CcchHHHHHHHHHHHHhC-------
Q psy6327 153 SRLLNAKLADFGFSRLLRTPKE----LSNTFCGTTSYAAPEIIRNSPYNP-----KLADIWSLGVVLYRILNK------- 216 (351)
Q Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g------- 216 (351)
+.++.+||+|||++........ ......||+.|+|||++.+..... .++|||||||++|+|++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 9999999999999987654332 234557999999999987653321 348999999999999999
Q ss_pred ---CCCCCCCCCC---chHHHHhhhCcccc--ccc---cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 217 ---KYPFGDPGTR---NRDVLKKQEGKEYL--FNR---KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 217 ---~~pf~~~~~~---~~~~~~~~~~~~~~--~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..||...... .............. .+. ...++..+.+||.+||+.||++|||+.++++|
T Consensus 261 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 7888654322 12222222221111 111 11345678999999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=345.07 Aligned_cols=246 Identities=17% Similarity=0.185 Sum_probs=184.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh-----hHHHhhhHHHHHHHHHhCC---------CCCcee
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-----RDYMEKFAPREIDILLKVS---------HPNIIG 71 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~---------hp~iv~ 71 (351)
..+|++++.||+|+||+||+|.+ +|+.||+|++...... .......+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35699999999999999999988 6899999999765432 1111233458999888885 666666
Q ss_pred eeeEE-----------------Ee-------------CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHH
Q psy6327 72 VHRMV-----------------KA-------------GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121 (351)
Q Consensus 72 ~~~~~-----------------~~-------------~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ 121 (351)
+.+++ .+ .+..|+|||||++|++.+.+.+ ..+++..+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~---------- 163 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATA---------- 163 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHH----------
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHH----------
Confidence 66653 32 7889999999999977776643 44555544
Q ss_pred HHHHHHHHHHHHHhH-hCCceeccCCCCCEeEcCCC--------------------CeEEeeccccccccCCcccccccc
Q psy6327 122 LEYLHEIANALEYLH-EVGIVHRDIKCENILISRLL--------------------NAKLADFGFSRLLRTPKELSNTFC 180 (351)
Q Consensus 122 ~~~~~qi~~~l~~lH-~~~i~H~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~ 180 (351)
..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+
T Consensus 164 ~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~ 238 (336)
T 2vuw_A 164 KSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVV 238 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEE
T ss_pred HHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEE
Confidence 446788888999999 99999999999999999887 899999999987643 2457
Q ss_pred cccceeccccccCCCCCCCcchHHHHHHH-HHHHHhCCCCCCCCCCCchHHHHhh----h-CccccccccccCCHhHHHH
Q psy6327 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVV-LYRILNKKYPFGDPGTRNRDVLKKQ----E-GKEYLFNRKYEISIGAKQL 254 (351)
Q Consensus 181 gt~~y~aPE~~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~~~~~~~~----~-~~~~~~~~~~~~s~~~~~l 254 (351)
||+.|+|||++.+.. +. ++||||+|++ .+++++|..||.+.... ....... . ......+....+|+++++|
T Consensus 239 gt~~y~aPE~~~g~~-~~-~~Diwsl~~~~~~~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DY-QFDIYRLMKKENNNRWGEYHPYSNVLWL-HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp CCCCTTCSGGGCCCS-SH-HHHHHHHHHHHHTTCTTSCCTHHHHHHH-HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHH
T ss_pred EeecccChhhhcCCC-cc-ceehhhhhCCCCcccccccCCCcchhhh-hHHHHhhhhhhccCcccchhhhhhcCHHHHHH
Confidence 999999999998766 44 5999998777 77888999998431100 0011111 1 1111111223578999999
Q ss_pred HHHhcCCCCCCCCCHHHHh-cCcccc
Q psy6327 255 IGRMLEPNPKHRPNAKDVQ-NHAWIQ 279 (351)
Q Consensus 255 i~~~L~~dp~~Rpt~~ell-~hp~~~ 279 (351)
|.+||+.| |+.|+| +||||+
T Consensus 316 i~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHHhccC-----CHHHHHhcCCCcC
Confidence 99999977 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=350.29 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=196.1
Q ss_pred cceeeeeecCcccceEEEEEEecCC---ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
.+|++.+.||+|+||.||+|.+..+ +..+|+|.+..... ......+.+|+.++++++||||+++++++.+ +..|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 4589999999999999999998643 56799998754322 2233455689999999999999999999854 5689
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+++|+|.+++... ...+++.. ++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 467 lv~E~~~~g~L~~~l~~~-~~~l~~~~----------~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR-KFSLDLAS----------LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp EEEECCTTCBHHHHHHHT-TTTCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEEEcCCCCcHHHHHHhc-cCCCCHHH----------HHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEec
Confidence 999999999999999753 23455433 3457788999999999999999999999999999999999999
Q ss_pred cccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 164 GFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 164 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
|+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.. ..+....+.... ..
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~--~~~~~~~i~~~~-~~ 611 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGE-RL 611 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHHTC-CC
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCC-CC
Confidence 99987644322 2233457889999999988877765 999999999999997 999997654 333333332221 22
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+.+..+++.+.+||.+||+.||++|||+.++++
T Consensus 612 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 334578999999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=312.76 Aligned_cols=226 Identities=15% Similarity=0.141 Sum_probs=180.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 46999999999999999999999999999999998765544444455669999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
||++|++|.++++. +..+. .++.++.|++.||+|||++||+||||||+|||++.++.+||+++|.
T Consensus 111 e~~~g~~L~~~l~~---~~~~~-----------~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~- 175 (286)
T 3uqc_A 111 EWIRGGSLQEVADT---SPSPV-----------GAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT- 175 (286)
T ss_dssp ECCCEEEHHHHHTT---CCCHH-----------HHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-
T ss_pred EecCCCCHHHHHhc---CCChH-----------HHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-
Confidence 99999999999954 22221 2345788999999999999999999999999999999999985542
Q ss_pred ccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchH-HH-HhhhCc-cccccc
Q psy6327 167 RLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD-VL-KKQEGK-EYLFNR 243 (351)
Q Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~-~~~~~~-~~~~~~ 243 (351)
++| ++. ++|||||||++|+|++|+.||...+..... .. ...... ......
T Consensus 176 -------------------~~~-------~~~-~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 176 -------------------MPD-------ANP-QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADI 228 (286)
T ss_dssp -------------------CTT-------CCH-HHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHH
T ss_pred -------------------cCC-------CCc-hhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhc
Confidence 232 333 499999999999999999999865432111 00 111111 111122
Q ss_pred cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 244 KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 244 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
...+++++.+||.+||+.||++| |+.++++.
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 24689999999999999999999 99999763
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.61 Aligned_cols=240 Identities=23% Similarity=0.346 Sum_probs=191.4
Q ss_pred cceeeeeecCcccceEEEEEEecC-CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE----
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKR-SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY---- 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~---- 81 (351)
.+|++.+.||+|+||.||+|.+.. +++.||+|++..... ......+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 569999999999999999999976 789999998864322 2223445689999999999999999999976554
Q ss_pred -EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 82 -LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 82 -~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.|+||||++|++|.+++.. .+++.. ++.++.||+.||.|||++||+||||||+|||++.+ .+||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~----~l~~~~----------~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ----KLPVAE----------AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEEEEECCCCEECC----C----CCCHHH----------HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEE
T ss_pred eeEEEEEeCCCCcHHHHHhC----CCCHHH----------HHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEE
Confidence 7999999999999987743 455544 34577889999999999999999999999999985 8999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
+|||+++..... ...+||+.|+|||++.+.. + .++|||||||++|+|++|.+||........ ..
T Consensus 223 ~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~-~-~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~ 286 (681)
T 2pzi_A 223 IDLGAVSRINSF----GYLYGTPGFQAPEIVRTGP-T-VATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PE 286 (681)
T ss_dssp CCCTTCEETTCC----SCCCCCTTTSCTTHHHHCS-C-HHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CT
T ss_pred EecccchhcccC----CccCCCccccCHHHHcCCC-C-CceehhhhHHHHHHHHhCCCCCcccccccc----------cc
Confidence 999999876443 4567999999999987654 4 459999999999999999999864321100 00
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
.......++.+.+||.+||+.||.+||+..+.+.|+|+.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 111123578899999999999999999999988888863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=306.47 Aligned_cols=189 Identities=14% Similarity=0.084 Sum_probs=135.9
Q ss_pred ecCcccceEEEEEEecCCceeEEEEecchhhh-------hhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEE
Q psy6327 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRL-------KRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 14 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+.|+.|.+..+...-.|+.+++|++..... ......+.+.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46778888888888778899999999965421 1223344567999999999 699999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++|++|.++|.+ .+++++. +++.||+.||+|+|++||+||||||+|||++.+|.+||+|||+
T Consensus 321 MEyv~G~~L~d~i~~--~~~l~~~-------------~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGl 385 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA--GEEIDRE-------------KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGS 385 (569)
T ss_dssp EECCCSEEHHHHHHT--TCCCCHH-------------HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHh--CCCCCHH-------------HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeeccc
Confidence 999999999999987 5666542 2567999999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYP 219 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 219 (351)
|+..........+.+||+.|+|||++.+.. ... +|+||+|+++++|.++..+
T Consensus 386 Ar~~~~~~~~~~t~vGTp~YmAPE~l~g~~-~~~-~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 386 IVTTPQDCSWPTNLVQSFFVFVNELFAENK-SWN-GFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred CeeCCCCCccccCceechhhccHHHhCCCC-CCc-ccccccccchhhhccccch
Confidence 998776666667789999999999998654 333 8999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=256.71 Aligned_cols=185 Identities=17% Similarity=0.209 Sum_probs=142.3
Q ss_pred eeeecCcccceEEEEEEecCCceeEEEEecchhhhh-----hHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK-----RDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+.||+|+||.||+|. ..+..+++|....+... .....+.+.+|+.++++++||||+++..++...+..|+|
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 35689999999999994 45778888876544332 222234567999999999999999655555566777999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||++|++|.+++.. ++.++.|++.||.|||++||+||||||+|||++. .+||+|||+
T Consensus 418 mE~~~ggsL~~~l~~--------------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp EECCCSEEHHHHSTT--------------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTT
T ss_pred EECCCCCCHHHHHHH--------------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECcc
Confidence 999999999999864 2357889999999999999999999999999999 999999999
Q ss_pred cccccCCccc-------ccccccccceeccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy6327 166 SRLLRTPKEL-------SNTFCGTTSYAAPEIIRN--SPYNPKLADIWSLGVVLYRILNKKYPF 220 (351)
Q Consensus 166 a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf 220 (351)
++........ ....+||+.|+|||++.. ..|+.. +|+|+..+-..+.+.++.+|
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhcccc
Confidence 9987553321 246789999999999976 455544 79999999888888777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=210.63 Aligned_cols=146 Identities=20% Similarity=0.153 Sum_probs=113.1
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH---------------HHhhhHHHHHHHHHhCCCCCceeee
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD---------------YMEKFAPREIDILLKVSHPNIIGVH 73 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---------------~~~~~~~~Ei~~l~~l~hp~iv~~~ 73 (351)
|.+.+.||+|+||.||+|.+ .+|+.+|+|.+........ .....+.+|+.++++++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 34459999999999999999 8899999999864332111 12344568999999998 4 6666
Q ss_pred eEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 74 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
+++.. +..|+||||++|++|.+ +.. .+ ...++.|++.||.|||++||+||||||+|||++
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~------------~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV------EN------------PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS 227 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC------SC------------HHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch------hh------------HHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE
Confidence 65544 44699999999999988 421 11 124678999999999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCcccccccccccceecccccc
Q psy6327 154 RLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIR 192 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 192 (351)
++.+||+|||+|+. +..++|||++.
T Consensus 228 -~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 99999999999873 44568888874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=177.76 Aligned_cols=141 Identities=16% Similarity=0.218 Sum_probs=105.2
Q ss_pred eeeeeecCcccceEEEEEEecCCcee--EEEEecchhhhh---------------------hHHHhhhHHHHHHHHHhCC
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETL--KACKAYDFKRLK---------------------RDYMEKFAPREIDILLKVS 65 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~---------------------~~~~~~~~~~Ei~~l~~l~ 65 (351)
|.+.+.||+|+||.||+|.+..+|+. +|+|++...... .......+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999788989 999987543211 1111234568999999998
Q ss_pred CCCc--eeeeeEEEeCCEEEEEEecCCC-C----ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhH-h
Q psy6327 66 HPNI--IGVHRMVKAGTYLYMIMDYAEK-K----DLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLH-E 137 (351)
Q Consensus 66 hp~i--v~~~~~~~~~~~~~lv~e~~~g-g----sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH-~ 137 (351)
|+++ +.++.. ...++||||+.+ | +|.++... .++.. +..++.|++.||.||| +
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~----------~~~i~~qi~~~l~~lH~~ 189 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELD----------VEGIFNDVVENVKRLYQE 189 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSC----------HHHHHHHHHHHHHHHHHT
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHH----------HHHHHHHHHHHHHHHHHH
Confidence 8764 344432 246899999942 3 67666432 11111 3356788999999999 9
Q ss_pred CCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 138 VGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 138 ~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
+||+||||||+|||++. .++|+|||+|....
T Consensus 190 ~givHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 190 AELVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999999999998 89999999997643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=164.81 Aligned_cols=140 Identities=16% Similarity=0.204 Sum_probs=98.2
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh---------------hH----HHhhhHHHHHHHHHhCCCCCc
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK---------------RD----YMEKFAPREIDILLKVSHPNI 69 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------------~~----~~~~~~~~Ei~~l~~l~hp~i 69 (351)
|++.+.||+|+||.||+|.+. +|+.+|+|++...... .. .......+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 889999999999999999985 6899999987543211 00 001112357777777755444
Q ss_pred eeeeeEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCC
Q psy6327 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCEN 149 (351)
Q Consensus 70 v~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~N 149 (351)
.-..-+.... .+|||||++|++|..+.. .++ +..++.|++.+|.+||++|||||||||.|
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~------------~~~l~~qll~~l~~lH~~gIVHrDLKp~N 235 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPD------------PASLYADLIALILRLAKHGLIHGDFNEFN 235 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC------CSC------------HHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc------cHH------------HHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 2221111222 379999999988865432 111 12356788999999999999999999999
Q ss_pred EeEcCCC----------CeEEeeccccccc
Q psy6327 150 ILISRLL----------NAKLADFGFSRLL 169 (351)
Q Consensus 150 Ill~~~~----------~~kl~Dfg~a~~~ 169 (351)
||+++++ .+.|+||+-+-..
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9998776 3889999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=2.9e-13 Score=118.48 Aligned_cols=140 Identities=15% Similarity=0.120 Sum_probs=104.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv 85 (351)
..|++...+|.|+.+.||++... +..+++|......... ...+.+|+.+++.|. +..+.++++++...+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 56889999999999999998754 6789999876432111 234568999999985 67888999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh----------------------------
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE---------------------------- 137 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~---------------------------- 137 (351)
|||++|.+|.+.+.. ...... ++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~~~-------~~~~~~----------~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-------EQSPEK----------IIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp EECCSSEEHHHHCCT-------TTCHHH----------HHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred EEecCCeehhhccCC-------cccHHH----------HHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence 999999999876311 011112 33445555556665
Q ss_pred -------------------------------CCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 138 -------------------------------VGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 138 -------------------------------~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
..++|+|++|.||+++++..+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765567999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.2e-12 Score=111.39 Aligned_cols=81 Identities=11% Similarity=0.022 Sum_probs=59.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCC--ceeeeeEEEeCCEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN--IIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~~~~~~~~~lv 85 (351)
++.+....+.|..+.||++.. .+|..+++|...... ...+.+|+.+++.+.+.+ +.+++.+...++..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 456544444666799999864 467789999865431 233458999999886434 56788988888889999
Q ss_pred EecCCCCChH
Q psy6327 86 MDYAEKKDLE 95 (351)
Q Consensus 86 ~e~~~ggsL~ 95 (351)
|||++|.+|.
T Consensus 94 ~e~i~G~~l~ 103 (264)
T 1nd4_A 94 LGEVPGQDLL 103 (264)
T ss_dssp EECCSSEETT
T ss_pred EEecCCcccC
Confidence 9999998884
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=7.4e-11 Score=108.02 Aligned_cols=155 Identities=12% Similarity=0.169 Sum_probs=96.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecc--hhhhhhHHHhhhHHHHHHHHHhCC--CCCceeeeeEEEeC---
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYD--FKRLKRDYMEKFAPREIDILLKVS--HPNIIGVHRMVKAG--- 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~--~~~~~~~~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~--- 79 (351)
....-++.|+.|.++.||++... +..+++|+.. ...... ....+.+|+.+++.|. +..+++++.++.+.
T Consensus 38 ~~~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~--~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~ 113 (359)
T 3dxp_A 38 AGPLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLP--SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI 113 (359)
T ss_dssp CCCCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred CCCceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCC--cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence 33445788999999999998764 4577888765 322111 1335568999999997 45678899888776
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHH-------------------------------
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI------------------------------- 128 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi------------------------------- 128 (351)
+..|+||||++|.++.+.. ...++......+..++...+.-+|.+
T Consensus 114 g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp SSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 4589999999988775421 12234444333333333333322221
Q ss_pred --------HHHHHHhH---------hCCceeccCCCCCEeEcCCCC--eEEeeccccccc
Q psy6327 129 --------ANALEYLH---------EVGIVHRDIKCENILISRLLN--AKLADFGFSRLL 169 (351)
Q Consensus 129 --------~~~l~~lH---------~~~i~H~Dlkp~NIll~~~~~--~kl~Dfg~a~~~ 169 (351)
-..+.+|. ...++|+|++|.|||++.++. +.|+||+.+...
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 01111111 146999999999999997653 689999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.04 E-value=9.4e-11 Score=104.79 Aligned_cols=200 Identities=17% Similarity=0.207 Sum_probs=114.8
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCC--ceeeeeEEEeC
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPN--IIGVHRMVKAG 79 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~--iv~~~~~~~~~ 79 (351)
+|++.. .-++.++.|....||++. ..+++|..... .....+.+|+.+++.+. +.. +.+++......
T Consensus 17 ~p~~~~-~~i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~ 85 (304)
T 3sg8_A 17 YPDFTI-NTIEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS 85 (304)
T ss_dssp CTTCCC-CCCCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC
T ss_pred CCCccc-eeeEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC
Confidence 344433 235668999999999864 45788875432 12334558999998884 333 44555554333
Q ss_pred C---EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHH-----------------------------
Q psy6327 80 T---YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE----------------------------- 127 (351)
Q Consensus 80 ~---~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~q----------------------------- 127 (351)
. ..|+||++++|.+|.+... ..++..+...+..++...+.-+++
T Consensus 86 ~~~~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (304)
T 3sg8_A 86 ETYQMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL 161 (304)
T ss_dssp SSCSCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred CCCCcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence 3 4589999999988875432 123333333333444333333322
Q ss_pred -----------HHHHHHH-hHh-------CCceeccCCCCCEeEcC--CCCeEEeeccccccccCCcccccccc-----c
Q psy6327 128 -----------IANALEY-LHE-------VGIVHRDIKCENILISR--LLNAKLADFGFSRLLRTPKELSNTFC-----G 181 (351)
Q Consensus 128 -----------i~~~l~~-lH~-------~~i~H~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~-----g 181 (351)
+...+.. +.. ..++|+|++|.||++++ +..+.|+||+.+.......+...... +
T Consensus 162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~ 241 (304)
T 3sg8_A 162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYG 241 (304)
T ss_dssp TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCC
T ss_pred cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccC
Confidence 0111111 111 35899999999999998 45578999999876433222111110 0
Q ss_pred cc-------ce--ec-cccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy6327 182 TT-------SY--AA-PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF 220 (351)
Q Consensus 182 t~-------~y--~a-PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 220 (351)
.. .| .. |+...... . ..+.|++|.++|.+.+|..+|
T Consensus 242 ~~~~~~~l~~Y~~~~~~~~~~r~~--~-~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 242 MEFVSKILNHYKHKDIPTVLEKYR--M-KEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHTCSCHHHHHHHHH--H-HHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCCCcHHHHHHHH--H-HHHHHHHHHHHHHHHcCCHHH
Confidence 00 01 11 22221111 1 158999999999999998887
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=8.5e-07 Score=77.38 Aligned_cols=142 Identities=13% Similarity=0.121 Sum_probs=91.7
Q ss_pred cCcccce-EEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEecCCCC
Q psy6327 15 LGEGAYG-NVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMIMDYAEKK 92 (351)
Q Consensus 15 LG~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~gg 92 (351)
+..|..| .||+......+..+.+|.-.... ...+.+|...|+.|. +-.+.+++.++.+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 3345444 69998887778888999754332 233458999998885 445778999999999999999999998
Q ss_pred ChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHH-----------------------------------------HHH
Q psy6327 93 DLEHYISKACNENIHENQARIWIRQIANALEYLHEI-----------------------------------------ANA 131 (351)
Q Consensus 93 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi-----------------------------------------~~~ 131 (351)
++.+...... .....+..++...+.-++.+ ...
T Consensus 106 ~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 106 TAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp EHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8877654310 11111222222222211110 011
Q ss_pred HHHhHhC-------CceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 132 LEYLHEV-------GIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 132 l~~lH~~-------~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
...+... .++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1222221 279999999999999877677999998865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=7.6e-07 Score=79.36 Aligned_cols=84 Identities=20% Similarity=0.109 Sum_probs=56.9
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCC---CceeeeeEEE-e
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHP---NIIGVHRMVK-A 78 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---~iv~~~~~~~-~ 78 (351)
||.+.. .-++.++.|....||.. +..+++|+-... .....+.+|+.+|+.|.+. .+.+.+.+.. .
T Consensus 16 ~p~~~~-~~v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~ 84 (306)
T 3tdw_A 16 FPDISI-QSVESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS 84 (306)
T ss_dssp CTTSCC-SCEEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT
T ss_pred CCCCCc-eeeeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC
Confidence 444432 23566888999999987 466788874211 1233456899999999642 3556666664 4
Q ss_pred CCEEEEEEecCCCCChHHH
Q psy6327 79 GTYLYMIMDYAEKKDLEHY 97 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~ 97 (351)
.+..|+||||++|.+|.+.
T Consensus 85 ~g~~~~v~e~i~G~~l~~~ 103 (306)
T 3tdw_A 85 DGNPFVGYRKVQGQILGED 103 (306)
T ss_dssp TSCEEEEEECCCSEECHHH
T ss_pred CCceEEEEeccCCeECchh
Confidence 5567899999999888763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=5.4e-07 Score=83.33 Aligned_cols=81 Identities=14% Similarity=0.105 Sum_probs=49.3
Q ss_pred eeeecCcccceEEEEEEecCCceeEEEEecchhhh-hhH---HHhhhHHHHHHHHHhCCC--C-CceeeeeEEEeCCEEE
Q psy6327 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL-KRD---YMEKFAPREIDILLKVSH--P-NIIGVHRMVKAGTYLY 83 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~---~~~~~~~~Ei~~l~~l~h--p-~iv~~~~~~~~~~~~~ 83 (351)
-++.||.|.++.||++....++..+++|....... ... ........|+.+++.+.. | .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 36789999999999998766678899997642211 000 012233478888887742 3 34456654 334457
Q ss_pred EEEecCCCCC
Q psy6327 84 MIMDYAEKKD 93 (351)
Q Consensus 84 lv~e~~~ggs 93 (351)
+||||++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999998643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.27 E-value=2.2e-05 Score=70.63 Aligned_cols=31 Identities=16% Similarity=0.199 Sum_probs=27.6
Q ss_pred CCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 138 VGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 138 ~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998778899999997753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=4.3e-06 Score=75.98 Aligned_cols=87 Identities=10% Similarity=0.110 Sum_probs=56.5
Q ss_pred eeeeeec-CcccceEEEEEEec--C----CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-C--CCceeeeeEEEe
Q psy6327 9 CSYISKL-GEGAYGNVYLVSDK--R----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-H--PNIIGVHRMVKA 78 (351)
Q Consensus 9 ~~~~~~L-G~G~~g~V~~~~~~--~----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h--p~iv~~~~~~~~ 78 (351)
...++.| +.|....+|++... . ++..+++|...............+.+|+.+++.|. + -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 88999999987643 1 25678888764432000000133458999988884 3 356778887765
Q ss_pred C---CEEEEEEecCCCCChH
Q psy6327 79 G---TYLYMIMDYAEKKDLE 95 (351)
Q Consensus 79 ~---~~~~lv~e~~~ggsL~ 95 (351)
. +..|+||||++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 5 3568999999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.92 E-value=1.6e-05 Score=70.38 Aligned_cols=81 Identities=10% Similarity=-0.049 Sum_probs=49.6
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc-eeeeeEEEeCCE
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-IGVHRMVKAGTY 81 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~ 81 (351)
+|.+.+|.-++.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ .+++....+ .
T Consensus 14 ~p~l~~~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~ 81 (301)
T 3dxq_A 14 IPMLAGYTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVDPA--T 81 (301)
T ss_dssp CTTTTTCCSCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--T
T ss_pred CCccccccceeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEECC--C
Confidence 455445655888999999999998 45778876532111 1112368888877752222 456554432 2
Q ss_pred EEEEEecC-CCCChH
Q psy6327 82 LYMIMDYA-EKKDLE 95 (351)
Q Consensus 82 ~~lv~e~~-~ggsL~ 95 (351)
-++++||+ +|.+|.
T Consensus 82 ~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 82 GVMVTRYIAGAQTMS 96 (301)
T ss_dssp CCEEEECCTTCEECC
T ss_pred CEEEEeecCCCccCC
Confidence 36899999 765553
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.92 E-value=5.7e-05 Score=70.24 Aligned_cols=80 Identities=11% Similarity=0.090 Sum_probs=46.9
Q ss_pred HhCCceeccCCCCCEeEcCCCCeEEeeccccccccCCcccccccc-cccceeccccccCCCCC--CCcchHHHHHHHHHH
Q psy6327 136 HEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC-GTTSYAAPEIIRNSPYN--PKLADIWSLGVVLYR 212 (351)
Q Consensus 136 H~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-gt~~y~aPE~~~~~~~~--~~~~DiwslG~il~~ 212 (351)
+...++|+|++|.|||++.++ ++++||+.+.......+...... -...|.+|+........ ....++.++...+|.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 456799999999999998876 99999998876432222111110 01345666554311100 011344466777777
Q ss_pred HHhC
Q psy6327 213 ILNK 216 (351)
Q Consensus 213 ll~g 216 (351)
.+.+
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00057 Score=60.74 Aligned_cols=77 Identities=16% Similarity=0.144 Sum_probs=58.8
Q ss_pred eeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC---CCCceeeeeEEEeCCEEEEEE
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS---HPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.-++.|+.|....+|+... ++..+++|...... ...+.+|+..|+.|. ...+++++.+....+..++||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3467789999999999875 46678888765321 234458888888874 366888888888888999999
Q ss_pred ecCCCCCh
Q psy6327 87 DYAEKKDL 94 (351)
Q Consensus 87 e~~~ggsL 94 (351)
||++|.++
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00012 Score=67.05 Aligned_cols=149 Identities=15% Similarity=0.142 Sum_probs=81.0
Q ss_pred eeecCcccceEEEEEEecC-------CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKR-------SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~ 83 (351)
++.|..|-...+|++.... ++..+.+|+..... .. ...+.+|..+++.|. +.-..++++.+.++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g---- 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QG---VDSLVLESVMFAILAERSLGPQLYGVFPEG---- 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETTE----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----
Confidence 4567778889999988642 35678888863321 11 122237999988885 33336677666542
Q ss_pred EEEecCCCCChH--------------HHHHhhccCCC--------chHHHHHHHHHHHHHH-------------HHHHHH
Q psy6327 84 MIMDYAEKKDLE--------------HYISKACNENI--------HENQARIWIRQIANAL-------------EYLHEI 128 (351)
Q Consensus 84 lv~e~~~ggsL~--------------~~l~~~~~~~~--------~~~~~~~~~~~i~~~~-------------~~~~qi 128 (351)
+||||++|.+|. +.+.+...... ...++..|..++.... .+-..+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999986553 11111111111 1234444544432210 000011
Q ss_pred HHHHHHhHh----CCceeccCCCCCEeEcCC----CCeEEeecccccc
Q psy6327 129 ANALEYLHE----VGIVHRDIKCENILISRL----LNAKLADFGFSRL 168 (351)
Q Consensus 129 ~~~l~~lH~----~~i~H~Dlkp~NIll~~~----~~~kl~Dfg~a~~ 168 (351)
..--+.|.. ..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 111112322 258999999999999876 6899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00014 Score=64.85 Aligned_cols=151 Identities=15% Similarity=0.152 Sum_probs=78.5
Q ss_pred eeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCC--ceeeeeE------EEeCCE
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN--IIGVHRM------VKAGTY 81 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~------~~~~~~ 81 (351)
.-++.|+.|....+|++... +| .+++|....... ...+..|+.++..|...+ +.+++.. ....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 34667888888999998653 33 678888764211 222336777777664212 3333321 233467
Q ss_pred EEEEEecCCCCChHH-----------H---HHhhccCCCch-----HHHHHHHHHHHHHH-------H-HHHHHHHHHHH
Q psy6327 82 LYMIMDYAEKKDLEH-----------Y---ISKACNENIHE-----NQARIWIRQIANAL-------E-YLHEIANALEY 134 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~-----------~---l~~~~~~~~~~-----~~~~~~~~~i~~~~-------~-~~~qi~~~l~~ 134 (351)
.+++++|++|.++.. . +... ...++. .....|...+.... . +...+...+..
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~-~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLA-SEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHH-TTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHH-hccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 899999999765311 1 1110 001100 01112211110000 0 00112334444
Q ss_pred hHh-------CCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 135 LHE-------VGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 135 lH~-------~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
++. .+++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 442 3699999999999999865568999997754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00039 Score=65.21 Aligned_cols=75 Identities=16% Similarity=0.131 Sum_probs=48.6
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEEEecCC
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI-IGVHRMVKAGTYLYMIMDYAE 90 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~ 90 (351)
++.|+.|-...+|++.....+..+.+|+..... .. .. ...+|..+++.|...++ .++++++. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 567888999999999876545788898864321 10 01 11379999999874444 57777763 2 25999999
Q ss_pred CCCh
Q psy6327 91 KKDL 94 (351)
Q Consensus 91 ggsL 94 (351)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.0003 Score=61.75 Aligned_cols=79 Identities=14% Similarity=0.032 Sum_probs=54.2
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-C--CCceeeeeEEEeCCEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-H--PNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h--p~iv~~~~~~~~~~~~~l 84 (351)
+..-++.+|.|..+.||++.. .+|+.+.+|+........ ...+..|+..|+.|. . -.+++++.+. . -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceE
Confidence 345678899999999999874 468889999765433221 234568999999884 2 2345555542 2 378
Q ss_pred EEecCCCCCh
Q psy6327 85 IMDYAEKKDL 94 (351)
Q Consensus 85 v~e~~~ggsL 94 (351)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00099 Score=55.28 Aligned_cols=136 Identities=23% Similarity=0.170 Sum_probs=84.3
Q ss_pred CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHh-HhCCceeccCCCCCEeEcCCCCeEEeecccccccc
Q psy6327 92 KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYL-HEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR 170 (351)
Q Consensus 92 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~l-H~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 170 (351)
-+|.+.|... +.++.|.+++.+ +.|.+.+|.-+ +...-..+=+.|..|++..+|+|.+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWAL----------c~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAV----------CYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHH----------HHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHH----------HHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---
Confidence 4799999765 789999887654 45555555454 212222344567899999999888763 1110
Q ss_pred CCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccccCCHh
Q psy6327 171 TPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250 (351)
Q Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 250 (351)
.....+.|||... .....+.=|||||+++|..+-=..|= .....+|+.
T Consensus 98 ---------~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e---------------------~eE~eLS~~ 145 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE---------------------NEERELSPP 145 (229)
T ss_dssp ------------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT---------------------TEEECCCHH
T ss_pred ---------ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc---------------------ccchhhCHH
Confidence 1233567888763 11223468999999999998522211 122379999
Q ss_pred HHHHHHHhcCCC-------------------------CCCCCCHHHHhc
Q psy6327 251 AKQLIGRMLEPN-------------------------PKHRPNAKDVQN 274 (351)
Q Consensus 251 ~~~li~~~L~~d-------------------------p~~Rpt~~ell~ 274 (351)
+.+||..|..-. +..|++++++++
T Consensus 146 LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 146 LEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp HHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred HHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 999999998662 457788888875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00064 Score=60.65 Aligned_cols=149 Identities=15% Similarity=0.197 Sum_probs=78.7
Q ss_pred eeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC--CCceeeeeE-----EEeCCEEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH--PNIIGVHRM-----VKAGTYLYM 84 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~-----~~~~~~~~l 84 (351)
+..|+ |....||++... +|+.+++|......... ..+..|..+++.|.. -.+++++.. ...++..++
T Consensus 31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~----~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCH----HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 34566 788899987543 46678899876332222 123367777776642 123444432 233567789
Q ss_pred EEecCCCCChH-----------HHH---Hhh-ccCCC---chHHHHHHH---HHHHH------------HHHHHHHHHHH
Q psy6327 85 IMDYAEKKDLE-----------HYI---SKA-CNENI---HENQARIWI---RQIAN------------ALEYLHEIANA 131 (351)
Q Consensus 85 v~e~~~ggsL~-----------~~l---~~~-~~~~~---~~~~~~~~~---~~i~~------------~~~~~~qi~~~ 131 (351)
+|+|++|.++. ..+ ... ..... +......+. ..... ....+..++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999875432 111 110 00000 110111111 00100 01112222222
Q ss_pred HHHh----HhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 132 LEYL----HEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 132 l~~l----H~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
+.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2222 234589999999999999 4 799999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0014 Score=60.96 Aligned_cols=74 Identities=15% Similarity=0.113 Sum_probs=48.4
Q ss_pred eeecCcccceEEEEEEecC-------CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCC-ceeeeeEEEeCCEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKR-------SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN-IIGVHRMVKAGTYLY 83 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~~~~ 83 (351)
++.|+.|....||++.... ++..+.+|+...... ...+.+|..+++.|...+ .+++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 5678889999999997643 256788898743211 011226888888885333 3567776543 2
Q ss_pred EEEecCCCCCh
Q psy6327 84 MIMDYAEKKDL 94 (351)
Q Consensus 84 lv~e~~~ggsL 94 (351)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00082 Score=60.18 Aligned_cols=149 Identities=11% Similarity=0.029 Sum_probs=73.9
Q ss_pred eeecCcccceE-EEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-C-CCceeeeeEEEeCCEEEEEEec
Q psy6327 12 ISKLGEGAYGN-VYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-H-PNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 12 ~~~LG~G~~g~-V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-p~iv~~~~~~~~~~~~~lv~e~ 88 (351)
++.|+.|+... +|+... .++..+++|....... ..+..|+.+++.|. + -.+.+++.+..+.+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 45676665555 666643 2255666775433210 22336777777774 2 23556676644444 689999
Q ss_pred CCCCChHHHHHhhcc------------------------CCCchHHH-------HHHHHH-HH-----HHHHHHHHHHHH
Q psy6327 89 AEKKDLEHYISKACN------------------------ENIHENQA-------RIWIRQ-IA-----NALEYLHEIANA 131 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~------------------------~~~~~~~~-------~~~~~~-i~-----~~~~~~~qi~~~ 131 (351)
+.+.++.+.+..... ..+..... ..|... .. .....+..++..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 987777665532100 00111110 001100 00 000111111111
Q ss_pred HH-Hh--HhCCceeccCCCCCEeEcCC----CCeEEeeccccccc
Q psy6327 132 LE-YL--HEVGIVHRDIKCENILISRL----LNAKLADFGFSRLL 169 (351)
Q Consensus 132 l~-~l--H~~~i~H~Dlkp~NIll~~~----~~~kl~Dfg~a~~~ 169 (351)
+. .+ +...++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 11 11 23469999999999999874 67899999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0011 Score=60.17 Aligned_cols=75 Identities=12% Similarity=0.070 Sum_probs=44.0
Q ss_pred eeecCcccceEEEEEEecC--------CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCC-ceeeeeEEEeCCEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKR--------SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN-IIGVHRMVKAGTYL 82 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~~~ 82 (351)
+..|+.|....+|++.... .+..+++|+....... . .....|..+++.|...+ +.++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---L-YNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---T-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---e-ecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 5678888889999987543 1267888876432211 0 11247888888875333 44666554 22
Q ss_pred EEEEecCCCCCh
Q psy6327 83 YMIMDYAEKKDL 94 (351)
Q Consensus 83 ~lv~e~~~ggsL 94 (351)
++||||++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999997543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0037 Score=57.94 Aligned_cols=149 Identities=14% Similarity=0.191 Sum_probs=85.5
Q ss_pred eeeecCcccceEEEEEEecCC-------ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEE
Q psy6327 11 YISKLGEGAYGNVYLVSDKRS-------ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~ 82 (351)
-++.|..|-...+|++..... +..+.+|+..... .. .-...+|..+++.|. +.-..++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADFP--E-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence 356677788899999886521 5778888864322 11 111237888888885 333456665432 2
Q ss_pred EEEEecCCCCChHH--------------HHHhh----c----------cCCCchHHHHHHHHHHHHHHH---------HH
Q psy6327 83 YMIMDYAEKKDLEH--------------YISKA----C----------NENIHENQARIWIRQIANALE---------YL 125 (351)
Q Consensus 83 ~lv~e~~~ggsL~~--------------~l~~~----~----------~~~~~~~~~~~~~~~i~~~~~---------~~ 125 (351)
++||||++|.+|.. .+.+. . ..+....++..|..++..... -.
T Consensus 146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~ 225 (424)
T 3mes_A 146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY 225 (424)
T ss_dssp EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence 68999999865421 11100 0 011123445555554433221 00
Q ss_pred HHHHHHHHHh----H--------------------hCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 126 HEIANALEYL----H--------------------EVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 126 ~qi~~~l~~l----H--------------------~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
..+...+..| . ...++|+|+.+.||+ +.++.+.++||..+..
T Consensus 226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 1111122222 1 124899999999999 7778899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.021 Score=51.10 Aligned_cols=32 Identities=22% Similarity=0.296 Sum_probs=28.0
Q ss_pred CCceeccCCCCCEeEcCCCCeEEeeccccccc
Q psy6327 138 VGIVHRDIKCENILISRLLNAKLADFGFSRLL 169 (351)
Q Consensus 138 ~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 169 (351)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998788999999887653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.41 E-value=0.019 Score=53.84 Aligned_cols=63 Identities=8% Similarity=0.066 Sum_probs=17.7
Q ss_pred eeeecCcccceEEEEEEecCCceeEEE------EecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE
Q psy6327 11 YISKLGEGAYGNVYLVSDKRSETLKAC------KAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK 77 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~~~~~ai------K~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 77 (351)
+.++|| ||.||++........||+ |.............. +.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~-~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTS-LVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCcccccccccccccccc-ccccccccccccccccCCCcceEE
Confidence 455676 999999988765567888 554433333332223 347889999999999999988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.35 E-value=0.37 Score=44.04 Aligned_cols=29 Identities=34% Similarity=0.478 Sum_probs=24.7
Q ss_pred ceeccCCCCCEeE------cCCCCeEEeecccccc
Q psy6327 140 IVHRDIKCENILI------SRLLNAKLADFGFSRL 168 (351)
Q Consensus 140 i~H~Dlkp~NIll------~~~~~~kl~Dfg~a~~ 168 (351)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 351 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-68 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-67 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-66 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-66 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-64 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-63 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-63 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-62 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-60 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-60 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-59 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-58 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-58 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-54 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-54 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-53 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-53 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-51 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-51 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-46 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-44 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-44 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-43 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-33 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-15 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 4e-69
Identities = 87/268 (32%), Positives = 135/268 (50%), Gaps = 19/268 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
LG+G +GNVYL +K+S+ + A K +L++ +E RE++I + HPNI+
Sbjct: 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ T +Y+I++YA + + K E + +I ++ANAL Y H
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK--- 125
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
++HRDIK EN+L+ K+ADFG+S P T CGT Y PE+I
Sbjct: 126 -------RVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMI 176
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
++ K D+WSLGV+ Y L K PF ++ K+ E+ F ++ GA
Sbjct: 177 EGRMHDEK-VDLWSLGVLCYEFLVGKPPF--EANTYQETYKRISRVEFTFPDF--VTEGA 231
Query: 252 KQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+ LI R+L+ NP RP ++V H WI
Sbjct: 232 RDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 1e-68
Identities = 72/271 (26%), Positives = 124/271 (45%), Gaps = 14/271 (5%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +G G+YG + K + K D+ + + E+++L ++ HPNI+
Sbjct: 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHPNIVR 67
Query: 72 VHRMV--KAGTYLYMIMDYAEKKDLEHYISKACNEN--IHENQARIWIRQIANALEYLHE 127
+ + + T LY++M+Y E DL I+K E + E + Q+ AL+ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
++ ++HRD+K N+ + N KL DFG +R+L + F GT Y +
Sbjct: 128 RSD-----GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247
PE + YN K +DIWSLG +LY + PF +++ K ++ Y
Sbjct: 183 PEQMNRMSYNEK-SDIWSLGCLLYELCALMPPF--TAFSQKELAGKIREGKFRR-IPYRY 238
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
S ++I RML HRP+ +++ + I
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-67
Identities = 79/270 (29%), Positives = 128/270 (47%), Gaps = 17/270 (6%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ LGEGAYG V L ++ +E A K D KR + +EI I ++H N++
Sbjct: 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVK 67
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + G Y+ ++Y +L I + + E A+ + Q+ + YLH I
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI--- 122
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR--TPKELSNTFCGTTSYAAPE 189
GI HRDIK EN+L+ N K++DFG + + R + L N CGT Y APE
Sbjct: 123 -------GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+++ ++ + D+WS G+VL +L + P+ P ++ +E K YL K +I
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK-KIDS 234
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
L+ ++L NP R D++ W
Sbjct: 235 APLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-66
Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 23/276 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I +LG+GA+G VY +K + L A K + +E + EIDIL HPNI+
Sbjct: 17 IGELGDGAFGKVYKAQNKETSVLAAAKV--IDTKSEEELEDYM-VEIDILASCDHPNIVK 73
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ L++++++ ++ + + + E+Q ++ +Q +AL YLH+
Sbjct: 74 LLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD---- 128
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
I+HRD+K NIL + + KLADFG S + ++F GT + APE++
Sbjct: 129 ------NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182
Query: 192 -----RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK-QEGKEYLFNRKY 245
++ PY+ K AD+WSLG+ L + + P VL K + + +
Sbjct: 183 MCETSKDRPYDYK-ADVWSLGITLIEMAEIEPPH--HELNPMRVLLKIAKSEPPTLAQPS 239
Query: 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
S K + + LE N R + H ++ +
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 9e-66
Identities = 70/286 (24%), Positives = 130/286 (45%), Gaps = 21/286 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
K+G+GA G VY D + A + + ++ + ++ EI ++ + +PNI+
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVN 81
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
G L+++M+Y L +++ C + E Q R+ ALE+LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSN--- 135
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
++HRDIK +NIL+ + KL DFGF + + +T GT + APE++
Sbjct: 136 -------QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
Y PK DIWSLG++ ++ + P+ + R + ++S
Sbjct: 189 TRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 252 KQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMT---AEEREA 294
+ + R L+ + + R +AK++ H +++ ++T A +EA
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-64
Identities = 60/274 (21%), Positives = 116/274 (42%), Gaps = 21/274 (7%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII 70
+ ++G G++ VY D + A ++L + ++F E ++L + HPNI+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPNIV 71
Query: 71 GVH----RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
+ VK + ++ + L+ Y+ + + + R W RQI L++LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 127 EIANALEYLHEVGIVHRDIKCENILI-SRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
I+HRD+KC+NI I + K+ D G + L R + GT +
Sbjct: 130 T--------RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEF 179
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245
APE+ Y+ D+++ G+ + + +YP+ + + ++ +
Sbjct: 180 MAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFDK 236
Query: 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
K++I + N R + KD+ NHA+ Q
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-64
Identities = 71/309 (22%), Positives = 121/309 (39%), Gaps = 56/309 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
IS+LG G G V+ VS K S + A K +K + RE+ +L + + P I+G
Sbjct: 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQII-RELQVLHECNSPYIVG 68
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + + + M++ + L+ + K I E + L YL
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLR----- 121
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
+ I+HRD+K NIL++ KL DFG S L ++N+F GT SY +PE +
Sbjct: 122 ----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERL 175
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPF------------------------------- 220
+ + Y+ + +DIWS+G+ L + +YP
Sbjct: 176 QGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 221 ---------GDPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKD 271
P ++L + S+ + + + L NP R + K
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 272 VQNHAWIQN 280
+ HA+I+
Sbjct: 295 LMVHAFIKR 303
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 1e-63
Identities = 65/307 (21%), Positives = 118/307 (38%), Gaps = 29/307 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ ++G G++G VY D R+ + A K + + + + +E+ L K+ HPN I
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+++M+Y + + + E + L YLH
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH--- 134
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
++HRD+K NIL+S KL DFG + ++ +N+F GT + APE+I
Sbjct: 135 -------NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVI 183
Query: 192 RNSPYNP--KLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
D+WSLG+ + +K P L E + S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMT---------AEEREALKIGKL 300
+ + L+ P+ RP ++ + H ++ E + E + L+ K+
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKM 301
Query: 301 KSKVFMQ 307
K +F +
Sbjct: 302 KKILFQE 308
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 203 bits (517), Expect = 2e-63
Identities = 76/328 (23%), Positives = 142/328 (43%), Gaps = 25/328 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+LG GA+G V+ V+++ + A K F + ++ +EI + + HP ++
Sbjct: 31 HEELGTGAFGVVHRVTERATGNNFAAK---FVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+H + + MI ++ +L ++ N + E++A ++RQ+ L ++HE
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN--- 143
Query: 132 LEYLHEVGIVHRDIKCENILISRLLN--AKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
VH D+K ENI+ + + KL DFG + L PK+ GT +AAPE
Sbjct: 144 -------NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPE 195
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EI 247
+ P D+WS+GV+ Y +L+ PF G + + L+ + ++ + I
Sbjct: 196 VAEGKPVGYY-TDMWSVGVLSYILLSGLSPF--GGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ--NEPTCQTMTAEEREALKIGKLKSKVF 305
S K I ++L +P R H W+ N P + R +K+K +
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTK-Y 311
Query: 306 MQKYTVVQALTSSNNVDVTEENKEKKYP 333
+ L +N +++ ++Y
Sbjct: 312 DAWPEPLPPLGRISNYSSLRKHRPQEYS 339
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 202 bits (516), Expect = 3e-63
Identities = 75/325 (23%), Positives = 142/325 (43%), Gaps = 22/325 (6%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +LG GA+G V+ +K + + K F + EI I+ ++ HP +I
Sbjct: 34 LEELGSGAFGVVHRCVEKATGRVFVAK---FINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+H + + +I+++ +L I+ + + E + ++RQ L+++HE
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH--- 146
Query: 132 LEYLHEVGIVHRDIKCENILIS--RLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
IVH DIK ENI+ + + K+ DFG + L P E+ T +AAPE
Sbjct: 147 -------SIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPE 198
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EI 247
I+ P D+W++GV+ Y +L+ PF G + + L+ + ++ F+ +
Sbjct: 199 IVDREPVGFY-TDMWAIGVLGYVLLSGLSPF--AGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGKLKSKVFMQ 307
S AK I +L+ P+ R D H W++ + + T KI + + +
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315
Query: 308 KYTVVQALTSSNNVDVTEENKEKKY 332
A+ N +++ ++Y
Sbjct: 316 WPAPQPAIGRIANFSSLRKHRPQEY 340
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-62
Identities = 68/273 (24%), Positives = 132/273 (48%), Gaps = 19/273 (6%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
LGEG++ V L + + A K + + + ++ + RE D++ ++ HP +
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ + LY + YA+ +L YI K + E R + +I +ALEYLH
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK--- 127
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPE 189
GI+HRD+K ENIL++ ++ ++ DFG +++L + +N+F GT Y +PE
Sbjct: 128 -------GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
++ +D+W+LG ++Y+++ PF + +K EY F K
Sbjct: 181 LLTEKSACKS-SDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEYDFPEK--FFP 235
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
A+ L+ ++L + R ++++ + ++ P
Sbjct: 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 2e-60
Identities = 88/276 (31%), Positives = 135/276 (48%), Gaps = 23/276 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
LG GA+ V L DKR++ L A K K L+ E EI +L K+ HPNI+
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVA 71
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + ++G +LY+IM +L I + E A I Q+ +A++YLH++
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL--- 126
Query: 132 LEYLHEVGIVHRDIKCENILISRL---LNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
GIVHRD+K EN+L L ++DFG S++ P + +T CGT Y AP
Sbjct: 127 -------GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-DPGSVLSTACGTPGYVAP 178
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--E 246
E++ PY+ D WS+GV+ Y +L PF + + ++ EY F+ Y +
Sbjct: 179 EVLAQKPYSKA-VDCWSIGVIAYILLCGYPPF--YDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
IS AK I ++E +P+ R + H WI +
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-60
Identities = 77/323 (23%), Positives = 136/323 (42%), Gaps = 30/323 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
LG G +G V+ + S+ K K + ++ +EI IL H NI+
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK----KEISILNIARHRNILH 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+H ++ L MI ++ D+ I+ + E ++E + ++ Q+ AL++LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSH--- 121
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNA--KLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
I H DI+ ENI+ ++ K+ +FG +R L+ Y APE
Sbjct: 122 -------NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-RLLFTAPEYYAPE 173
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY--EI 247
+ ++ + D+WSLG ++Y +L+ PF N+ +++ EY F+ + EI
Sbjct: 174 VHQHDVVSTA-TDMWSLGTLVYVLLSGINPF--LAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ------NEPTCQTMTAEERE-ALKIGKL 300
SI A + R+L K R A + H W++ + +T+ L L
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDL 290
Query: 301 KSKVFMQKYTVVQALTSSNNVDV 323
V + + A+ S V V
Sbjct: 291 NMVVSAARISCGGAIRSQKGVSV 313
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 191 bits (486), Expect = 1e-59
Identities = 84/282 (29%), Positives = 125/282 (44%), Gaps = 29/282 (10%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACK------AYDFKRLKRDYMEKFAPREIDILLKVS 65
LG G V K + A K F + + + +E+DIL KVS
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 66 -HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEY 124
HPNII + + T+ +++ D +K +L Y+++ + E + R +R + +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICA 125
Query: 125 LHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
LH++ IVHRD+K ENIL+ +N KL DFGFS L P E CGT S
Sbjct: 126 LHKL----------NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPS 174
Query: 185 YAAPEIIRNSPYNPKL-----ADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239
Y APEII S + D+WS GV++Y +L PF + +L+ Y
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--WHRKQMLMLRMIMSGNY 232
Query: 240 LFNRKY--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
F + S K L+ R L P+ R A++ H + Q
Sbjct: 233 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-59
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 19/271 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDIL-LKVSHPNII 70
LG+G++G V+L K++ A KA + D + E +L L HP +
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ + L+ +M+Y DL ++I ++A + +I L++LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK-- 122
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
GIV+RD+K +NIL+ + + K+ADFG + +NTFCGT Y APEI
Sbjct: 123 --------GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250
+ YN D WS GV+LY +L + PF G ++ + R +
Sbjct: 175 LLGQKYNHS-VDWWSFGVLLYEMLIGQSPF--HGQDEEELFHSIRMDNPFYPRW--LEKE 229
Query: 251 AKQLIGRMLEPNPKHRPNAK-DVQNHAWIQN 280
AK L+ ++ P+ R + D++ H +
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-58
Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 28/273 (10%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
++G G++G VY A K + ++ F E+ +L K H NI+
Sbjct: 13 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVNILL 68
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
L ++ + E L H++ + RQ A ++YLH
Sbjct: 69 FM-GYSTAPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK--- 123
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR--TPKELSNTFCGTTSYAAPE 189
I+HRD+K NI + L K+ DFG + + + G+ + APE
Sbjct: 124 -------SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 190 IIR---NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246
+IR +PY+ + +D+++ G+VLY ++ + P+ NRD + G+ YL +
Sbjct: 177 VIRMQDKNPYSFQ-SDVYAFGIVLYELMTGQLPY--SNINNRDQIIFMVGRGYLSPDLSK 233
Query: 247 I----SIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+ K+L+ L+ RP +
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-58
Identities = 80/288 (27%), Positives = 136/288 (47%), Gaps = 25/288 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL---KRDYMEKFAPREIDILLKVSHPN 68
+LG G + V +K + A K +R +R + RE+ IL ++ HPN
Sbjct: 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+I +H + + T + +I++ +L ++++ E++ E +A +++QI N + YLH +
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL 132
Query: 129 ANALEYLHEVGIVHRDIKCENILISR----LLNAKLADFGFSRLLRTPKELSNTFCGTTS 184
I H D+K ENI++ K+ DFG + + E N GT
Sbjct: 133 ----------QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-IFGTPE 181
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244
+ APEI+ P + AD+WS+GV+ Y +L+ PF G ++ L Y F +
Sbjct: 182 FVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPF--LGDTKQETLANVSAVNYEFEDE 238
Query: 245 Y--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAE 290
Y S AK I R+L +PK R +D H WI+ + T Q +++
Sbjct: 239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSA 286
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-56
Identities = 66/299 (22%), Positives = 111/299 (37%), Gaps = 42/299 (14%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKA--YDFKRLKRDYMEKFAPREIDILLKVSHPNI 69
+ LGEG + VY DK + + A K + +D + + A REI +L ++SHPNI
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
IG+ + + ++ D+ E + + + + ++ LEYLH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPE 189
I+HRD+K N+L+ KLADFG ++ +P T Y APE
Sbjct: 120 ---------WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY---- 245
++ + D+W++G +L +L + PG + D L + +
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFL--PGDSDLDQLTRIFETLGTPTEEQWPDM 228
Query: 246 ----------------------EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
LI + NP R A + N P
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 183 bits (464), Expect = 2e-55
Identities = 63/277 (22%), Positives = 116/277 (41%), Gaps = 23/277 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS---HPN 68
+G G +G VY + + A K D KR+K E A E +L VS P
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I+ + L I+D DL +++S+ + E R + +I LE++H
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAP 188
+V+RD+K NIL+ + +++D G + K + GT Y AP
Sbjct: 127 ----------FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAP 174
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248
E+++ AD +SLG +L+++L PF T+++ + + + S
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS-FS 233
Query: 249 IGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQN 280
+ L+ +L+ + R A++V+ + ++
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 179 bits (456), Expect = 1e-54
Identities = 74/274 (27%), Positives = 127/274 (46%), Gaps = 25/274 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ LG G++G V+L+ + + A K + + R + E +L V+HP II
Sbjct: 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + ++MIMDY E +L + ++ A+ + ++ ALEYLH
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK--- 123
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
I++RD+K ENIL+ + + K+ DFGF++ + +++ T CGT Y APE++
Sbjct: 124 -------DIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVV 173
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
PYN D WS G+++Y +L PF + +K E F +
Sbjct: 174 STKPYNKS-IDWWSFGILIYEMLAGYTPF--YDSNTMKTYEKILNAELRFPPF--FNEDV 228
Query: 252 KQLIGRMLEPNPKHRPN-----AKDVQNHAWIQN 280
K L+ R++ + R +DV+NH W +
Sbjct: 229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-54
Identities = 54/265 (20%), Positives = 113/265 (42%), Gaps = 24/265 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +G+G +G+V L + ++ K +K D + E ++ ++ H N++
Sbjct: 12 LQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 72 VHR-MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ +V+ LY++ +Y K L Y+ + + + + A+EYL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEI 190
VHRD+ N+L+S AK++DFG ++ + + +T + APE
Sbjct: 123 --------NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEA 171
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250
+R ++ K +D+WS G++L+ I + P +DV+ + E K Y +
Sbjct: 172 LREKKFSTK-SDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRVE-KGYKMDAPDGCPPA 228
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQNH 275
+++ + RP+ ++
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-54
Identities = 74/280 (26%), Positives = 111/280 (39%), Gaps = 29/280 (10%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFA---PREIDILLKVS--H 66
LG G +G+VY A K + R+ P E+ +L KVS
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
+I + + +I++ E + E AR + Q+ A+ + H
Sbjct: 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 127
Query: 127 EIANALEYLHEVGIVHRDIKCENILISR-LLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
G++HRDIK ENILI KL DFG LL+ F GT Y
Sbjct: 128 NC----------GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVY 175
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245
+ PE IR Y+ + A +WSLG++LY ++ PF +E +
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------EEIIRGQVFFRQ 225
Query: 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQ 285
+S + LI L P RP +++QNH W+Q+ Q
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-54
Identities = 54/282 (19%), Positives = 109/282 (38%), Gaps = 21/282 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKV-SHP 67
LG GA+G V + K LK E+ ++ ++ SH
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISK-----------ACNENIHENQARIWIR 116
NI+ + +Y+I +Y DL +Y+ N+ E + + +
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 117 QIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELS 176
+ L + +++A +E+L VHRD+ N+L++ K+ DFG +R + +
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221
Query: 177 --NTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKK 233
+ APE + Y K +D+WS G++L+ I + P+ PG K
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPY--PGIPVDANFYK 278
Query: 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+ ++ + + ++ + + RP+ ++ +
Sbjct: 279 LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-53
Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 22/274 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ LG+G +G V LV +K + A K + + E +L HP +
Sbjct: 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + L +M+YA +L ++S+ E +AR + +I +ALEYLH
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR--- 124
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
+V+RDIK EN+++ + + K+ DFG + + TFCGT Y APE++
Sbjct: 125 -------DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
++ Y D W LGVV+Y ++ + PF + + + +E F R +S A
Sbjct: 178 EDNDYGRA-VDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRT--LSPEA 232
Query: 252 KQLIGRMLEPNPKHRPN-----AKDVQNHAWIQN 280
K L+ +L+ +PK R AK+V H + +
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-53
Identities = 69/298 (23%), Positives = 121/298 (40%), Gaps = 41/298 (13%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ K+GEG YG VY +K + + A K REI +L +++HPNI+
Sbjct: 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVK 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ ++ LY++ ++ + DL+ ++ + I + ++ Q+ L + H
Sbjct: 66 LLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 121
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
++HRD+K +N+LI+ KLADFG +R P T Y APEI+
Sbjct: 122 -------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------------------ 233
Y DIWSLG + ++ ++ F PG D L +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 234 ---------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282
+ ++ + + L+ +ML +P R +AK H + Q+
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 8e-53
Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 32/279 (11%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVH 73
LG G G V + +KR++ A K R RE+++ + S P+I+ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------REVELHWRASQCPHIVRIV 71
Query: 74 RMVKA----GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ + L ++M+ + +L I ++ E +A ++ I A++YLH I
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI- 130
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLN---AKLADFGFSRLLRTPKELSNTFCGTTSYA 186
I HRD+K EN+L + KL DFGF++ T T C T Y
Sbjct: 131 ---------NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYV 180
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF--GDPGTRNRDVLKKQEGKEYLFNRK 244
APE++ Y+ D+WSLGV++Y +L PF + + + +Y F
Sbjct: 181 APEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 245 Y--EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281
E+S K LI +L+ P R + NH WI
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 173 bits (438), Expect = 2e-52
Identities = 64/275 (23%), Positives = 104/275 (37%), Gaps = 20/275 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
LG G V+L D R A K + RE ++HP I+
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 72 VHRMV----KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHE 127
V+ AG Y++M+Y + L + + +A I AL + H+
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ 129
Query: 128 IANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLR---TPKELSNTFCGTTS 184
GI+HRD+K NI+IS K+ DFG +R + + GT
Sbjct: 130 N----------GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 185 YAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244
Y +PE R + + +D++SLG VLY +L + PF + +E R
Sbjct: 180 YLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238
Query: 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+S ++ + L NP++R ++
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 2e-52
Identities = 56/279 (20%), Positives = 102/279 (36%), Gaps = 20/279 (7%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHP 67
Y+ +GEGA+G V+ + K LK + RE ++ + +P
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 68 NIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQ---------- 117
NI+ + + G + ++ +Y DL ++ + +
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 118 --IANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL 175
A L ++A + YL E VHRD+ N L+ + K+ADFG SR + +
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 176 --SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233
+ PE I + Y + +D+W+ GVVL+ I + G + +V+
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQP-YYGMAHEEVIYY 254
Query: 234 QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272
L + + L+ P RP+ +
Sbjct: 255 VRDGNILACPE-NCPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 8e-52
Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 25/279 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM-EKFAPREIDILLKVSHPNII 70
KLG+G +G V++ + + K LK M + +E ++ K+ H ++
Sbjct: 22 EVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
++ +V +Y++ +Y K L ++ + + Q QIA+ + Y+ +
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-- 132
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT-FCGTTSYAAPE 189
VHRD++ NIL+ L K+ADFG +RL+ + + + APE
Sbjct: 133 --------NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+ K +D+WS G++L + K PG NR+VL + E + Y E
Sbjct: 185 AALYGRFTIK-SDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE-RGYRMPCPPECPE 241
Query: 250 GAKQLIGRMLEPNPKHRPNAKDVQN--HAWIQN-EPTCQ 285
L+ + P+ RP + +Q + + EP Q
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (435), Expect = 1e-51
Identities = 60/313 (19%), Positives = 108/313 (34%), Gaps = 57/313 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
++K+G+G +G V+ +++ A K + K + REI IL + H N++
Sbjct: 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLKHENVVN 73
Query: 72 VHRMVKAGT--------YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE 123
+ + + +Y++ D+ E + + E
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE------------IKR 121
Query: 124 YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE----LSNTF 179
+ + N L Y+H I+HRD+K N+LI+R KLADFG +R K
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239
T Y PE++ D+W G ++ + + G + L
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM--QGNTEQHQLALISQLCG 239
Query: 240 LFNRK------------------------------YEISIGAKQLIGRMLEPNPKHRPNA 269
+ Y A LI ++L +P R ++
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
Query: 270 KDVQNHAWIQNEP 282
D NH + ++P
Sbjct: 300 DDALNHDFFWSDP 312
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 169 bits (428), Expect = 5e-51
Identities = 69/295 (23%), Positives = 118/295 (40%), Gaps = 43/295 (14%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ K+GEG YG VY + ET A K ++ REI IL ++ H NI+
Sbjct: 7 LEKIGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGIPSTTI-REISILKELKHSNIVK 64
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ ++ L ++ ++ ++ + C + A+ ++ Q+ N + Y H+
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHD---- 118
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
++HRD+K +N+LI+R K+ADFG +R P T Y AP+++
Sbjct: 119 ------RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY------ 245
S DIWS+G + ++N F PG D L + N K
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLF--PGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 246 ---------------------EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279
+ L+ +ML+ +P R AK HA+ +
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-50
Identities = 62/296 (20%), Positives = 122/296 (41%), Gaps = 41/296 (13%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ K+GEG YG V+ ++ + + A K REI +L ++ H NI+
Sbjct: 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKNIVR 65
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+H ++ + L ++ ++ ++ +++ S CN ++ + ++ Q+ L + H
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR--- 120
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
++HRD+K +N+LI+R KLA+FG +R P + T Y P+++
Sbjct: 121 -------NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------------------ 233
+ D+WS G + + N P PG D LK+
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 234 ---------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280
L N +++ + L+ +L+ NP R +A++ H + +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-49
Identities = 55/268 (20%), Positives = 113/268 (42%), Gaps = 24/268 (8%)
Query: 14 KLGEGAYGNVYLVSDKRSETLK--ACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+LG G +G V + + +K A K + ++ E +++ ++ +P I+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNPYIVR 72
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + +A ++ ++M+ AE L Y+ + N ++ + + Q++ ++YL E
Sbjct: 73 MIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL---SNTFCGTTSYAAP 188
VHRD+ N+L+ AK++DFG S+ LR + + AP
Sbjct: 127 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247
E I ++ K +D+WS GV+++ + + P+ G + +V E K
Sbjct: 180 ECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPY--RGMKGSEVTAMLE-KGERMGCPAGC 235
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
L+ + ++RP V+
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-49
Identities = 59/264 (22%), Positives = 114/264 (43%), Gaps = 20/264 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +LG G +G V++ + A K+ + D E +++ ++ H ++
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVR 72
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ +V +Y+I +Y E L ++ + N+ QIA + ++ E
Sbjct: 73 LYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT-FCGTTSYAAPEI 190
+HRD++ NIL+S L+ K+ADFG +RL+ + + + APE
Sbjct: 129 -------NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 191 IRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIG 250
I + K +D+WS G++L I+ PG N +V++ E + Y R
Sbjct: 182 INYGTFTIK-SDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238
Query: 251 AKQLIGRMLEPNPKHRPNAKDVQN 274
QL+ + P+ RP +++
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-49
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 15/292 (5%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPN 68
+ +GEG +G V K+ K + E+++L K+ HPN
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALE----- 123
II + + YLY+ ++YA +L ++ K+ + + A A+ L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV--LETDPAFAIANSTASTLSSQQLL 130
Query: 124 -YLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
+ ++A ++YL + +HRD+ NIL+ AK+ADFG SR +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLP 189
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242
+ A E + S Y +D+WS GV+L+ I++ G ++ +K + Y
Sbjct: 190 VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLP-QGYRLE 246
Query: 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH--AWIQNEPTCQTMTAEER 292
+ L+ + P RP+ + ++ T T E+
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEK 298
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (419), Expect = 2e-49
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 26/273 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPN 68
+G G +G V K + A K LK Y EK E I+ + HPN
Sbjct: 31 EQVIGAGEFGEVCSGHLKLPGKREIFVA--IKTLKSGYTEKQRRDFLSEASIMGQFDHPN 88
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+I + +V T + +I ++ E L+ ++ + Q +R IA ++YL ++
Sbjct: 89 VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADM 147
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT-----FCGTT 183
VHRD+ NIL++ L K++DFG SR L
Sbjct: 148 ----------NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 184 SYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242
+ APE I+ + +D+WS G+V++ +++ + P+ N+DV+ E ++Y
Sbjct: 198 RWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPY--WDMTNQDVINAIE-QDYRLP 253
Query: 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+ QL+ + + HRP + N
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 5e-49
Identities = 50/267 (18%), Positives = 110/267 (41%), Gaps = 22/267 (8%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM-EKFAPREIDILLKVSHPNI 69
++ ++G G +G V+L + K ++ M E+ E ++++K+SHP +
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ ++ + + ++ ++ E L Y+ + + L ++
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-----------QRGLFAAETLLGMCLDVC 111
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL-SNTFCGTTSYAAP 188
+ YL E ++HRD+ N L+ K++DFG +R + + S +A+P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248
E+ S Y+ K +D+WS GV+++ + ++ + + + V G R S
Sbjct: 172 EVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR--LAS 228
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQNH 275
Q++ + P+ RP +
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 7e-49
Identities = 56/276 (20%), Positives = 109/276 (39%), Gaps = 29/276 (10%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPNII 70
+LG G +G+V + + K LK+ + RE I+ ++ +P I+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAI---KVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ + + L ++M+ A L ++ E I + E LH+++
Sbjct: 73 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVA----------ELLHQVSM 120
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---LSNTFCGTTSYAA 187
++YL E VHRD+ N+L+ AK++DFG S+ L + + A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246
PE I ++ + +D+WS GV ++ L+ + P+ + +V+ E + E
Sbjct: 181 PECINFRKFSSR-SDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAFIE-QGKRMECPPE 236
Query: 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQ---NHAWIQ 279
L+ + RP+ V+ +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (413), Expect = 1e-48
Identities = 65/263 (24%), Positives = 113/263 (42%), Gaps = 20/263 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYME-KFAPREIDILLKVSHPNII 70
KLG G YG VY K+ A K LK D ME + +E ++ ++ HPN++
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVK-----TLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 71 GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
+ + Y+I ++ +L Y+ + + + QI++A+EYL +
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 134
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC-GTTSYAAPE 189
+HRD+ N L+ K+ADFG SRL+ ++ + APE
Sbjct: 135 --------NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 190 IIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISI 249
+ + ++ K +D+W+ GV+L+ I PG V + E K+Y R
Sbjct: 187 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLE-KDYRMERPEGCPE 243
Query: 250 GAKQLIGRMLEPNPKHRPNAKDV 272
+L+ + NP RP+ ++
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEI 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-48
Identities = 54/275 (19%), Positives = 102/275 (37%), Gaps = 14/275 (5%)
Query: 10 SYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVS- 65
S+ LG GA+G V + A K LK E+ +L +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQ------IA 119
H NI+ + G +I +Y DL +++ + + I + + +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 120 NALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT- 178
+ L + +++A + +L +HRD+ NIL++ K+ DFG +R ++
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 179 -FCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237
+ APE I N Y + +D+WS G+ L+ + + PG K +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP-YPGMPVDSKFYKMIKE 263
Query: 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272
+ ++ + +P RP K +
Sbjct: 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-48
Identities = 52/268 (19%), Positives = 107/268 (39%), Gaps = 24/268 (8%)
Query: 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYM-EKFAPREIDILLKVSHPNI 69
++ +LG G +G V + K +K M E E +++ +SH +
Sbjct: 8 FLKELGTGQFGVVKYG------KWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 70 IGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
+ ++ + +++I +Y L +Y+ + Q + + A+EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT-FCGTTSYAAP 188
+HRD+ N L++ K++DFG SR + + S+ ++ P
Sbjct: 120 ---------QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRIL-NKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247
E++ S ++ K +DIW+ GV+++ I K P+ N + + L+ R +
Sbjct: 171 EVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEHIAQGLRLY-RPHLA 226
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
S ++ RP K + ++
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-48
Identities = 81/332 (24%), Positives = 139/332 (41%), Gaps = 49/332 (14%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+S +GEGAYG V D ++ A K + Y ++ REI ILL+ H NIIG
Sbjct: 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTL-REIKILLRFRHENIIG 70
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
++ +++A T M Y + H + + + + +L++I
Sbjct: 71 INDIIRAPTIEQMKDVYL----VTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRG 121
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---LSNTFCGTTSYAAP 188
L+Y+H ++HRD+K N+L++ + K+ DFG +R+ + + T Y AP
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPF----------------GDPGTRNRDVLK 232
EI+ NS K DIWS+G +L +L+ + F G P + + +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 233 KQEGKEYLFNRKY-----------EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ-- 279
+ + YL + + A L+ +ML NP R + H +++
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 280 ----NEPTCQTM--TAEEREALKIGKLKSKVF 305
+EP + E + L KLK +F
Sbjct: 302 YDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 333
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-48
Identities = 50/271 (18%), Positives = 101/271 (37%), Gaps = 22/271 (8%)
Query: 12 ISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN 68
+ KLG+G++G V A K L + RE++ + + H N
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+I ++ +V + M+ + A L + K + + Q+A + YL
Sbjct: 73 LIRLYGVVLTP-PMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---LSNTFCGTTSY 185
+HRD+ N+L++ K+ DFG R L + + ++
Sbjct: 131 ----------RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244
APE ++ ++ +D W GV L+ + + P+ G +L K + + R
Sbjct: 181 CAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPW--IGLNGSQILHKIDKEGERLPRP 237
Query: 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+ ++ + P+ RP +++
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 6e-48
Identities = 71/316 (22%), Positives = 121/316 (38%), Gaps = 59/316 (18%)
Query: 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLK 63
P + + +G G++G VY S L A K ++ +D ++F RE+ I+ K
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQD--KRFKNRELQIMRK 69
Query: 64 VSHPNIIGVHRMV------KAGTYLYMIMDYAEK---KDLEHYISKACNENIHENQARIW 114
+ H NI+ + K YL +++DY + + HY + + +++
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLY 127
Query: 115 IRQIANALEYLHEIANALEYLHEVGIVHRDIKCENI-LISRLLNAKLADFGFSRLLRTPK 173
+ Q+ +L Y+H GI HRDIK +N+ L KL DFG ++ L
Sbjct: 128 MYQLFRSLAYIHS----------FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RG 176
Query: 174 ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233
E + ++ + Y APE+I + D+WS G VL +L + F PG D L +
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVE 234
Query: 234 ---------------------------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHR 266
+ + + A L R+LE P R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 267 PNAKDVQNHAWIQNEP 282
+ H++
Sbjct: 295 LTPLEACAHSFFDELR 310
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (409), Expect = 2e-47
Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 25/274 (9%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
I LG G++G V LV K S A K D +++ + + E IL V+ P ++
Sbjct: 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ K + LYM+M+Y ++ ++ + E AR + QI EYLH +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL--- 160
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
+++RD+K EN+LI + ++ DFGF++ ++ T CGT APEII
Sbjct: 161 -------DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEII 210
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEISIGA 251
+ YN D W+LGV++Y + PF + + +K + F S
Sbjct: 211 LSKGYNKA-VDWWALGVLIYEMAAGYPPF--FADQPIQIYEKIVSGKVRFPS--HFSSDL 265
Query: 252 KQLIGRMLEPNPKHR-----PNAKDVQNHAWIQN 280
K L+ +L+ + R D++NH W
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 4e-47
Identities = 65/308 (21%), Positives = 122/308 (39%), Gaps = 50/308 (16%)
Query: 12 ISKLGEGAYGNVYLVSDKRS-ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS---HP 67
++++GEGAYG V+ D ++ A K + + RE+ +L + HP
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLETFEHP 70
Query: 68 NIIGVHRMVKAG-----TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANAL 122
N++ + + T L ++ ++ ++ + E +
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM--------- 121
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGT 182
+ ++ L++LH +VHRD+K +NIL++ KLADFG +R+ + T
Sbjct: 122 --MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVT 178
Query: 183 TSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK--------- 233
Y APE++ S Y D+WS+G + + +K F G+ + D L K
Sbjct: 179 LWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLF--RGSSDVDQLGKILDVIGLPG 235
Query: 234 ----------------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAW 277
+ + + +I K L+ + L NP R +A +H +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295
Query: 278 IQNEPTCQ 285
Q+ C+
Sbjct: 296 FQDLERCK 303
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-46
Identities = 58/275 (21%), Positives = 106/275 (38%), Gaps = 13/275 (4%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPN 68
LG GA+G V + C+ K LK E+ IL+ + H
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77
Query: 69 IIGVHR--MVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQ----IANAL 122
+ K G L +I+++ + +L Y+ NE + A + + + + +
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 123 EYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL--SNTFC 180
Y ++A +E+L +HRD+ NIL+S K+ DFG +R + +
Sbjct: 138 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240
+ APE I + Y + +D+WS GV+L+ I + PG + + ++ +
Sbjct: 198 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLKEGTR 255
Query: 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+ Q + P RP ++ H
Sbjct: 256 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-46
Identities = 59/268 (22%), Positives = 107/268 (39%), Gaps = 21/268 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPN 68
+GEG +G+V+ E A K K + +E + + HP+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVA--IKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
I+ + ++ +++IM+ +L ++ R + +A+ + Y +++
Sbjct: 70 IVKLIGVITEN-PVWIIMELCTLGELRSFLQV-----------RKYSLDLASLILYAYQL 117
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL-SNTFCGTTSYAA 187
+ AL YL VHRDI N+L+S KL DFG SR + ++ + A
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEI 247
PE I + +D+W GV ++ IL G +N DV+ + E E L
Sbjct: 178 PESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENGERLPMPP-NC 234
Query: 248 SIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
L+ + +P RP +++
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 3e-46
Identities = 84/281 (29%), Positives = 134/281 (47%), Gaps = 24/281 (8%)
Query: 12 ISKLGEGAYGNVYLV---SDKRSETLKACKAYDFKRLKRDY-MEKFAPREIDILLKVSH- 66
+ LG GAYG V+LV S + L A K + + + E +L +
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 67 PNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
P ++ +H + T L++I+DY +L ++S+ E++ +I++ +I ALE+LH
Sbjct: 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLH 146
Query: 127 EIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS-RLLRTPKELSNTFCGTTSY 185
++ GI++RDIK ENIL+ + L DFG S + E + FCGT Y
Sbjct: 147 KL----------GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 186 AAPEIIRNSPYNP-KLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244
AP+I+R K D WSLGV++Y +L PF G +N + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
Query: 245 YEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQN 280
E+S AK LI R+L +PK R +A +++ H + Q
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-46
Identities = 62/273 (22%), Positives = 112/273 (41%), Gaps = 15/273 (5%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDF--KRLKRDYMEKFAP---REIDILLKVS- 65
LGEGA+G V L + K + K LK D EK E++++ +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 66 HPNIIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQI----ANA 121
H NII + LY+I++YA K +L Y+ + + + +
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT--F 179
+ +++A +EYL +HRD+ N+L++ K+ADFG +R + T
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239
+ APE + + Y + +D+WS GV+L+ I PG ++ K + + +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLLK-EGH 254
Query: 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272
++ + ++ P RP K +
Sbjct: 255 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-46
Identities = 67/281 (23%), Positives = 115/281 (40%), Gaps = 23/281 (8%)
Query: 15 LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPNIIG 71
+G G +G VY K S K K LK Y EK E I+ + SH NII
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVP-VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ ++ + +I +Y E L+ ++ + + Q +R IA ++YL +
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM--- 129
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFC---GTTSYAAP 188
VHRD+ NIL++ L K++DFG SR+L E + T + AP
Sbjct: 130 -------NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 189 EIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYEIS 248
E I + +D+WS G+V++ ++ N +V+K + +
Sbjct: 183 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAIN-DGFRLPTPMDCP 239
Query: 249 IGAKQLIGRMLEPNPKHRPNAKDVQN--HAWIQNEPTCQTM 287
QL+ + + RP D+ + I+ + +T+
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-45
Identities = 53/280 (18%), Positives = 111/280 (39%), Gaps = 24/280 (8%)
Query: 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDI 60
P L + +G G +G VY + ++ K A K L R E I
Sbjct: 24 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA--VKSLNRITDIGEVSQFLTEGII 81
Query: 61 LLKVSHPNIIGVHRM-VKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIA 119
+ SHPN++ + + +++ +++ Y + DL ++I + ++ +
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL---- 137
Query: 120 NALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTF 179
++A +++L VHRD+ N ++ K+ADFG +R + + S
Sbjct: 138 -------QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190
Query: 180 ----CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235
+ A E ++ + K +D+WS GV+L+ ++ + P P D+
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLL 248
Query: 236 GKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
L +Y +++ + P + RP+ ++ +
Sbjct: 249 QGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 5e-45
Identities = 51/269 (18%), Positives = 97/269 (36%), Gaps = 21/269 (7%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKF---APREIDILLKVSHPN 68
I LG GA+G VY K L+ K E ++ V +P+
Sbjct: 14 IKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+ + + T + L++ N L + +I
Sbjct: 73 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY------------LLNWCVQI 120
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNT--FCGTTSYA 186
A + YL + +VHRD+ N+L+ + K+ DFG ++LL ++ + +
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246
A E I + Y + +D+WS GV ++ ++ D G ++ E E L
Sbjct: 181 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPP-I 237
Query: 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+I ++ + + RP +++
Sbjct: 238 CTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-44
Identities = 53/269 (19%), Positives = 109/269 (40%), Gaps = 10/269 (3%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPN 68
+LG+G++G VY K + K + + E ++ + + +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 69 IIGVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
++ + +V G +IM+ + DL+ Y+ N + ++ ++ EI
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 129 ANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKEL--SNTFCGTTSYA 186
A+ + YL+ VHRD+ N +++ K+ DFG +R + +
Sbjct: 143 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 187 APEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKYE 246
+PE +++ + +D+WS GVVL+ I G N VL+ + L ++
Sbjct: 203 SPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVM-EGGLLDKPDN 259
Query: 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275
+L+ + NPK RP+ ++ +
Sbjct: 260 CPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-44
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 42/290 (14%)
Query: 14 KLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVH 73
+G+G +G V+ + E A K + R+ F EI + + H NI+G
Sbjct: 10 SIGKGRFGEVWRGKWRGEEV--AVKIFS----SREERSWFREAEIYQTVMLRHENILGFI 63
Query: 74 RMV----KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIA 129
T L+++ DY E L Y+++ + A+ L +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHM-- 118
Query: 130 NALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE----LSNTFCGTTSY 185
+ + I HRD+K +NIL+ + +AD G + + + N GT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 186 AAPEIIRNSPYNPKL-----ADIWSLGVVLYRILNKKYPFGD------------PGTRNR 228
APE++ +S ADI+++G+V + I + G P +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 229 DVLKKQEGKEYL------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272
+ ++K ++ L + E +++ N R A +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 4e-44
Identities = 71/334 (21%), Positives = 125/334 (37%), Gaps = 58/334 (17%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +G GAYG V D R+ A K + ++ RE+ +L + H N+IG
Sbjct: 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIG 81
Query: 72 VHRMVKAG------TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
+ + T Y++M + + K +E + E++ + + Q+ L Y+
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMG--TDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYI 137
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
H GI+HRD+K N+ ++ K+ DFG +R + + T Y
Sbjct: 138 HA----------AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWY 184
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF----------------GDPGTRNRD 229
APE+I N + DIWS+G ++ ++ K F G P
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 230 VLKKQEGKEYLFNRKY-----------EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278
L+ E K Y+ S A L+ +ML + + R A + H +
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
Query: 279 QN------EPTCQTMTAE-EREALKIGKLKSKVF 305
++ EP Q + + + K +
Sbjct: 305 ESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTY 338
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-43
Identities = 77/330 (23%), Positives = 124/330 (37%), Gaps = 50/330 (15%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+S +G GAYG+V D ++ A K + ++ RE+ +L + H N+IG
Sbjct: 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIG 81
Query: 72 VHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANA 131
+ + L D L ++ A NI + Q +++I
Sbjct: 82 LLDVFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDH----VQFLIYQILRG 133
Query: 132 LEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEII 191
L+Y+H I+HRD+K N+ ++ K+ DFG +R + T Y APEI+
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIM 190
Query: 192 RNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK------------------ 233
N + + DIWS+G ++ +L + F PGT + D LK
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 234 -----------QEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ--- 279
Q K N + A L+ +ML + R A HA+
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
Query: 280 ---NEPTCQTMTAE-EREALKIGKLKSKVF 305
+EP E L I + KS +
Sbjct: 309 DPDDEPVADPYDQSFESRDLLIDEWKSLTY 338
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 148 bits (373), Expect = 2e-42
Identities = 63/308 (20%), Positives = 116/308 (37%), Gaps = 62/308 (20%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNII 70
+ KLG G Y V+ + + K LK +K REI IL + PNII
Sbjct: 40 VRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIK-REIKILENLRGGPNII 93
Query: 71 GVHRMVKAGT--YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEI 128
+ +VK ++ ++ D + + + + R ++ +I AL+Y H +
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 129 ANALEYLHEVGIVHRDIKCENILI-SRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAA 187
GI+HRD+K N++I +L D+G + P + N + +
Sbjct: 149 ----------GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKG 197
Query: 188 PEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL---------------- 231
PE++ + D+WSLG +L ++ +K PF G N D L
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 232 -------------------KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV 272
+K+ + ++ +S A + ++L + + R A++
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
Query: 273 QNHAWIQN 280
H +
Sbjct: 317 MEHPYFYT 324
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 2e-41
Identities = 45/287 (15%), Positives = 90/287 (31%), Gaps = 36/287 (12%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
K+G G++G++YL +D + A K E I + I
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 72 VHRMV-KAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIAN 130
R G Y M+M+ + + C+ + Q+ + +EY+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK-- 122
Query: 131 ALEYLHEVGIVHRDIKCENILISRLLNAKLA---DFGFSRLLRTPKEL-------SNTFC 180
+HRD+K +N L+ L DFG ++ R + +
Sbjct: 123 --------NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 181 GTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240
GT YA+ + + D+ SLG VL P+ + ++ ++ +
Sbjct: 175 GTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
Query: 241 FNRKYE----ISIGAKQLIGRMLEPNPKHRPNAKDVQN---HAWIQN 280
+ +P+ ++ + + +
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (357), Expect = 2e-40
Identities = 45/289 (15%), Positives = 92/289 (31%), Gaps = 37/289 (12%)
Query: 5 DILECSY--ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILL 62
+++ Y ++GEG++G ++ ++ + A K R E
Sbjct: 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYK 55
Query: 63 KVSHPNII-GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANA 121
++ I V+ + G + +++D + C + +Q+
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLAR 113
Query: 122 LEYLHEIANALEYLHEVGIVHRDIKCENILISRLL-----NAKLADFGFSRLLRTPKE-- 174
++ +HE +V+RDIK +N LI R + DFG + R P
Sbjct: 114 VQSIHEK----------SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163
Query: 175 -----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPF-GDPGTRNR 228
GT Y + + + D+ +LG V L P+ G N+
Sbjct: 164 HIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNK 222
Query: 229 DVLKKQEGKEYLFNRK---YEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274
++ K+ + + + P+ +Q
Sbjct: 223 QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 4e-35
Identities = 58/315 (18%), Positives = 112/315 (35%), Gaps = 62/315 (19%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIG 71
+ +G GA G V D + A K + + ++ RE+ ++ V+H NII
Sbjct: 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 72 VH------RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYL 125
+ + ++ +Y++M+ + + + + + + Q+ +++L
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 135
Query: 126 HEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSY 185
H +HRD+K NI++ K+ DFG +R + + T Y
Sbjct: 136 HSAGI----------IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYY 184
Query: 186 AAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP-------------GTRNRDVLK 232
APE+I Y DIWS+G ++ ++ K F GT + +K
Sbjct: 185 RAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 233 KQEGKEYLFNRKY-------------------------EISIGAKQLIGRMLEPNPKHRP 267
K + + + A+ L+ +ML +P R
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 268 NAKDVQNHAWIQNEP 282
+ D H +I
Sbjct: 304 SVDDALQHPYINVWY 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (313), Expect = 2e-33
Identities = 60/344 (17%), Positives = 120/344 (34%), Gaps = 65/344 (18%)
Query: 12 ISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNII- 70
+ KLG G + V+L D + T A K ++ + E EI +L +V+ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE----DEIKLLQRVNDADNTK 73
Query: 71 ----GVHRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLH 126
G + ++K + + + + + + +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPLIYVKQISK 132
Query: 127 EIANALEYLH-EVGIVHRDIKCENILISR------LLNAKLADFGFSRLLRTPKELSNTF 179
++ L+Y+H GI+H DIK EN+L+ L+ K+AD G +
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TNS 189
Query: 180 CGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDP---------------- 223
T Y +PE++ +P+ ADIWS +++ ++ + F
Sbjct: 190 IQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 224 ---GTRNRDVLKKQEGKEYLFNRKY-------------------------EISIGAKQLI 255
G +L+ + FN + + + +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 256 GRMLEPNPKHRPNAKDVQNHAWIQNEPTCQTMTAEEREALKIGK 299
ML+ +P+ R +A + NH W+++ + + +RE G
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGS 352
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.5 bits (177), Expect = 1e-15
Identities = 33/205 (16%), Positives = 64/205 (31%), Gaps = 23/205 (11%)
Query: 13 SKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGV 72
+GEG V+ ++ K + +++ ++ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 73 HRMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANAL 132
R ++ L + YA + + + + + R+ E L I +
Sbjct: 65 FRALQKLQGLAVPKVYAWE---GNAVLMELIDAKELYRVRVENPD-----EVLDMILEEV 116
Query: 133 EYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRLLRTPKE---LSNTFCGTTSYAAPE 189
+ GIVH D+ N+L+S + DF S + L +Y
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYF--- 172
Query: 190 IIRNSPYNPKLADIWSLGVVLYRIL 214
+ Y + DI S + RIL
Sbjct: 173 ---SRTYRTE-KDINS---AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.63 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.16 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.33 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.61 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-66 Score=456.66 Aligned_cols=263 Identities=29% Similarity=0.530 Sum_probs=220.4
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
+|-+.+|++++.||+|+||+||+|.++.+|+.||+|++....... ..+.+.+|+.+|++++|||||++++++.+++.+
T Consensus 1 ~Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 1 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78 (271)
T ss_dssp CTTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence 467889999999999999999999999999999999987654332 234567999999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+|||||+||+|.+++.+ ...+++..++. ++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 79 ~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~----------i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~D 146 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEP--DIGMPEPDAQR----------FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISD 146 (271)
T ss_dssp EEEEECCTTEEGGGGSBT--TTBCCHHHHHH----------HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECC
T ss_pred EEEEeccCCCcHHHHHhc--CCCCCHHHHHH----------HHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEcc
Confidence 999999999999999976 56777766544 677788888899999999999999999999999999999
Q ss_pred ccccccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 163 FGFSRLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 163 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
||+|+...... ......+||+.|+|||++.+..++..++||||+||++|+|++|++||............ .......
T Consensus 147 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~~~~~~ 225 (271)
T d1nvra_ 147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTY 225 (271)
T ss_dssp CTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HHTTCTT
T ss_pred chhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-HhcCCCC
Confidence 99998765432 23456789999999999998887666699999999999999999999765543333322 2233333
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
.+....+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 3444578999999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-65 Score=449.13 Aligned_cols=257 Identities=34% Similarity=0.576 Sum_probs=223.6
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++++.||+|+||+||+|.++.+++.||+|++.............+.+|+.++++++|||||++++++.+++.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 36789999999999999999999999999999999987665554445666799999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||||+||+|.+++.+ ...+++..++. ++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 84 vmEy~~~g~L~~~l~~--~~~l~e~~~~~----------i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK--LSKFDEQRTAT----------YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHH----------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEeecCCCcHHHHHhh--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccc
Confidence 9999999999999987 56777766544 67788888889999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+|+..... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+ ..+....+....+.++
T Consensus 152 ~a~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~p-- 224 (263)
T d2j4za1 152 WSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANT--YQETYKRISRVEFTFP-- 224 (263)
T ss_dssp SCSCCCCC--CCEETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCCCCC--
T ss_pred eeeecCCC--cccccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCC--
Confidence 99875433 3456689999999999999888765 999999999999999999997644 4455555555554443
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
..+|+++++||.+||++||++|||++|+|+||||+.
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 368999999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-65 Score=453.19 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=221.9
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
+|+++++||+|+||+||+|.++.+|+.||+|++....... .+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 5999999999999999999999999999999987655433 2445699999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
||+||+|.+++.+ ..+++..++ .++.||+.||+|||++||+||||||+|||++.++++||+|||+|+
T Consensus 98 y~~gg~L~~~~~~---~~l~~~~~~----------~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 98 YLAGGSLTDVVTE---TCMDEGQIA----------AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp CCTTCBHHHHHHH---SCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ecCCCcHHHHhhc---cCCCHHHHH----------HHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 9999999998865 467776554 467788888999999999999999999999999999999999999
Q ss_pred cccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH-hhhCcccccccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK-KQEGKEYLFNRKYE 246 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~ 246 (351)
.+..........+||+.|+|||++.+..++.+ +||||+||++|+|++|..||.+.+. ..... ......+..+.+..
T Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGTPELQNPEK 241 (293)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHHCSCCCSSGGG
T ss_pred eeccccccccccccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCH--HHHHHHHHhCCCCCCCCccc
Confidence 87666666677889999999999999888765 9999999999999999999976542 22222 22223334445567
Q ss_pred CCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccccc
Q psy6327 247 ISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTCQT 286 (351)
Q Consensus 247 ~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 286 (351)
+|+++++||.+||++||++|||+.|+|+||||+.......
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~~~~ 281 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCCCCc
Confidence 9999999999999999999999999999999986544333
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-63 Score=451.56 Aligned_cols=261 Identities=30% Similarity=0.494 Sum_probs=227.7
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++++.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 46789999999999999999999999999999999987655443334455689999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||||+||+|.+++.+ ...+++..++. ++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 83 v~ey~~gg~L~~~~~~--~~~~~e~~~~~----------~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR--ERVFTEERARF----------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp EEECCTTCBHHHHHHH--HSCCCHHHHHH----------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ceeccCCCchhhhhhc--ccCCcHHHHHH----------HHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecc
Confidence 9999999999999987 57788876654 56778888889999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+|+............+||+.|+|||++.+..|+.+ +|||||||++|+|++|++||.+.+ .......+....+.++
T Consensus 151 ~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~--~~~~~~~i~~~~~~~p-- 225 (337)
T d1o6la_ 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILMEEIRFP-- 225 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCC--
T ss_pred cccccccCCcccccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcC--HHHHHHHHhcCCCCCC--
Confidence 99987666666677899999999999999999875 999999999999999999997655 4455555554444444
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEP 282 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~ 282 (351)
..+|+++++||.+||++||++|++ ++|+++||||++..
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 479999999999999999999994 89999999998653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-64 Score=444.82 Aligned_cols=260 Identities=27% Similarity=0.494 Sum_probs=219.8
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||+||+|.++.+|+.||||++.............+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 47999999999999999999999999999999998766544434455679999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|||+||+|.+++.. .+.+++..++. ++.|++.||+|||++||+||||||+|||+++++.+||+|||+|
T Consensus 88 Ey~~gg~L~~~~~~--~~~l~e~~~~~----------~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK--IGSFDETCTRF----------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHH----------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EccCCCCHHHhhhc--cCCCCHHHHHH----------HHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccc
Confidence 99999999999987 56788766554 5677888888999999999999999999999999999999999
Q ss_pred ccccCCc--ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 167 RLLRTPK--ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 167 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+.+.... ....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+ .......+....+.++
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~~~~~~~p-- 230 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGN--EYLIFQKIIKLEYDFP-- 230 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHTTCCCCC--
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcC--HHHHHHHHHcCCCCCC--
Confidence 8765432 23456789999999999999888765 999999999999999999997644 4555555555555444
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHH------HhcCccccCCcc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKD------VQNHAWIQNEPT 283 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~e------ll~hp~~~~~~~ 283 (351)
..+|+++++||.+||+.||++|||++| +++||||++..+
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 378999999999999999999999988 578999987644
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-63 Score=442.15 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=215.3
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMD 87 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (351)
.|++++.||+|+||+||+|.++.+++.||+|++....... .+.+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4899999999999999999999999999999987543322 3445589999999999999999999999999999999
Q ss_pred cCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccccc
Q psy6327 88 YAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSR 167 (351)
Q Consensus 88 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~ 167 (351)
||+||+|.+++.+. ...+++..++ .++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 90 y~~~g~L~~~~~~~-~~~l~e~~~~----------~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 90 FCAGGAVDAVMLEL-ERPLTESQIQ----------VVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp CCTTEEHHHHHHHH-TSCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCcHHHHHHhc-CCCCCHHHHH----------HHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhh
Confidence 99999999998653 4567776654 467788888889999999999999999999999999999999998
Q ss_pred cccCCcccccccccccceecccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhh-hCccccc
Q psy6327 168 LLRTPKELSNTFCGTTSYAAPEIIR-----NSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQ-EGKEYLF 241 (351)
Q Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~ 241 (351)
..........+.+||+.|+|||++. +..++. ++|||||||++|+|++|+.||.+.+. .+....+ ....+..
T Consensus 159 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~-k~DiwSlGvilyemltg~~Pf~~~~~--~~~~~~i~~~~~~~~ 235 (288)
T d2jfla1 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY-KADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIAKSEPPTL 235 (288)
T ss_dssp ECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTT-HHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHHHHHHSCCCCC
T ss_pred ccCCCcccccccccccccCCHHHHhhcccCCCCCCh-hhhHHHHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCCCC
Confidence 7655444455678999999999984 344554 49999999999999999999977553 3333332 2333344
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..+..+|+++++||.+||++||++|||++|+++||||+..
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 4456799999999999999999999999999999999743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-63 Score=447.14 Aligned_cols=262 Identities=33% Similarity=0.569 Sum_probs=205.0
Q ss_pred CCccc-eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 4 PDILE-CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 4 ~~~~~-~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
.|+.+ |++.+.||+|+||+||+|.++.+++.||+|++........ ...+.+|+.+|++++|||||++++++.+++.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45666 9999999999999999999999999999999976554432 34456899999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc---CCCCeE
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS---RLLNAK 159 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~---~~~~~k 159 (351)
|+|||||+||+|.+++.+ ...+++..+.. ++.||+.||+|||++||+||||||+|||+. +++.+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~----------~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vk 150 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVE--KGFYTERDASR----------LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM 150 (307)
T ss_dssp EEEECCCCSCBHHHHHHT--CSCCCHHHHHH----------HHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEE
T ss_pred EEEEeccCCCcHHHhhhc--ccCCCHHHHHH----------HHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEE
Confidence 999999999999999976 56788766554 677888888899999999999999999995 468899
Q ss_pred EeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
|+|||+|+..... ....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+.. .......+....+
T Consensus 151 l~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~~~~~ 226 (307)
T d1a06a_ 151 ISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDEN--DAKLFEQILKAEY 226 (307)
T ss_dssp ECCC-------------------CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHTTCC
T ss_pred EeccceeEEccCC-CeeeeeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHhccCC
Confidence 9999999875433 33456789999999999999888765 999999999999999999997654 3444444444443
Q ss_pred cc--cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 240 LF--NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 240 ~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
.+ +....+|+++++||.+||++||++|||+.|+++||||++...
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 272 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 272 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc
Confidence 33 334578999999999999999999999999999999986543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-63 Score=438.21 Aligned_cols=258 Identities=27% Similarity=0.500 Sum_probs=204.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe--CCEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA--GTYLY 83 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~ 83 (351)
..+|++++.||+|+||+||+|.++.+|+.||+|++......... .+.+.+|+++|++++|||||++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH-HHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH-HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 45899999999999999999999999999999999876655443 3445699999999999999999999854 45689
Q ss_pred EEEecCCCCChHHHHHhh--ccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC-----ceeccCCCCCEeEcCCC
Q psy6327 84 MIMDYAEKKDLEHYISKA--CNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG-----IVHRDIKCENILISRLL 156 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~-----i~H~Dlkp~NIll~~~~ 156 (351)
+|||||+||+|.+++.+. ....+++..+. .++.||+.||+|||++| |+||||||+|||++.++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~----------~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVL----------RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHH----------HHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHH----------HHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence 999999999999999653 24567776654 46778888888999976 99999999999999999
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 236 (351)
.+||+|||+|+..........+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+ ..+....+..
T Consensus 152 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~--~~~~~~~i~~ 228 (269)
T d2java1 152 NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFS--QKELAGKIRE 228 (269)
T ss_dssp CEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHH
T ss_pred cEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCC--HHHHHHHHHc
Confidence 9999999999987665555667889999999999998888765 999999999999999999997644 3444444433
Q ss_pred ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q psy6327 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWI 278 (351)
Q Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 278 (351)
..+. +.+..+|+++++||.+||+.||++|||++|+++|||+
T Consensus 229 ~~~~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 229 GKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 3322 2334789999999999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-62 Score=441.71 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=215.5
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
|+.++.||+|+||+||+|.++.+++.||||++...........+.+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 99999999999999999999999999999999876655555556667999999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
|.||+|..++.. ...+++..++ .++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 97 ~~~g~l~~~~~~--~~~l~e~~~~----------~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 97 CLGSASDLLEVH--KKPLQEVEIA----------AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp CSEEHHHHHHHH--TSCCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred cCCCchHHHHHh--CCCCCHHHHH----------HHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence 999999877765 5677776654 4677888899999999999999999999999999999999999987
Q ss_pred ccCCcccccccccccceeccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRN---SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
... ....+||+.|+|||++.+ ..|+. ++|||||||++|+|++|..||.+.. .......+...........
T Consensus 165 ~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~-~~DiwSlGvilyel~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 165 MAP----ANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPALQSG 237 (309)
T ss_dssp SSS----BCCCCSCGGGCCHHHHTTTTSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSCT
T ss_pred cCC----CCccccCccccCHHHHhccCCCCcCc-hhhhhhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCCCC
Confidence 543 345679999999999864 34555 4999999999999999999997654 3333333333333333345
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.+|+++++||.+||+.||++|||++|+|+||||....
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 7899999999999999999999999999999997643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-62 Score=428.83 Aligned_cols=253 Identities=21% Similarity=0.414 Sum_probs=209.6
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe----CCEEEE
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA----GTYLYM 84 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~~l 84 (351)
|++.++||+|+||+||+|.++.+++.||+|++......... .+.+.+|+++|++++|||||++++++.+ ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH-HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH-HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 57888999999999999999999999999999776654443 3446699999999999999999999865 467899
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCC--ceeccCCCCCEeEcC-CCCeEEe
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVG--IVHRDIKCENILISR-LLNAKLA 161 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~NIll~~-~~~~kl~ 161 (351)
|||||+||+|.+++.+ ...+++..++ .++.||+.||+|||+++ |+||||||+|||+++ ++.+||+
T Consensus 90 vmE~~~~g~L~~~l~~--~~~~~~~~~~----------~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR--FKVMKIKVLR----------SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EEeCCCCCcHHHHHhc--cccccHHHHH----------HHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 9999999999999987 4667776544 46778888899999999 999999999999974 7899999
Q ss_pred eccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
|||+|+.... ....+.+||+.|+|||++.+ .++. ++|||||||++|+|++|+.||.+... .......+.......
T Consensus 158 DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~-~~DIwSlGvilyel~~g~~Pf~~~~~-~~~~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 158 DLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVKPA 232 (270)
T ss_dssp CTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCT-HHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTTCCCG
T ss_pred ecCcceeccC--CccCCcccCccccCHHHhCC-CCCC-cCchhhHHHHHHHHHHCCCCCCCccc-HHHHHHHHHcCCCCc
Confidence 9999986443 23456789999999999875 4665 49999999999999999999976442 233334444333333
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
.....+++++++||.+||++||++|||+.|+|+||||+
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 33446899999999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-62 Score=439.25 Aligned_cols=259 Identities=30% Similarity=0.514 Sum_probs=222.1
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+|++++.||+|+||+||+|.++.+|+.||+|++...........+.+.+|+.++++++|||||++++++.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 36789999999999999999999999999999999976655443334556699999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||||+||+|..++.. ...+++..++ .++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 82 vmE~~~gg~l~~~~~~--~~~~~~~~~~----------~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK--SQRFPNPVAK----------FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EECCCCSCBHHHHHHH--TSSCCHHHHH----------HHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred EeeecCCccccccccc--cccccccHHH----------HHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCc
Confidence 9999999999999987 5666665544 356788888999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+|+..... ..+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+ ..+....+....+.+ +
T Consensus 150 ~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~~~--p 221 (316)
T d1fota_ 150 FAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSN--TMKTYEKILNAELRF--P 221 (316)
T ss_dssp SCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHCCCCC--C
T ss_pred cceEeccc---cccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcC--HHHHHHHHHcCCCCC--C
Confidence 99876432 346789999999999999888875 999999999999999999997654 444444444444333 3
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEPT 283 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 283 (351)
..+|++++++|.+||++||.+|+ |++++++||||++..+
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 47899999999999999999996 8999999999987643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-63 Score=445.78 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=210.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|+++++||+|+||+||+|.++.+|+.||+|++....... ....+.+|+.+|++++|||||++++++.+.+++|+||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT--HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999986543222 2344569999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+||+|.+++.+ .+.+++..++ .++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 84 Ey~~gg~L~~~l~~--~~~l~~~~~~----------~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK--AGRIPEQILG----------KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp ECCTTEEHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EcCCCCcHHHHHhh--cCCCCHHHHH----------HHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCC
Confidence 99999999999987 4667776654 367788888999997 5999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH-------------
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK------------- 232 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------------- 232 (351)
|+.... ....+.+||+.|+|||++.+.+|+.+ +||||+||++|+|++|+.||...+........
T Consensus 152 a~~~~~--~~~~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 152 SGQLID--SMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp CHHHHH--HTC---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred ccccCC--CccccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence 987543 23456789999999999999998876 99999999999999999999765432211110
Q ss_pred ---------------------------hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 233 ---------------------------KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 233 ---------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
......+.......+|.++++||.+||+.||++|||++|+|+||||+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000000011112468899999999999999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-62 Score=433.71 Aligned_cols=264 Identities=28% Similarity=0.474 Sum_probs=219.8
Q ss_pred CCccc-eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH---HHhhhHHHHHHHHHhCCCCCceeeeeEEEeC
Q psy6327 4 PDILE-CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD---YMEKFAPREIDILLKVSHPNIIGVHRMVKAG 79 (351)
Q Consensus 4 ~~~~~-~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 79 (351)
.++.+ |++.+.||+|+||+||+|.++.+|+.||+|++........ ...+.+.+|+.+|++++|||||++++++.+.
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 45555 9999999999999999999999999999999876544321 1234466999999999999999999999999
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC---
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL--- 156 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~--- 156 (351)
+.+|+|||||+||+|.+++.+ ...+++..++. ++.|++.||+|||++||+||||||+|||++.++
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~----------~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAE--KESLTEEEATE----------FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHH----------HHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSS
T ss_pred CEEEEEEEcCCCccccchhcc--ccccchhHHHH----------HHHHHHHHHHhhhhcceeecccccceEEEecCCCcc
Confidence 999999999999999999987 46777766544 677888888899999999999999999998766
Q ss_pred -CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh
Q psy6327 157 -NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 157 -~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 235 (351)
.+||+|||+|+...... ...+..||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+ ..+....+.
T Consensus 154 ~~vkl~DfG~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~ 229 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDT--KQETLANVS 229 (293)
T ss_dssp CCEEECCCTTCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHH
T ss_pred cceEecchhhhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCC--HHHHHHHHH
Confidence 49999999998765433 3445679999999999998888765 999999999999999999997654 445555544
Q ss_pred Ccccccc--ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcc
Q psy6327 236 GKEYLFN--RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPT 283 (351)
Q Consensus 236 ~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 283 (351)
...+.++ ....+|.++++||.+||+.||++|||++|+++||||+...+
T Consensus 230 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp TTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred hcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 4444333 23478999999999999999999999999999999986543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-61 Score=442.42 Aligned_cols=258 Identities=24% Similarity=0.431 Sum_probs=218.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.++.+|+.||+|++....... .+.+.+|+.+|++|+|||||++++++.+++.+|+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999986544322 345669999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC--CCCeEEeecc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR--LLNAKLADFG 164 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~--~~~~kl~Dfg 164 (351)
|||+||+|.+++.+. .+.+++..++. ++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 103 E~~~gg~L~~~l~~~-~~~l~e~~~~~----------i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 103 EFMSGGELFEKVADE-HNKMSEDEAVE----------YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp CCCCSCBHHHHHTCT-TSCBCHHHHHH----------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EcCCCCCHHHHHHhh-cCCCCHHHHHH----------HHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecc
Confidence 999999999999643 45677766544 6778888888999999999999999999964 5789999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc--
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN-- 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 242 (351)
+|+..... ....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+ ..+.+..+....+.++
T Consensus 172 ~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~ 247 (350)
T d1koaa2 172 LTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMDDS 247 (350)
T ss_dssp TCEECCTT-SCEEEECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCSCCG
T ss_pred hheecccc-cccceecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCcc
Confidence 99876543 33456789999999999999888765 999999999999999999997654 4455555444443332
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
....+|+++++||.+||++||++|||++|+|+||||+...
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 3346899999999999999999999999999999998654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-61 Score=440.36 Aligned_cols=261 Identities=28% Similarity=0.455 Sum_probs=223.6
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
.+.+.+|++++.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+|+.++|||||++++++.+....
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 45678899999999999999999999999999999999766554433344566999999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
++||||+.||+|..++.+ .+.+++..++ .++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 117 ~~v~e~~~~g~l~~~l~~--~~~l~e~~~~----------~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~D 184 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRR--IGRFSEPHAR----------FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp EEEEECCTTCBHHHHHHH--HCCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred ccccccccccchhhhHhh--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeee
Confidence 999999999999999977 4677776654 4677888888999999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
||+|+..... ..+.+||+.|||||++.+..++.+ +|||||||++|+|++|..||.+.+ .......+....+.+
T Consensus 185 FG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~~~- 257 (350)
T d1rdqe_ 185 FGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKVRF- 257 (350)
T ss_dssp CTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCC-
T ss_pred ceeeeecccc---cccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcC--HHHHHHHHhcCCCCC-
Confidence 9999876543 345789999999999999888765 999999999999999999997654 444445444444333
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcc
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNEPT 283 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 283 (351)
+..+|+++.+||.+||++||.+|+ |++++++||||++..+
T Consensus 258 -p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 258 -PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 347999999999999999999995 8999999999987643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.4e-61 Score=440.89 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=215.2
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHH---HHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAP---REIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+.+|++++.||+|+||.||+|.++.+|+.||+|++.............+. +|+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 367899999999999999999999999999999999766554332222222 45777778889999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
+|+|||||+||+|.+++.+ ...+++..++ .++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 82 ~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~----------~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQ--HGVFSEADMR----------FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp EEEEECCCCSCBHHHHHHH--HCSCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEEC
T ss_pred EEEEEEecCCCcHHHHHHh--cccccHHHHH----------HHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEe
Confidence 9999999999999999987 4667765544 467788888999999999999999999999999999999
Q ss_pred eccccccccCCcccccccccccceeccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH-hhhCccc
Q psy6327 162 DFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSP-YNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK-KQEGKEY 239 (351)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~ 239 (351)
|||+|+..... .....+||+.|+|||++.... ++. ++|||||||++|+|++|+.||.+.......... ......
T Consensus 150 DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~- 225 (364)
T d1omwa3 150 DLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA- 225 (364)
T ss_dssp CCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC-
T ss_pred eeceeeecCCC--cccccccccccchhHHhhcCCCCCc-ccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-
Confidence 99999876543 344568999999999997554 554 599999999999999999999876544433322 222222
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPN-----AKDVQNHAWIQNEP 282 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~ 282 (351)
...+..+|+++++||.+||++||++||| ++|+++||||++..
T Consensus 226 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 226 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp -CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 2333479999999999999999999999 79999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-61 Score=440.92 Aligned_cols=257 Identities=25% Similarity=0.450 Sum_probs=217.6
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||.||+|.++.+|+.||+|++....... ...+.+|+.+|++|+|||||++++++.+++.+|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34999999999999999999999999999999987544332 345568999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc--CCCCeEEeecc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS--RLLNAKLADFG 164 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~--~~~~~kl~Dfg 164 (351)
|||+||+|.+++... ...+++..++. ++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 106 E~~~gg~L~~~~~~~-~~~l~e~~~~~----------i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 106 EFLSGGELFDRIAAE-DYKMSEAEVIN----------YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp ECCCCCBHHHHTTCT-TCCBCHHHHHH----------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EcCCCChHHHHHHhc-CCCCCHHHHHH----------HHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecc
Confidence 999999999987652 34678766544 677888888899999999999999999998 56889999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccc--
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFN-- 242 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 242 (351)
+|+.+... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+ ..+.+..+....+.++
T Consensus 175 la~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~ 250 (352)
T d1koba_ 175 LATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDWEFDED 250 (352)
T ss_dssp TCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHCCCCCCSS
T ss_pred cceecCCC-CceeeccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCcc
Confidence 99886543 33456679999999999999888875 999999999999999999997654 4444444444333333
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
....+|+++++||.+||++||++|||+.|+|+||||++.
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 334789999999999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-61 Score=433.97 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=220.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHH-hCCCCCceeeeeEEEeCCEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILL-KVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~-~l~hp~iv~~~~~~~~~~~~~l 84 (351)
+.+|.+++.||+|+||+||+|.++.+++.||||++.............+.+|+.++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 468999999999999999999999999999999997655433222223336666654 7899999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||||+||+|.+++.. ...+++..++ .++.||+.||+|||++||+||||||+|||++.++++||+|||
T Consensus 81 vmEy~~~g~L~~~i~~--~~~~~e~~~~----------~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQS--CHKFDLSRAT----------FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHH----------HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEeecCCCcHHHHhhc--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccc
Confidence 9999999999999987 5677776544 467788888999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
+++............+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+ .......+....+.++
T Consensus 149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~~~~p-- 223 (320)
T d1xjda_ 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMDNPFYP-- 223 (320)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCC--
T ss_pred hhhhcccccccccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCC--
Confidence 99977666666667789999999999999998865 999999999999999999997654 4455555544444433
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHH-HHhcCccccCCc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAK-DVQNHAWIQNEP 282 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~-ell~hp~~~~~~ 282 (351)
..+|+++++||.+||++||++|||+. ++++||||++..
T Consensus 224 ~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 224 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 36899999999999999999999996 899999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.1e-60 Score=419.54 Aligned_cols=258 Identities=31% Similarity=0.467 Sum_probs=216.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhh------HHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR------DYMEKFAPREIDILLKVS-HPNIIGVHRMVKAG 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~ 79 (351)
.+|++.+.||+|+||+||+|.++.+|+.||+|++....... ......+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 47999999999999999999999999999999987654321 223345668999999997 99999999999999
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
+.+|+|||||+||+|.++++. ...+++..++. ++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~----------~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~k 150 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRK----------IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 150 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHH----------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred cceEEEEEcCCCchHHHHHHh--cCCCCHHHHHH----------HHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeE
Confidence 999999999999999999987 56788877654 677788888899999999999999999999999999
Q ss_pred EeeccccccccCCcccccccccccceeccccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHh
Q psy6327 160 LADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRN------SPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKK 233 (351)
Q Consensus 160 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 233 (351)
|+|||+++...... .....+||+.|+|||++.+ ..++ .++||||+||++|+|++|+.||.+.. .......
T Consensus 151 l~DFG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~-~~~DiwslGvilyeml~g~~Pf~~~~--~~~~~~~ 226 (277)
T d1phka_ 151 LTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYG-KEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRM 226 (277)
T ss_dssp ECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBC-THHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH
T ss_pred EccchheeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCC-chheEcccchhhhhhccCCCCCCCCC--HHHHHHH
Confidence 99999998765433 3455789999999999863 2233 35999999999999999999998654 3344433
Q ss_pred hhCccc--cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 234 QEGKEY--LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 234 ~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
+....+ ..+....+|+++++||.+||++||++|||++|+|+||||+.
T Consensus 227 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 333333 33344579999999999999999999999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-60 Score=426.38 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=207.2
Q ss_pred eeeecCcccceEEEEEEecCCceeEEEEecchhhhhh--HHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q psy6327 11 YISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKR--DYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIMDY 88 (351)
Q Consensus 11 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (351)
.+++||+|+||+||+|.++.+|+.||||++....... ......+.+|+.+|++++|||||++++++.+++++|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4789999999999999999999999999987654432 22344566999999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 89 AEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 89 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
|.|+++..+... ...+++..++. ++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~----------~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKA----------YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHH----------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred hcchHHhhhhhc--ccCCCHHHHHH----------HHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccc
Confidence 998877766654 56677766554 567788888899999999999999999999999999999999988
Q ss_pred ccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc---c----c--
Q psy6327 169 LRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK---E----Y-- 239 (351)
Q Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~----~-- 239 (351)
...........+||+.|+|||++......+.++||||+||++|+|++|.+||.+.+ ..+.+..+... . +
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 150 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcCCCChhhccc
Confidence 77666666677899999999998766544445999999999999999999997654 23322221100 0 0
Q ss_pred -----------c------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccc
Q psy6327 240 -----------L------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTC 284 (351)
Q Consensus 240 -----------~------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 284 (351)
. ......+++++.+||.+||++||++|||++|+|+||||++.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 0 00012568899999999999999999999999999999976643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=421.12 Aligned_cols=263 Identities=27% Similarity=0.463 Sum_probs=212.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|+++++||+|+||+||+|.++.+|+.||+|++....... .....+.+|+++|++++|||||++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 358999999999999999999999999999999997554332 2234556899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+. +++.+++.......+++..++. ++.||+.||+|||++||+||||||+|||++.++.+||+|||.
T Consensus 80 ~e~~~-~~~~~~~~~~~~~~l~e~~~~~----------~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 80 FEFLH-QDLKKFMDASALTGIPLPLIKS----------YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EECCS-EEHHHHHHHTTTTCCCHHHHHH----------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred EeecC-CchhhhhhhhcccCCCHHHHHH----------HHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCc
Confidence 99997 5666666555566788876554 677788888899999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---c-----
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---K----- 237 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~----- 237 (351)
|+....+.......+||+.|+|||++....+...++||||+||++|+|++|+.||.+.+ ..+....+.. .
T Consensus 149 a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 149 ARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRIFRTLGTPDEVV 226 (298)
T ss_dssp HHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTT
T ss_pred ceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC--HHHHHHHHHHhcCCCchhh
Confidence 99877666666777899999999998888776667999999999999999999997643 2222111100 0
Q ss_pred --------cc--cc---------cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 238 --------EY--LF---------NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 238 --------~~--~~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
.. .. .....+|.++++||.+||++||++|||++|+|+||||++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 00 00 01125688999999999999999999999999999998653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-59 Score=427.30 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=208.6
Q ss_pred ccceeeeee-cCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe----C
Q psy6327 6 ILECSYISK-LGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA----G 79 (351)
Q Consensus 6 ~~~~~~~~~-LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~----~ 79 (351)
+.+|.++++ ||+|+||+||+|.++.+++.||||++... ..+.+|+.++.++ +|||||+++++|++ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 567999865 99999999999999999999999998532 2234899987654 79999999999976 4
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---CC
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---LL 156 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~~ 156 (351)
..+|+|||||+||+|.+++.+.....+++..++. ++.||+.||+|||++||+||||||+|||++. .+
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~----------i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASE----------IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHH----------HHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHH----------HHHHHHHHHHHHHHcCCccccccccccccccccccc
Confidence 6799999999999999999875456788877654 5677888888999999999999999999986 46
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCc--hHHHHhh
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRN--RDVLKKQ 234 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~ 234 (351)
.+||+|||+|+...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+.+... ......+
T Consensus 152 ~~Kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i 229 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229 (335)
T ss_dssp CEEECCCTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred cccccccceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence 79999999998765433 3456789999999999998888875 999999999999999999997654221 1122223
Q ss_pred hCccccccc--cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q psy6327 235 EGKEYLFNR--KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 235 ~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 282 (351)
....+.++. ...+|+++++||.+||++||++|||+.|+++||||+...
T Consensus 230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 333333332 246899999999999999999999999999999997543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-60 Score=425.62 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=216.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++++.||+|+||+||+|.++.+++.||+|++..+... ...+.+|+.+|+.++|||||++++++++++.+|+||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3599999999999999999999999999999999765433 234568999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC--CCeEEeecc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL--LNAKLADFG 164 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~--~~~kl~Dfg 164 (351)
|||+||+|.+++.+. ...+++..++. ++.||+.||+|||++||+||||||+|||++.+ ..+||+|||
T Consensus 81 E~~~gg~L~~~i~~~-~~~l~e~~~~~----------i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 81 EFISGLDIFERINTS-AFELNEREIVS----------YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp CCCCCCBHHHHHTSS-SCCCCHHHHHH----------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHH----------HHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccc
Confidence 999999999999752 34678776554 67788888889999999999999999999854 579999999
Q ss_pred ccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccc-
Q psy6327 165 FSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNR- 243 (351)
Q Consensus 165 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 243 (351)
+++..... ......+||+.|+|||.+.+..++.+ +||||+||++|+|++|.+||.+.+ ..+....+....+.++.
T Consensus 150 ~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 150 QARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFDEE 225 (321)
T ss_dssp TCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCCCHH
T ss_pred hhhccccC-CcccccccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCChh
Confidence 99876443 33455679999999999998888765 999999999999999999997654 44555555444443332
Q ss_pred -cccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 244 -KYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 244 -~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
...+|+++++||.+||++||++|||+.|+++||||+..
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 24689999999999999999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-59 Score=411.39 Aligned_cols=252 Identities=29% Similarity=0.486 Sum_probs=209.2
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhH---HHhhhHHHHHHHHHhCC--CCCceeeeeEEEeCC
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRD---YMEKFAPREIDILLKVS--HPNIIGVHRMVKAGT 80 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~ 80 (351)
-.+|++.+.||+|+||+||+|.++.+|+.||+|++........ .....+.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4579999999999999999999999999999999976554321 11223448999999997 899999999999999
Q ss_pred EEEEEEecCCC-CChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-CCCe
Q psy6327 81 YLYMIMDYAEK-KDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-LLNA 158 (351)
Q Consensus 81 ~~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-~~~~ 158 (351)
..|+||||+.+ +++.+++.. ...+++..++. ++.||+.||+|||++||+||||||+|||++. ++.+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~----------~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE--RGALQEELARS----------FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHH----------HHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEE
T ss_pred eEEEEEEeccCcchHHHHHhc--cCCCCHHHHHH----------HHHHHHHHHHHHHHCCCccccCcccceEEecCCCeE
Confidence 99999999986 688888876 56778766554 5677888888999999999999999999985 4789
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
||+|||+|+..... ...+.+||+.|+|||++.+..++..++||||+||++|+|++|+.||... ..... ..
T Consensus 151 kl~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~i~~----~~ 220 (273)
T d1xwsa_ 151 KLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEIIR----GQ 220 (273)
T ss_dssp EECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHHH----CC
T ss_pred EECccccceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----hHHhh----cc
Confidence 99999999875432 3456789999999999988877666689999999999999999999642 12111 12
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
.. .+..+|+++++||.+||++||++|||++|+++||||++.
T Consensus 221 ~~--~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 221 VF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred cC--CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 22 234789999999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-58 Score=406.78 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=208.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||+||+|.++.+++.||||++....... +.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchH----HHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 46889999999999999999999999999999987544332 23558999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|||++|+|.+++.......+++... +.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~----------~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHH----------HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred ecccCcchHHHhhhccccchHHHHH----------HHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccce
Confidence 9999999999998755566676543 356788999999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
+....... ......||+.|+|||++.+..++.+ +||||+||++|+|++|..||.... .......... ..+..+.+.
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~-~~~~~~~~i~-~~~~~~~~~ 239 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLE-KDYRMERPE 239 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHH-TTCCCCCCT
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcc-hHHHHHHHHh-cCCCCCCCc
Confidence 97654433 2334568999999999998888765 999999999999999766654332 1233333322 233444555
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
.+|+++++||.+||+.||++|||++|+++
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 79999999999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.3e-58 Score=406.71 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=205.5
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|+++++||+|+||+||+|.++ +|+.||||++........ ..+.+.+|+.+|++++|||||++++++...+..+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGC-CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChH-HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 458999999999999999999986 789999999976544332 234456899999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
|||+.++.+..+... ...+++..++. ++.||+.||+|||++||+||||||+|||++.++.+||+|||.
T Consensus 79 ~e~~~~~~~~~~~~~--~~~l~~~~~~~----------i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVC--EGGLESVTAKS----------FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EECCSEEHHHHHHTS--TTCCCHHHHHH----------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEeehhhhHHHHHhh--cCCcchhhhHH----------HHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEeccccc
Confidence 999987777666654 56778776554 677888888899999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC---c-----
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---K----- 237 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~----- 237 (351)
+.....+........|++.|+|||.+.+..+.+.++||||+||++|+|++|+.||.+.+ ..+....+.. .
T Consensus 147 a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 147 ARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp HHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTT
T ss_pred ceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCChhh
Confidence 98876655555667799999999999876665566999999999999999999997644 2222211100 0
Q ss_pred --------c-----------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 238 --------E-----------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 238 --------~-----------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
. ........++++++|||.+||++||++|||++|+|+||||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0 000112357889999999999999999999999999999973
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-57 Score=405.71 Aligned_cols=263 Identities=24% Similarity=0.400 Sum_probs=205.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCC-ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC---CCCCceeeeeEEEe---
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRS-ETLKACKAYDFKRLKRDYMEKFAPREIDILLKV---SHPNIIGVHRMVKA--- 78 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~--- 78 (351)
..+|+++++||+|+||+||+|.+..+ ++.||+|++......... ...+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 35799999999999999999999765 678999998765443322 22334788877766 79999999999853
Q ss_pred --CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 79 --GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 79 --~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
...++++|||++++.+.... ......+++..++ .++.|++.||+|||++||+||||||+|||++..+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~----------~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIK----------DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred ccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHH----------HHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC
Confidence 35789999999866655443 3335667766544 3677888899999999999999999999999999
Q ss_pred CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC
Q psy6327 157 NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 236 (351)
.+||+|||+++..... ......+||+.|+|||++.+.+++.+ +||||+||++|+|++|++||.+.+ ..+.+..+..
T Consensus 154 ~~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~ 229 (305)
T d1blxa_ 154 QIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILD 229 (305)
T ss_dssp CEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHH
T ss_pred Ceeecchhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCC--HHHHHHHHHH
Confidence 9999999999865433 34456789999999999999988875 999999999999999999997654 2222221100
Q ss_pred -------------------------ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCCccc
Q psy6327 237 -------------------------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNEPTC 284 (351)
Q Consensus 237 -------------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 284 (351)
..........+++.+++||.+||++||++|||+.|+|+||||++...|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 000111123578999999999999999999999999999999876554
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-57 Score=402.00 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=203.3
Q ss_pred ccc-eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC----
Q psy6327 6 ILE-CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT---- 80 (351)
Q Consensus 6 ~~~-~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~---- 80 (351)
+.+ |++.+.||+|+||+||+|.+..+|+.||+|++......+......+.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 444 999999999999999999999999999999997766655555566779999999999999999999987543
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
..|+|||||+|++|.+++.. .+.+++..+. .++.||+.||+|||++||+||||||+|||++.++.++|
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~----------~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT--EGPMTPKRAI----------EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH--HCSCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEE
T ss_pred eEEEEEECCCCCEehhhhcc--cCCCCHHHHH----------HHHHHHHHHHHHHHhCCccCccccCcccccCcccccee
Confidence 58999999999999999977 5677776544 46778888889999999999999999999999999999
Q ss_pred eeccccccccCCc---ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc
Q psy6327 161 ADFGFSRLLRTPK---ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+|||.+....... ......+||+.|+|||++.+..++.+ +||||+||++|+|++|++||.+.+ ..+........
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~~~~~ 229 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVRE 229 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHC
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcC--HHHHHHHHHhc
Confidence 9999987654332 23456689999999999998888765 999999999999999999997654 33333222222
Q ss_pred cc--cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q psy6327 238 EY--LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQ 279 (351)
Q Consensus 238 ~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 279 (351)
.+ .......+|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus 230 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 22 2233457899999999999999999999544444566653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=405.67 Aligned_cols=264 Identities=22% Similarity=0.357 Sum_probs=202.1
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-----
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA----- 78 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----- 78 (351)
.++.+|+++++||+|+||+||+|.++.+|+.||||++........ ....+.+|+.+|++++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS-SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 467889999999999999999999999999999999876554332 23334589999999999999999999854
Q ss_pred ---CCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 79 ---GTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 79 ---~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
...+|+|||||.++.+..+... ...+++...+ .++.|++.||+|||++||+||||||+|||++.+
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~----------~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~ 153 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIK----------RVMQMLLNGLYYIHRNKILHRDMKAANVLITRD 153 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCT--TCCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred cccCceEEEEEeccCCCccchhhhc--ccccccHHHH----------HHHHHHHHHHHHhccCCEEecCcCchheeecCC
Confidence 3468999999987766554433 4566665544 367788889999999999999999999999999
Q ss_pred CCeEEeeccccccccCCc----ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q psy6327 156 LNAKLADFGFSRLLRTPK----ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVL 231 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 231 (351)
+.+||+|||+++...... ....+.+||+.|+|||++.+......++||||+||++|+|++|+.||.+.. .....
T Consensus 154 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--~~~~~ 231 (318)
T d3blha1 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQL 231 (318)
T ss_dssp SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHH
T ss_pred CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--HHHHH
Confidence 999999999998765322 223456799999999998876544445999999999999999999997543 22222
Q ss_pred HhhhCcccccc------------------------------ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 232 KKQEGKEYLFN------------------------------RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 232 ~~~~~~~~~~~------------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..+......++ .....++++.|||.+||++||++|||++|+|+||||+..
T Consensus 232 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp HHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred HHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 11100000000 001247788999999999999999999999999999865
Q ss_pred c
Q psy6327 282 P 282 (351)
Q Consensus 282 ~ 282 (351)
+
T Consensus 312 p 312 (318)
T d3blha1 312 P 312 (318)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-57 Score=408.93 Aligned_cols=263 Identities=20% Similarity=0.334 Sum_probs=206.3
Q ss_pred cceeeeeecCcccceEEEEEEecCCc-----eeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSE-----TLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.+|++.++||+|+||+||+|.+..++ ..||+|.+...... .....+.+|+.+|.++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 46899999999999999999987554 36899987544322 2234456899999998 8999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHH------------HHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQAR------------IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCE 148 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~------------~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~ 148 (351)
.+|+|||||+||+|.+++.+.. ..+++.... .-......++.++.||+.||+|||+++|+||||||+
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKR-EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT-TCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred eEEEEEEcCCCCcHHHHHHhcc-CCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 9999999999999999997642 121111100 001123456678999999999999999999999999
Q ss_pred CEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCC
Q psy6327 149 NILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGT 225 (351)
Q Consensus 149 NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 225 (351)
|||++.++.+||+|||+|+....... ...+..||+.|||||++.+..++.+ +|||||||++|||++ |.+||.+...
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987654433 2345678999999999998888765 999999999999997 8999976553
Q ss_pred CchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 226 RNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
. ..+.......+.++.+..+|+++++||.+||+.||++|||++||++|
T Consensus 273 ~--~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 D--ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp S--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H--HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2 22333333334455556899999999999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-56 Score=401.50 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=196.0
Q ss_pred ccceeeeeecCcccceEEEEEEecCCce---eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSET---LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYL 82 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 82 (351)
..+|++.++||+|+||+||+|.++.+++ .||+|.+....... ..+.+.+|+.+|++++|||||++++++.+++.+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH--HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 4679999999999999999999887664 58888875433222 234456999999999999999999999999999
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
|+|||||+||+|.+++... ...+++.. ++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~-~~~l~~~~----------~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~D 171 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQN-DGQFTVIQ----------LVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSD 171 (299)
T ss_dssp EEEEECCTTEEHHHHHHTT-TTCSCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred EEEEEecCCCcceeeeccc-cCCCCHHH----------HHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECC
Confidence 9999999999999988753 34566544 345788899999999999999999999999999999999999
Q ss_pred ccccccccCCccc-----ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhC
Q psy6327 163 FGFSRLLRTPKEL-----SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEG 236 (351)
Q Consensus 163 fg~a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 236 (351)
||+|+........ .....||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.. ..+....+..
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~--~~~~~~~i~~ 248 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMT--NQDVINAIEQ 248 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHT
T ss_pred cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCC--HHHHHHHHHc
Confidence 9999876543221 123457999999999998888765 999999999999998 899997654 3444444433
Q ss_pred ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 237 KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
....+.+..++.++.+||.+||+.||++|||+.|++++
T Consensus 249 -~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 249 -DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 23344556799999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-57 Score=397.36 Aligned_cols=253 Identities=22% Similarity=0.378 Sum_probs=195.7
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
-.+|++.+.||+|+||+||+|... ..||||++......... .+.+.+|+.+|++++|||||++++++.+ ..+++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTH-HHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHH-HHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 357999999999999999999764 35999998765544433 3455689999999999999999998754 458999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
||||+||+|.+++... ...+++.. ++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 82 ~Ey~~~g~L~~~l~~~-~~~~~~~~----------~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII-ETKFEMIK----------LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp EECCCEEEHHHHHHTS-CCCCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred EecCCCCCHHHHHhhc-cCCCCHHH----------HHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccc
Confidence 9999999999999753 34566544 345788999999999999999999999999999999999999999
Q ss_pred cccccCCc--ccccccccccceeccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--cc
Q psy6327 166 SRLLRTPK--ELSNTFCGTTSYAAPEIIRNS---PYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG--KE 238 (351)
Q Consensus 166 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~ 238 (351)
|+...... ....+..||+.|+|||++.+. .++. ++|||||||++|||+||+.||.+.............. .+
T Consensus 151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~-~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p 229 (276)
T d1uwha_ 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF-QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229 (276)
T ss_dssp SCC------------CCCCGGGCCHHHHTTCSSCCCCH-HHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC
T ss_pred eeeccccCCcccccccccCcccCCHHHHhcccCCCCCc-hhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 98765332 233466899999999998643 3444 4999999999999999999998654322211111111 11
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
........+|+++++||.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1122344689999999999999999999999999876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-56 Score=395.59 Aligned_cols=262 Identities=23% Similarity=0.417 Sum_probs=214.2
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
+.+|+++++||+|+||+||+|+++.+++.||||++........ ....+.+|+.+|+.++||||+++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT-HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH-HHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 3579999999999999999999999999999999966544332 234455999999999999999999999999999999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
++++.|++|..++.. .+.+++..++ .++.|++.||+|||++||+||||||+|||++.++.+||+|||.
T Consensus 80 ~~~~~~~~l~~~~~~--~~~~~~~~~~----------~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 80 FEFCDQDLKKYFDSC--NGDLDPEIVK----------SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EECCSEEHHHHHHHT--TTCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred eeecccccccccccc--ccccchhHHH----------HHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecch
Confidence 999999999888865 5677766544 4677888888999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh---C------
Q psy6327 166 SRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE---G------ 236 (351)
Q Consensus 166 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~------ 236 (351)
++.............+++.|+|||++....+.+.++||||+||++|+|++|+.||..... ..+...... .
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTT
T ss_pred hhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-HHHHHHHHHhhcCCCChhh
Confidence 998776665666667899999999988777655569999999999999999999754332 222221110 0
Q ss_pred ------------------ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 237 ------------------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 237 ------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..........+++.+++||.+||++||.+|||++|+|+||||++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 000111123568899999999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-56 Score=389.61 Aligned_cols=251 Identities=21% Similarity=0.343 Sum_probs=211.3
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
|..+|+++++||+|+||+||+|.++ +++.||||++....... +.+.+|+.++++++||||+++++++.+++.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 4578999999999999999999985 78899999987655443 235599999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
||||+++|+|.+++... ...+++... +.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 77 v~Ey~~~g~l~~~~~~~-~~~~~~~~~----------~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG 145 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREM-RHRFQTQQL----------LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 145 (258)
T ss_dssp EEECCTTEEHHHHHHSG-GGCCCHHHH----------HHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEccCCCcHHHhhhcc-ccCCcHHHH----------HHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcch
Confidence 99999999999997653 344555433 3578889999999999999999999999999999999999999
Q ss_pred ccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
+++....... ......||+.|+|||++.+..++.+ +|||||||++|||+| |+.||...+ ..+....+... ...+
T Consensus 146 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~--~~~~~~~i~~~-~~~~ 221 (258)
T d1k2pa_ 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQG-LRLY 221 (258)
T ss_dssp SCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSC--HHHHHHHHHTT-CCCC
T ss_pred hheeccCCCceeecccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCC--HHHHHHHHHhC-CCCC
Confidence 9987654433 2334678999999999998888865 999999999999998 899997665 44555555443 3344
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.+..+++++.+||.+||+.||++|||++++++|
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 555789999999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=395.99 Aligned_cols=254 Identities=22% Similarity=0.394 Sum_probs=205.7
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (351)
.+|++.+.||+|+||.||+|.++ ++..||||++....... +.+.+|+.+|++++|||||++++++.+ +..|+||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH----HHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 57999999999999999999976 57889999987544332 335699999999999999999998865 4579999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecccc
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGFS 166 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a 166 (351)
|||++|+|.+++.......+++.. ++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~----------~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINK----------LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHH----------HHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccce
Confidence 999999999988665444555544 4457888999999999999999999999999999999999999999
Q ss_pred ccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccccccc
Q psy6327 167 RLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRKY 245 (351)
Q Consensus 167 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (351)
+....... ......||+.|+|||++.+..++.+ +|||||||++|||+||..|+.... ...+........ ...+.+.
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~-~~~~~~~~i~~~-~~~~~p~ 233 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERG-YRMVRPD 233 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTT-CCCCCCT
T ss_pred EEccCCccccccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhc-CCCCCcc
Confidence 98754432 3345679999999999998888765 999999999999999655543322 233444444332 2333445
Q ss_pred cCCHhHHHHHHHhcCCCCCCCCCHHHHhc--Ccccc
Q psy6327 246 EISIGAKQLIGRMLEPNPKHRPNAKDVQN--HAWIQ 279 (351)
Q Consensus 246 ~~s~~~~~li~~~L~~dp~~Rpt~~ell~--hp~~~ 279 (351)
.+++++.+||.+||+.||++|||++++++ |+||.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 79999999999999999999999999988 77774
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=393.06 Aligned_cols=251 Identities=21% Similarity=0.398 Sum_probs=195.3
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
|..+|++++.||+|+||+||+|.++ ++..||||++....... +.+.+|+.++++++|||||++++++..++..|+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 4568999999999999999999976 56789999987544433 335589999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||||++|+|.+++... ...+++.. ++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 78 v~E~~~~g~L~~~l~~~-~~~~~~~~----------~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFG 146 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQ-RGLFAAET----------LLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG 146 (263)
T ss_dssp EEECCTTCBHHHHHHTT-TTCCCHHH----------HHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred EEEecCCCcHHHHhhcc-ccCCCHHH----------HHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccc
Confidence 99999999999998753 34455544 34578889999999999999999999999999999999999999
Q ss_pred ccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 165 FSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 165 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
+++....... ......||+.|+|||++.+..++.+ +|||||||++|||+|+ .+||.... ..+....+... ....
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~-~~~~ 222 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTG-FRLY 222 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHHT-CCCC
T ss_pred hheeccCCCceeecceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHhc-CCCC
Confidence 9987654433 2334678999999999998888865 9999999999999994 66665433 33344433322 2233
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.+..+++++.+||.+||+.||++|||++|+++|
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 344689999999999999999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-56 Score=405.99 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=200.5
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC------
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT------ 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------ 80 (351)
..|+++++||+|+||+||+|.++.+|+.||||++........ ..+.+.+|+.+|++++|||||++++++...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH-HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH-HHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 359999999999999999999999999999999975544333 3445569999999999999999999997654
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.+|+||||| |++|..+++. ..+++..++ .++.||+.||+|||++||+||||||+|||++.++.+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~----------~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQ----------FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHH----------HHHHHHHHHHHHHHhCCCcccccCcchhhccccccccc
Confidence 579999999 5788887754 567776654 46778888889999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC----
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG---- 236 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---- 236 (351)
+|||+|+..... ....+||+.|+|||++.+..+...++||||+||++|+|++|++||.+.+. .........
T Consensus 163 ~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 163 LDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTGT 237 (346)
T ss_dssp CCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCC
T ss_pred ccccceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh--HHHHHHHHhccCC
Confidence 999999875432 34567999999999998766555559999999999999999999976542 111111000
Q ss_pred -------------------------ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 237 -------------------------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 237 -------------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..........+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000011123578999999999999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-56 Score=393.85 Aligned_cols=253 Identities=21% Similarity=0.358 Sum_probs=200.3
Q ss_pred ceeee-eecCcccceEEEEEEec--CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q psy6327 8 ECSYI-SKLGEGAYGNVYLVSDK--RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYM 84 (351)
Q Consensus 8 ~~~~~-~~LG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (351)
.+.+. ++||+|+||+||+|.+. .+++.||||++........ ..+.+.+|+.+|++++|||||++++++.++. .|+
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~-~~l 84 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-LKDELLAEANVMQQLDNPYIVRMIGICEAES-WML 84 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH-HHHHHHHHHHHHHTCCCTTBCCEEEEEESSS-EEE
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH-HHHHHHHHHHHHHhCCCCCCceEEEEeccCC-EEE
Confidence 34443 46999999999999864 4678999999865543332 3345669999999999999999999997654 689
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeecc
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFG 164 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg 164 (351)
|||||++|+|.+++.+ ...+++... +.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 85 vmE~~~~g~L~~~l~~--~~~l~~~~~----------~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFG 152 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQ--NRHVKDKNI----------IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 152 (277)
T ss_dssp EEECCTTEEHHHHHHH--CTTCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EEEcCCCCcHHHHHhh--ccCCCHHHH----------HHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchh
Confidence 9999999999999986 566776543 4578889999999999999999999999999999999999999
Q ss_pred ccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccc
Q psy6327 165 FSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYL 240 (351)
Q Consensus 165 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (351)
+++....... ......||+.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+ ..+....+... ..
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~~~~i~~~-~~ 228 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKG-ER 228 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTT-CC
T ss_pred hhhhccccccccccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCC--HHHHHHHHHcC-CC
Confidence 9987654332 2234578999999999998888765 999999999999998 899998654 34444444332 23
Q ss_pred ccccccCCHhHHHHHHHhcCCCCCCCCCHHHH---hcCccc
Q psy6327 241 FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV---QNHAWI 278 (351)
Q Consensus 241 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el---l~hp~~ 278 (351)
.+.+..+|+++++||.+||+.||++|||++++ |+|+|+
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 34445789999999999999999999999998 456665
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-56 Score=404.78 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=200.5
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-----
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA----- 78 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----- 78 (351)
|...+|+.+++||+|+||+||+|.++.+|+.||||++..... ...+|+.+|++++||||+++++++..
T Consensus 17 ~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp CEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred cccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence 444579999999999999999999999999999999865432 22379999999999999999999843
Q ss_pred -CCEEEEEEecCCCCChHHHHH-hhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC
Q psy6327 79 -GTYLYMIMDYAEKKDLEHYIS-KACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL 156 (351)
Q Consensus 79 -~~~~~lv~e~~~ggsL~~~l~-~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~ 156 (351)
..++|+|||||+++.+..+.. ......+++..++. ++.||+.||+|||++||+||||||+|||++.++
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~----------i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~ 159 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL----------YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT 159 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHH----------HHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHH----------HHHHHHHHHHHHHhcCCcccCCCcceEEEecCC
Confidence 346899999998554333332 12245677766554 577788888899999999999999999999765
Q ss_pred -CeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh
Q psy6327 157 -NAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE 235 (351)
Q Consensus 157 -~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 235 (351)
.+||+|||+++..... ....+.+||+.|+|||++.+......++||||+||++|+|++|++||...+ ..+.+..+.
T Consensus 160 ~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~--~~~~l~~i~ 236 (350)
T d1q5ka_ 160 AVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEII 236 (350)
T ss_dssp CCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHH
T ss_pred CceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC--HHHHHHHHH
Confidence 8999999999876543 334556899999999998765544455999999999999999999997654 222221110
Q ss_pred C-----------------c----------cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 236 G-----------------K----------EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 236 ~-----------------~----------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. . .+.......+++++.+||.+||++||++|||+.|+|+||||+..
T Consensus 237 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0 0 00001123578999999999999999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=393.41 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=204.7
Q ss_pred cceeeeee-cCcccceEEEEEEecC--CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 7 LECSYISK-LGEGAYGNVYLVSDKR--SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 7 ~~~~~~~~-LG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
.+|.+... ||+|+||+||+|.++. ++..||||++...... ...+.+.+|+.+|++++|||||++++++.++ .+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH--HHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence 45777774 9999999999998753 4568999998644322 2234556999999999999999999999765 479
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+|||||+||+|.+++... ...+++... +.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 85 lvmE~~~~g~L~~~l~~~-~~~l~~~~~----------~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGK-REEIPVSNV----------AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp EEEECCTTEEHHHHHTTC-TTTSCHHHH----------HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred EEEEeCCCCcHHHHhhcc-ccCCCHHHH----------HHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccc
Confidence 999999999999998542 345666543 457888999999999999999999999999999999999999
Q ss_pred cccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccc
Q psy6327 164 GFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEY 239 (351)
Q Consensus 164 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 239 (351)
|+|+....... ......||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.. ..+....+....
T Consensus 154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i~~~~- 229 (285)
T d1u59a_ 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGK- 229 (285)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTC-
T ss_pred hhhhcccccccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-
Confidence 99987654332 2334568999999999998888765 999999999999998 999998755 344444443322
Q ss_pred cccccccCCHhHHHHHHHhcCCCCCCCCCHHHH---hcCcccc
Q psy6327 240 LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDV---QNHAWIQ 279 (351)
Q Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el---l~hp~~~ 279 (351)
..+.+..+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 230 ~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 234445799999999999999999999999887 5567663
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-56 Score=399.99 Aligned_cols=265 Identities=32% Similarity=0.506 Sum_probs=212.3
Q ss_pred CccceeeeeecCcccceEEEEEEe---cCCceeEEEEecchhhhhh-HHHhhhHHHHHHHHHhCCC-CCceeeeeEEEeC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSD---KRSETLKACKAYDFKRLKR-DYMEKFAPREIDILLKVSH-PNIIGVHRMVKAG 79 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~---~~~~~~~aiK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~ 79 (351)
.+.+|++++.||+|+||+||+|.+ +.+|+.||+|++....... ....+.+.+|+.++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 467899999999999999999987 4579999999987654321 1123344589999999976 8999999999999
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeE
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAK 159 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~k 159 (351)
...+++|||+.||+|.+++.. ...+++..+. .++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~----------~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQ--RERFTEHEVQ----------IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHH--HSCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred CceeeeeecccccHHHHHHHh--cccccHHHHH----------HHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEE
Confidence 999999999999999999987 4566665544 3567888888899999999999999999999999999
Q ss_pred EeeccccccccCCc-ccccccccccceeccccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCc
Q psy6327 160 LADFGFSRLLRTPK-ELSNTFCGTTSYAAPEIIRNSPY-NPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 160 l~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
|+|||+++.+.... ....+..|++.|+|||.+.+... ...++|||||||++|+|++|+.||...+.............
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~ 249 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence 99999998764332 33456789999999999876542 34459999999999999999999976553322221111111
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCC
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRP-----NAKDVQNHAWIQNE 281 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~ 281 (351)
....+.+..+|+++.+||.+||++||++|| |++|+++||||+..
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 222333447999999999999999999999 58999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=399.18 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=200.0
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC-----E
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT-----Y 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-----~ 81 (351)
.+|+++++||+|+||+||+|.++.+|+.||||++...... ...+.+.+|+.+|++|+||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh--HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 4599999999999999999999999999999998654322 22344558999999999999999999996543 3
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.|++ +|+.||+|.+++.. ..+++..++. ++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 86 ~~l~-~~~~~g~L~~~l~~---~~l~~~~i~~----------i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT---QHLSNDHICY----------FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH---CCCCHHHHHH----------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEE-EeecCCchhhhhhc---CCCCHHHHHH----------HHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEc
Confidence 4555 55668999999975 4677766544 67788888889999999999999999999999999999
Q ss_pred eccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhC--
Q psy6327 162 DFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEG-- 236 (351)
Q Consensus 162 Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-- 236 (351)
|||+|+....... .....+||+.|+|||++........++||||+||++|+|++|+.||.+... .+.......
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~~~~~~~~~~~ 229 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGIL 229 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHH
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH--HHHHHHHhhhc
Confidence 9999987644332 235567999999999987666555669999999999999999999976542 111111000
Q ss_pred --------------------------ccc-cccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 237 --------------------------KEY-LFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 237 --------------------------~~~-~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
... .......+|.++++||.+||++||++|||+.|+|+||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred cCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000 001123578899999999999999999999999999999854
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-55 Score=397.62 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=204.0
Q ss_pred CCCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEe--C
Q psy6327 3 FPDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKA--G 79 (351)
Q Consensus 3 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~--~ 79 (351)
+.+..+|+++++||+|+||+||+|.++.+|+.||+|++..... +.+.+|+.+|+.+. ||||+++++++.. .
T Consensus 31 ~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 31 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH------HHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 4466789999999999999999999999999999999864331 23458999999995 9999999999974 4
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCC-Ce
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLL-NA 158 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~-~~ 158 (351)
..+++|||||.+++|..+. +.+++..++ .++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~----------~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~v 169 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIR----------FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL 169 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT-----TSCCHHHHH----------HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred CceeEEEeecCCCcHHHHh-----cCCCHHHHH----------HHHHHHHHHHHHHhhcccccccccccceEEcCCCCee
Confidence 5699999999999987653 456766544 4678888999999999999999999999998655 59
Q ss_pred EEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH--hhhC
Q psy6327 159 KLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK--KQEG 236 (351)
Q Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~--~~~~ 236 (351)
||+|||+|+..... ......+||+.|+|||.+.+......++||||+||++|+|++|+.||............ ....
T Consensus 170 kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g 248 (328)
T d3bqca1 170 RLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248 (328)
T ss_dssp EECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred eecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHC
Confidence 99999999876543 33456679999999999887665445699999999999999999999754421111000 0000
Q ss_pred --------------------------------ccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 237 --------------------------------KEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 237 --------------------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
..........+|++++|||.+||++||++|||++|+|+||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp HHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred CchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 000011123478999999999999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=388.42 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=203.5
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (351)
..+|++.+.||+|+||+||+|.++.+ ..||||++....... +.+.+|+.++++++|||||++++++.++ ..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEecC-CeEEE
Confidence 36799999999999999999998765 569999987554432 3456999999999999999999998654 57899
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
||||++|+|..++.......+++.. ++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~----------~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQ----------LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EEecCCCchhhhhhhcccccchHHH----------HHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence 9999999999998765555666654 345788899999999999999999999999999999999999999
Q ss_pred cccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcccccccc
Q psy6327 166 SRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLFNRK 244 (351)
Q Consensus 166 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (351)
|+....... ......||+.|+|||++....++.+ +||||+||++|||++|..|+.... ...+....+.. ....+.+
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~-~~~~~~~~i~~-~~~~~~~ 236 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVER-GYRMPCP 236 (285)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHT-TCCCCCC
T ss_pred hhhccCCCceeeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHh-cCCCCCC
Confidence 987654332 3344679999999999998888765 999999999999999665554332 23334443332 2334455
Q ss_pred ccCCHhHHHHHHHhcCCCCCCCCCHHHHhc--CccccCCc
Q psy6327 245 YEISIGAKQLIGRMLEPNPKHRPNAKDVQN--HAWIQNEP 282 (351)
Q Consensus 245 ~~~s~~~~~li~~~L~~dp~~Rpt~~ell~--hp~~~~~~ 282 (351)
..+|+++++||.+||+.||++|||++++++ ++||....
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 689999999999999999999999999988 88887543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=385.67 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=196.8
Q ss_pred ccceeeeeecCcccceEEEEEEecCCc----eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSE----TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
..+|++.++||+|+||.||+|.++.++ ..||||++........ ...+.+|+.++++++|||||++++++.+...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH--HHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 456999999999999999999987654 5799999865433322 3345689999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++|||||.++++.+++... ...++... ++.++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~----------~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~ 152 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREK-DGEFSVLQ----------LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 152 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHT-TTCSCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEecccCcchhhhhcc-cccccHHH----------HHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEc
Confidence 99999999999999988753 34555543 34578899999999999999999999999999999999999
Q ss_pred eccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCcc
Q psy6327 162 DFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 162 Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|||++|..|+.... ...+........
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~- 229 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDG- 229 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTT-
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccC-CHHHHHHHHhcc-
Confidence 9999987654322 2234568999999999998888875 999999999999999655554322 234444444332
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...+.+..++..+.+||.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 334445578999999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=383.45 Aligned_cols=255 Identities=20% Similarity=0.311 Sum_probs=199.0
Q ss_pred CccceeeeeecCcccceEEEEEEecC-C--ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKR-S--ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~-~--~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
+..+|++++.||+|+||.||+|.+.. + ...||||++...........+.+.+|+.+|++++||||+++++++.+. .
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence 34679999999999999999998643 3 347899998766655544455667999999999999999999999765 5
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++|||||++|+|.+++... ...+++.. ++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~-~~~l~~~~----------~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKH-QGHFLLGT----------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHH-GGGSCHHH----------HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEEC
T ss_pred hheeeeeecCcchhhhhhcc-cCCCCHHH----------HHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeec
Confidence 78999999999999988753 34566544 34578889999999999999999999999999999999999
Q ss_pred eccccccccCCcc---cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 162 DFGFSRLLRTPKE---LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 162 Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|||++ |++||.+.+ ..+....+...
T Consensus 154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~--~~~~~~~i~~~ 230 (273)
T d1u46a_ 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKIDKE 230 (273)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTS
T ss_pred cchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcC--HHHHHHHHHhC
Confidence 9999998754432 2234567889999999998888765 999999999999998 899997654 55555666555
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
...++.+..+|+++++||.+||+.||++|||+.+|++
T Consensus 231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5555666689999999999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=382.81 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=193.4
Q ss_pred cceeeeeecCcccceEEEEEEecCC---ceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRS---ETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (351)
.+|++.+.||+|+||+||+|.+..+ +..||+|.+.... .......+.+|+.+|++++|||||++++++. ++.+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 4799999999999999999998654 4578888875433 2223445669999999999999999999996 45689
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+|||||++|+|.+++... ...+++.. ++.++.||+.||+|||+++|+||||||+||+++.++.+||+||
T Consensus 84 iv~E~~~~g~l~~~~~~~-~~~l~~~~----------~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR-KYSLDLAS----------LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred EEEEeccCCcHHhhhhcc-CCCCCHHH----------HHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccc
Confidence 999999999999987653 34566544 3457888999999999999999999999999999999999999
Q ss_pred cccccccCCcc-cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 164 GFSRLLRTPKE-LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 164 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
|+|+....... ......||+.|+|||++.+..++.+ +|||||||++|||++ |.+||.+.. ..+....+.... ..
T Consensus 153 G~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~--~~~~~~~i~~~~-~~ 228 (273)
T d1mp8a_ 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGE-RL 228 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTC-CC
T ss_pred hhheeccCCcceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCC-CC
Confidence 99987654332 3345668999999999998888765 999999999999998 899997655 334444433322 23
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
+.+..+|+++.+||.+||+.||++|||+.||++|
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4455799999999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=395.43 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=200.5
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeC-----CEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAG-----TYL 82 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~ 82 (351)
+|+++++||+|+||+||+|.++.+|+.||||++......... .+.+.+|+.+|++++|||||++++++... ...
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH-HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH-HHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 599999999999999999999999999999999765444333 33455999999999999999999998532 334
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEee
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLAD 162 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~D 162 (351)
+++++|+.||+|.+++.. +.+++..++ .++.||+.||+|||++||+||||||+|||++.++.+|++|
T Consensus 98 ~~i~~~~~gg~L~~~~~~---~~l~e~~~~----------~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~d 164 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC---QKLTDDHVQ----------FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 164 (348)
T ss_dssp CEEEEECCSEEHHHHHTT---CCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEEEEeecCCchhhhccc---ccccHHHHH----------HHHHHHHHHHHHHHhCCCcccccCCccccccccccccccc
Confidence 566677789999999864 567776654 4677888888999999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccc---
Q psy6327 163 FGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEY--- 239 (351)
Q Consensus 163 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--- 239 (351)
||++..... ...+..||+.|+|||++.+..+...++||||+||++|+|++|++||.+.+ .......+.....
T Consensus 165 fg~a~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 165 FGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPG 239 (348)
T ss_dssp C----CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCC
T ss_pred cchhcccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCC
Confidence 999976432 34556799999999998777665556999999999999999999997654 2211111100000
Q ss_pred --------------------c------ccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q psy6327 240 --------------------L------FNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQNE 281 (351)
Q Consensus 240 --------------------~------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 281 (351)
. ......++++++|||.+||+.||++|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0 00112578999999999999999999999999999999854
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=388.14 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=198.8
Q ss_pred CccceeeeeecCcccceEEEEEEecCCce----eEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSET----LKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT 80 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 80 (351)
...+|+++++||+|+||+||+|.+..+|+ .||+|.+...... ...+.+.+|+.++++++|||||++++++.++.
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 84 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST 84 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 34679999999999999999999988876 5777776532221 12344669999999999999999999998765
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
.++++||+.+|+|.+++... ...+++.. ++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 85 -~~~v~e~~~~~~l~~~~~~~-~~~~~~~~----------~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl 152 (317)
T d1xkka_ 85 -VQLITQLMPFGCLLDYVREH-KDNIGSQY----------LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 152 (317)
T ss_dssp -EEEEEECCTTCBHHHHHHHT-SSSCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEE
T ss_pred -eeEEEEeccCCccccccccc-ccCCCHHH----------HHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEe
Confidence 67788999999999988763 45566644 3457888999999999999999999999999999999999
Q ss_pred eeccccccccCCccc--ccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCc
Q psy6327 161 ADFGFSRLLRTPKEL--SNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGK 237 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 237 (351)
+|||+|+........ .....||+.|+|||++.+..++.+ +|||||||++|||+| |.+||.+... .+.......
T Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~- 228 (317)
T d1xkka_ 153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK- 228 (317)
T ss_dssp CCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHH-
T ss_pred eccccceecccccccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc-
Confidence 999999976543332 234568999999999998888765 999999999999998 8999976542 233333322
Q ss_pred cccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q psy6327 238 EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHA 276 (351)
Q Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 276 (351)
....+.+..+++++.+||.+||+.||++|||+.|+++|.
T Consensus 229 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 223344457899999999999999999999999999873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=391.04 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=192.1
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEE------eCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVK------AGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~------~~~ 80 (351)
.+|+++++||+|+||+||+|.++.+|+.||||++......... ...+.+|+.++++++|||||++++++. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~-~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHH-HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHH-HHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 5699999999999999999999999999999999765544333 345569999999999999999999995 347
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEE
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKL 160 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl 160 (351)
++|+|||||.++ +.+.+ ...+++..++ .++.||+.||+|||++||+||||||+|||++.++.+|+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~----~~~~~~~~i~----------~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVI----QMELDHERMS----------YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEEEEECCSEE-HHHHH----TSCCCHHHHH----------HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eeEEEEeccchH-HHHhh----hcCCCHHHHH----------HHHHHHHHHHHHhhhcccccccCCccccccccccceee
Confidence 899999999754 54544 2456665544 46778888899999999999999999999999999999
Q ss_pred eeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhh-----
Q psy6327 161 ADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQE----- 235 (351)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~----- 235 (351)
+|||+++..... ......+||+.|+|||++.+..++.+ +||||+||++|+|++|++||.+.+. ......+.
T Consensus 161 ~df~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~--~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 161 LDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGT 236 (355)
T ss_dssp CCCCC----------------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCC
T ss_pred echhhhhccccc-cccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCH--HHHHHHHHHhccC
Confidence 999998875443 33455679999999999999888876 9999999999999999999975541 11111100
Q ss_pred ------------------Ccc-----------------ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q psy6327 236 ------------------GKE-----------------YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNHAWIQN 280 (351)
Q Consensus 236 ------------------~~~-----------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 280 (351)
... .........|+++++||++||++||++|||++|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000 000001134678999999999999999999999999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=385.96 Aligned_cols=264 Identities=21% Similarity=0.322 Sum_probs=194.3
Q ss_pred cceeeeeecCcccceEEEEEEecC-----CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe-C
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKR-----SETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA-G 79 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~-~ 79 (351)
.+|++.++||+|+||.||+|.+.. +++.||+|++........ .+.+.+|+.++.++ +|+||+.+++++.. +
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~--~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHH--HHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 569999999999999999999754 457899999864433222 23344777777776 68999999998765 4
Q ss_pred CEEEEEEecCCCCChHHHHHhhccCCCchHHHH----HHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCC
Q psy6327 80 TYLYMIMDYAEKKDLEHYISKACNENIHENQAR----IWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRL 155 (351)
Q Consensus 80 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~----~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~ 155 (351)
..+++|||||++|+|.+++........+..... ........++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 578999999999999999976433222211110 0111234566788999999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCchHHHH
Q psy6327 156 LNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLK 232 (351)
Q Consensus 156 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~ 232 (351)
+.+||+|||+|+....... .....+||+.|+|||++.+..++.+ +||||+||++|||++| .+||.+.... .....
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~-~~~~~ 248 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKID-EEFCR 248 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCS-HHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCHH-HHHHH
Confidence 9999999999987654332 3345679999999999998888765 9999999999999986 5678665432 22222
Q ss_pred hhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 233 KQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
... .....+.+..+++++++||.+||+.||++|||+.|+++|
T Consensus 249 ~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHh-cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 222 222334445789999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-53 Score=381.88 Aligned_cols=262 Identities=21% Similarity=0.358 Sum_probs=205.8
Q ss_pred cceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|++++.||+|+||+||+|+++ .+++.||||++...... ...+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 46999999999999999999865 46789999998644322 234556699999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHH------------HHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCC
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIW------------IRQIANALEYLHEIANALEYLHEVGIVHRDIKCEN 149 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~------------~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~N 149 (351)
.++||||+.+|+|.+++................ ..+...++.++.|++.||+|||+++|+||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 999999999999999997632221111100000 01234577889999999999999999999999999
Q ss_pred EeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCC
Q psy6327 150 ILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKK-YPFGDPGTR 226 (351)
Q Consensus 150 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~ 226 (351)
||++.++.+||+|||+|+....... ...+.+||+.|+|||.+.+..++.+ +|||||||++|||++|. +||.+.+
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~p~~~~~-- 247 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMA-- 247 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCCCCCCCC--
Confidence 9999999999999999987644332 2345678999999999999888865 99999999999999985 6776544
Q ss_pred chHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 227 NRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..+......... ..+.+..+++++.+||.+||+.||++|||+.||++
T Consensus 248 ~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 444444444333 33344578999999999999999999999999964
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=382.39 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=201.4
Q ss_pred CccceeeeeecCcccceEEEEEEecCCcee--EEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCCE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETL--KACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~ 81 (351)
+..+|++.++||+|+||.||+|.++.++.. ||||.+.... .....+.+.+|+.+|+++ +|||||++++++.+++.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 456899999999999999999999988875 5666654222 222234456999999999 69999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhc--------------cCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCC
Q psy6327 82 LYMIMDYAEKKDLEHYISKAC--------------NENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKC 147 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp 147 (351)
.|+||||++||+|.+++.... ...+++ ...+.++.||+.||.|||+++|+||||||
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~----------~~~~~~~~qia~gl~~lH~~~iiHrDlkp 155 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS----------QQLLHFAADVARGMDYLSQKQFIHRDLAA 155 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCH----------HHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCH----------HHHHHHHHHHHHHHHhhhcCCcccccccc
Confidence 999999999999999997531 133333 33456788999999999999999999999
Q ss_pred CCEeEcCCCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCC
Q psy6327 148 ENILISRLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKK-YPFGDPGTR 226 (351)
Q Consensus 148 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~ 226 (351)
+|||++.++.+||+|||+++..... .......||+.|+|||.+.+..++.+ +|||||||++|||++|. +||.+.+
T Consensus 156 ~NIL~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~-- 231 (309)
T d1fvra_ 156 RNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMT-- 231 (309)
T ss_dssp GGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred ceEEEcCCCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCC--
Confidence 9999999999999999999865432 22335568999999999998888765 99999999999999965 5675543
Q ss_pred chHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 227 NRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..+....+.. ....+.+..+++++++||.+||+.||++|||+.+++++
T Consensus 232 ~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 232 CAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHh-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4444444332 23344555799999999999999999999999999876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=373.20 Aligned_cols=247 Identities=21% Similarity=0.409 Sum_probs=194.4
Q ss_pred CccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-CCEEE
Q psy6327 5 DILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA-GTYLY 83 (351)
Q Consensus 5 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~ 83 (351)
++.+|++.++||+|+||.||+|.++ |..||+|++..+.. .+.+.+|+.++++++||||+++++++.+ .+.+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 4678999999999999999999884 78899999864432 2335589999999999999999998854 45689
Q ss_pred EEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeec
Q psy6327 84 MIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADF 163 (351)
Q Consensus 84 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Df 163 (351)
+||||+++|+|.+++.+.....+++.. ++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~----------~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDC----------LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHH----------HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHH----------HHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccc
Confidence 999999999999999764334455443 4457888999999999999999999999999999999999999
Q ss_pred cccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHhhhCcccccc
Q psy6327 164 GFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVLKKQEGKEYLFN 242 (351)
Q Consensus 164 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (351)
|+++..... .....+|+.|+|||++.+..++.+ +|||||||++|||+| |++||.... ..+....+.. ....+
T Consensus 148 g~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i~~-~~~~~ 220 (262)
T d1byga_ 148 GLTKEASST---QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEK-GYKMD 220 (262)
T ss_dssp CC---------------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHTT-TCCCC
T ss_pred ccceecCCC---CccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHc-CCCCC
Confidence 999865432 334568999999999988888765 999999999999998 788887654 3333333332 23334
Q ss_pred ccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 243 RKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 243 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
.+..+++++++||.+||+.||++|||+.+++++
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 455789999999999999999999999999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=372.51 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=200.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCc-------eeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEe
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSE-------TLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKA 78 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 78 (351)
.+|.+.+.||+|+||.||+|.+..++ ..||+|++........ ...+.+|+..+.++ +|||||++++++.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH--HHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 56889999999999999999876543 5799999865443322 23345888888888 79999999999999
Q ss_pred CCEEEEEEecCCCCChHHHHHhhcc--------------CCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceecc
Q psy6327 79 GTYLYMIMDYAEKKDLEHYISKACN--------------ENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRD 144 (351)
Q Consensus 79 ~~~~~lv~e~~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~D 144 (351)
+..+++|||||++|+|.+++..... ..+++. .++.++.||+.||+|||+++|+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~----------~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK----------DLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHH----------HHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHH----------HHHHHHHHHHHHHHHhhhCCEEeee
Confidence 9999999999999999999976421 234443 3456788999999999999999999
Q ss_pred CCCCCEeEcCCCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy6327 145 IKCENILISRLLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFG 221 (351)
Q Consensus 145 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 221 (351)
|||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..++.+ +|||||||++|+|++ |.+||.
T Consensus 161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCC
Confidence 999999999999999999999987754432 2345678999999999998888865 999999999999998 799997
Q ss_pred CCCCCchHHHHhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 222 DPGTRNRDVLKKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
+.. .......... ...++.+..+|+++.+||.+||+.||++|||+.|+++
T Consensus 240 ~~~--~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 240 GVP--VEELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TCC--HHHHHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC--HHHHHHHHHc-CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 654 3344444433 3344455679999999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=375.30 Aligned_cols=263 Identities=19% Similarity=0.329 Sum_probs=204.6
Q ss_pred cceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKV-SHPNIIGVHRMVKAGT 80 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 80 (351)
.+|++.++||+|+||.||+|.+. .+++.||||++........ ...+.+|+.+++.+ +|||||++++++.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH--HHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 56888999999999999999853 5678999999875443322 33455899999999 6999999999999999
Q ss_pred EEEEEEecCCCCChHHHHHhhccCCCchHHHHHH------HHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC
Q psy6327 81 YLYMIMDYAEKKDLEHYISKACNENIHENQARIW------IRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR 154 (351)
Q Consensus 81 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~------~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~ 154 (351)
..++|||||++|+|.+++................ ......++.++.||+.||+|||+++++||||||+|||++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 9999999999999999998744332221111000 0123456678999999999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q psy6327 155 LLNAKLADFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILN-KKYPFGDPGTRNRDVL 231 (351)
Q Consensus 155 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 231 (351)
++.+|++|||.++....... .....+||+.|+|||++.+..++.+ +|||||||++|+|++ |.+||..... . ..+
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~-~-~~~ 257 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPV-D-SKF 257 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCS-S-HHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCH-H-HHH
Confidence 99999999999997654332 2345679999999999998888765 999999999999999 5666654442 2 222
Q ss_pred HhhhCccccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 232 KKQEGKEYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
............+..+|.++.+||.+||+.||++|||+.||++
T Consensus 258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2222223333444578999999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=378.71 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=205.6
Q ss_pred cceeeeeecCcccceEEEEEEec-----CCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDK-----RSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGTY 81 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 81 (351)
.+|++.+.||+|+||.||+|.+. .++..||||++....... ....+.+|+.++++++||||+++++++..+..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH--HHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 67999999999999999999875 346889999986443222 23445699999999999999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEe
Q psy6327 82 LYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLA 161 (351)
Q Consensus 82 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~ 161 (351)
.++|||||++|+|.+++............ ........++.++.|++.||.|||+++|+||||||+|||++.++++||+
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPV--LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTT--CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccc--cCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 99999999999999998653111000000 0000123355688999999999999999999999999999999999999
Q ss_pred eccccccccCCcc--cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHhhhCcc
Q psy6327 162 DFGFSRLLRTPKE--LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNK-KYPFGDPGTRNRDVLKKQEGKE 238 (351)
Q Consensus 162 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~ 238 (351)
|||+|+....... ......||+.|+|||.+.+..++.+ +|||||||++|||++| .+||.+.+ ..+....+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~--~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLS--NEQVLRFVMEGG 252 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSC--HHHHHHHHHTTC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhCC
Confidence 9999987654333 2334578999999999998888765 9999999999999998 57786544 444454444332
Q ss_pred ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy6327 239 YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQN 274 (351)
Q Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 274 (351)
..+.+..+++.+.+||.+||+.||++|||+.++++
T Consensus 253 -~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33444578999999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=367.30 Aligned_cols=250 Identities=18% Similarity=0.269 Sum_probs=194.2
Q ss_pred eeeeecCcccceEEEEEEecCCc---eeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEe-CCEEEEE
Q psy6327 10 SYISKLGEGAYGNVYLVSDKRSE---TLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKA-GTYLYMI 85 (351)
Q Consensus 10 ~~~~~LG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~lv 85 (351)
.+-++||+|+||+||+|.+..++ ..||||.+.... .......+.+|+.+|++++||||+++++++.. ++..++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999986543 468999986322 22223456699999999999999999999765 5689999
Q ss_pred EecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcCCCCeEEeeccc
Q psy6327 86 MDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISRLLNAKLADFGF 165 (351)
Q Consensus 86 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~~~~~kl~Dfg~ 165 (351)
||||++|+|.+++... ....+.. .++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+
T Consensus 108 ~E~~~~g~l~~~~~~~-~~~~~~~----------~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~ 176 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-THNPTVK----------DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 176 (311)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHH----------HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred EEEeecCchhhhhccc-cccchHH----------HHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccc
Confidence 9999999999998753 2333332 2446788999999999999999999999999999999999999999
Q ss_pred cccccCCcc----cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHHhhhCccccc
Q psy6327 166 SRLLRTPKE----LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLKKQEGKEYLF 241 (351)
Q Consensus 166 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (351)
++....... ......||+.|+|||.+....++.+ +||||||+++|||++|..||..... ..+........ ...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~i~~g-~~~ 253 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQG-RRL 253 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTT-CCC
T ss_pred hhhccccccccceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcC-CCC
Confidence 987654322 2234568999999999998888765 9999999999999998888764332 22222222222 122
Q ss_pred cccccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 242 NRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 242 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3344789999999999999999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-50 Score=358.17 Aligned_cols=256 Identities=18% Similarity=0.197 Sum_probs=196.3
Q ss_pred ccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCC-ceeeeeEEEeCCEEEE
Q psy6327 6 ILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPN-IIGVHRMVKAGTYLYM 84 (351)
Q Consensus 6 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~~~~l 84 (351)
-.+|++++.||+|+||.||+|.+..+|+.||||++..+... ..+.+|+++++.++|+| |+.+..++.+++..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 34699999999999999999999999999999987654332 33458999999998665 5566677788999999
Q ss_pred EEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC---CCCeEEe
Q psy6327 85 IMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR---LLNAKLA 161 (351)
Q Consensus 85 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~---~~~~kl~ 161 (351)
||||+. ++|.+.+... ...+++..+ +.++.|++.||+|||++||+||||||+|||++. +..+||+
T Consensus 81 vme~~~-~~l~~~~~~~-~~~~~~~~~----------~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFC-SRKFSLKTV----------LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp EEECCC-CBHHHHHHHT-TTCCCHHHH----------HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred EEEEcC-Cchhhhhhhc-cCCCcHHHH----------HHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeee
Confidence 999995 7777766543 456666554 346788899999999999999999999999864 4579999
Q ss_pred eccccccccCCcc-------cccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchHHHH-h
Q psy6327 162 DFGFSRLLRTPKE-------LSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRDVLK-K 233 (351)
Q Consensus 162 Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~ 233 (351)
|||+|+....... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............ .
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~ 227 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence 9999997654322 2345679999999999998888765 99999999999999999999765432221111 1
Q ss_pred hhCc---cccccccccCCHhHHHHHHHhcCCCCCCCCCHHH---HhcCcccc
Q psy6327 234 QEGK---EYLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKD---VQNHAWIQ 279 (351)
Q Consensus 234 ~~~~---~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e---ll~hp~~~ 279 (351)
.... .........+|+++.+||.+||+.||++||++++ +|+|+|.+
T Consensus 228 ~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 228 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 1111 1111122368999999999999999999999874 56677654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=359.64 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=185.2
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCceeeeeEEEeCC----EE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNIIGVHRMVKAGT----YL 82 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----~~ 82 (351)
.+|.+.+.||+|+||.||+|++ +|+.||||++....... ...+.|+..+.+++|||||++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~----~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhH----HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4689999999999999999986 58999999986543322 22235666667889999999999987543 68
Q ss_pred EEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh--------CCceeccCCCCCEeEcC
Q psy6327 83 YMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE--------VGIVHRDIKCENILISR 154 (351)
Q Consensus 83 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~--------~~i~H~Dlkp~NIll~~ 154 (351)
|+|||||++|+|.+++++ ..++.... +.++.|++.||+|||+ +||+||||||+|||++.
T Consensus 77 ~lv~Ey~~~g~L~~~l~~---~~l~~~~~----------~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~ 143 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR---YTVTVEGM----------IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp EEEEECCTTCBHHHHHHH---CCBCHHHH----------HHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT
T ss_pred EEEEecccCCCHHHHHhc---CCCCHHHH----------HHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC
Confidence 999999999999999976 34555443 3467788888999996 69999999999999999
Q ss_pred CCCeEEeeccccccccCCcc----cccccccccceeccccccCCCCC-----CCcchHHHHHHHHHHHHhCCCCCCCCCC
Q psy6327 155 LLNAKLADFGFSRLLRTPKE----LSNTFCGTTSYAAPEIIRNSPYN-----PKLADIWSLGVVLYRILNKKYPFGDPGT 225 (351)
Q Consensus 155 ~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (351)
++.+||+|||+++....... .....+||+.|+|||++.+.... +.++|||||||++|||++|..||.....
T Consensus 144 ~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~ 223 (303)
T d1vjya_ 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccc
Confidence 99999999999987654432 23456899999999998765321 2248999999999999999988743221
Q ss_pred C------------chHHHHh-hhCccc--ccccc---ccCCHhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy6327 226 R------------NRDVLKK-QEGKEY--LFNRK---YEISIGAKQLIGRMLEPNPKHRPNAKDVQNH 275 (351)
Q Consensus 226 ~------------~~~~~~~-~~~~~~--~~~~~---~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 275 (351)
. ....... ...... ..+.. ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1 1111111 111111 11111 1233468899999999999999999999763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-49 Score=350.27 Aligned_cols=248 Identities=17% Similarity=0.192 Sum_probs=198.4
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCC-CCceeeeeEEEeCCEEEEEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSH-PNIIGVHRMVKAGTYLYMIM 86 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 86 (351)
+|++.++||+|+||+||+|.+..+|+.||+|++..... ...+++|+++++.|.| +|++.+++++..+...++||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 69999999999999999999999999999998754432 2334589999999975 89999999999999999999
Q ss_pred ecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEcC-----CCCeEEe
Q psy6327 87 DYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILISR-----LLNAKLA 161 (351)
Q Consensus 87 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~~-----~~~~kl~ 161 (351)
||+ |++|.+++... ...++.... +.++.|++.||+|||++||+||||||+|||++. .+.+||+
T Consensus 81 e~~-~~~l~~~~~~~-~~~~~~~~~----------~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 81 DLL-GPSLEDLLDLC-GRKFSVKTV----------AMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHH----------HHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred Eec-CCCHHHHHHhh-ccchhhHHH----------HHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEc
Confidence 999 69999998753 345665443 346788899999999999999999999999974 5679999
Q ss_pred eccccccccCCc-------ccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCchH-HHHh
Q psy6327 162 DFGFSRLLRTPK-------ELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTRNRD-VLKK 233 (351)
Q Consensus 162 Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~ 233 (351)
|||+|+...... ......+||+.|||||++.+..++.+ +|||||||++|+|++|+.||......... ....
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence 999998764332 12345689999999999998888765 99999999999999999999765543322 1111
Q ss_pred hhCcc---ccccccccCCHhHHHHHHHhcCCCCCCCCCHHHHh
Q psy6327 234 QEGKE---YLFNRKYEISIGAKQLIGRMLEPNPKHRPNAKDVQ 273 (351)
Q Consensus 234 ~~~~~---~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 273 (351)
..... ........+|+++.+++..|+..+|++||+++.+.
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 11111 11112236899999999999999999999987764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-47 Score=349.36 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=190.0
Q ss_pred ceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-----------CCCceeeeeEE
Q psy6327 8 ECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-----------HPNIIGVHRMV 76 (351)
Q Consensus 8 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hp~iv~~~~~~ 76 (351)
+|+++++||+|+||+||+|+++.+|+.||||++....... +...+|+.+++.++ |+||+++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~----~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHH----HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccch----HHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4999999999999999999999999999999997654332 23347888888775 57899999887
Q ss_pred E--eCCEEEEEEecCCCCC-hHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHh-CCceeccCCCCCEeE
Q psy6327 77 K--AGTYLYMIMDYAEKKD-LEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHE-VGIVHRDIKCENILI 152 (351)
Q Consensus 77 ~--~~~~~~lv~e~~~ggs-L~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~NIll 152 (351)
. .....+++++++..+. ............+++..++ .++.||+.||+|||+ .||+||||||+|||+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~----------~i~~qil~al~~lh~~~~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK----------QISKQLLLGLDYMHRRCGIIHTDIKPENVLM 159 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHH----------HHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHH----------HHHHHHHHHHHHHhhhcCcccccCChhHeee
Confidence 5 4456677777665443 3444444445566665543 467788888999998 899999999999999
Q ss_pred cCCCC------eEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q psy6327 153 SRLLN------AKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVVLYRILNKKYPFGDPGTR 226 (351)
Q Consensus 153 ~~~~~------~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (351)
+.++. ++++|||.+..... .....+||+.|+|||++.+..++.+ +|+||+||++++|++|+.||......
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC------
T ss_pred eccCcccccceeeEeeccccccccc---ccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccc
Confidence 86543 89999999986543 3355679999999999998888765 99999999999999999999644321
Q ss_pred c----hHHHHh---hhCc-----------------------c--------------ccccccccCCHhHHHHHHHhcCCC
Q psy6327 227 N----RDVLKK---QEGK-----------------------E--------------YLFNRKYEISIGAKQLIGRMLEPN 262 (351)
Q Consensus 227 ~----~~~~~~---~~~~-----------------------~--------------~~~~~~~~~s~~~~~li~~~L~~d 262 (351)
. .+.... .... . .........++++.|||.+||++|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 0 000000 0000 0 000011134678999999999999
Q ss_pred CCCCCCHHHHhcCccccCCc
Q psy6327 263 PKHRPNAKDVQNHAWIQNEP 282 (351)
Q Consensus 263 p~~Rpt~~ell~hp~~~~~~ 282 (351)
|.+|||++|+|+||||++..
T Consensus 316 P~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTCT
T ss_pred hhHCcCHHHHhcCcccCCCC
Confidence 99999999999999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.1e-26 Score=191.01 Aligned_cols=172 Identities=18% Similarity=0.073 Sum_probs=116.5
Q ss_pred eeeeeecCcccceEEEEEEecCCceeEEEEecchhhhh---------------hHHHhhhHHHHHHHHHhCCCCCceeee
Q psy6327 9 CSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLK---------------RDYMEKFAPREIDILLKVSHPNIIGVH 73 (351)
Q Consensus 9 ~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------------~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 73 (351)
+.+.++||+|+||+||+|.+. +|+.||+|++...... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457889999999999999885 6889999986532111 011122334789999999999999988
Q ss_pred eEEEeCCEEEEEEecCCCCChHHHHHhhccCCCchHHHHHHHHHHHHHHHHHHHHHHHHHHhHhCCceeccCCCCCEeEc
Q psy6327 74 RMVKAGTYLYMIMDYAEKKDLEHYISKACNENIHENQARIWIRQIANALEYLHEIANALEYLHEVGIVHRDIKCENILIS 153 (351)
Q Consensus 74 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~NIll~ 153 (351)
++.. .+++|||+++..+.++ +... +..++.|++.+|.|||++||+||||||+|||++
T Consensus 81 ~~~~----~~lvme~~~~~~~~~l---------~~~~----------~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~ 137 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYRV---------RVEN----------PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS 137 (191)
T ss_dssp EEET----TEEEEECCCCEEGGGC---------CCSC----------HHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred EecC----CEEEEEeeccccccch---------hhHH----------HHHHHHHHHHHHHHHhhCCEEEccCChhheeee
Confidence 7642 2799999997655332 2222 124678899999999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCcccccccccccceeccccccCCCCCCCcchHHHHHHH
Q psy6327 154 RLLNAKLADFGFSRLLRTPKELSNTFCGTTSYAAPEIIRNSPYNPKLADIWSLGVV 209 (351)
Q Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i 209 (351)
+++ ++|+|||.|.....+.... ....-...-.+ .....|+.. +|+||+.--
T Consensus 138 ~~~-~~liDFG~a~~~~~~~~~~--~l~rd~~~~~~-~f~r~y~~~-~d~~s~~~~ 188 (191)
T d1zara2 138 EEG-IWIIDFPQSVEVGEEGWRE--ILERDVRNIIT-YFSRTYRTE-KDINSAIDR 188 (191)
T ss_dssp TTE-EEECCCTTCEETTSTTHHH--HHHHHHHHHHH-HHHHHHCCC-CCHHHHHHH
T ss_pred CCC-EEEEECCCcccCCCCCcHH--HHHHHHHHHHH-HHcCCCCCc-ccHHHHHHH
Confidence 754 9999999997754332210 00000000001 113455655 899997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.63 E-value=2.5e-07 Score=78.30 Aligned_cols=87 Identities=13% Similarity=0.034 Sum_probs=61.4
Q ss_pred cceeeeeecCcccceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEE
Q psy6327 7 LECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 7 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv 85 (351)
..|++++..+.++.+.||+.. .++..+.+|......... ...+.+|..++..|. +-.+.+++.+...++..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 357777776666668899875 345567788765433222 223457888888774 44467888888889999999
Q ss_pred EecCCCCChHHHH
Q psy6327 86 MDYAEKKDLEHYI 98 (351)
Q Consensus 86 ~e~~~ggsL~~~l 98 (351)
|++++|.++.+..
T Consensus 89 ~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 89 MSEADGVLCSEEY 101 (263)
T ss_dssp EECCSSEEHHHHT
T ss_pred EEecccccccccc
Confidence 9999988876554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.16 E-value=6.8e-06 Score=73.62 Aligned_cols=88 Identities=14% Similarity=0.107 Sum_probs=49.8
Q ss_pred CCccceeeeeecCcccceEEEEEEecCCceeEEEEecchhhh-hhH---HHhhhHHHHHHHHHhCC-C--CCceeeeeEE
Q psy6327 4 PDILECSYISKLGEGAYGNVYLVSDKRSETLKACKAYDFKRL-KRD---YMEKFAPREIDILLKVS-H--PNIIGVHRMV 76 (351)
Q Consensus 4 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~---~~~~~~~~Ei~~l~~l~-h--p~iv~~~~~~ 76 (351)
++....+ ++.||.|....||++.+..+++.+++|.-..... ... ........|+..|+.+. + ..+++++.+.
T Consensus 24 ~~~~~l~-~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d 102 (392)
T d2pula1 24 PSKSTLT-CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD 102 (392)
T ss_dssp ----CCE-EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE
T ss_pred CCCCCee-EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc
Confidence 3333444 5568999999999999888888888886432111 000 01122336888887663 2 3456666553
Q ss_pred EeCCEEEEEEecCCCCCh
Q psy6327 77 KAGTYLYMIMDYAEKKDL 94 (351)
Q Consensus 77 ~~~~~~~lv~e~~~ggsL 94 (351)
....++|||++.+..+
T Consensus 103 --~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 103 --TEMAVTVMEDLSHLKI 118 (392)
T ss_dssp --TTTTEEEECCCTTSEE
T ss_pred --CCCCEEEEeccCCccc
Confidence 3345789999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.12 E-value=5.2e-06 Score=69.48 Aligned_cols=79 Identities=13% Similarity=0.045 Sum_probs=52.8
Q ss_pred eeeeeecCccc-ceEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC--CCCceeeeeEEEeCCEEEEE
Q psy6327 9 CSYISKLGEGA-YGNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS--HPNIIGVHRMVKAGTYLYMI 85 (351)
Q Consensus 9 ~~~~~~LG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~~~~lv 85 (351)
+++. .+..|. -+.||+... .++..+.+|...... ...+..|+..++.|. .-.+.+++.+..+++..++|
T Consensus 13 ~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 13 YDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 4443 344444 468998865 456667888754332 223447888888774 33467788888888899999
Q ss_pred EecCCCCChH
Q psy6327 86 MDYAEKKDLE 95 (351)
Q Consensus 86 ~e~~~ggsL~ 95 (351)
|++++|.++.
T Consensus 85 ~~~i~G~~~~ 94 (255)
T d1nd4a_ 85 LGEVPGQDLL 94 (255)
T ss_dssp EECCSSEETT
T ss_pred EEeeeccccc
Confidence 9999987653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.33 E-value=0.00028 Score=62.74 Aligned_cols=74 Identities=14% Similarity=0.071 Sum_probs=49.4
Q ss_pred eeecCcccceEEEEEEecC-------CceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCC-CCCceeeeeEEEeCCEEE
Q psy6327 12 ISKLGEGAYGNVYLVSDKR-------SETLKACKAYDFKRLKRDYMEKFAPREIDILLKVS-HPNIIGVHRMVKAGTYLY 83 (351)
Q Consensus 12 ~~~LG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~ 83 (351)
++.|+.|-.-.+|++.... ..+.+.+++..... . . . ...+|..+++.+. +.-..++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~-~-i-dr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T-E-S-HLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C-H-H-HHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h-h-h-HHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 5678889999999987542 34567777764211 1 1 1 2337899998885 4334578887753 5
Q ss_pred EEEecCCCCCh
Q psy6327 84 MIMDYAEKKDL 94 (351)
Q Consensus 84 lv~e~~~ggsL 94 (351)
+|+||++|.+|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999997554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.03 E-value=0.00055 Score=59.10 Aligned_cols=68 Identities=13% Similarity=0.248 Sum_probs=42.7
Q ss_pred eEEEEEEecCCceeEEEEecchhhhhhHHHhhhHHHHHHHHHhCCCCCc--e---ee--eeEEEeCCEEEEEEecCCCCC
Q psy6327 21 GNVYLVSDKRSETLKACKAYDFKRLKRDYMEKFAPREIDILLKVSHPNI--I---GV--HRMVKAGTYLYMIMDYAEKKD 93 (351)
Q Consensus 21 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i--v---~~--~~~~~~~~~~~lv~e~~~ggs 93 (351)
-.||++.. .+|..+++|+......+... +..|+..+..|...++ + .. -..+..++..+.+++++.|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~----i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQ----ILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHH----HHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHH----HHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47998875 46888999987654333322 3368888777642211 1 11 123356778999999998643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.61 E-value=0.0026 Score=54.26 Aligned_cols=31 Identities=26% Similarity=0.363 Sum_probs=27.2
Q ss_pred CCceeccCCCCCEeEcCCCCeEEeecccccc
Q psy6327 138 VGIVHRDIKCENILISRLLNAKLADFGFSRL 168 (351)
Q Consensus 138 ~~i~H~Dlkp~NIll~~~~~~kl~Dfg~a~~ 168 (351)
.|+||+|+.++||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887678999998753
|